Citrus Sinensis ID: 006952

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620----
Protein Sequence
MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTMSPR
Secondary Structure (PSIPRED)
cEEEEEHHHHcccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccEEccccccccEEEEEEcccccccHHHHHHHHHHHHHHHHHcccccccEEEEcccEEEEEcccccccccccccEEEEEccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEEEccccccEEEEEEccccccHHHHHHHHHHHHHcccccccccccEEEEcccccEEEEccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHEEEEEEEEcccccccccccccccHHHHHHHHcccccccccccHHHHccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccEEcccccccccccccccccccccEEEEccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEEEccccHcccccccccccccccccccccHHHHHHHHHHHHcccccccccccEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEccEEEEEEEEccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHccccHcccccccccEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEEccccccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHccccHEEccHHHcccccHHHHHHHHHHHHHEccccccccccHHHEEEEEccccEEcccccccEEEEEccccccccccccccccccccEEcccccc
Coil and Loop (DISEMBL)
mlmlrtswdaeaevanpadyqykfcprgtnntASIIYVYNLSKLFNrklhedggnslyrnasvgdypdkVYGLFLCrfdvshqvCQNCIFDAIDILVEScngtkeatIWYDICMVRYSNNFFAttletspflcvqnenytkepdKFTQILNQTFNDVIRnatssdsknaaqtvnissfdtlqttahcipdlsksdctVCLNSAvaqiptcskgkrgarifcpscsIRYELYRFLvdtptvtvtapnktrKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKrkqeesqafplfpldLIDIVKATQDfsqenklgeggfgpvykgvlaDGKEIAVKRLsrtsgqglqeFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIyeympnksldvflfdstrsvqLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSnvlldhemnpkisdfgmarifggnqskantnrvvgtygymapeyamggiFSVKSDVFSFGVVLLEIISgkkstgfyhsehgpSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLcvqgdpidrptmSSVAVMLASdiltlpkptqpafslsRVVSAQfvshsedhcsvnaitlstmspr
Flexible Loop (DISEMBL)
mlmlrtswDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNAtssdsknaaqTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVaqiptcskgkrgarIFCPSCSIRYELYRFlvdtptvtvtapnktrkRWITIAEAASAIIVFLLSTSFLWCIIRRRNKrkqeesqafplfplDLIDIVKATQDFSqenklgeggfgpVYKGVLADGKEIAVKRLsrtsgqglqefKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIfggnqskantnrVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQfvshsedhcsvnaitlstmspr
Low Complexity Region (SEG)
MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTMSPR
Disordered region (IsUnstruct)
************EVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIR************TVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRR********QAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSH****CSV***********
Disordered Region (DISOPRED)
MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLV*******************IAEAASAIIVFLLSTSFLWCI******************PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF**********************ITLSTMSPR
Disordered Region (DISEMBL)
MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTMSPR
Disordered Region (DISPRO)
MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTP**********RKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRK*EESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRV**************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTMSPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	624	2.2.26 [Sep-21-2011]
Q8GYA4	669	Cysteine-rich receptor-li	yes	no	0.931	0.868	0.449	1e-149
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.932	0.862	0.443	1e-145
O65468	676	Cysteine-rich receptor-li	no	no	0.927	0.856	0.432	1e-141
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.913	0.845	0.427	1e-141
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.951	0.901	0.414	1e-141
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.913	0.909	0.436	1e-141
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.900	0.871	0.452	1e-136
O65479	666	Putative cysteine-rich re	no	no	0.975	0.914	0.427	1e-134
Q8H199	658	Cysteine-rich receptor-li	no	no	0.899	0.852	0.418	1e-129
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.905	0.844	0.414	1e-128

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  528 bits (1359), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 274/610 (44%), Positives = 379/610 (62%), Gaps = 29/610 (4%)

Query: 15  ANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDKVYGL 73
           A    Y Y  C    N T++  Y  NL  L       +   S  ++NA+VG  PD+V GL
Sbjct: 34  AQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGL 93

Query: 74  FLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSN-NFFATTLETSPFL 132
           F CR DVS +VC+ C+  A++  +  C   KEAT++YD C++RYSN N  +T + T   +
Sbjct: 94  FNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVI 153

Query: 133 CVQNENYT-KEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDL 191
            V   N T  + D  + ++  T N     A +S  K   +  N ++  +      C PDL
Sbjct: 154 LVNTRNVTSNQLDLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDL 213

Query: 192 SKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVT-------- 243
           ++ DC+ CL   + QIPT    + GARI  PSC+ RYE+Y F  ++              
Sbjct: 214 TRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTP 270

Query: 244 ---APNKTRKRWITIAEAASAIIVFLLSTSFL---WCIIRRRNKRKQEESQAFP------ 291
              AP ++ K   +     + ++  +++       +C + RR ++      AF       
Sbjct: 271 PVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTPSAFAGDDITT 330

Query: 292 --LFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK 349
                LD   I  AT DF + NK+G+GGFG VYKG L+DG E+AVKRLS++SGQG  EFK
Sbjct: 331 ADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFK 390

Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
           NEV ++AKLQH+NLVRLLG CL+  E +L+YEY+PNKSLD FLFD  +  QLDW RR  I
Sbjct: 391 NEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKI 450

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
           I G+ARGILYLH+DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +Q++ NT+R+
Sbjct: 451 IGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRI 510

Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
           VGTYGYM+PEYAM G +S+KSDV+SFGV++LEIISGKK++ FY ++    L++Y W LW 
Sbjct: 511 VGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWS 570

Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPT 589
            G   EL+D  + ++C + E+++ +HIGLLCVQ DP +RPT+S++ +ML S+ +TLP P 
Sbjct: 571 NGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPR 630

Query: 590 QPA-FSLSRV 598
           QP  F  SR+
Sbjct: 631 QPGLFFQSRI 640

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  515 bits (1326), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 272/613 (44%), Positives = 372/613 (60%), Gaps = 31/613 (5%)

Query: 14  VANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGG-NSLYRNASVGDYPD--KV 70
           V +   Y Y  CP  T  + +  Y+ NL  + +     +    SL+ NA+ G+  D  +V
Sbjct: 23  VTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRV 82

Query: 71  YGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSP 130
           YG+FLCR DVS ++C++C+  A +  ++ C   K A IWYD CMVRYSN      +   P
Sbjct: 83  YGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRP 142

Query: 131 FLCVQN-ENYTK-EPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCI 188
            + + N +N T+ +  +F + L     DV   A  S  K A +  N + F T+ +   C 
Sbjct: 143 GVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYSLVQCT 202

Query: 189 PDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDT---------PT 239
           PDL+  DC  CL   +  +P C     G R+  PSCS RYELY F  +T         P+
Sbjct: 203 PDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPS 262

Query: 240 VTVTAP------NKTRKRWITIAEAASAI---IVFLLSTSFLWCIIRRRNKRKQEESQAF 290
            TVTAP       K + + +T+   A A+   +  LL  +  W + RRRN +   E++  
Sbjct: 263 STVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDL 322

Query: 291 --------PLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG 342
                            I  AT  FS+ NKLG GGFG VYKG L  G+ +A+KRLS+ S 
Sbjct: 323 DEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGST 382

Query: 343 QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD 402
           QG +EFKNEV V+AKLQH+NL +LLG CL+  E +L+YE++PNKSLD FLFD+ +   LD
Sbjct: 383 QGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLD 442

Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
           W+RR  II+GIARGILYLH DSRL IIHRDLK SN+LLD +M+PKISDFGMARIFG +Q+
Sbjct: 443 WQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQT 502

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLA 522
           +ANT R+VGTYGYM+PEYA+ G +SVKSDV+SFGV++LE+I+GKK++ FY  +    L+ 
Sbjct: 503 QANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVT 562

Query: 523 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           Y+WKLW E    EL+D  ++ +    E+++ IHI LLCVQ D  +RP+M  + VM+ S  
Sbjct: 563 YVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFT 622

Query: 583 LTLPKPTQPAFSL 595
           +TLP P +  F L
Sbjct: 623 VTLPIPKRSGFLL 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  503 bits (1296), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 265/613 (43%), Positives = 373/613 (60%), Gaps = 34/613 (5%)

Query: 11  EAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDK 69
           +A   NP  Y    CP  T  +++  Y  NL  L +     +   S  ++N   G  PD+
Sbjct: 31  KASAQNPF-YLNHDCPNRTTYSSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDR 89

Query: 70  VYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETS 129
           V GLFLCR D+S +VC NC+  +++  +  C   +EA  +Y+ C++RYS+  F +T+   
Sbjct: 90  VTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYE 149

Query: 130 PFLCVQNEN----YTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTA 185
             L ++N N       + D+F  ++    N     A +S  K +     ++S  TL    
Sbjct: 150 GELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLV 209

Query: 186 HCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDT-------- 237
            C PDL++ DC  CL S++ ++      + GAR F PSC+ RYELY F  +T        
Sbjct: 210 QCTPDLARQDCFSCLTSSINRM--MPLFRIGARQFWPSCNSRYELYAFYNETAIGTPSPP 267

Query: 238 --------PTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQA 289
                   P  + + P K+    + +       ++  ++    +C + +R K+  + + A
Sbjct: 268 PLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIAL-VGYCFLAQRTKKTFDTASA 326

Query: 290 FPL---------FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRT 340
             +           LD   I  AT DF++ NK+G GGFG VYKG  ++GKE+AVKRLS+ 
Sbjct: 327 SEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKN 386

Query: 341 SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ 400
           S QG  EFK EV V+AKLQH+NLVRLLG  L+  E +L+YEYMPNKSLD  LFD T+  Q
Sbjct: 387 SRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQ 446

Query: 401 LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 460
           LDW +R +II GIARGILYLH+DSRL IIHRDLK SN+LLD ++NPKI+DFGMARIFG +
Sbjct: 447 LDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLD 506

Query: 461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL 520
           Q++ NT+R+VGTYGYMAPEYAM G FS+KSDV+SFGV++LEIISG+K++ F  S+    L
Sbjct: 507 QTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDL 566

Query: 521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
           L + W+LW    A +L+D ++  +C  +E+++ IHIGLLCVQ DP  RPT+S+V +ML S
Sbjct: 567 LTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTS 626

Query: 581 DILTLPKPTQPAF 593
           + +TLP P QP F
Sbjct: 627 NTVTLPVPRQPGF 639

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  503 bits (1294), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 262/613 (42%), Positives = 379/613 (61%), Gaps = 43/613 (7%)

Query: 20  YQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDKVYGLFLCRF 78
           Y   +CP  T  +++  Y  NL  L +     +   S  ++NA+ G  PD+V GLFLCR 
Sbjct: 29  YLNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNASYSTGFQNATAGKAPDRVTGLFLCRG 88

Query: 79  DVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSN-NFFATTLETSPFLCVQNE 137
           DVS +VC+NC+  +++  +  C   +EA  +Y+ C++RYS+ N  +T +       + N 
Sbjct: 89  DVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAITNEGEFILSNT 148

Query: 138 NY----TKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSK 193
           N      K+ D FT  ++ T ++    A +S  K       ++++  L     C PDL++
Sbjct: 149 NTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYGLLQCTPDLTR 208

Query: 194 SDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRF-------------------- 233
           +DC  CL S++  +   +  + GAR++ PSC+ RYELY F                    
Sbjct: 209 ADCLSCLQSSINGM---ALSRIGARLYWPSCTARYELYPFYNESAIETPPLPPPPPPPPP 265

Query: 234 ---LVDTPTVTVTA-PNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQA 289
              LV TP ++ ++ P K+    + +       ++  ++    +C + ++ K+  + + A
Sbjct: 266 RESLVSTPPISSSSLPGKSGNSTVLVVAVVVLAVLLFIAL-VGYCFLAKKKKKTFDTASA 324

Query: 290 FPL---------FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRT 340
             +           LD   I  AT DF++ NK+G GGFG VYKG  ++GKE+AVKRLS+ 
Sbjct: 325 SEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKN 384

Query: 341 SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ 400
           S QG  EFK EV V+AKLQH+NLVRLLG  L+  E +L+YEYMPNKSLD  LFD T+ +Q
Sbjct: 385 SRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQ 444

Query: 401 LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 460
           LDW +R +II GIARGILYLH+DSRL IIHRDLK SN+LLD ++NPKI+DFGMARIFG +
Sbjct: 445 LDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLD 504

Query: 461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL 520
           Q++ NT+R+VGTYGYMAPEYAM G FS+KSDV+SFGV++LEIISG+K++ F  S+    L
Sbjct: 505 QTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQDL 564

Query: 521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
           L + W+LW    A +L+D ++ ++C  +E+++ IHIGLLCVQ DP  RP +S+V +ML S
Sbjct: 565 LTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLTS 624

Query: 581 DILTLPKPTQPAF 593
           + +TLP P QP F
Sbjct: 625 NTVTLPVPRQPGF 637

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  501 bits (1289), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 263/635 (41%), Positives = 381/635 (60%), Gaps = 41/635 (6%)

Query: 24  FCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDKVYGLFLCRFDVSH 82
           +CP  T  +++  Y+ NL  L +     +   S  ++NA+VG   D+V GLFLCR DVS 
Sbjct: 32  YCPNATTYSSNSTYLTNLKTLLSSLSSRNASYSTGFQNATVGQALDRVTGLFLCRGDVSP 91

Query: 83  QVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSN-NFFATTLETSPFLCVQNENY-- 139
           +VC+NC+  A++     C   +EA  +Y+ C++RYS+ N  +T +       ++N N+  
Sbjct: 92  EVCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAITNEGEFILRNPNHIS 151

Query: 140 --TKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCT 197
               + ++FT ++    N +   A  +  K +     +++  T      C PDLS+ +C 
Sbjct: 152 PIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLVQCTPDLSRQNCM 211

Query: 198 VCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVT-------------- 243
            CL S++ ++P     + GAR F PSC+ RYELY F  +T   T                
Sbjct: 212 NCLTSSINRMPF---SRIGARQFWPSCNSRYELYDFYNETAIGTPPPPLPPLASPSLSDK 268

Query: 244 APNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKR--------KQEESQAFPLFPL 295
           + N        +     A+++F+      +C   +R K+         +++        L
Sbjct: 269 SGNSNVVVVAVVVPIIVAVLIFIAG----YCFFAKRAKKTYGTTPALDEDDKTTIESLQL 324

Query: 296 DLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           D   I  AT DFS+ NK+G GGFG VYKG  ++G E+AVKRLS+TS QG  EFKNEV V+
Sbjct: 325 DYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVV 384

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           A L+HKNLVR+LG  +E  E +L+YEY+ NKSLD FLFD  +  QL W +R  II GIAR
Sbjct: 385 ANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIAR 444

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GILYLH+DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +Q++ NT+R+VGTYGY
Sbjct: 445 GILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGY 504

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           M+PEYAM G FS+KSDV+SFGV++LEIISG+K+  F  ++    L+ + W+LW  G A +
Sbjct: 505 MSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALD 564

Query: 536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF-- 593
           L+D  +  SC ++E+++  HIGLLCVQ DP+ RP MS+++VML S+ + LP P QP F  
Sbjct: 565 LVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFV 624

Query: 594 ----SLSRVVSAQFVSHSEDHCSVNAITLSTMSPR 624
                 +R+ S Q  ++     S++  ++S + PR
Sbjct: 625 RSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  501 bits (1289), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 263/602 (43%), Positives = 366/602 (60%), Gaps = 32/602 (5%)

Query: 20  YQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDKVYGLFLCRF 78
           Y    CP  T  + +  Y+ NL  L +     +   S  +++A  G  PD+V GLFLCR 
Sbjct: 26  YIKHICPNTTTYSRNSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRG 85

Query: 79  DVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNEN 138
           DVS  VC+NC+  +I+  +  C   +++  +YD CM+RYS+    +TL         N N
Sbjct: 86  DVSPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGN 145

Query: 139 YT---KEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSD 195
            +    + ++F   ++ T N     A SS  K        ++  TL     C PDL++ D
Sbjct: 146 ISIDQNQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQD 205

Query: 196 CTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVT-------------- 241
           C  CL S++  +P     K G R    SC+ RYEL+ F  +T   T              
Sbjct: 206 CFSCLESSIKLMPLY---KTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPL 262

Query: 242 VTAPNKTRKRWITIAEAASAIIVFLLSTSFL---WCIIRRRNKRKQEESQAF-------P 291
           VT+P+   K W +     + ++  L++   L   +C  +R  K   + + AF        
Sbjct: 263 VTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRV-KNSSDNAPAFDGDDITTE 321

Query: 292 LFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNE 351
              LD   I  AT  FS+ NK+G+GGFG VYKG  ++G E+AVKRLS++SGQG  EFKNE
Sbjct: 322 SLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQGDTEFKNE 381

Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
           V V+AKLQH+NLVRLLG  +   E +L+YEYMPNKSLD FLFD  +  QLDW RR  +I 
Sbjct: 382 VVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWTRRYKVIG 441

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
           GIARGILYLH+DSRL IIHRDLK SN+LLD +MNPK++DFG+ARIFG +Q++ NT+R+VG
Sbjct: 442 GIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQENTSRIVG 501

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG 531
           T+GYMAPEYA+ G FSVKSDV+SFGV++LEIISGKK+  FY ++    L+ + W+LW  G
Sbjct: 502 TFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTHAWRLWSNG 561

Query: 532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQP 591
            A +L+D ++  +C ++E+++ IHI LLCVQ DP +RP +S++ +ML S+ +TLP P QP
Sbjct: 562 TALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTVTLPVPLQP 621

Query: 592 AF 593
            F
Sbjct: 622 GF 623

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  486 bits (1251), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 265/586 (45%), Positives = 359/586 (61%), Gaps = 24/586 (4%)

Query: 58  YRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRY 117
           ++ A+ G  PD+V GLFLCR DVS +VC++C+  A++  +  C   KE   +Y+ C++RY
Sbjct: 65  FQTATAGQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCLLRY 124

Query: 118 SNNFFATTLETSPFLCVQNEN--YTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNI 175
           SN     TL T   + +Q+     + + D+F  ++    N     A  S  K A + +++
Sbjct: 125 SNRNIVATLNTDGGMFMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARSFKKWAVRKIDL 184

Query: 176 SSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFL- 234
           ++  +L     C PDL + DC  CL   + Q+   +  K G RI  PSC+ RY+ Y F  
Sbjct: 185 NASQSLYGMVRCTPDLREQDCLDCLKIGINQV---TYDKIGGRILLPSCASRYDNYAFYN 241

Query: 235 ---VDTPTVTVTAPNKT-RKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAF 290
              V TP  +   P K      I IA      ++FLL  +     +R +NKR   E +  
Sbjct: 242 ESNVGTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFS--VRAKNKRTLNEKEPV 299

Query: 291 P----------LFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRT 340
                          D   I  AT  F   NKLG+GGFG VYKG L+ G ++AVKRLS+T
Sbjct: 300 AEDGNDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKT 359

Query: 341 SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ 400
           SGQG +EF+NEV V+AKLQH+NLV+LLG CLE  E +L+YE++PNKSLD FLFDST  ++
Sbjct: 360 SGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMK 419

Query: 401 LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 460
           LDW RR  II GIARGILYLH+DSRL IIHRDLK  N+LLD +MNPKI+DFGMARIFG +
Sbjct: 420 LDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMD 479

Query: 461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH-SEHGPS 519
           Q++A T RVVGTYGYM+PEYAM G FS+KSDV+SFGV++LEIISG K++  Y   E   +
Sbjct: 480 QTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGN 539

Query: 520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA 579
           L+ Y W+LW  G  +EL+D     +   +E+ + IHI LLCVQ D  DRPTMSS+  ML 
Sbjct: 540 LVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLT 599

Query: 580 SDILTLPKPTQPAFSL-SRVVSAQFVSHSEDHCSVNAITLSTMSPR 624
           + ++ L +P  P F   S+   A     S  HCSV+  +++ ++PR
Sbjct: 600 TSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 282/660 (42%), Positives = 383/660 (58%), Gaps = 51/660 (7%)

Query: 6   TSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVG 64
           TS+ A A+  NP  Y Y  C   T  +++  Y  NL  L +     +   S  ++NA+ G
Sbjct: 17  TSFTASAQ--NPF-YLYHNCSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAG 73

Query: 65  DYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFAT 124
             PD V GLFLCR +VS +VC++CI  +++  +  C   +EA  +Y+ CM+RYSN    +
Sbjct: 74  QAPDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILS 133

Query: 125 TLETSPFLCVQNEN--YTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQ 182
           TL T   + +QN     + + D+F  ++    N     A  S  + A    ++++  +L 
Sbjct: 134 TLNTDGGVFMQNARNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLY 193

Query: 183 TTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFL----VDTP 238
               C PDL++ DC  CL  ++ Q+   +  K G R F PSC+ RY+ Y F     V TP
Sbjct: 194 GMVQCTPDLTEQDCLDCLQQSINQV---TYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTP 250

Query: 239 TVTVTAPNKT-RKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPLFPL-- 295
             +   P K      I IA      ++FLL  +F      RR KRK+    A PLF +  
Sbjct: 251 QDSSPRPGKGGNSSVIVIAVVVPITVLFLLFVAFFSV---RRAKRKKTIG-AIPLFKVKR 306

Query: 296 --------------------------DLIDIVKATQDFSQENKLGEGGFGPVYKGVLADG 329
                                     D   IV AT  F   NKLG+GGFG VYKG    G
Sbjct: 307 KETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSG 366

Query: 330 KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD 389
            ++AVKRLS+ SGQG +EF+NEV V+AKLQH+NLV+LLG CLE  E +L+YE++PNKSLD
Sbjct: 367 VQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLD 426

Query: 390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
            FLFD T   QLDW RR  II GIARGILYLH+DSRL IIHRDLK  N+LLD +MNPK++
Sbjct: 427 YFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVA 486

Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFGMARIFG +Q++ANT RVVGTYGYMAPEYAM G FS+KSDV+SFGV++LEI+SG K++
Sbjct: 487 DFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNS 546

Query: 510 GFYHSEHGPS-LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDR 568
                +   S L+ Y W+LW  G  +EL+D     +   +E+ + IHI LLCVQ D  DR
Sbjct: 547 SLDQMDGSISNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDANDR 606

Query: 569 PTMSSVAVMLASDILTLPKPTQPAFSL-SRVVSAQFVSHSEDHC---SVNAITLSTMSPR 624
           PTMS++  ML +  + L  P  P F L S+   A+    S D     S++  ++++++PR
Sbjct: 607 PTMSAIVQMLTTSSIALAVPRPPGFFLRSKQEQAERACPSMDTSDLFSIDEASITSVAPR 666

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  463 bits (1191), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 254/607 (41%), Positives = 359/607 (59%), Gaps = 46/607 (7%)

Query: 58  YRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYD---ICM 114
           + N+S+G  PD+VY L +C       VC +CI  A ++L+++C    E   W +   +CM
Sbjct: 58  FYNSSIGQGPDRVYALGMCIEGAEPDVCSDCIEYASNLLLDTCLNQTEGLAWPEKRILCM 117

Query: 115 VRYSNNFFATTLETSPFLCVQN-ENYTKEPDKFTQILNQTFNDVIRNATSSDSKN---AA 170
           VRYSN+ F  +L+  P   + N ++ T    +F Q+  +    +I + TS  SK    AA
Sbjct: 118 VRYSNSSFFGSLKAEPHFYIHNVDDITSNLTEFDQVWEELARRMIASTTSPSSKRKYYAA 177

Query: 171 QTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYEL 230
               +++F  +     C PDLS  DC +CL  +V    TC  GK+G  ++  SC  R+EL
Sbjct: 178 DVAALTAFQIIYALMQCTPDLSLEDCHICLRQSVGDYETCCNGKQGGIVYRASCVFRWEL 237

Query: 231 YRF-----------------LVDTPTVTVTAPNKTRKRWITIAEA-------ASAIIVFL 266
           + F                     P VT TA   T+K  ITI+          + I+VFL
Sbjct: 238 FPFSEAFSRISLAPPPQSPAFPTLPAVTNTA---TKKGSITISIGIVWAIIIPTVIVVFL 294

Query: 267 LSTSFLWCIIRRRNKRKQEESQAFPL---FPLDLIDIVKATQDFSQENKLGEGGFGPVYK 323
           +  +  + + RRR K  Q  S    +      D   I  AT  FS+ N +G GGFG V+ 
Sbjct: 295 VLLALGFVVYRRR-KSYQGSSTDITITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFM 353

Query: 324 GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM 383
           GVL +G E+A+KRLS+ S QG +EFKNEV V+AKL H+NLV+LLG CLE  E +L+YE++
Sbjct: 354 GVL-NGTEVAIKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFV 412

Query: 384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE 443
           PNKSLD FLFD T+  QLDW +R +II+GI RGILYLH+DSRL IIHRDLK SN+LLD +
Sbjct: 413 PNKSLDYFLFDPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDAD 472

Query: 444 MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
           MNPKI+DFGMARIFG +QS ANT ++ GT GYM PEY   G FS +SDV+SFGV++LEII
Sbjct: 473 MNPKIADFGMARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEII 532

Query: 504 SGKKSTGFYHSEHG-PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ 562
            G+ +   + S+    +L+ Y W+LW      EL+D  + ++C+  E+ + IHI LLCVQ
Sbjct: 533 CGRNNRFIHQSDTTVENLVTYAWRLWRNDSPLELVDPTISENCETEEVTRCIHIALLCVQ 592

Query: 563 GDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVS-----HSEDHCSVNAIT 617
            +P DRP++S++ +ML ++   LP P QP F    ++S Q        +  +  ++N +T
Sbjct: 593 HNPTDRPSLSTINMMLINNSYVLPDPQQPGFFFP-IISNQERDGLDSMNRSNPQTINDVT 651

Query: 618 LSTMSPR 624
           ++   PR
Sbjct: 652 ITDFEPR 658

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  458 bits (1178), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 254/613 (41%), Positives = 355/613 (57%), Gaps = 48/613 (7%)

Query: 58  YRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRY 117
           + N+  G  P++V+   +C      + C +CI  A D + ESC    +A  W D CMVRY
Sbjct: 59  FFNSKFGQAPNRVFINGMCIPGTKPETCSDCIKGASDKISESCPNKTDAYTWPDCCMVRY 118

Query: 118 SNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDV-IRNATSSDSKN-------- 168
           SN  F+ +L   P   + +    ++      + ++ + ++ +R  T++   +        
Sbjct: 119 SNVSFSGSLVMEPSETLYHTGDIEDTGTNLTVFDRIWEELMLRTITAASLSSSNGSSFGQ 178

Query: 169 ---AAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCS 225
              AA+  ++++F T+     C PD+S  DC  CL ++V    +C +GK+G  +  PSC 
Sbjct: 179 KYFAAEVASLTTFQTMYAMMQCTPDVSSKDCEFCLKTSVGDYESCCRGKQGGAVIRPSCF 238

Query: 226 IRYELYRFLVDTPTVT----------------VTAP-----NKTRKRWITIAEAASAIIV 264
           +R++LY +      VT                +  P     N T K  I        +I+
Sbjct: 239 VRWDLYPYAGAFENVTFPPPPPQSLPQPPVSLIPPPVSDRANTTIKGIIVAIVVPIIVIL 298

Query: 265 FLLSTSFLWCIIRRRNKRKQEESQAFP------LFPLDLIDIVKATQDFSQENKLGEGGF 318
             L    + C  RR+   K  E QA                I  AT  FS  N +G GGF
Sbjct: 299 VSLVVLLVVC--RRKKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGF 356

Query: 319 GPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL 378
           G VY+G L+ G E+AVKRLS+TSGQG +EFKNE  +++KLQHKNLVRLLG CLE  E +L
Sbjct: 357 GEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKIL 416

Query: 379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV 438
           +YE++PNKSLD FLFD  +  +LDW RR +II GIARGILYLH+DSRL IIHRDLK SN+
Sbjct: 417 VYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNI 476

Query: 439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVV 498
           LLD +MNPKI+DFGMARIFG +QS+ANT R+ GT+GYM+PEYAM G FS+KSDV+SFGV+
Sbjct: 477 LLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVL 536

Query: 499 LLEIISGKKSTGFYH-SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG 557
           +LEIISGKK++ FY+  + G +L+ + W+LW  G   EL+D  + +S   +E  + IHI 
Sbjct: 537 VLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIA 596

Query: 558 LLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLS-RVVSAQFVSHSEDHC----- 611
           LLCVQ DP DRP + ++ +ML S   TL  P  P F LS R +    V ++E        
Sbjct: 597 LLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPG 656

Query: 612 SVNAITLSTMSPR 624
           S+N  +++   PR
Sbjct: 657 SINDASITEFYPR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	624
359477817	670	PREDICTED: cysteine-rich receptor-like p	0.963	0.897	0.520	1e-180
224076400	666	predicted protein [Populus trichocarpa]	0.969	0.908	0.529	1e-178
147776074	815	hypothetical protein VITISV_005300 [Viti	0.927	0.710	0.530	1e-178
255555021	686	ATP binding protein, putative [Ricinus c	0.985	0.896	0.491	1e-173
351721533	667	cysteine-rich protein precursor [Glycine	0.982	0.919	0.467	1e-161
359496581	666	PREDICTED: cysteine-rich receptor-like p	0.959	0.899	0.468	1e-158
224076491	627	predicted protein [Populus trichocarpa]	0.913	0.909	0.498	1e-158
255555035	671	ATP binding protein, putative [Ricinus c	0.939	0.873	0.465	1e-157
356575777	671	PREDICTED: cysteine-rich receptor-like p	0.959	0.892	0.465	1e-155
296088180	699	unnamed protein product [Vitis vinifera]	0.964	0.861	0.445	1e-155

>gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 341/655 (52%), Positives = 416/655 (63%), Gaps = 54/655 (8%)

Query: 17  PADYQ----YKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYG 72
           PA+YQ    Y FC    ++  S  +  NL  L +R L+ +GG S +     G+ PDKVYG
Sbjct: 23  PANYQPGFLYTFC-NNNSHAGSTKFQSNLGALLSRSLNNEGGISSFSMVYEGEDPDKVYG 81

Query: 73  LFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFL 132
           LFLCR DVS  +CQ+CI  A   +V+ C   KEA IWY+ C +RYSN  F + LE  P L
Sbjct: 82  LFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYNECFLRYSNRSFFSNLEMKPTL 141

Query: 133 CVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLS 192
            + N      PDKF Q L + F ++   ATSSD   A   V +S+F  L     C  DL 
Sbjct: 142 YMWNTQNASAPDKFDQKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYGIVQCTRDLR 201

Query: 193 KSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRF-LVDTPTVTVTAPN----- 246
            S C  CL+  V  IP   +GK+G R+  PSC IRYE+Y F  V+ P V    P+     
Sbjct: 202 MSYCRRCLDEVVGYIPNFMEGKQGGRVLAPSCYIRYEVYPFAAVEDPVVEAQVPSSISPR 261

Query: 247 --KTRK-RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEE----------------- 286
             K RK +WI    + S I+V      +   +IRRR     EE                 
Sbjct: 262 GRKGRKTKWIATGTSLSGIVVVAFCVYY---VIRRRKGADPEEKESKGDLCLLDLGGGRL 318

Query: 287 -----------------SQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADG 329
                            S+ FP+   D+  + +ATQ FS +NKLGEGGFGPVYKG L+DG
Sbjct: 319 DAEDYSSETLQGDMLAKSKEFPVIGFDI--VYEATQHFSNDNKLGEGGFGPVYKGTLSDG 376

Query: 330 KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD 389
           KEIAVKRLS TSGQGLQEFKNEV +IAKLQH+NLVRLLGCCLE NE LLIYEYMPNKSLD
Sbjct: 377 KEIAVKRLSSTSGQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLD 436

Query: 390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
            FLFDSTR ++LDWK R SII GIARGI YLHEDSRL+IIHRDLK SN+LLD +MNPKIS
Sbjct: 437 FFLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKIS 496

Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+ARIF G+++  NT ++VG+YGYMAPEYAM G++S KSDVFSFGVVLLEII+G+K+ 
Sbjct: 497 DFGLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNA 556

Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
           GF+ S  G SLL+Y W+LW EG   ELMD ++  SC   E L+  HIGLLCVQ D  DRP
Sbjct: 557 GFHLSGMGLSLLSYAWQLWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRP 616

Query: 570 TMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTMSPR 624
           TMSSV +ML S+ LTL +P +PAFS+ R  + Q ++ S    SVN +T ST  PR
Sbjct: 617 TMSSVIIMLRSESLTLRQPERPAFSVGRFANNQEIA-SGSSSSVNGLTASTTVPR 670

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa]

 Score =  633 bits (1632), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 338/638 (52%), Positives = 421/638 (65%), Gaps = 33/638 (5%)

Query: 16  NPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDKVYGLF 74
           N  +Y + FC      T++  Y  NL+ L +        NS+ + NAS G  PD VYGLF
Sbjct: 33  NNPNYLHHFCD--DTTTSTTTYKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLF 90

Query: 75  LCRFDVSHQVCQNCIFDAI-DILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLC 133
            CR D+S  VCQNC+ +A  DI+   C   K A IWYD C +RYSN    +T+E  P   
Sbjct: 91  FCRGDLSTDVCQNCVANATKDIVQRRCPTQKVAFIWYDECFLRYSNKIMFSTMERDPNYT 150

Query: 134 VQN-ENYTKEPDKFTQILNQTFNDVIR--NATSSDSKNAAQTVNISSFDTLQTTAHCIPD 190
           + N EN     D   ++LN  F  V R  N  +   K  A   N ++   L     C PD
Sbjct: 151 LWNPENVAVHADFNRELLNTIFTAVNRAANMPAGAKKFRATKANYTTEHYLYVLVQCTPD 210

Query: 191 LSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVT-APN--- 246
           LS  DC  CL +A + +  C   KRG RI  PSC + +E Y    +T   +   AP+   
Sbjct: 211 LSSGDCEQCLLAAYSGLEICCNEKRGGRILFPSCIVNFETYINYNETYVESAALAPSPVP 270

Query: 247 ------------KTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRK--------QEE 286
                        ++K WI I    S I+  LL +SF + + RR+ +          + +
Sbjct: 271 QEKHFCYAGDKGSSKKTWIIIGATLSTIVGVLLLSSFAYTMWRRKKRDDCSNEIMYGEVK 330

Query: 287 SQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQ 346
           SQ   L  LD++  +KAT  +S ENKLG+GGFGPVYKGV+ DGKEIAVKRLSRTSGQGL+
Sbjct: 331 SQDSFLIQLDIV--LKATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRTSGQGLR 388

Query: 347 EFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR 406
           EF NEV +IA+LQH+NLV+LLGCCLE+NE LL+YEYMPNKSLDVFLFDS   VQLDW+RR
Sbjct: 389 EFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQLDWQRR 448

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           +SII GIARG+LYLHEDSRL+IIHRDLK SN+LLD+EMNPKISDFGMARIFGGN S+ANT
Sbjct: 449 LSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGNHSEANT 508

Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK 526
           NR+VGTYGYMAPEYAM G+ SVKSDVFSFGV++LEIISGK++ GF+ SE G SLL + WK
Sbjct: 509 NRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGKSLLNFTWK 568

Query: 527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
           LW EG   ELMDS++++S    E+LK IHIGLLCVQ DP+DRPTMSSV VMLA D   +P
Sbjct: 569 LWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQEDPVDRPTMSSVVVMLAGDNFKIP 628

Query: 587 KPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTMSPR 624
            PT+PAFS+ R+V+ +  S ++   SVN +TLS + PR
Sbjct: 629 IPTKPAFSVGRIVAEETTSSNQRVSSVNKVTLSNVLPR 666

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera]

 Score =  632 bits (1631), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 333/628 (53%), Positives = 404/628 (64%), Gaps = 49/628 (7%)

Query: 40  NLSKLFNRKLHEDGGNSLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVES 99
           NL  L +R L+ +GG S +     G+ PDKVYGLFLCR DVS  +CQ+CI  A   +V+ 
Sbjct: 194 NLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQV 253

Query: 100 CNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIR 159
           C   KEA IWY+ C +RYSN  F + LE  P L + N      PDKF Q L + F ++  
Sbjct: 254 CQHKKEAIIWYNECFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNLTA 313

Query: 160 NATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARI 219
            ATSSD   A   V +S+F  L     C  DL  S C  CL+  V  IP   +GK G R+
Sbjct: 314 KATSSDGMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFMEGKEGGRV 373

Query: 220 FCPSCSIRYELYRF-LVDTPTVTVTAPN-------KTRK-RWITIAEAASAIIVFLLSTS 270
             PSC IRYE+Y F  V+ P V    P+       K RK +WI    + S I+V      
Sbjct: 374 LAPSCYIRYEIYPFAAVEDPIVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVAFCVY 433

Query: 271 FLWCIIRRRNKRKQEE----------------------------------SQAFPLFPLD 296
           +   +IRRR     EE                                  S+ FP+   D
Sbjct: 434 Y---VIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQGDMLAKSKEFPVIGFD 490

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIA 356
           +  + +ATQ FS +NKLGEGGFGPVYKG L+DGKEIAVKRLSRTSGQGLQEFKNEV +IA
Sbjct: 491 I--VYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFKNEVILIA 548

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           KLQH+NLVRLLGCCLE NE LLIYEYMPNKSLD FLFDSTR ++LDWK R SII GIARG
Sbjct: 549 KLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARG 608

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           I YLHEDSRL+IIHRDLK SN+LLD +MNPKISDFG+ARIF G+++  NT ++VG+YGYM
Sbjct: 609 ISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGSYGYM 668

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           APEYAM G++S KSDVFSFGVVLLEII+G+K+ GF+ S  G SLL+Y W+LW EG   EL
Sbjct: 669 APEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLSGMGLSLLSYAWQLWNEGKGLEL 728

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLS 596
           MD ++  SC   E L+  HIGLLCVQ D  DRPTMSSV +ML S+ L+L +P +PAFS+ 
Sbjct: 729 MDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPTMSSVIIMLRSESLSLRQPERPAFSVG 788

Query: 597 RVVSAQFVSHSEDHCSVNAITLSTMSPR 624
           R  + Q ++ S    SVN +T ST  PR
Sbjct: 789 RFANNQEIA-SGSSSSVNGLTASTAVPR 815

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis]

 Score =  614 bits (1583), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 336/683 (49%), Positives = 426/683 (62%), Gaps = 68/683 (9%)

Query: 2   LMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLF--NRKLHEDGGNSLYR 59
            +LR +  +E+E     +Y Y  C   T  T +  Y  NL++L    R    +  N  Y 
Sbjct: 12  FLLRLAIASESE----PNYIYHVCSNSTAFTRNSTYQNNLNRLLLSIRTNAINRPNGFY- 66

Query: 60  NASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSN 119
           + S G+  D+VYGLF C  D+S +VCQ+C+  A   +V  C   K A +WYD C++RYSN
Sbjct: 67  DTSEGEGEDRVYGLFFCTADLSTEVCQDCVISATRDIVGRCPIEKTAIVWYDECILRYSN 126

Query: 120 NFFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATS--SDSKNAAQTVNISS 177
               + L  SP L + N     + + F+++L  T       A +     K A    N ++
Sbjct: 127 QTIYSILALSPGLYMWNAQNVSDQEGFSELLATTMIKTANQAAAPLGAIKFATLVANFTA 186

Query: 178 FDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDT 237
              L T A C PDLS SD   CL++A++ +P C  GKRG RI  PSC+IRYE Y F  +T
Sbjct: 187 SQKLYTLAQCTPDLSYSDSAQCLHTAISNLPLCCDGKRGGRILYPSCNIRYEFYPFYNET 246

Query: 238 P---------TVTVTAPN------------------------KTRK--------RWITIA 256
                       TV   N                        K  K        R   IA
Sbjct: 247 GFHREVSPFNNTTVVEGNPHSPILPPPPPPPIHPPAPMEKLGKVEKGGEGSKPTRTKVIA 306

Query: 257 EAASAIIVFLLSTSFLWCIIRRRNKRK--------------QEESQAFPLFPLDLIDIVK 302
              +AI+  LL +SF +   RR+ +++              + ++Q FP+ P D+I+  +
Sbjct: 307 SVTAAIVGILLFSSFFYITWRRKIQKEGRTRDEYSCENITGEMDAQDFPMIPFDIIE--E 364

Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
           AT+ FS + KLGEGGFGPVYKG L DGKEIAVKRLSRTSGQGL EF NEVT+I KLQH+N
Sbjct: 365 ATEHFSDDAKLGEGGFGPVYKGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLIFKLQHRN 424

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           LVRLLGCCLE++E LLIYEYMPNKSLDVFLFDS   V+LDW+RR+SII GIARG+LYLHE
Sbjct: 425 LVRLLGCCLEKSEKLLIYEYMPNKSLDVFLFDSHMGVRLDWQRRLSIISGIARGLLYLHE 484

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
           DSRL+IIHRDLK SN+LLD++MNPKISDFGMARIFGGN SK+ TNR+VGTYGYM+PEYAM
Sbjct: 485 DSRLRIIHRDLKASNILLDYDMNPKISDFGMARIFGGNDSKS-TNRIVGTYGYMSPEYAM 543

Query: 483 GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
            G+FS+KSD+FSFGV+LLEIISG+++  FY  E G SLL + WKLW +    EL+D  V 
Sbjct: 544 EGLFSMKSDIFSFGVLLLEIISGRRNNRFYVEEEGESLLTFAWKLWNKDQGLELLDPAVV 603

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQ 602
            S    E+LK +HIGLLCVQ DP +RPTMSSV VMLASD +TLP+P +PAFS+ + V+  
Sbjct: 604 NSSVAIEVLKCVHIGLLCVQDDPAERPTMSSVVVMLASDTITLPQPRKPAFSIGQFVARS 663

Query: 603 FVSHSEDHC-SVNAITLSTMSPR 624
             S S     SVN +TLS +SPR
Sbjct: 664 ATSSSNPKVSSVNQVTLSNVSPR 686

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max]

 Score =  573 bits (1477), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 304/650 (46%), Positives = 401/650 (61%), Gaps = 37/650 (5%)

Query: 10  AEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASVG---DY 66
           A+ E ++   Y Y  C  G N TA+  Y  NL  L    L  +   + + N +VG     
Sbjct: 20  AQEEQSSTPVYLYHNC-SGGNTTANSAYQLNLRTLLT-SLSSNATTTEFSNNTVGLGTSP 77

Query: 67  PDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTL 126
            D+VYGLF+CR DV   +CQ C+ +A   L   C+  K+A IWYD C VRYSN  F +T+
Sbjct: 78  SDRVYGLFMCRGDVPSALCQQCVVNATGRLRSQCSLAKQAVIWYDECTVRYSNRSFFSTV 137

Query: 127 ETSPFLCVQNENYTKEPDKFTQILNQTFN---DVIRNATSSDSKNAAQTVNISSFDTLQT 183
           +T P + + N       D F ++L QT N   D   N +    K A    NIS F +L  
Sbjct: 138 DTRPRVGLLNTANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYC 197

Query: 184 TAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVT 243
            A C PDLS+ +C  CL+  +  +P C +GK+G R+  PSC++RYELY F   T +   +
Sbjct: 198 LAQCTPDLSQENCRSCLSGVIGDLPWCCQGKQGGRVLYPSCNVRYELYPFYRVTASPPSS 257

Query: 244 ---------------APNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEES- 287
                          +P  +     TI      I V +L      C + RR ++KQ+ S 
Sbjct: 258 SPSPPTLLPPPTSPISPGSSGISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSV 317

Query: 288 ----QAFPL-----FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLS 338
                A+ +        D   I  AT  FS +NKLGEGGFG VYKG L+ G+ +AVKRLS
Sbjct: 318 KEGKTAYDIPTVDSLQFDFSTIEAATNKFSADNKLGEGGFGEVYKGTLSSGQVVAVKRLS 377

Query: 339 RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS 398
           ++SGQG +EFKNEV V+AKLQH+NLVRLLG CL+  E +L+YEY+PNKSLD  LFD  + 
Sbjct: 378 KSSGQGGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYEYVPNKSLDYILFDPEKQ 437

Query: 399 VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 458
            +LDW RR  II GIARGI YLHEDSRL+IIHRDLK SN+LLD +MNPKISDFGMARIFG
Sbjct: 438 RELDWGRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLDGDMNPKISDFGMARIFG 497

Query: 459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
            +Q++ NT+R+VGTYGYMAPEYAM G FSVKSDV+SFGV+L+EI+SGKK++ FY ++   
Sbjct: 498 VDQTQGNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLLMEILSGKKNSSFYQTDGAE 557

Query: 519 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
            LL+Y W+LW +G   ELMD ++++S +Q E+++ IHIGLLCVQ DP DRPTM+++ +ML
Sbjct: 558 DLLSYAWQLWKDGTPLELMDPILRESYNQNEVIRSIHIGLLCVQEDPADRPTMATIVLML 617

Query: 579 ASDILTLPKPTQPAFSLSRVVSAQFVSH----SEDHCSVNAITLSTMSPR 624
            S+ +TLP PTQPAF +                    SVN +++S M PR
Sbjct: 618 DSNTVTLPTPTQPAFFVHSGTDPNMPKELPFDQSIPMSVNDMSISEMDPR 667

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  565 bits (1457), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 300/641 (46%), Positives = 393/641 (61%), Gaps = 42/641 (6%)

Query: 22  YKFCPRGTNNTASIIYVYNLSKLFNRKLHEDG---GNSLYRNASVGDYPDKVYGLFLCRF 78
           Y FC   +N   +  Y  +L+ L    L  D        + N + G  PD VYGL+LCR 
Sbjct: 30  YSFCTENSNYVPNSTYQSSLNVLLT-SLSSDATILNGRKFHNTTAGQAPDMVYGLYLCRG 88

Query: 79  DVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNEN 138
           DV+  VCQ+C+  A   ++  C   KEA  WYD CM+RYSN    + +E  P L + N  
Sbjct: 89  DVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSL 148

Query: 139 YTKEPDKFTQILNQTFNDVIRNATSSDSKN---AAQTVNISSFDTLQTTAHCIPDLSKSD 195
              +PD+F QI+N+T   +I  AT + S+         N ++   +     C PDLS S+
Sbjct: 149 DMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSN 208

Query: 196 CTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAP---------- 245
           C+ CL +  ++I  C  GK+GARI  PSC+ RYELY F  D    T  AP          
Sbjct: 209 CSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSLLSP 268

Query: 246 -----NKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPL-------- 292
                N ++     I   A ++++F +     +C I R+ K+K   ++   +        
Sbjct: 269 PGKKGNSSQLLIAIIVPVAVSVVIFSI---LCYCFICRKAKKKYSSTEEEKVENDITTVQ 325

Query: 293 -FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNE 351
               D   +  AT +FS +NK+GEGGFG VYKG L+ GKEIA+KRLSR+S QG  EFKNE
Sbjct: 326 SLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIAIKRLSRSSAQGAVEFKNE 385

Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
           V ++AKLQH+NLVRLLG CLE  E +L+YEY+PNKSLD FLFD  +  QLDW RR  II 
Sbjct: 386 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLFDPDKQGQLDWSRRYKIIG 445

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
           GIARGILYLHEDS+LK+IHRDLK SNVLLD +MNPKISDFGMARIFGG+Q++ +T RVVG
Sbjct: 446 GIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGMARIFGGDQTRGSTKRVVG 505

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG 531
           TYGYM+PEYAM G FS KSDV+SFGV++LEIISGKK + FY S+    LL Y WKLW +G
Sbjct: 506 TYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKKISHFYESDQTEDLLGYAWKLWRDG 565

Query: 532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQP 591
              ELMD +++ S  + E+++ IH+GLLCVQ DP DRP+M+SV +ML+S  +TLP P QP
Sbjct: 566 TPLELMDPIMRDSYARNEVIRCIHMGLLCVQEDPDDRPSMASVVLMLSSYSVTLPLPQQP 625

Query: 592 AFSLSRVVSAQFVSHSEDH--------CSVNAITLSTMSPR 624
           AF +     + F   +E           SVN  ++S + PR
Sbjct: 626 AFFIGSGTQSGFPIKAESDQSTSKSTPWSVNETSISELYPR 666

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076491|ref|XP_002304951.1| predicted protein [Populus trichocarpa] gi|222847915|gb|EEE85462.1| predicted protein [Populus trichocarpa]

 Score =  565 bits (1455), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 304/610 (49%), Positives = 385/610 (63%), Gaps = 40/610 (6%)

Query: 18  ADYQYKFCPRGTNNTASIIY-VYNLSKLFNRKLHEDGGNSL-YRNASVGDYPDKVYGLFL 75
           A+Y Y  C   T +T +  Y V     L +   +    N++ + N S G   D+VYGLF+
Sbjct: 26  ANYLYHNCQNATTSTINSTYRVNLNLLLSSLASNATLNNTIGFYNTSFGQSTDQVYGLFI 85

Query: 76  CRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSN-NFFATTLETSPFLCV 134
           CR D+S+ VCQNC+  A + +V+ C     + ++YD C++RYSN N F+   ++  F  +
Sbjct: 86  CRGDLSNSVCQNCVTFATEDIVQRCPIGIASIVYYDACILRYSNRNIFSKVDQSPGFSLL 145

Query: 135 QNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQ---TTAHCIPDL 191
             +N T EP +F  ++  T ND+   A S+        VN +SF+  Q   + A C PDL
Sbjct: 146 NTQNITTEPQRFNNLVGATANDLATRAASAPPGAKKFAVNKTSFNAFQNIYSLAQCTPDL 205

Query: 192 SKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAPNKTRKR 251
           S SDC  CL++A+A +P C   K G R+  PSC I YE+  F         TA  K    
Sbjct: 206 SSSDCNRCLSAAIAGLPNCCSSKIGGRVLFPSCYIHYEITEF------YNATAIKKGGVP 259

Query: 252 WITIAEAASAIIVFLLSTSFLWCIIRRRNKRK----------QE---------------- 285
            + I      I V +   S  +C +RR  K +          QE                
Sbjct: 260 TVLIMAIVIPIAVSIALFSMCFCFLRRARKTRDYVPENDALLQELACPRGVTMTDEGQLV 319

Query: 286 ESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL 345
            S+  P   +DL  I +AT +FS  NKLG+GGFG VYKGVL DGKEIAVKRLSR S QGL
Sbjct: 320 SSEDLPF--MDLTTIREATDNFSDSNKLGQGGFGTVYKGVLPDGKEIAVKRLSRKSWQGL 377

Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 405
           +EFKNEV VIAKLQH+NLVRLLGC +E +E LLIYE+M NKSLD+F+FD+ R   LDW+ 
Sbjct: 378 EEFKNEVKVIAKLQHRNLVRLLGCGMEGDEKLLIYEFMHNKSLDIFIFDAERRALLDWET 437

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
             +I  GIARG+LYLHEDSRL+IIHRDLK SNVLLDHEM  KISDFGMARIF  NQ+KAN
Sbjct: 438 CYNIAGGIARGLLYLHEDSRLRIIHRDLKPSNVLLDHEMVAKISDFGMARIFCENQNKAN 497

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW 525
           T RVVGT+GYMAPEYAMGG+FSVKSDVFSFGV+LLEI SG++S+GFY SEHG +LLAY W
Sbjct: 498 TRRVVGTFGYMAPEYAMGGLFSVKSDVFSFGVILLEITSGQRSSGFYLSEHGQTLLAYTW 557

Query: 526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL 585
           +LW EG   EL+D  +        +++ +H+GLLCVQ DP DRPTMS V + L SD + L
Sbjct: 558 RLWNEGREIELVDPSLMDRSQTEGIVRCMHVGLLCVQEDPSDRPTMSFVVLALGSDPIAL 617

Query: 586 PKPTQPAFSL 595
           P+P QPAFSL
Sbjct: 618 PQPKQPAFSL 627

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555035|ref|XP_002518555.1| ATP binding protein, putative [Ricinus communis] gi|223542400|gb|EEF43942.1| ATP binding protein, putative [Ricinus communis]

 Score =  560 bits (1443), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 292/627 (46%), Positives = 394/627 (62%), Gaps = 41/627 (6%)

Query: 1   MLMLRTSWDAEAEVANPADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRN 60
           + +LR +   +AE     +Y+Y FC   T  T +  Y  NL+++ +   +    +  + N
Sbjct: 12  LFLLRLAIIVKAE---SPEYRYHFCSNTTTFTPNSTYQTNLNQVLSSLSNNANNSIGFFN 68

Query: 61  ASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNN 120
              G  PD VYG FLCR DVS  VCQ+C+  A   +V+ C   K A +WYD C++RY N 
Sbjct: 69  IPSGQQPDDVYGSFLCRGDVSTDVCQDCVTFATQDIVKRCPIEKVAIVWYDQCLLRYENQ 128

Query: 121 FFATTLETSPFLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDS---KNAAQTVNISS 177
            F +T++ +P + + N     +PD+F  +L  T  ++  +A+S+ S   K AA   N ++
Sbjct: 129 SFISTMDQTPGVFLSNTQDISDPDRFDNLLATTMENLATDASSAASGEKKFAATDDNFTA 188

Query: 178 FDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDT 237
           F  L +   C PDLS   C  CL  A++ +P+C  GKRGA +  PSC++RYE+Y F   T
Sbjct: 189 FQKLYSLVQCTPDLSNPGCRQCLRGAISNLPSCCGGKRGANVLYPSCNVRYEVYPFFNAT 248

Query: 238 P-----------------TVTVTAPNKTRKRWIT-------IAEAASAIIVFLLSTSFLW 273
                             T + T P    +  I+       +A  A AI++F    S  +
Sbjct: 249 AVEPPPPSPSPAVPPPPPTGSGTRPETEGQSGISTVIIVAIVAPVAIAIVLF----SLAY 304

Query: 274 CIIRRRNKRKQEESQ-------AFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVL 326
           C +RRR ++K +  Q             +DL  +  AT  FS +NKLGEGGFG VYKG+L
Sbjct: 305 CYLRRRPRKKYDAVQEDGNEITTVESLQIDLNTVEAATNKFSADNKLGEGGFGEVYKGIL 364

Query: 327 ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK 386
            +G+EIAVK+LSR+SGQG QEFKNEV ++AKLQH+NLVRLLG CLE  E +L+YE++ NK
Sbjct: 365 PNGQEIAVKKLSRSSGQGAQEFKNEVVLLAKLQHRNLVRLLGFCLEGAEKILVYEFVSNK 424

Query: 387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP 446
           SLD FLFD  +  QLDW  R  I+ GIARGILYLHEDS+L+I+HRDLK SN+LLD  MNP
Sbjct: 425 SLDYFLFDPEKQRQLDWSTRYKIVGGIARGILYLHEDSQLRIVHRDLKVSNILLDRNMNP 484

Query: 447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           KISDFG ARIFG +QS+ NT R+VGTYGYM+PEYAM G FSVKSD++SFGV++LEII GK
Sbjct: 485 KISDFGTARIFGVDQSQGNTKRIVGTYGYMSPEYAMHGQFSVKSDMYSFGVLILEIICGK 544

Query: 507 KSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPI 566
           K++ FY  +    L++Y+WK W +G   E+MD V+K S  + E+L+ I IGLLCVQ DP 
Sbjct: 545 KNSSFYEIDGAGDLVSYVWKHWRDGTPMEVMDPVIKDSYSRNEVLRCIQIGLLCVQEDPA 604

Query: 567 DRPTMSSVAVMLASDILTLPKPTQPAF 593
           DR TM++V +ML S  +TLP P QPAF
Sbjct: 605 DRLTMATVVLMLNSFSVTLPVPQQPAF 631

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max]

 Score =  555 bits (1430), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 296/636 (46%), Positives = 390/636 (61%), Gaps = 37/636 (5%)

Query: 25  CPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSLYRNASV-GDYP-DKVYGLFLCRFDVSH 82
           CP     TA+  +  N+  LF+        N+++ N++V G  P D VYGLF+CR DV  
Sbjct: 37  CP-SNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPF 95

Query: 83  QVCQNCIFDAIDILVE--SCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYT 140
           Q+C  C+ +A   L     C+ +K+A IWYD CMVRYSN  F +T++T P + + N    
Sbjct: 96  QLCGQCVINATQKLSSDLQCSLSKQAVIWYDECMVRYSNRSFFSTVDTRPAIGLLNSANI 155

Query: 141 KEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCL 200
                F +++  T N+    A     K A +  NIS F TL     C PDLS   C  CL
Sbjct: 156 SNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSCL 215

Query: 201 NSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFL---VDTPTVTVTAPNKTRKRWITIAE 257
           + A+  +P C +GK+G RI  PSC++RY+LY F    V  P  +V   + +      I+ 
Sbjct: 216 SDAIGLLPWCCEGKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGNIISY 275

Query: 258 AASAI-------------IVFLLSTSFLWCIIRRRNKRK--------QEESQAFPLFPLD 296
             S I             +  LL    +W + +R  K++        + E  A      D
Sbjct: 276 GGSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAKKRNSAQDPKTETEISAVESLRFD 335

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIA 356
              I  AT  FS  NKLGEGGFG VYKG+L  G+E+AVKRLS+ SGQG  EFKNEV V+A
Sbjct: 336 FSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVKRLSKNSGQGGTEFKNEVEVVA 395

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           KLQHKNLVRLLG CLE  E +L+YE++ NKSLD  LFD  +   LDW RR  I++GIARG
Sbjct: 396 KLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDPEKQKSLDWTRRYKIVEGIARG 455

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           I YLHEDSRLKIIHRDLK SNVLLD +MNPKISDFGMARIFG +Q++ANTNR+VGTYGYM
Sbjct: 456 IQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGVDQTQANTNRIVGTYGYM 515

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           +PEYAM G +S KSDV+SFGV++LEIISGK+++ FY ++    LL+Y WKLW +    EL
Sbjct: 516 SPEYAMHGEYSAKSDVYSFGVLILEIISGKRNSSFYETDVAEDLLSYAWKLWKDEAPLEL 575

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF--- 593
           MD  +++S  + E+++ IHIGLLCVQ DPIDRPTM+SV +ML S  +TL  P QPAF   
Sbjct: 576 MDQSLRESYTRNEVIRCIHIGLLCVQEDPIDRPTMASVVLMLDSYSVTLQVPNQPAFYIN 635

Query: 594 -----SLSRVVSAQFVSHSEDHCSVNAITLSTMSPR 624
                ++ + +     + +    SVN +++S + PR
Sbjct: 636 SRTEPNMPKGLKIDQSTTNSTSKSVNDMSVSEVDPR 671

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088180|emb|CBI35672.3| unnamed protein product [Vitis vinifera]

 Score =  554 bits (1428), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 299/671 (44%), Positives = 392/671 (58%), Gaps = 69/671 (10%)

Query: 22  YKFCPRGTNNTASIIYVYNLSKLFNRKLHEDG---GNSLYRNASVGDYPDKVYGLFLCRF 78
           Y FC   +N   +  Y  +L+ L    L  D        + N + G  PD VYGL+LCR 
Sbjct: 30  YSFCTENSNYVPNSTYQSSLNVLLT-SLSSDATILNGRKFHNTTAGQAPDMVYGLYLCRG 88

Query: 79  DVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNEN 138
           DV+  VCQ+C+  A   ++  C   KEA  WYD CM+RYSN    + +E  P L + N  
Sbjct: 89  DVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSL 148

Query: 139 YTKEPDKFTQILNQTFNDVIRNATSSDSKN---AAQTVNISSFDTLQTTAHCIPDLSKSD 195
              +PD+F QI+N+T   +I  AT + S+         N ++   +     C PDLS S+
Sbjct: 149 DMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSN 208

Query: 196 CTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPT---------------- 239
           C+ CL +  ++I  C  GK+GARI  PSC+ RYELY F  D                   
Sbjct: 209 CSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSLLSP 268

Query: 240 -----------VTVTAPNK--------------TRKRWITIA----EAASAIIVFLLSTS 270
                      + +  P                 RKRW         + S  +  ++ + 
Sbjct: 269 PGKKGNSSQLLIAIIVPVAGTLIISGFLCYCWLNRKRWNIFTNNYHHSYSNNLSVVIFSI 328

Query: 271 FLWCIIRRRNKRKQEESQAFPL---------FPLDLIDIVKATQDFSQENKLGEGGFGPV 321
             +C I R+ K+K   ++   +            D   +  AT +FS +NK+GEGGFG V
Sbjct: 329 LCYCFICRKAKKKYSSTEEEKVENDITTVQSLQFDFGTLEAATNNFSDDNKIGEGGFGDV 388

Query: 322 YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE 381
           YKG L+ GKEIA+KRLSR+S QG  EFKNEV ++AKLQH+NLVRLLG CLE  E +L+YE
Sbjct: 389 YKGTLSSGKEIAIKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYE 448

Query: 382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD 441
           Y+PNKSLD FLFD  +  QLDW RR  II GIARGILYLHEDS+LK+IHRDLK SNVLLD
Sbjct: 449 YVPNKSLDCFLFDPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLD 508

Query: 442 HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLE 501
            +MNPKISDFGMARIFGG+Q++ +T RVVGTYGYM+PEYAM G FS KSDV+SFGV++LE
Sbjct: 509 GDMNPKISDFGMARIFGGDQTRGSTKRVVGTYGYMSPEYAMRGHFSAKSDVYSFGVLVLE 568

Query: 502 IISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCV 561
           IISGKK + FY S+    LL Y WKLW +G   ELMD +++ S  + E+++ IH+GLLCV
Sbjct: 569 IISGKKISHFYESDQTEDLLGYAWKLWRDGTPLELMDPIMRDSYARNEVIRCIHMGLLCV 628

Query: 562 QGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRVVSAQFVSHSEDH--------CSV 613
           Q DP DRP+M+SV +ML+S  +TLP P QPAF +     + F   +E           SV
Sbjct: 629 QEDPDDRPSMASVVLMLSSYSVTLPLPQQPAFFIGSGTQSGFPIKAESDQSTSKSTPWSV 688

Query: 614 NAITLSTMSPR 624
           N  ++S + PR
Sbjct: 689 NETSISELYPR 699

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	624
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.578	0.539	0.538	1.9e-140
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.568	0.525	0.532	4.7e-133
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.576	0.533	0.505	1.2e-132
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.961	0.930	0.436	2e-127
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.527	0.396	0.556	1.2e-125
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.581	0.542	0.529	2.8e-122
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.612	0.574	0.472	5.9e-120
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.618	0.571	0.490	7.5e-120
TAIR|locus:2123071	636	CRK33 "cysteine-rich RLK (RECE	0.850	0.834	0.439	1.2e-115
TAIR|locus:2127323	642	CRK27 "cysteine-rich RLK (RECE	0.929	0.903	0.435	3.9e-115

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 1.9e-140, Sum P(2) = 1.9e-140
 Identities = 203/377 (53%), Positives = 269/377 (71%)

Query:   235 VDTPTVTVTAPNKTRK----RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAF 290
             + TP V+  AP ++ K    + + IA     I+  LL  +  +C + RR ++      AF
Sbjct:   267 ISTPPVS--APPRSGKDGNSKVLVIAIVVPIIVAVLLFIAG-YCFLTRRARKSYYTPSAF 323

Query:   291 P--------LFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG 342
                         LD   I  AT DF + NK+G+GGFG VYKG L+DG E+AVKRLS++SG
Sbjct:   324 AGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSG 383

Query:   343 QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD 402
             QG  EFKNEV ++AKLQH+NLVRLLG CL+  E +L+YEY+PNKSLD FLFD  +  QLD
Sbjct:   384 QGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLD 443

Query:   403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
             W RR  II G+ARGILYLH+DSRL IIHRDLK SN+LLD +MNPKI+DFGMARIFG +Q+
Sbjct:   444 WTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQT 503

Query:   463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLA 522
             + NT+R+VGTYGYM+PEYAM G +S+KSDV+SFGV++LEIISGKK++ FY ++    L++
Sbjct:   504 EENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVS 563

Query:   523 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
             Y W LW  G   EL+D  + ++C + E+++ +HIGLLCVQ DP +RPT+S++ +ML S+ 
Sbjct:   564 YAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNT 623

Query:   583 LTLPKPTQPA-FSLSRV 598
             +TLP P QP  F  SR+
Sbjct:   624 VTLPVPRQPGLFFQSRI 640

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 989 (353.2 bits), Expect = 4.7e-133, Sum P(2) = 4.7e-133
 Identities = 196/368 (53%), Positives = 261/368 (70%)

Query:   237 TPTVTVTA-PNKTRKRWI-TIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFPL-- 292
             TP +T  + P K+    +  +A    A+++F+    +  C + +R K+  + + A  +  
Sbjct:   274 TPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGY--CFLAQRTKKTFDTASASEVGD 331

Query:   293 -------FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL 345
                      LD   I  AT DF++ NK+G GGFG VYKG  ++GKE+AVKRLS+ S QG 
Sbjct:   332 DMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGE 391

Query:   346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 405
              EFK EV V+AKLQH+NLVRLLG  L+  E +L+YEYMPNKSLD  LFD T+  QLDW +
Sbjct:   392 AEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQ 451

Query:   406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
             R +II GIARGILYLH+DSRL IIHRDLK SN+LLD ++NPKI+DFGMARIFG +Q++ N
Sbjct:   452 RYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDN 511

Query:   466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW 525
             T+R+VGTYGYMAPEYAM G FS+KSDV+SFGV++LEIISG+K++ F  S+    LL + W
Sbjct:   512 TSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTW 571

Query:   526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL 585
             +LW    A +L+D ++  +C  +E+++ IHIGLLCVQ DP  RPT+S+V +ML S+ +TL
Sbjct:   572 RLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTL 631

Query:   586 PKPTQPAF 593
             P P QP F
Sbjct:   632 PVPRQPGF 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 943 (337.0 bits), Expect = 1.2e-132, Sum P(2) = 1.2e-132
 Identities = 188/372 (50%), Positives = 254/372 (68%)

Query:   235 VDTPTVTVTAPNKTRKRWITIAEAASAI---IVFLLSTSFLWCIIRRRNKRKQEESQ--- 288
             V  P + + +  K + + +T+   A A+   +  LL  +  W + RRRN +   E++   
Sbjct:   265 VTAPPLNIPS-EKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLD 323

Query:   289 -----AFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ 343
                  +          I  AT  FS+ NKLG GGFG VYKG L  G+ +A+KRLS+ S Q
Sbjct:   324 EDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQ 383

Query:   344 GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW 403
             G +EFKNEV V+AKLQH+NL +LLG CL+  E +L+YE++PNKSLD FLFD+ +   LDW
Sbjct:   384 GAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDW 443

Query:   404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK 463
             +RR  II+GIARGILYLH DSRL IIHRDLK SN+LLD +M+PKISDFGMARIFG +Q++
Sbjct:   444 QRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQ 503

Query:   464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAY 523
             ANT R+VGTYGYM+PEYA+ G +SVKSDV+SFGV++LE+I+GKK++ FY  +    L+ Y
Sbjct:   504 ANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTY 563

Query:   524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL 583
             +WKLW E    EL+D  ++ +    E+++ IHI LLCVQ D  +RP+M  + VM+ S  +
Sbjct:   564 VWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTV 623

Query:   584 TLPKPTQPAFSL 595
             TLP P +  F L
Sbjct:   624 TLPIPKRSGFLL 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
 Identities = 273/626 (43%), Positives = 375/626 (59%)

Query:    20 YQYKFCPRGTNNTASIIYVYNLSKLFNR--KLHEDGGNSLYRNASVGDYPDKVYGLFLCR 77
             Y Y  C   T  +++  Y  NL  L +    L+    ++ ++ A+ G  PD+V GLFLCR
Sbjct:    25 YLYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYSTGFQTATAGQAPDRVTGLFLCR 84

Query:    78 FDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNE 137
              DVS +VC++C+  A++  +  C   KE   +Y+ C++RYSN     TL T   + +Q+ 
Sbjct:    85 VDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYEQCLLRYSNRNIVATLNTDGGMFMQSA 144

Query:   138 N--YTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSD 195
                 + + D+F  ++    N     A  S  K A + +++++  +L     C PDL + D
Sbjct:   145 RNPLSVKQDQFRDLVLTPMNLAAVEAARSFKKWAVRKIDLNASQSLYGMVRCTPDLREQD 204

Query:   196 CTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRFL----VDTPTVTVTAPNKT-RK 250
             C  CL   + Q+   +  K G RI  PSC+ RY+ Y F     V TP  +   P K    
Sbjct:   205 CLDCLKIGINQV---TYDKIGGRILLPSCASRYDNYAFYNESNVGTPQDSSPRPGKGGNS 261

Query:   251 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRKQEESQAFP----------LFPLDLIDI 300
               I IA      ++FLL  +     +R +NKR   E +                 D   I
Sbjct:   262 SVIIIAVVVPITVLFLLLVAVF--SVRAKNKRTLNEKEPVAEDGNDITTAGSLQFDFKAI 319

Query:   301 VKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH 360
               AT  F   NKLG+GGFG VYKG L+ G ++AVKRLS+TSGQG +EF+NEV V+AKLQH
Sbjct:   320 EAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQH 379

Query:   361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
             +NLV+LLG CLE  E +L+YE++PNKSLD FLFDST  ++LDW RR  II GIARGILYL
Sbjct:   380 RNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYL 439

Query:   421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
             H+DSRL IIHRDLK  N+LLD +MNPKI+DFGMARIFG +Q++A T RVVGTYGYM+PEY
Sbjct:   440 HQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEY 499

Query:   481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP-SLLAYIWKLWCEGHAAELMDS 539
             AM G FS+KSDV+SFGV++LEIISG K++  Y  +    +L+ Y W+LW  G  +EL+D 
Sbjct:   500 AMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDP 559

Query:   540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL-SRV 598
                 +   +E+ + IHI LLCVQ D  DRPTMSS+  ML + ++ L +P  P F   S+ 
Sbjct:   560 SFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQ 619

Query:   599 VSAQFVSHSEDHCSVNAITLSTMSPR 624
               A     S  HCSV+  +++ ++PR
Sbjct:   620 EQAGPSIDSSTHCSVDEASITRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 929 (332.1 bits), Expect = 1.2e-125, Sum P(2) = 1.2e-125
 Identities = 186/334 (55%), Positives = 235/334 (70%)

Query:   296 DLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
             D   IV AT +F   NKLG+GGFG VYKG    G ++AVKRLS+TSGQG +EF+NEV V+
Sbjct:   497 DFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVVV 556

Query:   356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             AKLQH+NLVRLLG CLE  E +L+YE++ NKSLD FLFD+T   QLDW RR  II GIAR
Sbjct:   557 AKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIAR 616

Query:   416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
             GILYLH+DSRL IIHRDLK  N+LLD +MNPK++DFGMARIFG +Q++ANT RVVGTYGY
Sbjct:   617 GILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYGY 676

Query:   476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS-LLAYIWKLWCEGHAA 534
             MAPEYAM G FS+KSDV+SFGV++ EIISG K++  Y  +   S L+ Y W+LW  G   
Sbjct:   677 MAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQL 736

Query:   535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFS 594
             +L+D     +    ++ + IHI LLCVQ D  DRP MS++  ML +  + L  P QP F 
Sbjct:   737 DLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVLAVPKQPGFF 796

Query:   595 L-SRVVSAQFVSHSEDH---CSVNAITLSTMSPR 624
                R      V  S D    CS++  ++++++PR
Sbjct:   797 FRGRHEQVGEVGSSVDRLALCSIDDASITSVAPR 830

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 974 (347.9 bits), Expect = 2.8e-122, Sum P(2) = 2.8e-122
 Identities = 199/376 (52%), Positives = 255/376 (67%)

Query:   262 IIVFLLSTSFLWCIIRRRNKRKQEESQAFP------LFPLDLIDIVKATQDFSQENKLGE 315
             IIV L+S   L  + RR+   K  E QA                I  AT  FS  N +G 
Sbjct:   294 IIVILVSLVVLLVVCRRKKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGR 353

Query:   316 GGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE 375
             GGFG VY+G L+ G E+AVKRLS+TSGQG +EFKNE  +++KLQHKNLVRLLG CLE  E
Sbjct:   354 GGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEE 413

Query:   376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKT 435
              +L+YE++PNKSLD FLFD  +  +LDW RR +II GIARGILYLH+DSRL IIHRDLK 
Sbjct:   414 KILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKA 473

Query:   436 SNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSF 495
             SN+LLD +MNPKI+DFGMARIFG +QS+ANT R+ GT+GYM+PEYAM G FS+KSDV+SF
Sbjct:   474 SNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSF 533

Query:   496 GVVLLEIISGKKSTGFYH-SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI 554
             GV++LEIISGKK++ FY+  + G +L+ + W+LW  G   EL+D  + +S   +E  + I
Sbjct:   534 GVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCI 593

Query:   555 HIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLS-RVVSAQFVSHSEDHC-- 611
             HI LLCVQ DP DRP + ++ +ML S   TL  P  P F LS R +    V ++E     
Sbjct:   594 HIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRS 653

Query:   612 ---SVNAITLSTMSPR 624
                S+N  +++   PR
Sbjct:   654 IPGSINDASITEFYPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 882 (315.5 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
 Identities = 186/394 (47%), Positives = 263/394 (66%)

Query:   236 DTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRR----RNKRKQEESQAFP 291
             +T +VT    N+   + +  A A+ AI+V  +    ++  +RR    RN   + E++   
Sbjct:   267 ETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKHENENIS 326

Query:   292 L--FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK 349
                   D   +  AT  FS ENKLGEGGFG VYKGVL+DG++IAVKRLS+ + QG  EFK
Sbjct:   327 TDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGETEFK 386

Query:   350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
             NE  ++AKLQH+NLV+LLG  +E  E LL+YE++P+ SLD F+FD  +  +L+W+ R  I
Sbjct:   387 NEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRYKI 446

Query:   410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNR 468
             I G+ARG+LYLH+DSRL+IIHRDLK SN+LLD EM PKI+DFGMAR+F   + ++  TNR
Sbjct:   447 IGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYTNR 506

Query:   469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW 528
             +VGT+GYMAPEY M G FS K+DV+SFGV++LEIISGKK++GF   +    L+++ W+ W
Sbjct:   507 IVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAWRNW 566

Query:   529 CEGHAAELMDSVVK--QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
              EG A  L+D ++    S     +++ I+IGLLCVQ    +RP+M+SV +ML    + L 
Sbjct:   567 KEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTIALS 626

Query:   587 KPTQPAF-SLSRVVS--AQFVSHSEDHCSVNAIT 617
             +P++PAF S S  VS  +  + H+    + N+ T
Sbjct:   627 EPSKPAFFSHSNAVSDSSSSLGHNAKTSNYNSNT 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 917 (327.9 bits), Expect = 7.5e-120, Sum P(2) = 7.5e-120
 Identities = 198/404 (49%), Positives = 259/404 (64%)

Query:   238 PTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIR--RRNKRKQ---EESQAFPL 292
             P   ++   K R   + I      I + LL  +F     +  R N  ++   EES     
Sbjct:   274 PPPLISERGKGRNSSVIIVVVVPIIALLLLFVAFFSLRAKKTRTNYEREPLTEESDDITT 333

Query:   293 ---FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK 349
                   D   I  AT  F + NKLG+GGFG VYKG+   G ++AVKRLS+TSGQG +EF 
Sbjct:   334 AGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFA 393

Query:   350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
             NEV V+AKLQH+NLVRLLG CLE +E +L+YE++PNKSLD F+FDST    LDW RR  I
Sbjct:   394 NEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKI 453

Query:   410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
             I GIARGILYLH+DSRL IIHRDLK  N+LL  +MN KI+DFGMARIFG +Q++ANT R+
Sbjct:   454 IGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRI 513

Query:   470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS---LLAYIWK 526
             VGTYGYM+PEYAM G FS+KSDV+SFGV++LEIISGKK++  Y  + G S   L+ Y W+
Sbjct:   514 VGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMD-GTSAGNLVTYTWR 572

Query:   527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
             LW  G   EL+D   + +    E+ + IHI LLCVQ +  DRPTMS++  ML +  + L 
Sbjct:   573 LWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALA 632

Query:   587 KPTQPAFSL--SRVVSAQFVS----HSEDHCSVNAITLSTMSPR 624
              P +P F    S+      V     ++   CSV+  +++ ++PR
Sbjct:   633 VPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2123071 CRK33 "cysteine-rich RLK (RECEPTOR-like protein kinase) 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 1140 (406.4 bits), Expect = 1.2e-115, P = 1.2e-115
 Identities = 243/553 (43%), Positives = 346/553 (62%)

Query:    58 YRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYD---ICM 114
             + N+S+G  PD+V+ + +C       VC +C+  A D L E+C    EA  W     +C 
Sbjct:    61 FYNSSIGKVPDEVHVMGMCIDGTEPTVCSDCLKVAADQLQENCPNQTEAYTWTPHKTLCF 120

Query:   115 VRYSNNFFATTLETSPFLCVQNENYT-KEPDKFTQILNQTFNDVIRNATSSD------SK 167
              RYSN+ F   +   P L +++ N   K    +   + +   D + +  SSD      S+
Sbjct:   121 ARYSNSSFFKRVGLHP-LYMEHSNVDIKSNLTYLNTIWEALTDRLMSDASSDYNASLSSR 179

Query:   168 N--AAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCS 225
                AA   N+++F  +     C PDL K  C  CL  AV++     + +RG  +  PSC 
Sbjct:   180 RYYAANVTNLTNFQNIYALMLCTPDLEKGACHNCLEKAVSEYGNL-RMQRGI-VAWPSCC 237

Query:   226 IRYELYRFLVDTPTVTVTAPNKTRKR----WITIAEAASAIIVFLLSTSFLWCIIRRRNK 281
              R++LY F +    +T++ P  +++     +      A+ +++ +LST  +  + R+R  
Sbjct:   238 FRWDLYPF-IGAFNLTLSPPPGSKRNISVGFFVAIVVATGVVISVLSTLVVVLVCRKRKT 296

Query:   282 RKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS 341
                EES  + L   DL  I  AT  FS+ N LG+GGFG V+KGVL DG EIAVKRLS+ S
Sbjct:   297 DPPEESPKYSL-QYDLKTIEAATCTFSKCNMLGQGGFGEVFKGVLQDGSEIAVKRLSKES 355

Query:   342 GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQL 401
              QG+QEF+NE +++AKLQH+NLV +LG C+E  E +L+YE++PNKSLD FLF+ T+  QL
Sbjct:   356 AQGVQEFQNETSLVAKLQHRNLVGVLGFCMEGEEKILVYEFVPNKSLDQFLFEPTKKGQL 415

Query:   402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 461
             DW +R  II G ARGILYLH DS LKIIHRDLK SN+LLD EM PK++DFGMARIF  +Q
Sbjct:   416 DWAKRYKIIVGTARGILYLHHDSPLKIIHRDLKASNILLDAEMEPKVADFGMARIFRVDQ 475

Query:   462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS-EHGPSL 520
             S+A+T RVVGT+GY++PEY M G FSVKSDV+SFGV++LEIISGK+++ F+ + E G +L
Sbjct:   476 SRADTRRVVGTHGYISPEYLMHGQFSVKSDVYSFGVLVLEIISGKRNSNFHETDESGKNL 535

Query:   521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
             + Y W+ W  G   EL+DS ++++    E+ + IHI LLCVQ DP  RP +S++ +ML S
Sbjct:   536 VTYAWRHWRNGSPLELVDSELEKNYQSNEVFRCIHIALLCVQNDPEQRPNLSTIIMMLTS 595

Query:   581 DILTLPKPTQPAF 593
             + +TLP P  P +
Sbjct:   596 NSITLPVPQSPVY 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)]

 Score = 1135 (404.6 bits), Expect = 3.9e-115, P = 3.9e-115
 Identities = 271/622 (43%), Positives = 366/622 (58%)

Query:    28 GTNNTASIIYVYNLSKLFNRKLHE--DGGNSLYRNASVGDYPDKVYGLFLCRFDVS-HQV 84
             G N T++  Y  NL++L +  L +     N  Y N S+     +V  + LCR DV  +Q 
Sbjct:    38 GGNFTSNTSYSLNLNRLIS-SLPDLTPTINGFY-NISING---EVNAIALCRGDVKPNQD 92

Query:    85 CQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFFATTLETSPFLCVQNENYTKEPD 144
             C +CI  A   LVESC    EA IW + CM RY++      +E  PF    +     + +
Sbjct:    93 CISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSRIILGQMEPVPFSYTSSNVSVTDKE 152

Query:   145 KFTQILNQTFNDV-IRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSA 203
              F++ L    + +  +   ++++K       +    T+   A C PDLS+SDC +CL   
Sbjct:   153 GFSKGLGDLLDSLGAKIDAANETKEVKFAAGVKG--TIYALAQCTPDLSESDCRICLAQI 210

Query:   204 VAQIPTCSKGKRGARIFCPSCSIRYELYRFLVDTPTVTVTAP-----NKTRK-------- 250
              A +PTC  GK G     PSC  R+E+Y F   + T     P     N TR+        
Sbjct:   211 FAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLSSHNNNTRRSDQGKSKD 270

Query:   251 RWITIAEAASAIIVFLLSTSFLWCIIRRRNKRK------QEESQAFPLFPLDLIDIVKAT 304
             R  T+  A   I+  +L   FL+  ++RR K+K      + E ++      D   I  AT
Sbjct:   271 RSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENAENEFESTDSLHFDFETIRVAT 330

Query:   305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
              DFS  NK+GEGGFG VYKG L DG EIAVKRLS  SGQG  EFK EV ++ KLQHKNLV
Sbjct:   331 DDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKTEVLLMTKLQHKNLV 390

Query:   365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
             +L G  ++E+E LL+YE++PN SLD FLFD  +  QLDW++R +II G++RG+LYLHE S
Sbjct:   391 KLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIVGVSRGLLYLHEGS 450

Query:   425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
                IIHRDLK+SNVLLD +M PKISDFGMAR F  + ++A T RVVGTYGYMAPEYAM G
Sbjct:   451 EFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVGTYGYMAPEYAMHG 510

Query:   485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
              FSVK+DV+SFGV++LEII+GK+++G    E G  L  + W+ W EG + EL+D V+ Q+
Sbjct:   511 RFSVKTDVYSFGVLVLEIITGKRNSGLGLGE-GTDLPTFAWQNWIEGTSMELIDPVLLQT 569

Query:   545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT--LPKPTQPAFSLSRVVSAQ 602
              D+ E ++ + I L CVQ +P  RPTM SV  ML+SD  +  LPKP+QP F   R  SA 
Sbjct:   570 HDKKESMQCLEIALSCVQENPTKRPTMDSVVSMLSSDSESRQLPKPSQPGF-FRR--SAS 626

Query:   603 FVSHSEDHCSVNAITLSTMSPR 624
             F        S+N ++L+ +S R
Sbjct:   627 F------SISLNDVSLTDLSAR 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8GYA4	CRK10_ARATH	2, ., 7, ., 1, 1, ., -	0.4491	0.9310	0.8684	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	624
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-55
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-54
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-53
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-50
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-39
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-37
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-35
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-28
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-28
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-27
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-26
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-25
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-25
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-24
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-23
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-23
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-22
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-22
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-21
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-20
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-20
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	5e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-15
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  187 bits (477), Expect = 4e-55
 Identities = 93/278 (33%), Positives = 126/278 (45%), Gaps = 41/278 (14%)

Query: 310 ENKLGEGGFGPVYKGVLADGK-----EIAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNL 363
             KLGEG FG VYKG L         E+AVK L    S Q ++EF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V+LLG C EE    ++ EYM    L  +L       +L     +S    IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEY 480
                IHRDL   N L+   +  KISDFG++R    +    +  R  G      +MAPE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 481 AMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWK---LWCEGHAAEL 536
              G F+ KSDV+SFGV+L EI + G++    Y       +L Y+     L    +    
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYRLPQPPNCPPE 231

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
           +  ++ Q                C   DP DRPT S +
Sbjct: 232 LYDLMLQ----------------CWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  186 bits (475), Expect = 9e-55
 Identities = 96/278 (34%), Positives = 131/278 (47%), Gaps = 40/278 (14%)

Query: 310 ENKLGEGGFGPVYKGVLADGK-----EIAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNL 363
             KLGEG FG VYKG L         E+AVK L    S Q ++EF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V+LLG C EE   +++ EYMP   L  +L    R  +L     +S    IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEY 480
                IHRDL   N L+   +  KISDFG++R    +    +  +V G      +MAPE 
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175

Query: 481 AMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWK---LWCEGHAAEL 536
              G F+ KSDV+SFGV+L EI + G++    Y       +L Y+ K   L    +    
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYRLPKPPNCPPE 232

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
           +  ++ Q                C   DP DRPT S +
Sbjct: 233 LYKLMLQ----------------CWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  186 bits (474), Expect = 1e-54
 Identities = 100/289 (34%), Positives = 136/289 (47%), Gaps = 47/289 (16%)

Query: 311 NKLGEGGFGPVYKGVLADGK----EIAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
            KLGEG FG VYKG L        E+AVK L    S +  ++F  E  V+ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFL------FDSTRSVQLDWKRRISIIKGIARGILY 419
           LLG C EE    L+ EYM    L  +L      F S     L  K  +S    IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAP 478
           L      K +HRDL   N L+  ++  KISDFG++R ++  +  +  T   +    +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           E    GIF+ KSDV+SFGV+L EI + G            P         +      E++
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGAT----------P---------YPGLSNEEVL 217

Query: 538 DSVVK-------QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA 579
           + + K       + C   EL + +   L C Q DP DRPT S +   L 
Sbjct: 218 EYLRKGYRLPKPEYCPD-ELYELM---LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (469), Expect = 2e-54
 Identities = 75/194 (38%), Positives = 109/194 (56%), Gaps = 11/194 (5%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           LGEGGFG VY       GK++A+K + +  S   L+E   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +EN   L+ EY    SL   L +     +L     + I+  I  G+ YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 431 RDLKTSNVLLDH-EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSV 488
           RDLK  N+LLD      K++DFG++++   ++S   T  +VGT  YMAPE  +G G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 489 KSDVFSFGVVLLEI 502
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  183 bits (468), Expect = 1e-53
 Identities = 89/264 (33%), Positives = 116/264 (43%), Gaps = 22/264 (8%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRL--SRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           KLG G FG VYK      GK +AVK L       +  Q  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +++   L+ EY     L  +L        L       I   I RG+ YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FS 487
           IHRDLK  N+LLD     KI+DFG+A+    + S   T   VGT  YMAPE  +GG  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177

Query: 488 VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 547
            K DV+S GV+L E+++GK    F        L      L        L     K S   
Sbjct: 178 PKVDVWSLGVILYELLTGK--PPFSGENILDQLQLIRRILGP-----PLEFDEPKWSSGS 230

Query: 548 AELLKYIHIGLLCVQGDPIDRPTM 571
            E    I    L    DP  RPT 
Sbjct: 231 EEAKDLIK-KCLNK--DPSKRPTA 251

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  179 bits (457), Expect = 4e-52
 Identities = 92/282 (32%), Positives = 126/282 (44%), Gaps = 44/282 (15%)

Query: 312 KLGEGGFGPVYKGVLADGKE-----IAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVR 365
           KLGEG FG VYKG L    E     +AVK L    S +  +EF  E +++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           LLG C +     ++ EYMP   L  FL      + L     + +   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--LQMALQIAKGMEYLES--- 120

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              +HRDL   N L+   +  KISDFG++R I+  +  +      +    +MAPE    G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179

Query: 485 IFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWK-------LWCEGHAAEL 536
            F+ KSDV+SFGV+L EI + G++    Y       +L  +           C     EL
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLELLEDGYRLPRPENCPDELYEL 236

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           M                    L C   DP DRPT S +   L
Sbjct: 237 M--------------------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (445), Expect = 2e-50
 Identities = 81/282 (28%), Positives = 126/282 (44%), Gaps = 32/282 (11%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLV 364
           +    KLGEG FG VY       GK +A+K + +   +  +E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           RL     +E++  L+ EY     L   L      +  D  R    ++ I   + YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEAR--FYLRQILSALEYLHS-- 115

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              I+HRDLK  N+LLD + + K++DFG+AR     +        VGT  YMAPE  +G 
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            +    D++S GV+L E+++GK    F   +     L  ++K   +             S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK--PPFPGDDQ----LLELFKKIGKPK-PPFPPPEWDIS 224

Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
            +  +L++     LL    DP  R T        A + L  P
Sbjct: 225 PEAKDLIR----KLLVK--DPEKRLT--------AEEALQHP 252

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  153 bits (390), Expect = 1e-42
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 33/274 (12%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN 362
           ++++   LG G FG VY  +  D G+ +AVK   LS  S + L+  + E+ +++ LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 363 LVRLLGCCL-EENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG----IARG 416
           +VR  G    EE  +L I+ EY+   SL   L       +   K    +I+     I  G
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL-------KKFGKLPEPVIRKYTRQILEG 113

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YLH      I+HRD+K +N+L+D +   K++DFG A+  G  ++   T  V GT  +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           APE   G  +   +D++S G  ++E+ +GK    +    +  + L  I      G + E 
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALYKI------GSSGEP 222

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
            +     S +  + L        C++ DP  RPT
Sbjct: 223 PEIPEHLSEEAKDFL------RKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  143 bits (362), Expect = 9e-39
 Identities = 66/203 (32%), Positives = 113/203 (55%), Gaps = 11/203 (5%)

Query: 306 DFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            F    K+G+GGFG VYK      GKE+A+K +   S +  ++  NE+ ++ K +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARGILYLHED 423
           +  G  L+++E  ++ E+    SL   L  + +++       I+ + K + +G+ YLH  
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ---IAYVCKELLKGLEYLHS- 116

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               IIHRD+K +N+LL  +   K+ DFG++     + +KA  N +VGT  +MAPE   G
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKA-RNTMVGTPYWMAPEVING 171

Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
             +  K+D++S G+  +E+  GK
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  138 bits (349), Expect = 9e-37
 Identities = 80/291 (27%), Positives = 124/291 (42%), Gaps = 49/291 (16%)

Query: 311 NKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
            +LGEG FG V            G+++AVK L+ +   Q   +F+ E+ ++  L H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 365 RLLGCCLE--ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +  G C +       LI EY+P+ SL  +L       Q++ KR +     I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK----ANTNRVVGTYGYMAP 478
               + IHRDL   N+L++ E   KISDFG+A++    + K             + Y AP
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY-AP 181

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD 538
           E      FS  SDV+SFGV L E+        F + +   S  A   ++           
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQG----- 228

Query: 539 SVVKQSCDQAELLK--------------YIHIGLLCVQGDPIDRPTMSSVA 575
                     ELLK                 +  LC + +P DRP+ + + 
Sbjct: 229 --QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (335), Expect = 5e-35
 Identities = 69/194 (35%), Positives = 103/194 (53%), Gaps = 15/194 (7%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE 372
           +G+G FG V  G    G+++AVK L   S    Q F  E +V+  L+H NLV+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRD 432
            N   ++ EYM   SL  +L    R+V +   +++     +  G+ YL E      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 433 LKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGGIFSVKS 490
           L   NVL+  ++  K+SDFG+A+       +A+  +  G     + APE      FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  133 bits (336), Expect = 6e-35
 Identities = 77/226 (34%), Positives = 115/226 (50%), Gaps = 27/226 (11%)

Query: 300 IVKATQDFSQENKLGEGGFGPVYKGVLADGKE------IAVKRLSRT-SGQGLQEFKNEV 352
           I  +   F +E  LGEG FG VYKG L    E      +A+K L      +  QEF+ E 
Sbjct: 2   IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEA 59

Query: 353 TVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-----------DSTRSVQ- 400
            +++ LQH N+V LLG C +E  + +++EY+ +  L  FL                +V+ 
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 401 -LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFG 458
            LD    + I   IA G+ YL   S    +HRDL   N L+   +  KISDFG++R I+ 
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            +  +  +  ++    +M PE  + G F+ +SD++SFGVVL EI S
Sbjct: 177 ADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  131 bits (332), Expect = 1e-34
 Identities = 68/200 (34%), Positives = 107/200 (53%), Gaps = 6/200 (3%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           ++F+ E KLG G FG V++G+  +   +A+K L        Q+F+ EV  + +L+HK+L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L   C       +I E M   SL  FL      V L     I +   +A G+ YL E  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ- 123

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N+L+  ++  K++DFG+AR+   +   ++  ++   Y + APE A  G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179

Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSDV+SFG++L E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  131 bits (332), Expect = 2e-34
 Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 24/223 (10%)

Query: 293 FPLDLIDIVKATQD----FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE 347
               L DIV    D    +    K+GEG  G VYK    A GKE+A+K++ R   Q  + 
Sbjct: 4   LKAALKDIVSE-GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61

Query: 348 FKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL----DVFLFDSTRSVQLDW 403
             NE+ ++   +H N+V      L  +E  ++ EYM   SL                   
Sbjct: 62  IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP----- 116

Query: 404 KRRIS-IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
             +I+ + + + +G+ YLH      +IHRD+K+ N+LL  + + K++DFG A      +S
Sbjct: 117 --QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           K N+  VVGT  +MAPE      +  K D++S G++ +E+  G
Sbjct: 172 KRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  132 bits (333), Expect = 7e-34
 Identities = 88/318 (27%), Positives = 138/318 (43%), Gaps = 26/318 (8%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQH-KNLVRLL 367
           KLGEG FG VY     D K +A+K L++      + ++ F  E+ ++A L H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               +E    L+ EY+   SL+  L    R   L     + I+  I   + YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 428 IIHRDLKTSNVLLDHEMN-PKISDFGMARIFGGNQSKAN----TNRVVGTYGYMAPEYAM 482
           IIHRD+K  N+LLD +    K+ DFG+A++     S ++     +  VGT GYMAPE  +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 483 GGIF---SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS-LLAYIWKLWCEGHAAELMD 538
           G      S  SD++S G+ L E+++G        +    S  L  I +L         + 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-----PTPSLA 236

Query: 539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSLSRV 598
           S +  S  +        +    +  DP +R + SS    L+ D+L   K  +   S    
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD---LSHDLLAHLKLKESDLSDLLK 293

Query: 599 VSAQFVSHSEDHCSVNAI 616
                        S+ A+
Sbjct: 294 PDDSAPLRLSLPPSLEAL 311

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  127 bits (322), Expect = 3e-33
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 45/291 (15%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKN 362
            +    ++G+G FG VY     +DGK   +K   LS  S +  ++  NEV ++ KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-------LDWKRRISIIKGIAR 415
           +++      E+ +  ++ EY     L   +    +  +       LDW  ++ +      
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL------ 114

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH     KI+HRD+K  N+ L      K+ DFG++++       A T  VVGT  Y
Sbjct: 115 ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           ++PE      ++ KSD++S G VL E+ + K    F     G +LL    K+  +G    
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--FE----GENLLELALKI-LKGQYPP 222

Query: 536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
           +       S +   L+         +Q DP +RP+         + IL  P
Sbjct: 223 IPSQY---SSELRNLVS------SLLQKDPEERPS--------IAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (320), Expect = 6e-33
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKN 362
            D     +LG G  G V K +    GK +AVK +     + +Q +   E+ ++ K     
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V   G      +  +  EYM   SLD  L +    +      +I++   + +G+ YLHE
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHE 118

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
               KIIHRD+K SN+L++     K+ DFG++       S A T   VGT  YMAPE   
Sbjct: 119 K--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQ 172

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
           G  +SVKSD++S G+ L+E+ +G+
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  127 bits (321), Expect = 6e-33
 Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 23/223 (10%)

Query: 313 LGEGGFGPVYKGVLADGKE------IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVR 365
           LGEG FG V+ G     +       +AVK L  T+    ++ F+ E  ++   QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLF----DSTRSV-------QLDWKRRISIIKGIA 414
             G C E +  ++++EYM +  L+ FL     D+           +L   + + I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTY 473
            G++YL   +    +HRDL T N L+ +++  KI DFGM+R ++  +  +   + ++   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
            +M PE  M   F+ +SDV+SFGVVL EI +  K   +  S  
Sbjct: 190 -WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 5e-32
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 29/208 (13%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           + +G G FG VYKG+ L  G  +A+K++S      + L+    E+ ++  L+H N+V+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR--------ISIIKGIARGILY 419
           G     +   +I EY  N SL        R +    K+            +  + +G+ Y
Sbjct: 66  GSIETSDSLYIILEYAENGSL--------RQII---KKFGPFPESLVAVYVYQVLQGLAY 114

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE     +IHRD+K +N+L   +   K++DFG+A           +  VVGT  +MAPE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPE 169

Query: 480 -YAMGGIFSVKSDVFSFGVVLLEIISGK 506
              M G  S  SD++S G  ++E+++G 
Sbjct: 170 VIEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (311), Expect = 1e-31
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 41/277 (14%)

Query: 306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQHK 361
           D  +   LG+G  G VYK      GK  A+K++        +  ++   E+  +   +  
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESP 59

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIIKGIARGILY 419
            +V+  G   +E E  ++ EYM   SL     D  + V       +   I + I +G+ Y
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLA----DLLKKVGK-IPEPVLAYIARQILKGLDY 114

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH  ++  IIHRD+K SN+L++ +   KI+DFG++++      + NT   VGT  YM+PE
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPE 170

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK------KSTGFYHSEHGPSLLAYIWKLWCEGHA 533
              G  +S  +D++S G+ LLE   GK          F+       L+  I    C+G  
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------ELMQAI----CDGPP 220

Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
             L            E   +I     C+Q DP  RP+
Sbjct: 221 PSLPAEEFSP-----EFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  122 bits (308), Expect = 2e-31
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 12/204 (5%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + F    KLGEG +G VYK +    G+ +A+K +       LQE   E++++ +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60

Query: 364 VRLLGCCLEENESLLIYEYMPNKS-LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           V+  G   +  +  ++ EY    S  D  +   T    L  +   +I+    +G+ YLH 
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLH- 116

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
               K IHRD+K  N+LL+ E   K++DFG++       +K NT  V+GT  +MAPE   
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
              ++ K+D++S G+  +E+  GK
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 2e-31
 Identities = 96/289 (33%), Positives = 128/289 (44%), Gaps = 50/289 (17%)

Query: 311 NKLGEGGFGPVYKGV--LADGKEI--AVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVR 365
            +LG G FG V KGV  +  GKE+  AVK L +     G +EF  E +V+A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK------GIARGILY 419
           L+G C  E   +L+ E  P   L  +L           +R I +         +A G+ Y
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKK---------RREIPVSDLKELAHQVAMGMAY 110

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTY--GY 475
           L        +HRDL   NVLL +    KISDFGM+R  G      +A T    G +   +
Sbjct: 111 LESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKW 164

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAA 534
            APE    G FS KSDV+S+GV L E  S G K    Y    G  ++A +      G   
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMKGAEVIAMLES----GERL 217

Query: 535 ELMDSVVKQSCDQAELLKYIH-IGLLCVQGDPIDRPTMSSVAVMLASDI 582
              +      C Q      I+ I L C +  P DRPT S +      D 
Sbjct: 218 PRPE-----ECPQ-----EIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 3e-31
 Identities = 81/268 (30%), Positives = 121/268 (45%), Gaps = 35/268 (13%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG G FG V+ G      ++AVK L +      + F  E  ++ KL+H  LV+L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
           C EE    ++ EYM   SL  FL       +L   + + +   IA G+ YL        I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMGGIF 486
           HRDL   N+L+   +  KI+DFG+AR+   ++  A      G      + APE A  G F
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRF 181

Query: 487 SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI---WKLWC-EGHAAELMDSVVK 542
           ++KSDV+SFG++L EI++  +    Y       +L  +   +++        EL D    
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP--YPGMTNREVLEQVERGYRMPRPPNCPEELYD---- 235

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPT 570
                        + L C   DP +RPT
Sbjct: 236 -------------LMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  119 bits (301), Expect = 2e-30
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)

Query: 309 QENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           + NK+G G FG VY  V L  G+ +AVK  R+     + ++E  +E+ V+  L+H NLV+
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
             G  +   +  +  EY    +L+  L +  R +     R  +    +  G+ YLH    
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYT--LQLLEGLAYLHSH-- 118

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT--NRVVGTYGYMAPEYAMG 483
             I+HRD+K +N+ LDH    K+ DFG A     N +        + GT  YMAPE   G
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 484 GIFSVK---SDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
           G        +D++S G V+LE+ +GK+      +E        ++ +   GH   + DS 
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHV-GAGHKPPIPDS- 230

Query: 541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS 572
           ++ S +  + L        C++ DP  RPT S
Sbjct: 231 LQLSPEGKDFLD------RCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 3e-30
 Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 34/215 (15%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKR---------LSRTSGQGLQEFKNEVTVIA 356
           + +  KLGEG +G VYK      G+ +A+K+         +  T+   L+E    ++++ 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA-- 414
           +L+H N+V+LL     E +  L++EY  +  L  +L    R   L      ++IK I   
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLS----PNLIKSIMYQ 106

Query: 415 --RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
             RG+ Y H  S  +I+HRDLK  N+L++ +   K++DFG+AR F G   +  T+ VV T
Sbjct: 107 LLRGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-T 161

Query: 473 YGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
             Y APE  +G   +S   D++S G +  E+I+GK
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  118 bits (298), Expect = 5e-30
 Identities = 73/207 (35%), Positives = 112/207 (54%), Gaps = 15/207 (7%)

Query: 306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKN 362
           DF   NK+G+G FG V+K V  AD +  A+K+  LS+ + +  +E  +E  V+AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL---FDSTRSVQLDWKRRISIIKGIARGILY 419
           ++R     L++ +  ++ EY  N  L   L             W+  I I+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH     KI+HRD+K+ N+ LD   N KI D G+A++   N + ANT  +VGT  Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK 506
                 ++ KSDV++ GVVL E  +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 5e-30
 Identities = 73/221 (33%), Positives = 121/221 (54%), Gaps = 26/221 (11%)

Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGK----EIAVKRLSRTSG-QGLQEFKNEVT 353
           I+K T+   +   LG G FG VYKGV + +G+     +A+K L   +  +  +E  +E  
Sbjct: 3   ILKETE-LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRRISI 409
           V+A + H ++VRLLG CL   +  LI + MP   L  ++ +   ++     L+W  +I  
Sbjct: 62  VMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI-- 118

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTN 467
               A+G+ YL E+ RL  +HRDL   NVL+    + KI+DFG+A++   ++    A   
Sbjct: 119 ----AKGMSYL-EEKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKK 507
           +V     +MA E  +  I++ KSDV+S+GV + E+++ G K
Sbjct: 172 KV--PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 3e-29
 Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 12/196 (6%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           KLG G FG V++G+  +   +AVK L   +    ++F  E  ++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
            E    ++ E M   SL  +L        L   + I +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMGGIFSV 488
           DL   NVL+      K++DFG+AR+   +  +A      G      + APE A+   FS+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 489 KSDVFSFGVVLLEIIS 504
           KSDV+SFG++L EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 6e-29
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 23/209 (11%)

Query: 313 LGEGGFGPVYKGVLAD------GKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLV 364
           LG+G FG VY+G+            +A+K ++   +  + + EF NE +V+ +    ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG--------IARG 416
           RLLG       +L++ E M    L  +L  S R    +                  IA G
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGY 475
           + YL      K +HRDL   N ++  ++  KI DFGM R I+  +  +     ++    +
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 187

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           MAPE    G+F+ KSDV+SFGVVL E+ +
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 7e-29
 Identities = 64/225 (28%), Positives = 113/225 (50%), Gaps = 20/225 (8%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEF----KNEVTVIAKLQHKNLVR 365
            ++GEG +G VYK      G+ +A+K++ R      + F      E+ ++ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI-RME-NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 366 LLGCCLEE--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           L      +      +++EYM +   D+     +  V+    +    +K +  G+ YLH +
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               I+HRD+K SN+L++++   K++DFG+AR +    S   TNRV+ T  Y  PE  +G
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175

Query: 484 GI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
              +  + D++S G +L E+  GK     +        L  I++L
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK---PIFQGSTELEQLEKIFEL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 9e-29
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 310 ENKLGEGGFGPVYKGVLA-DGKE---IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLV 364
           E  +G G FG V +G L   GK+   +A+K L   S    + +F  E +++ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           RL G   +    ++I EYM N SLD FL       +    + + +++GIA G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
            +  +HRDL   N+L++  +  K+SDFG++R    +++   T        + APE     
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+  SDV+SFG+V+ E++S
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  114 bits (286), Expect = 2e-28
 Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 24/271 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L +     ++EF  E  V+ +++H NLV
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 65

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 124

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 180

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  +G+  E       +
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKGYRMER-----PE 228

Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C      K   +   C Q +P DRP+ + +
Sbjct: 229 GCPP----KVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  114 bits (286), Expect = 2e-28
 Identities = 68/195 (34%), Positives = 104/195 (53%), Gaps = 7/195 (3%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
             KLG G FG V+ G      ++A+K L + S    + F  E  ++ +LQH  LVRL   
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             +E    +I EYM N SL  FL  +   ++L   + I +   IA G+ ++    R   I
Sbjct: 70  VTQE-PIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A          + APE    G F++K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIK 183

Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L EI++
Sbjct: 184 SDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  114 bits (286), Expect = 2e-28
 Identities = 82/270 (30%), Positives = 135/270 (50%), Gaps = 41/270 (15%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLS-----RTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG G FG VY+G+ L DG   AVK +S     +T  + +++ + E+ +++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 367 LGCCLEENESLLIY-EYMPNKSLDVFL--FDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           LG   EE ++L I+ E +P  SL   L  + S     +    R  I+ G+     YLH+ 
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR 121

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--TNRVVGTYGYMAPEYA 481
                +HRD+K +N+L+D     K++DFGMA+     Q           G+  +MAPE  
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVI 173

Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
              G + + +D++S G  +LE+ +GK     +    G   +A ++K+        + D +
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP---WSQLEG---VAAVFKIGRSKELPPIPDHL 227

Query: 541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
             ++ D      +I   L C+Q DP  RPT
Sbjct: 228 SDEAKD------FI---LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  114 bits (286), Expect = 3e-28
 Identities = 71/210 (33%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 311 NKLGEGGFGPVYKGVL----ADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNL 363
             LG G FG VY+G+      D  E+ V   +     S Q   +F  E  +++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILY 419
           VRL+G   E     ++ E M    L  FL ++     R   L  K  +   + +A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMAR-IFGGNQSKANTNRVVGTYG 474
           L E+     IHRD+   N LL  +  P    KI+DFGMAR I+  +  +    R +    
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG-GRAMLPIK 186

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  + GIF+ K+DV+SFGV+L EI S
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  114 bits (286), Expect = 3e-28
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 50/298 (16%)

Query: 310 ENKLGEGGFGPVYK----GVLADGKE--IAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKN 362
              +G+G FG V++    G+L       +AVK L    S     +F+ E  ++A+  H N
Sbjct: 10  VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST-------------------RSVQLDW 403
           +V+LLG C       L++EYM    L+ FL   +                     + L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQS 462
             ++ I K +A G+ YL E    K +HRDL T N L+   M  KI+DFG++R I+  +  
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG--KKSTGFYHSEHGPSL 520
           KA+ N  +    +M PE      ++ +SDV+++GVVL EI S   +   G  H E    +
Sbjct: 187 KASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----V 241

Query: 521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           + Y+     +G+           SC     L+  ++  LC    P DRP+ +S+  +L
Sbjct: 242 IYYVR----DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 8e-28
 Identities = 76/264 (28%), Positives = 122/264 (46%), Gaps = 21/264 (7%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+G+G FG VYKGVL    E+AVK    T    L ++F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           +++    ++ E +P  SL  FL    +  +L  K+ + +    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL   N L+      KISDFGM+R   G     +         + APE    G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 491 DVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 550
           DV+S+G++L E  S   +                +         E ++S  +    Q   
Sbjct: 177 DVWSYGILLWETFSLGDTP---------------YPGMSNQQTRERIESGYRMPAPQLCP 221

Query: 551 LKYIHIGLLCVQGDPIDRPTMSSV 574
            +   + L C   DP +RP+ S +
Sbjct: 222 EEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  111 bits (278), Expect = 2e-27
 Identities = 74/211 (35%), Positives = 107/211 (50%), Gaps = 15/211 (7%)

Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVT 353
           P + I +VK         KLG G FG V+ G   +  ++AVK L +     +Q F  E  
Sbjct: 4   PRESIKLVK---------KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEAN 53

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGI 413
           ++  LQH  LVRL     +E    +I EYM   SL  FL  S    ++   + I     I
Sbjct: 54  LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQI 112

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A G+ Y+    R   IHRDL+ +NVL+   +  KI+DFG+AR+   N+  A         
Sbjct: 113 AEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PI 168

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE    G F++KSDV+SFG++L EI++
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  111 bits (279), Expect = 2e-27
 Identities = 74/223 (33%), Positives = 113/223 (50%), Gaps = 24/223 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           +D   + +LGEG FG V+           D   +AVK L   S    Q+F+ E  ++  L
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL 64

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL---------FDSTRSV---QLDWKRR 406
           QH+++VR  G C E    L+++EYM +  L+ FL               V   QL   + 
Sbjct: 65  QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           ++I   IA G++YL   + L  +HRDL T N L+   +  KI DFGM+R I+  +  +  
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKK 507
             R +    +M PE  +   F+ +SD++SFGVVL EI + GK+
Sbjct: 182 -GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 4e-27
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 313 LGEGGFGPVYKGV--LADGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG+G FG V   V     GK  A+K L +      + ++    E  +++++ H  +V+L 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 368 GCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
               +  E L L+ EY P   L             +  R       I   + YLH    L
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGEL-FSHLSKEGRFSEERARFY--AAEIVLALEYLH---SL 112

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            II+RDLK  N+LLD + + K++DFG+A+      S+ NT    GT  Y+APE  +G  +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 487 SVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
               D +S GV+L E+++GK    FY  + 
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK--PPFYAEDR 198

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  110 bits (275), Expect = 5e-27
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
             QE  +G G FG V+ G   + +++A+K + R      ++F  E  V+ KL H  LV+L
Sbjct: 8   LVQE--IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
            G C E +   L++E+M +  L  +L    +  +   +  + +   +  G+ YL   +  
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMG 483
            +IHRDL   N L+      K+SDFGM R    +Q  ++T    GT     + +PE    
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSF 175

Query: 484 GIFSVKSDVFSFGVVLLEIISGKK 507
             +S KSDV+SFGV++ E+ S  K
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 311 NKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLG 368
           ++LGEG  G V K  L +   I A+K ++      LQ +   E+ +    +   +V+  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 369 CCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGILYL 420
             L+E+ S +    EY    SLD     S          RI       I + + +G+ YL
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H     KIIHRD+K SN+LL  +   K+ DFG++       S A T    GT  YMAPE 
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPER 174

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
             G  +S+ SDV+S G+ LLE+   +
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  109 bits (273), Expect = 2e-26
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 51/290 (17%)

Query: 313 LGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 368 GCCLE--ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           G C         L+ EY+P  SL  +L       +LD ++ +     I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAPEY 480
            + +HRDL T N+L++ E   KI DFG+ ++   ++        V   G     + APE 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESPIFWYAPES 182

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLA-YIWKLWCEGHAAELMDS 539
                FSV SDV+SFGVVL E+        F +S+   S  A ++  +  +     +   
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMI--- 231

Query: 540 VVKQSCDQAELLKY-------------IH-IGLLCVQGDPIDRPTMSSVA 575
                    ELLK              I+ I   C   DP  RP+ S +A
Sbjct: 232 ----VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 3e-26
 Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 21/205 (10%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKR-----LSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG VY     D G+E+AVK+      S  + + +   + E+ ++  LQH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 367 LGCCLEENESLLIY-EYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGILYLHE 422
            GC L ++E+L I+ EYMP  S+   L      T +V   + R+I        G+ YLH 
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLHS 122

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +    I+HRD+K +N+L D   N K+ DFG + R+     S      V GT  +M+PE  
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
            G  +  K+DV+S G  ++E+++ K
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  108 bits (271), Expect = 4e-26
 Identities = 69/207 (33%), Positives = 120/207 (57%), Gaps = 14/207 (6%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTS-GQGLQEFK-NEVTVIAKLQHKN 362
           D+++  K+GEG +G VYKG     G+ +A+K++   S  +G+      E++++ +LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLF-DSTRSVQ-LDWKRRISIIKGIARGILYL 420
           +V L    ++E+   LI+E++   S+D+  + DS    Q +D +   S +  I +GIL+ 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H     +++HRDLK  N+L+D++   K++DFG+AR F G   +  T+ VV T  Y APE 
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172

Query: 481 AMGGI-FSVKSDVFSFGVVLLEIISGK 506
            +G   +S   D++S G +  E+ + K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  107 bits (268), Expect = 4e-26
 Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 37/271 (13%)

Query: 313 LGEGGFGPVY--------KGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +G G FG V+        K V+   K+I V+++++      Q   NE  V+  L H N++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
                 LE+   +++ EY P  +L  ++     S+ LD     +I+    + +L LH   
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDED---TILHFFVQILLALHHVH 118

Query: 425 RLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              I+HRDLKT N+LLD H+M  KI DFG+++I   ++SKA T  VVGT  Y++PE   G
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEG 175

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
             ++ KSD+++ G VL E+ S K++   + + + P+L+  I      G  A + D     
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRA---FEAANLPALVLKIMS----GTFAPISDRY--- 225

Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
               +  L+ + + +L +  DP  RP +S +
Sbjct: 226 ----SPDLRQLILSMLNL--DPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  107 bits (269), Expect = 5e-26
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 22/210 (10%)

Query: 313 LGEGGFGPVYKG----VLADGKE---IAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLV 364
           LG G FG VY+G    +L  G     +AVK L + +  Q  +EF  E  +++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFD----STRSVQLDWKRRISIIKGIARGILYL 420
           +LLG CL      +I E M    L  +L D          L  K  + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 421 HEDSRLKIIHRDLKTSNVLL-----DHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYG 474
               ++  IHRDL   N L+     D +   KI DFG+AR I+  +  +     ++    
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +MAPE  + G F+ +SDV+SFGV++ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  107 bits (269), Expect = 8e-26
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 35/228 (15%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFK-----NEVTVIAKL 358
            DF     +GEG F  V         KE A+K L +   Q ++E K      E  V+ +L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 359 -QHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
             H  +++L     ++ E+L  + EY PN  L  ++    +   LD K        I   
Sbjct: 59  NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLA 114

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS-------------- 462
           + YLH      IIHRDLK  N+LLD +M+ KI+DFG A++   N S              
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 463 ----KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
               +      VGT  Y++PE          SD+++ G ++ ++++GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  106 bits (265), Expect = 1e-25
 Identities = 67/196 (34%), Positives = 107/196 (54%), Gaps = 9/196 (4%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
             KLG G FG V+ G      ++AVK L +      + F  E  ++ KL+H  LV+L   
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
             EE    ++ EYM   SL  FL D   R+++L     + +   +A G+ Y+    R+  
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
           IHRDL+++N+L+   +  KI+DFG+AR+   N+  A          + APE A+ G F++
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 182

Query: 489 KSDVFSFGVVLLEIIS 504
           KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (280), Expect = 2e-25
 Identities = 92/351 (26%), Positives = 159/351 (45%), Gaps = 41/351 (11%)

Query: 247 KTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRN----KRKQEESQAFPLFPLD------ 296
           KT   W  I     A +V  L  +F +  IR RN    KR + E   + L   D      
Sbjct: 624 KTPSWWFYITCTLGAFLVLALV-AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKS 682

Query: 297 --LIDIVKATQDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQEFKNEVT 353
             + DI+ + ++   EN +  G  G  YKG  + +G +  VK ++  +        +E+ 
Sbjct: 683 ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIA 735

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGI 413
            + KLQH N+V+L+G C  E  + LI+EY+  K+L   L +      L W+RR  I  GI
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGI 789

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A+ + +LH      ++  +L    +++D +  P +                   +   + 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISS 842

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC--EG 531
            Y+APE       + KSD++ FG++L+E+++GK         HG S++   W  +C  + 
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVE--WARYCYSDC 899

Query: 532 HAAELMDSVVKQ--SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
           H    +D  ++   S +Q E+++ +++ L C   DP  RP  + V   L S
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 11/204 (5%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKN 362
           + F+    +G+G FG VYK +     + +A+K +    +   +++ + E+  +++ +   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           + +  G  L+ ++  +I EY    S      D  +  +LD      I++ +  G+ YLHE
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
           +     IHRD+K +N+LL  E + K++DFG++       SK NT   VGT  +MAPE   
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIK 171

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
              +  K+D++S G+  +E+  G+
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  105 bits (265), Expect = 3e-25
 Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 312 KLGEGGFGPVY--------KGVLADGKE---------IAVKRLSRT-SGQGLQEFKNEVT 353
           KLGEG FG V+                E         +AVK L    S    ++F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL--------FDSTRSVQLDWKR 405
           ++++L   N+ RLLG C  +    +I EYM N  L+ FL          +  S  L +  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKA 464
            + +   IA G+ YL     L  +HRDL T N L+      KI+DFGM+R ++  +  + 
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              R      +MA E  + G F+ KSDV++FGV L EI++
Sbjct: 189 Q-GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 3e-25
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE 372
           LG G FG V+ G      ++A+K + R       +F  E  V+ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRD 432
           +    ++ EYM N  L  +L +    +  +W   + +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 433 LKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMGGIFSVK 489
           L   N L+  +   K+SDFG+AR    +Q  ++     GT     +  PE      FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181

Query: 490 SDVFSFGVVLLEIISGKK 507
           SDV+SFGV++ E+ S  K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  105 bits (262), Expect = 3e-25
 Identities = 67/211 (31%), Positives = 114/211 (54%), Gaps = 27/211 (12%)

Query: 308 SQENKLGEGGFGPVYKGVL--ADGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKN 362
           +++  +G G FG V++G+L     KE+AV   +   G   +  Q+F +E +++ +  H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST---RSVQLDWKRRISIIKGIARGILY 419
           ++RL G   +   +++I EYM N +LD +L D      S QL     + +++GIA G+ Y
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKY 122

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG----- 474
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +     T     T G     
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPI 174

Query: 475 -YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      F+  SDV+SFG+V+ E++S
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  104 bits (261), Expect = 6e-25
 Identities = 79/227 (34%), Positives = 121/227 (53%), Gaps = 27/227 (11%)

Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVL---ADGKE---IAVKRLS-RTSGQGLQEFKNE 351
           +I  +T  F +E  LGE  FG VYKG L   A G++   +A+K L  +  G   +EFK+E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-------------DSTRS 398
             + ++LQH N+V LLG   +E    +I+ Y  +  L  FL              D T  
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 399 VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IF 457
             L+    + I+  IA G+ +L   S   ++H+DL T NVL+  ++N KISD G+ R ++
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +  K   N ++    +M+PE  M G FS+ SD++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  104 bits (260), Expect = 7e-25
 Identities = 67/208 (32%), Positives = 118/208 (56%), Gaps = 20/208 (9%)

Query: 313 LGEGGFGPVYKGVLA-DGKEIAVKR--LSRTSGQG-------LQEFKNEVTVIAKLQHKN 362
           +G G FG VY G+ A  G+ +AVK+  L   S          L     E+ ++ +LQH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V+ LG  L+ +   +  EY+P  S+   L ++  + +    R  + ++ I +G+ YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLH- 123

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN--QSKANTNR--VVGTYGYMAP 478
            +R  IIHRD+K +N+L+D++   KISDFG+++    N   +K N  R  + G+  +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E      ++ K+D++S G +++E+++GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  104 bits (261), Expect = 7e-25
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 313 LGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVR 365
           LG G FG V+    KG+  +G E  + VK L +T  + LQ EF+ E+ +  KL HKN+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFL------FDSTRSVQLDWKRRISIIKGIARGILY 419
           LLG C E     +I EY     L  FL       +  +   L  K+++++   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           L   S  + +HRDL   N L+  +   K+S   +++    N         +    ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIPLRWLAPE 188

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 FS KSDV+SFGV++ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (258), Expect = 1e-24
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 7/195 (3%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 11  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 184 SDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (257), Expect = 1e-24
 Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           ++      +G+G FG V  G    G ++AVK +   +    Q F  E +V+ +L+H NLV
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62

Query: 365 RLLGCCLEENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           +LLG  +EE   L I  EYM   SL  +L    RSV L     +     +   + YL  +
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN 121

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
           +    +HRDL   NVL+  +   K+SDFG+ +     Q             + APE    
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALRE 173

Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FS KSDV+SFG++L EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  102 bits (256), Expect = 2e-24
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 312 KLGEGGFGPVYKGVL-----ADGKEIAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVR 365
           +LGE  FG +YKG L        + +A+K L    + Q   EF+ E +++A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLF--------------DSTRSVQLDWKRRISIIK 411
           LLG   +E    +++EY+    L  FL               D T    LD    + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVV 470
            IA G+ YL   S    +H+DL   N+L+  +++ KISD G++R I+  +  +     ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
               +M PE  M G FS  SD++SFGVVL EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  103 bits (257), Expect = 3e-24
 Identities = 77/234 (32%), Positives = 125/234 (53%), Gaps = 24/234 (10%)

Query: 300 IVKATQDFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRLSRTSG-QGLQEFKNEVT 353
           I+K T+   +   LG G FG VYKG+     E     +A+K L+ T+G +   EF +E  
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRRISI 409
           ++A + H +LVRLLG CL     L + + MP+  L  ++ +   ++     L+W  +I  
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI-- 118

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
               A+G++YL E    +++HRDL   NVL+    + KI+DFG+AR+  G++ + N +  
Sbjct: 119 ----AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLL 521
                +MA E      F+ +SDV+S+GV + E+++  GK   G    E  P LL
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 15/194 (7%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
            +GEG FG V +G    G+++AVK +        Q F  E  V+ KL HKNLVRLLG  L
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRS-VQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
             N   ++ E M   +L  FL    R+ V +    + S+   +A G+ YL      K++H
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123

Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL   N+L+  +   K+SDFG+AR+        + +++     + APE      FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKS 178

Query: 491 DVFSFGVVLLEIIS 504
           DV+S+GV+L E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (254), Expect = 4e-24
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 12/208 (5%)

Query: 306 DFSQENK---LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK 361
           ++ +  +   LG+G +G VY    L+    IA+K +     + +Q    E+ + + L+H+
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+ LG   E     +  E +P  SL   L      ++ + +  I   K I  G+ YLH
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 422 EDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           +    +I+HRD+K  NVL++ +    KISDFG ++   G      T    GT  YMAPE 
Sbjct: 126 D---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPEV 180

Query: 481 AMGGI--FSVKSDVFSFGVVLLEIISGK 506
              G   +   +D++S G  ++E+ +GK
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  101 bits (253), Expect = 5e-24
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 37/275 (13%)

Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG   +  L     D   +  K   L+R S +  ++  NE+ +++ LQH N++  
Sbjct: 8   LGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFD---STRSVQLDWKRRISIIKGIARGILYLHED 423
               +++N  L+  EY    +L    +D     +    + +  +  +  I   + Y+H+ 
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTL----YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               I+HRD+KT N+ L      K+ DFG+++I G   S A T  VVGT  YM+PE   G
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQG 175

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
             ++ KSD+++ G VL E+++ K++          + L  + K+    +   +       
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTPVV------- 222

Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           S   +EL+  +H     +Q DP  RPT   V    
Sbjct: 223 SVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  100 bits (251), Expect = 1e-23
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 16/206 (7%)

Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLS------RTSGQGLQEFKNEVTVIAKLQHKNLV 364
             LG+G +G VY G+   G+ IAVK++         + +  ++ + EV ++  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           + LG CL++N   +  E++P  S+   L       +  + +     K I  G+ YLH + 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC 122

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR---IFGGNQSKANTNRVV-GTYGYMAPEY 480
              ++HRD+K +NV+L      K+ DFG AR     G + + +N  + + GT  +MAPE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
                +  KSD++S G  + E+ +GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  101 bits (254), Expect = 1e-23
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 25/221 (11%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQHK 361
           D+    KLGEG FG VYK   +  G+ +A+K++   +   G  +   + E+ ++ KL+H 
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHP 67

Query: 362 NLVRLLGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           N+V L+   +E       +   +Y   P    D+       SV+L   +    +  +  G
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEG 127

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF---------GGNQSKAN-T 466
           I YLHE+    I+HRD+K +N+L+D++   KI+DFG+AR +         GG       T
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 467 NRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           N VV T  Y  PE  +G   ++   D++  G V  E+ + +
Sbjct: 185 NLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 11/202 (5%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLV 364
           F++  ++G+G FG VYKG+    KE+ A+K +     +  +++ + E+TV+++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           R  G  L+  +  +I EY+   S      D  +   L+     +I++ I +G+ YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL  + + K++DFG+A      Q K NT   VGT  +MAPE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 485 IFSVKSDVFSFGVVLLEIISGK 506
            +  K+D++S G+  +E+  G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (252), Expect = 1e-23
 Identities = 75/220 (34%), Positives = 112/220 (50%), Gaps = 38/220 (17%)

Query: 313 LGEGGFGPVYKGVLADGKEI---------AVKRL-SRTSGQGLQEFKNEVTVIAKL-QHK 361
           LGEG FG V   V A+   +         AVK L    + + L +  +E+ ++  + +HK
Sbjct: 20  LGEGAFGQV---VKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRRIS 408
           N++ LLG C +E    ++ EY  + +L  FL            D  R     L  K  +S
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMAR-IFGGNQSKAN 465
               +ARG+ +L   S+ K IHRDL   NVL+  DH M  KI+DFG+AR I   +  +  
Sbjct: 137 FAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKT 191

Query: 466 TN-RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           TN R+     +MAPE     +++ +SDV+SFGV+L EI +
Sbjct: 192 TNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  100 bits (251), Expect = 2e-23
 Identities = 84/294 (28%), Positives = 130/294 (44%), Gaps = 52/294 (17%)

Query: 313 LGEGGFGPVYKGV------LADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVR 365
           LGEG FG V K         A    +AVK L   +    L++  +E  ++ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----------------------LDW 403
           L G C ++   LLI EY    SL  FL +S R V                       L  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRES-RKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK 463
              IS    I+RG+ YL E   +K++HRDL   NVL+      KISDFG++R      S 
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLL 521
              ++      +MA E     I++ +SDV+SFGV+L EI++  G    G       P  L
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-----APERL 238

Query: 522 AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA 575
              + L   G+  E  +     +C +       ++ L C + +P  RPT + ++
Sbjct: 239 ---FNLLKTGYRMERPE-----NCSEE----MYNLMLTCWKQEPDKRPTFADIS 280

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 312 KLGEGGFGPVYK-GVLADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           ++GEG  G V+K      G+ +A+K+  L R  G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR----GILYLHEDS 424
                +  +L+ EYMP+  L   L D  R +        + +K   R    G+ Y+H   
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLP------EAQVKSYMRMLLKGVAYMHA-- 117

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              I+HRDLK +N+L+  +   KI+DFG+AR+F   + +  +++ V T  Y APE   G 
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGA 175

Query: 485 -IFSVKSDVFSFGVVLLEIISG 505
             +    D+++ G +  E+++G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 67/209 (32%), Positives = 106/209 (50%), Gaps = 19/209 (9%)

Query: 306 DFSQENKLGEGGFGPVYK-GVLADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKN 362
           DF    KLG+G +G VYK   L+D +  A+K   L   S +  ++  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-----QLDWKRRISIIKGIARGI 417
           ++      L+ N+  ++ EY P   L   +    +       Q  W+  I +     RG+
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGL 116

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
             LHE    KI+HRDLK++N+LL      KI D G++++   N +K      +GT  YMA
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----QIGTPHYMA 169

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE   G  +S KSD++S G +L E+ +  
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 12/199 (6%)

Query: 312 KLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN--EVTVIAKLQHKNLVRLLG 368
           K+GEG +G VYK       EI A+K++               E+ ++ +L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               + +  L++E+M     D++     R   L      S +  + +G+ + H      I
Sbjct: 66  VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFS 487
           +HRDLK  N+L++ E   K++DFG+AR FG    +  T+ VV T  Y APE  +G   +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 488 VKSDVFSFGVVLLEIISGK 506
              D++S G +  E++S +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
             +G+G FG V K    +DGK +  K +     + +  Q+  +EV ++ +L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 368 G-CCLEENESLLIY-EYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILYLH--E 422
                  N++L I  EY     L   +    +  + ++ +    I+  +   +   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
           D    ++HRDLK +N+ LD   N K+ DFG+A+I G + S A T   VGT  YM+PE   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
              +  KSD++S G ++ E+ +  
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (249), Expect = 4e-23
 Identities = 70/221 (31%), Positives = 115/221 (52%), Gaps = 34/221 (15%)

Query: 312 KLGEGGFGPVY----KGVLA---------DGKE--IAVKRL-SRTSGQGLQEFKNEVTVI 355
           KLGEG FG V+    +G+           DG+   +AVK L +  +     +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-----------LDWK 404
           ++L++ N++RLLG C+ ++   +I EYM N  L+ FL  S R ++           +   
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVSIA 129

Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSK 463
             + +   IA G+ YL   + L  +HRDL T N L+ +    KI+DFGM+R ++ G+  +
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
               R V    +MA E  + G F+  SDV++FGV L E+ +
Sbjct: 187 IQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 99.0 bits (246), Expect = 6e-23
 Identities = 67/216 (31%), Positives = 112/216 (51%), Gaps = 22/216 (10%)

Query: 310 ENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +LGEG FG V+           D   +AVK L   S    ++F  E  ++  LQH+++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL----------FDSTRSVQLDWKRRISIIKGI 413
           V+  G C+E +  ++++EYM +  L+ FL           +  R  +L   + + I + I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGT 472
           A G++YL   +    +HRDL T N L+   +  KI DFGM+R ++  +  +   + ++  
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKK 507
             +M PE  M   F+ +SDV+S GVVL EI + GK+
Sbjct: 187 R-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 98.7 bits (246), Expect = 8e-23
 Identities = 71/207 (34%), Positives = 114/207 (55%), Gaps = 17/207 (8%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFK-NEVTVIAKLQHKNLV 364
           F Q  KLGEG +  VYKG      EI A+K +   + +G       E++++ +L+H+N+V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRISIIKGIARGILYLHE 422
           RL      EN+ +L++EYM     D+  +  T  V+  LD     S    + +GI + HE
Sbjct: 62  RLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT--NRVVGTYGYMAPEY 480
           +   +++HRDLK  N+L++     K++DFG+AR FG      NT  N VV T  Y AP+ 
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDV 171

Query: 481 AMGG-IFSVKSDVFSFGVVLLEIISGK 506
            +G   +S   D++S G ++ E+I+G+
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 26/271 (9%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           + KLG+G FG V+ G      ++A+K L +      + F  E  ++ KL+H  LV L   
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ E+M   SL  FL +      L   + + +   IA G+ Y+    R+  I
Sbjct: 70  VSEE-PIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 490 SDVFSFGVVLLEIISGKKS--TGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ 547
           SDV+SFG++L E+++  +    G  + E                   E ++   +  C Q
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNRE-----------------VLEQVERGYRMPCPQ 226

Query: 548 AELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                   +  LC + DP +RPT   +   L
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 13/203 (6%)

Query: 310 ENKLGEGGFGPVYKGVL-ADGKE---IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V +G L   GK    +A+K L S  + +  ++F +E +++ +  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L G   +    ++I E+M N +LD FL       Q    + + +++GIA G+ YL E  
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE-- 124

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG---TYGYMAPEYA 481
            +  +HRDL   N+L++  +  K+SDFG++R    + S       +G      + APE  
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               F+  SDV+S+G+V+ E++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 56/199 (28%), Positives = 106/199 (53%), Gaps = 15/199 (7%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQH---KNLVRLL 367
           +G G +G VY+G  +  G+ +A+K ++  T    + + + EV ++++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  L+     +I EY    S+   +    ++  +  K    II+ +   + Y+H+     
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-F 486
           +IHRD+K +N+L+ +  N K+ DFG+A +   N SK +T   VGT  +MAPE    G  +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179

Query: 487 SVKSDVFSFGVVLLEIISG 505
             K+D++S G+ + E+ +G
Sbjct: 180 DTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 69/202 (34%), Positives = 112/202 (55%), Gaps = 17/202 (8%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKNLVRLLG 368
           K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 369 CCLEENESLLIYEYMPNKSLDVFL---FDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
               EN+  L++E+     LD+ L    DS+    LD     S +  + +GI Y H  S 
Sbjct: 66  VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH 118

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG- 484
            +++HRDLK  N+L+D E   K++DFG+AR F G   +  T+ VV T  Y APE  +G  
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSR 175

Query: 485 IFSVKSDVFSFGVVLLEIISGK 506
            +S   D++S G +  E+++ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 75/270 (27%), Positives = 127/270 (47%), Gaps = 24/270 (8%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG G FG V+        ++AVK + +     ++ F  E  V+  LQH  LV+L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 370 CLEENESLLIYEYMPNKSLDVFL-FDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
             +E    +I E+M   SL  FL  D      L   + I     IA G+ ++ + +    
Sbjct: 70  VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---Y 123

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
           IHRDL+ +N+L+   +  KI+DFG+AR+   N+  A          + APE    G F++
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTI 182

Query: 489 KSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 548
           KSDV+SFG++L+EI++  +    Y     P ++  + +    G+     ++  ++  +  
Sbjct: 183 KSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALER----GYRMPRPENCPEELYN-- 234

Query: 549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                  I + C +  P +RPT   +  +L
Sbjct: 235 -------IMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 76/270 (28%), Positives = 130/270 (48%), Gaps = 34/270 (12%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQG---LQEFKNEVTVIAKLQHKNLVR 365
           LG G F   Y+   +  G  +AVK+++    TS +    ++  + E+ ++A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI--IKGIARGILYLHED 423
           +LG   E++   L  E+M   S+   L          +K  + I   + + RG+ YLHE+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN 122

Query: 424 SRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKAN--TNRVVGTYGYMAPEY 480
              +IIHRD+K +N+L+D      +I+DFG A       + A     +++GT  +MAPE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY-HSEHGPSLLAYIWKLWCEGHAAELMDS 539
             G  +    DV+S G V++E+ + K       HS H    LA I+K+     A  + + 
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATTAPSIPEH 235

Query: 540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
           +     D         + L C++  P DRP
Sbjct: 236 LSPGLRD---------VTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 45/287 (15%)

Query: 313 LGEGGFGPVYKGVLA--DGK--EIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V +G L+  DG   ++AVK  +L   +   ++EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 367 LGCCLEENES------LLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGI 417
           +G C E +        ++I  +M +  L  FL  S       +L  +  +  +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN---QSKANTNRVVGTY 473
            YL   S    IHRDL   N +L  +M   ++DFG+++ I+ G+   Q +     V    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKS--TGFYHSEHGPSLLAYIWKLWCEG 531
            ++A E     +++ KSDV++FGV + EI +  ++   G  + E        I+     G
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDYLRHG 231

Query: 532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           +        +KQ  D  + L  +     C + DP DRPT + +  +L
Sbjct: 232 NR-------LKQPEDCLDELYDLMY--SCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 67/237 (28%), Positives = 117/237 (49%), Gaps = 27/237 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKG------VLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           +D   + +LGEG FG V+           D   +AVK L   +    ++F+ E  ++  L
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 64

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF----DSTRSV---------QLDWKR 405
           QH+++V+  G C + +  ++++EYM +  L+ FL     D+   V         +L   +
Sbjct: 65  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKA 464
            + I   IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++  +  + 
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLL 521
             + ++    +M PE  M   F+ +SDV+SFGV+L EI +  K   F   +   + +
Sbjct: 182 GGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF---QLSNTEV 234

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 65/207 (31%), Positives = 90/207 (43%), Gaps = 27/207 (13%)

Query: 312 KLGEGGFGPVYKG--VLADGKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRL 366
           KLG+G FG V +G    + GK I  AVK L        + +F  E  ++  L H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-------WKRRISIIKGIARGILY 419
            G  L     +++ E  P  SL     D  R   L            + I  G+     Y
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMR----Y 112

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMA 477
           L      + IHRDL   N+LL  +   KI DFG+ R    N+       +  V  + + A
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCA 168

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           PE      FS  SDV+ FGV L E+ +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 3e-22
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 29/233 (12%)

Query: 307 FSQENKLGEGGFGPVYKGVL---ADGKEIAVKRL--SRTSGQGL-QEFKNEVTVIAKLQH 360
           +  E  +G G +G VYK       DGKE A+K+    +    G+ Q    E+ ++ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 361 KNLVRLLGCCLEENESL--LIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGI 417
           +N+V L+   LE  +    L+++Y  +    +  F    + V +      S++  I  G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGN-QSKANTNRVVGT 472
            YLH +    ++HRDLK +N+L+  E       KI D G+AR+F    +  A+ + VV T
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 473 YGYMAPEYAMGGIFSVKS-DVFSFGVVLLEIISG-----------KKSTGFYH 513
             Y APE  +G     K+ D+++ G +  E+++            KKS  F  
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.9 bits (241), Expect = 3e-22
 Identities = 71/202 (35%), Positives = 99/202 (49%), Gaps = 18/202 (8%)

Query: 313 LGEGGFGPV----YKGVLAD-GKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRL 366
           LGEG FG V    Y       G+ +AVK L R  GQ     +K E+ ++  L H+N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            GCC E+      LI EY+P  SL  +L      + L   + +   + I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQ- 126

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEYAM 482
               IHRDL   NVLLD++   KI DFG+A+    G    +   +     + Y A E   
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183

Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              FS  SDV+SFGV L E+++
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 91.4 bits (227), Expect = 3e-22
 Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 5/106 (4%)

Query: 22  YKFCPRGTNN---TASIIYVYNLSKLFNR--KLHEDGGNSLYRNASVGDYPDKVYGLFLC 76
           +  C   T+    TA+  +  NL+ L +             +   + G  PD VYGL  C
Sbjct: 1   FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQC 60

Query: 77  RFDVSHQVCQNCIFDAIDILVESCNGTKEATIWYDICMVRYSNNFF 122
           R D+S   C++C+  A+  L   C   K   IWYD C +RY +  F
Sbjct: 61  RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 32/272 (11%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKR--LSRTSGQGLQE--------FKNEVTVIAKLQHK 361
           +G+G +G VY  +    G+ +AVK+  L  T                ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 362 NLVRLLGCCLEENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           N+V+ LG      E L I+ EY+P  S+   L       + + +      + +  G+ YL
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE- 479
           H      I+HRDLK  N+L+D +   KISDFG+++             + G+  +MAPE 
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 480 -YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD 538
            ++    +S K D++S G V+LE+ +G++             +A ++KL  +  A  +  
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAIAAMFKLGNKRSAPPIPP 235

Query: 539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
            V       A     +     C   +P +RPT
Sbjct: 236 DVSMNLSPVA-----LDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.1 bits (239), Expect = 4e-22
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 310 ENKLGEGGFGPVYKGVLA--DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V  G L     +EI V   +  +G   +  ++F +E +++ +  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ YL   S
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL---S 123

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------YMAP 478
            +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R     G      + AP
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAP 178

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+V+ E++S
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 96.1 bits (239), Expect = 6e-22
 Identities = 69/220 (31%), Positives = 108/220 (49%), Gaps = 31/220 (14%)

Query: 312 KLGEGGFGPVY------------KGVLADGKE-----IAVKRLSRTSGQGLQ-EFKNEVT 353
           KLGEG FG V+            K    D        +AVK L   + +  + +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL--------FDSTRSVQLDWKR 405
           ++++L+  N++RLL  C+  +   +I EYM N  L+ FL         +    V + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKA 464
            I +   IA G+ YL   S L  +HRDL T N L+      KI+DFGM+R ++ G+  + 
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              R V    +M+ E  + G F+  SDV++FGV L EI++
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 96.5 bits (240), Expect = 6e-22
 Identities = 70/230 (30%), Positives = 112/230 (48%), Gaps = 43/230 (18%)

Query: 312 KLGEGGFGPVYKGVLADGKE-----------------IAVKRL-SRTSGQGLQEFKNEVT 353
           KLGEG FG V+   + + ++                 +AVK L    +     +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ------------- 400
           ++++L+  N++RLLG C++E+   +I EYM N  L+ FL  S+  +              
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDDKEENGNDAVPPA 129

Query: 401 -----LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 455
                + +   + +   IA G+ YL   S L  +HRDL T N L+   +  KI+DFGM+R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 456 -IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            ++ G+  +    R V    +MA E  + G F+  SDV++FGV L EI+ 
Sbjct: 187 NLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 95.1 bits (236), Expect = 9e-22
 Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)

Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WK 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ +            K
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLK 119

Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 120 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176

Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 95.1 bits (236), Expect = 9e-22
 Identities = 61/209 (29%), Positives = 112/209 (53%), Gaps = 11/209 (5%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLV 364
           F++  ++G+G FG V+KG+    +++ A+K +     +  +++ + E+TV+++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +  G  L+  +  +I EY+   S      D  R+   D  +  +++K I +G+ YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSE- 120

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             K IHRD+K +NVLL  + + K++DFG+A      Q K NT   VGT  +MAPE     
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYH 513
            +  K+D++S G+  +E+  G+      H
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMH 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 15/214 (7%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLV 364
           F++  K+G+G FG V+KG+     K +A+K +     +  +++ + E+TV+++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +  G  L++ +  +I EY+   S      D      LD  +  +I++ I +G+ YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL      K++DFG+A      Q K   N  VGT  +MAPE     
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQS 176

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
            +  K+D++S G+  +E+  G+      HSE  P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP----HSELHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 95.6 bits (237), Expect = 1e-21
 Identities = 58/211 (27%), Positives = 115/211 (54%), Gaps = 10/211 (4%)

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ I    + +++  K+G+G  G V+  + +A G+E+A+K+++       +   NE+ V+
Sbjct: 11  IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVM 70

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            +L++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 71  KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQ 126

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ NVLL  + + K++DFG        QSK +T  +VGT  +
Sbjct: 127 ALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E++ G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN-----------EVTV 354
           + +  KLGEG +  VYK      G+ +A+K++       L E K            E+ +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKL 55

Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGI 413
           + +L+H N++ LL     ++   L++E+M    L+  + D S      D K   S +   
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIK---SYMLMT 111

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
            RG+ YLH      I+HRDLK +N+L+  +   K++DFG+AR F G+ ++  T++VV T 
Sbjct: 112 LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TR 166

Query: 474 GYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            Y APE   G   + V  D++S G +  E++   
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLGCCL 371
           LG+G FG V+KG L D   +AVK       Q L+ +F +E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           +     ++ E +P    D   F   +  +L  K+ +      A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 432 DLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           DL   N L+      KISDFGM+R    G  S +   ++     + APE    G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175

Query: 491 DVFSFGVVLLEIIS 504
           DV+S+G++L E  S
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 71/219 (32%), Positives = 118/219 (53%), Gaps = 29/219 (13%)

Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKNEVT 353
           I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ--------LDWKR 405
           V+A + + ++ RLLG CL     L I + MP   L     D  R  +        L+W  
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHKDNIGSQYLLNWCV 116

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
           +I      A+G+ YL E+ RL  +HRDL   NVL+    + KI+DFG+A++ G ++ + +
Sbjct: 117 QI------AKGMNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                    +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 25/203 (12%)

Query: 312 KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           +LG+G FG VYK      G LA  K I  K     S + L+++  E+ ++A   H  +V+
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYLHEDS 424
           LLG    + +  ++ E+ P  ++D  + +  R +    + +I +I + +   + YLH   
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS-- 128

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
            +KIIHRDLK  NVLL  + + K++DFG++      ++    +  +GT  +MAPE  M  
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 483 ---GGIFSVKSDVFSFGVVLLEI 502
                 +  K+D++S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 94.2 bits (234), Expect = 3e-21
 Identities = 57/211 (27%), Positives = 114/211 (54%), Gaps = 10/211 (4%)

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+K+++       +   NE+ V+
Sbjct: 11  IVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVM 70

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + +H N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 126

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK +T  +VGT  +
Sbjct: 127 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E++ G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)

Query: 313 LGEGGFGPVYKGVL--ADGKEI--AVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G+G FG VY G L  +DG++I  AVK L+R T  + +++F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 368 GCCL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+   T +  +  K  I     +A+G+ YL      
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK--- 117

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVG-TYGYMAPEYAMGG 484
           K +HRDL   N +LD     K++DFG+AR I+       + +        +MA E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 313 LGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG VYK      G+ A  K I ++     S + L++F  E+ ++++ +H N+V L
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGL 67

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 EN+  ++ E+    +LD  + +  R +     R +   + +   + +LH     
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVC--RQMLEALNFLHSH--- 122

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           K+IHRDLK  N+LL  + + K++DFG++        K +T   +GT  +MAPE      F
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETF 180

Query: 487 S-----VKSDVFSFGVVLLEI 502
                  K+D++S G+ L+E+
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 44/291 (15%)

Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ + S +   EF NE +V+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WKRRISIIKGI 413
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R            + +   
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE    G+F+  SD++SFGVVL EI S  +    Y       +L ++         
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV--------- 234

Query: 534 AELMDSVVKQSCDQAE-LLKYIH-IGLLCVQGDPIDRPTMSSVAVMLASDI 582
              MD       DQ +   + +  +  +C Q +P  RPT   +  +L  D+
Sbjct: 235 ---MDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.0 bits (233), Expect = 5e-21
 Identities = 73/266 (27%), Positives = 120/266 (45%), Gaps = 28/266 (10%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS---RTSGQGLQEFKNEVTVIAKLQHKN 362
           F+   ++G G FG VY        E+ A+K++S   + S +  Q+   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
            +   GC L E+ + L+ EY    + D+          L      +I  G  +G+ YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +   +IHRD+K  N+LL      K++DFG A I     S AN+   VGT  +MAPE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194

Query: 483 G---GIFSVKSDVFSFGVVLLEIISGKKS-------TGFYH--SEHGPSLLAYIWKLWCE 530
               G +  K DV+S G+  +E+   K         +  YH      P+L +  W  +  
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254

Query: 531 GHAAELMDSVVKQSCDQAELLKYIHI 556
                 +  + +      ELLK++ +
Sbjct: 255 NFVDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 92.3 bits (229), Expect = 7e-21
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 14/199 (7%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +LG G FG V  G      ++A+K +   S     EF  E  V+ KL H+ LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           ++    ++ EYM N  L  +L +  +  Q    + + + K +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMGGIFSV 488
           DL   N L+D +   K+SDFG++R    ++  ++    VG+     +  PE  +   FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 489 KSDVFSFGVVLLEIIS-GK 506
           KSDV++FGV++ E+ S GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 92.4 bits (230), Expect = 9e-21
 Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQH-KN 362
           D     ++G G FG V K +    G  +AVKR+  T  +  Q     ++ V+ +      
Sbjct: 5   DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIIKGIA----RG 416
           +V+  G    E +  +  E M + SLD F     + V    K  I   I+  IA    + 
Sbjct: 65  IVKFYGALFREGDCWICMELM-DISLDKF----YKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YL E+  LKIIHRD+K SN+LLD   N K+ DFG   I G         R  G   YM
Sbjct: 120 LNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYM 174

Query: 477 APE----YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           APE     A  G + V+SDV+S G+ L E+ +GK
Sbjct: 175 APERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 313 LGEGGFGPVYK-GVLADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGFG V    V A GK  A K+L +      +G Q   NE  ++ K+     +  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59

Query: 369 CCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
              E  + L L+   M    L   +++          R I     I  G+ +LH   + +
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRR 115

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           I++RDLK  NVLLD   N +ISD G+A    G +         GT GYMAPE   G ++ 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYD 172

Query: 488 VKSDVFSFGVVLLEIISGK 506
              D F+ G  L E+I+G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 79/249 (31%), Positives = 125/249 (50%), Gaps = 38/249 (15%)

Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLS-RTSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V +    G+     +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRRISI 409
           ++ LLG C +E    +I EY    +L  FL           FD T+    QL +K  +S 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNR 468
              +ARG+ YL  +SR + IHRDL   NVL+  +   KI+DFG+AR +   +  K  +N 
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWK 526
            +    +MAPE     +++ +SDV+SFG+++ EI  + G    G    E        ++K
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--------LFK 247

Query: 527 LWCEGHAAE 535
           L  EGH  +
Sbjct: 248 LLREGHRMD 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 17/220 (7%)

Query: 312 KLGEGGFGPVYKGVLADGK---EIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLL 367
           +LG G FG V KGV    K   ++A+K L   + + ++ E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G C  E   +L+ E      L+ FL  S +  ++     + ++  ++ G+ YL   +   
Sbjct: 62  GVCEAEA-LMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGGI 485
            +HRDL   NVLL ++   KISDFG+++  G + S     R  G +   + APE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174

Query: 486 FSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYI 524
           FS +SDV+S+G+ + E  S G+K    Y    GP ++++I
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP---YKKMKGPEVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 61/204 (29%), Positives = 114/204 (55%), Gaps = 11/204 (5%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKNL 363
           F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H  
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  +G
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 174

Query: 484 G-IFSVKSDVFSFGVVLLEIISGK 506
              +S   D++S G +  E+++ +
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 32/272 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKN 362
           QD   +  LG G  G VYK   L   + +AVK +       LQ +  +E+ ++ K     
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           ++   G    EN   +  E+M   SLDV+     R +      RI++   + +G+ YL  
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS 113

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
              LKI+HRD+K SN+L++     K+ DFG++     + +K      VGT  YMAPE   
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERIS 166

Query: 483 GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
           G  + + SDV+S G+  +E+  G+          G SL+             +L+  +V 
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-SLMPL-----------QLLQCIVD 214

Query: 543 QSC----DQAELLKYIHIGLLCVQGDPIDRPT 570
           +            K++H    C++  P +RP 
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 85.2 bits (211), Expect = 5e-20
 Identities = 41/104 (39%), Positives = 54/104 (51%), Gaps = 2/104 (1%)

Query: 132 LCVQN--ENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIP 189
           LC  N   NYT     F   LN   + +  NA SS  K  A   + ++ DT+   A C  
Sbjct: 3   LCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRG 62

Query: 190 DLSKSDCTVCLNSAVAQIPTCSKGKRGARIFCPSCSIRYELYRF 233
           DLS SDC  CL +AV+++  C   K+G RI+  SC +RYE Y F
Sbjct: 63  DLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 90.9 bits (225), Expect = 5e-20
 Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 28/263 (10%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKN 362
           F   +++G G FG VY    +   E+ AVK++S +  Q     Q+   EV  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
            +   GC L+E+ + L+ EY    + D+          L      +I  G  +G+ YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +   +IHRD+K  N+LL      K++DFG A       S AN+   VGT  +MAPE  +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190

Query: 483 G---GIFSVKSDVFSFGVVLLEIISGKKS-------TGFYH--SEHGPSLLAYIWKLWCE 530
               G +  K DV+S G+  +E+   K         +  YH      P+L +  W     
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250

Query: 531 GHAAELMDSVVKQSCDQAELLKY 553
           G     +  + ++    AELL++
Sbjct: 251 GFVDYCLQKIPQERPASAELLRH 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.6 bits (224), Expect = 5e-20
 Identities = 56/211 (26%), Positives = 114/211 (54%), Gaps = 10/211 (4%)

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+K+++       +   NE+ V+
Sbjct: 11  IVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVM 70

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 71  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 126

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK +T  +VGT  +
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 181

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E++ G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 83/297 (27%), Positives = 136/297 (45%), Gaps = 47/297 (15%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA-DGKEI--AVKRLSR-TSGQGLQEFKNEVTVIAKL-Q 359
           +D   E+ +GEG FG V + ++  DG ++  A+K L    S    ++F  E+ V+ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST-------------RSVQLDWKRR 406
           H N++ LLG C       +  EY P  +L  FL  S               +  L  ++ 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           +     +A G+ YL E    + IHRDL   NVL+   +  KI+DFG++R   G +     
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175

Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLLAYI 524
                   +MA E     +++ KSDV+SFGV+L EI+S  G    G   +E        +
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------L 227

Query: 525 WKLWCEGHAAELMDSVVKQSCDQA--ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA 579
           ++   +G+  E       ++CD    EL++       C +  P +RP  + ++V L+
Sbjct: 228 YEKLPQGYRME-----KPRNCDDEVYELMRQ------CWRDRPYERPPFAQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 306 DFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK 361
                 K+GEG  G V    +A     G+++AVK++     Q  +   NEV ++   QH 
Sbjct: 20  YLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V +    L  +E  ++ E++   +L     D     +++ ++  ++   + + + +LH
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLH 132

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPE 479
                 +IHRD+K+ ++LL  +   K+SDFG    F    SK    R  +VGT  +MAPE
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPE 185

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK 506
                 +  + D++S G++++E++ G+
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 25/203 (12%)

Query: 312 KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           +LG+G FG VYK      GVLA  K I  K     S + L+++  E+ ++A   H N+V+
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVK 66

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYLHEDS 424
           LL     EN   ++ E+    ++D  + +  R +    + +I ++ K     + YLHE+ 
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN- 122

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             KIIHRDLK  N+L   + + K++DFG++      ++    +  +GT  +MAPE  M  
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 485 I-----FSVKSDVFSFGVVLLEI 502
                 +  K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 313 LGEGGFGPVYKGV-LADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +       K      +AVK L  T+    +E   +E+ +++ L  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            LLG C      L+I EY     L  FL    R   L  +  +S    +A+G+ +L   +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQ--SKANTNRVVGTYGYMAPEYA 481
               IHRDL   NVLL H    KI DFG+AR I   +    K N    V    +MAPE  
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESI 215

Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
              +++ +SDV+S+G++L EI S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 89.9 bits (223), Expect = 9e-20
 Identities = 71/212 (33%), Positives = 109/212 (51%), Gaps = 26/212 (12%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKE-IAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +  K+GEG +G VYK       E IA+K  RL +           E++++ ++QH N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL---FDSTRSVQLDWKRRISIIKG----IARG 416
           VRL      E    L++EY     LD+ L    DS+     D+ +   +IK     I RG
Sbjct: 64  VRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP----DFAKNPRLIKTYLYQILRG 114

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGY 475
           I Y H     +++HRDLK  N+L+D   N  K++DFG+AR F G   +  T+ VV T  Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWY 169

Query: 476 MAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            APE  +G   +S   D++S G +  E+++ K
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 37/283 (13%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQ 359
             +F  E K+G+G F  VYK + L DG+ +A+K++        +  Q+   E+ ++ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI-SIIKGIARGIL 418
           H N+++ L   +E NE  ++ E      L   +    +  +L  +R I      +   + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           ++H     +I+HRD+K +NV +      K+ D G+ R F    + A++  +VGT  YM+P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD 538
           E      ++ KSD++S G +L E+ + +  + FY                  G    L  
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY------------------GDKMNLYS 215

Query: 539 SVVK-QSCDQAELLKYI------HIGLLCVQGDPIDRPTMSSV 574
              K + CD   L           +   C+  DP  RP +S V
Sbjct: 216 LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 28/268 (10%)

Query: 312 KLGEGGFGPVY--KGVLADGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLL 367
           K+GEG FG +Y  K   +D +   +K +  T    +  +  K EV ++AK++H N+V   
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               E     ++ EY     L +   +  R V     + +S    I+ G+ ++H+    K
Sbjct: 66  ASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---K 121

Query: 428 IIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           I+HRD+K+ N+ L    M  K+ DFG+AR    +   A T   VGT  Y++PE      +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPY 179

Query: 487 SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD 546
           + K+D++S G VL E+ + K      H   G +L   + K+ C+G+ A +  +    S D
Sbjct: 180 NNKTDIWSLGCVLYELCTLK------HPFEGNNLHQLVLKI-CQGYFAPISPNF---SRD 229

Query: 547 QAELLKYIHIGLLCVQGDPIDRPTMSSV 574
              L+  +       +  P DRP+++S+
Sbjct: 230 LRSLISQL------FKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 19/228 (8%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRL-SRTSGQGLQEFKNEVTVIAK 357
             +  +   LG G FG V+KG+ + +G  I    A+K +  R+  Q  QE  + +  +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 358 LQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRISIIKGIA 414
           L H  +VRLLG C     SL L+ +  P  SL     D  R  +  LD +R ++    IA
Sbjct: 66  LDHAYIVRLLGIC--PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIA 119

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           +G+ YL E    +++HR+L   N+LL  +   +I+DFG+A +   +  K   +       
Sbjct: 120 KGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLL 521
           +MA E  + G ++ +SDV+S+GV + E++S G +          P LL
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 34/271 (12%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS---RTSGQGLQEFKNEVTVIAKLQHKN 362
           FS   ++G G FG VY        E+ A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
            ++  GC L E+ + L+ EY    + D+          L      ++  G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +   +IHRD+K  N+LL      K+ DFG A I       A  N  VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 483 G---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS 539
               G +  K DV+S G+  +E+   ++    ++     +L           H A+  +S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALY----------HIAQ-NES 231

Query: 540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
              QS   +E  +  +    C+Q  P DRPT
Sbjct: 232 PALQSGHWSEYFR--NFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 313 LGEGGFGPVYKGVLADGKEI---AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LGEG FG V +G L     I   AVK  +++  +   +++F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 368 GCCLE--ENES----LLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGIL 418
           G CL+  E+E     ++I  +M +  L  FL  S        L  +  +  +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGT-YGYM 476
           YL   S    IHRDL   N +L+  MN  ++DFG++ +I+ G+  +    R+      ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVKWI 181

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEI 502
           A E     +++ KSDV+SFGV + EI
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 22/205 (10%)

Query: 313 LGEGGFGPVY------KGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           LGEG FG V       +G    G+++AVK L   + G  + + K E+ ++  L H+N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 366 LLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
             G C E+  +   LI E++P+ SL  +L  +   + L  + + ++   I +G+ YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS----KANTNRVVGTYGYMAPE 479
           SR + +HRDL   NVL++ E   KI DFG+ +    ++     K + +  V  Y   APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---APE 182

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
             +   F + SDV+SFGV L E+++
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 12/208 (5%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNL 363
           D+     +G G    VY  +     E +A+KR+        + E + EV  +++  H N+
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61

Query: 364 VRLLGCCLEENESLLIYEYMPNKS-LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           V+     +  +E  L+  Y+   S LD+      R   LD     +++K + +G+ YLH 
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHS 120

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGM-ARIF--GGNQSKANTNRVVGTYGYMAPE 479
           + +   IHRD+K  N+LL  + + KI+DFG+ A +   G    K      VGT  +MAPE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR-KTFVGTPCWMAPE 176

Query: 480 YAMGGI-FSVKSDVFSFGVVLLEIISGK 506
                  +  K+D++SFG+  +E+ +G 
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 34/215 (15%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCC 370
           +GEG +G VYK      G+ +A+K +        +E K E  ++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 371 L------EENESLLIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRIS------IIKGIARG 416
           +       +++  L+ E     S+       T  V+      +R+       I++   RG
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSV-------TDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YLHE+   K+IHRD+K  N+LL      K+ DFG++        + NT   +GT  +M
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWM 180

Query: 477 APE-----YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           APE           +  +SDV+S G+  +E+  GK
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 7/195 (3%)

Query: 312 KLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLGC 369
           ++G G FG V+ G L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
           C ++    ++ E +       FL   T   +L  K  I +++  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL   N L+  +   KISDFGM+R        +          + APE    G +S +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 55/211 (26%), Positives = 113/211 (53%), Gaps = 10/211 (4%)

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 127

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK   + +VGT  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYW 182

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 19/203 (9%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGL-QEFKNEVTVIAKLQ---HKNLV 364
            ++GEG +G VYK   L  G+ +A+K++    S +G+      E+ ++ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 365 RLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           RLL  C       E +  L++E++ ++ L  +L        L  +    +++ + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH     +I+HRDLK  N+L+  +   KI+DFG+ARI+   +    +  VV T  Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTS--VVVTLWYRAPE 176

Query: 480 YAMGGIFSVKSDVFSFGVVLLEI 502
             +   ++   D++S G +  E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 73/237 (30%), Positives = 122/237 (51%), Gaps = 21/237 (8%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRL-----SRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG G FG VY    AD G+E+AVK++     S+ + + +   + E+ ++  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 367 LGCCLE-ENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            GC  + E + L I+ EYMP  S+   L  +  ++  +  RR +  + I +G+ YLH + 
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYT--RQILQGVSYLHSN- 125

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              I+HRD+K +N+L D   N K+ DFG + RI     S      V GT  +M+PE   G
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
             +  K+DV+S    ++E+++ K     Y +      +A I+K+  +     L D V
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTKPMLPDGV 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 56/205 (27%), Positives = 107/205 (52%), Gaps = 19/205 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           +D+    ++G G +G VYK   +A G+ +A+K +    G   +  + E++++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR----SVQLDWKRRISIIKGIARGILY 419
           V   G  L  ++  ++ EY    SL   ++  TR     +Q+ +  R ++     +G+ Y
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETL-----KGLAY 116

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE      IHRD+K +N+LL  + + K++DFG++       +K  +   +GT  +MAPE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPE 171

Query: 480 YA---MGGIFSVKSDVFSFGVVLLE 501
            A     G +  K D+++ G+  +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 7/196 (3%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +LG G FG V+ G      ++A+K +        ++F  E  V+ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           ++    ++ E+M N  L  +L    R  +L     +S+ + +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSD 491
           DL   N L+      K+SDFGM R    ++  +++        +  PE      +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183

Query: 492 VFSFGVVLLEIISGKK 507
           V+SFGV++ E+ +  K
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)

Query: 306 DFSQENKLGEGGFGPVYKG-VLADG--KEIAVKRLSRTSGQG-LQEFKNEVTVIAKL-QH 360
           D   ++ +GEG FG V K  +  DG   + A+KR+   + +   ++F  E+ V+ KL  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-------------TRSVQLDWKRRI 407
            N++ LLG C       L  EY P+ +L  FL  S             + +  L  ++ +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R   G +      
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 181

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                  +MA E     +++  SDV+S+GV+L EI+S
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 70/217 (32%), Positives = 108/217 (49%), Gaps = 34/217 (15%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSG----QGLQEFKNEVTVIAKL 358
           +F + N++GEG +G VY+       EI A+K  R+           L+E    +T++  L
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNL 63

Query: 359 QHKNLVRLL----GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +H N+V L     G  L+     L+ EY   + L   L +             S +K + 
Sbjct: 64  RHPNIVELKEVVVGKHLDS--IFLVMEYC-EQDLASLLDNMPTPFS------ESQVKCLM 114

Query: 415 ----RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
               RG+ YLHE+    IIHRDLK SN+LL  +   KI+DFG+AR + G  +K  T +VV
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV 170

Query: 471 GTYGYMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
            T  Y APE  +G      + D+++ G +L E+++ K
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.7 bits (214), Expect = 7e-19
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 21/214 (9%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRL-----SRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG VY     D G+E+A K++     S  + + +   + E+ ++  LQH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 367 LGCCLEENE-SLLIY-EYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGILYLH 421
            GC  +  E +L I+ EYMP  S+   L      T SV   + R+I        G+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLH 123

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEY 480
            +    I+HRD+K +N+L D   N K+ DFG + R+     S      V GT  +M+PE 
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS 514
             G  +  K+DV+S G  ++E+++ K     Y +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 312 KLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQEFKN----EVTVIAKLQHKNLVRL 366
            +GEG +G V K    A G+ +A+K+   +     ++ K     EV V+ +L+H+N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 +    L++EY+    L++ L  S   +  D  R  S I  + + I Y H     
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVR--SYIWQLLQAIAYCH---SH 119

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            IIHRD+K  N+L+      K+ DFG AR      +   T+ V  T  Y APE  +G   
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178

Query: 487 SVKS-DVFSFGVVLLEIISG 505
             K  DV++ G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 86.8 bits (215), Expect = 8e-19
 Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 12/200 (6%)

Query: 313 LGEGGFGPVYKGVL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGFG V    + A GK  A K+L++      +G +    E  ++AK+ H   +  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 369 CCLEENESL-LIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
              +    L L+   M    L   +++    +      R       I  G+ +LH+    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           +II+RDLK  NVLLD++ N +ISD G+A      QSK  T    GT G+MAPE   G  +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEY 174

Query: 487 SVKSDVFSFGVVLLEIISGK 506
               D F+ GV L E+I+ +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 15/204 (7%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFK---NEVTVIAKLQHK 361
           DF    ++G+GG+G V+     D  EI A+KR+ ++    L E +    E  ++   + +
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            LV+LL    ++    L  EY+P       L  +   V  +   R  + +     +  LH
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH 118

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L  IHRDLK  N L+D   + K++DFG+++   G  + AN+  VVG+  YMAPE  
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEVL 170

Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
            G  +    D +S G +L E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 80/249 (32%), Positives = 120/249 (48%), Gaps = 44/249 (17%)

Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   V+A+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-------------DSTRSVQLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L                    QL +K  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI +  G    G    E        
Sbjct: 200 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 250

Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 251 LFKLLKEGH 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 34/219 (15%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVT------VIAKLQ------- 359
           LGEG FG V   V+A+   I   + ++     ++  K++ T      ++++++       
Sbjct: 20  LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRR 406
           HKN++ LLG C ++    ++ EY    +L  +L           FD+ +    QL +K  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR +   +  K  
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           TN  +    +MAPE     +++ +SDV+SFGV+L EI +
Sbjct: 194 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 68/218 (31%), Positives = 113/218 (51%), Gaps = 17/218 (7%)

Query: 313 LGEGGFGPVYKGVLA-DGKEI----AVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG G FG VYKG+   DG+ +    A+K L   TS +  +E  +E  V+A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRISIIKGIARGILYLHEDS 424
           LG CL     L + + MP   L     D  R  +  +  +  ++    IA+G+ YL E  
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
            ++++HRDL   NVL+    + KI+DFG+AR+   ++++ + +       +MA E  +  
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 485 IFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLL 521
            F+ +SDV+S+GV + E+++ G K      +   P LL
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLG 368
           N++G G  G VYK +    G+  A+K +       ++ +   E+ ++  + H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 369 CCLEENESLLIYEYMPNKSLD-------VFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
                 E  ++ E+M   SL+        FL D  R           I+ GIA    YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH 185

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE-- 479
              R  I+HRD+K SN+L++   N KI+DFG++RI    Q+    N  VGT  YM+PE  
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIAYMSPERI 240

Query: 480 ---YAMGGIFSVKSDVFSFGVVLLEIISGK 506
                 G       D++S GV +LE   G+
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 79/249 (31%), Positives = 122/249 (48%), Gaps = 44/249 (17%)

Query: 313 LGEGGFGPVYKGVLADG--------KE---IAVKRLS-RTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   V+A+         KE   +AVK L    + + L +  +E+ ++  + +
Sbjct: 23  LGEGCFGQV---VMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR +   +  K  
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     +++ +SDV+SFGV++ EI +  G    G    E        
Sbjct: 197 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------- 247

Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 248 LFKLLKEGH 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 30/210 (14%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           N++ EG +G VY+      G+ +A+K+L      +G     L+E      ++ KLQH N+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILLKLQHPNI 66

Query: 364 VRL----LGCCLEENESLLIYEYMPN--KSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           V +    +G  L  ++  ++ EY+ +  KSL   +    +           ++  +  G+
Sbjct: 67  VTVKEVVVGSNL--DKIYMVMEYVEHDLKSL---METMKQPFLQ--SEVKCLMLQLLSGV 119

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH++    I+HRDLKTSN+LL++    KI DFG+AR +G    K  T  VV T  Y A
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVV-TLWYRA 174

Query: 478 PEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G   +S   D++S G +  E+++ K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 15/203 (7%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRL-----SRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG VY    AD G+E+AVK++     S  + + +   + E+ ++  L H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 367 LGCCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            GC  +  E  L    E+MP  S+   L  S  ++  +  R+ +  + I  G+ YLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT--RQILEGVSYLHSN- 125

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              I+HRD+K +N+L D   N K+ DFG + R+     S      V GT  +M+PE   G
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
             +  K+D++S G  ++E+++ K
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 37/217 (17%)

Query: 305 QDFSQENKLGEGGFGPVY-------------KGVLADGKEIAVKRLSRTSGQGLQEFKNE 351
           +D    + LG G  G V              K V    K    K++ R           E
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-----------E 53

Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
           + ++ + +   +V   G  L EN   +  E+M   SLD  ++     + ++   +I    
Sbjct: 54  LQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKI--AV 110

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN--QSKANTNRV 469
            +  G+ YL+   R  I+HRD+K SN+L++     K+ DFG++    G    S A+T   
Sbjct: 111 AVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADT--F 162

Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           VGT  YM+PE   GG ++VKSDV+S G+ ++E+  GK
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 81/279 (29%), Positives = 129/279 (46%), Gaps = 36/279 (12%)

Query: 312 KLGEGGFGPVYKGVL---ADGKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHKNLVRL 366
           +LG G FG V KG+       K +AVK L   +       E   E  V+ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           +G C  E+  +L+ E      L+ FL    ++  +  K    ++  ++ G+ YL E +  
Sbjct: 62  IGICEAES-WMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTY--GYMAPEYAM 482
             +HRDL   NVLL  +   KISDFG+++  G +++  KA T+   G +   + APE   
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH---GKWPVKWYAPECMN 171

Query: 483 GGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
              FS KSDV+SFGV++ E  S G+K    Y    G  +   I          E M+   
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP---YKGMKGNEVTQMIES-------GERMECPQ 221

Query: 542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
           +   +  +L+K      LC      +RP  + V + L +
Sbjct: 222 RCPPEMYDLMK------LCWTYGVDERPGFAVVELRLRN 254

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRT---SGQGLQEFKNEVTVIAKLQHKN 362
           F     +G+G FG V      D K++ A+K +++        ++   NE  ++ +L H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARG 416
           LV L     ++ E++    Y+    +D+ L    R   L  K + S       I  I   
Sbjct: 62  LVNLWYS-FQDEENM----YL---VVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLA 112

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YLH      IIHRD+K  N+LLD + +  I+DF +A     +     T    GT GYM
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYM 166

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKK 507
           APE      +SV  D +S GV   E + GK+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.4 bits (208), Expect = 5e-18
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 47/289 (16%)

Query: 313 LGEGGFGPVYKGVLA-DGKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKL-QHKNLVRLL 367
           +GEG FG V K  +  DG  +  A+KR+   + +   ++F  E+ V+ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIA 414
           G C       L  EY P+ +L  FL  S               +  L  ++ +     +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           RG+ YL +    + IHRDL   N+L+      KI+DFG++R   G +             
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
           +MA E     +++  SDV+S+GV+L EI+S  G    G   +E        +++   +G+
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGY 228

Query: 533 AAELMDSVVKQSCDQA--ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA 579
             E        +CD    +L++       C +  P +RP+ + + V L 
Sbjct: 229 RLEK-----PLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLN 266

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)

Query: 313 LGEGGFGPV------YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+GGFG V        G +   K++  KRL + SG+ +   + E+  + K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 +    L+   M    L   +++      L+ +R I     I  GIL+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            I++RD+K  NVLLD + N ++SD G+A      ++     +  GT GYMAPE      +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171

Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S   D F+ G  + E+++G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 313 LGEGGFGPVYK-GVLADGKEIAVKRLSRTS--GQGLQE-FKNEVTVIAKLQHKNLVRLLG 368
           LG GGFG V    V +  +  A+K + +      G QE   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 369 CCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQL--DWKRRISIIKGIARGILYLHEDSR 425
              ++ + + ++ EY     L    +   R   L  ++  R   I  +     YLH    
Sbjct: 60  RTFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---N 111

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             II+RDLK  N+LLD     K+ DFG A+     +S   T    GT  Y+APE  +   
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +    D +S G++L E+++G+
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 19/208 (9%)

Query: 307 FSQENKLGEGGFGPVYKGVLA----DGKEIAVKRL--SRTSGQGLQEFKNEVTVIAKLQH 360
           + +  K+GEG FG   K +L     DGK+  +K +  S+ S +  +E + EV V++ ++H
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVF-LFDSTRSVQLDWKRRISIIKGIARGIL 418
            N+V+      EEN +L ++ +Y      D++   ++ R V     + +     I   + 
Sbjct: 59  PNIVQYQES-FEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           ++H+    KI+HRD+K+ N+ L  +   K+ DFG+AR+       A T   +GT  Y++P
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSP 170

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E      ++ KSD+++ G VL E+ + K
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.5 bits (209), Expect = 7e-18
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 59/300 (19%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN---EVTVIAKLQHKN 362
           F+   ++G G FG VY        E+ A+K++S +  Q  +++++   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVF--LFDSTRSVQLDWKRRISIIKGIARGILYL 420
            +   GC L E+ + L+ EY    + D+        + V++      +I  G  +G+ YL
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-----AAICHGALQGLAYL 131

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE- 479
           H     + IHRD+K  N+LL      K++DFG A +       +  N  VGT  +MAPE 
Sbjct: 132 HS---HERIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEV 182

Query: 480 -YAMG-GIFSVKSDVFSFGVVLLEIISGKKS-------TGFYH--SEHGPSLLAYIWKLW 528
             AM  G +  K DV+S G+  +E+   K         +  YH      P+L +  W   
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSD- 241

Query: 529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKP 588
                                   ++     C+Q  P DRP   S   +L    +   +P
Sbjct: 242 --------------------YFRNFVD---SCLQKIPQDRP---SSEELLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 12/198 (6%)

Query: 312 KLGEGGFGPVYKGVLADGKEI-AVKRLSRTS-GQGLQEFK-NEVTVIAKLQHKNLVRLLG 368
           K+GEG +G V+K    +  EI A+KR+      +G+      E+ ++ +L+HKN+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               + +  L++EY  ++ L  + FDS     +D +   S +  + +G+ + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFS 487
           +HRDLK  N+L++     K++DFG+AR F G   +  +  VV T  Y  P+   G  ++S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 488 VKSDVFSFGVVLLEIISG 505
              D++S G +  E+ + 
Sbjct: 179 TSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 312 KLGEGGFGPVYKGVLADGK----EIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRL 366
            +GEG FG VY+GV    +     +AVK     +   ++E F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           +G    EN   ++ E  P   L  +L        LD    I     ++  + YL      
Sbjct: 73  IGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
           + +HRD+   NVL+      K+ DFG++R +   +  KA+  ++     +MAPE      
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184

Query: 486 FSVKSDVFSFGVVLLEIIS-GKK 507
           F+  SDV+ FGV + EI+  G K
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 62/215 (28%), Positives = 113/215 (52%), Gaps = 23/215 (10%)

Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQHKN 362
           F    ++GEG +G VYK    D G+ +A+K++   +   G  +   + E+ ++ +L H+N
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 363 LVRLLGCCLEENESL----------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG 412
           +V L     ++ ++L          L++EYM +   D+     +  V        S +K 
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +  G+ Y H+ + L   HRD+K SN+LL+++   K++DFG+AR++   +S+  TN+V+ T
Sbjct: 125 LLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-T 180

Query: 473 YGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
             Y  PE  +G   +    DV+S G +L E+ + K
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQH- 360
           D     +LG G +G V K   +  G  +AVKR+  T     QE K    ++ +  +    
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDC 59

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVF---LFDSTRSVQLDWKRRISIIKGIARGI 417
              V   G    E +  +  E M + SLD F   ++D   ++  D   +I++   I + +
Sbjct: 60  PYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKAL 116

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN--QSKANTNRVVGTYGY 475
            YLH   +L +IHRD+K SNVL++     K+ DFG++    G    S A T    G   Y
Sbjct: 117 EYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTID-AGCKPY 169

Query: 476 MAPEYAMGGI----FSVKSDVFSFGVVLLEIISGK 506
           MAPE     +    + VKSDV+S G+ ++E+ +G+
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 25/207 (12%)

Query: 310 ENKLGEGGFGPVYKGVLA-DGKE---IAVKRLSRTSGQGLQE--FKNEVTVIAKLQHKNL 363
           E  LG G FG + +G L    K    +A+  L R      Q   F  E   + +  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VRL G     N  +++ EYM N +LD FL       QL   + + ++ G+A G+ YL E 
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE- 125

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------YMA 477
             +  +H+ L    VL++ ++  KIS F         + K+    +  T        + A
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFRR-----LQEDKSEA--IYTTMSGKSPVLWAA 176

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           PE      FS  SDV+SFG+V+ E++S
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)

Query: 316 GGFGPVYKGVLA----DGKEIAVKRLSRTSGQG---LQEFKNEVTVIAKLQHKNLVRLLG 368
           G +G V+   LA     G   A+K + +        + +   E  ++++ Q   +V+L  
Sbjct: 4   GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 369 CCLEENESLLIYEYMPNKSLDVF-LFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               +    L+ EY+P    D+  L ++  S+  D  R    I  I   + YLH      
Sbjct: 61  SFQGKKNLYLVMEYLPGG--DLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNG 113

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFG------MARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           IIHRDLK  N+L+D   + K++DFG      + R    N  +    R+VGT  Y+APE  
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +G   S   D +S G +L E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEI--AVKRLSRTSGQGLQEFKNEVTVIAK 357
           DF +  +LG G  G V K      G++   K I   +K   R   Q ++E K    V+ +
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRELK----VLHE 55

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
                +V   G    + E  +  E+M   SLD  L      +  +   +ISI   + RG+
Sbjct: 56  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGL 112

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+
Sbjct: 113 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMS 166

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE   G  ++V+SD++S G+ L+E+  G+
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQHK 361
           +F  E K+G G F  VY+   L D K +A+K++        +  Q+   E+ ++ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLD--VFLFDSTRSV---QLDWKRRISIIKGIARG 416
           N+++ L   +E+NE  ++ E      L   +  F   + +   +  WK  + +   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
               H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEI 502
           +PE      ++ KSD++S G +L E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 23/206 (11%)

Query: 315 EGGFGPVYKGVLADGK-----EIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLG 368
           EG FG ++ G+L D K     E+ VK +   + +  +     E  ++  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 369 CCLEENES-LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK------GIARGILYLH 421
            C+E+ E   ++Y YM   +L +FL    R  + +  + +S  +       IA G+ YLH
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALSTQQLVHMAIQIACGMSYLH 134

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQS--KANTNRVVGTYGYMAP 478
              +  +IH+D+   N ++D E+  KI+D  ++R +F  +      N NR V    +MA 
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMAL 188

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E  +   +S  SDV+SFGV+L E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 311 NKLGEGGFGPVYKG--VLADG----KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +KLGEG +  VYKG   L D     KEI   RL    G      + EV+++  L+H N+V
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L      E    L++EY+ +K L  +L D   S+ +   +    +  + RG+ Y H   
Sbjct: 68  TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH--- 121

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           R K++HRDLK  N+L++     K++DFG+AR      +K  +N VV T  Y  P+  +G 
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDILLGS 179

Query: 485 I-FSVKSDVFSFGVVLLEIISGK 506
             +S + D++  G +  E+ +G+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 20/201 (9%)

Query: 312 KLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           K+GEG  G V    +A     G+++AVK +     Q  +   NEV ++   QH+N+V + 
Sbjct: 28  KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
              L   E  ++ E++   +L     D     +L+ ++  ++ + + + + YLH      
Sbjct: 85  KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGI 485
           +IHRD+K+ ++LL  +   K+SDFG    F    SK    R  +VGT  +MAPE      
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193

Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +  + D++S G++++E++ G+
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)

Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECN 61

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 117

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 305 QDFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
            DF + ++LG G  G V K      G++   K I ++       Q ++E +    V+ + 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
               +V   G    + E  +  E+M   SLD  L ++ R +  +   ++SI   + RG+ 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI--AVLRGLA 117

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + +I+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQHK 361
           +F  E K+G G F  VY+   L DG  +A+K++        +   +   E+ ++ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFL--FDSTRSV---QLDWKRRISIIKGIARG 416
           N+++     +E+NE  ++ E      L   +  F   + +   +  WK  + +   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
               H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEI 502
           +PE      ++ KSD++S G +L E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 312 KLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V        GK++AVK++     Q  +   NEV ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + R + YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL  +   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E+I G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 76/274 (27%), Positives = 118/274 (43%), Gaps = 39/274 (14%)

Query: 311 NKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           ++LG+G +G VYK      GV    KEI   RL     +   +   E+ ++ K     +V
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLELDESK-FNQIIMELDILHKAVSPYIV 62

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
              G    E    +  EYM   SLD        +  +       I   + +G+ +L E+ 
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN--QSKANTNRVVGTYGYMAPEYAM 482
              IIHRD+K +NVL++     K+ DFG++    GN   S A TN  +G   YMAPE   
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN--IGCQSYMAPERIK 174

Query: 483 GG------IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
            G       ++V+SDV+S G+ +LE+  G+     Y  E   ++ A +  +  +G    L
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAI-VDGDPPTL 230

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
                  S D  + +        C+   P  RPT
Sbjct: 231 PSGY---SDDAQDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 23/188 (12%)

Query: 311 NKLGEGGFGPVYKGVLADGKEI-AVKRL---SRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
            K+G+G FG V+K      K+I A+K++   +   G  +   + E+ ++  L+H+N+V L
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNL 76

Query: 367 LGCC----LEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +  C       N       L++E+  +   D+    S ++V+        ++K +  G+ 
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ-SKAN--TNRVVGTYGY 475
           Y+H   R KI+HRD+K +N+L+  +   K++DFG+AR F  ++ SK N  TNRVV T  Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189

Query: 476 MAPEYAMG 483
             PE  +G
Sbjct: 190 RPPELLLG 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.6 bits (193), Expect = 5e-16
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCL 371
           +G G +G VYKG      ++A  ++   +G   +E K E+ ++ K   H+N+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 372 EEN------ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           ++N      +  L+ E+    S+   L  +T+   L  +    I + I RG+ +LH+   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM--- 482
            K+IHRD+K  NVLL      K+ DFG++        + NT   +GT  +MAPE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDE 187

Query: 483 --GGIFSVKSDVFSFGVVLLEIISG 505
                +  KSD++S G+  +E+  G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG V +  L       +++AVK L     S   ++EF  E   + +  H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 367 LGCCLEENES------LLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGI 417
           +G  L           ++I  +M +  L  FL  S        L  +  +  +  IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN---QSKANTNRVVGTY 473
            YL   S    IHRDL   N +L+  M   ++DFG+++ I+ G+   Q  A+   V    
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV---- 179

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            ++A E     +++  SDV++FGV + EI++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 69/204 (33%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 313 LGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKNEVTVIAKL------QHKNLVR 365
           LG+G FG V    L    E+ AVK L +     LQ+   E T+  K       +H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 366 LLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           L   C +  + L  + EY+    L   +F   RS + D  R       I  G+ +LHE  
Sbjct: 61  LH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER- 115

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGYMAPEYAM 482
              II+RDLK  NVLLD E + KI+DFGM +  I GG      T+   GT  Y+APE   
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEILS 169

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
              +    D ++ GV+L E+++G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 313 LGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKNEVTVIAK------LQHKNLVR 365
           LG+G FG V    L    E  A+K L +     L++   E T++ +       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 366 LLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           L  C  +  E L  + EY+    L   +F    S + D  R       I  G+ +LH+  
Sbjct: 61  LF-CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              II+RDLK  NVLLD + + KI+DFGM +     + KA+T    GT  Y+APE   G 
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171

Query: 485 IFSVKSDVFSFGVVLLEIISGK 506
            ++   D +SFGV+L E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)

Query: 312 KLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN--EVTVIAKLQ-HKNLVRLL 367
           +LG+G FG VY     +  E+ A+K++ +      +E  N  EV  + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI-SIIKGIARGILYLHEDSRL 426
               E +E   ++EYM     +++     R  +   +  I SII  I +G+ ++H   + 
Sbjct: 65  EVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE------- 479
              HRDLK  N+L+      KI+DFG+AR     +S+      V T  Y APE       
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           Y      S   D+++ G ++ E+ + +
Sbjct: 176 Y------SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 29/208 (13%)

Query: 311 NKLGEGGFGPVYKGV------LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            KLGEG +  V+KG       L   KEI   RL    G      + EV+++  L+H N+V
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFD-----STRSVQLDWKRRISIIKGIARGILY 419
            L      +    L++EY+ +K L  ++ D     S  +V++        +  I RG+ Y
Sbjct: 68  TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAY 119

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H   R K++HRDLK  N+L++     K++DFG+AR      +K  +N VV T  Y  P+
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPD 174

Query: 480 YAMGGI-FSVKSDVFSFGVVLLEIISGK 506
             +G   +S + D++  G +  E+ SG+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 29/206 (14%)

Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFKNEVTVIAK------LQHKN 362
           LG+G FG V   +LA  KE     AVK L +     LQ+   E T+  K        H  
Sbjct: 3   LGKGSFGKV---MLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPF 57

Query: 363 LVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           L +L  CC +  + L  + E++    L   +F   +S + D  R       I   +++LH
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGYMAPE 479
           +     II+RDLK  NVLLDHE + K++DFGM +  IF G      T+   GT  Y+APE
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPE 166

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                ++    D ++ GV+L E++ G
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 24/243 (9%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV--------IAKLQHK 361
           + +LG+G FG VY  ++ D K +A +RL       + E     TV        ++KL H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILYL 420
            +V+     LE +   +I EY   + LD  L +   + + L   +       +  G+ Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H+    +I+HRDLK  N+ L + +  KI DFG++R+  G+   A T    GT  YM+PE 
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
                +  KSD++S G +L E+          H+  G + L+ + ++  EG    L ++ 
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC------LAHAFEGQNFLSVVLRI-VEGPTPSLPETY 229

Query: 541 VKQ 543
            +Q
Sbjct: 230 SRQ 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 42/237 (17%)

Query: 302 KATQDFSQENK-LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--------- 350
             ++ + Q+   LGEG +G V K      GK +A+K++                      
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 351 -----EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 405
                E+ ++ +++H+N++ L+   +E +   L+ + M +    V      R ++L   +
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV----DRKIRLTESQ 120

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG------- 458
              I+  I  G+  LH+      +HRDL  +N+ ++ +   KI+DFG+AR +G       
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 459 -----GNQSKAN-TNRVVGTYGYMAPEYAMGGI---FSVKSDVFSFGVVLLEIISGK 506
                  Q +   T++VV T  Y APE  MG     F+V  D++S G +  E+++GK
Sbjct: 178 LSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 20/214 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKG--VLADGKEIAVKRLS-RTSGQGLQ-EFKNEVTVIAKLQ- 359
           Q +    ++GEG +G V+K   +   G+ +A+KR+  +T  +G+      EV V+  L+ 
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 360 --HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG 412
             H N+VRL   C       E +  L++E++ ++ L  +L D      +  +    ++  
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 118

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           + RG+ +LH     +++HRDLK  N+L+      K++DFG+ARI+     +     VV T
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 172

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y APE  +   ++   D++S G +  E+   K
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 46/199 (23%)

Query: 329 GKEIAVKRLSRTSGQGLQEFKN---------EVTVIAKLQHKNLVRLLGCCLEENESLLI 379
           G+ +A+K+LSR        F+N         E+ ++  + HKN++ LL            
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83

Query: 380 YEYMPNKSLDVF--------LFDST--RSVQ--LDWKRRISIIKGIARGILYLHEDSRLK 427
             + P KSL+ F        L D+   + +Q  LD +R   ++  +  GI +LH      
Sbjct: 84  --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           IIHRDLK SN+++  +   KI DFG+AR  G +     T  VV  Y Y APE  +G  + 
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYK 195

Query: 488 VKSDVFSFGVVLLEIISGK 506
              D++S G ++ E+I G 
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 30/230 (13%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKNLVRLLGCC 370
           K+G G +G VYK    DGK+     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 371 LEENES--LLIYEYMPNKSLDVFLFD-----STRSVQLDWKRRISIIKGIARGILYLHED 423
           L  ++    L+++Y  +    +  F      + + +QL      S++  I  GI YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 424 SRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIFGGN-QSKANTNRVVGTYGYMA 477
               ++HRDLK +N+L+  E  P     KI+D G AR+F    +  A+ + VV T+ Y A
Sbjct: 128 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 478 PEYAMGGIFSVKS-DVFSFGVVLLEIISG-----------KKSTGFYHSE 515
           PE  +G     K+ D+++ G +  E+++            K S  F+H +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKNLVRLLGCC 370
           K+G G +G VYK    DGK+     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 371 LE--ENESLLIYEYMPNKSLDVFLFD-----STRSVQLDWKRRISIIKGIARGILYLHED 423
           L   + +  L+++Y  +    +  F      + + VQL      S++  I  GI YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 424 SRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIFGGN-QSKANTNRVVGTYGYMA 477
               ++HRDLK +N+L+  E  P     KI+D G AR+F    +  A+ + VV T+ Y A
Sbjct: 128 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 478 PEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           PE  +G     K+ D+++ G +  E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 6e-15
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 41/216 (18%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVTVIAKLQHKN 362
           +G G +G V   V    G+++A+K++S         F +         E+ ++  L+H+N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHEN 60

Query: 363 LVRLL-----GCCLEENESLLIYEYMP---NKSLDVFLFDSTRSVQLDWKRRIS-IIKGI 413
           ++ LL         + N+  ++ E M    +K     +  S + +  D    I   +  I
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHK-----VIKSPQPLTDD---HIQYFLYQI 112

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--TNRVVG 471
            RG+ YLH      +IHRDLK SN+L++   + KI DFG+AR    ++ +    T  VV 
Sbjct: 113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV- 168

Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           T  Y APE  +    ++   D++S G +  E+++ K
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 313 LGEGGFGPVYKGVLADG-------KEIAVKRLS-----RTSGQGLQEFKNEVTVIAK-LQ 359
           LG G FG VYK    +        KEI V   +     R   + + +  +EVT+I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           H N+VR     LE +   ++ + +    L + F     +  +   +R  +I   +   + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH++ R  I+HRDL  +N++L  +    I+DFG+A+     Q ++    VVGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEI 502
           E      +  K+DV++FG +L ++
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 17/221 (7%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFK--NEVTVIAKLQHKNLVRLLG 368
           KLGEG +  VYKG+   +G+ +A+K +S  + +G+  F    E +++  L+H N+V LL 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIV-LLH 69

Query: 369 CCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
             +   E+L  ++EYM     D+  +       L        +  + RG+ Y+H      
Sbjct: 70  DIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQH 123

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-F 486
           I+HRDLK  N+L+ +    K++DFG+AR      S+  ++ VV T  Y  P+  +G   +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDY 181

Query: 487 SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           S   D++  G + +E++ G     F         L  IW +
Sbjct: 182 SSALDIWGAGCIFIEMLQG--QPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ-GLQ-EFKNEVTVIAKLQ---HKNLVR 365
           ++G G +G VYK      G  +A+K +   + + GL      EV ++ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 366 LLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           L+  C       E +  L++E++ ++ L  +L D      L  +    +++   RG+ +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H +    I+HRDLK  N+L+      K++DFG+ARI+    +      VV T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEV 178

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
            +   ++   D++S G +  E+   K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 313 LGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK------LQHKNLVR 365
           LG+G FG V+   L    +  A+K L +     L +   E T++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 366 LLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           L  C  +  E+L  + EY+    L   +F      + D  R       I  G+ +LH   
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGYMAPEYAM 482
              I++RDLK  N+LLD + + KI+DFGM +  + G     A T    GT  Y+APE  +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILL 169

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
           G  ++   D +SFGV+L E++ G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 27/214 (12%)

Query: 306 DFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQEFKN---EVTVIAKLQH- 360
           D     ++G G  G VYK      G  +AVK++ RT  +  +E K    ++ V+ K  H 
Sbjct: 16  DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHD 72

Query: 361 -KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV--QLDWKRRISIIKGIARGI 417
              +V+  G  + +++  +  E M +  LD  L      +   +  K  ++I+K +    
Sbjct: 73  CPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKAL---- 127

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYM 476
            YL E     +IHRD+K SN+LLD   N K+ DFG++ R+     SKA T R  G   YM
Sbjct: 128 HYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYM 181

Query: 477 APEY----AMGGIFSVKSDVFSFGVVLLEIISGK 506
           APE          + +++DV+S G+ L+E+ +G+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKN 362
           F Q   LG+GGFG V    V A GK  A K+L +      +G     NE  ++ K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L      ++   L+   M    L   ++    +   +  R +     I  G+  LH+
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQ 120

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +   +I++RDLK  N+LLD   + +ISD G+A  +  G   K      VGT GYMAPE  
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVV 173

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
               ++   D ++ G +L E+I+G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.1 bits (183), Expect = 3e-14
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 38/216 (17%)

Query: 311 NKLGEGGFGPVYKGVLADGKEI-AVKRL-----SRTSGQG-------LQEFKNEVTVIAK 357
            KLG+G +G V+K +    KE+ A+K++     + T  Q        LQE  +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 358 LQHKNLVRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             H N+V+LL     EN+    L++EYM     +  L    R+  L+   +  I+  + +
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLK 118

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV----VG 471
            + Y+H  S   +IHRDLK SN+LL+ +   K++DFG+AR       +   N V    V 
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELEENPENPVLTDYVA 174

Query: 472 TYGYMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           T  Y APE  +G     K  D++S G +L E++ GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 19/203 (9%)

Query: 311 NKLGEGGFGPVYKGV------LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +KLGEG +  V+KG       L   KEI   RL    G      + EV+++  L+H N+V
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKNLKHANIV 66

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L      E    L++EY+ +  L  +L D+  ++      +I + + + RG+ Y H   
Sbjct: 67  TLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH--- 120

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           + KI+HRDLK  N+L++ +   K++DFG+AR      +K  +N VV T  Y  P+  +G 
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGS 178

Query: 485 I-FSVKSDVFSFGVVLLEIISGK 506
             +S   D++  G +L E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.8 bits (181), Expect = 5e-14
 Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 9/158 (5%)

Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           E  ++  + H +++R+    +    + ++   +P+ S D++ + + RS  L   + + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
           K I  G+ YLH     +IIHRD+KT N+ ++      I D G A+             + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKS 508
           GT    APE      ++ K+D++S G+VL E+++   +
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255

Length = 357

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 35/225 (15%)

Query: 307 FSQENKLGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + Q   +G G  G V   +  VL  G  +AVK+LSR        F+N+    AK  ++ L
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRP-------FQNQTH--AKRAYREL 71

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIK 411
           V LL C   +N   L+  + P KSL+ F        L D+       ++LD +R   ++ 
Sbjct: 72  V-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY 130

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            +  GI +LH      IIHRDLK SN+++  +   KI DFG+AR    N     T  VV 
Sbjct: 131 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVT 185

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
            Y Y APE  +G  +    D++S G ++ E++ G  S  F  ++H
Sbjct: 186 RY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG--SVIFQGTDH 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 73.2 bits (179), Expect = 7e-14
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)

Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79

Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 193

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E+I G 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLS-----RTSGQGLQEFKNEVTVIAKLQH 360
           F     LG+GGFG V    V A GK  A K+L      +  G+ +    NE  ++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           + +V L     E  ++L L+   M    L   +++       D +R +     I  G+  
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLED 117

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAP 478
           LH   R +I++RDLK  N+LLD   + +ISD G+A  I  G   +      VGT GYMAP
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E      ++   D +  G ++ E+I GK
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 23/198 (11%)

Query: 316 GGFGPVYKGVLAD----GKEIAVKRLSRTSGQGLQEFKN---EVTVIAKLQHKNLVRLLG 368
           G FG VY   LA     G   A+K L ++      +  N   E  ++        V  L 
Sbjct: 7   GAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 369 CCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
              +  + L L+ EY+        L  +   +  DW ++   I  +  G+  LH+     
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG--- 117

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           IIHRD+K  N+L+D   + K++DFG++R   G ++K    + VGT  Y+APE  +G    
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPETILGVGDD 171

Query: 488 VKSDVFSFGVVLLEIISG 505
             SD +S G V+ E + G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 313 LGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK----LQHKN-LVRL 366
           LG+G FG V    L   G+  AVK L +     L +   E T++ K    L  +N  +  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 367 LGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L C  +  E L  + E++    L   + D  R    D  R       I  G+ +LH    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGYMAPEYAMG 483
             II+RDLK  NV+LD + + KI+DFGM +  +FG N  +A+T    GT  Y+APE   G
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST--FCGTPDYIAPEILQG 170

Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
             ++   D +SFGV+L E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 31/214 (14%)

Query: 313 LGEGGFGPVYKGVL---------ADGKEIAVKR-LSRTSGQGLQEFKNEVTVIAKLQHKN 362
           LG+G F  +YKGVL           G+E++V   +  +  +    F    +++++L HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           LV+L G C+ + E++++ EY+    LDVFL     +V L WK  + + K +A  + YL +
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 423 DSRLKIIHRDLKTSNVLL----DHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGY 475
               K++H ++   N+L+     +E      K+SD G+       + +      V    +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPW 170

Query: 476 MAPEYAMGGIFSVKS--DVFSFGVVLLEIISGKK 507
           +APE    G  S+    D +SFG  LLEI S  +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           +DF    ++G G +G VYK   +  G+  A+K +    G+     + E+ ++   +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 364 VRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRS-VQLDWKRRISIIKGIARGILYLH 421
           V   G  L  ++  +  E+    SL D++      S  Q+ +  R ++     +G+ YLH
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
              +   +HRD+K +N+LL    + K++DFG++       +K  +   +GT  +MAPE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVA 178

Query: 482 M---GGIFSVKSDVFSFGVVLLEI 502
                G ++   D+++ G+  +E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
            D+    ++G G +G VYK   L  G+  AVK +    G      + E+ ++ + +H N+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 364 VRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRS-VQLDWKRRISIIKGIARGILYLH 421
           V   G  L   +  +  EY    SL D++      S +Q+ +  R ++     +G+ YLH
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
              ++   HRD+K +N+LL    + K++DFG+A       +K  +   +GT  +MAPE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVA 178

Query: 482 M---GGIFSVKSDVFSFGVVLLEI 502
                G ++   D+++ G+  +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 25/210 (11%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKR-LSRTSGQGLQEFK-NEVTVIAKLQHKN-LVRLL 367
           K+GEG +G VYK      GK +A+K+       +G+      E++++  L     +VRLL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 368 GCCLEENES-------LLIYEYMPNKSLDVFLFDSTR---SVQLDWKRRISIIKGIARGI 417
              +E  E         L++EY+ +  L  F+ DS        L  K   S +  + +G+
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYM 476
            + H   +  ++HRDLK  N+L+D +    KI+D G+ R F     K+ T+ +V T  Y 
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178

Query: 477 APEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           APE  +G   +S   D++S G +  E+   
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCL 371
           +G G +G VYKG      ++A  ++   +    +E K E+ ++ K   H+N+    G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 372 E------ENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +      +++  L+ E+    S+ D+       +++ DW   I   + I RG+ +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC--REILRGLAHLHAH- 140

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
             K+IHRD+K  NVLL      K+ DFG++        + NT   +GT  +MAPE     
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 196

Query: 483 ---GGIFSVKSDVFSFGVVLLEIISG 505
                 +  +SD++S G+  +E+  G
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 13/205 (6%)

Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKN 362
           F Q   LG+GGFG V    V A GK  A KRL +      +G     NE  ++ K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L      ++   L+   M    L   +++       + +R +     I  G+  LH 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHR 120

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYA 481
           ++    ++RDLK  N+LLD   + +ISD G+A +I  G   +      VGT GYMAPE  
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVL 173

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
               +++  D +  G ++ E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 53/234 (22%)

Query: 305 QDFSQENKLGEGGFGPV----YKGVLADGKEIAVKRLSRT----SGQGLQEFKNEVTVIA 356
            DF     LG G FG V    +KG    GK  A+K LS+       Q ++   NE  ++ 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQ 56

Query: 357 KLQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            ++H  LV L G   +++ +L L+ EY+P   L    F   R        R      +AR
Sbjct: 57  SIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRFPE--PVAR 104

Query: 416 --------GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                    + YLH    L I++RDLK  N+LLD +   KI+DFG A+   G      T 
Sbjct: 105 FYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTY 156

Query: 468 RVVGTYGYMAPEYAMGGIFSVK-----SDVFSFGVVLLEIISGKKSTGFYHSEH 516
            + GT  Y+APE     I   K      D ++ G+++ E+++G     F+    
Sbjct: 157 TLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG--YPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVV 470
           IA G+ +LH      II+RDLK  NV+LD E + KI+DFGM +  IFGG      T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           GT  Y+APE      +    D ++FGV+L E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)

Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72

Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 186

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 15/204 (7%)

Query: 307 FSQENKLGEGGFGPVYKG-VLADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +  KLGEG +  VYKG    +GK +A+K  RL    G      + E +++  L+H N+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANI 65

Query: 364 VRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           V LL   +   E+L L++EY+     D+  +       L  +     +  + RG+ Y+H+
Sbjct: 66  V-LLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
                I+HRDLK  N+L+      K++DFG+AR      S   +N VV T  Y  P+  +
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVLL 176

Query: 483 GGI-FSVKSDVFSFGVVLLEIISG 505
           G   +S   D++  G + +E+I G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 15/199 (7%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           KLGEG +  VYKG     G+ +A+K  RL    G      + E +++  L+H N+V  L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69

Query: 369 CCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
             +   ++L L++EY+ +  L  ++ D    + +    R+ + + + RG+ Y H   + +
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLFLFQ-LLRGLAYCH---QRR 123

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-F 486
           ++HRDLK  N+L+      K++DFG+AR      SK  +N VV T  Y  P+  +G   +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRPPDVLLGSTEY 181

Query: 487 SVKSDVFSFGVVLLEIISG 505
           S   D++  G +  E+ +G
Sbjct: 182 STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 57/301 (18%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           LG G  G V+  V +D  K +AVK++  T  Q ++    E+ +I +L H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRISIIKG-------------IARG 416
                L            +   +S   VQ  ++      + +G             + RG
Sbjct: 73  PSGSDL------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQS-KANTNRVVGTYG 474
           + Y+H  +   ++HRDLK +NV ++ E +  KI DFG+ARI   + S K   +  + T  
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 475 YMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
           Y +P   +      K+ D+++ G +  E+++GK                    L+   H 
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-------------------PLFAGAHE 224

Query: 534 AELM----DSV-VKQSCDQAELLKYIHIGLLCVQGDPIDR-----PTMSSVAVMLASDIL 583
            E M    +SV V +  D+ ELL  I   +    G+P        P ++  A+     IL
Sbjct: 225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284

Query: 584 T 584
           T
Sbjct: 285 T 285

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 14/199 (7%)

Query: 312 KLGEGGFGPVYKGVLAD-GKEIAVKR-LSRTSGQGLQEFK-NEVTVIAKLQHKNLVRLLG 368
            +GEG +G V K    + G+ +A+K+ L     + +++    E+ ++ +L+H+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILYLHEDSRLK 427
               +    L++E++ +  LD    D  +    LD  R    +  I RGI + H  +   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           IIHRD+K  N+L+      K+ DFG AR       +  T+  V T  Y APE  +G    
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKY 178

Query: 488 VKS-DVFSFGVVLLEIISG 505
            ++ D+++ G ++ E+++G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKN 362
           F     LG+GGFG V    V A GK  A K+L +      +G     NE  ++ K+  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 363 LVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           +V L     E  ++L L+   M    L   +++       D +R I     +  G+  L 
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ 119

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEY 480
              R +I++RDLK  N+LLD   + +ISD G+A +I  G   +      VGT GYMAPE 
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEV 172

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
                ++   D +  G ++ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 313 LGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN----EVTVIAKLQHKNLVRLL 367
           +GEG +G V K    + KEI A+K+   +     +E K     E+ ++  L+ +N+V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
                  +  L++EY+    L+  L +   +     K R S I  + + I + H++    
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN---D 120

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           I+HRD+K  N+L+ H    K+ DFG AR      S AN    V T  Y +PE  +G  + 
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 488 VKSDVFSFGVVLLEIISGK 506
              D++S G +L E+  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 14/199 (7%)

Query: 313 LGEGGFGPVY---KGVLAD-GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G FG V+   K    D G+  A+K L + +   +     K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 E +  LI +++    L   L       + D K  ++    +A  + +LH    L
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLH---SL 117

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            II+RDLK  N+LLD E + K++DFG+++    ++ KA +    GT  YMAPE       
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 175

Query: 487 SVKSDVFSFGVVLLEIISG 505
           +  +D +SFGV++ E+++G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 5/95 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I RG+ YLH      I+HRD+K  N+L++     KI DFG+AR+   ++SK  T  VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 473 YGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           Y Y APE  MG   ++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKN 362
             +   + +GEG +G V        G ++A+K++S    Q   Q    E+ ++ + +H+N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 363 LVRLLGC----CLEE-NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           ++ +L        E  N+  ++ E M        L+   ++  L        +  I RG+
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGL 119

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV---VGTYG 474
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+ARI   +    +T  +   V T  
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATRW 174

Query: 475 YMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           Y APE  +      K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 16/205 (7%)

Query: 311 NKLGEGGFGPVYKGVLADGKEIA---VKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRL 366
           +++G G FG V  G    G   A   VK L  ++    Q  F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIIKGIARGILYLHEDS 424
           LG C+E    LL+ E+ P   L  +L  +   V    ++ +   +   +A G+L+LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA--- 481
           +   IH DL   N  L  +++ KI D+G+A            +       ++APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 482 ----MGGIFSVKSDVFSFGVVLLEI 502
               +    + KS+++S GV + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 57/166 (34%), Positives = 80/166 (48%), Gaps = 17/166 (10%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +ARG+ +L   SR K IHRDL   N+LL      KI DFG+AR    +            
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE     +++ +SDV+SFGV+L EI S   S         P     I + +C+  
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---------PYPGVQINEEFCQ-- 288

Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
              L D    ++ + A    Y  I L C QGDP +RPT S++  +L
Sbjct: 289 --RLKDGTRMRAPENATPEIY-RIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  + Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE     II+RDLK  NVLLD E + K++D+GM +   G +    T+   GT  Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
              G  +    D ++ GV++ E+++G+       S   P
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 22/203 (10%)

Query: 311 NKLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQEFKN--EVTVIAKLQ-HKNLVRL 366
            K+GEG F  V K      GK  A+K + +   + L++  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 367 LGCCLEE-NESL-LIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRISIIKGIARGILYLHE 422
           +    +     L L++E M     D+ L++  +  +  L  KR  S +  + + + ++H 
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
             R  I HRD+K  N+L+  +   K++DFG  R   G  SK      + T  Y APE  +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171

Query: 483 -GGIFSVKSDVFSFGVVLLEIIS 504
             G +  K D+++ G V  EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 38/231 (16%)

Query: 313 LGEGGFGPVYKGV---LADGK-----EIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           LG+G F  ++KG+   + D       E+ +K L ++     + F    +++++L HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
              G C+  +ES+++ EY+   SLD +L  +   + + WK  + + K +A  + +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDK- 119

Query: 425 RLKIIHRDLKTSNVLLDHEM-----NP---KISDFGMARIFGGNQSKANTNRVVGTYGYM 476
              + H ++   NVLL  E      NP   K+SD G++        K     ++    ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV---LPK---EILLERIPWV 171

Query: 477 APE-YAMGGIFSVKSDVFSFGVVLLEIISG----------KKSTGFYHSEH 516
            PE        S+ +D +SFG  L EI SG          +K   FY   H
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH 222

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 61/236 (25%)

Query: 313 LGEGGFGPVYKGVLA----DGKEIAVKRLSRT----SGQGLQEFKNEVTVIAKLQHKNLV 364
           +G G FG V+   L      G+  A+K L ++      Q +   + E  ++A      +V
Sbjct: 9   IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64

Query: 365 RLLGCCLEENESL-LIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIIKGIARG 416
           +L     ++ E L L+ EYMP   L       DVF  ++ R               IA  
Sbjct: 65  KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-------------IAEL 110

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA---------------------- 454
           +L L    +L  IHRD+K  N+L+D + + K++DFG+                       
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 455 -----RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
                R     Q +   N  VGT  Y+APE   G  + ++ D +S GV+L E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQ 359
           T  +     +G G FG V        G+ +A+K++ +   T     + ++ E+ ++  L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67

Query: 360 HKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           H+N++ L    +   E +  + E +     D+    ++R ++  + +    +  I RG+ 
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQ--YFLYQILRGLK 122

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y+H      ++HRDLK SN+L++   + KI DFG+ARI    Q    T  V   Y Y AP
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAP 174

Query: 479 EYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           E  +    + V+ D++S G +  E++ GK
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 56/171 (32%), Positives = 79/171 (46%), Gaps = 18/171 (10%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +ARG+ +L   SR K IHRDL   N+LL      KI DFG+AR    +            
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE     +++ +SDV+SFGV+L EI S   S         P     I + +C   
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---------PYPGVQIDEEFCR-- 287

Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL 583
              L +    ++ + A    Y  I L C   +P DRPT S +  +L  D+L
Sbjct: 288 --RLKEGTRMRAPEYATPEIY-SIMLDCWHNNPEDRPTFSELVEIL-GDLL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.7 bits (168), Expect = 5e-12
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 31/243 (12%)

Query: 329 GKEIAVKRLSRTSGQGLQE---FKNEVTVIAKLQHKNLVRLL--GCCLEENESLLIYEYM 383
           G E+A+K L   + +   +   F+ E  + A+L H N+V LL  G          ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 384 PNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL-- 440
           P ++L +V   D         +  + ++  +A      H      I+HRDLK  N+++  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114

Query: 441 -DHEMNPKISDFGMARIFGG-----NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFS 494
                + K+ DFG+  +  G       +   T  V+GT  Y APE   G   +  SD+++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 495 FGVVLLEIISGKKS-TG-----FYHSEHGPSLLAYIWKLWCEGHA-AELMDSVVKQSCDQ 547
           +G++ LE ++G++   G       + +  P  ++     W  GH   +++   + +   Q
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSL--PPWIAGHPLGQVLRKALNKDPRQ 232

Query: 548 AEL 550
              
Sbjct: 233 RAA 235

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 34/209 (16%)

Query: 313 LGEGGFGPV----YKGVLADGKEIAVKRL------SRTSGQGLQEFKNEVTVIAKLQHKN 362
           LG G FG V    YK     G+  A+K L      +R   + L   K         +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSL------DVFLFDSTRSVQLDWKRRISIIKGIARG 416
           LV L  C   E+    + EY     L      DVF             R +     +  G
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----------SEPRAVFYAACVVLG 113

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YLHE+   KI++RDLK  N+LLD E   KI+DFG+ +   G   + +T    GT  ++
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFL 168

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           APE      ++   D +  GV++ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 313 LGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKNEVTVIAK------LQHKNLVR 365
           LG+G FG V    L    E+ A+K L +     LQ+   + T+  K       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L  C   ++    + EY+    L   +F   RS + D  R       +   +++LH   R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH---R 114

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGYMAPEYAMG 483
             +I+RDLK  N+LLD E + K++DFGM +  I  G      T    GT  Y+APE    
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQE 170

Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
             +    D ++ GV++ E+++G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 58/222 (26%)

Query: 313 LGEGGFGPV----YKGVLADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQHKNLVR- 365
           +G+G +G V    ++    DGK+  +K+L+    S +  +  + E  ++++L+H N+V  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 366 -------------LLGCC--------LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK 404
                        ++G C        L+E +  L+ E   N+ ++ F       VQ    
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE---NQVVEWF-------VQ---- 110

Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
                   IA  + YLHE     I+HRDLKT NV L      K+ D G+AR+       A
Sbjct: 111 --------IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159

Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           +T  ++GT  YM+PE      ++ KSDV++ G  + E+ + K
Sbjct: 160 ST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 313 LGEGGFGP--VYKGVLADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG FG   + + V +D K  A+K  RL ++S   +++ + E  ++AK++H N+V    
Sbjct: 8   VGEGSFGRALLVQHVNSDQK-YAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDS-----TRSVQLDWKRRISIIKGIARGILYLHED 423
               +    ++ EY     L   +             L W  ++ +      G+ ++HE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              +++HRD+K+ N+ L      K+ DFG AR+     + A T   VGT  Y+ PE    
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWEN 174

Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
             ++ KSD++S G +L E+ + K
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 27/212 (12%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRT---SGQGLQEFKNEVTVIAKLQH 360
            D  +   +G G FG V+       +   A+K ++       +  Q   NE  V+ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG------IA 414
             ++RL     ++    ++ EY+P   L  +L +S          R S   G      I 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---------GRFSNSTGLFYASEIV 111

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
             + YLH     +I++RDLK  N+LLD E + K++DFG A+     + +  T  + GT  
Sbjct: 112 CALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPE 163

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           Y+APE       +   D ++ G+++ E++ G 
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G +G V   +    G+++A+K+LSR   S    +    E+T++  +QH+N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 370 CLEE---NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                  +E    Y  MP    D+          L   +   ++  +  G+ Y+H     
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            IIHRDLK  N+ ++ +   KI DFG+AR      + A     V T  Y APE  +  + 
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 487 SVKS-DVFSFGVVLLEIISGK 506
             ++ D++S G ++ E+++GK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 3/95 (3%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           IA  +L L    +L II+RD+K  N+LLD E +  ++DFG+++ F     +       GT
Sbjct: 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGT 169

Query: 473 YGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISG 505
             YMAPE   GG        D +S GV+  E+++G
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 35/219 (15%)

Query: 313 LGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G G +G V           +A+K+LSR        F++ +   AK  ++ L RLL    
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRP-------FQSAIH--AKRTYREL-RLLKHMD 72

Query: 372 EENESLLIYEYMPNKSLDVF-------------LFDSTRSVQLDWKRRISIIKGIARGIL 418
            EN   L+  + P  SL+ F             L +  +  +L       ++  I RG+ 
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V T  Y AP
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAP 184

Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSEH 516
           E  +  +   ++ D++S G ++ E+++GK  T F  S+H
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK--TLFPGSDH 221

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 65.9 bits (160), Expect = 3e-11
 Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 22/184 (11%)

Query: 330 KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE---YMPNK 386
           + +  KR+   S   +Q  +NE+  + +L H+N++++        E +L  E   YM  +
Sbjct: 193 ERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI--------EEILRSEANTYMITQ 243

Query: 387 SLDVFLFDSTRSVQLDWKRRI------SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL 440
             D  L+        DWK R       +I+K +   + Y+H+    K+IHRD+K  N+ L
Sbjct: 244 KYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300

Query: 441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLL 500
           + +    + DFG A  F   + +A     VGT    +PE   G  +   +D++S G++LL
Sbjct: 301 NCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359

Query: 501 EIIS 504
           +++S
Sbjct: 360 DMLS 363

Length = 501

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 27/190 (14%)

Query: 398 SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 457
            + LD +  +S    +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR  
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 262

Query: 458 GGNQSKANTNRVVGTYG-----YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                + ++N VV         +MAPE     +++ +SDV+S+G++L EI S   S    
Sbjct: 263 ---DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS---- 315

Query: 513 HSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS 572
               G  + +  +K+  EG+    M S     C  +E+   +     C   DP+ RPT  
Sbjct: 316 -PYPGMPVDSKFYKMIKEGYR---MLS---PECAPSEMYDIMKS---CWDADPLKRPTFK 365

Query: 573 SVAVMLASDI 582
            +  ++   +
Sbjct: 366 QIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 312 KLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN----EVTVIAKLQHKNLVRL 366
           K+GEG +G V+K    + G+ +A+K+   +    +   K     E+ ++ +L+H NLV L
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           +     + +  L++EY  +  L+  L  + R V     ++I  I    + + + H   + 
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKI--IWQTLQAVNFCH---KH 119

Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI- 485
             IHRD+K  N+L+  +   K+ DFG ARI  G      T+  V T  Y APE  +G   
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTD-YVATRWYRAPELLVGDTQ 177

Query: 486 FSVKSDVFSFGVVLLEIISG 505
           +    DV++ G V  E+++G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G G +G V        G  +AVK+LSR        F++   + AK  ++ L RLL    
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQS--IIHAKRTYREL-RLLKHMK 74

Query: 372 EENESLLIYEYMPNKSL----DVFLFDSTRSVQLDWKRRIS---------IIKGIARGIL 418
            EN   L+  + P +SL    DV+L        L+   +           +I  I RG+ 
Sbjct: 75  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V T  Y AP
Sbjct: 135 YIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAP 186

Query: 479 EYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E  +  + ++   D++S G ++ E+++G+  T F  ++H
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDH 223

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 32/79 (40%), Positives = 49/79 (62%), Gaps = 5/79 (6%)

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-F 486
           +++RDLK +N+LLD   + +ISD G+A  F    SK   +  VGT+GYMAPE    G+ +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAY 173

Query: 487 SVKSDVFSFGVVLLEIISG 505
              +D FS G +L +++ G
Sbjct: 174 DSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.9 bits (161), Expect = 4e-11
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRT-SGQGL--QEFKNEVTVIAKLQHKNLVRLL 367
            +G+GG G VY        + +A+K++    S   L  + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 368 GCCLEENESLLIYEYMPN------KSL--DVFLFDSTRS---VQLDWKRRISIIKGIARG 416
             C   ++   +Y  MP       KSL   V+  +S       +      +SI   I   
Sbjct: 69  SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ-----SKANTN---- 467
           I Y+H  S+  ++HRDLK  N+LL       I D+G A      +        +      
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 468 -------RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                  ++VGT  YMAPE  +G   S  +D+++ GV+L ++++
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 35/219 (15%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G G +G V   +    G ++A+K+L R        F++E+   AK  ++ L RLL    
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRP-------FQSEL--FAKRAYREL-RLLKHMK 72

Query: 372 EENESLLIYEYMPNKSLDVFL-------FDSTRSVQLDWKRRIS------IIKGIARGIL 418
            EN   L+  + P+ SLD F        F  T   +L    ++S      ++  + +G+ 
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q+ +     V T  Y AP
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAP 184

Query: 479 EYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E  +  + ++   D++S G ++ E+++GK    F   +H
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK--PLFKGHDH 221

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 29/207 (14%)

Query: 313 LGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQEFKN---EVTVIAKLQHKNLVRLL- 367
           +G G +G V        ++ +AVK+LSR   Q L   +    E+ ++  ++H+N++ LL 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 368 ----GCCLEE-NESLLIYEYMPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYL 420
                  +E  NE  L+   M     ++      S   VQ        +I  + RG+ Y+
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKYI 134

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H      IIHRDLK SNV ++ +   +I DFG+AR     Q+       V T  Y APE 
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEI 186

Query: 481 AMGGI-FSVKSDVFSFGVVLLEIISGK 506
            +  + ++   D++S G ++ E++ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 8/147 (5%)

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H  LV L  C   E+    + E++    L   +F   R  +L  +        I+  + +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE     II+RDLK  NVLLD E + K++D+GM +   G +    T+   GT  Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK 506
              G  +    D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 26/167 (15%)

Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--- 407
           E  ++  + H ++++L G       + LI   +P    D++ +       L  KR I   
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182

Query: 408 ---SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
              +I + + R I YLHE+    IIHRD+K  N+ ++H  +  + DFG A          
Sbjct: 183 DILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF----PVDI 235

Query: 465 NTNRVVGTYGYMA---PEYAMGGIFSVKSDVFSFGVVLLEIISGKKS 508
           N N+  G  G +A   PE      +    D++S G+VL E+ +   S
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 24/155 (15%)

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS---KANTNRVVGTYGYMAPEYAMGGI 485
           IHRD+   NVLL      KI DFG+AR    + +   K N    V    +MAPE     +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFDCV 290

Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLL--AYIWKLWCEGHAAELMDSVVKQ 543
           ++V+SDV+S+G++L EI S  KS   Y     P +L  +  +K+   G+         + 
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP--Y-----PGILVNSKFYKMVKRGY---------QM 334

Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           S       +   I  +C   +P +RPT S ++ ++
Sbjct: 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 24/204 (11%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC-- 369
           +G GGFG VY    AD GK  A+K L +   + ++  + E   + +    +LV    C  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 370 --CLE-----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
             C+       ++   I + M    L   L  S   V  + + R    + I  G+ ++H 
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATE-IILGLEHMH- 114

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +R  +++RDLK +N+LLD   + +ISD G+A  F    SK   +  VGT+GYMAPE   
Sbjct: 115 -NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQ 168

Query: 483 GGI-FSVKSDVFSFGVVLLEIISG 505
            G  +   +D FS G +L +++ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCC 370
           +G+G +G VYK     DG   AVK L   S    +E + E  ++  L  H N+V+  G  
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 371 LEENESL-----LIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILYLHEDS 424
            + ++ +     L+ E     S+   +       Q LD      I+ G   G+ +LH + 
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY---- 480
             +IIHRD+K +N+LL  E   K+ DFG++      + + NT+  VGT  +MAPE     
Sbjct: 148 --RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 203

Query: 481 -AMGGIFSVKSDVFSFGVVLLEIISG 505
                 +  + DV+S G+  +E+  G
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 8/144 (5%)

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           LV L  C    +   L+ EY+    L   +F   R  +L  +        I   + +LHE
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
                II+RDLK  NVLLD + + K++D+GM +   G      T+   GT  Y+APE   
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
           G  +    D ++ GV++ E+++G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 312 KLGEGGFGPVYKGVLADG---KEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLL 367
           ++G G FG V  G +  G    ++ VK L  ++  Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQL---DWKRRISIIKGIARGILYLHEDS 424
           G C E    LL+ E+ P   L  +L  S R  +L   D      +   IA G+L+LH+++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY---A 481
               IH DL   N LL  ++  KI D+G++            +++     ++APE     
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 482 MGGIFSV----KSDVFSFGVVLLEI 502
            G +  V    +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVV 470
           IA G+ +LH      II+RDLK  NV+LD E + KI+DFGM +  ++ G      T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           GT  Y+APE      +    D ++FGV+L E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKNEVTVIAK----LQH 360
           DF+    LG+G FG V         E+ A+K L +     +Q+   E T++ K    LQ 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQD 58

Query: 361 KN--LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           K   L +L  C    +    + EY+    L   ++   +  +    + +     I+ G+ 
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV-VGTYGYMA 477
           +LH      II+RDLK  NV+LD E + KI+DFGM +    +     T R   GT  Y+A
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIA 169

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE      +    D +++GV+L E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 13/185 (7%)

Query: 327 ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK 386
              K++ VK     +  G +    E+ ++  + H+ ++ L+     ++   ++   MP  
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKY 168

Query: 387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP 446
             D+F +   RS  L  ++ I+I + +   + YLH      IIHRD+KT N+ LD   N 
Sbjct: 169 KCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224

Query: 447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            + DFG A     +          GT    +PE      +  K+D++S G+VL E +S K
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVK 283

Query: 507 KSTGF 511
             T F
Sbjct: 284 NVTLF 288

Length = 392

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 313 LGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKN---EVTVIAK-LQHKNLV 364
           +G+G FG V    LA    DGK  AVK L + +    +E K+   E  V+ K ++H  LV
Sbjct: 3   IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L       ++   + +Y+    L    F   R       R       IA  + YLH   
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
            L II+RDLK  N+LLD + +  ++DFG+ +   G +    T+   GT  Y+APE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +    D +  G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +A+G+ +L   SR K IHRDL   N+LL      KI DFG+AR    +            
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +MAPE     +++++SDV+SFGV+L EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.9 bits (147), Expect = 6e-10
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A GK  A+K L +       E  + +T   V+   +H  L  
Sbjct: 3   LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L      ++    + EY+    L    F  +R       R       I   + YLH    
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG-- 114

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
            KI++RDLK  N++LD + + KI+DFG+ +   G    A      GT  Y+APE      
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 51/223 (22%)

Query: 305 QDFSQENKLGEGGFGPV----YKGVLADGKEIAVKRLSRTS---GQGLQEFKNEVTVIAK 357
            DF     LG G FG V    +KG    G+  A+K L +      + +Q    E +++ +
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILME 74

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYM---------------PNKSLDVFLFDSTRSVQLD 402
           L H  +V ++    +EN    + E++               PN   DV  F     V   
Sbjct: 75  LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN---DVAKFYHAELVL-- 129

Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
                           YLH      II+RDLK  N+LLD++ + K++DFG A+     + 
Sbjct: 130 -------------AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KV 168

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
              T  + GT  Y+APE           D ++ GV+L E I+G
Sbjct: 169 PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 51/221 (23%)

Query: 311 NKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLVRLLG 368
           N +G G FG VY+ +  D  E +A+K++ +       ++KN E+ ++  L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 369 C----CLEENESLL----IYEYMP-------------NKSLDVFLFDSTRSVQLDWKRRI 407
                C ++NE  +    + E++P             N +L +FL     S QL      
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-KLYSYQL------ 179

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMAR-IFGGNQSKAN 465
                  R + Y+H      I HRDLK  N+L+D   +  K+ DFG A+ +  G +S + 
Sbjct: 180 ------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS- 229

Query: 466 TNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
               + +  Y APE  +G   ++   D++S G ++ E+I G
Sbjct: 230 ---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 30/86 (34%), Positives = 52/86 (60%), Gaps = 5/86 (5%)

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH+     +I+RDLK  N+LLD++ +  + DFG+ ++   +  K NT    GT  Y+APE
Sbjct: 109 LHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPE 163

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
             +G  ++   D ++ GV+L E+++G
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSR----TSGQGLQEFKNEVTVIAKLQHKNLV 364
           LG+GG+G V++     G +     A+K L +     + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 365 RLLGCCLEENESLLIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIIKGIARGI 417
            L+       +  LI EY+    L        +F+ D+              +  I+  +
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY----------LSEISLAL 113

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGY 475
            +LH   +  II+RDLK  N+LLD + + K++DFG+ +  I  G      T+   GT  Y
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEY 166

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           MAPE  M        D +S G ++ ++++G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 18/213 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQH 360
           +DF  ++ +G G FG V      A G   A+K + ++   + + +  F+ E  +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK-GIARGILY 419
             + +L     +++   L+ EY P   L   L  +    Q D      + +  +A  +L 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDE----DMAQFYLAELVLA 114

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           +H   ++  +HRD+K  NVL+D   + K++DFG A     N+   N+   VGT  Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPE 173

Query: 480 Y------AMGGIFSVKSDVFSFGVVLLEIISGK 506
                     G + V+ D +S GV+  E+I G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT--NRVV 470
           + RG+ Y+H      +IHRDLK SN+L++ +   +I DFGMAR    + ++        V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 471 GTYGYMAPE--YAMGGIFSVKSDVFSFGVVLLEII 503
            T  Y APE   ++   ++   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 3/98 (3%)

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           +S    +ARG+ +L   +    +HRDL   NVLL      KI DFG+AR    + +  + 
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MAPE     +++  SDV+S+G++L EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 24/219 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGK--EIAVKRLSRTS---GQGLQEFKNEVTVIAKLQ 359
           +DF+    LG G FG V      +     +A+KR  ++     + +    +E  ++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR---SVQLDWKRRISIIKGIARG 416
           H   V L G   +E+   L+ E++       FL  + R    V   +  +I +I      
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI------ 143

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
             YL     L I++RDLK  N+LLD +   K++DFG A++         T  + GT  Y+
Sbjct: 144 FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYI 195

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSE 515
           APE  +       +D ++ G+ + EI+ G     FY +E
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG--CPPFYANE 232

Length = 340

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 2/90 (2%)

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           IL L    +L I++RD+K  N+LLD E +  ++DFG+++ F  ++ K  T    GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 477 APEYAMGGIFSVKS-DVFSFGVVLLEIISG 505
           APE   G     K+ D +S G+++ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 21/207 (10%)

Query: 313 LGEGGFGPVYKGVL--ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGC 369
           +G+G +G V+K VL   +G + AVK L        +E + E  ++  L  H N+V+  G 
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGM 83

Query: 370 CLEEN-----ESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
             +++     +  L+ E     S+ D+      R  +++      I+     G+ +LH +
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY--- 480
              K IHRD+K +N+LL  E   K+ DFG++      + + NT+  VGT  +MAPE    
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIAC 198

Query: 481 --AMGGIFSVKSDVFSFGVVLLEIISG 505
              +   +  + DV+S G+  +E+  G
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 31/91 (34%), Positives = 52/91 (57%)

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           +L +H      +IHRD+K++N+LL      K+ DFG ++++    S        GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKK 507
           APE      +S K+D+FS GV+L E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 19/201 (9%)

Query: 313 LGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKN---EVTVIAK-LQHKNLV 364
           +G+G FG V   +LA    DG   AVK L + +    +E  +   E  V+ K L+H  LV
Sbjct: 3   IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L        +   + +Y+    L    F   R       R       +A  I YLH   
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
            L II+RDLK  N+LLD + +  ++DFG+ +   G + +  T+   GT  Y+APE     
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +    D +  G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 6/104 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   + YLH  S   +++RDLK  N++LD + + KI+DFG+ +   G +  A      GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
             Y+APE      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 27/209 (12%)

Query: 312 KLGEGGFGPVYKGVLADGKEIA---VKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLL 367
           ++G G FG V    +     +A   VK L   +    Q EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK-------GIARGILYL 420
           G C+E    LL++EY     L  +L       Q  W RR S +         IA G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H   +   +H DL   N  L  ++  K+ D+G+             +       ++APE 
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Query: 481 A---MGGIFSVK----SDVFSFGVVLLEI 502
                GG+ + +    S+V++ GV L E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 64/258 (24%), Positives = 98/258 (37%), Gaps = 71/258 (27%)

Query: 305 QDFSQENKLGEGGFGPVYKGV--LADGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQ 359
           +DF     +G+G FG V + V     GK  A+K L ++       L   K E  V+A+  
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIIKG 412
              +V L     +     LI E++P   L       D F  D TR               
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY------------- 106

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN----------QS 462
           +A  +L +    +L  IHRD+K  N+L+D   + K+SDFG++  F             Q 
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166

Query: 463 KANTNRV-----------------------------------VGTYGYMAPEYAMGGIFS 487
           K+N NR+                                   VGT  Y+APE  +   + 
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226

Query: 488 VKSDVFSFGVVLLEIISG 505
            + D +S G ++ E + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 313 LGEGGFGPVYKGVLAD---------GKEIAVKRLSRTSGQGLQE----FKNEVTVIAKLQ 359
           LG G    +Y G+L             E  +K + +      ++    F    +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           HK++V L G C+ + E++++ E++    LD+F+   +  +   WK +++  K +A  + Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVA--KQLASALSY 120

Query: 420 LHEDSRLKIIHRDLKTSNVLL-----DHEMNP--KISDFGMARIFGGNQSKANTNRVVGT 472
           L ED  L  +H ++ T N+LL     D E  P  K+SD G+       Q        V  
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VER 171

Query: 473 YGYMAPEYAM-GGIFSVKSDVFSFGVVLLEI 502
             ++APE        S+ +D +SFG  L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 7/104 (6%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   + YLH      +++RDLK  N++LD + + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
             Y+APE      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 313 LGEGGFGPVY--KGVLA--DGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLV 364
           LG G +G V+  + V     GK  A+K L + +     +  +  + E  V+  ++    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 365 RLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGILYLHE 422
             L    + +  L LI +Y+    L   L    R  +    + + I  G I   + +LH 
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHLH- 122

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
             +L II+RD+K  N+LLD   +  ++DFG+++ F  ++ +       GT  YMAP+   
Sbjct: 123 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVR 179

Query: 483 GGI--FSVKSDVFSFGVVLLEIISG 505
           GG        D +S GV++ E+++G
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 20/211 (9%)

Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   +H  L  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L       +    + EY     L    F  +R      +R       I   + YLH    
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 115

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+APE      
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 20/217 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
           +DF     +G G FG V        K++ A+K LS+       +   F  E  ++A    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           + +V+L     ++++ L ++ EYMP   L V L  S   +   W R        A  +L 
Sbjct: 103 EWIVQLH-YAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLA 154

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           L     +  IHRD+K  N+LLD   + K++DFG       N      +  VGT  Y++PE
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPE 213

Query: 480 YAMG----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                   G +  + D +S GV L E++ G   T FY
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 65/249 (26%), Positives = 101/249 (40%), Gaps = 64/249 (25%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQH 360
           DF     +G G FG V      D G   A+K+L ++      Q +   + E  ++A+  +
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADN 60

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIIKG 412
             +V+L     ++   L LI EY+P   +       D F  + TR               
Sbjct: 61  PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY------------- 106

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM------------ARIFGGN 460
           IA  IL +    +L  IHRD+K  N+LLD + + K+SDFG+             RI    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 461 Q-------------SKANT-----NR------VVGTYGYMAPEYAMGGIFSVKSDVFSFG 496
                         SK        NR       VGT  Y+APE  +   ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 497 VVLLEIISG 505
           V++ E++ G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)

Query: 305 QDFSQENKLGEGGFGPV----YKGVLADGKEIAVKRLSRTSGQGLQE---FKNEVTVIAK 357
           +D+     +G G FG V    +K   +  K  A+K LS+       +   F  E  ++A 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 358 LQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
                +V+L  C  ++++ L ++ EYMP   L   +  S   V   W +  +     A  
Sbjct: 100 ANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYT-----AEV 151

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           +L L     + +IHRD+K  N+LLD   + K++DFG              +  VGT  Y+
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYI 210

Query: 477 APEYAMG----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           +PE        G +  + D +S GV L E++ G   T FY
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 54/225 (24%)

Query: 312 KLGEGGFGPV----YKGVLADGKEIAVKRLSRTSGQG------------LQEFKNEVTVI 355
           +LG+G +G V         ++ + +A+K+++    +             L+ F+      
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----- 60

Query: 356 AKLQHKNLVRLLGCCLEE---------NESLLIYEYMPNKSLDVFLFDSTRS-VQLDWKR 405
               HKN+      CL +         NE  L  E M     +  L    RS   L    
Sbjct: 61  ----HKNIT-----CLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLTDAH 106

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
             S I  I  G+ Y+H  +   ++HRDLK  N+L++ +   KI DFG+AR F  N  +  
Sbjct: 107 FQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163

Query: 466 ---TNRVVGTYGYMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
              T   V T  Y APE  +      K+ DV+S G +L E++  K
Sbjct: 164 GFMTE-YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 38/213 (17%)

Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN---------EVTVIAKLQHKN 362
           +G G +G V     ++  +++A+K+++         F N         E+ ++  L H+N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 363 LVRLLGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARG 416
           ++ +            N+  ++YE M     D  L    RS Q L        +  + RG
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--TNRVVGTYG 474
           + Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR       K +  T  VV T  
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVV-TRW 173

Query: 475 YMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           Y APE  +    ++   DV+S G +  E++  K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)

Query: 348 FKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           F    ++++++ H +L  + G C+  +E++++ E++ +  LDV L      V + WK  I
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-----MNP--KISDFGMARIFGGN 460
           ++ + +A  + YL ED  L  +H ++   N+LL         +P  K+SD G++  F   
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175

Query: 461 QSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEI 502
             +    R+     ++APE   GG   S  +D +SFG  LLEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 19/201 (9%)

Query: 313 LGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKN---EVTVIAK-LQHKNLV 364
           +G+G FG V   +LA    DGK  AVK L +      +E K+   E  V+ K ++H  LV
Sbjct: 3   IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L        +   + +++    L    F   R       R       IA  + YLH   
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
            + I++RDLK  N+LLD + +  ++DFG+ +   G      T    GT  Y+APE     
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +    D +  G VL E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 3/119 (2%)

Query: 383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH 442
           +P    D++ +   R   L   +  ++ + +   I Y+H +    IIHRD+KT NVL++ 
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNG 295

Query: 443 EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLE 501
             +  + DFG A    G+ S      + GT    APE   G  ++   D++S G+V+ E
Sbjct: 296 PEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 14/162 (8%)

Query: 349 KNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
           ++E+  +A   H  +V+       +++ LLI EY     L+       + ++   K  + 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN-------KQIKQRLKEHLP 165

Query: 409 IIKGIARGILY------LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
             +    G+L+      L E    K++HRDLK++N+ L      K+ DFG ++ +  + S
Sbjct: 166 F-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
               +   GT  Y+APE      +S K+D++S GV+L E+++
Sbjct: 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 46/196 (23%), Positives = 90/196 (45%), Gaps = 22/196 (11%)

Query: 321 VYKGVLADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL 377
           +YKG+  + KE+ ++      +     +   +NE+  + ++   N++++ G  ++  + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 378 ----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDL 433
               LI EY     L   L D  +   L +K ++ +     +G+  L+        +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL-DKEK--DLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149

Query: 434 KTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS---VKS 490
            + + L+      KI   G+ +I      K N N +V    Y + +  +  IFS   +K 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMV----YFSYKM-LNDIFSEYTIKD 203

Query: 491 DVFSFGVVLLEIISGK 506
           D++S GVVL EI +GK
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 8/96 (8%)

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI-FGGNQSKANTNRVVGTY 473
           R + Y+H  +   + HRDLK  N+L + +   KI DFG+AR+ F    +       V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 474 GYMAPEYAMGGIFSVKS---DVFSFGVVLLEIISGK 506
            Y APE   G  FS  +   D++S G +  E+++GK
Sbjct: 171 WYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 24/225 (10%)

Query: 299 DIVKATQDFSQENKLGEGGFGPV----YKGVLADGKEIAVKRLSRTSGQGLQE---FKNE 351
           D+    +D+     +G G FG V    +K   +  K  A+K LS+       +   F  E
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
             ++A      +V+L     ++    ++ EYMP   L   +  S   V   W R  +   
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYT--- 148

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
             A  +L L     +  IHRD+K  N+LLD   + K++DFG        +     +  VG
Sbjct: 149 --AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVG 205

Query: 472 TYGYMAPEYAMG----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           T  Y++PE        G +  + D +S GV L E++ G   T FY
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 10/106 (9%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVG 471
           +A  +L +    +L  +HRD+K  NVLLD   + +++DFG   R+      ++N    VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165

Query: 472 TYGYMAPEY--AMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           T  Y++PE   AM    G +  + D +S GV + E++ G+  T FY
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +A G+ +L   +    +HRDL   NVL+      KI DFG+AR    + +  +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +MAPE     +++  SDV+SFG++L EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-ANTNRVVG 471
           IA  +L L    +  I++RDLK  N+LLD   +  + DFG+++    N +    TN   G
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCG 158

Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           T  Y+APE  +    ++   D +S GV++ E+  G
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.3 bits (122), Expect = 1e-06
 Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 50/248 (20%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKN-----EVTVIAKLQHKNLVRL 366
           K+G G FG V+       +E    +    S +GL+E +      EV V+ +L+HKN+VR 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 367 LGCCLEE-NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR--------ISIIKGIARGI 417
           +   L + N+ L I     +        D +R++Q  +K          + I + +   +
Sbjct: 78  IDRFLNKANQKLYILMEFCDAG------DLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 418 LYLHE----DSRLKIIHRDLKTSNVLLD-------------HEMN----PKISDFGMARI 456
            Y H      +  +++HRDLK  N+ L              + +N     KI DFG+++ 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV--KSDVFSFGVVLLEIISGKKSTGFYHS 514
             G +S A++   VGT  Y +PE  +    S   KSD+++ G ++ E+ SGK  T F+ +
Sbjct: 192 I-GIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKA 246

Query: 515 EHGPSLLA 522
            +   L++
Sbjct: 247 NNFSQLIS 254

Length = 1021

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           IA  + YLH    L I++RDLK  N+LLD + +  ++DFG+ +     +    T+   GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             Y+APE      +    D +  G VL E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 17/217 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
            DF     +G G FG V    +   + I A+K L++       E   F+ E  V+     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           + +  L     +EN   L+ +Y     L   L      +  D  R       IA  +L +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAI 115

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H   +L  +HRD+K  NVLLD   + +++DFG   +         ++  VGT  Y++PE 
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 481 AMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                   G +  + D +S GV + E++ G+  T FY
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 6e-06
 Identities = 59/239 (24%), Positives = 88/239 (36%), Gaps = 49/239 (20%)

Query: 305 QDFSQENKLGEGGFGPVY----KGVLADGKEIAVKRLSRTSGQGLQEFKN---EVTVIAK 357
           + F +   LG+G  G V+    KG    GK  A+K L +       + K    E  ++A 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H  L  L      E    L+ +Y P               Q        + +  A  +
Sbjct: 58  LDHPFLPTLYASFQTETYLCLVMDYCPGGE-----LFRLLQRQPGKCLSEEVARFYAAEV 112

Query: 418 L----YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM-------------ARIFGGN 460
           L    YLH    L I++RDLK  N+LL    +  +SDF +             A   G  
Sbjct: 113 LLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 461 QSK--------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           +S                 +N  VGT  Y+APE   G       D ++ G++L E++ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 43/237 (18%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG----QGLQEFKNEVTVIAKLQHK 361
           DF     +G G FG V      D   I   ++ R +     + +   + E  ++ +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            +V++     ++    LI E++P   +   L       +   +  I+        +L + 
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA------ETVLAID 115

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA------------RIFGGN--------- 460
              +L  IHRD+K  N+LLD + + K+SDFG+             R    N         
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 461 ---QSKANT---NR------VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
              + KA T   NR       VGT  Y+APE  M   ++   D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 17/217 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
           +DF     +G G FG V    L +  ++ A+K L++       E   F+ E  V+    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           + +  L     +EN   L+ +Y     L   L      +  D  R       +A  ++ +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAI 115

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
               +L  +HRD+K  N+L+D   + +++DFG       + +   ++  VGT  Y++PE 
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEI 174

Query: 481 AMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                   G +  + D +S GV + E++ G+  T FY
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGE--TPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 38/179 (21%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTSGQGLQE-FKNE------VT 353
           DF    KLGEG FG VYK  L +       +  +K   + +  G  E + NE        
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVRRACPN 189

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEY---------MPNK----SLDVFLFDSTRSVQ 400
             A   +  L  +     +E+E  L++ Y         M +K    +++ +L    + + 
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 401 LDWKRRISIIKGIARGILY----LHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMA 454
              +R   II+ I R IL+    LH      I+HRD+K  N++        KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 43/238 (18%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQE----FKNEVTVIAKLQH 360
           +DF     +G G FG V      D   +   ++ R +    +E     + E  ++ +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
             +V++     ++    LI E++P   +   L       + + +  I      A  +L +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYI------AETVLAI 114

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG---------------------- 458
               +L  IHRD+K  N+LLD + + K+SDFG+                           
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 459 --GNQSKANT---NR------VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
              ++ KA T   NR       VGT  Y+APE  M   ++   D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 42/206 (20%), Positives = 83/206 (40%), Gaps = 22/206 (10%)

Query: 313 LGEGGFGPVYKGVLADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
             +     + K        +AVK+  L   S + L+  + E+    +LQH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           + ++E  ++   M   S +  L  +     L       I+K +   + Y+H       IH
Sbjct: 69  IVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIH 124

Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG--------YMAPEY-- 480
           R +K S++LL  +    +S    +             RVV  +         +++PE   
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 481 -AMGGIFSVKSDVFSFGVVLLEIISG 505
             + G ++ KSD++S G+   E+ +G
Sbjct: 182 QNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 35/134 (26%)

Query: 330 KEIAVK-RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC------LEENESLLIYEY 382
            E+  K R  RT        + E  ++AK       R  G        ++ +  L++ EY
Sbjct: 35  PELDEKLRRERT--------RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEY 80

Query: 383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH 442
           +  + L   L           + R  +++ + R +  LH+     I+H DL TSN++L  
Sbjct: 81  IEGELLKDAL----------EEARPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSG 127

Query: 443 EMNPKISDFGMARI 456
                  DFG+   
Sbjct: 128 G-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 30/147 (20%), Positives = 58/147 (39%), Gaps = 15/147 (10%)

Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV--RLLGC 369
            L  G    VY  +    ++  +K           + + EV ++  L  K L   ++L  
Sbjct: 5   LLKGGLTNRVYL-LGTKDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
              +  S L+ E++  ++LD          ++  + +  I + +A  +  LH+   L + 
Sbjct: 62  GESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARI 456
           H DL   N+L+D      I D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.8 bits (106), Expect = 7e-05
 Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 16/100 (16%)

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI---------FGGNQSKANTN-- 467
           YLH      I+HRDLK  N+L+    + K++DFG+++I         + G+  K      
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 468 --RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             +V GT  Y+APE  +   +    D ++ G++L E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 20/161 (12%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQH 360
           ++F     +  G FG VY G    + K  AVK + +    +   + + + E   +A  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
             +V L       N   L+ EY+    +   L     FD   +V+         I  +A 
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVAL 115

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 456
            + YLH   R  IIHRDLK  N+L+ +E + K++DFG++++
Sbjct: 116 ALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 15/149 (10%)

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGIL 418
           + N ++L          +LI +Y+     D  LFD  +    L       II+ +   + 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            LH   +  IIH D+K  NVL D   +   + D+G+ +I  G  S  +     GT  Y +
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-GTPSCYD-----GTLDYFS 174

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE   G  + V  D ++ GV+  E+++GK
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 23/52 (44%), Positives = 34/52 (65%), Gaps = 1/52 (1%)

Query: 404 KRRISIIKGIARGILY-LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
           KR I++IKG+ R +L  L +  R+ I+HRD+K  N+L+  +   KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 42/235 (17%)

Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           DI  +TQ F   + LGEG FG V +      KE    ++ R   +  ++ K E+  + K+
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182

Query: 359 QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDV-FLFDSTRSVQLDW---------KRRI 407
           +  +          +   L+ I  Y  N++  +  +        LDW         +   
Sbjct: 183 RQADP--------ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLA 234

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNP-------------KISDF 451
            II      + Y H  + L ++H DLK  N+L+   D  ++P             +I D 
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           G     G    + +   +V T  Y +PE  +G  +   +D++S G ++ E+ +GK
Sbjct: 293 G-----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 53/255 (20%), Positives = 98/255 (38%), Gaps = 67/255 (26%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTS---GQGLQEFKNEVTVIAKLQHKN 362
           F +   LG G FG V      D K + A+K L +        +   K E  ++A+  ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG------IARG 416
           +VRL     +++    + +Y+P   +   L             R+ I         IA  
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAEL 110

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF----------GGNQSKANT 466
              +    ++  IHRD+K  N+L+D + + K++DFG+   F           G+  + ++
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170

Query: 467 -----------------------------------NRVVGTYGYMAPEYAMGGIFSVKSD 491
                                              + +VGT  Y+APE  +   ++   D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230

Query: 492 VFSFGVVLLEIISGK 506
            +S GV+L E++ G+
Sbjct: 231 WWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 29/138 (21%), Positives = 56/138 (40%), Gaps = 44/138 (31%)

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM---------ARIFGGN 460
           I  +   I  +H   ++  IHRD+K  N+L+D + + K++DFG+         ++ +   
Sbjct: 107 IAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163

Query: 461 --------------------------------QSKANTNRVVGTYGYMAPEYAMGGIFSV 488
                                             +   + +VGT  Y+APE  +   ++ 
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223

Query: 489 KSDVFSFGVVLLEIISGK 506
             D +S GV+L E++ G+
Sbjct: 224 LCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 8/78 (10%)

Query: 313 LGEGGFGPVYKGV-LADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  ++    +E   +E+ +++ L QHKN+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 365 RLLGCCLEENESLLIYEY 382
            LLG C      L+I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.7 bits (91), Expect = 0.004
 Identities = 25/127 (19%), Positives = 51/127 (40%), Gaps = 34/127 (26%)

Query: 336 RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC------LEENESLLIYEYMPNKSLD 389
           R  RT        +NE  ++++       R  G        ++ +   ++ EY+  K L 
Sbjct: 40  RRERT--------RNEARLLSRA------RKAGVNTPVVYDVDPDNKTIVMEYIEGKPLK 85

Query: 390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
             + +              +++ I R +  LH+     I+H DL TSN+++  +    + 
Sbjct: 86  DVIEE----------GNDELLREIGRLVGKLHK---AGIVHGDLTTSNIIV-RDDKLYLI 131

Query: 450 DFGMARI 456
           DFG+ + 
Sbjct: 132 DFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	624
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
PRK10345	210	hypothetical protein; Provisional	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
smart00090	237	RIO RIO-like kinase.	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
KOG1243	690	consensus Protein kinase [General function predict	99.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.12
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
COG4248	637	Uncharacterized protein with protein kinase and he	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.78
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
PRK09902	216	hypothetical protein; Provisional	98.56
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.45
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.37
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.29
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.25
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.22
PF01636	239	APH: Phosphotransferase enzyme family This family	98.22
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.16
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
PLN02876	822	acyl-CoA dehydrogenase	97.99
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.97
PRK10593	297	hypothetical protein; Provisional	97.93
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.9
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.76
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.64
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.57
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.51
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.39
PRK05231	319	homoserine kinase; Provisional	97.33
PLN02236	344	choline kinase	97.25
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.13
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.08
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.05
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.94
KOG2270	520	consensus Serine/threonine protein kinase involved	96.84
PLN02756	418	S-methyl-5-thioribose kinase	96.74
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.59
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.53
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.44
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.43
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.03
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.03
PRK11768	325	serine/threonine protein kinase; Provisional	95.91
COG2334	331	Putative homoserine kinase type II (protein kinase	95.9
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.85
PRK12396	409	5-methylribose kinase; Reviewed	95.8
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.6
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.56
PTZ00384	383	choline kinase; Provisional	95.31

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-56  Score=460.80  Aligned_cols=287  Identities=48%  Similarity=0.796  Sum_probs=255.4

Q ss_pred             CCCCCCHHHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEE
Q 006952          291 PLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC  370 (624)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  370 (624)
                      +...+++.++.++|++|+..+.||+|+||.||+|.+.+|..||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45668999999999999999999999999999999999999999988766543145699999999999999999999999


Q ss_pred             EecCc-ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          371 LEENE-SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       371 ~~~~~-~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                      .+.++ .+|||||+++|+|.++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99984 99999999999999999875544 89999999999999999999999988899999999999999999999999


Q ss_pred             ccccccccCCCCCCcccccc-ccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRV-VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      |||+++........  .... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+..|++..+
T Consensus       220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999765431111  1112 79999999999999999999999999999999999999887655555566999999999


Q ss_pred             hcCCccccccchhh-cCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          529 CEGHAAELMDSVVK-QSCDQ-AELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       529 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .++...+++|+.+. ..++. .++.++.+++++|++.+|.+||+|.||+++|+.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            99999999999987 55554 689999999999999999999999999999954

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-47  Score=390.89  Aligned_cols=257  Identities=33%  Similarity=0.513  Sum_probs=211.8

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCCcceEEeEEEecC-cceEEEEec
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-ESLLIYEYM  383 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lV~Ey~  383 (624)
                      +...+.||+|+||+||+|.+.....||||++......  ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3445669999999999999975455999999865432  2569999999999999999999999999988 799999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccccCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQS  462 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  462 (624)
                      ++|+|.++++.. ....+++..++.|+.|||+||+|||++..  ||||||||+||||+.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999764 46679999999999999999999999852  99999999999999997 99999999998764322 


Q ss_pred             CccccccccccCccChhhhc--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          463 KANTNRVVGTYGYMAPEYAM--GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                       .......||+.|||||++.  ...|+.|+|||||||++|||+||+.||...      ...+.+......+....+... 
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~------~~~~~~~~v~~~~~Rp~~p~~-  270 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL------APVQVASAVVVGGLRPPIPKE-  270 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhcCCCCCCCcc-
Confidence             2233367999999999999  669999999999999999999999997522      223444444434443333332 


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                              ....+..++.+||+.||+.||++.+|+..|+....
T Consensus       271 --------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  271 --------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             --------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                    34457788889999999999999999999986533

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=381.95  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=207.9

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..|...+.||+|+|+.||+++. ..|+.||+|++.+.   .....+++.+||++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999997 78999999999763   3445678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      |+|++++|.+++.   ++..+++.+++.++.||+.||.|||+.+   |+|||||..|+||+++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999884   5678999999999999999999999985   999999999999999999999999999987644


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ..  +....+|||.|+|||++.....+..+||||+|||+|-|+.|++||+-      ..+.+.-.+....+    ..   
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet------k~vkety~~Ik~~~----Y~---  236 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET------KTVKETYNKIKLNE----YS---  236 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc------chHHHHHHHHHhcC----cc---
Confidence            33  34458999999999999999999999999999999999999999852      11222111111111    00   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          .|........+|+.++|+.||.+|||+++|+.
T Consensus       237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                11122234567888999999999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=358.80  Aligned_cols=252  Identities=29%  Similarity=0.407  Sum_probs=206.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-ceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-SLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lV~Ey  382 (624)
                      +++..+.||+|..|+|||++++ +++.+|+|.+.... ....+++.+|+++++..+||+||.++|.|..... ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4556788999999999999987 47788999995443 3456789999999999999999999999999985 9999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      |.+|+|+.++..   .+.+++...-+|+.++++||.|||+..  +||||||||+||||+..|.+||+|||.+..+...  
T Consensus       160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999843   356899999999999999999999742  6999999999999999999999999999876443  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ..+.++||..|||||.+.+..|+.++||||||+.++|+.+|+-|+... .....+..+..-. +..+....+.+.   
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~-Iv~~ppP~lP~~---  305 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCA-IVDEPPPRLPEG---  305 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHH-HhcCCCCCCCcc---
Confidence              445689999999999999999999999999999999999999997643 1112222222221 222222222222   


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           ....++..++-.||++||.+|||++|+++
T Consensus       306 -----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 -----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 12345788889999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=359.44  Aligned_cols=199  Identities=31%  Similarity=0.555  Sum_probs=179.4

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ...+|...+.||+|.|++||+|+++ ++.+||||.+.+.  ..+..+.+..||.+|+.++|||||+|++++..++..+||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3467888889999999999999976 4889999999776  566677889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC------CCeEEecccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE------MNPKISDFGM  453 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg~  453 (624)
                      ||||.+|+|..+|+.   ...+++.....++.||+.||++||+++   ||||||||.||||+.+      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999954   447999999999999999999999985   9999999999999775      4589999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      ++.+...   ......+|++.|||||+++..+|+.|+|+||+|+|||++++|+.||.
T Consensus       162 AR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  162 ARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            9987533   33446899999999999999999999999999999999999999974

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=371.96  Aligned_cols=255  Identities=31%  Similarity=0.466  Sum_probs=208.8

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      +.+...+.||+|.||.||.|.++....||+|.++.... ..+.|.+|+.+|++|+|+|||+|+|+|..++..+||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            34556789999999999999998777999999986532 34778899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      .|+|.++|.. .....++..+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+++...++....
T Consensus       285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999976 3456789999999999999999999998   59999999999999999999999999999665444322


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      .. ...-...|.|||.+..+.|+.|||||||||+||||+| |+.|++      .....+.+..+-...++          
T Consensus       361 ~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~------~msn~ev~~~le~GyRl----------  423 (468)
T KOG0197|consen  361 SE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP------GMSNEEVLELLERGYRL----------  423 (468)
T ss_pred             cC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC------CCCHHHHHHHHhccCcC----------
Confidence            22 2233678999999999999999999999999999999 677743      22233333322222221          


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..|..++..+.+|+..||..+|++|||++.+...|+..
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            12333455688899999999999999999998888653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=347.16  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=210.6

Q ss_pred             cCccccCccccCCceeEEEEE-ecCCcEEEEEEccc--cCcccHHHHHHHHHHHHhcCCCCcceEEe-EEEecCc-ceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLLG-CCLEENE-SLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~-~~~~~~~-~~lV  379 (624)
                      .+|.++++||+|.||.|||+. +.+|..+|.|.+.-  .+.+..+....|+.+|++|+|||||++++ .+.++.+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468888999999999999998 56899999998863  34556778899999999999999999999 4555555 8999


Q ss_pred             EEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          380 YEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDS-RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      |||+..|+|...+... ..+..+++..+|+++.|++.||..+|++- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998753 34567999999999999999999999843 123999999999999999999999999999988


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .....  -....+|||.||+||.+++..|+.||||||+||++|||..-++||.      +.++++.-.+. ..+....+.
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~------g~n~~~L~~KI-~qgd~~~~p  249 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY------GDNLLSLCKKI-EQGDYPPLP  249 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc------cccHHHHHHHH-HcCCCCCCc
Confidence            65433  3446899999999999999999999999999999999999999974      22444443332 233222121


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +        .-....+.+|+..|+..||+.||+...++..+.+.
T Consensus       250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            1        23345678888999999999999966666655543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-44  Score=352.90  Aligned_cols=252  Identities=27%  Similarity=0.364  Sum_probs=200.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      .+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+...       .......+|+++|++|+|||||++++++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            456778899999999999999954 699999999976421       122345799999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEeccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFG  452 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg  452 (624)
                      .||||||++||.|.+.+..   +..+.+.....++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            9999999999999998854   345677778899999999999999996   9999999999999766   679999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF---SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      +|+..+.   ......++|||.|.|||++.+...   ..|+|+||+||+||-+++|.+||.-  +...+++.+.+.    
T Consensus       325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~--~~~~~sl~eQI~----  395 (475)
T KOG0615|consen  325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE--EYTDPSLKEQIL----  395 (475)
T ss_pred             hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc--ccCCccHHHHHh----
Confidence            9998753   234556899999999999977653   4588999999999999999999752  223333443332    


Q ss_pred             cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .++.......      -..-..+..+++.+||+.||++|||+.|+++
T Consensus       396 ~G~y~f~p~~------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYAFGPLQ------WDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCcccccChh------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2222211110      1122345678888999999999999999865

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.2e-44  Score=386.56  Aligned_cols=260  Identities=32%  Similarity=0.486  Sum_probs=214.7

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .+....+.||+|+||+||+|+..      +...||||.++..... ..++|++|++++..++|||||+|+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34556688999999999999853      2456999999887665 7899999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC-------C----CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          378 LIYEYMPNKSLDVFLFDST-------R----SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      +|+|||..|+|.+||....       .    ..+++..+.+.|+.|||.||+||-++.   +|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            9999999999999996321       1    234889999999999999999999884   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++.+-..+.........-.++|||||.++.++||.+||||||||+|||+++ |+.|+.-   -..++.++   
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g---lSn~EVIe---  716 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG---LSNQEVIE---  716 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc---cchHHHHH---
Confidence            9999999997655443333323345789999999999999999999999999999999 8888642   22222222   


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                       ....++..         +++...+.++.+|++.||+.+|.+||+++||-..|+....
T Consensus       717 -~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  717 -CIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             23333332         3455667789999999999999999999999999976543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=341.58  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=200.3

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|+..+.||+|+||+||.++.++ ++.+|+|++++..   ....+..++|..+|.+++||+||+++..|.+.+.++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            5789999999999999999999765 7889999997643   34567788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      +||+.||.|..+|.   +...+++..+..++.+|+.||.|||+++   ||||||||+|||||++|+++|+|||+++..-.
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999984   4567999999999999999999999996   99999999999999999999999999985432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .  ...+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||..      .+...+..+..... ..     
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~------~~~~~~~~~I~~~k-~~-----  243 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA------EDVKKMYDKILKGK-LP-----  243 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC------ccHHHHHHHHhcCc-CC-----
Confidence            2  2334558999999999999999999999999999999999999999742      22233333322222 00     


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                          ..+.-...+..+++...|+.||++|.
T Consensus       244 ----~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 ----LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence                01111223456777788999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=356.11  Aligned_cols=272  Identities=29%  Similarity=0.459  Sum_probs=215.3

Q ss_pred             HHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       298 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      .+++...+++.+..+||+|.||+||+|.|.  ..||||++....  .+..+.|++|+..+++-+|.||+-++|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444555567788899999999999999985  579999987643  4467899999999999999999999999998877


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                       .+|..+|+|.+|+.+|+..+  ..++..+.+.|++||++||.|||.++   |||||||..||+|.++++|||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999997644  56888999999999999999999984   9999999999999999999999999997


Q ss_pred             ccCCCCCCccccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      .-............-|...|||||+++.   ..|+..+||||||+++|||++|..|+.....+      +.+|   ..++
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------qIif---mVGr  607 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------QIIF---MVGR  607 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh------heEE---Eecc
Confidence            6443322222333457789999999975   45899999999999999999999997622222      2222   2222


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPT  589 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~  589 (624)
                      ..-..|....   ......++.+|...||..++++||.+.+|+.+|+....++|+=.
T Consensus       608 G~l~pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~  661 (678)
T KOG0193|consen  608 GYLMPDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN  661 (678)
T ss_pred             cccCccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence            2222222211   12334467788889999999999999999998887665555433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=339.90  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=205.4

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--cceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--ESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV~  380 (624)
                      ..++...+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|.....+  .+.++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3457778999999999999999765 8999999987664444677899999999999999999999855544  589999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++|+|.+++.....  .+++..+..+..||++||.|||+++   |+|+||||+||||+. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999965432  6999999999999999999999986   999999999999999 79999999999987653


Q ss_pred             -CCCCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 -NQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                       ...........||+.|||||++..+. ...++|||||||++.||+||++||...     .....+..+.......+.+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC
Confidence             12223344578999999999999643 345999999999999999999998633     12233333333333333222


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      +.         ...+..+++.+|++.+|+.|||+.+++..--
T Consensus       246 ~~---------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  246 DS---------LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             cc---------cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            22         2234667888999999999999999987653

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=340.40  Aligned_cols=269  Identities=28%  Similarity=0.424  Sum_probs=210.7

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHh--cCCCCcceEEeEEEecC----cceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK--LQHKNLVRLLGCCLEEN----ESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~~l  378 (624)
                      ......+.||+|+||.||||.+. ++.||||++.....   +.|.+|-.+.+.  |+|+||+++++.-....    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            44555678999999999999996 59999999976544   456666666554  58999999999876555    7899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED------SRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      |+||.++|+|.++|.    ...++|....+|+..+++||+|||+.      .+++|+|||||.+||||.+|++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999994    34689999999999999999999986      36789999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCC-CC-----hhhHHHHHHHHHHHHHhCCCCCC--------CCCC---C
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FS-----VKSDVFSFGVVLLEIISGKKSTG--------FYHS---E  515 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDv~S~Gvil~elltg~~p~~--------~~~~---~  515 (624)
                      ++..+........+...+||.+|||||++.+.. +.     .+.||||+|.|||||++...-..        ...+   +
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            999988776666677789999999999998753 22     36899999999999999654321        1101   1


Q ss_pred             CCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 006952          516 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL  585 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~  585 (624)
                      ..+.+.+...-+..+...+.+.+.....    ..+.-+.+.+..||+.||+.|.|+.=|.+.+.......
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            1223333333334444555555555432    44556788899999999999999999999987654443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=347.88  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=210.4

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ..|....+||+|+.|.||.+.. ..++.||||++........+.+.+|+.+|+..+|+|||++++.+...++.|.||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4566778999999999999984 468899999998777666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+.+.    ...+++.++..|+.++++||.|||.++   |+|||||.+|||++.++.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999883    345899999999999999999999996   99999999999999999999999999988765544 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       .....+|||.|||||++....|..|.||||||++++||+-|++||-.      +..+..++.....+...--.      
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~P~lk~------  491 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGTPKLKN------  491 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCCCCcCC------
Confidence             33457899999999999999999999999999999999999999632      33444444444444322111      


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        +......+.++..+||+.||++||++.|+++
T Consensus       492 --~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 --PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              1122335678888999999999999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=364.05  Aligned_cols=267  Identities=28%  Similarity=0.446  Sum_probs=216.3

Q ss_pred             CCCHHHHHHHhcCc---------cccCccccCCceeEEEEEecC-C---cEEEEEEccccC-cccHHHHHHHHHHHHhcC
Q 006952          294 PLDLIDIVKATQDF---------SQENKLGEGGFGPVYKGVLAD-G---KEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQ  359 (624)
Q Consensus       294 ~~~~~~~~~~~~~~---------~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~  359 (624)
                      +.+++|.-.+..+|         .+++.||.|.||.||+|+++- |   ..||||.++... ++.+.+|..|..+|.+.+
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            45666655554443         567999999999999999763 3   369999998754 456788999999999999


Q ss_pred             CCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006952          360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL  439 (624)
Q Consensus       360 h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIl  439 (624)
                      ||||++|.|+.......+||.|||+||+|+.||..+.  .++++.+..-++++|+.||.||-+.   ++|||||.++|||
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL  763 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL  763 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence            9999999999999999999999999999999997543  5699999999999999999999987   4999999999999


Q ss_pred             EcCCCCeEEeccccccccCCCCCCc-cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 006952          440 LDHEMNPKISDFGMARIFGGNQSKA-NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHG  517 (624)
Q Consensus       440 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~  517 (624)
                      |+.|..+|++|||++|.+.++.... .+..-.-..+|.|||.+...+++..||||||||++||.++ |.+|+-..   ..
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm---SN  840 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SN  840 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---ch
Confidence            9999999999999999876554221 2211222578999999999999999999999999999877 88985311   11


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ++.+..+             ..-.+-..+.+.+..|.+|++.|||+|-.+||.+.+|+..|.+.
T Consensus       841 QdVIkaI-------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  841 QDVIKAI-------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             HHHHHHH-------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            1111111             11111234566777899999999999999999999999999764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-40  Score=347.86  Aligned_cols=260  Identities=28%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             hcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC-
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN-  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-  374 (624)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46788899999999999999974      2356799999875432 3456789999999999 8999999999987654 


Q ss_pred             cceEEEEeccCCChhhhhhcCCC---------------------------------------------------------
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTR---------------------------------------------------------  397 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  397 (624)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            47899999999999998864211                                                         


Q ss_pred             --CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCc
Q 006952          398 --SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY  475 (624)
Q Consensus       398 --~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  475 (624)
                        ...+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999985   999999999999999999999999999865433222222334567889


Q ss_pred             cChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHH
Q 006952          476 MAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI  554 (624)
Q Consensus       476 ~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  554 (624)
                      +|||++.+..++.++||||||+++|||++ |+.||......      .........+.....         +......+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~~~---------~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRMRA---------PENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCCCC---------CCCCCHHHH
Confidence            99999999999999999999999999997 99997532211      111122222221111         111234578


Q ss_pred             HHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          555 HIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       555 ~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +|+.+||+.||++|||+.||++.|+..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=332.74  Aligned_cols=262  Identities=24%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .+.|+....||.|..++||+|+. +.++.||||++.-.. ....+.+.+|+..|..++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46788999999999999999994 457899999997543 3347889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      ||.+|++.+++...-.. .+++..+..|++++++||.|||.+|   .||||||+.||||+++|.+||+|||.+..+-...
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999764433 3899999999999999999999997   9999999999999999999999999876543322


Q ss_pred             -CCccc-cccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          462 -SKANT-NRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       462 -~~~~~-~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                       ..... +.+.||+.|||||+++.  ..|+.|+||||||++..||.+|+.||..+.+.+      ....-. .+......
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tL-qn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTL-QNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHh-cCCCCCcc
Confidence             22222 56789999999999654  458999999999999999999999987544332      111111 12211111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      -..+..+........+.+++-.||+.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111111112225778888999999999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.7e-41  Score=321.18  Aligned_cols=260  Identities=23%  Similarity=0.341  Sum_probs=203.2

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc-c-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG-Q-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +.|+...++|+|+||.|||++.++ |+.||||++....+ . ..+-..+||.+|++++|+|+|.|+.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            457778899999999999999875 89999999976544 2 33456799999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      ||+..-|+++-..   ...++.....+++.|+++|+.|+|++   ++|||||||+||||+.++.+||+|||+|+.+..+.
T Consensus        82 ~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9999888776533   23478899999999999999999998   49999999999999999999999999999886422


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc----------
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE----------  530 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  530 (624)
                        ...+..+.|..|.|||.+.+ .+|...+|||++||++.||++|.+-|.   ...+.+.+..+.+...+          
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P---G~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP---GRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC---CcchHHHHHHHHHHHcccCHHHHHHhc
Confidence              23345778999999999987 789999999999999999999997753   33344444444433211          


Q ss_pred             -CC------ccccccc-hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          531 -GH------AAELMDS-VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       531 -~~------~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ..      +++.-++ .+...++ ....-+++++..||+.||++|++-+|++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             10      0111000 1111111 11225788999999999999999998863

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.3e-40  Score=338.26  Aligned_cols=263  Identities=28%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             cCccccCccccCCceeEEEEEecC-----------------CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-----------------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRL  366 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l  366 (624)
                      ++|...+.||+|+||.||++.+++                 +..||+|.+.... .....++.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568888999999999999998543                 3369999987643 3345678999999999999999999


Q ss_pred             EeEEEecCcceEEEEeccCCChhhhhhcCC----------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 006952          367 LGCCLEENESLLIYEYMPNKSLDVFLFDST----------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH  430 (624)
Q Consensus       367 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH  430 (624)
                      ++++.+.+..++||||+++++|.+++....                ....++|..++.++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885421                1235788999999999999999999985   999


Q ss_pred             cCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCC--CC
Q 006952          431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK--KS  508 (624)
Q Consensus       431 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~--~p  508 (624)
                      |||||+|||+++++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||+++.  .|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999998654333222233345678999999999889999999999999999999754  45


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          509 TGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      +...   ............+..........      .+......+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       242 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGEL---TDEQVIENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcC---CHHHHHHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            4321   12222222222221111111000      01122345788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=338.68  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=206.4

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      +..++|...+.||+|+|++|++++.+ .++++|||++.+.   .+...+.+..|-+.|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            44578999999999999999999965 5889999998754   233345677899999999 899999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      |+|+||+++|+|.++|.   +.+.+++...+.++.+|+.||+|||+.|   ||||||||+|||||+|+++||.|||.+..
T Consensus       150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999995   4467999999999999999999999986   99999999999999999999999999998


Q ss_pred             cCCCCCC-----------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          457 FGGNQSK-----------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       457 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      +......           .....++||..|.+||++.++..+..+|+|+||||||+|+.|++||.   ........+.+.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr---a~NeyliFqkI~  300 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR---AANEYLIFQKIQ  300 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc---cccHHHHHHHHH
Confidence            7542211           11245899999999999999999999999999999999999999974   111111222221


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      .  .+....+-        +    .....+|+.+.|..||.+|+|.++|-+.-
T Consensus       301 ~--l~y~fp~~--------f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  301 A--LDYEFPEG--------F----PEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             H--hcccCCCC--------C----CHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            1  11111111        1    23456778888999999999999997654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.6e-40  Score=308.31  Aligned_cols=275  Identities=25%  Similarity=0.387  Sum_probs=213.6

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .+|...++||+|.||.||+|+. +.|+.||||+++.....  ......+||+.|+.++|+||+.|+++|-..+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677789999999999999995 46999999999765332  23456899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |++ .+|...+.+  +...+...++..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 488888865  4456889999999999999999999996   9999999999999999999999999999987655


Q ss_pred             CCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc--
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD--  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  538 (624)
                      .....  .+-|..|.|||.+.|. .|+..+|+||.|||+.||+-+.+-+   ....+.+.+..+.+.+......++.+  
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f---pG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF---PGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC---CCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            43332  3679999999998875 6899999999999999999998654   33344445555544443332222211  


Q ss_pred             ----c--------hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCc
Q 006952          539 ----S--------VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPA  592 (624)
Q Consensus       539 ----~--------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~~p~  592 (624)
                          -        ......-.......++++..++..||.+|+|++|.+++=  ...++|.|+.|.
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~  294 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPS  294 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChh
Confidence                0        000111122334568899999999999999999997743  344466666553

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=369.77  Aligned_cols=258  Identities=33%  Similarity=0.530  Sum_probs=208.3

Q ss_pred             cCccccCccccCCceeEEEEEecC--Cc----EEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD--GK----EIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~--g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .+......||+|.||.||+|...+  |.    .||||.+.+.. .+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445667889999999999999653  33    48999998764 456789999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC----CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          378 LIYEYMPNKSLDVFLFDST----RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      +++|||++|+|..+|.+.+    +...+...+.+.++.|||+|+.||++++   +|||||..+|+||++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999998652    2456889999999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      |+.+...+.........-...|||||.++.+.|+.|+|||||||+|||++| |..|+.-   ....++..   .....++
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~---~~n~~v~~---~~~~ggR  922 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS---RSNFEVLL---DVLEGGR  922 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC---cchHHHHH---HHHhCCc
Confidence            996544333222222234568999999999999999999999999999999 7777642   11111111   1122221


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          +      ..+..++.++.+|+++||+.+|++||++..|++.+...
T Consensus       923 ----L------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  923 ----L------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             ----c------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence                1      12344556788999999999999999999999988654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-40  Score=333.59  Aligned_cols=262  Identities=27%  Similarity=0.388  Sum_probs=200.5

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  378 (624)
                      .+.|+..++||+|.||.||+++. .+|+.||+|++....  .....-..+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35677788999999999999994 568999999987654  34455667999999999999999999998886  57899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |+|||++ +|.-++..  ....+++.++..++.||+.||+|+|..+   |+|||||.+|||||.+|.+||+|||+|+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 56665532  3456999999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---cc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---AA  534 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  534 (624)
                      ......-+ ..+-|..|.|||.+.+. .|+..+|+||.||||.||+.|++.+.-   ......+..+.+......   |.
T Consensus       270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G---~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG---RTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC---ccHHHHHHHHHHHhCCCChhccc
Confidence            55444333 44569999999999875 699999999999999999999988642   222233333433322221   11


Q ss_pred             --cc-----ccc------hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 --EL-----MDS------VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 --~~-----~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ++     +.+      .+.+.+ .......++|+..+|..||.+|.|+.+++.
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              11     111      111100 011223567777899999999999998864

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=346.13  Aligned_cols=245  Identities=29%  Similarity=0.432  Sum_probs=200.7

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ..+-||.|+.|.||.|+++ ++.||||+++...       +.+|+-|++|+|+||+.+.|+|....-++||||||..|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3566999999999999996 6899999886332       4578899999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .++|.   ....++......|..+||.||.|||.+   +|||||||.-||||..+..+||+|||-++.....   .....
T Consensus       200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            99994   345678888899999999999999998   5999999999999999999999999999876433   33446


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ++||..|||||++.+...++|+|||||||+||||+||..|+..      .+....+|.+-     .    ..|.-..+..
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd------VdssAIIwGVG-----s----NsL~LpvPst  335 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD------VDSSAIIWGVG-----S----NSLHLPVPST  335 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc------cchheeEEecc-----C----CcccccCccc
Confidence            8999999999999999999999999999999999999999642      22223344321     1    1111122233


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL  585 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~  585 (624)
                      .+.-+.-|+.+||+..|.+||++++|+..|.-...++
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            3344556778899999999999999999997654443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=339.89  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=204.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHH--HHHHHHHHhcC-CCCcceEEeEEEecC-cceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEF--KNEVTVIAKLQ-HKNLVRLLGCCLEEN-ESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~l  378 (624)
                      .++|...++||.|.||.||+|+.+ .|+.||||++++.-.. +++.  .+|+..|++|+ ||||++|.+++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            467888999999999999999954 5889999999876443 3332  57999999998 999999999999887 8999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |||||+ .+|++++.+.  +..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||.+.
T Consensus        88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999995 5899988653  668999999999999999999999997   9999999999999999999999999999875


Q ss_pred             CCCCCccccccccccCccChhhhc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAM-GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..   ...+..+.|..|.|||++. .+.|+.+.|+|++|||++||.+-++-|....   +.+.+..+-.++.......+.
T Consensus       162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s---E~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS---EIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc---HHHHHHHHHHHhCCCccccch
Confidence            43   2344678899999999875 5678999999999999999999998764222   222222222222222222111


Q ss_pred             c-----chhhc-----------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          538 D-----SVVKQ-----------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       538 d-----~~l~~-----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      .     ..+.-           ..-.....++++++..|+++||.+|||+.|.+++=
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1     00100           11122456788999999999999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=340.62  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=203.3

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc----Cc-ccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT----SG-QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENE  375 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  375 (624)
                      ..+.|...+.||+|.||+|+.|... .++.||+|.+.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4578999999999999999999854 5899999977653    12 33556778999999998 9999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEeccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMA  454 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a  454 (624)
                      .++||||+.+|+|.+++.+   ...+.+.+...++.||+.|++|||+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   456888999999999999999999986   9999999999999999 99999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCCC-CC-hhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc-C
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FS-VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE-G  531 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~  531 (624)
                      ....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.      .+.....++.... -
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~ki~~~~~  240 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRKIRKGEF  240 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHHHhcCCc
Confidence            8764  1222344579999999999999977 75 789999999999999999999853      2222222221111 1


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA  575 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  575 (624)
                      .....++           ...+..++.+|++.||.+|+|+.+|+
T Consensus       241 ~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  241 KIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             cCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1222221           34577889999999999999999997

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-40  Score=339.18  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=217.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..  ++..+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777889999999999999966 47889999987653  4456778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+.+ +|..+|.+   ...++++.+..|+.++..||.|||+.+   |+|||+||.|||++.++.+|++|||+++.++.+.
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 99999954   456999999999999999999999984   9999999999999999999999999999876543


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                        ...+.+.|||.|||||.+.++.|+..+|.||+|||+||+++|++||-      ..++.+.+.....++.         
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v---------  217 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPV---------  217 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCC---------
Confidence              23345789999999999999999999999999999999999999962      2233444443333321         


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCCcc
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLASDILTLPKPTQPAF  593 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~~~~p~~p~~  593 (624)
                        ..+......+.+++...|++||..|.|..+++.  ++++...-...|..|+|
T Consensus       218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~  269 (808)
T KOG0597|consen  218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF  269 (808)
T ss_pred             --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence              112233456778888899999999999999865  45555555556666655

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.8e-39  Score=326.61  Aligned_cols=246  Identities=19%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCccc---HHHHHHHHHHHHhcCCCCcceEEeEEEe----cCcceEEEEe
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG---LQEFKNEVTVIAKLQHKNLVRLLGCCLE----ENESLLIYEY  382 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV~Ey  382 (624)
                      ...||+|++|.||+|.+ +|+.||||++.......   .+.+.+|+.+|.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 68999999997654333   5778899999999999999999999877    3457899999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.+++..   ...+++...+.++.|++.||.|||+..  +++||||||+|||+++++.+||+|||+++...... 
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999854   346899999999999999999999852  37899999999999999999999999998654321 


Q ss_pred             CccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          463 KANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...   .   ...........+....     
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~---~---~~~~~~~i~~~~~~~~-----  242 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---T---TKEIYDLIINKNNSLK-----  242 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC---C---HHHHHHHHHhcCCCCC-----
Confidence                13457899999999976  68899999999999999999999997522   1   1111111111111111     


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          .+......+.+++.+||+.||++|||++||++.|+..
T Consensus       243 ----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        243 ----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                1111233577889999999999999999999999753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.5e-39  Score=380.36  Aligned_cols=264  Identities=26%  Similarity=0.481  Sum_probs=215.5

Q ss_pred             HHHhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ......+...+.||+|+||.||+|+. .++..||||++......    ...|++.+++++|||||+++|+|.+.+..++|
T Consensus       686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            33445678889999999999999997 47899999998754322    23568899999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++.      .++|.++..|+.||++||+|||....++|+||||||+||+++.++..++. ||.......
T Consensus       762 ~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        762 HEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            99999999999984      38999999999999999999997655679999999999999999888875 665443211


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                            .....||+.|+|||++.+..++.++|||||||++|||++|+.|+... .........|.+..+.......++++
T Consensus       835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc-cCCCCcHHHHHHHhcCccchhheeCc
Confidence                  11236789999999999999999999999999999999999997432 22344566666655555555666666


Q ss_pred             hhhc--CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          540 VVKQ--SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       540 ~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      .+..  ..+.++..++.+++.+||+.||++||||+||++.|+...
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            6543  234567778999999999999999999999999998653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-39  Score=340.68  Aligned_cols=259  Identities=29%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             hcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      .++|+..+.||+|+||.||+++.      ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35788899999999999999973      235689999987543 33456788999999999 89999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCC----------------------------------------------------------
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTR----------------------------------------------------------  397 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  397 (624)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998854221                                                          


Q ss_pred             --------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          398 --------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       398 --------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                                    ...+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124789999999999999999999985   999999999999999999999999999866433222


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......      ....+....+.....      
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~------  338 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRMLS------  338 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCCC------
Confidence            22222345678999999999999999999999999999998 78776422111      112222222211110      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         +.....++.+|+.+||+.||++|||+.||+++|++
T Consensus       339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               01112357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.5e-39  Score=322.03  Aligned_cols=250  Identities=35%  Similarity=0.545  Sum_probs=193.7

Q ss_pred             ccCccccCCceeEEEEEec-----CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          309 QENKLGEGGFGPVYKGVLA-----DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+.||.|.||.||+|.+.     .+..|+||.+.... ....+++.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999987     25679999996543 33478899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.++|... ....+++..++.|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999764 3456899999999999999999999984   99999999999999999999999999987633222


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      ........+...|+|||.+.+..++.++||||||+++|||++ |+.|+...      .......+. .++......+   
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~-~~~~~~~~~~---  228 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKL-KQGQRLPIPD---  228 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHH-HTTEETTSBT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccc-cccccceecc---
Confidence            222333456789999999999999999999999999999999 67775321      222222222 2222222111   


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                            .....+.+++.+||..+|++|||+.+|++.|
T Consensus       229 ------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 ------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  1133577899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-39  Score=343.49  Aligned_cols=260  Identities=28%  Similarity=0.431  Sum_probs=202.4

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      .++|...+.||+|+||.||+++..      ++..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357888999999999999998842      24579999997543 33356788999999999 89999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCC-----------------------------------------------------------
Q 006952          376 SLLIYEYMPNKSLDVFLFDST-----------------------------------------------------------  396 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------  396 (624)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885321                                                           


Q ss_pred             --------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          397 --------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       397 --------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                              ....+++..+++|+.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    0124788999999999999999999985   99999999999999999999999999986543322222222


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ  547 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  547 (624)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||.......      ...+....+.....         +.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~~~---------~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQMSR---------PD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCccC---------CC
Confidence            345678999999999999999999999999999997 999975322111      11111111110000         01


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          548 AELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       548 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .....+.+++.+||+.||++|||+.+|+++|++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1124577899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=339.95  Aligned_cols=260  Identities=32%  Similarity=0.437  Sum_probs=204.1

Q ss_pred             cCccccCccccCCceeEEEEEecC--C--cE-EEEEEccc---cCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD--G--KE-IAVKRLSR---TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      ++....++||+|+||.||+|.++.  +  .. ||||..+.   .......+|.+|..+|++++|||||+++|++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            445556899999999999999753  2  23 89998875   3356678999999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|||+|+||+|+++|.....  .++..+++.++.+.|.||+|||++.   ++||||..+|+|++.++.+||+|||+++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999965332  6899999999999999999999984   99999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      -..  .........-...|+|||.+..+.|+.++|||||||++||+++ |..|+.   ..   ...+...+....+....
T Consensus       312 ~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~---g~---~~~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  312 GSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP---GM---KNYEVKAKIVKNGYRMP  383 (474)
T ss_pred             Ccc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC---CC---CHHHHHHHHHhcCccCC
Confidence            421  1111111134679999999999999999999999999999999 777753   22   22222222222232222


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      ...         ..+..+..++.+||+.+|++||+|.+|.+.|+.......
T Consensus       384 ~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 IPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCC---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            211         223346667779999999999999999999976544433

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-38  Score=323.75  Aligned_cols=260  Identities=28%  Similarity=0.435  Sum_probs=209.1

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .+|...+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999842      345689999877666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 006952          379 IYEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN  445 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  445 (624)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986432             1235899999999999999999999985   999999999999999999


Q ss_pred             eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHH
Q 006952          446 PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYI  524 (624)
Q Consensus       446 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  524 (624)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+.....      .. .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~-~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TE-V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-H
Confidence            99999999976544332222334456789999999999999999999999999999999 9988643211      11 1


Q ss_pred             HHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          525 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       525 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                      ......+......         ......+.+++.+||+.+|++|||+++|+++|.....
T Consensus       235 ~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            2222222222211         1123457899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.7e-38  Score=328.29  Aligned_cols=197  Identities=29%  Similarity=0.416  Sum_probs=173.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            67889999999999999999976 578899998876432 3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++......  
T Consensus        85 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          85 MDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999854   335889999999999999999999864  5999999999999999999999999998765322  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  203 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP  203 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence              1234568999999999999999999999999999999999999975

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=331.85  Aligned_cols=264  Identities=28%  Similarity=0.431  Sum_probs=213.9

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +...+.++||+|.||.|..+....+.+||||+++.... ....+|.+||++|.+|+||||++|+|+|..++.+++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            34566799999999999999998889999999987654 45689999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|..++..+.... ..-.....|+.||+.||+||.+-   ++|||||.++|+|++.++++||+|||++|.+-..+..
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999997643222 45566678999999999999986   6999999999999999999999999999977655555


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      ......+-..+|||||.+..++++.++|||+||+++||+++  ...|++.   -.+++.++-.-.+...+.....+.   
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~---lt~e~vven~~~~~~~~~~~~~l~---  767 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ---LTDEQVVENAGEFFRDQGRQVVLS---  767 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh---hhHHHHHHhhhhhcCCCCcceecc---
Confidence            44555667899999999999999999999999999999866  5677542   222233333333333222222211   


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                         .+.-....+.++++.||..+.++||++++|...|...
T Consensus       768 ---~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  768 ---RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               2334455688999999999999999999999998754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.9e-38  Score=320.48  Aligned_cols=257  Identities=30%  Similarity=0.505  Sum_probs=205.1

Q ss_pred             cCccccCccccCCceeEEEEEecC------CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|+..+.||+|+||.||+|....      ...|++|.+..... ...+.+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998643      25799999875433 34567899999999999999999999999988999


Q ss_pred             EEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 006952          378 LIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM  444 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  444 (624)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864321             145889999999999999999999985   99999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHH
Q 006952          445 NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       445 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  523 (624)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||.....   .+    
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~----  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QE----  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HH----
Confidence            999999999986543332222334456889999999998999999999999999999998 9888642111   11    


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ....+..+....         .+......+.+|+.+||+.||.+||+++||++.|++
T Consensus       235 ~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            112222222111         122234568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-40  Score=327.85  Aligned_cols=248  Identities=23%  Similarity=0.387  Sum_probs=205.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..|...+.||+|.||.||+|... .++.||+|++.-. .+...+++..|+.++.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999965 5888999999754 445678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +.+|++.+.+.   ....+++..+..|++++..||.|||.++   .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999884   3334577888889999999999999985   99999999999999999999999999987755433


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .  ...++|||.|||||+++...|+.|+||||||++.+||.+|.+|+...++..-..            .+.+-..|.+.
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L~  232 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRLD  232 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCccc
Confidence            3  356899999999999998899999999999999999999999976444321100            11111223333


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +.+    ...+.+++..||+.||+.||++.++++
T Consensus       233 ~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 GDF----SPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccc----CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            322    234778888999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=337.87  Aligned_cols=241  Identities=26%  Similarity=0.374  Sum_probs=203.3

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcce
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  377 (624)
                      ..++|...+.||+|.||+|+.+..+ +++.+|||++++..   .++.+..+.|..++... +||.+++|+.+|.+.++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3578999999999999999999976 47789999998864   45667788888888888 5999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+.||++..+.    +...+++..+..++..|+.||.|||+++   |||||||.+|||||.+|.+||+|||+++.-
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999954433    4467999999999999999999999996   999999999999999999999999999853


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      -.  ....+..++|||.|||||++.+..|+..+|.|||||+||||+.|+.||.-                   +...++.
T Consensus       519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-------------------ddEee~F  577 (694)
T KOG0694|consen  519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-------------------DDEEEVF  577 (694)
T ss_pred             CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-------------------CCHHHHH
Confidence            21  23356679999999999999999999999999999999999999999742                   1222333


Q ss_pred             cchhhc--CCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          538 DSVVKQ--SCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       538 d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                      |.++..  .++.....+.+.|+.+.+..+|++|.-+
T Consensus       578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            444333  2344555677888899999999999876

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.5e-38  Score=314.34  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=201.3

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|+..+.||+|+||.||++.++++..+++|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4578889999999999999999888899999886443 334678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++...  ...+++..++.++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||.++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988542  235899999999999999999999985   999999999999999999999999998765332221 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...      +......... .+...  ..+    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~------~~~~~~~~i~-~~~~~--~~~----  223 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK------SNYEVVEMIS-RGFRL--YRP----  223 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHH-CCCCC--CCC----
Confidence            1122335668999999998889999999999999999999 88886421      1122222211 11111  111    


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                         ......+.+++.+||+.+|++||++.+|++.|.
T Consensus       224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               111235789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.2e-38  Score=319.66  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=205.1

Q ss_pred             cCccccCccccCCceeEEEEEecC------CcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|.+.+.||+|+||.||+|...+      ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467788999999999999998643      478999998765544 4578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC-----------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          378 LIYEYMPNKSLDVFLFDST-----------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      +||||+++++|.+++....           ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986432           2345889999999999999999999985   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||....   .......  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH--
Confidence            9999999876533322222223446788999999999999999999999999999998 998864221   1111111  


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                        ...+......         ......+.+++.+||+.||++||++.||++.|+
T Consensus       237 --~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 --ITQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              1122221111         112345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.6e-38  Score=323.18  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      |+..+.||+|+||.||++... +|+.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667889999999999999964 68999999986532   22335678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999998887542 2345899999999999999999999985   9999999999999999999999999998653322 


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+........ ..       
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-~~-------  223 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKEDQ-EE-------  223 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhccc-cc-------
Confidence              1224568999999999999999999999999999999999999985322211   1111111111111 01       


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                        .+......+.+|+.+||+.||++||+     ++++++
T Consensus       224 --~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 --YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              11112235778899999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=306.29  Aligned_cols=195  Identities=31%  Similarity=0.447  Sum_probs=177.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||.|+||.|...+.+ +|.-+|+|++++..-   +..+...+|..+|+.+.||+++++.+.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888899999999999999976 577899999987643   33456778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||++||.|..++.   +...+++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+++.... 
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            9999999999994   4556999999999999999999999985   99999999999999999999999999987643 


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                          .+-..+|||.|+|||++....+...+|.|||||++|||+.|.+||.
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence                3556899999999999999999999999999999999999999974

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-38  Score=320.60  Aligned_cols=256  Identities=30%  Similarity=0.480  Sum_probs=209.2

Q ss_pred             HhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ...+|...+.||+|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34678889999999999999999988999999999877666677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++.+. ....+++..++.++.||++||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999653 3346899999999999999999999985   99999999999999999999999999976643221


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....      ..+...... .+...       
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~------~~~~~~~~~-~~~~~-------  223 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN------NHEVYDQIT-AGYRM-------  223 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHH-hCCcC-------
Confidence            1  113345778999999998899999999999999999998 788874221      111111111 11111       


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        ..+......+.+++.+||+.||++|||++++++.|+.
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              0111223457799999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-38  Score=319.72  Aligned_cols=254  Identities=27%  Similarity=0.361  Sum_probs=200.9

Q ss_pred             cCccccCccccCCceeEEEEEec----CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .+|++.+.||+|+||.||+|.++    .+..||+|.++.... ...+.+.+|+..+++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888899999999999999864    356899999876533 3346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|++++...  ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.++++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999998542  346899999999999999999999985   99999999999999999999999998765322


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....      ...... ....+....   
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~------~~~~~~-~~~~~~~~~---  228 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS------GQDVIK-AVEDGFRLP---  228 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC------HHHHHH-HHHCCCCCC---
Confidence            111 11112335678999999999999999999999999999875 999874221      111111 111221110   


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                            .+......+.+++..||+.+|++||++++|.+.|++
T Consensus       229 ------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         229 ------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                  111223457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.8e-38  Score=318.10  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=202.0

Q ss_pred             HhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      ..++|+..+.||+|+||.||+|...      .+..||+|++..... ....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999998753      246799999865332 345678899999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCC-------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTR-------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      .++||||+++++|.+++.....       ...+++..++.++.|+++||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864221       234678899999999999999999975   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      +|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+...   .   ... ..+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~---~---~~~-~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM---S---NEQ-VLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC---C---HHH-HHHH
Confidence            99999876543322222222345778999999999999999999999999999999 67776421   1   111 1122


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ...+......         ......+.+++.+||+.+|++|||+.|+++.|+
T Consensus       234 ~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            2222211111         112235788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-37  Score=319.21  Aligned_cols=259  Identities=29%  Similarity=0.473  Sum_probs=206.3

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999842      245689999887666667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          379 IYEYMPNKSLDVFLFDST----------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999886422          2235899999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....      ..... ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~------~~~~~-~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVI-EC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHH-HH
Confidence            99999986543322222223445788999999999999999999999999999998 888864211      11111 11


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ...+......     ...    ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       235 i~~~~~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGRVLQRP-----RTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCCcCCCC-----CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            2222211111     112    235789999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.7e-38  Score=333.42  Aligned_cols=261  Identities=27%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             HhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcC-CCCcceEEeEEEecC
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEEN  374 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~  374 (624)
                      ..++|.+.++||+|+||.||+|+..      .+..||||++..... ...+.+.+|+.+++++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567888999999999999999853      134799999975433 34567899999999995 999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCC---------------------------------------------------------
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTR---------------------------------------------------------  397 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  397 (624)
                      ..+|||||+++|+|.+++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999988864210                                                         


Q ss_pred             ------------------------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          398 ------------------------------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       398 ------------------------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                                                          ...+++..++.++.||++||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124788889999999999999999985   99999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCH
Q 006952          442 HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSL  520 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~  520 (624)
                      +++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+......     
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-----  346 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-----  346 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence            999999999999986543322222333456788999999999999999999999999999997 88886422111     


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                       .........+....         .+......+.+++.+||+.+|++||++.+|+++|...
T Consensus       347 -~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         347 -STFYNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             -HHHHHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence             11111111111111         1112234678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-37  Score=313.26  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=204.2

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|+..++||+|++|.||+|...+++.|++|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5788899999999999999998888899999886543 235788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++... ....+++..++.++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||+++........ 
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            99999998542 3346888999999999999999999975   999999999999999999999999999876433221 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||++.++.++.++||||||+++|||++ |+.||...   ........    ..........     .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~----~~~~~~~~~~-----~  227 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM---SNSDVMSA----LQRGYRMPRM-----E  227 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC---CHHHHHHH----HHcCCCCCCC-----C
Confidence            1222345678999999998899999999999999999998 88887421   11111111    1111111000     1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .    ....+.+++.+|++.+|++||++++|.++|+.
T Consensus       228 ~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         228 N----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1    22357789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-39  Score=334.90  Aligned_cols=248  Identities=27%  Similarity=0.376  Sum_probs=205.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +-|+.++.||.|+-|.|-.|++. .|+.+|||++.+..   ......+.+||.+|+.+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788899999999999999964 69999999987652   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|-|.+++.   .++.+++.+..+++.||+.|+.|+|..+   |+||||||+|+|||+.+++||+|||+|..-..+
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999994   4567899999999999999999999984   999999999999999999999999999764332


Q ss_pred             CCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .   --...+|+|+|.+||++++..| ..++||||.|||||.|++|+.||+      ++++.....++- .| ..++.  
T Consensus       166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlKV~-~G-~f~MP--  232 (786)
T KOG0588|consen  166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLKVQ-RG-VFEMP--  232 (786)
T ss_pred             c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHHHH-cC-cccCC--
Confidence            2   2234689999999999999998 578999999999999999999985      233333333321 11 11222  


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                             .+...++.+|+.+|+..||++|-|++||++.-
T Consensus       233 -------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  233 -------SNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -------CcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                   22234577888999999999999999998854

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4e-38  Score=321.28  Aligned_cols=257  Identities=29%  Similarity=0.446  Sum_probs=201.9

Q ss_pred             cCccccCccccCCceeEEEEEe-----cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .+|+..+.||+|+||.||+|..     ..+..+++|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     246789999987543 3445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCC--------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 006952          379 IYEYMPNKSLDVFLFDST--------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM  444 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  444 (624)
                      ||||+++++|.+++....              ....+++...+.++.|++.||.|||+.+   |+|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885321              1235789999999999999999999985   99999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHH
Q 006952          445 NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       445 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  523 (624)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...   ......+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~---~~~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF---SNQEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH
Confidence            999999999986543322222233445778999999998889999999999999999998 88886321   11111111


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                          .........         +.....++.+++.+||+.||++||++.+|.+.|+.
T Consensus       239 ----~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 ----VRKRQLLPC---------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                111111111         11122357788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=331.05  Aligned_cols=253  Identities=23%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 48899999987542   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   345889999999999999999999985   99999999999999999999999999976533 


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ............   ..+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~---~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST------PNETWENLKYWK---ETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC------HHHHHHHHHhcc---ccccCC
Confidence                2234678999999999999999999999999999999999999975211      111111111000   000000


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ............+.+++.+||+.+|.+||++.+|++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000001123457788889999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=326.44  Aligned_cols=245  Identities=24%  Similarity=0.277  Sum_probs=198.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||++..+ +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999976 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999854   345889999999999999999999985   999999999999999999999999998865322


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                           .....|++.|+|||++.+..++.++||||||+++|||++|+.||...      ......... ..+.. .     
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~------~~~~~~~~i-~~~~~-~-----  216 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD------NPFGIYEKI-LAGKL-E-----  216 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH-HhCCc-C-----
Confidence                 22356899999999999989999999999999999999999997421      111111111 11111 0     


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~  577 (624)
                          .+......+.+++.+||+.||.+||+     ++++++.
T Consensus       217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                11111235678999999999999995     7777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=313.84  Aligned_cols=248  Identities=21%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.+++.   ++++.-.+.+||++|..|+||||+.++.+|++.+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35788889999999999999985 67999999998765   345566788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||..+|.|++++.   ....+++.+...++.||..|+.|+|.++   ++|||||.+|||||.|+++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999994   4567999999999999999999999984   99999999999999999999999999988754


Q ss_pred             CCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..   --..++|+|.|.+||++++..| .+.+|-||+||+||-|+.|..||+-      -+....+++ +..+-..+-  
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG------~Dhk~lvrQ-Is~GaYrEP--  273 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG------RDHKRLVRQ-ISRGAYREP--  273 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC------chHHHHHHH-hhcccccCC--
Confidence            33   2345899999999999999988 6889999999999999999999852      222222222 222222211  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                               +.+....-|+.|||..||++|-|+.+|...+
T Consensus       274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ---------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                     1223455688899999999999999998876

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-38  Score=344.47  Aligned_cols=253  Identities=19%  Similarity=0.240  Sum_probs=203.7

Q ss_pred             cCccccCccccCCceeEEEEEec-C-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-D-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..|...+.||+|++|.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++...+..+|||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            34888999999999999999854 3 577899987665555556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      +++|+|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999888542 23456889999999999999999999985   9999999999999999999999999998765433


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .........||+.|+|||++.+..++.++||||||+++|||++|+.||..      ............ +.....     
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~------~~~~~~~~~~~~-~~~~~~-----  291 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG------PSQREIMQQVLY-GKYDPF-----  291 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHh-CCCCCC-----
Confidence            22233456799999999999999999999999999999999999999742      112222222221 111110     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          +......+.+++.+||+.+|++||++.+++.
T Consensus       292 ----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 ----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                1112235788999999999999999999864

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-37  Score=322.77  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=200.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCc----EEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .+|+..+.||+|+||.||+|++. +++    .||+|++.... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    38999987543 34457889999999999999999999999764 5789


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ++||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998643  345889999999999999999999985   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|++..      ...+ .......+...  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~------~~~~-~~~~~~~~~~~--~  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------PASE-ISSILEKGERL--P  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------CHHH-HHHHHhCCCCC--C
Confidence            4332222222334678999999999999999999999999999998 99887421      1111 11222221111  0


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .       +......+.+++.+||+.+|++||++.+|+..|...
T Consensus       232 ~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         232 Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0       011123577899999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.7e-38  Score=319.40  Aligned_cols=262  Identities=23%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999976 57889999987542  3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |++++.+..+..   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2345889999999999999999999885   9999999999999999999999999998764322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH-----------HH-h
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK-----------LW-C  529 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~-~  529 (624)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.||......   +....+..           .+ .
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI---DQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhCCCCHHHHHhhhc
Confidence            1 1223456899999999999989999999999999999999999997532111   11111110           00 0


Q ss_pred             cCCccccccchhhc------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAAELMDSVVKQ------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .........+....      .........+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000000      000112345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-38  Score=327.75  Aligned_cols=241  Identities=22%  Similarity=0.231  Sum_probs=193.6

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||+++.+ +|+.||+|++.+..   ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68899999987542   234466788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccc
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT  466 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  466 (624)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99988853   346899999999999999999999985   999999999999999999999999998753221  1122


Q ss_pred             cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCC
Q 006952          467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD  546 (624)
Q Consensus       467 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  546 (624)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...      +......... .+.. .         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~~~-~~~~-~---------~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELIL-MEEI-R---------FP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC------CHHHHHHHHH-cCCC-C---------CC
Confidence            3467999999999999999999999999999999999999997421      1111111111 1111 0         11


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          547 QAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       547 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                      ......+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12233577889999999999999     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.8e-38  Score=326.43  Aligned_cols=260  Identities=28%  Similarity=0.418  Sum_probs=202.6

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec-C
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE-N  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~  374 (624)
                      .++|++.+.||+|+||.||+|...      .++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357889999999999999999742      24789999987543 23346678899999999 899999999988754 4


Q ss_pred             cceEEEEeccCCChhhhhhcCCC---------------------------------------------------------
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTR---------------------------------------------------------  397 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  397 (624)
                      ..++++||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            57899999999999988853211                                                         


Q ss_pred             -CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCcc
Q 006952          398 -SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM  476 (624)
Q Consensus       398 -~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  476 (624)
                       ...++|..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136899999999999999999999985   9999999999999999999999999998764433323333445677899


Q ss_pred             ChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHH
Q 006952          477 APEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH  555 (624)
Q Consensus       477 aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  555 (624)
                      |||++.+..++.++|||||||++|||++ |+.||......      +........+.....         +.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~---------~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEGTRMRA---------PEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhccCCCCC---------CccCCHHHHH
Confidence            9999999999999999999999999998 99887421111      111122222211111         1122345789


Q ss_pred             HHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          556 IGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       556 l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ++.+||+.+|++||++.||+++|+..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=319.49  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             cCccccCccccCCceeEEEEEecC---------------CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD---------------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLG  368 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~  368 (624)
                      ++|++.+.||+|+||.||++...+               ...||+|++.... ....+.+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987542               2348999987543 334567899999999999999999999


Q ss_pred             EEEecCcceEEEEeccCCChhhhhhcCC---------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006952          369 CCLEENESLLIYEYMPNKSLDVFLFDST---------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL  439 (624)
Q Consensus       369 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIl  439 (624)
                      ++......++||||+++++|.+++....         ....+++..++.++.|++.||.|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999885422         1124789999999999999999999985   999999999999


Q ss_pred             EcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhC--CCCCCCCCCCCC
Q 006952          440 LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG--KKSTGFYHSEHG  517 (624)
Q Consensus       440 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg--~~p~~~~~~~~~  517 (624)
                      +++++.+||+|||++................++..|+|||.+.++.++.++||||||+++|||+++  ..|+....   .
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~---~  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS---D  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---h
Confidence            999999999999999765433222222234457789999999999999999999999999999984  44543211   1


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ........+.+..........      .+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHHhhhhccccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            112222222121111110000      01112346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-37  Score=325.01  Aligned_cols=199  Identities=29%  Similarity=0.411  Sum_probs=173.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|+..+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367889999999999999999976 577889998875432 345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++..   ...+++.....++.|+++||.|||+.+  +|+|+||||+|||+++++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999853   345888999999999999999999753  5999999999999999999999999998755322 


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF  511 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~  511 (624)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               12235689999999999998999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=312.90  Aligned_cols=255  Identities=29%  Similarity=0.456  Sum_probs=203.9

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|+..+.||+|++|.||+|...+++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688899999999999999998888899999987543 23567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 346899999999999999999999985   999999999999999999999999999876532211


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       .......+..|+|||++.+..++.++||||||+++|||++ |+.|+.-.   ..   .. ...........        
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~---~~-~~~~~~~~~~~--------  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---TN---AE-VLQQVDQGYRM--------  223 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---CH---HH-HHHHHHcCCCC--------
Confidence             1111223457999999999999999999999999999999 88886421   11   11 11111111100        


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                       ..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             0111223467889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-38  Score=327.31  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=198.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||+++.+ +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999976 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999998854   345788899999999999999999985   999999999999999999999999999865332


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||..      ......... ...+... +    
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~------~~~~~~~~~-i~~~~~~-~----  234 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD------DTPFRIYEK-ILAGRLK-F----  234 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC------CCHHHHHHH-HhcCCcC-C----
Confidence                 2235789999999999999999999999999999999999999742      111121122 1122111 0    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~  577 (624)
                           +.....++.+++.+||+.||.+||+     +++++..
T Consensus       235 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 -----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 0111234678999999999999997     6777643

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.8e-38  Score=313.78  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=194.9

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      +.||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999975 68899999876543 34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+++..  ....+++..++.++.|+++||.|||+.+   |+|+||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2345899999999999999999999985   99999999999999999999999999875432211111111


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ  547 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  547 (624)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+.....      .. ...........         ..+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------~~-~~~~~~~~~~~---------~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------QQ-TREAIEQGVRL---------PCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------HH-HHHHHHcCCCC---------CCcc
Confidence            223467999999999999999999999999999998 8877642111      11 11111111111         1111


Q ss_pred             HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          548 AELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       548 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      .....+.+++.+|++.+|++|||+.+|.++|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.2e-37  Score=310.24  Aligned_cols=254  Identities=30%  Similarity=0.467  Sum_probs=202.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .+|...+.||+|++|.||+|..+ .++.|++|.+... ....+++.+|+.++++++|+||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999965 4788999988754 334567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++... ....+++..++.++.|+++||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999988542 3346899999999999999999999985   999999999999999999999999999866433211


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...      .... .++..........      
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------~~~~-~~~~~~~~~~~~~------  226 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQ-VYELLEKGYRMER------  226 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHH-HHHHHHCCCCCCC------
Confidence             1112234668999999999999999999999999999998 88886421      1111 1222222111111      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         +......+.+++.+||+.+|++||++.+++++|+.
T Consensus       227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence               11123457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=314.95  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=203.6

Q ss_pred             cCccccCccccCCceeEEEEEecC----CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|+..+.||+|+||.||+|.++.    ...|+||.+.... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999999753    3579999987543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998543  236899999999999999999999975   99999999999999999999999999987652


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...........+++.|+|||.+.+..++.++||||||+++|||++ |..|+...   ...   . .......+.....  
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~---~~~---~-~~~~~~~~~~~~~--  229 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---SNQ---D-VIKAVEDGYRLPP--  229 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC---CHH---H-HHHHHHcCCCCCC--
Confidence            222222222345678999999998999999999999999999998 88886321   111   1 1111111111100  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                             +......+.+++.+||+.+|++||++.+|++.|...
T Consensus       230 -------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         230 -------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   112234578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=327.37  Aligned_cols=241  Identities=22%  Similarity=0.270  Sum_probs=192.0

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 4788999998653   234456778999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            998853   345899999999999999999999985   9999999999999999999999999987542221  12334


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||..      .+............ . .         .+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~------~~~~~~~~~~~~~~-~-~---------~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD------ENVNEMYRKILQEP-L-R---------FPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC------CCHHHHHHHHHcCC-C-C---------CCCc
Confidence            6799999999999999999999999999999999999999742      12222222222111 0 0         1111


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      ....+.+++.+||+.||++||++.++.+.|
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            223567888999999999998654444444

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-37  Score=315.64  Aligned_cols=256  Identities=30%  Similarity=0.421  Sum_probs=201.5

Q ss_pred             CccccCccccCCceeEEEEEecC------CcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      +|+..+.||+|+||.||+|...+      ++.||+|++...... ..+.+.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46677899999999999998642      478999999765433 34678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcC-------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 006952          379 IYEYMPNKSLDVFLFDS-------------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN  445 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  445 (624)
                      ++||+++++|.+++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999988421             11235888999999999999999999985   999999999999999999


Q ss_pred             eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHH
Q 006952          446 PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYI  524 (624)
Q Consensus       446 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  524 (624)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+...      ......
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------~~~~~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------SNQDVI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC------CHHHHH
Confidence            99999999886543332222233456789999999998899999999999999999998 77775421      111111


Q ss_pred             HHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          525 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       525 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                       .....+.....         +......+.+++..||+.+|++||++++|++.|+.
T Consensus       237 -~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 -EMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             11222221111         11223447789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.3e-38  Score=320.81  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=196.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999975 58899999987543 23345678999999999999999999999998899999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            985 888877532  235788999999999999999999985   99999999999999999999999999876432221


Q ss_pred             CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---ccccc-
Q 006952          463 KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---AAELM-  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-  537 (624)
                        ......+++.|+|||++.+ ..++.++||||+|+++|||++|+.||....   ....+..+.+......   +..+. 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST---VKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHHhhcccc
Confidence              1223567999999998865 568999999999999999999999974221   1111222211111100   00000 


Q ss_pred             ----cchhhcCC--------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 ----DSVVKQSC--------DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 ----d~~l~~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ...+....        .......+.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                00000000        0011235678999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.4e-37  Score=308.93  Aligned_cols=252  Identities=28%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|...+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4677889999999999999998777789999887543 334678999999999999999999999998888999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++....  ..+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||.++........ 
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999999885432  26899999999999999999999985   999999999999999999999999998765332211 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|++||.+.+..++.++||||||+++|||++ |+.|+.....      ...... ...+......      
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~------  223 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEK-VSQGLRLYRP------  223 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHH-HhcCCCCCCC------
Confidence            1112335678999999998889999999999999999999 8888743221      111111 1111111100      


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                         ......+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               111346788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.2e-38  Score=320.60  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=197.0

Q ss_pred             HhcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ..++|+....||+|+||.||.++.++ |..+|+|++++...   ...+.++.|-.+|....+|.||+|+..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            35789999999999999999999764 88999999988653   345667789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||++||++..+|.   +...|++.....++.+++-|++-||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999994   4567999999999999999999999986   9999999999999999999999999985431


Q ss_pred             CC----------------------CCCc-----c------------------ccccccccCccChhhhcCCCCChhhHHH
Q 006952          459 GN----------------------QSKA-----N------------------TNRVVGTYGYMAPEYAMGGIFSVKSDVF  493 (624)
Q Consensus       459 ~~----------------------~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~~~ksDv~  493 (624)
                      ..                      ....     .                  ....+|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      0000     0                  0135799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC---
Q 006952          494 SFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT---  570 (624)
Q Consensus       494 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---  570 (624)
                      |+|||+|||+.|-+||.-..      ..+.-.++..-.......+..   ..    ..+..+||.+|+. ||++|..   
T Consensus       373 SLG~ImyEmLvGyPPF~s~t------p~~T~rkI~nwr~~l~fP~~~---~~----s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSET------PQETYRKIVNWRETLKFPEEV---DL----SDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhhhccCCCcC---cc----cHHHHHHHHHHhc-CHHHhcCccc
Confidence            99999999999999974211      111111111101111111111   11    1345567778888 9999975   


Q ss_pred             HHHHH
Q 006952          571 MSSVA  575 (624)
Q Consensus       571 ~~ev~  575 (624)
                      +.||-
T Consensus       439 ~~EIK  443 (550)
T KOG0605|consen  439 AEEIK  443 (550)
T ss_pred             HHHHh
Confidence            55553

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.2e-37  Score=319.12  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=195.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467899999999999999999976 588999999875433 233467889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 567666643  2345888999999999999999999985   9999999999999999999999999987543221


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc------
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA------  534 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  534 (624)
                        .......|++.|+|||++.+ ..++.++||||+|+++|||++|+.||.....  ....+..+..........      
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence              12223568999999999875 4578999999999999999999999853211  111111111111110000      


Q ss_pred             ---ccc--------cchhhcCCC-HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 ---ELM--------DSVVKQSCD-QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 ---~~~--------d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         ...        ...+....+ ......+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               000        000000000 001234678889999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=340.59  Aligned_cols=261  Identities=22%  Similarity=0.281  Sum_probs=206.4

Q ss_pred             HHHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          298 IDIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       298 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      .+.....++|.+.+.||+|+||.||+++.. +++.||||++...  .......+.+|+..+..++|+|+++++..+...+
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            344455689999999999999999999854 6899999998654  2344567889999999999999999988775432


Q ss_pred             --------cceEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 006952          375 --------ESLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN  445 (624)
Q Consensus       375 --------~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  445 (624)
                              ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    2579999999999999886432 3356899999999999999999999985   999999999999999999


Q ss_pred             eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          446 PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       446 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      +||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+......
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~------~~~~~~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG------ENMEEVMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------CCHHHHHH
Confidence            999999999876543333333456799999999999999999999999999999999999999742      12222222


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ... .+....+         +......+.+++.+||+.||.+||++.++++.
T Consensus       256 ~~~-~~~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTL-AGRYDPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHh-cCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            221 1111111         11123457789999999999999999999764

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5e-37  Score=314.41  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=202.1

Q ss_pred             CccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      +|...+.||+|+||.||+|+..      ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999853      235688888875543 345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCC---------------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006952          379 IYEYMPNKSLDVFLFDST---------------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSN  437 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N  437 (624)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235889999999999999999999885   9999999999


Q ss_pred             EEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 006952          438 VLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEH  516 (624)
Q Consensus       438 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~  516 (624)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.-..   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999986543322222223345678999999988889999999999999999998 888864211   


Q ss_pred             CCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          517 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          .+.++.....+....         .+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus       235 ----~~~~~~~~~~~~~~~---------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 ----PERLFNLLKTGYRME---------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ----HHHHHHHHhCCCCCC---------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                112222222221111         1111234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=328.18  Aligned_cols=248  Identities=26%  Similarity=0.400  Sum_probs=192.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45666789999999999999965 589999999865433 3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|....       ..++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986432       3466778899999999999999985   99999999999999999999999999986543221


Q ss_pred             CccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||......   +......... ......  
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~-~~~~~~--  295 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAIC-MSQPPE--  295 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHh-ccCCCC--
Confidence              1234578999999998743     23456899999999999999999998622211   1111111111 011000  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                             .+......+.+++.+||+.||++|||+.||++.
T Consensus       296 -------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 -------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   111223457889999999999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=313.27  Aligned_cols=270  Identities=24%  Similarity=0.368  Sum_probs=205.2

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--------------ccHHHHHHHHHHHHhcCCCCcceE
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--------------QGLQEFKNEVTVIAKLQHKNLVRL  366 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~h~niv~l  366 (624)
                      +..++|++...||+|.||.|-+++.. +++.||||++.+...              ...++..+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999965 688999999876421              124678899999999999999999


Q ss_pred             EeEEEe--cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 006952          367 LGCCLE--ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM  444 (624)
Q Consensus       367 ~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  444 (624)
                      +.+..+  .+..|||+|||..|.+.+.-   .....+.+.++++++.++..||+|||.++   ||||||||+|+||++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            999876  45689999999998875432   33444999999999999999999999996   99999999999999999


Q ss_pred             CeEEeccccccccCCCCC---CccccccccccCccChhhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          445 NPKISDFGMARIFGGNQS---KANTNRVVGTYGYMAPEYAMGGI----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       445 ~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                      ++||+|||.+..+.....   ........|||.|||||...++.    .+.+.||||+||+||.|+.|+.||-      +
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~------~  321 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF------D  321 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc------c
Confidence            999999999987632211   11222368999999999987633    3568899999999999999999973      1


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC-CCCCCCCCCCc
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD-ILTLPKPTQPA  592 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~-~~~~~~p~~p~  592 (624)
                      +..++...+.         +...+.-....++-.++..|++++|++||+.|.+..+|....--. ..+-|.++.|-
T Consensus       322 ~~~~~l~~KI---------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~  388 (576)
T KOG0585|consen  322 DFELELFDKI---------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPS  388 (576)
T ss_pred             chHHHHHHHH---------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcc
Confidence            1122222221         111121112223455677899999999999999999997765322 22444455443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-37  Score=328.35  Aligned_cols=258  Identities=20%  Similarity=0.234  Sum_probs=193.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .+|...+.||+|+||.||++... .++.||+|....      +.+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            56999999999999999999965 588999997542      35688999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      . ++|..++..   ...+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... .
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            5 678777743   345889999999999999999999985   9999999999999999999999999987532211 1


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC----CCCHHHHHHHHHhcCCcc-----
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH----GPSLLAYIWKLWCEGHAA-----  534 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~-----  534 (624)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.|+-......    ....+..+..........     
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            12234579999999999999999999999999999999999998753211111    111111111111000000     


Q ss_pred             -ccccchh---------h-cCC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 -ELMDSVV---------K-QSC-----DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 -~~~d~~l---------~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ..++...         . ...     .......+.+++.+||+.||++|||++|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000         0 000     0112346788999999999999999999975

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5e-37  Score=312.62  Aligned_cols=255  Identities=28%  Similarity=0.425  Sum_probs=199.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCc----EEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|+..+.||+|+||.||+|++. +++    .+++|.+..... ....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999964 344    478888764432 34567888999999999999999999875 455789


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   ++|+||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998542  346899999999999999999999985   9999999999999999999999999998664


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.....       ....+.+..+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------HEVPDLLEKGERLA--  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcCC--
Confidence            3332222334557789999999999999999999999999999998 9888642111       11112222222111  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .+   ..+    ...+.+++.+||+.+|++|||+.|+++.|...
T Consensus       232 ~~---~~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         232 QP---QIC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             CC---CCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11   111    23467788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.5e-37  Score=317.35  Aligned_cols=264  Identities=29%  Similarity=0.419  Sum_probs=204.6

Q ss_pred             hcCccccCccccCCceeEEEEEecC-----------------CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-----------------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVR  365 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~  365 (624)
                      .++|++.+.||+|+||.||++...+                 +..||+|++.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999988643                 2458999987654 334678899999999999999999


Q ss_pred             EEeEEEecCcceEEEEeccCCChhhhhhcCC--------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006952          366 LLGCCLEENESLLIYEYMPNKSLDVFLFDST--------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSN  437 (624)
Q Consensus       366 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N  437 (624)
                      +++++..++..++++||+++++|.+++....        ....+++..++.++.|+++||.|||+.+   |+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986532        1236899999999999999999999985   9999999999


Q ss_pred             EEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCCC
Q 006952          438 VLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSE  515 (624)
Q Consensus       438 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt--g~~p~~~~~~~  515 (624)
                      |+++.++.++|+|||+++...............+++.|+|||++.++.++.++||||||+++|||++  +..|+...   
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~---  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL---  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc---
Confidence            9999999999999999886543332222334456789999999998889999999999999999998  55564321   


Q ss_pred             CCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          516 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ............+..........      .+.....++.+++.+||+.||++|||+.||++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            11122222222221111111111      01112246889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4e-38  Score=329.54  Aligned_cols=263  Identities=23%  Similarity=0.288  Sum_probs=206.8

Q ss_pred             hcCccccCccccCCceeEEEEEecC--CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD--GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|...+.||+|+||.||+|..++  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578899999999999999998653  3689999986532   3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999853   345889999999999999999999985   9999999999999999999999999998653


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...      +........ ..+.. . ..
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~------~~~~~~~~i-~~~~~-~-~p  248 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN------EPLLIYQKI-LEGII-Y-FP  248 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC------CHHHHHHHH-hcCCC-C-CC
Confidence            22     23457999999999999988999999999999999999999997421      111111121 11111 0 11


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH--hccC------CCCCCCCCCCccc
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVM--LASD------ILTLPKPTQPAFS  594 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~--L~~~------~~~~~~p~~p~~~  594 (624)
                              ......+.+++.+|++.||++|+     +++++++.  +.+.      ...++.|..|.+.
T Consensus       249 --------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~  309 (340)
T PTZ00426        249 --------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK  309 (340)
T ss_pred             --------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence                    11123467888999999999995     89998764  2211      2345566677664

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.8e-37  Score=309.64  Aligned_cols=254  Identities=27%  Similarity=0.443  Sum_probs=196.2

Q ss_pred             cccCccccCCceeEEEEEecCCc---EEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec------Ccc
Q 006952          308 SQENKLGEGGFGPVYKGVLADGK---EIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE------NES  376 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~  376 (624)
                      .+.+.||+|+||.||+|.+.+..   .+|+|.++..  .....+.+.+|+.++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45688999999999999976432   5899988654  234467789999999999999999999987542      246


Q ss_pred             eEEEEeccCCChhhhhhcCC---CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          377 LLIYEYMPNKSLDVFLFDST---RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      ++++||+++++|.+++....   ....+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999998874321   2345899999999999999999999975   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++.+.............+++.|++||.+.+..++.++||||||+++|||++ |+.||...   ..   . ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~---~-~~~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---EN---S-EIYDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CH---H-HHHHHHHcCC
Confidence            987643322111223345778999999999999999999999999999999 78886421   11   1 1222222222


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .....         ......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       232 ~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         232 RLKQP---------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            11111         1122347789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.4e-38  Score=318.98  Aligned_cols=262  Identities=28%  Similarity=0.462  Sum_probs=200.2

Q ss_pred             cCccccCccccCCceeEEEEEec-----CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-----DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  377 (624)
                      ++|++.+.||+|+||.||++..+     ++..|++|++........+.+.+|+.++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888899999999999999743     5789999999877666678899999999999999999999987543  4578


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +|+||+++++|.+++...  ...+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998542  245899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCCc-cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC---------CCCHHHHHHHH
Q 006952          458 GGNQSKA-NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH---------GPSLLAYIWKL  527 (624)
Q Consensus       458 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~---------~~~~~~~~~~~  527 (624)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|..++.......         ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4332211 1111223456999999999899999999999999999999877643211100         00000001111


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ......         ...+......+.+++.+||+.+|++|||+.||++.|+.
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            111100         00111223458889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=339.45  Aligned_cols=256  Identities=25%  Similarity=0.308  Sum_probs=205.2

Q ss_pred             hcCccccCccccCCceeEEEEEecCC-cEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeE-EEe------cC
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADG-KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGC-CLE------EN  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~------~~  374 (624)
                      ..++++++.|.+|||+.||.+....+ .++|+|++-..++...+.+++||++|++|+ |+|||.+++. ...      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45678889999999999999998766 999999998888889999999999999996 9999999993 222      13


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      +.+|.||||++|.|-+++...... .|++.++++|+.|+++|+.+||... ++|||||||-+||||..+++.||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            568999999999999999654433 3999999999999999999999984 78999999999999999999999999998


Q ss_pred             cccCCCCCC-ccc------cccccccCccChhhh---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH
Q 006952          455 RIFGGNQSK-ANT------NRVVGTYGYMAPEYA---MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI  524 (624)
Q Consensus       455 ~~~~~~~~~-~~~------~~~~gt~~y~aPE~~---~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~  524 (624)
                      .-.-..... ...      -...-|+.|+|||.+   .+...++|+|||+|||+||-|+..+.||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            643222211 000      012368999999976   567789999999999999999999999862111          


Q ss_pred             HHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          525 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       525 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                               ..++...-.-...+.+..++.+||..||+.||.+||++-+|+..+..
T Consensus       264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                     11111111111124567788899999999999999999999988743

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-37  Score=323.69  Aligned_cols=241  Identities=22%  Similarity=0.244  Sum_probs=192.5

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 68899999987542   334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccc
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT  466 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  466 (624)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888843   346899999999999999999999985   9999999999999999999999999987532211  122


Q ss_pred             cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCC
Q 006952          467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD  546 (624)
Q Consensus       467 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  546 (624)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||....      ........... .. .         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~~~~~-~~-~---------~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILME-EI-R---------FP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHhcC-CC-C---------CC
Confidence            34578999999999999999999999999999999999999974211      11111111111 10 0         01


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          547 QAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       547 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                      ......+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            11123467888899999999998     8888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.5e-37  Score=323.89  Aligned_cols=242  Identities=22%  Similarity=0.235  Sum_probs=193.9

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||++... +++.||+|++.+..   ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 58899999987542   334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccc
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT  466 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  466 (624)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            99888843   346899999999999999999999985   9999999999999999999999999987532211  122


Q ss_pred             cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCC
Q 006952          467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD  546 (624)
Q Consensus       467 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  546 (624)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...      +.......... ... .         .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~------~~~~~~~~~~~-~~~-~---------~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILM-EDI-K---------FP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC------CHHHHHHHhcc-CCc-c---------CC
Confidence            3457999999999999999999999999999999999999997421      11111111111 110 0         11


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 006952          547 QAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVM  577 (624)
Q Consensus       547 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~  577 (624)
                      ......+.+++.+||+.||++||     ++.|+++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            11223567888999999999997     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=311.79  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=199.6

Q ss_pred             CccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +|...+.||+|+||.||++.++++..+++|.+..... ....+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5778899999999999999988778899999865432 345788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|.+++....  ..+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++......... 
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            99999985432  36899999999999999999999985   9999999999999999999999999987654322111 


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....      ....... ..+....         
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~~~---------  221 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN------SEVVESV-SAGYRLY---------  221 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHH-HcCCcCC---------
Confidence            111223457999999999999999999999999999999 7888753211      1111111 1111100         


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      .+......+.+++.+||+.+|++|||+.||++.|.
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            01112346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.7e-37  Score=308.79  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=205.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+.++++++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999965 68899999876422   333457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++++|.+++.... ....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885422 2345788999999999999999999985   99999999999999999999999999886643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ...  ......|++.|+|||.+.+..++.++|+||||+++|||++|+.|+...    ..+........ ........   
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~----~~~~~~~~~~~-~~~~~~~~---  228 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQKI-EQCDYPPL---  228 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc----cccHHHHHHHH-hcCCCCCC---
Confidence            221  122346888999999999888999999999999999999999996321    11222222221 11111110   


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                           ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus       229 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 -----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                 1112334578899999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-37  Score=311.22  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=203.7

Q ss_pred             cCccccCccccCCceeEEEEEecC------CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|...+.||+|+||.||+|....      +..|++|.+..... .....+.+|+.+++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            578888999999999999998643      36899999875532 34567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCC-------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          378 LIYEYMPNKSLDVFLFDSTR-------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                      +||||+++++|.+++.....       ...+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence            99999999999999864321       234789999999999999999999875   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      ||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+...      +.... .+...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~------~~~~~-~~~~~  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL------SNEEV-LKFVI  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC------CHHHH-HHHHh
Confidence            999886543332222233456789999999998889999999999999999998 88886421      11111 12222


Q ss_pred             cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      .+........         ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       236 ~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGGHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCCCCCCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            2222221111         1346788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=298.03  Aligned_cols=264  Identities=24%  Similarity=0.277  Sum_probs=209.1

Q ss_pred             HhcCccccCccccCCceeEEEEE-ecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----c
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----S  376 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----~  376 (624)
                      ..++|.+.+.||+|||+-||.++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+..     .
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35789999999999999999998 56788999999988887888999999999999999999999998765443     8


Q ss_pred             eEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      +|+++|+..|+|.+.+.... +...+++.++++|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999886543 3447999999999999999999999985 579999999999999999999999999987


Q ss_pred             ccCCCCCC-------ccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          456 IFGGNQSK-------ANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       456 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ...-.-..       .......-|..|.|||.+.   +...++++|||||||+||+|+.|..||+...+ .+.++     
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl-----  251 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL-----  251 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE-----
Confidence            65321100       0011223588999999885   34578999999999999999999999874322 22121     


Q ss_pred             HHHhcCCccccccc-hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          526 KLWCEGHAAELMDS-VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       526 ~~~~~~~~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                              .-.+.. .+.-.........+.+++.+|+|.||.+||+..+++..+...
T Consensus       252 --------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  252 --------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    111111 111111112445688999999999999999999999988653

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-37  Score=317.25  Aligned_cols=267  Identities=29%  Similarity=0.405  Sum_probs=198.8

Q ss_pred             ccccCccccCCceeEEEEEe-----cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--cceE
Q 006952          307 FSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--ESLL  378 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~l  378 (624)
                      |...+.||+|+||+||.+..     .+++.||+|.+..... .....+.+|+.++++++||||+++++++...+  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37788999999999988653     3577899999876533 34567889999999999999999999987643  4789


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +|||+++++|.+++..    ..+++..++.++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999853    24899999999999999999999985   9999999999999999999999999998664


Q ss_pred             CCCCCc-cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKA-NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..................+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence            322211 112234566799999999888999999999999999999999986532211 000000000000000011111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +.......+......+.+++.+||+.+|++|||+++|+++|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11111111222345688899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.5e-37  Score=313.14  Aligned_cols=256  Identities=32%  Similarity=0.476  Sum_probs=202.4

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++...++||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45677889999999999999742      356799999887766667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCC------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          379 IYEYMPNKSLDVFLFDSTR------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      +|||+++++|.+++.....            ...+++..++.++.||+.||.|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135889999999999999999999885   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |++||.-.   .....   ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~---~~  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL---SNTEA---IE  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC---CHHHH---HH
Confidence            9999999876543322222223345788999999999999999999999999999998 88886321   11111   11


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      .. ..+......     ..+    ...+.+++.+||+.||++||++.+|++.|+
T Consensus       236 ~~-~~~~~~~~~-----~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CI-TQGRELERP-----RTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HH-HcCccCCCC-----CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11 111111111     112    234778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.6e-37  Score=314.48  Aligned_cols=263  Identities=26%  Similarity=0.411  Sum_probs=201.0

Q ss_pred             cCccccCccccCCceeEEEEEec-----------------CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-----------------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRL  366 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l  366 (624)
                      ++|+..+.||+|+||.||++...                 ++..+|+|++.... ....+.+.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                 23468999987543 3345788999999999999999999


Q ss_pred             EeEEEecCcceEEEEeccCCChhhhhhcCCC--------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006952          367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTR--------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV  438 (624)
Q Consensus       367 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI  438 (624)
                      ++++...+..++||||+++++|.+++.....        ...+++..++.++.||+.||.|||+.+   |+|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        234788899999999999999999985   99999999999


Q ss_pred             EEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 006952          439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSEH  516 (624)
Q Consensus       439 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt--g~~p~~~~~~~~  516 (624)
                      |+++++.++|+|||+++.+.............+++.|++||...++.++.++||||||+++|||++  |..|+.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence            999999999999999986543322222223345678999999888899999999999999999998  5666532211  


Q ss_pred             CCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          517 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                       ..........+.......... .     +......+.+++.+||+.||.+||++.+|++.|+
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 -EQVIENTGEFFRDQGRQVYLP-K-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             -HHHHHHHHHHHhhccccccCC-C-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             111111111111111111110 0     1112246788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-37  Score=314.82  Aligned_cols=257  Identities=30%  Similarity=0.461  Sum_probs=200.7

Q ss_pred             hcCccccCccccCCceeEEEEEecC------CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|...+.||+|++|.||+|.+.+      +..|++|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999999754      56789998865433 3345789999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCC----CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEe
Q 006952          377 LLIYEYMPNKSLDVFLFDSTR----SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKIS  449 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  449 (624)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999985   99999999999998764   58999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||....   ......    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~---~~~~~~----~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---NQEVME----FV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HH
Confidence            9999986633222211222334568999999999999999999999999999997 888864211   111111    11


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      .......         .+......+.+++.+||+.+|++||++.+|++.|.
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111111         11112345778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.3e-37  Score=314.74  Aligned_cols=261  Identities=24%  Similarity=0.336  Sum_probs=192.2

Q ss_pred             cCccccCccccCCceeEEEEEec--CCcEEEEEEccccC--cccHHHHHHHHHHHHhc---CCCCcceEEeEEEe-----
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA--DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL---QHKNLVRLLGCCLE-----  372 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~-----  372 (624)
                      ++|+..+.||+|+||.||+++..  +++.||+|++....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863  46789999886533  22234566788877766   69999999999863     


Q ss_pred             cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      ....++||||++ ++|.+++... ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999996 5888887542 2345899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +++.....   .......|++.|+|||.+.+..++.++||||||+++|||++|++||.....   .+.+..+........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCC
Confidence            99865432   223345689999999999988999999999999999999999999753211   112222211110000


Q ss_pred             cccc------ccchhh--cC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAEL------MDSVVK--QS-----CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~------~d~~l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..+.      ....+.  ..     ........+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000      000000  00     00112235678999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=308.39  Aligned_cols=255  Identities=26%  Similarity=0.463  Sum_probs=199.0

Q ss_pred             ccccCccccCCceeEEEEEecC----CcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----
Q 006952          307 FSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----  375 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  375 (624)
                      |.+.+.||+|+||.||+|.+..    +..||+|+++...  ......+.+|+..++.++|+||+++++.+...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998653    3679999987543  2345678999999999999999999999876554     


Q ss_pred             -ceEEEEeccCCChhhhhhcCC---CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          376 -SLLIYEYMPNKSLDVFLFDST---RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       376 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432   2346899999999999999999999985   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+..   ..........    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~---~~~~~~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG---VENHEIYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHH----Hc
Confidence            99986643332222222345678999999988889999999999999999999 7887642   1111122211    12


Q ss_pred             CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       531 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      +.....         +......+.+++.+||+.||.+|||+.||++.|+.
T Consensus       231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            211111         11223467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.6e-37  Score=320.49  Aligned_cols=262  Identities=22%  Similarity=0.337  Sum_probs=193.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----cce
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----ESL  377 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  377 (624)
                      +|+..+.||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999965 5899999998643  2233457889999999999999999999886532     369


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688888743   345899999999999999999999985   999999999999999999999999999864


Q ss_pred             CCCCC-CccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH------
Q 006952          458 GGNQS-KANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW------  528 (624)
Q Consensus       458 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------  528 (624)
                      ..... ........||+.|+|||++.+  ..++.++||||||+++|||++|+.||.....   ......+....      
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLITDLLGTPSPE  230 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Confidence            32211 112234578999999999876  6789999999999999999999999743211   11111111110      


Q ss_pred             -----hcCCccccccchhhc-CCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          529 -----CEGHAAELMDSVVKQ-SCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       529 -----~~~~~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                           ......+........ ..+     ......+.+++.+||+.||++|||++||++.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                 000000000000000 000     0112346789999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.7e-37  Score=314.92  Aligned_cols=259  Identities=30%  Similarity=0.437  Sum_probs=204.1

Q ss_pred             HhcCccccCccccCCceeEEEEEecC------CcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN  374 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  374 (624)
                      ..++|+..+.||+|+||.||++....      ...+++|.+.... .....++.+|+.++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34678889999999999999998642      3579999887542 33456788999999999 7999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcC-------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDS-------------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                      ..+++|||+++++|..++...             .....+++..++.++.||+.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998542             22346899999999999999999999875   99999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCH
Q 006952          442 HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSL  520 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~  520 (624)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...      ..
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~  240 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------PV  240 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC------CH
Confidence            999999999999987644332222222345678999999999999999999999999999998 88886421      11


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .+ ..+....+....         .+......+.+++.+||+.+|++|||+.||++.|+.
T Consensus       241 ~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         241 EE-LFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             HH-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            11 112222221111         111223457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.4e-37  Score=309.79  Aligned_cols=246  Identities=29%  Similarity=0.402  Sum_probs=193.5

Q ss_pred             ccccCCceeEEEEEec---CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          312 KLGEGGFGPVYKGVLA---DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      .||+|+||.||+|.++   +++.+|+|+++....  ...+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   578899999865432  34567899999999999999999999875 45678999999999


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc-c
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA-N  465 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~  465 (624)
                      +|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   345889999999999999999999985   9999999999999999999999999998764332211 1


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||....      ....... ...+.....        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~-i~~~~~~~~--------  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK------GNEVTQM-IESGERMEC--------  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH-HHCCCCCCC--------
Confidence            112234678999999988889999999999999999998 998875221      1112211 122211111        


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                       +......+.+++.+||+.||++||++.+|++.|++
T Consensus       220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             11123457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-37  Score=321.62  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=195.6

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||++..+ +++.||+|++++..   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999975 58899999997542   33456688999999998 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999888743   346899999999999999999999985   999999999999999999999999998742211  112


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC--CCCHHHHHHHHHhcCCccccccchhhc
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH--GPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+..+........ +       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------  224 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-I-------  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-C-------
Confidence            234679999999999999999999999999999999999999986432222  112222333332222211 1       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPT------MSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~ev~~  576 (624)
                        +......+.+++.+||+.||.+||+      +.++++
T Consensus       225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              1111235778899999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.3e-36  Score=323.74  Aligned_cols=262  Identities=25%  Similarity=0.362  Sum_probs=203.9

Q ss_pred             HHhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcC-CCCcceEEeEEEec
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEE  373 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~  373 (624)
                      ...++|.+.+.||+|+||.||+|++.      .++.||+|++..... ...+.+.+|+.++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34457888899999999999999864      246799999976433 33457889999999997 99999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCC--------------------------------------------------------
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTR--------------------------------------------------------  397 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------  397 (624)
                      +..++|+||+++|+|.++++....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999999864211                                                        


Q ss_pred             ---------------------------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006952          398 ---------------------------------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV  438 (624)
Q Consensus       398 ---------------------------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI  438 (624)
                                                             ...+++...+.++.||+.||.|||+.+   |+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                                   124678888999999999999999874   99999999999


Q ss_pred             EEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 006952          439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHG  517 (624)
Q Consensus       439 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~  517 (624)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....    
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~----  346 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP----  346 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC----
Confidence            999999999999999986533222222223457889999999998889999999999999999998 888864221    


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                        ...........+.....         +......+.+++.+||+.+|++||++++|++.|+..
T Consensus       347 --~~~~~~~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 --MNEQFYNAIKRGYRMAK---------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             --chHHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              11111121212211110         111234578889999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-36  Score=313.76  Aligned_cols=259  Identities=28%  Similarity=0.403  Sum_probs=204.3

Q ss_pred             hcCccccCccccCCceeEEEEEec--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++|.+.+.||+|+||.||+++..        ++..|++|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888899999999999999741        24579999887543 34467889999999999 899999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          374 NESLLIYEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      ...++||||+++++|.+++....             ....+++..+..++.||++||.|||+.+   |+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            99999999999999999986532             1245789999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      ++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+..      ..
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~------~~  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------IP  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc------CC
Confidence            9999999999999987654333222333446678999999999889999999999999999998 6777531      12


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ....... ...+.....         +......+.+++.+||+.+|.+|||+.||++.|+..
T Consensus       245 ~~~~~~~-~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         245 VEELFKL-LKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHHHHH-HHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            2222222 222211111         111234577889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.6e-37  Score=312.35  Aligned_cols=260  Identities=28%  Similarity=0.419  Sum_probs=202.5

Q ss_pred             HhcCccccCccccCCceeEEEEEecC------CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      ..++|++.+.||+|+||.||+|..++      +..||+|.+..... .....+.+|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45788999999999999999997542      45799998865432 234567899999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCC-------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          376 SLLIYEYMPNKSLDVFLFDST-------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      .++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996422       1244577888999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      +|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..|+..   ..   ....... 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~---~~---~~~~~~~-  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG---LS---NEQVLKF-  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC---CC---HHHHHHH-
Confidence            99999886543322222222345678999999999999999999999999999999 6777632   11   1111111 


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...+.....         +......+.+++.+||+.+|++|||+.++++.|++.
T Consensus       234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            111111111         111124688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-36  Score=301.43  Aligned_cols=247  Identities=28%  Similarity=0.397  Sum_probs=197.1

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChh
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD  389 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  389 (624)
                      +.||+|+||.||+|...++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999876543 33457889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcccccc
Q 006952          390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV  469 (624)
Q Consensus       390 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  469 (624)
                      +++...  ...+++..++.++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            988542  345789999999999999999999885   999999999999999999999999998754322211 11122


Q ss_pred             ccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       470 ~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      .+++.|+|||++.++.++.++||||||+++|||++ |..||...      ..... ......+....         .+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~------~~~~~-~~~~~~~~~~~---------~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM------TNQQA-REQVEKGYRMS---------CPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC------CHHHH-HHHHHcCCCCC---------CCCC
Confidence            34678999999999999999999999999999998 88887421      11111 11111111111         1112


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ....+.+++.+|++.+|++||++.||++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2346888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-36  Score=312.54  Aligned_cols=258  Identities=29%  Similarity=0.430  Sum_probs=203.2

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      .++|...+.||+|+||.||++...      .+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357889999999999999999742      24579999987653 33456789999999999 79999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+++++|.+++.... ...+++.++..++.||+.||.|||+++   |+|+||||+|||++.++.++|+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999985422 234899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .....+....+...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~  263 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------DSKFYKLIKEGYRM  263 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------hHHHHHHHHcCCcC
Confidence            6543322222223446788999999999999999999999999999998 8888642111      11111111111111


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .         .+......+.+++.+||+.+|++|||+.||++.|.+
T Consensus       264 ~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         264 A---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             C---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            0         011112357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4e-37  Score=320.92  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=194.5

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||++..+ +++.||+|++.+.   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5788999998754   233456678899998877 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999888743   345899999999999999999999985   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC--CCCHHHHHHHHHhcCCccccccchhhc
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH--GPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+..+........         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---------
Confidence            234678999999999999999999999999999999999999985322221  112223333332222211         


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCC------HHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPT------MSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~ev~~  576 (624)
                       .+......+.+++.+||+.||++||+      +.++++
T Consensus       224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence             11112335678899999999999998      566643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-36  Score=310.06  Aligned_cols=258  Identities=29%  Similarity=0.483  Sum_probs=202.9

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|+..+.||+|+||.||++...      ++..||+|++..... ...+++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357888999999999999999864      467899999875433 3456789999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCC-------------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 006952          377 LLIYEYMPNKSLDVFLFDST-------------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSN  437 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~N  437 (624)
                      ++|+||+++++|.+++....                   ....+++..++.++.||+.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986321                   1235788999999999999999999985   9999999999


Q ss_pred             EEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 006952          438 VLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEH  516 (624)
Q Consensus       438 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~  516 (624)
                      |++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..|+...    
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~----  236 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM----  236 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence            9999999999999999876543322222222345678999999998999999999999999999998 77775311    


Q ss_pred             CCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          517 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        ...+... ....+....         .+......+.+++.+||+.+|++|||+.||++.|++
T Consensus       237 --~~~~~~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 --AHEEVIY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --CHHHHHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              1112221 122222111         111223468889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-38  Score=321.20  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=209.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-ceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-SLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lV~  380 (624)
                      ++|...+.+|+|+||.++..+.+ +++.+++|.+.-.  .....+...+|+.++++++|||||.+.+.+++++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788899999999999998865 5778999987643  34445577899999999999999999999999988 89999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      +|++||++.+.|...+ ...++++.+..++.||+.|+.|||++   +|+|||||+.|||++.+..+||+|||+++.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996533 56799999999999999999999977   5999999999999999999999999999988655


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ..  .....+||+.||.||++.+..|..|+|||||||++|||++-+++|.      ..+....+.+....-     .   
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~------a~~m~~Li~ki~~~~-----~---  223 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK------ASNMSELILKINRGL-----Y---  223 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC------ccchHHHHHHHhhcc-----C---
Confidence            42  3345889999999999999999999999999999999999999974      222223332222111     1   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        ...+......+..++..|++.+|+.||++.+++.+
T Consensus       224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              12234445668889999999999999999999876

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-36  Score=303.94  Aligned_cols=253  Identities=30%  Similarity=0.483  Sum_probs=201.0

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|.+.++||+|+||.||++..+++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46788899999999999999988888999999875433 3467899999999999999999999875 456889999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            99999998642 2345899999999999999999999985   999999999999999999999999999866433211 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...      .......... .....         
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~------~~~~~~~~~~-~~~~~---------  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------NNREVLEQVE-RGYRM---------  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHH-cCCCC---------
Confidence            1122335678999999988889999999999999999999 88886421      1112221111 11100         


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ..+......+.+++.+|++.+|++|||+.++.++|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1111223458889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.6e-37  Score=311.09  Aligned_cols=246  Identities=26%  Similarity=0.339  Sum_probs=193.5

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||+|+||+||++... +++.+|+|++....   ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999965 68899999986542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcccc
Q 006952          389 DVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN  467 (624)
Q Consensus       389 ~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  467 (624)
                      ..++... .....+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8887542 23456899999999999999999999985   99999999999999999999999999976543322  223


Q ss_pred             ccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCH
Q 006952          468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQ  547 (624)
Q Consensus       468 ~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  547 (624)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .. .........+..          ..+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~-~~~~~~~~~~~~----------~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--EN-KELKQRILNDSV----------TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hH-HHHHHhhcccCC----------CCcc
Confidence            4578999999999999999999999999999999999999975321111  11 111111111100          1111


Q ss_pred             HHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          548 AELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       548 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                      .....+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2234577889999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-36  Score=314.88  Aligned_cols=240  Identities=25%  Similarity=0.318  Sum_probs=188.3

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.. +++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 47789999987542   23345566677777655 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988853   335889999999999999999999985   9999999999999999999999999997543222  22


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...      +..+....... ..      +.    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~-~~------~~----~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE------DEDELFDSILN-DR------PH----F  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC------CHHHHHHHHHc-CC------CC----C
Confidence            33467999999999999999999999999999999999999997521      11222222111 11      00    1


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMS-SVA  575 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  575 (624)
                      +......+.+++.+||+.+|++||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111223467888899999999999875 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-36  Score=309.68  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=197.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||+++.. +++.||+|.+.... ....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35677889999999999999864 68899999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996543       3678888999999999999999985   999999999999999999999999998765322  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCC-CHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP-SLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ..... .+...........    
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----  221 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP----  221 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccCCCCCC----
Confidence              122357899999999999999999999999999999999999997532222111 11111 1111111111110    


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .    .....++.+++.+|++.+|++||+++|+++.
T Consensus       222 ~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 V----GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0    1122357788999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-37  Score=320.20  Aligned_cols=241  Identities=24%  Similarity=0.308  Sum_probs=192.2

Q ss_pred             CccccCCceeEEEEEe----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.||+|+||.||+++.    ..++.||+|++.+..    ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    357889999987532    23345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999998843   345788888999999999999999985   9999999999999999999999999987542221 


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||...      +......... .+.. .       
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~------~~~~~~~~~~-~~~~-~-------  218 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE------NRKKTIDKIL-KGKL-N-------  218 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC------CHHHHHHHHH-cCCC-C-------
Confidence             1223457899999999999988999999999999999999999997521      1122222221 1111 0       


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                        .+......+.+++.+||+.+|++||     ++.++++
T Consensus       219 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 --LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              1111223577899999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-36  Score=313.77  Aligned_cols=259  Identities=30%  Similarity=0.417  Sum_probs=202.4

Q ss_pred             hcCccccCccccCCceeEEEEEec--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++|.+.+.||+|+||.||++...        .+..+|+|.+.... .....++.+|+.+++++ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367899999999999999999753        23569999987643 34456788999999999 799999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      +..++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999965321             235899999999999999999999875   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...      .
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~------~  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------P  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC------C
Confidence            9999999999999876543221111222234568999999999899999999999999999998 77776421      1


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..... +....+...+.         +......+.+++.+||+.+|++||||.+|++.|...
T Consensus       248 ~~~~~-~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         248 VEELF-KLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHH-HHHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            11111 11222211111         111234577889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.6e-36  Score=304.69  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=207.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||+|++|.||+|... +|+.|++|.++..   .....+.+.+|++++++++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 7899999988642   2233567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++++|..++.+.. ....+++.+++.++.|+++||.|||+.+   |+|+||+|+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 3445899999999999999999999985   99999999999999999999999999876543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+....    .+....... ...+......  
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~~~~~--  229 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEKCDYPPLP--  229 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhh-hhcCCCCCCC--
Confidence            221  1223468889999999998899999999999999999999999964211    122222111 1111111111  


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                            .......+.+++.+||+.+|++|||+.+|+++|++.
T Consensus       230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                  112234577899999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-36  Score=308.25  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=204.0

Q ss_pred             hcCccccCccccCCceeEEEEEecC-----CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~  376 (624)
                      .++|...+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     6789999887543 3345778899999999999999999998876 4668


Q ss_pred             eEEEEeccCCChhhhhhcCCCC-----cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRS-----VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                      ++++||+++++|.+++......     ..+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653322     56899999999999999999999875   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+...   .   .... ......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~---~~~~-~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---D---PFEM-AAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---C---HHHH-HHHHHc
Confidence            99986543322222223345778999999998889999999999999999999 99887421   1   1111 111212


Q ss_pred             CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       531 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +....  .+   ..+    ...+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       235 ~~~~~--~~---~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 GYRLA--QP---INC----PDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             CCCCC--CC---CcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11100  00   111    23578899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.3e-37  Score=322.62  Aligned_cols=200  Identities=25%  Similarity=0.368  Sum_probs=173.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||+|+||.||++... +++.||||++.+..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999865 58899999987532   233467888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   346899999999999999999999985   999999999999999999999999998754321


Q ss_pred             CCC---------------------------------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCC
Q 006952          461 QSK---------------------------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK  507 (624)
Q Consensus       461 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~  507 (624)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCC
Q 006952          508 STG  510 (624)
Q Consensus       508 p~~  510 (624)
                      ||.
T Consensus       235 Pf~  237 (363)
T cd05628         235 PFC  237 (363)
T ss_pred             CCC
Confidence            974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=304.67  Aligned_cols=266  Identities=25%  Similarity=0.365  Sum_probs=209.4

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHh--cCCCCcceEEeEEEecC----cce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK--LQHKNLVRLLGCCLEEN----ESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~~  377 (624)
                      .++....+.||+|.||.||+|.+. |+.||||++...++..   +.+|.++.+.  |+|+||+.+++.-..+.    +++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            356777899999999999999995 8999999998766543   4556666655  59999999999876654    478


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      ||.+|.++|||.++|.    ...++....++++..+|.||++||-+     |+|.|.|||||+.||||..|+.+.|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            9999999999999994    35689999999999999999999964     78899999999999999999999999999


Q ss_pred             cccccCCC--CCCccccccccccCccChhhhcCCC----C--ChhhHHHHHHHHHHHHHhCC----------CCCCCCCC
Q 006952          453 MARIFGGN--QSKANTNRVVGTYGYMAPEYAMGGI----F--SVKSDVFSFGVVLLEIISGK----------KSTGFYHS  514 (624)
Q Consensus       453 ~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~ksDv~S~Gvil~elltg~----------~p~~~~~~  514 (624)
                      +|......  ......+..+||.+|||||++....    +  -..+||||||+++||+....          .||  ++-
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py--yd~  439 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY--YDV  439 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc--ccC
Confidence            99876544  2344566789999999999986543    2  23689999999999987532          342  333


Q ss_pred             CCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          515 EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ...+...+..++.....+..-.+++.   -.+.+.+..+.+++..||..+|..|-|+=-|-+.|.+..
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            33333445555555554444333332   234667788999999999999999999999988887654

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-36  Score=306.93  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=205.3

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||+|++|.||++.. .+++.++||.+....   ....+++.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999995 478999999876532   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++++|.+++... .....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988542 23456899999999999999999999985   99999999999999999999999999876543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|||++|..|+....    .+....... ......     +
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~-----~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEQCDY-----P  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc----chHHHHhhh-hhcCCC-----C
Confidence            321  1223568899999999999899999999999999999999999974211    111111111 111110     1


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .+   ........+.+++.+||+.+|++||||.+|++++++.
T Consensus       227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            00   0112234577889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-38  Score=290.40  Aligned_cols=249  Identities=27%  Similarity=0.372  Sum_probs=205.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .+...++.+|+++-..|+||||++++++|.+....+|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468999999999999999999965 57789999987643   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      +||.++|.+...|.. .+...+++.....++.|+|.||.|+|..   +++||||||+|+|++.++.+||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999964 2445688899999999999999999987   59999999999999999999999999886432 


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                         .......+||..|.+||...+...+.++|+|++|++.||++.|.+||+-..   .......+.+.       ++.. 
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~-------~~~~-  241 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV-------DLKF-  241 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc-------cccC-
Confidence               233446899999999999999999999999999999999999999986322   22222222221       1111 


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                            +........+++..|+..+|.+|.+..||+..
T Consensus       242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 ------PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  11222346788899999999999999999764

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=302.99  Aligned_cols=250  Identities=36%  Similarity=0.504  Sum_probs=202.3

Q ss_pred             CccccCCceeEEEEEecC----CcEEEEEEccccCccc-HHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||++....    +..|++|.+....... .+.+.+|+..++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999764    7889999987655433 67899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCC------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          386 KSLDVFLFDSTR------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       386 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ++|.+++.....      ...+++..++.++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865421      367899999999999999999999985   99999999999999999999999999987654


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...........+++.|+|||.+....++.++||||+|+++|||++ |..|+...   .   .... ......+.....  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~---~~~~-~~~~~~~~~~~~--  228 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---S---NEEV-LEYLRKGYRLPK--  228 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC---C---HHHH-HHHHHcCCCCCC--
Confidence            432223334567889999999998889999999999999999999 58887532   1   1111 111211111111  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                             +......+.+++.+||+.+|++|||+.|+++.|+
T Consensus       229 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 -------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   1112346788999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=325.84  Aligned_cols=253  Identities=24%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999976 58899999987542   244567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998543   56899999999999999999999975   999999999999999999999999999865433


Q ss_pred             C---------------------------CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 006952          461 Q---------------------------SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH  513 (624)
Q Consensus       461 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~  513 (624)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0112234568999999999999999999999999999999999999975221


Q ss_pred             CCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 006952          514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-MSSVAVM  577 (624)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~~  577 (624)
                            ......+.............   ..    ....+.+++..|++ +|.+||+ ++++++.
T Consensus       235 ------~~~~~~~i~~~~~~~~~p~~---~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 ------LQETYNKIINWKESLRFPPD---PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ------HHHHHHHHhccCCcccCCCC---CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                  11222221110000000000   00    23456778889997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-36  Score=303.21  Aligned_cols=250  Identities=30%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|++|.||+++.+ +++.|++|.+...  .....+.+.+|+.++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999975 5889999988643  334567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2356899999999999999999999875   99999999999999999999999999886643322


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......|++.|+|||+..+..++.++||||||+++|||++|+.|+....      ......+. ..+.....      
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~-~~~~~~~~------  221 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN------QGALILKI-IRGVFPPV------  221 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH-HcCCCCCC------
Confidence              1223568899999999999999999999999999999999999975322      11112211 11111111      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         +......+.+++.+||+.+|++||++.+|++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               11223457889999999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.8e-36  Score=305.36  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=191.8

Q ss_pred             CccccCCceeEEEEEecC---CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||+|...+   +..+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799998876543 33457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC--CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          387 SLDVFLFDST--RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       387 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +|.+++....  .....++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2235677888899999999999999985   9999999999999999999999999987543332222


Q ss_pred             cccccccccCccChhhhcCC-------CCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          465 NTNRVVGTYGYMAPEYAMGG-------IFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||......   ......   . .+.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~---~-~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYT---V-REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH---h-hcccCCC
Confidence            23345678899999998642       35789999999999999996 99997532211   111111   1 1111222


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      .++.+....    ...+.+++..|+ .+|++|||++||+..|.
T Consensus       231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222222111    223566778898 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=326.59  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||+|+||.||+++.. +++.||||++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999975 58899999987532   234466789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999854   345899999999999999999999985   999999999999999999999999998754321


Q ss_pred             CCCc------------------------------------cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh
Q 006952          461 QSKA------------------------------------NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS  504 (624)
Q Consensus       461 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt  504 (624)
                      ....                                    ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 006952          505 GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT---MSSVAV  576 (624)
Q Consensus       505 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~  576 (624)
                      |..||...      +.....................   ..    ...+.+++.+|+. +|.+|++   +.|+++
T Consensus       235 G~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~~---~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSD------NPQETYRKIINWKETLQFPDEV---PL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCC------CHHHHHHHHHcCCCccCCCCCC---CC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99997521      1122222221111111111100   11    2245567777886 9999998   888866

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.6e-37  Score=321.05  Aligned_cols=251  Identities=22%  Similarity=0.295  Sum_probs=195.8

Q ss_pred             CccccCccccCCceeEEEEEec----CCcEEEEEEccccC----cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      +|++.+.||+|+||.||+++..    .++.||+|++.+..    ....+.+.+|+.++.++ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998853    57899999986532    23346678899999999 599999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998853   345889999999999999999999985   99999999999999999999999999976


Q ss_pred             cCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      +..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.......  .......... ...   
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~-~~~---  227 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRIL-KCD---  227 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHh-cCC---
Confidence            533222 122346799999999999865 47889999999999999999999985322221  1111111111 111   


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                         +.+    +......+.+++.+||+.||++||     +++++++
T Consensus       228 ---~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 ---PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               111    111223467888999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-36  Score=306.66  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=200.9

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|.+.++||+|+||.||+|+..++..|++|++..... ..+.+.+|+.++++++|+||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            56889999999999999999987777899999875332 3467899999999999999999999874 456799999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++... ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||.++.+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            99999998542 2345789999999999999999999985   999999999999999999999999999866433221 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||+..+..++.++||||||+++|||++ |+.|+....   .   ........ .+...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~---~~~~~~~~-~~~~~---------  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---N---REVLDQVE-RGYRM---------  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---h---HHHHHHHh-cCCCC---------
Confidence            1123346678999999998899999999999999999999 777764211   1   11111111 11100         


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..+......+.+++.+|++.+|++||++.+++++|+..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            11122344678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-36  Score=304.60  Aligned_cols=255  Identities=27%  Similarity=0.484  Sum_probs=201.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-Cc---EEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GK---EIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|+..+.||+|+||.||+|+.+. ++   .+++|.+.... ....+.+.+|+.++.+++|+|++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            577888999999999999999753 33   69999987653 33457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999998542  346899999999999999999999985   99999999999999999999999999876543


Q ss_pred             CCCCcc-ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQSKAN-TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...... ......+..|+|||++.++.++.++||||||+++|||++ |+.|+....      ..... +........   
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~------~~~~~-~~i~~~~~~---  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS------NHEVM-KAINDGFRL---  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC------HHHHH-HHHhcCCCC---
Confidence            221111 111223457999999998899999999999999999998 999974211      11111 111111100   


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                            .........+.+++.+||+.+|++||++.+|++.|++
T Consensus       230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                  0011223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.7e-37  Score=297.64  Aligned_cols=279  Identities=24%  Similarity=0.348  Sum_probs=207.0

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCccc--HHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQG--LQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      +..++|+..++|++|.||.||+|+.+ +++.||+|+++...+..  --.-.+||.+|.+++|||||.+..+....  +..
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            34577899999999999999999965 57889999997654321  12347899999999999999999987653  568


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      +||||||+. +|..++..  -...+...++..+..|+++|++|||...   |+|||||++|+|+.+.|.+||+|||+||.
T Consensus       153 y~VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence            999999976 77777754  2356888999999999999999999997   99999999999999999999999999999


Q ss_pred             cCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---  532 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  532 (624)
                      ++....  ..+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.   .....+.+..+.+......   
T Consensus       227 ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~---G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  227 YGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP---GKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             hcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC---CCchHHHHHHHHHHhCCCcccc
Confidence            876532  23456779999999999875 58999999999999999999998753   2223334444433332221   


Q ss_pred             cccccc--------------chhhcCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCcc
Q 006952          533 AAELMD--------------SVVKQSCDQA-ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF  593 (624)
Q Consensus       533 ~~~~~d--------------~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~~p~~  593 (624)
                      +..+..              ..++..+... ....-.++....|..||.+|-|++|-++  ..-....|.|..|.+
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~  375 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSM  375 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhh
Confidence            111110              1111111111 1123345666788999999999998865  233455566665544

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.5e-36  Score=304.49  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=188.9

Q ss_pred             CccccCCceeEEEEEecC---CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999998543   3468888876543 234467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC--CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          387 SLDVFLFDSTR--SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       387 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865332  234568888999999999999999985   9999999999999999999999999987543222111


Q ss_pred             cccccccccCccChhhhcC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          465 NTNRVVGTYGYMAPEYAMG-------GIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ......+++.|+|||++..       ..++.++||||||+++|||++ |..|+.....      .......... ....+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVLKQVVRE-QDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhhc-cCccC
Confidence            2223445778999998743       456889999999999999999 6777642211      1112222222 12222


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ..+.+....    ...+.+++..|+ .||++|||+++|++.|.
T Consensus       231 ~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222222222    233556677788 59999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.2e-37  Score=308.69  Aligned_cols=255  Identities=23%  Similarity=0.376  Sum_probs=199.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++.+...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357888999999999999999964 6888999998766555566788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++..+.... 
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            999999998853   345889999999999999999999985   9999999999999999999999999998653221 


Q ss_pred             CccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                       .......|++.|+|||.+.   ...++.++||||||+++|||++|+.|+........      ... +....   ...+
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~~-~~~~~---~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFL-MSKSN---FQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------hee-eecCC---CCCC
Confidence             1122356889999999874   34578899999999999999999998632111100      000 00000   0001


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      ....  .......+.+++.+||+.+|++|||+++|++.|
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1100  111224577889999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.8e-37  Score=324.90  Aligned_cols=253  Identities=20%  Similarity=0.297  Sum_probs=193.5

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .|...+.||+|+||+||+++.. +++.||||++....   ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999865 57899999987542   3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999854   345888999999999999999999985   9999999999999999999999999976432100


Q ss_pred             C---------------------------------------------CccccccccccCccChhhhcCCCCChhhHHHHHH
Q 006952          462 S---------------------------------------------KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFG  496 (624)
Q Consensus       462 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G  496 (624)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhh--cccCCCCCCCCHHHH
Q 006952          497 VVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLL--CVQGDPIDRPTMSSV  574 (624)
Q Consensus       497 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ev  574 (624)
                      |++|||++|+.||.....      .....+.........+...   ...+    ..+.+++.+  |+..+|..||++.+|
T Consensus       236 ~il~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~---~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTP------TETQLKVINWENTLHIPPQ---VKLS----PEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCH------HHHHHHHHccccccCCCCC---CCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999753211      1111111111110111000   0112    234455544  667777789999999


Q ss_pred             HHH
Q 006952          575 AVM  577 (624)
Q Consensus       575 ~~~  577 (624)
                      +..
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-36  Score=318.28  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=199.6

Q ss_pred             cCccccCccccCCceeEEEEEe------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC-c
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN-E  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-~  375 (624)
                      ++|+..+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...+ .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5788999999999999999973      346789999997543 23456788999999999 7899999999887654 5


Q ss_pred             ceEEEEeccCCChhhhhhcCCC----------------------------------------------------------
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTR----------------------------------------------------------  397 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  397 (624)
                      .+++|||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999998854210                                                          


Q ss_pred             ------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcccccccc
Q 006952          398 ------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG  471 (624)
Q Consensus       398 ------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  471 (624)
                            ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  124688889999999999999999985   99999999999999999999999999986533322222223345


Q ss_pred             ccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHH
Q 006952          472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL  550 (624)
Q Consensus       472 t~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  550 (624)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+......      .........+.......         ...
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~---------~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMRAPD---------YTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCCCCC---------CCC
Confidence            678999999999999999999999999999997 88886422111      11112222222111110         112


Q ss_pred             HHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          551 LKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       551 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..+.+++..||+.+|++|||+.||++.|+..
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            3578899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.8e-36  Score=301.93  Aligned_cols=249  Identities=31%  Similarity=0.432  Sum_probs=198.5

Q ss_pred             CccccCCceeEEEEEecC--C--cEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD--G--KEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  2  3689999987665 567789999999999999999999999988 888999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC-c
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-A  464 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~  464 (624)
                      ++|.+++.+... ..+++...+.++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865432 56899999999999999999999985   999999999999999999999999999876442221 1


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+...      ...+.............        
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------~~~~~~~~~~~~~~~~~--------  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL------SGSQILKKIDKEGERLE--------  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcCCcCC--------
Confidence            1223456789999999999999999999999999999999 99987421      11121111111111110        


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                       .+......+.+++.+|++.+|++||++.+|++.|.
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             01112345788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=304.10  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=199.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-----ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-----QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|...+.||+|++|.||++... +++++++|.+.....     ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999964 588999998864321     234578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   345788999999999999999999985   9999999999999999999999999987654


Q ss_pred             CCCCCc-cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKA-NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.-.      +......+.........+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~~~~~-  228 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF------EAMAAIFKIATQPTNPQL-  228 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc------chHHHHHHHhccCCCCCC-
Confidence            322111 112345788999999999988999999999999999999999996421      111222221111111111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                              +......+.+++.+||+.+|.+|||+.++++.
T Consensus       229 --------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         229 --------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                    11223357788899999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-36  Score=325.43  Aligned_cols=262  Identities=21%  Similarity=0.260  Sum_probs=195.4

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+|.+.+.||+|+||.||++.... ++.||||...      ...+.+|+.++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999764 7889999643      23457899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +. ++|..++...  ...++|..++.|+.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6787777432  236899999999999999999999985   99999999999999999999999999986643322


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-CCCCCCHHHHHHHHHhcCCc--cccc--
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH-SEHGPSLLAYIWKLWCEGHA--AELM--  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~--  537 (624)
                      ........||+.|+|||++.+..++.++|||||||++|||++|..++-... ..........+.+.......  .++.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222234679999999999999999999999999999999999886642111 11111111111111111110  0000  


Q ss_pred             -cchh------------hcCCCH-------HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 -DSVV------------KQSCDQ-------AELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 -d~~l------------~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                       ...+            ......       .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence             0000            000000       011257789999999999999999999864

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-36  Score=306.82  Aligned_cols=253  Identities=30%  Similarity=0.461  Sum_probs=201.6

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|...++||+|+||.||++..++++.||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            56888899999999999999998899999999875443 3467899999999999999999999864 457899999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05067          84 NGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence            99999988543 3346899999999999999999999875   999999999999999999999999999765422211 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||.-.   ..   ...... ...+.....       
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~---~~~~~~-~~~~~~~~~-------  224 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM---TN---PEVIQN-LERGYRMPR-------  224 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC---Ch---HHHHHH-HHcCCCCCC-------
Confidence            1122345678999999998889999999999999999999 99887421   11   111111 111111111       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        +......+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 --PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              11122358889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.5e-36  Score=301.06  Aligned_cols=253  Identities=29%  Similarity=0.469  Sum_probs=199.8

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|.....||+|++|.||++..+.+..+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999998877789999886543 23467899999999999999999999875 456789999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999998643 2345889999999999999999999885   999999999999999999999999999765433211 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.|+...   .......    ....+...         
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~----~~~~~~~~---------  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE----QVERGYRM---------  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHH----HHHcCCCC---------
Confidence            1122345678999999998899999999999999999999 88886421   1111111    11111110         


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ..+......+.+++.+||+.+|++||++++|+++|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0111223457889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-36  Score=316.45  Aligned_cols=243  Identities=23%  Similarity=0.342  Sum_probs=193.5

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||++... +++.||+|++.+..   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999965 57889999997642   23456688999999988 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            999888743   345899999999999999999999985   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||................+........ +         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~---------  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-I---------  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-C---------
Confidence            234679999999999999999999999999999999999999986433333333333343333322111 1         


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                      +......+.+++.+||+.||.+||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11112346788899999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-36  Score=301.39  Aligned_cols=250  Identities=31%  Similarity=0.440  Sum_probs=202.7

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|+..+.||+|+||.||++... |+.|++|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888899999999999999875 78999999976654 5678899999999999999999999999988999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999985432 236899999999999999999999985   99999999999999999999999999986532211 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                          ...++..|+|||.+.++.++.++||||||+++|||++ |..|+....   ...    .......+...+..     
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~----~~~~~~~~~~~~~~-----  221 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKD----VVPHVEKGYRMEAP-----  221 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHH----HHHHHhcCCCCCCc-----
Confidence                2234568999999998899999999999999999998 888864221   111    11111111111111     


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                          ......+.+++.+||+.+|++||++++|+++|++
T Consensus       222 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 ----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ----cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                1123457789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-36  Score=310.42  Aligned_cols=256  Identities=30%  Similarity=0.439  Sum_probs=198.2

Q ss_pred             cCccccCccccCCceeEEEEEecC-Cc--EEEEEEcccc-CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GK--EIAVKRLSRT-SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999999754 33  4788888743 334456789999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          380 YEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      +||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1135889999999999999999999985   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||++......   ........+..|+|||++.+..++.++||||||+++|||++ |+.||....      ......
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~------~~~~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT------CAELYE  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Confidence            99999998642211   11111223457999999998889999999999999999998 988874211      111111


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      . ...+....         .+......+.+++.+||+.+|.+||++.+|++.|....
T Consensus       230 ~-~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         230 K-LPQGYRME---------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             H-HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1 11111110         01112235778999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.7e-37  Score=319.83  Aligned_cols=244  Identities=24%  Similarity=0.319  Sum_probs=191.2

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHH---HhcCCCCcceEEeEEEecCcceEE
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVI---AKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      |++.+.||+|+||.||++... +++.||||++++..   ....+.+.+|+.++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999965 58899999987542   23345666776655   456799999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999887742    35899999999999999999999985   99999999999999999999999999874322


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .  ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...      +......... .+...     
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~------~~~~~~~~i~-~~~~~-----  219 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD------DEEEVFDSIV-NDEVR-----  219 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC------CHHHHHHHHH-hCCCC-----
Confidence            1  12223467999999999999999999999999999999999999997421      1111111111 11110     


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                           .+......+.+++.+||+.||.+||     ++.++++
T Consensus       220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 1111223467889999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.3e-36  Score=304.73  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=199.6

Q ss_pred             cCccccCccccCCceeEEEEEecC-C---cEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-G---KEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..|+..+.||+|+||.||+|.++. +   ..|+||.+... .....++|.+|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999999753 3   35999998764 334467899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999988543  346899999999999999999999985   99999999999999999999999999876543


Q ss_pred             CCCCcccc-ccc--cccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          460 NQSKANTN-RVV--GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       460 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ........ ...  .+..|+|||.+.+..++.++||||||+++|||++ |+.|+....   ..+....+    .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i----~~~~~~~  231 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAI----EQDYRLP  231 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHH----HcCCcCC
Confidence            22211111 111  2457999999999999999999999999999886 998864211   11111111    1111000


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                               .+.+....+.+++.+||+.+|.+||++.+|+..|++
T Consensus       232 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         232 ---------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                     011123357789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-36  Score=315.87  Aligned_cols=242  Identities=23%  Similarity=0.288  Sum_probs=192.1

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+|+.+ +++.||+|++.+..   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 47899999987542   33456677899999876 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988843   345889999999999999999999985   9999999999999999999999999987532221  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....      .......... +...  .        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------~~~~~~~i~~-~~~~--~--------  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN------EDDLFESILH-DDVL--Y--------  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC------HHHHHHHHHc-CCCC--C--------
Confidence            234578999999999999999999999999999999999999975221      1122222211 1100  0        


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCC-------CHHHHHHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRP-------TMSSVAVM  577 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~ev~~~  577 (624)
                      +......+.+++.+||+.||++||       ++.++++.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            111123567888999999999999       78887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=320.22  Aligned_cols=253  Identities=29%  Similarity=0.464  Sum_probs=206.6

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .+....++||.|.||.||.|+|+. .-.||||.++.+.. ..++|..|..+|+.++|||+|+|+|+|..+...|||.|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            456677999999999999999875 56899999986544 4689999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      .+|+|.++|.... +..++-...+.++.||+.||+||..+   ++|||||..+|.|+.++.-+||+|||+++++..+...
T Consensus       346 ~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  346 CYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             cCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            9999999997643 44677788899999999999999987   5999999999999999999999999999998765433


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      ... ...-.+.|.|||-+....++.|+|||+|||+||||.| |..|+.   .   .++. .+..++.++...        
T Consensus       422 AHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP---G---idlS-qVY~LLEkgyRM--------  485 (1157)
T KOG4278|consen  422 AHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP---G---IDLS-QVYGLLEKGYRM--------  485 (1157)
T ss_pred             ccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC---C---ccHH-HHHHHHhccccc--------
Confidence            222 1223678999999999999999999999999999998 666642   1   2222 223333333211        


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                       +-+..+..++.+|++.||+++|.+||++.||.+.++
T Consensus       486 -~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  486 -DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             -cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence             112334557899999999999999999999987764

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.1e-36  Score=311.38  Aligned_cols=258  Identities=29%  Similarity=0.442  Sum_probs=201.4

Q ss_pred             cCccccCccccCCceeEEEEEec--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN  374 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  374 (624)
                      ++|.+.+.||+|+||.||++...        ....+|+|.+.... ......+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999742        24568999887543 33456788999999999 6999999999999988


Q ss_pred             cceEEEEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                      ..+++|||+++++|.+++....             ....+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999986532             1245899999999999999999999985   99999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCH
Q 006952          442 HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSL  520 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~  520 (624)
                      +++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..||...      ..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~------~~  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI------PV  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC------CH
Confidence            999999999999986543222111222234567999999999999999999999999999999 78776321      11


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .. .......+...+.         +......+.+++.+||+.+|++|||+.+|++.|...
T Consensus       243 ~~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         243 EE-LFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HH-HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11 1111122211111         111223577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=308.03  Aligned_cols=252  Identities=25%  Similarity=0.321  Sum_probs=199.0

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999965 58899999986532   2223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887542 2346899999999999999999999985   9999999999999999999999999988653322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .   .....|++.|+|||++.+..++.++||||||+++|||++|+.||.....   ......+........         
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE---KVKREEVERRVKEDQ---------  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch---hhHHHHHHHHhhhcc---------
Confidence            1   1234689999999999998999999999999999999999999853211   111111111111111         


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~  577 (624)
                       ...+......+.+++..||+.||++||     +++++++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             011122234577899999999999999     88888553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-37  Score=322.64  Aligned_cols=243  Identities=21%  Similarity=0.235  Sum_probs=192.3

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999987542   234566788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccc
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT  466 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  466 (624)
                      +|..++..   ...+++..+..++.||+.||.|||+..  +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM  153 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence            99888843   346899999999999999999999731  49999999999999999999999999987532221  122


Q ss_pred             cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCC
Q 006952          467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD  546 (624)
Q Consensus       467 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  546 (624)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||....      ......... .... .+         +
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~------~~~~~~~i~-~~~~-~~---------p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELIL-MEEI-RF---------P  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC------HHHHHHHHh-cCCC-CC---------C
Confidence            24569999999999999999999999999999999999999974211      111111111 1110 00         1


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 006952          547 QAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVM  577 (624)
Q Consensus       547 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~  577 (624)
                      ......+.+++.+||+.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            11123467888999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=303.37  Aligned_cols=248  Identities=30%  Similarity=0.437  Sum_probs=197.4

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChh
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD  389 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  389 (624)
                      ++||+|+||.||++...+++.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998765443 5678899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcccccc
Q 006952          390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV  469 (624)
Q Consensus       390 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  469 (624)
                      +++...  ...+++..++.++.+++.+|.|||+++   ++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  235789999999999999999999985   999999999999999999999999999765432222121222


Q ss_pred             ccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       470 ~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      .++..|+|||.+.++.++.++||||||+++|||++ |..|+.....      .. ..........         ...+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~-~~~~~~~~~~---------~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQ-TRERIESGYR---------MPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HH-HHHHHhcCCC---------CCCCcc
Confidence            34567999999998899999999999999999999 7777632211      11 1111111110         011112


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ....+.+++.+|++.+|.+|||+.||++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2346888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-36  Score=309.57  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=199.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCc----EEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .++|...+.||+|+||.||+|++. +++    .||+|++.... ....+++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            357888899999999999999854 444    48999987543 3345678899999999999999999999875 4578


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998542  346899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....   ...+.    .....+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~----~~~~~~~~~~~  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIP----DLLEKGERLPQ  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HHHHCCCcCCC
Confidence            43322222222335678999999999999999999999999999998 888864211   11111    11222211111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                               +......+.+++.+||+.||++||++.+++..|...
T Consensus       233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                     111233577899999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=323.87  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=198.2

Q ss_pred             hcCccccCccccCCceeEEEEEec---CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA---DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..+|.+.+.||+|+||.||++...   .+..|++|.+...     +...+|+.++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999754   3568999987643     23468999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      |++. ++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 57777772   3456899999999999999999999985   999999999999999999999999999866544


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc-------
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA-------  533 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  533 (624)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..+.+.......       
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            3333334567999999999999999999999999999999999999997433222211111111111110000       


Q ss_pred             ----------------cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 ----------------AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                      ...+.+.+..   ......+.+++.+||+.||++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                            0000011100   0112356778899999999999999999764

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-36  Score=312.56  Aligned_cols=261  Identities=27%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|+||.||++... ++..+++|.+..... ....++.+|++++.+++||||+++++.+.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999965 577889998865432 3346688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            999999999854   245889999999999999999999742  5999999999999999999999999998754322  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc--------
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA--------  534 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  534 (624)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+......   ................        
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccC
Confidence              123456889999999998888999999999999999999999997422211   1111000000000000        


Q ss_pred             ------------ccccchhhc---CCC-HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          535 ------------ELMDSVVKQ---SCD-QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       535 ------------~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                  +..+.....   ..+ ......+.+++.+||+.+|++|||+.+|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        000000000   000 0122357899999999999999999999765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-36  Score=308.47  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=201.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .+|...+.||+|++|.||+|+.. +++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888899999999999999964 68899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            99999998843    34789999999999999999999985   99999999999999999999999999876533221 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....      ..........+. ....      
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~~~~~~~-~~~~------  237 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT-PELQ------  237 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHHHhcCCC-CCCC------
Confidence             12234688999999999988899999999999999999999999742211      111111111111 0000      


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .+......+.+++.+||+.+|++||++.+|+.
T Consensus       238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             11122345778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-36  Score=322.74  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=195.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----cce
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----ESL  377 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  377 (624)
                      +|+..+.||+|+||.||++... +++.||||++....  ....+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 68999999986532  234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +|+||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 567776632   346899999999999999999999985   999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......   ..+..+..........++
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHHHH
Confidence            432221 22234678999999998874 4799999999999999999999997532211   111111111110000000


Q ss_pred             c---------------c-chhh--cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          537 M---------------D-SVVK--QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       537 ~---------------d-~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .               . +...  ..........+.+++.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0               0 0000  00011123457789999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.4e-37  Score=320.92  Aligned_cols=252  Identities=22%  Similarity=0.287  Sum_probs=198.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||++... +++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999965 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998543  246899999999999999999999985   999999999999999999999999999876433


Q ss_pred             CCCccccccccccCccChhhhc------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAM------GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ... ......||+.|+|||++.      ...++.++||||||+++|||++|+.||...      .......+........
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~------~~~~~~~~i~~~~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG------TSAKTYNNIMNFQRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC------CHHHHHHHHHcCCCcc
Confidence            221 222356899999999986      456789999999999999999999997421      1112222222111111


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...+.       ......+.+++..|++ +|.+||++.+++.
T Consensus       229 ~~~~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11110       0112346677788998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.9e-36  Score=300.06  Aligned_cols=248  Identities=26%  Similarity=0.410  Sum_probs=193.5

Q ss_pred             ccccCCceeEEEEEec---CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCC
Q 006952          312 KLGEGGFGPVYKGVLA---DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      .||+|+||.||+|++.   .+..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   345799999876543 33567899999999999999999999885 457899999999999


Q ss_pred             hhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc-cc
Q 006952          388 LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA-NT  466 (624)
Q Consensus       388 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~  466 (624)
                      |.+++..  ....+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||++.......... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998853  2346899999999999999999999985   9999999999999999999999999997654332211 11


Q ss_pred             cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       467 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....      ... +......+....         .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~-~~~~~~~~~~~~---------~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK------GPE-VMSFIEQGKRLD---------C  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC------HHH-HHHHHHCCCCCC---------C
Confidence            12233578999999988889999999999999999996 998874211      111 112222221111         1


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            122234677899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-37  Score=324.35  Aligned_cols=253  Identities=23%  Similarity=0.261  Sum_probs=193.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||++... +++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999865 68899999986532   334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999998853   345888999999999999999999985   999999999999999999999999998643211


Q ss_pred             CC-------------C--------------------------------ccccccccccCccChhhhcCCCCChhhHHHHH
Q 006952          461 QS-------------K--------------------------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSF  495 (624)
Q Consensus       461 ~~-------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~  495 (624)
                      ..             .                                .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00             0                                00012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCC---CCHH
Q 006952          496 GVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDR---PTMS  572 (624)
Q Consensus       496 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~  572 (624)
                      ||++|||++|+.||....      ................+.+.       ......+.+++.+|++ +|.+|   |++.
T Consensus       235 Gvil~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSEN------SHETYRKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCC------HHHHHHHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999974211      11111111111111111110       0112346677788887 66665   6999


Q ss_pred             HHHHH
Q 006952          573 SVAVM  577 (624)
Q Consensus       573 ev~~~  577 (624)
                      |++..
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            88764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.7e-36  Score=308.14  Aligned_cols=254  Identities=30%  Similarity=0.486  Sum_probs=197.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCc----EEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|+..+.||+|+||.||++++. ++.    .+|+|.+..... ....++.+|+.++++++||||+++++++... ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778899999999999999864 344    478898875433 3345788999999999999999999998754 4679


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ++||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999988542  335889999999999999999999985   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....       ..........+..... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~-  232 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-------TREIPDLLEKGERLPQ-  232 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHCCCCCCC-
Confidence            3332222223445778999999999999999999999999999997 888864211       1111222222211110 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                              +......+.+++..||..+|++||++++|++.|+.
T Consensus       233 --------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         233 --------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    11123457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-36  Score=321.69  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=197.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|+..+.||+|+||.||+++.+ +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467899999999999999999975 58899999986532   23345678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999998843    24778888899999999999999985   99999999999999999999999999986543


Q ss_pred             CCCCccccccccccCccChhhhcCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGG----IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...      +................
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~  267 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMDHKNSLT  267 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC------CHHHHHHHHHcCCCcCC
Confidence            221 122345799999999998653    4789999999999999999999997521      11222222221111111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPID--RPTMSSVAVM  577 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~  577 (624)
                      ..+.       ......+.+++.+||+.+|.+  ||++.|++..
T Consensus       268 ~~~~-------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 FPDD-------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCc-------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1110       011235677888999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.1e-37  Score=318.87  Aligned_cols=236  Identities=25%  Similarity=0.338  Sum_probs=188.6

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.+ +++.||||++.+.   .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 4789999998753   234456778899998877 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988853   345889999999999999999999985   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....      ........ ..+...          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i-~~~~~~----------~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFEAI-LNDEVV----------Y  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHH-hcCCCC----------C
Confidence            234579999999999999999999999999999999999999975221      11222111 111110          0


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                      +......+.+++.+||+.||++||+.
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11122356788999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-36  Score=300.01  Aligned_cols=255  Identities=30%  Similarity=0.469  Sum_probs=203.8

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|.+.+.||+|+||.||++..++++.++||.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            467889999999999999999988888999999875433 3567899999999999999999999999888999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..+......
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999999998653 2346899999999999999999999985   999999999999999999999999998866432111


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.-   ...   ........ .+....       
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~---~~~---~~~~~~~~-~~~~~~-------  224 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG---MTN---REVLEQVE-RGYRMP-------  224 (261)
T ss_pred             -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC---CCH---HHHHHHHH-cCCCCC-------
Confidence             1112234568999999998899999999999999999999 8888631   111   11111111 111000       


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        .+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 --RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              011113457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-36  Score=307.27  Aligned_cols=248  Identities=25%  Similarity=0.304  Sum_probs=192.7

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||+|+||.||++..+ +|+.+|+|++.....   ...+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999965 589999999864321   2234456799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      ..++... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            8887542 3345889999999999999999999985   9999999999999999999999999987654322   1223


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||.......  ........... .....     ....    
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~~~-----~~~~----  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE-DEVKF-----EHQN----  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc-ccccc-----cccc----
Confidence            468999999999999899999999999999999999999975322111  11111111111 11100     0011    


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ....+.+++.+||+.||++||+++|+++.+.
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            2234678999999999999999987765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-37  Score=320.05  Aligned_cols=238  Identities=24%  Similarity=0.275  Sum_probs=190.3

Q ss_pred             CccccCCceeEEEEEe----cCCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          311 NKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      +.||+|+||.||++..    .+|+.+|+|++.....  .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3578999999875432  234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999998843   345899999999999999999999985   9999999999999999999999999987643321  1


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...      +.......... ... .         
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~------~~~~~~~~i~~-~~~-~---------  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK------DRKETMTMILK-AKL-G---------  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC------CHHHHHHHHHc-CCC-C---------
Confidence            223467899999999999888999999999999999999999997421      11222222211 111 0         


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSS  573 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  573 (624)
                      .+......+.+++.+||+.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11112234678889999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.3e-36  Score=305.68  Aligned_cols=258  Identities=26%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++.+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3445677777789999999999999965 577899999887766667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEecccccccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIF  457 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~  457 (624)
                      |+||+++++|.+++.........++..+..++.||++||.|||+.+   |+||||||+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999865322222378888999999999999999885   999999999999976 678999999998765


Q ss_pred             CCCCCCccccccccccCccChhhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .....  ......|++.|+|||++.+..  ++.++||||||+++|||++|+.|+......   .  ...+........  
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~--~~~~~~~~~~~~--  230 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---Q--AAMFKVGMFKIH--  230 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---h--hhHhhhhhhccC--
Confidence            33221  122345789999999986644  789999999999999999999997421111   0  111110000000  


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                             ...+......+.+++.+||+.+|.+|||+.||++
T Consensus       231 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 -------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                   0111222345778899999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-36  Score=301.28  Aligned_cols=240  Identities=23%  Similarity=0.381  Sum_probs=187.7

Q ss_pred             CccccCCceeEEEEEecC-------------CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          311 NKLGEGGFGPVYKGVLAD-------------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      +.||+|+||.||+|++..             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258999887665556678899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-------eEEec
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-------PKISD  450 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D  450 (624)
                      +||||+++++|+.++..  +...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988753  2345899999999999999999999985   999999999999987664       89999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhc-CCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAM-GGIFSVKSDVFSFGVVLLEII-SGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      ||++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+....      ..+ .....
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~-~~~~~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT------LAE-KERFY  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc------hhH-HHHHH
Confidence            9998654221      2345788999999887 466899999999999999998 4777753211      111 11111


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ... . ....         .....+.+|+.+||+.||++||++.+|++.|+
T Consensus       223 ~~~-~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ-C-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC-c-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            111 0 0111         11235778999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-36  Score=315.26  Aligned_cols=241  Identities=25%  Similarity=0.298  Sum_probs=190.8

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCC-CCcceEEeEEEecCcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQH-KNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~  380 (624)
                      +|+..+.||+|+||.||+|+.+ +++.||||++.+.   .....+.+..|+.++..++| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999976 4678999998753   23445678889999999975 56888999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988843   345889999999999999999999985   999999999999999999999999998743211


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ......... .... .     
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~-~~~~-~-----  219 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQSIM-EHNV-S-----  219 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHH-cCCC-C-----
Confidence            1  12234578999999999999999999999999999999999999975211      111121111 1110 0     


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                          .+......+.+++.+||+.||.+||+.
T Consensus       220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                011112356788899999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=327.78  Aligned_cols=259  Identities=21%  Similarity=0.324  Sum_probs=190.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEec--------C
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--------N  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------~  374 (624)
                      .++|...+.||+|+||.||+|+.. .++.||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999975 58899999886432    2345799999999999999999987542        1


Q ss_pred             cceEEEEeccCCChhhhhhc-CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFG  452 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  452 (624)
                      ..++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999986 56555543 223456899999999999999999999985   99999999999999665 69999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      +++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|++||....   ..+.+..+.+.....
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS---SVDQLVRIIQVLGTP  290 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC
Confidence            998654322   12235689999999998764 68999999999999999999999974211   111122221111111


Q ss_pred             Cc---------------cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 HA---------------AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 ~~---------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..               .......+...++.....++.+++.+||+.||.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00               0000011111111122346788999999999999999999874

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.8e-37  Score=306.38  Aligned_cols=252  Identities=30%  Similarity=0.483  Sum_probs=198.2

Q ss_pred             ccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccH--HHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      |+..+.||+|+||+||+++... ++.+|+|++........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5667899999999999999765 56899999987654432  23456999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++.   +...+++..+..++.||++||.+||+.+   |+|+||||+||++++++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999996   3456899999999999999999999985   9999999999999999999999999987641  122


Q ss_pred             ccccccccccCccChhhhc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAM-GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .......++..|+|||++. +...+.++||||+|+++|+|++|..|+...   ...+......+.....    .......
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~---~~~~~~~~~~~~~~~~----~~~~~~~  225 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES---NSDDQLEIIEKILKRP----LPSSSQQ  225 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS---SHHHHHHHHHHHHHTH----HHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc---cchhhhhhhhhccccc----ccccccc
Confidence            2334567899999999998 888999999999999999999999997532   1111111111111000    0000000


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         .......+.+++.+||+.||++||++.++++
T Consensus       226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0001257889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-36  Score=305.46  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             cCccccCccccCCceeEEEEEec-C---CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-D---GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|++.+.||+|+||.||+|... +   +..+++|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788899999999999999864 2   3369999987543 23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998542  245899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCc-cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQSKA-NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....   ......    ..++...   
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~----~~~~~~~---  228 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKA----IEEGYRL---  228 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHH----HhCCCcC---
Confidence            32211 1112233568999999998899999999999999999887 9988642211   111111    1111100   


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                       +     .+......+.+++.+|++.+|.+||+|.+|++.|..
T Consensus       229 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         229 -P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             -C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence             0     011123457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6e-36  Score=305.45  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=200.8

Q ss_pred             cCccccCccccCCceeEEEEEe-----cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      ..|...+.||+|+||.||.+..     .++..|++|.++... ....+.+.+|+.++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467788999999999999974     247789999987553 34456789999999999999999999998875  457


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998532  235899999999999999999999985   99999999999999999999999999986


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCC--------CCCCCHHHHHHHH
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS--------EHGPSLLAYIWKL  527 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~--------~~~~~~~~~~~~~  527 (624)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||++++.|......        .............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221 112234567789999999888899999999999999999998766321100        0001111111111


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...+.....         +......+.+++.+||+.+|++|||+++|++.|+.
T Consensus       239 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGKRLPR---------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCccCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            111111111         11123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-36  Score=308.12  Aligned_cols=239  Identities=22%  Similarity=0.369  Sum_probs=185.6

Q ss_pred             ccccCCceeEEEEEecC-------------------------CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceE
Q 006952          312 KLGEGGFGPVYKGVLAD-------------------------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL  366 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l  366 (624)
                      .||+|+||.||+|.+..                         ...|++|++........+.+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         13589998876555555678899999999999999999


Q ss_pred             EeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC--
Q 006952          367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM--  444 (624)
Q Consensus       367 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--  444 (624)
                      ++++......++||||+++++|+.++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999988542  345789999999999999999999885   99999999999997654  


Q ss_pred             -----CeEEeccccccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 006952          445 -----NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEII-SGKKSTGFYHSEHG  517 (624)
Q Consensus       445 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~ell-tg~~p~~~~~~~~~  517 (624)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.....   
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---  227 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP---  227 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh---
Confidence                 3799999987643211      12356788999998865 56899999999999999995 68888642211   


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ......    .....  ..         +......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       228 ~~~~~~----~~~~~--~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SEKERF----YEKKH--RL---------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHH----HHhcc--CC---------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111111    11100  00         0011235778999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-36  Score=314.54  Aligned_cols=241  Identities=25%  Similarity=0.297  Sum_probs=191.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +|...+.||+|+||.||+++.. +++.||+|++.+..   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999976 47789999987542   23345567788888887 5899999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   345889999999999999999999985   999999999999999999999999998754221


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....      ........ .....       
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~~~~~~i-~~~~~-------  218 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSI-MEHNV-------  218 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC------HHHHHHHH-HhCCC-------
Confidence            1  12234678999999999999999999999999999999999999975211      11111111 11111       


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                         ..+......+.+++.+|++.+|++|++.
T Consensus       219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               0111123457788999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.6e-36  Score=313.40  Aligned_cols=241  Identities=27%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||++... +++.||||++.+..   ......+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 47899999987542   33456678899999888 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999888843   336899999999999999999999985   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||....      ........ ......          .
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~~~~~~~i-~~~~~~----------~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------EDELFQSI-LEDEVR----------Y  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------HHHHHHHH-HcCCCC----------C
Confidence            234568999999999999999999999999999999999999974211      11111111 111110          0


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTM-----SSVAV  576 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~  576 (624)
                      +......+.+++.+||+.||.+||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11122357788999999999999999     88865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-36  Score=312.35  Aligned_cols=241  Identities=24%  Similarity=0.325  Sum_probs=189.6

Q ss_pred             CccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+|...+ ++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999764 7889999987642   23345667788888765 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999998853   345889999999999999999999985   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....      ....... .....      +..    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~-i~~~~------~~~----  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD------EEELFQS-IRMDN------PCY----  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC------HHHHHHH-HHhCC------CCC----
Confidence            234578999999999999999999999999999999999999974211      1111111 11111      000    


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHH-HHHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMS-SVAV  576 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~~  576 (624)
                      +......+.+++.+||+.||++||++. ++..
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111123467888999999999999997 5643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-35  Score=310.61  Aligned_cols=259  Identities=29%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             cCccccCccccCCceeEEEEEecC--------CcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN  374 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  374 (624)
                      .+|.+.+.||+|+||.||++....        +..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999997421        2368999887543 33467889999999999 8999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                      ..++++||+++++|.+++....             ....+++..++.++.||++||.|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986421             2345889999999999999999999985   99999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCH
Q 006952          442 HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSL  520 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~  520 (624)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..      ...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~------~~~  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG------IPV  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC------CCH
Confidence            999999999999986643322222222334567999999999999999999999999999998 7777632      112


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      .... +....+.....         +......+.+++.+||+.+|++||++.||++.|....
T Consensus       243 ~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 EELF-KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHH-HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            2222 22222211111         1112335778999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.1e-36  Score=303.07  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=196.8

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEec------
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE------  373 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~------  373 (624)
                      .+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888999999999999999975 47889999986543 3346788999999999 799999999998763      


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      ...+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            3478999999999999988642 3346889999999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      +.......  .......|++.|+|||++.     +..++.++||||||+++|||++|+.|+.....      ........
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~~  229 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIP  229 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHHh
Confidence            87653322  1223456899999999986     34578899999999999999999999742111      11111111


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      . .......+    ...    ...+.+++.+||+.+|.+|||+.+|++
T Consensus       230 ~-~~~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 R-NPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             c-CCCCCCCC----CCc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1 11111111    111    235778899999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-36  Score=313.56  Aligned_cols=240  Identities=25%  Similarity=0.319  Sum_probs=189.2

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.+ +|+.||+|.++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 57899999987542   23445667788888765 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999988843   345889999999999999999999985   999999999999999999999999998743211  112


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...   .   .... .+...... ..         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~---~---~~~~-~~~~~~~~-~~---------~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---D---EDEL-FESIRVDT-PH---------Y  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---C---HHHH-HHHHHhCC-CC---------C
Confidence            33467899999999999999999999999999999999999997421   1   1111 11111111 00         0


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMS-SVA  575 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  575 (624)
                      +.....++.+++.+||+.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111123567888999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-36  Score=322.91  Aligned_cols=199  Identities=24%  Similarity=0.380  Sum_probs=170.7

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .|+..+.||+|+||.||+++.. +++.||+|++.+..   ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999965 57889999987542   2345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998854   245788899999999999999999985   9999999999999999999999999975331100


Q ss_pred             C---------------------------------------------CccccccccccCccChhhhcCCCCChhhHHHHHH
Q 006952          462 S---------------------------------------------KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFG  496 (624)
Q Consensus       462 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~G  496 (624)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0011235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCC
Q 006952          497 VVLLEIISGKKSTG  510 (624)
Q Consensus       497 vil~elltg~~p~~  510 (624)
                      |++|||++|+.||.
T Consensus       236 vil~elltG~~Pf~  249 (382)
T cd05625         236 VILYEMLVGQPPFL  249 (382)
T ss_pred             HHHHHHHhCCCCCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=301.41  Aligned_cols=271  Identities=22%  Similarity=0.267  Sum_probs=211.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||.|.-|+||.+.+++ +..+|+|++.+..   .+...+.+.|-+||+.++||.++.|+..++.++..+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            467778899999999999999875 4789999998764   334556778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC-
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG-  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-  459 (624)
                      |||+||+|+.+++. .....+++..+..++.+++-||+|||-.|   ||+|||||+||||.++|++-|+||+++..... 
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999988754 45567999999999999999999999986   99999999999999999999999998754311 


Q ss_pred             --------------------------------CCC---------------------CccccccccccCccChhhhcCCCC
Q 006952          460 --------------------------------NQS---------------------KANTNRVVGTYGYMAPEYAMGGIF  486 (624)
Q Consensus       460 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  486 (624)
                                                      ...                     ....+.++||-+|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     012234679999999999999999


Q ss_pred             ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCC
Q 006952          487 SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPI  566 (624)
Q Consensus       487 ~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~  566 (624)
                      +..+|+|+|||++|||+.|+.||.-....  +.+..    +         +...+.-.....-...+.+||.+.|.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~N----I---------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRN----I---------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHH----H---------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999998532221  11111    1         111111111112334577888999999999


Q ss_pred             CCCC----HHHHHH--HhccCCCCCCCCCCCccc
Q 006952          567 DRPT----MSSVAV--MLASDILTLPKPTQPAFS  594 (624)
Q Consensus       567 ~RPs----~~ev~~--~L~~~~~~~~~p~~p~~~  594 (624)
                      +|..    +.||-+  +.++..+.+-.-.+||+.
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i  411 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI  411 (459)
T ss_pred             hhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence            9998    777743  345555555555556553

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.6e-37  Score=320.00  Aligned_cols=241  Identities=22%  Similarity=0.258  Sum_probs=187.7

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHH-HHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVT-VIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.. +|+.+|+|++.+..   ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 58899999986542   233345556655 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            999888743   346899999999999999999999985   999999999999999999999999998753221  112


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...      +.......... ....  +    ... 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~------~~~~~~~~~~~-~~~~--~----~~~-  218 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR------DVAEMYDNILH-KPLV--L----RPG-  218 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC------CHHHHHHHHHc-CCcc--C----CCC-
Confidence            23467999999999999999999999999999999999999997421      12222222211 1110  0    111 


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         ....+.+++.+|++.+|.+||++++.+.
T Consensus       219 ---~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         219 ---ASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             ---CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence               2234668889999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.3e-36  Score=301.15  Aligned_cols=249  Identities=26%  Similarity=0.432  Sum_probs=201.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ++|+..+.||+|+||.||++...+ ++.+++|.+.....  .+.+.+|++++++++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999875 78999999875533  678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999853  2346899999999999999999999985   99999999999999999999999999886643321 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+.......      ... .........     +  
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~-----~--  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIF-MIPNKPPPT-----L--  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhh-hhccCCCCC-----C--
Confidence             2223457889999999999999999999999999999999999975322111      000 000000000     0  


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..+......+.+++.+||+.+|++|||+.||++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            011122345788899999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.4e-36  Score=338.49  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|.+.++||+|+||.||+|+.. .++.||+|++.....   ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999975 588999999875422   23567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC--------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          381 EYMPNKSLDVFLFDST--------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      ||+++++|.+++....        ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885421        1234567888999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCC----------------CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006952          453 MARIFGGNQS----------------KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH  516 (624)
Q Consensus       453 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~  516 (624)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986521110                00112356999999999999999999999999999999999999997531111 


Q ss_pred             CCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhccC
Q 006952          517 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-TMSSVAVMLASD  581 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~  581 (624)
                        ..   ...    ...   .++... .........+.+++.+|++.||++|| +++++.+.|...
T Consensus       238 --ki---~~~----~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        238 --KI---SYR----DVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             --hh---hhh----hhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              11   000    000   000000 00011223577889999999999995 677777766543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-36  Score=322.98  Aligned_cols=252  Identities=20%  Similarity=0.269  Sum_probs=192.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +|++.+.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999965 58899999986532   2335668899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999854   345788889999999999999999985   9999999999999999999999999975331000


Q ss_pred             -----------------------------------------CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHH
Q 006952          462 -----------------------------------------SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLL  500 (624)
Q Consensus       462 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~  500 (624)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000112357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC---CHHHHHHH
Q 006952          501 EIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP---TMSSVAVM  577 (624)
Q Consensus       501 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~ev~~~  577 (624)
                      ||++|+.||....      ................+..   ....+    ..+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       236 ell~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~~---~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADT------PAETQLKVINWETTLHIPS---QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCC------HHHHHHHHhccCccccCCC---CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999975321      1111111111010000000   01112    23445555655 4999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.2e-36  Score=299.24  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +|...+.||+|+||.||++... +++.+++|.++.. .....+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999965 5889999988643 2345577889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++... ....+++...+.++.||+.||.|||+.+   |+|+||||+||++++++.++|+|||+++....... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999887532 3345789999999999999999999985   99999999999999999999999999876543221 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..      .+......... .+.....       
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~------~~~~~~~~~~~-~~~~~~~-------  220 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA------NSWKNLILKVC-QGSYKPL-------  220 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC------CCHHHHHHHHh-cCCCCCC-------
Confidence             12235688999999999998899999999999999999999999742      12222222221 2211111       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        +......+.+++.+||+.||++|||+.+|+..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              11122346788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.2e-36  Score=304.30  Aligned_cols=262  Identities=28%  Similarity=0.443  Sum_probs=202.4

Q ss_pred             cCccccCccccCCceeEEEEEec-----CCcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-----DGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  376 (624)
                      +.|...+.||+|+||.||++++.     .++.+|||.+...... ..+.+.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45667789999999999999864     3678999998765543 56789999999999999999999999887  5578


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998542  235899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCC--------CHHHHHHHH
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP--------SLLAYIWKL  527 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~  527 (624)
                      ....... .......++..|++||.+.+..++.++||||||+++|||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532221 1111234456799999999889999999999999999999999886422111100        011111111


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...+..         ...+......+.+++.+||+.+|++|||+.||+++|..
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            111110         01111223468889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-36  Score=296.69  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=200.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCC-cceEEeEEEecC------
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKN-LVRLLGCCLEEN------  374 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~------  374 (624)
                      ..|...++||+|.||+||+|+.+ +|+.||+|++.-..++  .-....+|+.++++|+|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45666778999999999999955 6889999998765442  3345578999999999999 999999999877      


Q ss_pred             cceEEEEeccCCChhhhhhcCCCC-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRS-VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      ..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            678999999 45888888654322 35666889999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++.+.-+...  ....++|..|.|||++.+. .|+...||||+|||+.||+++++-|.-   ....+.+..+.+......
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG---~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG---DSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC---CcHHHHHHHHHHHcCCCC
Confidence            9976533322  3346789999999999987 689999999999999999998876532   222333333433332222


Q ss_pred             ---ccccc-----cchhhcCC-C----HHH---HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          533 ---AAELM-----DSVVKQSC-D----QAE---LLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       533 ---~~~~~-----d~~l~~~~-~----~~~---~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         ++...     +....... +    ...   .....+++.+||+.+|.+|.|++..+++
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               22111     00000000 0    000   1357789999999999999999999875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-36  Score=301.99  Aligned_cols=238  Identities=26%  Similarity=0.454  Sum_probs=187.7

Q ss_pred             CccccCCceeEEEEEecCCc-----------EEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          311 NKLGEGGFGPVYKGVLADGK-----------EIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999986533           5788877655433 6788999999999999999999999988 778999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-------CeEEeccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-------NPKISDFG  452 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg  452 (624)
                      |||+++++|++++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999986432  26889999999999999999999875   99999999999999887       79999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCC--CCChhhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGG--IFSVKSDVFSFGVVLLEIISG-KKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      ++.....      .....++..|+|||++.+.  .++.++||||||+++|||++| ..|+......   ...    ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~----~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKE----RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHH----HHHh
Confidence            9876532      1224567789999998876  789999999999999999995 5555322111   111    1111


Q ss_pred             cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ....  ...         .....+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       221 ~~~~--~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR--LPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC--CCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1110  000         01156788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1e-35  Score=303.28  Aligned_cols=249  Identities=25%  Similarity=0.390  Sum_probs=196.9

Q ss_pred             ccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      |+..+.||+|+||.||++.... +..+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5667889999999999999764 778899998776666677889999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..  ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            999888754  2346899999999999999999999985   9999999999999999999999999987643221  12


Q ss_pred             ccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          466 TNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .....+++.|+|||++.     +..++.++|||||||++|||++|++|+....      .......... ........+ 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~-~~~~~~~~~-  231 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN------PMRVLLKIAK-SEPPTLAQP-  231 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC------HHHHHHHHhh-cCCCCCCCc-
Confidence            23356899999999984     3457889999999999999999999964211      1111111111 111111111 


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            ......+.+++.+||+.+|.+||++.+|++
T Consensus       232 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 ------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  111235778899999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.3e-36  Score=302.01  Aligned_cols=250  Identities=31%  Similarity=0.493  Sum_probs=196.0

Q ss_pred             CccccCCceeEEEEEecC-------CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLAD-------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.||+|+||.||+|+..+       ++.++||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998653       2578999886543 23467789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCC----CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-----CeEEecccc
Q 006952          383 MPNKSLDVFLFDST----RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-----NPKISDFGM  453 (624)
Q Consensus       383 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~  453 (624)
                      +++++|.+++....    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986532    2234789999999999999999999875   99999999999999877     899999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +................++..|+|||++.++.++.++||||||+++|||++ |+.|+....   .   ....... ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~---~~~~~~~-~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---N---QEVLQHV-TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---H---HHHHHHH-hcCC
Confidence            976543322222223345788999999999999999999999999999998 998864211   1   1111111 1111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ...         .+......+.+++.+||+.+|.+||++.+|++.|.
T Consensus       231 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RLQ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ccC---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            110         11112345778999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.5e-36  Score=307.78  Aligned_cols=254  Identities=30%  Similarity=0.442  Sum_probs=197.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCc--EEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGK--EIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|+..+.||+|+||.||+|.++ ++.  .+++|.+.... ....+.+.+|+.++.++ +|+||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57888899999999999999965 344  45888776433 34456788999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          380 YEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      |||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432             1235889999999999999999999885   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||++......   .......++..|+|||++.+..++.++||||||+++|||++ |..||....      ......
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~  234 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYE  234 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC------hHHHHH
Confidence            99999998642111   11112234668999999988889999999999999999998 998874211      111111


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .. ..+.....         +......+.+++.+||+.+|++||++.++++.|..
T Consensus       235 ~~-~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         235 KL-PQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HH-hcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11 11110100         11112357789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.7e-36  Score=301.12  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=200.6

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      .+|...+.||+|+||.||++.+.++..+++|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46778899999999999999987788999998875433 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++...  ...+++..++.++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999988542  235789999999999999999999885   999999999999999999999999998765432211 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+...      ......... ..+.  ....+.   
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------~~~~~~~~~-~~~~--~~~~~~---  224 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR------SNSEVVETI-NAGF--RLYKPR---  224 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC------CHHHHHHHH-hCCC--CCCCCC---
Confidence            1112335678999999998899999999999999999998 88886421      111112111 1111  111111   


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                          .....+.+++.+||+.+|++|||+.+|+++|.
T Consensus       225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                11246888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-35  Score=297.32  Aligned_cols=248  Identities=28%  Similarity=0.407  Sum_probs=197.1

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lV~Ey~  383 (624)
                      ++|...+.||+|+||.||++... |..+++|.+....  ..+.+.+|+.++++++|+|++++++++.. ....++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46788899999999999999875 7889999886443  34678999999999999999999998654 45689999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++... ....+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998643 2345889999999999999999999985   9999999999999999999999999987543221  


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...      ......... ..+.....      
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~-~~~~~~~~------  220 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRV-EKGYKMDA------  220 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHH-hcCCCCCC------
Confidence               12334668999999999899999999999999999998 88886421      122222111 11111111      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         +......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence               11223457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-36  Score=319.69  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=195.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|+..+.||+|+||.||+++.. +++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999976 4788999998642   223345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999998843    24788899999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGG----IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ... .......||+.|+|||++.+.    .++.++||||+|+++|||++|+.||...      +......+.........
T Consensus       195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~  267 (370)
T cd05621         195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD------SLVGTYSKIMDHKNSLN  267 (370)
T ss_pred             CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCcccC
Confidence            221 122346799999999998754    3788999999999999999999997421      12222222221111111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPID--RPTMSSVAVM  577 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~  577 (624)
                      +...       ......+.+++..|++.+|.+  ||++.|+++.
T Consensus       268 ~p~~-------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 FPED-------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCc-------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1110       011233556777888755544  8999999775

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=299.49  Aligned_cols=249  Identities=29%  Similarity=0.430  Sum_probs=192.8

Q ss_pred             CccccCCceeEEEEEecC-Cc--EEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD-GK--EIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+|++++ +.  .+++|.++... ....+.+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 43  46888887533 34456789999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          386 KSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       386 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      ++|.+++....             ....+++..++.++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1235789999999999999999999975   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||...      +....... ...+
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~------~~~~~~~~-~~~~  227 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEK-LPQG  227 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc------CHHHHHHH-HhCC
Confidence            98632211   11111223567999999988889999999999999999997 89887421      11111111 1111


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...+.         +......+.+++.+||+.+|.+|||+.+++..|+..
T Consensus       228 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 YRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCCC---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            11111         111223577999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-36  Score=312.46  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=195.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999975 577899999875432 3345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 777776432  335788999999999999999999985   99999999999999999999999999876433221


Q ss_pred             CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc---ccc--
Q 006952          463 KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA---AEL--  536 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--  536 (624)
                        ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.....   .+....+.+.......   ..+  
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV---EDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhhhcc
Confidence              1223467899999998865 4689999999999999999999999753221   1111111111111000   000  


Q ss_pred             -------------ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 -------------MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 -------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                   ..+... . .......+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLIN-H-APRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhhcCccCCCchhh-h-ccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                         000000 0 0011235678999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-35  Score=299.95  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=197.8

Q ss_pred             CccccCccccCCceeEEEEEecCCcEEEEEEccccCc------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677889999999999999988899999998864321      2235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999853   235789999999999999999999885   99999999999999999999999999876532


Q ss_pred             CCC----CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          460 NQS----KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       460 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...    ........|+..|+|||++.+..++.++||||||+++|||++|+.||.....     ........-.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~  229 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFYIGAHRGLMPR  229 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHHhhhccCCCCC
Confidence            111    1112235688999999999998899999999999999999999999742111     1111100000011111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           +.    ......+.+++.+||+.+|++||++.+|++
T Consensus       230 -----~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 -----LP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----CC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 11    112345778899999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-36  Score=306.47  Aligned_cols=256  Identities=26%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56778899999999999999965 58889999876543 34457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|++++..   ...+++..+..++.+++.+|.|||+..  +++|+||||+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999988743   345899999999999999999999742  4999999999999999999999999998654222  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC-----CCHHHHHHHHHhcCCccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG-----PSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  537 (624)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||........     .............. ...+.
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  234 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLP  234 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCC
Confidence              12245689999999999888999999999999999999999999864332111     11112222211111 00000


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                              .......+.+++.+|++.||++|||+.||+++.
T Consensus       235 --------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         235 --------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                    011234577889999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-35  Score=297.92  Aligned_cols=254  Identities=28%  Similarity=0.459  Sum_probs=201.7

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|...+.||+|+||.||++...++..+++|.+.... ...+.+.+|+.++++++|+||+++++.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            35788899999999999999998778889999887543 335678999999999999999999999887 7789999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.+..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998643 2346889999999999999999999875   999999999999999999999999999765432211


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       ......++..|+|||++..+.++.++|+||||+++|+|++ |+.|+...   .......    ....+.....      
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~----~~~~~~~~~~------  224 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIR----ALERGYRMPR------  224 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC---CHHHHHH----HHhCCCCCCC------
Confidence             1222345678999999998889999999999999999999 88886421   1111111    1111111111      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         .......+.+++.+|++.+|++||++.++.++|+.
T Consensus       225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               11223457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-35  Score=299.11  Aligned_cols=250  Identities=28%  Similarity=0.397  Sum_probs=190.8

Q ss_pred             CccccCCceeEEEEEecC----CcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCcceEEEEecc
Q 006952          311 NKLGEGGFGPVYKGVLAD----GKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENESLLIYEYMP  384 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lV~Ey~~  384 (624)
                      +.||+|+||.||+|.+.+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998642    357999998643 33446788899999999999999999998764 455789999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC-
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-  463 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  463 (624)
                      +++|.+++...  ...+++..+..++.||++||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998542  234677888999999999999999875   999999999999999999999999999765332111 


Q ss_pred             -ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          464 -ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK-KSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       464 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       .......++..|+|||.+.+..++.++||||||+++|||++|. +|+..   .   +............... .     
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~---~~~~~~~~~~~~~~~~-~-----  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---V---DSFDITVYLLQGRRLL-Q-----  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC---C---CHHHHHHHHhcCCCCC-C-----
Confidence             1112334577899999999889999999999999999999965 44421   1   1122222221111110 0     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          +......+.+++.+||+.+|++||++.+|++.|++.
T Consensus       224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                011123577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=296.77  Aligned_cols=248  Identities=35%  Similarity=0.501  Sum_probs=194.4

Q ss_pred             CccccCCceeEEEEEecC----CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      ++||+|+||.||+|++..    +..+++|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    26899999876544 34567899999999999999999999876 4567999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc-
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA-  464 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-  464 (624)
                      ++|.+++...   ..+++..+..++.|++.+|.|||+.+   ++|+||||+|||++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999543   36899999999999999999999885   9999999999999999999999999998664332211 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...   ........+    ........       
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~---~~~~~~~~~----~~~~~~~~-------  219 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAML----ESGERLPR-------  219 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHH----HcCCcCCC-------
Confidence            1111223567999999999999999999999999999998 89987432   111222222    12211111       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                        +......+.+++.+||+.+|++||++.+|++.|+..
T Consensus       220 --~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 --PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              111224577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.3e-36  Score=304.66  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=195.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|+..+.||+|++|.||+|+.. +++.|++|++....  ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999975 58899999986532  23346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      ++ ++|.+++........+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 588888755444467899999999999999999999985   99999999999999999999999999876533211


Q ss_pred             CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC----------
Q 006952          463 KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG----------  531 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  531 (624)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+......   .........+...          
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhcchh
Confidence              12234568899999988754 4789999999999999999999987421110   0000000000000          


Q ss_pred             ------CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 ------HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 ------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            .........+.. .......++.+++.+||+.||++|||+.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  000000000000 00011235678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.8e-36  Score=303.08  Aligned_cols=252  Identities=22%  Similarity=0.373  Sum_probs=198.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ++|...+.||+|+||.||+++.. +++.|++|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            57888899999999999999965 58899999987665555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..   ...+++.+++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.......  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999998843   346899999999999999999999985   9999999999999999999999999987653221  


Q ss_pred             ccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          464 ANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .......|+..|+|||.+.   .+.++.++||||||+++|||++|+.|+......      ...................
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM------RALFLMTKSNFQPPKLKDK  234 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch------hhHHhhhccCCCCCccccc
Confidence            2223457899999999874   456889999999999999999999986321111      1111111111111101000


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ..+    ...+.+++.+||+.+|++||++++|++
T Consensus       235 --~~~----~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         235 --MKW----SNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --CCC----CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence              011    224678999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.2e-37  Score=317.85  Aligned_cols=237  Identities=24%  Similarity=0.271  Sum_probs=186.2

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHH-HHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVT-VIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.. +|+.||+|++.+..   ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 58899999987532   222344455554 56789999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999988853   346889999999999999999999985   999999999999999999999999998753221  122


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...      +..+...... .....      +..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~------~~~~~~~~i~-~~~~~------~~~--  217 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DTAEMYDNIL-NKPLR------LKP--  217 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC------CHHHHHHHHH-cCCCC------CCC--
Confidence            33457999999999999999999999999999999999999997421      1222222221 11110      011  


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMS  572 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~  572 (624)
                        .....+.+++.+||+.||.+||++.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 --NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              1134577889999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=300.29  Aligned_cols=254  Identities=20%  Similarity=0.317  Sum_probs=188.9

Q ss_pred             CccccCCceeEEEEEecCCc---EEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          311 NKLGEGGFGPVYKGVLADGK---EIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.||+|+||.||++...++.   .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999854433   46677766443 344578999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          387 SLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       387 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      +|.+++.... .....++.....++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999986532 2335677788899999999999999885   99999999999999999999999999764322211122


Q ss_pred             ccccccccCccChhhhcC-------CCCChhhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          466 TNRVVGTYGYMAPEYAMG-------GIFSVKSDVFSFGVVLLEIISG-KKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+..   ..   .......... +......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~---~~---~~~~~~~~~~-~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH---LS---DREVLNHVIK-DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC---CC---HHHHHHHHHh-hcccccC
Confidence            234567889999998753       2457899999999999999975 556531   11   1122222222 2222333


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ++.+...++    .++.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333332222    34666778899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-35  Score=303.58  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=199.7

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +.|++.+.||+|+||.||+|.... ++.+++|.+........+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            568888999999999999999754 8899999998776666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|..++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            999998877542  235899999999999999999999875   9999999999999999999999999987543221  


Q ss_pred             ccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          464 ANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      .......+++.|+|||++.     ...++.++||||||+++|||++|+.|+....      ......+.. .........
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~~-~~~~~~~~~  237 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIA-KSEPPTLSQ  237 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc------HHHHHHHHh-cCCCccCCC
Confidence            1223456788999999884     3456889999999999999999999974221      111111111 111111111


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                             +......+.+++.+||+.+|++||++.+|++
T Consensus       238 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         238 -------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                   1112235778899999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.7e-36  Score=309.25  Aligned_cols=196  Identities=29%  Similarity=0.481  Sum_probs=159.7

Q ss_pred             cCccccCCceeEEEEEec---CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcceEEEEecc
Q 006952          310 ENKLGEGGFGPVYKGVLA---DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENESLLIYEYMP  384 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~  384 (624)
                      .++||+|+||.||+|+.+   +++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999965   467899999865432  3457889999999999999999999865  345789999986


Q ss_pred             CCChhhhhhcC------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEeccccc
Q 006952          385 NKSLDVFLFDS------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMA  454 (624)
Q Consensus       385 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  454 (624)
                      + +|.+++...      .+...+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 776666421      12235889999999999999999999985   9999999999999    45678999999999


Q ss_pred             cccCCCCC-CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCC
Q 006952          455 RIFGGNQS-KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGF  511 (624)
Q Consensus       455 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~  511 (624)
                      +.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87644322 1223346789999999998774 589999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-35  Score=298.68  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=199.6

Q ss_pred             CccccCccccCCceeEEEEEecC--CcEEEEEEcccc----------CcccHHHHHHHHHHHHh-cCCCCcceEEeEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD--GKEIAVKRLSRT----------SGQGLQEFKNEVTVIAK-LQHKNLVRLLGCCLE  372 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~  372 (624)
                      +|...+.||+|+||.||++..+.  ++.+++|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999765  678999987532          22234567788888875 699999999999999


Q ss_pred             cCcceEEEEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887542 23456899999999999999999999632  5999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      |++.......   ......|+..|++||.+.+..++.++||||||+++|||++|+.|+..      .......... ..+
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~------~~~~~~~~~~-~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS------TNMLSLATKI-VEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc------cCHHHHHHHH-hhc
Confidence            9998654332   22345688999999999998899999999999999999999999631      1122222111 111


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ......    ...    ....+.+++.+||+.||++||++.||.++|.
T Consensus       229 ~~~~~~----~~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYEPLP----EGM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCCcCC----ccc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111111    111    1235778899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9e-36  Score=306.25  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=201.6

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788899999999999999996 46899999999776655667789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999998843    34788999999999999999999985   99999999999999999999999999876543221


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........  ..    .....+. ....     
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~~-~~~~-----  236 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNGT-PELQ-----  236 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCCC-CCCC-----
Confidence              12235688999999999998899999999999999999999999743211110  00    0000010 0000     


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        .+......+.+++.+||+.+|++||++.+|++
T Consensus       237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 --NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11122334678889999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.3e-35  Score=299.48  Aligned_cols=257  Identities=27%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|.....||+|+||.||+++.+      +.+.|++|.+...... ..+++.+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999964      2457999988765443 4678999999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhhcCCCC------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRS------VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                      +||||+++++|.+++......      ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998653322      26899999999999999999999985   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      |++....... ........++..|+|||.+.+...+.++||||||+++|||++ |..|+...   .......    ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~---~~~~~~~----~~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL---SDEEVLN----RLQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc---chHHHHH----HHHc
Confidence            9987543221 112233456788999999988889999999999999999999 67776321   1111111    1111


Q ss_pred             CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       531 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      +......    ...    ....+.+++.+||+.+|++||++.|++..|.+
T Consensus       234 ~~~~~~~----~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLELPV----PEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcCCCC----CCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1111111    011    22357889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-35  Score=304.38  Aligned_cols=249  Identities=24%  Similarity=0.424  Sum_probs=200.9

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .+|...+.||.|++|.||+++. .+++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999985 468899999987665555678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|..++..    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999998843    34899999999999999999999985   99999999999999999999999999876543322 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ........... ......     
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~~~~~~-~~~~~~-----  237 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPELQN-----  237 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-CcccCC-----
Confidence             12234688999999999988899999999999999999999999743211      11111111111 111000     


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        +......+.+++.+||+.+|++||++.+|+.
T Consensus       238 --~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 --PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              1112235778899999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=298.42  Aligned_cols=275  Identities=24%  Similarity=0.322  Sum_probs=205.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccc--cCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe-----cCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-----ENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~~~  375 (624)
                      ...|...+.||+|+||.|+++..+ +|+.||||++..  ......++..+|+.+|+.++|+||+.+++.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            445666789999999999999965 689999999973  344556788999999999999999999999876     345


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .|+|+|+| ..+|...+.   .+..++......++.||++||.|+|+.+   |+||||||+|+|++.+-.+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            79999999 678988883   3445899999999999999999999984   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC--
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH--  532 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  532 (624)
                      ...........+..+.|..|.|||++.. ..|+...||||.|||+.||++|++-|...+.-   +.+..+......+.  
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v---~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV---HQLQLILELLGTPSEE  250 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH---HHHHHHHHhcCCCCHH
Confidence            8765433333456778999999998754 67999999999999999999999887543322   22222222111110  


Q ss_pred             ---------ccccccchhhc-CCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hccCCCCCCCC
Q 006952          533 ---------AAELMDSVVKQ-SCDQ-----AELLKYIHIGLLCVQGDPIDRPTMSSVAVM--LASDILTLPKP  588 (624)
Q Consensus       533 ---------~~~~~d~~l~~-~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~~~~~p  588 (624)
                               ....+...... ..+.     ..-...++|..+||..||.+|+|++|.++.  |+....+-.+|
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                     00011100000 0000     112246788889999999999999999764  34444444445

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.1e-36  Score=305.43  Aligned_cols=247  Identities=27%  Similarity=0.449  Sum_probs=198.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4566788999999999999865 47789999887543 344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..    ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            99999988742    35889999999999999999999875   9999999999999999999999999987654322  


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      .......|+..|+|||++.+..++.++||||||+++|||++|+.|+......   ....    ....+..     +.+  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~----~~~~~~~-----~~~--  221 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF----LIPKNSP-----PTL--  221 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh----hhhcCCC-----CCC--
Confidence            1122346788999999999999999999999999999999999996422111   1111    1111111     111  


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        .......+.+++.+||+.+|++||++.+|++.
T Consensus       222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              11223457789999999999999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.5e-36  Score=305.44  Aligned_cols=250  Identities=26%  Similarity=0.338  Sum_probs=196.2

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      |+..+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999965 588999999865432   2234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999888542 2345899999999999999999999875   99999999999999999999999999876532221


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......   .............      ..  
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~~~------~~--  223 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEVQ------EE--  223 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhhhh------hh--
Confidence               123468999999999999999999999999999999999999985322111   1111111111000      00  


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                        .+......+.+++.+||+.||++|||     +.|+++
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              11112234678889999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-35  Score=298.55  Aligned_cols=248  Identities=29%  Similarity=0.459  Sum_probs=196.8

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc---------cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ---------GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      |.....||+|++|.||+|... +++.+++|.+......         ..+.+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            567789999999999999864 5789999988654322         235688999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999843   345888999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          457 FGGNQSK----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       457 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      .......    .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....      ....+.... ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~  228 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT------QLQAIFKIG-ENA  228 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc------HHHHHHHHh-ccC
Confidence            6432211    11123457889999999998889999999999999999999999975211      111111111 111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...         .+......+.+++.+||+.+|.+||++.||++
T Consensus       229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 SPE---------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCc---------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111         11122345778889999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=299.47  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=200.5

Q ss_pred             cCccccCccccCCceeEEEEEecC-Cc----EEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GK----EIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .+|...+.||+|+||.||+|..++ |+    .+++|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999999653 33    589998876543 345678999999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |+||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998643  334899999999999999999999975   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.|+.....      .... .....+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~-~~~~~~~~~~--  231 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIP-DLLEKGERLP--  231 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHH-HHHhCCCCCC--
Confidence            3322222222234568999999988889999999999999999999 9999753211      1111 1111111110  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .       +......+.+++.+||..+|.+||++.++++.|+..
T Consensus       232 ~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         232 Q-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             C-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0       111223577888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=305.43  Aligned_cols=240  Identities=23%  Similarity=0.398  Sum_probs=188.5

Q ss_pred             CccccCCceeEEEEEecC--------CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.||+|+||.||+|....        ..++++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998642        234888888766555667889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--------eEEeccccc
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN--------PKISDFGMA  454 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg~a  454 (624)
                      +++|+|..++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998643  236889999999999999999999985   999999999999987765        589999988


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK-KSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      .....      .....+++.|+|||++.+. .++.++||||||+++|||++|. .|+...   +   ..... .... ..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~---~---~~~~~-~~~~-~~  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL---D---SQKKL-QFYE-DR  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc---c---HHHHH-HHHH-cc
Confidence            65422      2234678899999999874 5799999999999999999995 443211   1   11111 1111 10


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                       ..         .+.....++.+++.+||+.+|++|||+++|++.|+
T Consensus       222 -~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             11         11112245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=296.57  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=202.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999975 47889999998766666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            999999988542  245889999999999999999999985   9999999999999999999999999987654321  


Q ss_pred             ccccccccccCccChhhhcCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          464 ANTNRVVGTYGYMAPEYAMGG---IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+.....      ............    ....
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------~~~~~~~~~~~~----~~~~  225 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------MRALFLISKSNF----PPPK  225 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccC----CCcc
Confidence            112235688899999998776   789999999999999999999999742111      111111111100    0000


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +.  ........+.+++.+||+.+|.+|||+.+|+.
T Consensus       226 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00  11223456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.2e-36  Score=313.30  Aligned_cols=241  Identities=24%  Similarity=0.305  Sum_probs=190.6

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +|+..+.||+|+||.||++..+ +++.||+|++.+..   ....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667889999999999999965 58899999987542   234466778999998885 678888999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|..++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999988843   345899999999999999999999985   999999999999999999999999998754222


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ......... .... .     
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~-~~~~-~-----  219 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED------EDELFQSIM-EHNV-S-----  219 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHH-hCCC-C-----
Confidence            1  12234568999999999999999999999999999999999999975221      111111111 1111 0     


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                          .+......+.+++.+||+.+|.+|++.
T Consensus       220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                111122356788999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-36  Score=315.63  Aligned_cols=243  Identities=22%  Similarity=0.233  Sum_probs=187.1

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHH-HHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEV-TVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 46789999987532   12223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|.+++..   ...+.+.....++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            999998853   345778888899999999999999985   9999999999999999999999999987532211  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...      ............ ...  ..       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~-~~~--~~-------  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNILNK-PLQ--LK-------  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC------CHHHHHHHHHhC-CcC--CC-------
Confidence            33467999999999999999999999999999999999999997421      112222222111 110  01       


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                       ......+.+++.+||+.+|.+||+..+.+..+
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         217 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence             11123467888899999999999987544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-35  Score=296.03  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=198.6

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC-----cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-----GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +|...+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+.++++++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999976 78999999886543     23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      +||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   235889999999999999999999985   99999999999999999999999999876543


Q ss_pred             CCCCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.|+....      .....+..........+  
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~--  223 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKELPPI--  223 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhcccCCCc--
Confidence            22   223456889999999987776 8999999999999999999999974221      11222221111111111  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                             +......+.+++.+||+.+|.+||++.+++.
T Consensus       224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                   1112345678899999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.9e-36  Score=316.48  Aligned_cols=258  Identities=21%  Similarity=0.268  Sum_probs=198.3

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      +....++|...+.||+|+||.||++..+ +++.+|+|++.+..   ....+.+.+|+.+++.++||||+++++.+.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445588999999999999999999976 47889999986422   2334567889999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999998843    24788888999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGG----IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||..      .+............
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~  263 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNHK  263 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC------CCHHHHHHHHHcCC
Confidence            6643221 122346799999999998754    378999999999999999999999742      12222222222211


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHHh
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPID--RPTMSSVAVML  578 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~L  578 (624)
                      ....+.+.       ......+.+++.+|++.++.+  ||++.+|++..
T Consensus       264 ~~~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 NSLTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CcccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111111       112234667788899844443  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-36  Score=315.46  Aligned_cols=237  Identities=23%  Similarity=0.255  Sum_probs=185.5

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHH-HHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVT-VIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57899999986532   222344555554 67889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|...+..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            999888743   345788889999999999999999985   9999999999999999999999999987532211  22


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...      +.......... ... .         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~-~~~-~---------~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DVSQMYDNILH-KPL-Q---------L  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC------CHHHHHHHHhc-CCC-C---------C
Confidence            33467899999999999989999999999999999999999997421      12222222211 110 0         1


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMS  572 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~  572 (624)
                      +......+.+++.+||+.+|.+||+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            112234577899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=298.87  Aligned_cols=248  Identities=25%  Similarity=0.435  Sum_probs=200.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||.|++|.||+|+.. +++.|++|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35778889999999999999965 58899999987543 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++...    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999988532    6899999999999999999999985   9999999999999999999999999998765432 


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       .......+++.|+|||++.+..++.++||||||+++|||++|+.|+.....      ....... ...........   
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~~-~~~~~~~~~~~---  221 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFLI-PKNNPPSLEGN---  221 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHHh-hhcCCCCCccc---
Confidence             122335688899999999998899999999999999999999999752221      1111111 11111111110   


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .    ....+.+++.+||+.+|++|||++++++
T Consensus       222 -~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 -K----FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -c----cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             0    2335778899999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-35  Score=313.68  Aligned_cols=260  Identities=25%  Similarity=0.300  Sum_probs=193.9

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----  374 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  374 (624)
                      ..++|...+.||+|+||.||++... .|+.||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999965 5889999998653  2334567889999999999999999999986543     


Q ss_pred             -cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          375 -ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       375 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                       ..++||||++++ |...+.     ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             468999999764 544442     23788889999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH------
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL------  527 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------  527 (624)
                      ++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......   .......+.      
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~  243 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI---DQWNKVIEQLGTPSA  243 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCcH
Confidence            97543221   223456899999999999999999999999999999999999998532110   000000000      


Q ss_pred             -------------HhcC-Cc-----cccccchhhc---CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          528 -------------WCEG-HA-----AELMDSVVKQ---SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       528 -------------~~~~-~~-----~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                   .... ..     .+........   .........+.+++.+||+.||++|||+.|++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                         0000 00     0000000000   0001112457789999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-35  Score=304.04  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      |+..+.||+|+||+||++... +++.+|+|.+....   ....+.+.+|+.++++++|+|++.+.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999975 58899999986542   22345578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999888542 2346899999999999999999999985   9999999999999999999999999987653221 


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......|+..|+|||++.+..++.++|+||||+++|||++|+.||.....   ......+........ ..       
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~---~~~~~~~~~~~~~~~-~~-------  223 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE---KVKREEVDRRVLETE-EV-------  223 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhhccc-cc-------
Confidence              11235689999999999999999999999999999999999999752211   111111111111111 00       


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                        ........+.+++..|++.||++||+     +.+++.
T Consensus       224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 --YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              01111234678888999999999999     666655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.9e-35  Score=295.37  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=202.7

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999999998854 5889999987653  344567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++.... ...+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986432 356899999999999999999999885   99999999999999999999999999986643332


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...      ...+...... .+......     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~-~~~~~~~~-----  222 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIV-QGNYTPVV-----  222 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHH-cCCCCCCc-----
Confidence              223456899999999998888999999999999999999999987421      1222222221 12211111     


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                          ......+.+++.+||+.+|++||+++++++.+
T Consensus       223 ----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         223 ----SVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                11234577889999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.9e-35  Score=306.58  Aligned_cols=196  Identities=29%  Similarity=0.480  Sum_probs=159.0

Q ss_pred             cCccccCCceeEEEEEecC---CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcceEEEEecc
Q 006952          310 ENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENESLLIYEYMP  384 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~  384 (624)
                      ..+||+|+||.||+|+.++   +..||+|.+.....  ...+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3579999999999999653   56899998875432  3467899999999999999999999864  455789999987


Q ss_pred             CCChhhhhhcC------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEeccccc
Q 006952          385 NKSLDVFLFDS------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMA  454 (624)
Q Consensus       385 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  454 (624)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 665555321      12345889999999999999999999985   9999999999999    56678999999999


Q ss_pred             cccCCCCCC-ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 006952          455 RIFGGNQSK-ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGF  511 (624)
Q Consensus       455 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~  511 (624)
                      +........ .......||+.|+|||++.+ ..++.++||||||+++|||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876543221 22334578999999999876 4579999999999999999999999853

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.9e-36  Score=316.79  Aligned_cols=200  Identities=25%  Similarity=0.374  Sum_probs=172.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..+.||+|+||.||++..+ +++.||+|++....   ....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999975 58899999986532   334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999853   345889999999999999999999985   999999999999999999999999998754321


Q ss_pred             CCC---------------------------------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCC
Q 006952          461 QSK---------------------------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK  507 (624)
Q Consensus       461 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~  507 (624)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 01123579999999999999999999999999999999999999


Q ss_pred             CCC
Q 006952          508 STG  510 (624)
Q Consensus       508 p~~  510 (624)
                      ||.
T Consensus       235 Pf~  237 (360)
T cd05627         235 PFC  237 (360)
T ss_pred             CCC
Confidence            974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-36  Score=304.41  Aligned_cols=253  Identities=24%  Similarity=0.386  Sum_probs=199.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778899999999999999976 6899999988654 333456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|..++........+++..+..++.||++||.|||++.  +|+|+||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999998865433446899999999999999999999742  59999999999999999999999999987653221 


Q ss_pred             CccccccccccCccChhhhcCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGI------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                         .....+++.|+|||.+.+..      ++.++||||||+++|||++|+.||...   ............ ..+.... 
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~~~~~-~~~~~~~-  229 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE---TYANIFAQLSAI-VDGDPPT-  229 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc---chhhHHHHHHHH-hhcCCCC-
Confidence               22345788999999985543      488999999999999999999997422   111111111111 1111111 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                              .+......+.+++.+||+.+|++||++.+++.
T Consensus       230 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         230 --------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                    12223445778999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-35  Score=299.92  Aligned_cols=248  Identities=25%  Similarity=0.425  Sum_probs=200.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34667788999999999999975 58899999987543 34567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998843    35788999999999999999999875   99999999999999999999999999976543221


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......++..|+|||++.+..++.++|+||||+++|||++|+.|+......      ..... ......         
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~---------  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLFL-IPKNNP---------  218 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhhh-hhcCCC---------
Confidence              222346788999999999888999999999999999999999997422111      11110 001111         


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..........+.+++.+||+.+|++||++.+|++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11223345568899999999999999999999664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-35  Score=298.75  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=198.0

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc----------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG----------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      +|...+.||+|+||.||+|... +++.+|+|.++....          ...+.+.+|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999864 588999998754211          12346788999999999999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999988543   46899999999999999999999975   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +...............|+..|+|||.+....  ++.++|+||||+++|||++|..|+..      ...............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~------~~~~~~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD------EEAIAAMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC------cchHHHHHHhhcccc
Confidence            7654322222233456889999999987654  78999999999999999999999741      111222222211111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ...+.+ ...    ......+.+++.+||+.+|++||++.+|++.
T Consensus       230 ~~~~~~-~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPP-DVS----MNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCc-ccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111 111    1123467788999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-36  Score=307.47  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=195.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||++..+ +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999975 57889999986543 23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      ++ ++|..++...  ...+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888877542  335789999999999999999999985   99999999999999999999999999875432221


Q ss_pred             CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC---Ccccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG---HAAELMD  538 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d  538 (624)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|++||.....   ......+.......   .+..++.
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhc
Confidence              12234578899999988654 578999999999999999999999753211   11111111111100   0000000


Q ss_pred             ---------chhhcC----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 ---------SVVKQS----CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ---------~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                               +.....    ........+.+++.+||+.||.+|||+.||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                     000000    00111235678999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=309.41  Aligned_cols=255  Identities=22%  Similarity=0.274  Sum_probs=193.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999965 5889999998652   2233466889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998532  345889999999999999999999985   999999999999999999999999998765432


Q ss_pred             CCCccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .. .......||+.|+|||++..     +.++.++|||||||++|||++|+.||..      .+..+.............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~------~~~~~~~~~i~~~~~~~~  228 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKEHFQ  228 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC------CCHHHHHHHHHcCCCccc
Confidence            21 11223468999999999863     4578899999999999999999999742      122222222222211111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcc--cCCCCCCCCHHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCV--QGDPIDRPTMSSVAVM  577 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~ev~~~  577 (624)
                      +....  ...    ...+.+++.+|+  ..++..||++.++++.
T Consensus       229 ~~~~~--~~~----~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 FPPDV--TDV----SEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCcc--CCC----CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11110  111    223445555555  4455558899988765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-35  Score=302.49  Aligned_cols=260  Identities=24%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhc---CCCCcceEEeEEEec-----C
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKL---QHKNLVRLLGCCLEE-----N  374 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~-----~  374 (624)
                      +|+..+.||+|+||.||++..+ +++.||+|.+.....  .....+.+|+.+++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999976 588999998875322  2234556777777766   699999999998653     3


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..+++|||+++ +|..++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            47899999985 787777542 2345899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      +......   ......|+..|+|||++.+..++.++||||||+++|||++|++||....   .......+..........
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC---HHHHHHHHHHHhCCCChh
Confidence            8654322   1223568999999999999899999999999999999999999874221   111111121111110000


Q ss_pred             cc----------ccchhh---cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 EL----------MDSVVK---QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 ~~----------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..          ..+...   ..........+.+++.+||+.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00          000000   0001112345778999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=300.75  Aligned_cols=253  Identities=24%  Similarity=0.395  Sum_probs=201.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|.+.+.||+|++|.||++... ++..+++|.+........+.+.+|+.++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888999999999999999975 5889999998876666677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999988542  235899999999999999999999985   9999999999999999999999999987543221 


Q ss_pred             CccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                       .......+++.|+|||.+.     ...++.++||||||+++|||++|+.|+...      +......+. .......+.
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~------~~~~~~~~~-~~~~~~~~~  229 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL------NPMRVLLKI-LKSEPPTLD  229 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC------CHHHHHHHH-hcCCCCCcC
Confidence             1223456899999999875     344678999999999999999999997422      111111111 111111110


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .       +......+.+++..||+.+|.+||++.+|++.
T Consensus       230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         230 Q-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0       11112356788899999999999999999653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=334.03  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=197.0

Q ss_pred             HHhcCccccCccccCCceeEEEEEecC-CcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      ...++|.+.+.||+|+||.||++.... +..+|+|.+...  .......+..|+.++++|+|||||+++++|...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            445789999999999999999999764 678899988643  233456789999999999999999999998654  457


Q ss_pred             eEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEEcCC--------
Q 006952          377 LLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSR----LKIIHRDLKTSNVLLDHE--------  443 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~ivH~Dlkp~NIll~~~--------  443 (624)
                      +|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            89999999999999986422 23468999999999999999999998531    249999999999999642        


Q ss_pred             ---------CCeEEeccccccccCCCCCCccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 006952          444 ---------MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFY  512 (624)
Q Consensus       444 ---------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~~~  512 (624)
                               ..+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     348999999998654322   1234578999999999864  45889999999999999999999997421


Q ss_pred             CCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          513 HSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           ......+.. .....  .+.   + ..    ....+.+|+..||+.+|.+||++.|++.
T Consensus       247 -----~~~~qli~~-lk~~p--~lp---i-~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 -----NNFSQLISE-LKRGP--DLP---I-KG----KSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             -----CcHHHHHHH-HhcCC--CCC---c-CC----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                 122222221 11111  000   0 11    1235778899999999999999999983

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.5e-35  Score=296.33  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||.|+||.||++... ++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999965 57889999986543 33567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++........+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433456899999999999999999999885   99999999999999999999999999876654322


Q ss_pred             C--ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          463 K--ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       463 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .  .......|+..|+|||++... .++.++|+||||+++|||++|+.|+......      ....+...... .. ...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~-~~~  229 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDP-PS-LET  229 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCC-CC-cCC
Confidence            2  122345688999999998877 7899999999999999999999997532111      11111111111 00 000


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..   ........+.+++.+||+.||++||++.+|++
T Consensus       230 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 GA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00   00122345778999999999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.8e-35  Score=293.80  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=199.0

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-cceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-ESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lV~E  381 (624)
                      +|+..+.||+|++|.||++..+ +++.+++|++....  ....+.+.+|+.++++++|+|++++++.+...+ ..+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999965 47889999986543  334567889999999999999999999876544 5789999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++... ....+++.+++.++.|++.||.+||+.+   |+|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999988642 2345899999999999999999999985   9999999999999999999999999998664322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .  ......+++.|+|||++.+..++.++||||||++++||++|+.|+...      +......... .+....      
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~------~~~~~~~~~~-~~~~~~------  221 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRII-EGKLPP------  221 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHH-hcCCCC------
Confidence            1  222456889999999999999999999999999999999999987421      1222222221 222111      


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         .+......+.+++.+|++.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 ---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               112233457889999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-36  Score=285.88  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=199.7

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-----c---ccHHHHHHHHHHHHhc-CCCCcceEEeEEEe
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-----G---QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLE  372 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~---~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~  372 (624)
                      --..|...+.||.|..+.|-++..+ .|+++|+|++....     +   ...+.-..|+.+|+++ -||+|+++.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456788899999999999998865 58899999886432     1   1234456799999999 69999999999999


Q ss_pred             cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      +...++|+|.|+.|.|.++|   .....+++++..+|+.|+.+|++|||..   +||||||||+|||+|+|.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999   4456799999999999999999999998   59999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMG------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      ++..+....   .-...+|||+|+|||.+..      ..|+..+|+|+.|||+|.|+.|.+||-  +..+     ....+
T Consensus       169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQ-----mlMLR  238 (411)
T KOG0599|consen  169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQ-----MLMLR  238 (411)
T ss_pred             eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHH-----HHHHH
Confidence            998775443   2346899999999998853      357889999999999999999999962  2211     11122


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+.+|+..---.+.      .+.....-+|+.+|||.||++|-|.+|+++
T Consensus       239 ~ImeGkyqF~speW------adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 MIMEGKYQFRSPEW------ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHhcccccCCcch------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            23333222111111      112234567899999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.4e-35  Score=296.32  Aligned_cols=255  Identities=24%  Similarity=0.428  Sum_probs=196.4

Q ss_pred             ccccCccccCCceeEEEEEec----CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----
Q 006952          307 FSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----  375 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  375 (624)
                      |.+.+.||+|+||.||+|.+.    .++.||||++....  ....+++.+|+.++++++||||+++++++...+.     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999854    36789999987542  3346678899999999999999999999875432     


Q ss_pred             -ceEEEEeccCCChhhhhhcCC---CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          376 -SLLIYEYMPNKSLDVFLFDST---RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       376 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                       .++++||+++++|..++....   ....+++...+.++.||+.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence             368899999999988875321   2235789999999999999999999985   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      |+++...............+++.|++||.+.+..++.++||||||+++|||++ |++|+...   ........    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~----~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNY----LIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHH----HHc
Confidence            99986543322222223345678999999999889999999999999999999 77776421   11111111    111


Q ss_pred             CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       531 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ......         +......+.+++.+||+.+|++|||+.+|++.|++
T Consensus       231 ~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRLKQ---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            111110         11123468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-35  Score=300.75  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|+..+.||+|++|.||+++.+ +++.||+|++....  ....+.+.+|+.++++++|+|++++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788899999999999999976 58899999886543  2234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|+.++..   ...+++..++.++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999998887633   335899999999999999999999975   9999999999999999999999999998764432


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh-----------
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC-----------  529 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  529 (624)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.-...   .+....+.+...           
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD---VDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChHHhhhcc
Confidence            1  1223457889999999876 5578999999999999999999999752211   111111111100           


Q ss_pred             cCCc-cccccchhhcCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHA-AELMDSVVKQSCDQ-----AELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~-~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .... .....+......+.     .....+.+++.+||+.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000 00000000000010     11345788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-35  Score=312.22  Aligned_cols=191  Identities=23%  Similarity=0.338  Sum_probs=163.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+|.+.+.||+|+||.||+|+.. .++.||+|.....      ....|+.++++++|+||+++++++......++|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999976 4678999975432      235699999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +. ++|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            95 577777743  3346899999999999999999999985   999999999999999999999999998753221  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                       .......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             1222456899999999999999999999999999999999976553

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-35  Score=297.65  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=198.8

Q ss_pred             cCccccCccccCCceeEEEEEecCC----cEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADG----KEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|...+.||+|+||.||+|...+.    ..|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577889999999999999986542    468999887654 4456789999999999999999999998875 457899


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998542  235899999999999999999999875   99999999999999999999999999986543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..... .....++..|+|||.+....++.++||||||+++|||++ |+.||....   ..   ...... ..+.....  
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~---~~~~~~-~~~~~~~~--  229 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK---NN---DVIGRI-ENGERLPM--  229 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC---HH---HHHHHH-HcCCcCCC--
Confidence            32211 112334568999999988889999999999999999986 999874221   11   111111 11111111  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                             +......+.+++.+|+..+|++|||+.++++.|...
T Consensus       230 -------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         230 -------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   111234577889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.8e-35  Score=293.57  Aligned_cols=247  Identities=30%  Similarity=0.435  Sum_probs=196.1

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|...+.||+|+||.||++.. +++.+++|.+....  ..+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 57889999986543  346789999999999999999999998654 5799999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++... ....+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998643 2345889999999999999999999875   9999999999999999999999999987543211   


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                        .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||....      .... ......+.....       
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~-~~~~~~~~~~~~-------  218 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEV-KECVEKGYRMEP-------  218 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHH-HHHHhCCCCCCC-------
Confidence              12234568999999998899999999999999999998 888864211      1111 111111111111       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        +......+.+++.+||+.+|++||++++|++.|++
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              11123457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6e-35  Score=292.89  Aligned_cols=250  Identities=36%  Similarity=0.518  Sum_probs=198.6

Q ss_pred             cccCccccCCceeEEEEEecC-----CcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .+.+.||+|+||.||+++..+     +..||+|++...... ..+.+.+|+..+++++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456889999999999999764     378999999765443 56789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999854221 22899999999999999999999985   9999999999999999999999999998765432


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ..... ...+++.|+|||.+.+..++.++||||+|++++||++ |+.|+..   .   ......... ..+......   
T Consensus       158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~---~~~~~~~~~-~~~~~~~~~---  226 (258)
T smart00219      158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG---M---SNEEVLEYL-KKGYRLPKP---  226 (258)
T ss_pred             ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---C---CHHHHHHHH-hcCCCCCCC---
Confidence            22111 2336789999999988889999999999999999998 6777542   1   112222111 111111111   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                            ......+.+++.+|++.+|++|||+.|+++.|
T Consensus       227 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 ------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  11234577899999999999999999998865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.4e-36  Score=304.79  Aligned_cols=261  Identities=25%  Similarity=0.345  Sum_probs=197.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|+..+.||+|+||.||++..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999976 488999998865432  234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|+.+...   ...+++..++.++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887643   234899999999999999999999985   9999999999999999999999999987654332


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc----------
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE----------  530 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  530 (624)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++|+....   .......+......          
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS---DIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc---hHHHHHHHHHHhCCCchhhHHHhc
Confidence            2  1223567899999999876 447889999999999999999998874211   11111111110000          


Q ss_pred             -CCc-cccccchhhc-----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          531 -GHA-AELMDSVVKQ-----SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       531 -~~~-~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ... .....+....     .........+.+++.+||+.+|++||++.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000 0000000000     001122346888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-35  Score=302.63  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=197.0

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+..+++++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            334467999999999999865 5889999998765555667789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++.......  ..
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~  174 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK  174 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence            999998743    34889999999999999999999985   9999999999999999999999999987653322  12


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...      ......... ...     +.+.+..  
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------~~~~~~~~~-~~~-----~~~~~~~--  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE------PPLQAMRRI-RDN-----LPPRVKD--  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH-Hhc-----CCCcccc--
Confidence            23356889999999998888999999999999999999999997421      111111111 111     1111111  


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .......+.+++.+||+.||.+|||+++|++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            00112346678889999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-36  Score=299.29  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=195.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----ceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----SLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----~~l  378 (624)
                      -.|...+.+|.|.||.||+|++.+ +++||||++-.+.+.    -.+|+++|+.+.|||||+|+-+|....+     ..|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            356678899999999999999654 689999998655432    1469999999999999999999875332     468


Q ss_pred             EEEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEeccccccc
Q 006952          379 IYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARI  456 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  456 (624)
                      ||||+|. +|.+++.+. ..+..++...+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 677777532 23456777888889999999999999975   9999999999999977 8999999999998


Q ss_pred             cCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      +..+...   ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.   .++..+.+..+.+.+.-....+
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp---G~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP---GDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC---CCCHHHHHHHHHHHhCCCCHHH
Confidence            7554433   234458899999998774 68999999999999999999998764   3344444444444443332221


Q ss_pred             c----------ccchhhcC-----CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 L----------MDSVVKQS-----CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~----------~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +          ..+.+...     .......+.++++.++++.+|.+|.++.|++.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1          11111111     12233456788999999999999999998865

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4e-35  Score=301.43  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc-----cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ-----GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +|...+.||+|++|.||+|... +++.|+||++......     ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677789999999999999965 5889999998765422     335577899999999999999999999998899999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+++   |+|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999985432  36899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC-------
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG-------  531 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  531 (624)
                      ....  .....+++.|+|||.+.+ ..++.++||||||+++|||++|.+++...   ................       
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD---SDIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC---ccHHHHHHHHHHcCCCchhhhhh
Confidence            3211  122356788999998865 45789999999999999999997765421   1111111111110000       


Q ss_pred             --CccccccchhhcCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          532 --HAAELMDSVVKQSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       532 --~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        ..............+     ......+.+++.+||+.+|++|||+.||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              000000000000111     1223567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4e-35  Score=305.75  Aligned_cols=198  Identities=18%  Similarity=0.277  Sum_probs=163.6

Q ss_pred             ccCccccC--CceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          309 QENKLGEG--GFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       309 ~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ..+.||+|  +|++||+++.+ +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  78999999865 68899999987542  233456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885422 235899999999999999999999985   999999999999999999999999875433211110


Q ss_pred             -----ccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          464 -----ANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       464 -----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                           .......++..|+|||++.+  ..++.++||||||+++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                 01112346778999999876  458999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=312.29  Aligned_cols=247  Identities=30%  Similarity=0.460  Sum_probs=201.1

Q ss_pred             CccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChh
Q 006952          311 NKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD  389 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  389 (624)
                      -.||+|.||+||.|+..+ ...+|||-+........+-+..||.+.++|+|+|||+++|.+.+++..-+.||-+|||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            369999999999999765 4579999998887777888999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccccccccCCCCCCccccc
Q 006952          390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       390 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+|........-++...-.+..||++||.|||++.   |||||||-+||||+. .|.+||+|||-++.+..  ....+..
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence            99976544444478888899999999999999984   999999999999964 67899999999986643  2334556


Q ss_pred             cccccCccChhhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCC
Q 006952          469 VVGTYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCD  546 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~--~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  546 (624)
                      +-||..|||||++..+.  |...+|||||||.+.||.||++||--..   .+  .....+   -|...  +.    ...+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg---sp--qAAMFk---VGmyK--vH----P~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG---SP--QAAMFK---VGMYK--VH----PPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC---Ch--hHhhhh---hccee--cC----CCCc
Confidence            88999999999997654  8899999999999999999999973111   11  111111   11100  11    2234


Q ss_pred             HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          547 QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       547 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+...+..+++++|+..||.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            556667889999999999999999999875

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-35  Score=311.53  Aligned_cols=262  Identities=25%  Similarity=0.305  Sum_probs=194.9

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC----
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN----  374 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  374 (624)
                      ...++|...+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999865 58899999987542  234567789999999999999999999986543    


Q ss_pred             --cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          375 --ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       375 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                        ..++||||+++ +|...+.     ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence              46899999976 5555552     24788999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH------
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK------  526 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~------  526 (624)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  ......+..      
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCH
Confidence            998653321   223457899999999999999999999999999999999999997522110  000000000      


Q ss_pred             -----------HHhcC--Cccccc------cchhh--cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          527 -----------LWCEG--HAAELM------DSVVK--QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       527 -----------~~~~~--~~~~~~------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                 .+...  ......      +....  ..........+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                       00000  000000      00000  00111123457889999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-35  Score=297.96  Aligned_cols=249  Identities=23%  Similarity=0.390  Sum_probs=200.3

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|+..+.||+|+||.||++... +|+.|++|++...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999965 5889999998653  233456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999888542 2335789999999999999999999985   99999999999999999999999999976543221


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......|++.|+|||++.+..++.++|+||||+++++|++|+.|+...      +......... .+.....      
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~-~~~~~~~------  221 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVLKII-RGSYPPV------  221 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC------CHHHHHHHHh-cCCCCCC------
Confidence              122345788999999999989999999999999999999999996421      1222222221 1111111      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         +......+.+++.+||+.+|++||++.+|++
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               1122345778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6e-35  Score=295.07  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=191.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-----cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-----GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      .+|...+.||+|+||.||++... .+..|++|++....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888899999999999999965 58899999886432     12345688999999999999999999998763  457


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999998853   234788999999999999999999875   99999999999999999999999999876


Q ss_pred             cCCCCC-CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          457 FGGNQS-KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       457 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.-.      .....+.+.......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~------~~~~~~~~~~~~~~~--  227 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY------EAMAAIFKIATQPTN--  227 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc------chHHHHHHHhcCCCC--
Confidence            532211 11122355889999999999988999999999999999999999997421      111212111111111  


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         +.    .+......+..++ +||..+|++||+++||++
T Consensus       228 ---~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 ---PQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               11    1111122233444 788899999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.9e-35  Score=300.51  Aligned_cols=259  Identities=24%  Similarity=0.361  Sum_probs=198.4

Q ss_pred             HHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEe----
Q 006952          299 DIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLE----  372 (624)
Q Consensus       299 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----  372 (624)
                      .+..+.++|+..+.||+|+||.||+++.. +++.+++|.+.... .....+.+|+.+++++ +||||+++++++..    
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            44456789999999999999999999875 57889999876532 2235678899999999 69999999998853    


Q ss_pred             -cCcceEEEEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          373 -ENESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       373 -~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                       ++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence             34579999999999999887532 23346889999999999999999999985   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+++.......  ......|++.|+|||++..     ..++.++||||||+++|||++|+.|+.....      .....
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------~~~~~  239 (286)
T cd06638         168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------MRALF  239 (286)
T ss_pred             CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------hHHHh
Confidence            999876543221  2223468999999998753     4478899999999999999999999742211      11111


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      +. ..........+       ......+.+++.+||+.||++|||+.||++.
T Consensus       240 ~~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 KI-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hc-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11 11111111111       1112357789999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=295.15  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      -|.+..+||+|.||.||++.++ .|+.+|||++...  .+.+++.+||.+|++...|++|+++|.+.....+|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3667789999999999999976 5899999998754  456899999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      .|+..+.+.-  ++.++.+.++..++...++||+|||..   +-+|||||..||||+.+|.+||+|||.+..+.+.... 
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-  185 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-  185 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence            9999999853  566899999999999999999999987   4799999999999999999999999999877554433 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                       .+.+.|||.|||||+++.-.|..++||||+|+...||.-|++|+...++-...         +.   +..-..+..+  
T Consensus       186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FM---IPT~PPPTF~--  250 (502)
T KOG0574|consen  186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FM---IPTKPPPTFK--  250 (502)
T ss_pred             -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------Ee---ccCCCCCCCC--
Confidence             34589999999999999999999999999999999999999997533222110         00   0001111111  


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      -+..-..++-+++.+||-++|++|-|+-++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            123334567889999999999999999887653

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.8e-35  Score=310.53  Aligned_cols=260  Identities=23%  Similarity=0.292  Sum_probs=194.3

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec------
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE------  373 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  373 (624)
                      ..++|...+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999965 57889999987542  33456788999999999999999999987643      


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      ...++||||+++ +|...+.     ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346899999976 5656552     24788899999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh----
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC----  529 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  529 (624)
                      ++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......   .....+.....    
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~  246 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP  246 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence            98653321   223456899999999999999999999999999999999999997532111   11111100000    


Q ss_pred             --------------cCC--c-----cccccchhh---cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          530 --------------EGH--A-----AELMDSVVK---QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       530 --------------~~~--~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                    ...  .     .+.....+.   ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                          000  0     000000000   00011122457789999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-35  Score=297.73  Aligned_cols=253  Identities=27%  Similarity=0.455  Sum_probs=199.7

Q ss_pred             CccccCccccCCceeEEEEEe-cCCcEEEEEEccccCc------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      +|+..+.||+|++|.||++.. .+++.+++|.+.....      ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999985 4688999999865331      235678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEecccccccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  457 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  457 (624)
                      |+||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   345889999999999999999999985   99999999999998776 5999999998766


Q ss_pred             CCCCCC--ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          458 GGNQSK--ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       458 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ......  .......|+..|+|||.+.+..++.++||||+|+++++|++|+.|+.....   ................  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~--  229 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH---SNHLALIFKIASATTA--  229 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---cchHHHHHHHhccCCC--
Confidence            433111  112235688999999999888899999999999999999999999753221   1112222111111111  


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                             ...+......+.+++.+|++.+|++||++.++++
T Consensus       230 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 -------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   1122233456788999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-35  Score=300.67  Aligned_cols=248  Identities=22%  Similarity=0.356  Sum_probs=197.6

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      |+....||+|+||.||++... +++.|++|.+........+.+.+|+.++..++|||++++++.+..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999965 6889999998765555567788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..    ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.....  .
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            999987732    35889999999999999999999985   99999999999999999999999999876543221  1


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.|+....      ........ ........ ..      
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~-~~~~~~~~-~~------  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKRL-RDSPPPKL-KN------  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH-hccCCCCc-cc------
Confidence            223568999999999998899999999999999999999999974211      11222211 11110000 00      


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .......+.+++.+||+.+|++||++++|++.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00112346788899999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=307.86  Aligned_cols=249  Identities=25%  Similarity=0.451  Sum_probs=202.9

Q ss_pred             cccCccccCCceeEEEEEecC---Cc--EEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLAD---GK--EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ...+.||+|-||.||+|+..+   |+  .||||.-+.+ .....+.|..|..+|++++||||++|+|+|.+. ..|+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            445789999999999999643   33  4899987763 445678999999999999999999999999764 6799999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      .++.|.|..+|...  +..++......++.||+.||.|||+.   ++|||||..+|||+....-+||+|||++|.+....
T Consensus       471 L~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  471 LAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             cccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            99999999999653  44588888999999999999999998   59999999999999999999999999999987654


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ....+ ...-.+.|||||-++-..++..||||=|||.+||+++ |..||.--...                +....+..-
T Consensus       546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iEnG  608 (974)
T KOG4257|consen  546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIENG  608 (974)
T ss_pred             hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEecCC
Confidence            43322 3445789999999999999999999999999999877 88897421111                111111111


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      -+-.+++.++..|..|+.+||..+|.+||.+.||...|+
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            122456667778999999999999999999999987773

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=304.85  Aligned_cols=267  Identities=24%  Similarity=0.356  Sum_probs=195.9

Q ss_pred             CccccCccccCCceeEEEEEecC---CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccce
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESL  377 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  377 (624)
                      .|...+.||+|++|.||+|+...   ++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36778899999999999999754   7899999988743   34456778999999999999999999999988  7799


Q ss_pred             EEEEeccCCChhhhhhcCC--CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC----CCCeEEecc
Q 006952          378 LIYEYMPNKSLDVFLFDST--RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH----EMNPKISDF  451 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  451 (624)
                      +||||+++ +|.+++....  ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 5555553222  2236889999999999999999999985   999999999999999    899999999


Q ss_pred             ccccccCCCCC-CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCC-C-----HHHH
Q 006952          452 GMARIFGGNQS-KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP-S-----LLAY  523 (624)
Q Consensus       452 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~-~-----~~~~  523 (624)
                      |++........ ........+++.|+|||.+.+. .++.++||||||++++||++|++|+......... .     .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 2223345678999999988764 5789999999999999999999998643322200 0     0000


Q ss_pred             HHHHHhcC------------CccccccchhhcCCC---------H--HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          524 IWKLWCEG------------HAAELMDSVVKQSCD---------Q--AELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       524 ~~~~~~~~------------~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +...+...            ......+.......+         .  ....++.+++.+||+.||++|||+.|++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000            000000000000001         0  22346888999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.7e-35  Score=296.08  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=201.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +|+..+.||+|++|.||++..+ +++.+++|++..... ...+++.+|++++++++||||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999976 588999999876543 44567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      ++++|.+++....  ..+++.....++.|++++|.|||+ .   +++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999985432  568899999999999999999998 6   499999999999999999999999999875532211


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                          ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ............. .........    
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~----  226 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIV-NEPPPRLPS----  226 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHh-cCCCCCCCh----
Confidence                125688899999999999999999999999999999999999753321 1122233322221 111111111    


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ......+.+++.+||..+|++|||+.+++.
T Consensus       227 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 ----GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                012335778999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=324.35  Aligned_cols=253  Identities=29%  Similarity=0.445  Sum_probs=207.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCc----EEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +++..++||+|+||+||+|.+- +|+    +||||++... ..+..+++.+|+.+|.+|+|||+++|+|+|.... ..||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            3455789999999999999953 343    5899988654 4456789999999999999999999999998876 8899


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ++|++.|.|.+++..  .+..+.-+..+.|..|||+||.|||++   +++||||..+||||.+-..+||.|||+++....
T Consensus       776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999975  344577888999999999999999988   599999999999999999999999999998876


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      +..........-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+       +.+.+..+..     
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR-----  918 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER-----  918 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc-----
Confidence            665555544455788999999999999999999999999999999 888864322222       2222222211     


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                          -..++-...++..++++||..|+..||+++++...+.+
T Consensus       919 ----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  919 ----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence                12345566778899999999999999999999888754

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-34  Score=290.72  Aligned_cols=251  Identities=29%  Similarity=0.472  Sum_probs=204.9

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~  380 (624)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 688999999876543  4567899999999999999999999999988  7899999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++...   ..+++..++.++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998543   27899999999999999999999975   999999999999999999999999999876544


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ..........++..|+|||.+.+...+.++||||||+++++|++|+.|+....     ......+..........+    
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~----  225 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPEI----  225 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcCC----
Confidence            32112234568899999999998889999999999999999999999975332     222333322211111111    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           +......+.+++.+|++.+|.+||++.+++.
T Consensus       226 -----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 -----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -----CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                 1122456888999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=307.61  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=205.0

Q ss_pred             HhcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc---ccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcce
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESL  377 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~  377 (624)
                      ....|...+.||+|.||.||+++.+. |+.+|+|.+.+...   ...+.+.+|+.+|++++ |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34578888999999999999999775 99999999976543   24568999999999998 999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CCeEEecccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE----MNPKISDFGM  453 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~  453 (624)
                      +|||++.||.|.+.+...    .+++.....++.||+.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998654    3899999999999999999999985   9999999999999543    4799999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..  ..+.....     ....+..
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~--~~~~~~~~-----~i~~~~~  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG--ETEFEIFL-----AILRGDF  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC--CChhHHHH-----HHHcCCC
Confidence            998754   3345568999999999999999999999999999999999999999742  22111111     1112222


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                       ++.++     .-.......-+++..++..||.+|+|+.++++.
T Consensus       256 -~f~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 -DFTSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -CCCCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence             11111     111123345578889999999999999999883

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=299.58  Aligned_cols=262  Identities=22%  Similarity=0.337  Sum_probs=195.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|++|.||+|..+ +++.|+||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 588999999865432 2234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++ +|.+++....  ..+++.....++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 8988875432  36889999999999999999999985   99999999999999999999999999875432211


Q ss_pred             CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc-----
Q 006952          463 KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL-----  536 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  536 (624)
                      .  .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....  ........++...........     
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST--DVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            1  112346889999998875 457899999999999999999999974221  111111112211111100000     


Q ss_pred             ------------ccchhhcCC-CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 ------------MDSVVKQSC-DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ------------~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                  ....+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                        000000000 0011246778999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=300.04  Aligned_cols=253  Identities=22%  Similarity=0.253  Sum_probs=199.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcc---cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|++|.||++...+ ++.+|+|.+......   ..+.+.+|+++++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999999764 889999998765322   4567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+.+++|.+++.. .....+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998853 23356899999999999999999999985   999999999999999999999999998754321


Q ss_pred             CCC---------------------------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 006952          461 QSK---------------------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH  513 (624)
Q Consensus       461 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~  513 (624)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           11223468899999999999889999999999999999999999974221


Q ss_pred             CCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 006952          514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT----MSSVAV  576 (624)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~ev~~  576 (624)
                      .      ........... .. ..       ........+.+++.+||+.+|++|||    +.|++.
T Consensus       237 ~------~~~~~~~~~~~-~~-~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 R------DETFSNILKKE-VT-FP-------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             h------HHHHHHHhcCC-cc-CC-------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1      11111111111 00 00       01113456888999999999999999    666555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.5e-35  Score=298.86  Aligned_cols=261  Identities=26%  Similarity=0.365  Sum_probs=201.4

Q ss_pred             HHHHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC
Q 006952          297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN  374 (624)
Q Consensus       297 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  374 (624)
                      +.++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...+
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3455667889999999999999999999975 58899999886543 2245678899999999 8999999999987643


Q ss_pred             -----cceEEEEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          375 -----ESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       375 -----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                           ..++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence                 478999999999999988532 23346899999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCC-----CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  523 (624)
                      +|||++........  ......|+..|+|||.+....     ++.++||||||+++|||++|+.|+....      ....
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~------~~~~  241 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH------PVKT  241 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc------HHHH
Confidence            99999886543221  122346889999999876533     6889999999999999999999974211      1111


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..+.. ......+.+       +......+.+++.+||+.+|++||++.|+++.
T Consensus       242 ~~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 LFKIP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11111 111111111       11122357889999999999999999999763

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=302.84  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|+..+.||+|++|.||++..+ +++.|++|+++...  ....+.+.+|++++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999976 47899999886532  3345788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |++++.+..++.   +...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999887776553   2345899999999999999999999985   9999999999999999999999999988764433


Q ss_pred             CCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc----------
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE----------  530 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  530 (624)
                      . .......++..|+|||++.+. .++.++||||||+++|+|++|++|+.....   .+.+......+..          
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD---IDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHhhhcc
Confidence            2 122335678899999999888 789999999999999999999998752211   1111111111100          


Q ss_pred             --CC-----ccccccc-hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          531 --GH-----AAELMDS-VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       531 --~~-----~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ..     .....+. .....++......+.+++.+||+.+|++|||+++|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              00     0000000 0011111222466889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-34  Score=295.48  Aligned_cols=260  Identities=26%  Similarity=0.348  Sum_probs=200.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--cceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--ESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV~  380 (624)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+..  ..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 578899999875433 34567899999999999999999999986643  579999


Q ss_pred             EeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++++|.+++... .....+++.....++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887532 23455888999999999999999999985   99999999999999999999999999875432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .....+..... .......+.+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYI-VNMPNPELKDE  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHH-hcCCchhhccC
Confidence            21    12345788999999999999999999999999999999999998643221 11122221111 11111111111


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...   .......+.+++.+||+.+|++|||+.||++
T Consensus       232 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 PGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            100   0112346789999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=308.57  Aligned_cols=244  Identities=30%  Similarity=0.438  Sum_probs=196.0

Q ss_pred             CccccCccccCCceeEEEEEe-cCCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      -|...+.||.|+||.||-++. .+.+.||||++.-.   +...|+++.+|+..|++++|||++.+.|++..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466678899999999999995 46788999998754   34557899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      ||-| +-.+++..  .++++.+.++..|..+.+.||.|||+.+   .||||||+.||||.+.|.|||+|||.+....   
T Consensus       107 YClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  107 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            9954 55666643  3456888999999999999999999985   9999999999999999999999999987653   


Q ss_pred             CCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          462 SKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                         ..+.++|||.|||||++.   .++|+.|+||||+|++..||.-.++|.-   .-...+.+..+.    ....     
T Consensus       178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMNAMSALYHIA----QNes-----  242 (948)
T KOG0577|consen  178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIA----QNES-----  242 (948)
T ss_pred             ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---CchHHHHHHHHH----hcCC-----
Confidence               345689999999999984   4789999999999999999999998842   111111122111    1111     


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      |.+.   ..+-...+.+++-.||++-|.+|||..++++
T Consensus       243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            1111   2233445788888999999999999998765

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-35  Score=306.98  Aligned_cols=260  Identities=24%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             HHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec----
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE----  373 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----  373 (624)
                      ....++|...+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999964 57899999987542  22345678999999999999999999987643    


Q ss_pred             --CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          374 --NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       374 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                        ...++++|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence              3468899987 778887763    235899999999999999999999985   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      |+++.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   ...+..+..... 
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~-  233 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVG-  233 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhC-
Confidence            999865322     223568999999999877 5689999999999999999999999742111   111111111100 


Q ss_pred             CCccccccch--------hh--cCCCH--------HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          531 GHAAELMDSV--------VK--QSCDQ--------AELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       531 ~~~~~~~d~~--------l~--~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ....+.....        +.  ...+.        .....+.+++.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000        00  00000        011236789999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.8e-35  Score=293.26  Aligned_cols=252  Identities=28%  Similarity=0.429  Sum_probs=205.1

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|+..+.||+|++|.||+++... ++.|++|++..... ...+.+.+|+..+.+++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999774 89999999876654 4567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      +++++|.+++...   ..+++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998543   568999999999999999999999 75   9999999999999999999999999988664332


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      ..  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....   ....+...... .......     
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~-~~~~~~~-----  223 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFELMQAIC-DGPPPSL-----  223 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHHHHHHHh-cCCCCCC-----
Confidence            22  1235678999999999999999999999999999999999999753322   12222222211 1111111     


Q ss_pred             hcCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          542 KQSCDQA-ELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                          +.. ....+.+++.+||+.+|++||++.++++.
T Consensus       224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                111 33468889999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-34  Score=292.07  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=194.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-----cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-----GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      .+|+..+.||+|+||.||++... ++..|+||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999975 48899999875322     22346788999999999999999999998764  346


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      +++|||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            799999999999998853   234788889999999999999999985   99999999999999999999999999876


Q ss_pred             cCCCCC-CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          457 FGGNQS-KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       457 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+...      ..............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~------~~~~~~~~~~~~~~---  226 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF------EAMAAIFKIATQPT---  226 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc------chHHHHHHHhcCCC---
Confidence            533211 11223356889999999998888999999999999999999999997421      11111111111111   


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        .    ...+......+..++.+|+. +|++||+++||++
T Consensus       227 --~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 --N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              0    11122333456777888885 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-34  Score=290.70  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~  380 (624)
                      +|+..+.||+|+||.||++... +++.+++|.+....  ....+.+.+|+.++++++|+||+++++++...  ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677889999999999999864 57889999886532  33456788999999999999999999988653  3468999


Q ss_pred             EeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          381 EYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      ||+++++|.+++... .....+++..++.++.||++||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643 22456899999999999999999999332  235999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+....      ..... +....+....  
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~-~~~~~~~~~~--  229 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQLA-SKIKEGKFRR--  229 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHHH-HHHhcCCCCC--
Confidence            543321  223568999999999999889999999999999999999999975322      11111 1122222111  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                             .+......+.+++.+|++.+|++||++.+|+++
T Consensus       230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   122234567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.4e-35  Score=306.88  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=192.8

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||+++.+. ++.+|+|++.+.   .....+.+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468889999999999999999764 678999998642   2223455888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  235889999999999999999999985   999999999999999999999999998754322


Q ss_pred             CCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..      .+......+.........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~------~~~~~~~~~i~~~~~~~~  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC------CCHHHHHHHHhCCCcccc
Confidence            21 1222357999999999986     34678999999999999999999999742      122333333222211111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccC--CCCCCCCHHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQG--DPIDRPTMSSVAVM  577 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~ev~~~  577 (624)
                      +...  ....    ...+.+++.+|++.  ++..||++.|+++.
T Consensus       229 ~p~~--~~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPAQ--VTDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCc--cccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1110  0111    22355566666654  44447899988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.3e-35  Score=306.81  Aligned_cols=255  Identities=21%  Similarity=0.248  Sum_probs=194.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||+++.. +++.||+|.+.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999976 5788999998653   2233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999642  235888999999999999999999985   999999999999999999999999999765433


Q ss_pred             CCCccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .. .......||+.|+|||++.+     +.++.++||||||+++|||++|+.||..      .+......+.........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~------~~~~~~~~~i~~~~~~~~  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC------CCHHHHHHHHHcCCCccc
Confidence            22 11223569999999999876     5678899999999999999999999742      122222222222111111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPID--RPTMSSVAVM  577 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~  577 (624)
                      + .+.. .    .....+.+++.+|++.++.+  |++++++++.
T Consensus       229 ~-p~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F-PSHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C-CCcc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1 1110 0    11234666777788765543  4688888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-35  Score=302.62  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=200.0

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEcc--ccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ...|++.++||.||.+.||++...+.+.+|+|++.  ..+.+...-|.+|+.+|.+|+ |.+||+|++|-..++..||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            46788999999999999999998888899999765  345567788999999999994 999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||- ..+|..+|.... .....| .+..+..||+.++.++|+++   |||.||||.|+|+-. |.+||+|||.|..+..+
T Consensus       440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            986 568888885532 233445 67789999999999999996   999999999999864 68999999999999888


Q ss_pred             CCCccccccccccCccChhhhcCCC-----------CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGI-----------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      .........+||+.||+||.+....           .+.++||||+|||||+|+.|+.||+.+        ...+.++  
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n~~aKl--  582 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------INQIAKL--  582 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HHHHHHH--
Confidence            8777777899999999999985432           567999999999999999999998521        1111111  


Q ss_pred             cCCccccccchhhcCCCH-HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAAELMDSVVKQSCDQ-AELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ..+.++.-.-.++. .....+++++..||+.||.+|||..|+++
T Consensus       583 ----~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 ----HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                11222211111110 00112888999999999999999999865

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-34  Score=299.15  Aligned_cols=257  Identities=18%  Similarity=0.226  Sum_probs=200.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36788899999999999999976 47889999887653   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999854   245899999999999999999999985   999999999999999999999999998642110


Q ss_pred             CC-------------CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          461 QS-------------KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       461 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ..             ........++..|+|||.+.+..++.++|+||||+++|||++|+.|+...      ...+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~------~~~~~~~~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD------TPEELFGQV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH
Confidence            00             00111245788999999998888999999999999999999999997411      111222111


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      . .+..   ..+....    .....+.+++.+||+.+|++||+..++.+.|+..
T Consensus       229 ~-~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         229 I-SDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             H-hccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            1 1110   0111001    1223467899999999999999988888777664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.7e-35  Score=296.43  Aligned_cols=261  Identities=23%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|++|.||+|... +|+.|++|++....  ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999965 68899999987644  33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      + +++|.+++....  ..+++..++.++.||+++|.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885433  46899999999999999999999985   99999999999999999999999999987644321


Q ss_pred             CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc--------
Q 006952          463 KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA--------  533 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  533 (624)
                       .......|+..|+|||.+.+. .++.++||||+|++++||++|++++..   .........+.........        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG---ENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC---CCHHHHHHHHHHHcCCCChHHHhhccC
Confidence             112235688999999988654 468999999999999999999776532   1111111111111111000        


Q ss_pred             ----cccccc-----hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 ----AELMDS-----VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ----~~~~d~-----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                          ..+..+     .+.. ...+....+.+++.+||+.+|++|||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                000000     0000 001123578889999999999999999999763

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-35  Score=298.31  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=193.0

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|+..+.||+|+||.||+++.. +|+.+++|++....  ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4677889999999999999975 58899999986532  22335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++ +|.+++...  ...+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            975 677766432  345899999999999999999999985   99999999999999999999999999986543221


Q ss_pred             CccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---------
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---------  532 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  532 (624)
                        ......+++.|+|||.+.+.. ++.++||||||+++|||++|+.|+..  ..+....+..+.+......         
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC--CCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence              122345788999999987754 68999999999999999999988532  1111111111111110000         


Q ss_pred             --ccccccchhh----cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 --AAELMDSVVK----QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 --~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ..........    ..........+.+++.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              0000000000    0000112345678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.8e-35  Score=298.68  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=201.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ++|...+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67888999999999999999864 57899999987655555678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999998843    24788999999999999999999985   99999999999999999999999999876543322 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......|++.|++||.+.++.++.++||||||+++|||++|+.||.......      ........+.. ..       
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~~~~~~~~~~-~~-------  235 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTP-EL-------  235 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------heeehhcCCCC-CC-------
Confidence             1223468889999999988889999999999999999999999975321111      11001111110 00       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..+......+.+++.+||+.+|++||++.+++.+
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111223457789999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.8e-34  Score=289.29  Aligned_cols=248  Identities=28%  Similarity=0.429  Sum_probs=197.9

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|++|.||++... +++.+++|.+....  ....+.+.+|+.++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777899999999999999864 57889999986542  33467889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  461 (624)
                      +++++|.+++... ....+++..+..++.|++++|.|||+++   ++|+||||+||++++++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998542 2345899999999999999999999985   99999999999998654 57999999998664332


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+....      ......... ......+.+   
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~---  223 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN------LPALVLKIM-SGTFAPISD---  223 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc------hHHHHHHHH-hcCCCCCCC---
Confidence               1223568899999999998889999999999999999999999974221      111111111 111111111   


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            .....+.+++.+||+.+|++|||+.|+++
T Consensus       224 ------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 ------RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  12335778999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=307.75  Aligned_cols=240  Identities=21%  Similarity=0.258  Sum_probs=184.0

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc---CCCCcceEEeEEEecCcceEEEEeccC
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL---QHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      ||+|+||.||+++.. +++.||||++.+..   ......+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 58899999986532   22233445666776665   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999988843   346899999999999999999999985   9999999999999999999999999987532221  12


Q ss_pred             ccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          466 TNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...      +..+.... ...+.. .+...    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~------~~~~~~~~-i~~~~~-~~~~~----~  220 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE------DTQQMYRN-IAFGKV-RFPKN----V  220 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC------CHHHHHHH-HHcCCC-CCCCc----c
Confidence            2346799999999998765 4799999999999999999999997421      11222221 211111 11111    1


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCC----CHHHHHH
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRP----TMSSVAV  576 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~ev~~  576 (624)
                          ....+.+++.+||+.||.+||    ++.++++
T Consensus       221 ----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         221 ----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                123466888999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.4e-35  Score=298.72  Aligned_cols=262  Identities=24%  Similarity=0.340  Sum_probs=196.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  378 (624)
                      .++|+..+.||+|+||.||+|..+ +++.+++|.++....  .....+.+|+.++.+++||||+++++++...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357888899999999999999976 578899999875432  2234567899999999999999999999887  78999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |+||+++ +|.+++...  ...+++..++.++.||++||.|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9999975 888877542  236899999999999999999999985   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH----------
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL----------  527 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------  527 (624)
                      ....  ......+++.|+|||.+.+.. ++.++|+||||+++|||++|+.|+......   .....+...          
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHH
Confidence            4321  122345788999999887644 689999999999999999999997532211   111111110          


Q ss_pred             -Hhc------CCccccccchhhcCCCHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 -WCE------GHAAELMDSVVKQSCDQA-ELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 -~~~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       +..      ..........+....+.. ....+.+++.+||+.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             000      000011111111112211 2445778999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-34  Score=293.52  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=198.8

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3445678999999999999964 688999999876555556778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999998854    35889999999999999999999985   99999999999999999999999998875543221  


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+..      .+........... .......      
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~------~~~~~~~~~~~~~-~~~~~~~------  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN------EPPLQAMKRIRDN-LPPKLKN------  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC------CCHHHHHHHHHhc-CCCCCcc------
Confidence            12235688999999999888899999999999999999999999642      1122222222111 1111100      


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .......+.+++.+||+.+|++||++.++++
T Consensus       238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             1112346888999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-34  Score=294.58  Aligned_cols=262  Identities=27%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +|+..+.||+|++|.||+|+.. +|+.|+||++..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999976 588999999876543 23466788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++ +|.+++........+++..+..++.||++||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 78887765444456899999999999999999999885   99999999999999999999999999976533221 


Q ss_pred             ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---------c
Q 006952          464 ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---------A  533 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~  533 (624)
                       ......+++.|++||.+.+. .++.++||||||+++|||++|+.|+.....   ......+........         .
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN---EDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhHHHHhcC
Confidence             11234578899999988664 568999999999999999999999753221   111111111110000         0


Q ss_pred             cccccchh------hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AELMDSVV------KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ........      ...........+.+++.+|++.||.+||++.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000      00001122346788999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.9e-34  Score=289.26  Aligned_cols=252  Identities=29%  Similarity=0.477  Sum_probs=199.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|+||.||++... +++.|++|.+......  ..+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4677889999999999999965 6889999998765543  678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999854   234788999999999999999999985   99999999999999999999999999887644332


Q ss_pred             Ccc--ccccccccCccChhhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          463 KAN--TNRVVGTYGYMAPEYAMGGI---FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       463 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...  .....+++.|+|||++.+..   .+.++||||||+++|||++|+.||....     .......... .+....+.
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-----~~~~~~~~~~-~~~~~~~~  228 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-----NEFQIMFHVG-AGHKPPIP  228 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-----chHHHHHHHh-cCCCCCCC
Confidence            211  12356788999999998766   8899999999999999999999975221     1111111111 11111111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      . .      ......+.+++.+||+.+|.+||++.+++.
T Consensus       229 ~-~------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 D-S------LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             c-c------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1 0      011334668889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-34  Score=296.42  Aligned_cols=264  Identities=23%  Similarity=0.318  Sum_probs=194.9

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++.+|...+.||+|+||.||+|... +++.|++|++..... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 588999999875433 33346789999999999999999999999998999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+. ++|..++...  ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 5666665432  235788888999999999999999985   999999999999999999999999998754322


Q ss_pred             CCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC-------
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH-------  532 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  532 (624)
                      ..  ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.....  ....+...+..+....       
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence            11  12234578999999998764 578999999999999999999999753221  1111111221111000       


Q ss_pred             --ccccccchhhcCC---------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 --AAELMDSVVKQSC---------DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 --~~~~~d~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        .............         .......+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              0000000000000         0011345678899999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-34  Score=295.84  Aligned_cols=243  Identities=26%  Similarity=0.341  Sum_probs=197.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|...+.||+|++|.||++... +++.+|+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999975 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999854   346889999999999999999999975   999999999999999999999999998865433


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                           .....|++.|+|||.+.+...+.++||||||+++|+|++|+.|+....      ... ..+....+...      
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~-~~~~~~~~~~~------  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PIQ-IYEKILEGKVR------  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHH-HHHHHhcCCcc------
Confidence                 234568899999999988888999999999999999999999974221      111 11111111110      


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVA  575 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~  575 (624)
                          .+......+.+++.+||+.+|.+||     +++|++
T Consensus       217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                1111134577899999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=282.19  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=197.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccc--cCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +++|++.+.||+|.|+.||++... .|+.+|+|.+..  -+....+++++|+.+-+.|+||||++|++...+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888889999999999999865 588999998753  34557889999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEecccccccc
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~  457 (624)
                      |++.|++|..-|.   .+..+++..+-..++||+++|.|+|.++   |||||+||+|++|-...   -+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999976553   2355777888899999999999999985   99999999999995433   4899999999987


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...   .......|||+|||||++....|+..+|||+-|||||-|+.|.+||.  . ++...+.+.+.    .+... +.
T Consensus       164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~--~-~~~~rlye~I~----~g~yd-~~  232 (355)
T KOG0033|consen  164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW--D-EDQHRLYEQIK----AGAYD-YP  232 (355)
T ss_pred             CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC--C-ccHHHHHHHHh----ccccC-CC
Confidence            632   23345789999999999999999999999999999999999999973  2 12223333332    11111 00


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+..     +.......+|+.+||..||.+|-|+.|.+.
T Consensus       233 ~~~w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 SPEW-----DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             Cccc-----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            0000     001123457788999999999999988753

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=312.87  Aligned_cols=251  Identities=29%  Similarity=0.405  Sum_probs=203.8

Q ss_pred             ccccCccccCCceeEEEEEecC--Cc--EEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          307 FSQENKLGEGGFGPVYKGVLAD--GK--EIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ....++||+|.||.|++|.|+.  |+  .||||.++..... ...+|.+|+.+|-+|+|+|+++|+|+..+ ....||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3445789999999999999864  44  5899999876654 77899999999999999999999999988 67889999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      .++.|+|.+.|.+ ..+..|-......++.|||.||.||..++   +|||||..+|+||-....+||+|||+.+.++.+.
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999977 55667888889999999999999999985   9999999999999999999999999999887654


Q ss_pred             CCccc-cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          462 SKANT-NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       462 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..... ....-...|.|||.+....|+.++|||+|||++|||+| |+.||--   -   .-.+...          .+|.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G---~---~g~qIL~----------~iD~  330 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG---C---RGIQILK----------NIDA  330 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC---C---CHHHHHH----------hccc
Confidence            43322 22233568999999999999999999999999999999 6677631   1   1112111          1221


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      --+-..+..+..++.+++..||..+|++|||+..|.+.+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            111123455677899999999999999999999997443

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.4e-35  Score=322.04  Aligned_cols=260  Identities=20%  Similarity=0.233  Sum_probs=189.3

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCC------CCcceEEeEEEec-
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH------KNLVRLLGCCLEE-  373 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~~~~~~~-  373 (624)
                      ..+++|++.+.||+|+||.||++... .++.||||+++... ...+.+..|+.+++.++|      .+++++++++... 
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            45688999999999999999999965 47789999986532 223456778888887765      4588899988765 


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---------
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---------  444 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---------  444 (624)
                      ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++.  +|+||||||+|||++.++         
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence            4578899987 6778777743   346899999999999999999999741  499999999999998765         


Q ss_pred             -------CeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          445 -------NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       445 -------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                             .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~---  350 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN---  350 (467)
T ss_pred             ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---
Confidence                   49999999875422     122346799999999999999999999999999999999999999853221   


Q ss_pred             CCHHHHHHHHHh-------cC----Cccccc----------cc-----hhhcC--CCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          518 PSLLAYIWKLWC-------EG----HAAELM----------DS-----VVKQS--CDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       518 ~~~~~~~~~~~~-------~~----~~~~~~----------d~-----~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                      ...+..+.+...       ..    ...++.          ++     .....  ........+.+|+.+||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            111111111100       00    000000          00     00000  0001123577899999999999999


Q ss_pred             CHHHHHH
Q 006952          570 TMSSVAV  576 (624)
Q Consensus       570 s~~ev~~  576 (624)
                      |++|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2e-34  Score=294.03  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=194.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|+..+.||+|++|.||+++.. +++.|+||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999975 58899999886543  22346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      ++ ++|..++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5788877542 3356899999999999999999999985   99999999999999999999999999876543221


Q ss_pred             CccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC----------
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG----------  531 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  531 (624)
                        ......+++.|+|||.+.+.. ++.++||||||+++|||++|+.||....  .......... .....          
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFR-TLGTPDEVVWPGVTS  230 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHH-HhCCCChhhhhhhhH
Confidence              122345688999999887654 5889999999999999999999874211  1111111110 00000          


Q ss_pred             ------CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 ------HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 ------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            .........+.. ........+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                  000000000000 00011234678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.8e-34  Score=285.44  Aligned_cols=249  Identities=29%  Similarity=0.489  Sum_probs=202.5

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677789999999999999976 688999999987665566889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++....  ..+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999885432  46899999999999999999999974   99999999999999999999999999886644321  


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                       .....++..|++||.+.+...+.++||||||+++++|++|+.|+....      ......... ..........     
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~~~~-----  220 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP------PMKALFKIA-TNGPPGLRNP-----  220 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHH-hcCCCCcCcc-----
Confidence             234568899999999998889999999999999999999999974221      111111111 1111111111     


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ......+.+++.+||+.||++|||+.+|++
T Consensus       221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              001345788999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=308.94  Aligned_cols=251  Identities=24%  Similarity=0.419  Sum_probs=203.5

Q ss_pred             cCccccCccccCCceeEEEEEecCCc-EEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +.|.+...||.|+||.||+++.++.. ..|.|++...+....++|.-||++|....||+||+|++.+..++.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34566778999999999999987644 45788888888888999999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      .||-.+.++..-  ...+++.++.-++.|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+-....  ..
T Consensus       112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            999999888653  34689999999999999999999998   599999999999999999999999999754321  22


Q ss_pred             ccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          464 ANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      .....+.|||.|||||+.+     ...|+.++||||||+.|.||.-+.+|.      ...+....+.+.-... .+.++.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH------helnpMRVllKiaKSe-PPTLlq  257 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSE-PPTLLQ  257 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc------cccchHHHHHHHhhcC-CCcccC
Confidence            2344689999999999875     467999999999999999999999984      2233334443332222 222222


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +       ......+-++...||..||..||+..++++
T Consensus       258 P-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 P-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             c-------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1       222345667888999999999999999865

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.1e-34  Score=293.03  Aligned_cols=252  Identities=26%  Similarity=0.422  Sum_probs=202.8

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++.|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999986 588999999976554 56778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996532  36899999999999999999999975   9999999999999999999999999987553322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .  ......++..|++||.+.+..++.++||||||+++|+|++|+.|+.....      ........ .........   
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~---  238 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFLIT-TKGIPPLKN---  238 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hcCCCCCcc---
Confidence            1  12234578899999999988899999999999999999999999742111      11111111 111111111   


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          .......+.+++.+||+.+|.+||++.+|++
T Consensus       239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                1112345778999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-34  Score=295.03  Aligned_cols=247  Identities=26%  Similarity=0.440  Sum_probs=198.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      -|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667788999999999999864 67899999876443 334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            99999998843    35889999999999999999999985   99999999999999999999999999876543221 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+....      ....... ........     +  
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~~~~~~~-----~--  221 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH------PMKVLFL-IPKNNPPT-----L--  221 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc------hHHHHHH-HhcCCCCC-----C--
Confidence             1223467889999999998889999999999999999999999974211      1111111 11111111     1  


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        +......+.+++.+||+.+|.+||++.++++.
T Consensus       222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              11223457788999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=293.24  Aligned_cols=247  Identities=23%  Similarity=0.425  Sum_probs=196.5

Q ss_pred             CccccCccccCCceeEEEEEe-cCCcEEEEEEcccc-CcccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .|+..+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778999999999999996 46889999998754 3345677889999999996   999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..    ..+++...+.++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    26899999999999999999999985   999999999999999999999999999876543


Q ss_pred             CCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..  ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+.....      ...... ......     +
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~~-~~~~~~-----~  220 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMML-IPKSKP-----P  220 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhhc-cccCCC-----C
Confidence            31  22335688999999988754 468999999999999999999999752211      111110 001111     1


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+...   .....+.+++.+||+.||++||++.++++
T Consensus       221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11110   12345778889999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-35  Score=294.85  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=199.3

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc----
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE----  375 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~----  375 (624)
                      ..+++|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.....    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999975 578899998876543 346789999999999 69999999999976543    


Q ss_pred             --ceEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          376 --SLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       376 --~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                        .++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence              799999999999999885422 2456899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ++........  ......|+..|+|||++..     ..++.++||||||+++|||++|+.|+.....      .....+.
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~  230 (275)
T cd06608         159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------MRALFKI  230 (275)
T ss_pred             cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch------HHHHHHh
Confidence            9876543221  1223568899999998753     3467899999999999999999999742111      1111111


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .......+.       .+......+.+++.+||+.||++|||+.+|++
T Consensus       231 -~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 -PRNPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -hccCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             111111111       11223446788999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-34  Score=287.98  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=198.9

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|+||.||++..+ +|..+++|.+....  ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999976 47899999986542  23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-eEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~  461 (624)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2345799999999999999999999985   999999999999998864 6999999987664322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      ..  .....|++.|+|||++.+..++.++|+||||+++|||++|+.|+...      .......... .+......    
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~-~~~~~~~~----  223 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN------NLHQLVLKIC-QGYFAPIS----  223 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHh-cccCCCCC----
Confidence            11  12345889999999999888999999999999999999999997421      2222232222 11111111    


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                           ......+.+++.+|++.+|++|||+.+|++.
T Consensus       224 -----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 -----PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 1112357788999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=295.36  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=196.2

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceEEEE
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLLIYE  381 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV~E  381 (624)
                      |++.+.||+|++|.||+++.. +++.+++|++....  ....+.+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999976 48899999998653  33456788999999999999999999999888  78999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++ +|.+++...  ...+++..++.++.||++||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888877542  246899999999999999999999985   9999999999999999999999999998764432


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---cc---
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---AA---  534 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---  534 (624)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.-...   ......+.+......   +.   
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence            1 11223456788999997765 4578999999999999999999999742221   111111111111100   00   


Q ss_pred             -----------ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 -----------ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 -----------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                 ......+.......+...+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       000011111111112456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-34  Score=292.39  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=191.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHH-HHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTV-IAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|++.+.||+|+||.||+++.+ +|+.||+|++..... .....+..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999976 589999999875432 233455566665 566689999999999999999999999


Q ss_pred             eccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          382 YMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       382 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      |++ ++|.+++... .....+++..++.++.||+.||.|||++.  +++||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 6787776542 23456899999999999999999999862  4999999999999999999999999998865322


Q ss_pred             CCCccccccccccCccChhhhcC----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .   ......|+..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.....     ..+...... .+....+
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~~  228 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVV-EEPSPQL  228 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHH-hcCCCCC
Confidence            1   1223467889999998865    4468899999999999999999999742111     112222211 1111111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..    ..    ....+.+++.+||+.+|++||++.+|++
T Consensus       229 ~~----~~----~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 PA----EK----FSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             Cc----cc----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11    11    1235778999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.2e-35  Score=306.21  Aligned_cols=194  Identities=27%  Similarity=0.400  Sum_probs=166.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-C-----CCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-H-----KNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~~~~~  377 (624)
                      .+|.+.+.||+|.||.|-++... +++.||||+++.... ...+-..|+.+|..|+ |     -|+|+++++|...++.+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            37888999999999999999954 589999999986543 3455578999999996 4     48999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC--CeEEecccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM--NPKISDFGMAR  455 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~  455 (624)
                      ||+|.+ ..+|.++|..+ +...++...+..|+.||+.||..||+.+   |||+||||+||||.+-.  .+||+|||.+.
T Consensus       265 iVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999 56899999653 4455999999999999999999999875   99999999999997654  69999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      .......     ..+.+..|.|||++.+..|+.+.||||||||+.||++|.+-|
T Consensus       340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            6533221     456788999999999999999999999999999999997654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=305.27  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----ES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~  376 (624)
                      +++|.+.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 68899999987533 334567889999999999999999999876543     46


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+||+++ +|...+.    ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999975 7766663    235899999999999999999999985   99999999999999999999999999876


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ....... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+   .......+..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~---~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCCHH
Confidence            5432211 11223568999999998754 568999999999999999999999974211   111111111111111000


Q ss_pred             c---cccch----hh-----cCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hccCC
Q 006952          535 E---LMDSV----VK-----QSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM--LASDI  582 (624)
Q Consensus       535 ~---~~d~~----l~-----~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~  582 (624)
                      .   +.+..    +.     ...+     ......+.+++.+||+.+|++|||+.|+++.  ++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0   00000    00     0000     1113457899999999999999999999886  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-35  Score=306.56  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=196.0

Q ss_pred             cccCccccCCceeEEEEEec-CCcEEEEEEcc--c--cCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc--ceEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLA-DGKEIAVKRLS--R--TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE--SLLIY  380 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~--~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lV~  380 (624)
                      +....||+|+|-+||+|... +|.+||=-.++  .  ......++|..|+.+|+.|+||||+++++++.+...  ..+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999975 36666532222  1  234556899999999999999999999999988766  67899


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~  459 (624)
                      |.+..|+|..|+..   ...++.+.+..|++||++||.|||++. |+|||||||-+||||+.+ |.|||+|+|+|.....
T Consensus       123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999954   456788899999999999999999985 789999999999999876 7899999999998654


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..    ...++|||.|||||... ..|.+.+||||||+.++||+|+..|+.     +-.+..+.-+++. .|.-+..+..
T Consensus       199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~-SGiKP~sl~k  267 (632)
T KOG0584|consen  199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVT-SGIKPAALSK  267 (632)
T ss_pred             cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHH-cCCCHHHhhc
Confidence            32    23478999999999887 789999999999999999999999964     2333333333332 3322222221


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhccC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLASD  581 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~  581 (624)
                      .     .   ..++.++|.+|+.. .++|||+.|++.  +|..+
T Consensus       268 V-----~---dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  268 V-----K---DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             c-----C---CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            1     1   23466888899998 999999999975  44443

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-34  Score=290.15  Aligned_cols=259  Identities=25%  Similarity=0.361  Sum_probs=193.1

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      |+..+.||+|++|.||+|... +|..|++|++....  ....+.+.+|+.++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456788999999999999965 68999999987543  233467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      + ++|.+++.... ...+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 68888875422 246899999999999999999999974   999999999999999999999999998765332211


Q ss_pred             ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC---------Cc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG---------HA  533 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  533 (624)
                        .....+++.|+|||++.+. .++.++||||||+++|||++|+.||.....  ...+.... +.....         ..
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIF-RTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH-HHhCCCChHHhhhhhhc
Confidence              1223568899999987664 578999999999999999999999742111  00111110 000000         00


Q ss_pred             ccc-------ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AEL-------MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+.       ...... .........+.+++.+|++.+|++|||++||++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000       000000 001112245778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-34  Score=294.68  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=199.0

Q ss_pred             CHHHHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEe-
Q 006952          296 DLIDIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLE-  372 (624)
Q Consensus       296 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-  372 (624)
                      ++.++....+.|+..+.||+|+||.||+|... +++.+++|.+.... .....+..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555567788999999999999999999974 57889999886543 2345688999999999 79999999999863 


Q ss_pred             -----cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 006952          373 -----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK  447 (624)
Q Consensus       373 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  447 (624)
                           ....+++|||+++++|.+++... ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 34678999999999999988542 2345788889999999999999999985   99999999999999999999


Q ss_pred             EeccccccccCCCCCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH
Q 006952          448 ISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLA  522 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~  522 (624)
                      |+|||++.......  .......|++.|+|||.+.     ...++.++||||||+++|||++|+.||......      .
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~  233 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------R  233 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------h
Confidence            99999987653221  1223356889999999875     345788999999999999999999997422111      1


Q ss_pred             HHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          523 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       523 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...... ......    ....    .....+.+++.+||+.||.+||++.||++
T Consensus       234 ~~~~~~-~~~~~~----~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 ALFLIP-RNPPPK----LKSK----KWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhhHh-hCCCCC----Cccc----ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            010000 000000    0011    12235788899999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.4e-34  Score=294.46  Aligned_cols=246  Identities=28%  Similarity=0.423  Sum_probs=192.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +.|...+.||+|+||.||+|+.. +++.|++|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55888899999999999999975 588999998864432   33467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||++ |++.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 466665532  2235899999999999999999999985   999999999999999999999999998754322


Q ss_pred             CCCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                            ....+++.|+|||++.   .+.++.++||||||+++|||++|+.|+...      +.......... .......
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~------~~~~~~~~~~~-~~~~~~~  235 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQ-NDSPTLS  235 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc------cHHHHHHHHhc-CCCCCCC
Confidence                  2346788999999874   456889999999999999999999996421      11111111111 1111100


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                              .......+.+++.+||+.+|++||++.+|+..
T Consensus       236 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         236 --------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                    11223457889999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.8e-34  Score=292.84  Aligned_cols=259  Identities=23%  Similarity=0.312  Sum_probs=193.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc-----
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE-----  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~-----  375 (624)
                      ++|+..+.||+|+||.||++... +++.||+|++.....  .....+.+|+.+++++ +|+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999975 588999998765432  2346788999999999 46999999999987665     


Q ss_pred             ceEEEEeccCCChhhhhhcCCC--CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTR--SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFG  452 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  452 (624)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78887754322  346899999999999999999999985   999999999999998 8899999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh--
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC--  529 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  529 (624)
                      +++.+.....  ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....      ......+...  
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~------~~~~~~~~~~~~  228 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS------ELQQLLHIFKLL  228 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHHHh
Confidence            9876533211  1122356889999998865 457899999999999999999999874211      1111111111  


Q ss_pred             -cCCcc---cc------------ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 -EGHAA---EL------------MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 -~~~~~---~~------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .....   ..            ....+. .........+.+++.+||+.||.+||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             00000   00            000000 000112345788999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.6e-34  Score=297.83  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=195.4

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC--cc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN--ES  376 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~--~~  376 (624)
                      ..++|...+.||+|+||.||+|... +++.+++|++...  .......+.+|+.+++++ +||||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888999999999999999976 5788999988542  233445677899999999 9999999999986543  57


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588887743    26889999999999999999999985   99999999999999999999999999986


Q ss_pred             cCCCCCC---ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH----
Q 006952          457 FGGNQSK---ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW----  528 (624)
Q Consensus       457 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----  528 (624)
                      .......   .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......   ..........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL---NQLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence            6433221   12234568999999998755 45789999999999999999999997432111   1111111000    


Q ss_pred             -------hcCCccccccchhhcC------CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          529 -------CEGHAAELMDSVVKQS------CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       529 -------~~~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                             .......+++......      ........+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   0000000111000000      000123467889999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-34  Score=291.45  Aligned_cols=247  Identities=26%  Similarity=0.299  Sum_probs=199.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +|...+.||+|+||.||++... +++.|++|.+.+..   ....+.+.+|+.++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999976 58899999987543   2446788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++...   ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999988542   46889999999999999999999985   9999999999999999999999999987654322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+......    ...........  ...      
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~------  219 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADV------  219 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccc------
Confidence               223456888999999999888999999999999999999999997533222    11111111111  000      


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCH--HHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTM--SSVA  575 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~ev~  575 (624)
                        ..+......+.+++.+||+.||.+||++  +|++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 --LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              1111223567889999999999999999  5553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.5e-34  Score=290.31  Aligned_cols=242  Identities=25%  Similarity=0.276  Sum_probs=184.6

Q ss_pred             ccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHh---cCCCCcceEEeEEEecCcceEEEEecc
Q 006952          312 KLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAK---LQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~---l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..++..   .+|||++.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 588999998865321   122334455444433   479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988853   345899999999999999999999985   9999999999999999999999999987553221   


Q ss_pred             cccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.......   . .........      ...    
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~~~------~~~----  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---K-HEIDRMTLT------VNV----  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---H-HHHHHHhhc------CCc----
Confidence             123468999999998864 557999999999999999999999975322211   1 111111100      011    


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVM  577 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~  577 (624)
                      ..+.....++.+++.+||+.||++||     |++|+++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11122234577888999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.3e-34  Score=293.08  Aligned_cols=255  Identities=27%  Similarity=0.397  Sum_probs=193.4

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999965 58899999987543 234567889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhhc--CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      +.. ++.++...  ......+++..+..++.|+++||+|||+..  +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 44433211  122356899999999999999999999752  4999999999999999999999999999765332


Q ss_pred             CCCccccccccccCccChhhhcCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGG---IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..   .....|++.|+|||.+.+.   .++.++||||||+++|||++|+.||....     .......+... +....  
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~~--  230 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPPI--  230 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCCc--
Confidence            21   1234578899999998776   68999999999999999999999975322     12222222111 11111  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         +...........+.+++.+||+.+|++|||+++|++.
T Consensus       231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 ---LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1111111233467889999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-34  Score=316.26  Aligned_cols=200  Identities=24%  Similarity=0.402  Sum_probs=157.9

Q ss_pred             HhcCccccCccccCCceeEEEEEecC--CcEEEEE------------------EccccCcccHHHHHHHHHHHHhcCCCC
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD--GKEIAVK------------------RLSRTSGQGLQEFKNEVTVIAKLQHKN  362 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~h~n  362 (624)
                      ..++|++.+.||+|+||.||++.++.  +...++|                  .+. ........+.+|+.++++++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34689999999999999999987542  2222222                  111 11223456889999999999999


Q ss_pred             cceEEeEEEecCcceEEEEeccCCChhhhhhcCCC--CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR--SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       363 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      |+++++++...+..++|+|++. ++|.+++.....  ...........|+.||+.||.|||+.+   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 466666543211  122345667789999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKS  508 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p  508 (624)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999876433221 22245799999999999999999999999999999999998854

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3e-34  Score=296.34  Aligned_cols=264  Identities=22%  Similarity=0.336  Sum_probs=192.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  375 (624)
                      .++|+..+.||+|+||.||++... +++.||||.+....  ......+.+|+.++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999975 58899999886543  2223456789999999999999999999876544     


Q ss_pred             ---ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          376 ---SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       376 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                         .++||||+.+ +|.+.+..  ....+++.+++.++.||++||.|||+++   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999975 77776643  2346899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCC--ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          453 MARIFGGNQSK--ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       453 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      ++..+......  .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.....   ......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~---~~~~~~~~~~~~  241 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE---QHQLTLISQLCG  241 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhC
Confidence            99866432221  112234578899999988664 468899999999999999999988743221   112222222111


Q ss_pred             c---CCccc-----cccc---------hhhcC-CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 E---GHAAE-----LMDS---------VVKQS-CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~---~~~~~-----~~d~---------~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .   +....     ..+.         ..... ....+...+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0   00000     0000         00000 00011234678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.6e-34  Score=299.75  Aligned_cols=260  Identities=25%  Similarity=0.329  Sum_probs=195.3

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----  374 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  374 (624)
                      ..++|+..+.||+|+||.||++... +++.||||.+.+.  .....+.+.+|+.++++++|+||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 6889999998653  2334466788999999999999999999986443     


Q ss_pred             -cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          375 -ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       375 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                       ..++||||+.+ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence             46899999965 77776632     2788899999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH------
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL------  527 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------  527 (624)
                      ++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.   ......+...      
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  238 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSD  238 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            986543221   2234678999999999999999999999999999999999999753211   0000000000      


Q ss_pred             ------------HhcCC-------ccccccchhh----cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          528 ------------WCEGH-------AAELMDSVVK----QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       528 ------------~~~~~-------~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                  +....       ..+.....+.    ..........+.+++.+||+.||++|||+.|++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                        00000       0001111000    00011234567899999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-33  Score=284.53  Aligned_cols=242  Identities=23%  Similarity=0.296  Sum_probs=193.2

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||.|++|.||+++.. +++.+++|.+....   ....+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 48899999987543   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999854   234889999999999999999999975   9999999999999999999999999998764332   2223


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ..|++.|++||.+.+..++.++|+||||+++|||++|+.|+.....    +...............         ..+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~---------~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGKL---------EFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCCC---------CCCcc
Confidence            4688999999999888899999999999999999999999753221    1122221111101111         11111


Q ss_pred             HHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                      ....+.+++.+||+.+|++||+     ++|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2346889999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-33  Score=289.58  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             cCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          310 ENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ...||+|+||.||++..+ +++.|+||++..........+.+|+.++++++|+|++++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999875 6889999998765555567789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+++..    ..+++.....++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++........  ....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            988743    34789999999999999999999985   99999999999999999999999999876543221  1233


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ..|++.|+|||.+.+..++.++|+||||+++|||++|+.|+...   ..........    ... ......      ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~---~~~~~~~~~~----~~~-~~~~~~------~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIR----DNL-PPKLKN------LHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH----hhC-CcccCC------ccc
Confidence            56889999999998888999999999999999999999997421   1111111111    110 000000      011


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....+.+++.+||+.+|.+||++.+|++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1234678889999999999999999877

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.3e-34  Score=295.48  Aligned_cols=263  Identities=26%  Similarity=0.362  Sum_probs=193.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  378 (624)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999975 588999999864432  2234567899999999999999999998765  45799


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+.+ +|.+++...  ...+++..+..++.||++||.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 787777542  246899999999999999999999986   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc---
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA---  534 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  534 (624)
                      .....  .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.-.   .....+..+..........   
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK---SEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCChhhch
Confidence            33211  122345788999999865 45789999999999999999999997421   1111122111111100000   


Q ss_pred             cc-----ccch-hh-cCC------CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          535 EL-----MDSV-VK-QSC------DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       535 ~~-----~d~~-l~-~~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..     .... +. ...      .......+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00     0000 00 000      00113356789999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-33  Score=289.64  Aligned_cols=261  Identities=25%  Similarity=0.349  Sum_probs=192.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|+..+.||+|++|.||+|..+ +++.|++|++.....  ...+.+.+|+.++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999975 688999999865432  334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccccccccCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGN  460 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~  460 (624)
                      |++ ++|.+++.. .....+++..+..++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 477776643 22334688888999999999999999985   999999999999985 457999999999765432


Q ss_pred             CCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc------
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA------  533 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  533 (624)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......   +....+.........      
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcccc
Confidence            11  11234578899999988764 5789999999999999999999997532111   111111111110000      


Q ss_pred             ---ccc-------ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 ---AEL-------MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ---~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         ...       ....+. ........++.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000       000000 001112335778999999999999999999986

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-33  Score=290.81  Aligned_cols=247  Identities=28%  Similarity=0.432  Sum_probs=193.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .|...+.||+|+||.||+++.. ++..+++|++....   ....+.+.+|+.++++++|+|++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667889999999999999965 58899999986542   2334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++ +|.+.+..  ....+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 67666643  2345899999999999999999999985   99999999999999999999999999875432  


Q ss_pred             CCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          462 SKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                          .....|++.|+|||++.   .+.++.++||||||+++|||++|+.|+...      ............+. .... 
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~~~~-~~~~-  245 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES-PTLQ-  245 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHhccC-CCCC-
Confidence                12346788999999874   456899999999999999999999986421      11111111111111 0000 


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                             .......+.+++.+||+.+|.+||++.+|++.+-
T Consensus       246 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         246 -------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -------CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                   1112235778899999999999999999988653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=282.36  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=195.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-----CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-----SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      .+|+..+.||+|+||.||++... +++.|++|.+...     .......+++|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999965 5889999987532     223456788999999999999999999998764  347


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++++||+++++|.+++..   ...+++.....++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998853   234788999999999999999999985   99999999999999999999999999986


Q ss_pred             cCCCCC-CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          457 FGGNQS-KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       457 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...... ........|+..|+|||.+.+..++.++|+||||+++|||++|+.||...      .....+.+....+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~  229 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY------EAMAAIFKIATQPTKPM  229 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc------CHHHHHHHHHcCCCCCC
Confidence            532211 11122356889999999999888999999999999999999999997421      11122222221111111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                               .+......+.+++.+|++ +|.+||+..+++.
T Consensus       230 ---------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         230 ---------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                     122223457788889999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-33  Score=287.76  Aligned_cols=244  Identities=27%  Similarity=0.359  Sum_probs=190.1

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||+|+||+||++... +|+.+++|.+....   ....+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 58899999886532   22345667899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            99886533 246899999999999999999999985   9999999999999999999999999987654311   1223


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||........   ...+.......      .    ...+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~------~----~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLEM------A----VEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhccccc------c----ccCCcc
Confidence            4578899999999888899999999999999999999999753222111   11111110000      0    011111


Q ss_pred             HHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          549 ELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                      ....+.+++.+||+.+|++||     +..+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            234577899999999999999     5665654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=290.96  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .-|..++.||+|.|..|-.+++- .|.+||||++.+..-+  ....+..|+.-|+.++|||||+|+.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45677788999999999888843 6999999999876433  34567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCCeEEeccccccccCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL-DHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      .-.+|+|.+||.+..  ..+.+....+++.||+.|+.|+|+.+   +|||||||+||.+ .+-|-+||.|||++..+...
T Consensus        98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999997644  45889999999999999999999975   9999999999876 55678999999999876543


Q ss_pred             CCCccccccccccCccChhhhcCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFS-VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .   .-+..+|+..|-|||++.+..|+ +.+||||+|||||.|++|++||+-..+.+               .+..++|=
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC  234 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC  234 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence            3   23457899999999999998885 68999999999999999999986433222               11122221


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        +-..+.....+|.+|+..||+.||.+|-+.+||+.
T Consensus       235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence              01233444567899999999999999999999965

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-33  Score=290.58  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=196.3

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC----
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN----  374 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----  374 (624)
                      ...++|++.+.||+|+||.||+|+.+ +++.|++|+++...  ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999976 48899999987543  233456788999999999999999999987655    


Q ss_pred             ------cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          375 ------ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       375 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                            ..++|+||+++ ++...+..  ....+++..++.++.||+.||.|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  68999999986 56565543  2346899999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      +|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|++|+..   ......+..+.+.
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~---~~~~~~~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA---NQELAQLELISRL  233 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHH
Confidence            999999865433211 11223467889999988653 578999999999999999999998742   1111222222222


Q ss_pred             HhcCCcc---ccc--------c------chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAA---ELM--------D------SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~---~~~--------d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .......   .+.        +      ........ .....+.+++.+||+.+|.+||++++|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111100   000        0      00000000 11346789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-34  Score=288.97  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             cccCCceeEEEEEecC-CcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||+|+||.||+++... |+.+++|.+.....   ...+.+.+|+.++++++|+||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 89999999875433   4567789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC------
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS------  462 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------  462 (624)
                      .+++...   ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998542   36899999999999999999999985   99999999999999999999999999875433211      


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      ........++..|++||.......+.++||||||+++|||++|+.|+....      .......... +... ...    
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~-~~~----  222 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET------PEEIFQNILN-GKIE-WPE----  222 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhc-CCcC-CCc----
Confidence            112234567889999999988889999999999999999999999974221      1122211111 1110 000    


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                       ..  .....+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus       223 -~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         223 -DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             -cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence             00  0134577899999999999999997777777644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=280.91  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=200.7

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|+..+.||+|++|.||+++.. +++.|++|.+.....  ...+.+.+|++++.+++|+|++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999865 578999999876654  4567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++...   ..+++..+..++.|++.+|.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988542   56899999999999999999999985   99999999999999999999999999987654332


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .  .....++..|+|||...+...+.++||||+|+++|+|++|+.|+....      .....++... .....+      
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~------  219 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRIVQ-DDHPPL------  219 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-cCCCCC------
Confidence            1  223567899999999988888999999999999999999999874211      1122222111 111111      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         +......+.+++.+||+.+|++||++.+++.
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               1111345778999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-33  Score=290.33  Aligned_cols=261  Identities=18%  Similarity=0.216  Sum_probs=190.7

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCC
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      .+.+|.|+++.||++.. +++.||||++...  .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34456666666666655 6899999998754  34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC-----
Q 006952          388 LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS-----  462 (624)
Q Consensus       388 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----  462 (624)
                      |.+++.... ...+++.....++.|+++||.|||+++   |+||||||+||+++.++.+||+|||.+........     
T Consensus        86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999986432 235888999999999999999999985   99999999999999999999999998875432211     


Q ss_pred             CccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH----hcC-----
Q 006952          463 KANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW----CEG-----  531 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~-----  531 (624)
                      ........++..|+|||++..  ..++.++||||||+++|||++|+.||......  ....+......    ...     
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhh
Confidence            111223456788999999876  35789999999999999999999997532111  11111110000    000     


Q ss_pred             --Cccc----cccchh----hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          532 --HAAE----LMDSVV----KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       532 --~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        ....    ..++..    ...........+.+++.+||+.||++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              0000    000000    001112223467889999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.6e-33  Score=279.64  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=203.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...+.||+|++|.||++... +++.+++|++.....  ...+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999975 588999999876543  4567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      +++++|.+++.... ....+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886532 2367899999999999999999999985   9999999999999999999999999998764432


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                        .......|++.|+|||...+..++.++|+||+|+++++|++|+.|+....      ......... ......+     
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~-----  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKIL-KGQYPPI-----  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHh-cCCCCCC-----
Confidence              12233568899999999998889999999999999999999999974221      122222221 1111111     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          +......+.+++.+||..+|++|||+.++++
T Consensus       224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1112345778999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=290.97  Aligned_cols=259  Identities=24%  Similarity=0.340  Sum_probs=196.3

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      |+..+.||+|++|.||++... +++.+++|++......  ....+.+|+.++++++|+||+++++++......++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456678999999999999975 6889999998754332  4567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++ +|..++...  ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            76 777777542  246899999999999999999999985   9999999999999999999999999998765433  


Q ss_pred             ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC---Ccccccc-
Q 006952          464 ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG---HAAELMD-  538 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d-  538 (624)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.....   .+............   ....+.+ 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---IDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCchHhcccchhh
Confidence            112234578899999998876 789999999999999999999988742211   11111111111000   0000000 


Q ss_pred             ----------c--hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 ----------S--VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ----------~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                .  ............++.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0  0000011223456889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=304.03  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEec------Ccc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE------NES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~  376 (624)
                      ..|...+.||+|+||.||+|+. ..|+.||||.+.... ....+...+|+++|++++|+|||++++.-++.      ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3456678899999999999995 469999999998754 34567788999999999999999999986543      357


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCC--eEEeccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD--HEMN--PKISDFG  452 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~Dfg  452 (624)
                      .+|||||.+|+|...|..+.+...+++.+.+.++.++..||.|||+++   |+||||||.||++-  ++|+  -||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            899999999999999999888889999999999999999999999885   99999999999983  3343  6999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      .|+.++++.   ....++||..|.+||.+.. +.|+..+|.|||||++||.+||..||.......  ...+.+|....+.
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkk  244 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKK  244 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccC
Confidence            999886554   4556899999999999984 889999999999999999999999986544332  2333444433332


Q ss_pred             Ccccc--ccchhh------------cCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          532 HAAEL--MDSVVK------------QSCDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       532 ~~~~~--~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                      .....  ..+..+            .+.......++-++...++..+|++|-
T Consensus       245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            21111  111111            112233444566677778888888887

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.2e-33  Score=291.50  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=190.0

Q ss_pred             CccccC--CceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEG--GFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      ..||+|  +||+||++... .|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  99999999975 68999999987533  23457789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc-
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA-  464 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-  464 (624)
                      ++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886532 235889999999999999999999885   9999999999999999999999998654332111110 


Q ss_pred             ----cccccccccCccChhhhcCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC-------
Q 006952          465 ----NTNRVVGTYGYMAPEYAMGG--IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG-------  531 (624)
Q Consensus       465 ----~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  531 (624)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||......      ..........       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT------QMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH------HHHHHHhcCCCCCCccc
Confidence                01112345679999998764  4789999999999999999999997532111      0000000000       


Q ss_pred             -----------------------------CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 -----------------------------HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 -----------------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                                   ....+.+..+...........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                         000111111111122234456889999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-33  Score=287.57  Aligned_cols=256  Identities=18%  Similarity=0.202  Sum_probs=181.0

Q ss_pred             hcCccccCccccCCceeEEEEEecCC----cEEEEEEccccCcccHH-----------HHHHHHHHHHhcCCCCcceEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADG----KEIAVKRLSRTSGQGLQ-----------EFKNEVTVIAKLQHKNLVRLLG  368 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~-----------~~~~Ei~~l~~l~h~niv~l~~  368 (624)
                      .++|.+.+.||+|+||.||+|...++    ..+++|+..........           ....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36799999999999999999997653    45666654332221111           1123334455678999999999


Q ss_pred             EEEecCc----ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 006952          369 CCLEENE----SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM  444 (624)
Q Consensus       369 ~~~~~~~----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  444 (624)
                      ++.....    .++++|++.. ++.+.+..   ....++..+..|+.|+++||.|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            8765542    3567776643 45444422   223578888999999999999999985   99999999999999999


Q ss_pred             CeEEeccccccccCCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 006952          445 NPKISDFGMARIFGGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS  519 (624)
Q Consensus       445 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~  519 (624)
                      .++|+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ...
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~--~~~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH--NGN  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc--chH
Confidence            9999999999876432211     112234699999999999999999999999999999999999999863311  111


Q ss_pred             HHHHHH----HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          520 LLAYIW----KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       520 ~~~~~~----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ......    +....+..       .....    ...+.+++..|++.+|++||++.+|.+.|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKI-------KIKNA----NKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHHHhhhhhh-------ccCCC----CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111111    11111110       00111    245778888999999999999999998763

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-34  Score=300.13  Aligned_cols=261  Identities=22%  Similarity=0.310  Sum_probs=195.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----Cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  375 (624)
                      .++|...+.||+|+||.||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999965 5889999998753  233345678899999999999999999988654     24


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++|+||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 678877743   346899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc----
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE----  530 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  530 (624)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....   .......+......    
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD---YVHQLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHHhCCCChH
Confidence            654322  11223457889999998865 468999999999999999999999974221   11111111111110    


Q ss_pred             -------CCcccccc-------chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          531 -------GHAAELMD-------SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       531 -------~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                             ....+.++       ..... .......++.+++.+||+.+|++|||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                   00000000       00000 011223457899999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-33  Score=286.49  Aligned_cols=257  Identities=23%  Similarity=0.277  Sum_probs=189.6

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcC-CCCcceEEeEEEec--CcceEEEE
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEE--NESLLIYE  381 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E  381 (624)
                      |+..+.||+|+||.||++... +++.||+|+++.... .......+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999965 588999999875422 22234457899999985 99999999999987  78999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++ +|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9974 777776432  246899999999999999999999985   999999999999999 999999999998654322


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH-----------Hh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL-----------WC  529 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~  529 (624)
                      .   .....++..|+|||.+.. +.++.++||||||+++|||++|+.||.....   .+........           ..
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence            1   123457889999997654 5578999999999999999999999743211   1111111111           10


Q ss_pred             cCCccccccchhhc----CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAAELMDSVVKQ----SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .........+....    .........+.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            01000000000000    001123467889999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-33  Score=282.33  Aligned_cols=249  Identities=21%  Similarity=0.257  Sum_probs=189.2

Q ss_pred             HHHHHHhcCccccCcc--ccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          298 IDIVKATQDFSQENKL--GEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       298 ~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++....++|++.+.+  |+|+||.||+++.+ ++..+++|.+........     |+.....+ +|||++++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444445677776666  99999999999965 578899998865432211     23233323 799999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccc
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFG  452 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg  452 (624)
                      +..++||||+++++|.+++...   ..+++..+..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999998542   37899999999999999999999985   99999999999999998 99999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++......      ....++..|+|||++.+..++.++||||||+++|||++|+.|+..... +......+....   ..
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~---~~  225 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ---QK  225 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh---cc
Confidence            98765322      124578999999999998999999999999999999999999862221 111111111111   11


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-MSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~  576 (624)
                      .....         ......+.+++.+||+.+|.+||+ ++++++
T Consensus       226 ~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 KLPFI---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cCCcc---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00111         122345778889999999999995 688863

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-33  Score=281.94  Aligned_cols=249  Identities=27%  Similarity=0.365  Sum_probs=201.3

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|++.+.||+|++|.||+++.+ +++.+++|.+....  .....++.+|+.++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999855 67899999987543  33456778999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      +++++|.+++.... ....+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885522 2356899999999999999999999985   999999999999999999999999999876443 


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                         ......+++.|++||.+.+..++.++|+||||+++|||++|+.|+....      ...... ....+....      
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~~~~~-~~~~~~~~~------  220 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS------MQDLRY-KVQRGKYPP------  220 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHH-HHhcCCCCC------
Confidence               1223457889999999999999999999999999999999999974221      111111 111222111      


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         .+......+.+++.+|++.+|++||++.++++.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               112334568899999999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-34  Score=298.69  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=204.2

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .....|.+...||+|.|+.|..+++. .+.+||||.+++..-  ...+.+.+|+++|..|+|||||+++.+.+....+++
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34578899999999999999999965 589999999987643  334668899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+.+|.+.+++.+.   ....+..+..++.|+.++++|||++.   |+|||||++||||+.+.++||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            99999999999999653   34555888889999999999999985   9999999999999999999999999998875


Q ss_pred             CCCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...   .....+|++.|.|||++++..+ .+++|+||+|++||-|++|..||+.                   +.+.++-
T Consensus       207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-------------------~~lk~Lr  264 (596)
T KOG0586|consen  207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-------------------QNLKELR  264 (596)
T ss_pred             ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-------------------ccccccc
Confidence            332   2345789999999999999876 6899999999999999999999852                   1122222


Q ss_pred             cchhhcC--CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQS--CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ++.+.+.  .+.....++-+++.++|-.+|.+|+++++|.+
T Consensus       265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            2222221  12222335778888999999999999999965

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-33  Score=291.11  Aligned_cols=263  Identities=27%  Similarity=0.382  Sum_probs=192.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  374 (624)
                      .++|...+.||+|+||.||+++.. +++.+++|++.....  .....+.+|++++++++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999965 588999998865432  22346788999999999999999999876543      


Q ss_pred             --cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          375 --ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       375 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                        ..++|+||+.+ +|...+..  ....+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999875 56555543  2346899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCCc---------cccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH
Q 006952          453 MARIFGGNQSKA---------NTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLA  522 (624)
Q Consensus       453 ~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~  522 (624)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|++||.....   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---~~~~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---IDQLH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence            998654322111         11234578889999987654 578999999999999999999998742111   11222


Q ss_pred             HHHHHHhcCCc---------cccc--------cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          523 YIWKLWCEGHA---------AELM--------DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       523 ~~~~~~~~~~~---------~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .++..+.....         ....        .+.+.... ......+.+++.+||+.+|++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            22221111000         0000        00000000 011246789999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-33  Score=287.75  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=192.5

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc-ccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|...+.||+|++|.||++..++ ++.||||++..... ....++..|+.++.++. |+||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999999875 88999999875432 33456677888777775 9999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++ +|..++...  ...+++..+..++.||++||.|||+..  +|+||||+|+||++++++.+||+|||++..+....
T Consensus        95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9854 666665432  236899999999999999999999742  49999999999999999999999999987654322


Q ss_pred             CCccccccccccCccChhhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGI----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....     ..+...+..... ...+.
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~-~~~~~  240 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEE-PPSLP  240 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCC-CCCCC
Confidence            11   2235788999999987553    78899999999999999999999743211     112222222111 11111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..   .    .....+.+++.+||+.||.+||++.+|++.
T Consensus       241 ~~---~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 PN---E----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC---C----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10   0    122357889999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=289.55  Aligned_cols=200  Identities=30%  Similarity=0.433  Sum_probs=177.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +.|+.-++||+|+||.||-++.. .|+.+|.|++.+..   .+......+|-.+|.+++.+.||.+-..|++.+.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777789999999999999966 48899999886543   234456789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ..|.||+|.-+|.+... ..+++.+++.++.+|+-||++||+.   +||.|||||+|||||+.|+++|+|+|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999976443 6799999999999999999999998   4999999999999999999999999999988655


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF  511 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~  511 (624)
                      ...   ...+||.+|||||++++..|+...|.||+||++|||+.|+.||..
T Consensus       341 ~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  341 KPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             Ccc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            433   234899999999999999999999999999999999999999853

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-33  Score=291.44  Aligned_cols=278  Identities=21%  Similarity=0.293  Sum_probs=201.4

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--  374 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--  374 (624)
                      +....++|...+.||+|+||.||++... ++..||||++....  ....+.+.+|+.++++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445678999999999999999999854 68899999986532  223456889999999999999999999987654  


Q ss_pred             ----cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          375 ----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       375 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                          ..++||||+ +++|..++..    ..+++..+..++.||++||.|||+.+   |+||||||+||+++.++.++|+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                348999998 7788887742    35899999999999999999999985   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH---
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK---  526 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---  526 (624)
                      ||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....   ........+   
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~  233 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTG  233 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcC
Confidence            9998765322     223457889999999876 4588999999999999999999999752211   001100000   


Q ss_pred             --------HHhcCCcccccc-------chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH--HHhccCCCCCCCCC
Q 006952          527 --------LWCEGHAAELMD-------SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA--VMLASDILTLPKPT  589 (624)
Q Consensus       527 --------~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~--~~L~~~~~~~~~p~  589 (624)
                              .+..........       ..+. .........+.+++.+|++.||++|||+.+++  ..++.....-..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~  312 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETE  312 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccC
Confidence                    000000000000       0000 00011223477899999999999999999998  34444333333444


Q ss_pred             CCccc
Q 006952          590 QPAFS  594 (624)
Q Consensus       590 ~p~~~  594 (624)
                      .|+|.
T Consensus       313 ~~~~~  317 (343)
T cd07880         313 APPYD  317 (343)
T ss_pred             CCCcc
Confidence            44443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.5e-34  Score=316.43  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=189.5

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEe--------
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--------  372 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------  372 (624)
                      -..+|+..+.||+||||.||+++.+ ||+.+|||++... +......+.+|+..+++|+|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4467889999999999999999976 8999999999765 34455778999999999999999999831100        


Q ss_pred             ----------------------------------------------------------------------c---------
Q 006952          373 ----------------------------------------------------------------------E---------  373 (624)
Q Consensus       373 ----------------------------------------------------------------------~---------  373 (624)
                                                                                            .         
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                  0         


Q ss_pred             --------------------------------CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH
Q 006952          374 --------------------------------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH  421 (624)
Q Consensus       374 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH  421 (624)
                                                      ..+||-||||+...|.+++..+....  .-...++++.+|++||.|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                            01367799999988888885433211  35678899999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC----------------CCCCCccccccccccCccChhhhcCC-
Q 006952          422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG----------------GNQSKANTNRVVGTYGYMAPEYAMGG-  484 (624)
Q Consensus       422 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~-  484 (624)
                      +++   ||||||||.||+||++..|||+|||++....                ........+..+||..|+|||++.+. 
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            997   9999999999999999999999999998721                01111133457899999999999765 


Q ss_pred             --CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhccc
Q 006952          485 --IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ  562 (624)
Q Consensus       485 --~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  562 (624)
                        .|+.|+|+||+|||++||+.   ||+     ....-...+ ...+.+.++.-      .++...+...=..++.++++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~-----TsMERa~iL-~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFG-----TSMERASIL-TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCC-----chHHHHHHH-HhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence              49999999999999999985   332     111222222 22334444333      11222333344678889999


Q ss_pred             CCCCCCCCHHHHHH
Q 006952          563 GDPIDRPTMSSVAV  576 (624)
Q Consensus       563 ~dP~~RPs~~ev~~  576 (624)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999854

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-33  Score=286.45  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=198.4

Q ss_pred             CccccCccccCCceeEEEEEec----CCcEEEEEEccccC----cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      +|...+.||+|++|.||+++..    +++.||||.+.+..    ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677889999999999998842    56789999886532    23346688999999999 599999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   345889999999999999999999875   99999999999999999999999999876


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|..|+......  ..............   
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~---  228 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK---  228 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC---
Confidence            5433211 122346889999999987765  788999999999999999999997532111  11111111111110   


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          .    ..+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus       229 ----~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         229 ----P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ----C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                0    01111223467889999999999999999998887653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-33  Score=282.39  Aligned_cols=259  Identities=24%  Similarity=0.356  Sum_probs=192.0

Q ss_pred             ccccCccccCCceeEEEEEecC-CcEEEEEEccccCc--ccHHHHHHHHHHHHhc---CCCCcceEEeEEEecCc-----
Q 006952          307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG--QGLQEFKNEVTVIAKL---QHKNLVRLLGCCLEENE-----  375 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~-----  375 (624)
                      |++.+.||+|+||.||+++.+. ++.+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567889999999999999864 89999999875332  2234566788877766   59999999999998776     


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .+++|||+++ +|.+++.... ...+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7888775422 235899999999999999999999985   9999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++|++|+.....   ......+...........
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCCChHh
Confidence            7643321   1234578899999999999999999999999999999999988652111   111111111110000000


Q ss_pred             c----------ccchhh---cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          536 L----------MDSVVK---QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       536 ~----------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .          ......   ..........+.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0          000000   0011122356778999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=280.63  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=188.3

Q ss_pred             CccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHH-HhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVI-AKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||++... +++.||+|.+.+...   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999975 588999999875432   2223345555544 445899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      ++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999853   235889999999999999999999985   99999999999999999999999999875432      


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+....      ... .+......... . ....    
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~-~~~~~~~~~~~-~-~~~~----  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET------PDA-VFDNILSRRIN-W-PEEV----  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC------HHH-HHHHHHhcccC-C-CCcc----
Confidence            223467889999999988889999999999999999999999974211      111 11111111110 0 0000    


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            11123457889999999999999988777776654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.2e-34  Score=297.16  Aligned_cols=264  Identities=20%  Similarity=0.335  Sum_probs=195.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec----Ccc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE----NES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----~~~  376 (624)
                      .++|+..+.||+|++|.||++... +|+.|++|++....  ....+.+.+|+.++++++||||+++++++...    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368889999999999999999965 58999999987543  23456778899999999999999999987643    457


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999996 588888743   344899999999999999999999985   99999999999999999999999999976


Q ss_pred             cCCCCCC--ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH-----
Q 006952          457 FGGNQSK--ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW-----  528 (624)
Q Consensus       457 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  528 (624)
                      .......  .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.-...   ......+....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~---~~~~~~~~~~~g~~~~  233 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY---VHQLKLILSVLGSPSE  233 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh---HHHHHHHHHHhCCChh
Confidence            5432211  11123568899999998865 4688999999999999999999999742111   11111111000     


Q ss_pred             ------hcCCccccccchh-hcCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          529 ------CEGHAAELMDSVV-KQSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       529 ------~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                            ..+...+..+... ....+     ......+.+++.+||+.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  0000000000000 00000     1124568899999999999999999998774

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-32  Score=285.35  Aligned_cols=244  Identities=28%  Similarity=0.442  Sum_probs=189.4

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      |...+.||+|+||.||+|+.. +++.|++|++.....   ...+.+.+|+.++++++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555677999999999999965 588999999865332   3346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +.+ ++.+++..  ....+++..+..++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 66666643  2345899999999999999999999985   9999999999999999999999999886422    


Q ss_pred             CccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                        ......|+..|+|||++.   .+.++.++||||||+++|||++|+.|+...      +............ ...... 
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~------~~~~~~~~~~~~~-~~~~~~-  242 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQND-SPTLQS-  242 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcC-CCCCCc-
Confidence              122456889999999984   456889999999999999999999986321      1111121111111 111111 


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         ..+    ...+.+++.+||+.+|.+||++.+++..
T Consensus       243 ---~~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 ---NEW----TDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               111    2346788999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=285.92  Aligned_cols=259  Identities=25%  Similarity=0.334  Sum_probs=192.9

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEec
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      |.+.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456788999999999999976 478899999865432 22234567999999998 999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                       +++|.+++.... ...+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788888875432 346899999999999999999999985   99999999999999999999999999876543221 


Q ss_pred             ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH--------H-----h
Q 006952          464 ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL--------W-----C  529 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~-----~  529 (624)
                        .....++..|+|||.+.+ ..++.++|+||||++++||++|++|+......   +........        |     .
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI---DQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH---HHHHHHHHhcCCCChhhhhhHhhh
Confidence              123457889999998754 55789999999999999999999887432111   111110000        0     0


Q ss_pred             cCCcccccc----chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          530 EGHAAELMD----SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       530 ~~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .......+.    ..+.... ......+.+++.+||+.+|++|||++||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000    0000000 1113568899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.9e-33  Score=284.81  Aligned_cols=251  Identities=23%  Similarity=0.291  Sum_probs=194.2

Q ss_pred             CccccCccccCCceeEEEEEe----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      +|+..+.||+|+||.||++..    .+|+.||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999986    368899999987532    22346788999999999 699999999999998889


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345788999999999999999999985   99999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccCccChhhhcCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGG--IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ...... .......|+..|+|||.+...  .++.++||||||+++|+|++|+.|+.....  ................  
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~--  229 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEP--  229 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccCC--
Confidence            543221 122245688999999998753  467899999999999999999999753221  1122222222111110  


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                               ..+......+.+++.+||+.+|++||     +..+++.
T Consensus       230 ---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 ---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                     01111233567889999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.2e-33  Score=285.18  Aligned_cols=249  Identities=27%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|...+.||+|++|.||+++.. +++.|++|++....   ....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999975 68999999987532   233467889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999854   336999999999999999999999985   99999999999999999999999999886643


Q ss_pred             CCCC------------------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHH
Q 006952          460 NQSK------------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLL  521 (624)
Q Consensus       460 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~  521 (624)
                      ....                  .......++..|+|||.......+.++||||||+++++|++|+.|+....      ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN------EY  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc------HH
Confidence            3221                  22234567899999999988889999999999999999999999975221      11


Q ss_pred             HHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 006952          522 AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM----SSVAV  576 (624)
Q Consensus       522 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~ev~~  576 (624)
                      ....... ...          ...+......+.+++.+||+.+|.+||++    +++++
T Consensus       229 ~~~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTFQKIL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1111111 000          01111123457889999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-32  Score=288.50  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=190.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  374 (624)
                      ..+|...+.||+|+||.||+|+.. +|+.||||++.+..  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 68999999987532  233456789999999999999999999987543      


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            35899999864 665554     125889999999999999999999985   999999999999999999999999998


Q ss_pred             cccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc--C
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE--G  531 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~  531 (624)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....      ........+..  .
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~------~~~~~~~~~~~~~~  233 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGV  233 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCC
Confidence            754321     223467889999999876 468999999999999999999999975221      11111111110  0


Q ss_pred             Ccccc------------cc---chhhcCCC---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          532 HAAEL------------MD---SVVKQSCD---QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       532 ~~~~~------------~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ....+            .+   ........   ......+.+++.+||+.||++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000            00   00000000   0112357789999999999999999999843

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.6e-33  Score=282.68  Aligned_cols=241  Identities=24%  Similarity=0.265  Sum_probs=184.2

Q ss_pred             ccccCCceeEEEEEec-CCcEEEEEEccccCcc---cHHHHHHHHH---HHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          312 KLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ---GLQEFKNEVT---VIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~Ei~---~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      .||+|+||.||++... +++.||+|.+.+....   ....+.+|..   .++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 5889999998654321   1222344443   3444579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|..++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999988843   346899999999999999999999985   9999999999999999999999999987553221   


Q ss_pred             cccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........   ... .......      ...   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~---~~~-~~~~~~~------~~~---  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEI-DRMTLTM------AVE---  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch---HHH-HHHhhcc------CCC---
Confidence             2234689999999998754 689999999999999999999999753222111   111 1111110      001   


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                       .+......+.+++.+|++.+|.+||     ++.++++
T Consensus       218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             1111234577888999999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=324.68  Aligned_cols=255  Identities=29%  Similarity=0.393  Sum_probs=200.5

Q ss_pred             HHhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ..+-+|....+||.|.||.||.+.. .+|...|+|-++...  ......+.+|..++..|+|||+|+++|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3345677789999999999999995 458888999876543  4456778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      .||||++|+|.+.+...   ...++.....+..|++.|+.|||++|   ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            99999999999998542   23555666678899999999999997   9999999999999999999999999999876


Q ss_pred             CCC--CCccccccccccCccChhhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          459 GNQ--SKANTNRVVGTYGYMAPEYAMGGI---FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       459 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      .+.  ....-+...||+.|||||++.+..   -..+.||||+||+++||+||++||.-++.+      ..+.-....+..
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYHVAAGHK 1459 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhHHhccCC
Confidence            542  122334568999999999997654   456899999999999999999998643322      111112222332


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      +.+...         ...+-.+++..||+.||++|-++.|+++.
T Consensus      1460 Pq~P~~---------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 PQIPER---------LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCchh---------hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            222222         22334567789999999999888887664

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-33  Score=290.52  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=193.8

Q ss_pred             cCccc-cCccccCCceeEEEEEec-CCcEEEEEEccccCccc--------------HHHHHHHHHHHHhcCCCCcceEEe
Q 006952          305 QDFSQ-ENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQG--------------LQEFKNEVTVIAKLQHKNLVRLLG  368 (624)
Q Consensus       305 ~~~~~-~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~~  368 (624)
                      ++|.. .+.||+|+||.||++..+ +++.||||++.......              ...+.+|+.++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 567999999999999965 58899999886543221              124778999999999999999999


Q ss_pred             EEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       369 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      ++...+..++||||++ ++|.+++..   ...+++.....++.|++.||.|||+.+   |+|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 588888743   345889999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCC------------CCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 006952          449 SDFGMARIFGGNQ------------SKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSE  515 (624)
Q Consensus       449 ~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~  515 (624)
                      +|||++.......            .........+++.|+|||.+.+. .++.++||||||+++|||++|+.|+..... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-  239 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-  239 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            9999998664111            01111223467889999998764 468999999999999999999999753221 


Q ss_pred             CCCCHHHHHHHHHhcCCccccc---------------cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          516 HGPSLLAYIWKLWCEGHAAELM---------------DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        ...+..+...........+.               ...... ........+.+++.+||+.+|++|||+.|++..
T Consensus       240 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 --IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             --HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence              12222222211111110000               000000 001123457789999999999999999999864

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.2e-33  Score=290.53  Aligned_cols=262  Identities=22%  Similarity=0.314  Sum_probs=190.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEec----------
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE----------  373 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----------  373 (624)
                      .+|...+.||+|+||.||+|... +++.|++|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67889999999999999999975 5889999998776666677889999999999999999999876553          


Q ss_pred             ----CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEE
Q 006952          374 ----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKI  448 (624)
Q Consensus       374 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl  448 (624)
                          ...++|+||++ ++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                24689999997 588777732    35889999999999999999999985   999999999999974 557899


Q ss_pred             eccccccccCCCCCC-ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH
Q 006952          449 SDFGMARIFGGNQSK-ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      +|||+++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......  ........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~~  234 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILES  234 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh
Confidence            999998765322111 11123457889999998754 567889999999999999999999974221100  00000000


Q ss_pred             H----------HhcCCccccccchhhcCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          527 L----------WCEGHAAELMDSVVKQSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       527 ~----------~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .          ..................+     .....++.+++.+||+.||++|||+.+|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0          0000000000000000000     112245778999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-34  Score=295.96  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=198.0

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----cce
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----ESL  377 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  377 (624)
                      +|.+.+.||+|++|.||+++.. +++.++||++....  ....+.+.+|+.++++++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999976 48899999987644  344577899999999999999999999998775     689


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      ++|||+++ +|.+++..   ...+++..++.++.||++||.|||+.+   |+|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 78887743   237899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCC-CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC----
Q 006952          458 GGNQS-KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG----  531 (624)
Q Consensus       458 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  531 (624)
                      ..... ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......   .....+.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhH
Confidence            44321 1122334678899999999887 7899999999999999999999997432211   1111111110000    


Q ss_pred             -------Cccccccchhh------cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          532 -------HAAELMDSVVK------QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       532 -------~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                             ...+.+.....      ..........+.+++.+||+.+|++||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   00000000000      00001123457889999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=310.06  Aligned_cols=261  Identities=30%  Similarity=0.421  Sum_probs=205.5

Q ss_pred             HHhcCccccCccccCCceeEEEEEecC--------CcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEE
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCL  371 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  371 (624)
                      ...+++.+.+.||+|.||.|++|....        ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            334455666799999999999998431        34699999986543 4678899999999999 7999999999999


Q ss_pred             ecCcceEEEEeccCCChhhhhhcCC-----C------C--cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006952          372 EENESLLIYEYMPNKSLDVFLFDST-----R------S--VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV  438 (624)
Q Consensus       372 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI  438 (624)
                      ..+..++|+||+..|+|..++...+     .      .  ..++....+.++.|||.||+||++.   ++|||||..+||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence            9999999999999999999997654     0      0  2388899999999999999999998   499999999999


Q ss_pred             EEcCCCCeEEeccccccccCCCCCCccccccc--cccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCC
Q 006952          439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVV--GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSE  515 (624)
Q Consensus       439 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~  515 (624)
                      |+.++..+||+|||+++........... ...  -...|||||.+....|+.|+|||||||+||||+| |..|+.-    
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~----  524 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG----  524 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC----
Confidence            9999999999999999965443322211 111  2456999999999999999999999999999999 5666531    


Q ss_pred             CCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          516 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                        ......+++...+|...+...         ....++.+++..||+.+|++||++.++++.+...
T Consensus       525 --~~~~~~l~~~l~~G~r~~~P~---------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  525 --IPPTEELLEFLKEGNRMEQPE---------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --CCcHHHHHHHHhcCCCCCCCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              111122233444444333222         2234577899999999999999999999999873

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.1e-33  Score=289.84  Aligned_cols=262  Identities=23%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCc
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENE  375 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~  375 (624)
                      +...+++|...+.||+|+||.||++... +++.||+|++.+..  ....+.+.+|+.++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999865 68899999886432  2345678899999999999999999999876 456


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++++||+ +++|..++..    ..+++.....++.||++||.|||+.+   |+|+||+|+||++++++.++|+|||++.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence            88999998 5688877732    34788888899999999999999985   9999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH-------
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL-------  527 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------  527 (624)
                      .....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....   ......+.+.       
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH---VNQFSIITDLLGTPPDD  228 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence            54221     123457889999998766 5689999999999999999999998753221   0011111110       


Q ss_pred             ----HhcCCccccccchh-hcCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          528 ----WCEGHAAELMDSVV-KQSCDQA-----ELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       528 ----~~~~~~~~~~d~~l-~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                          +..+...+++.... ....+..     ....+.+++.+||+.+|++||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00011011100000 0011111     12467889999999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-33  Score=281.76  Aligned_cols=258  Identities=27%  Similarity=0.369  Sum_probs=195.9

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      |+..+.||+|++|.||+|+.. +++.+++|.+....  ....+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999976 48999999987653  334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      + ++|.+++....  ..+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999885432  46899999999999999999999985   99999999999999999999999999986543322 


Q ss_pred             ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh-----------cC
Q 006952          464 ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC-----------EG  531 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~  531 (624)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|++|+.....   ...+..+.+...           .-
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence             12234457889999998776 789999999999999999999988742111   111111111100           00


Q ss_pred             -----CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 -----HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 -----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           ..............+ .....+.+++.+||+.+|++||++.+|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                 000000000000000 11346889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=269.22  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             CCCCHHHHHHHhcCccccCccccCCceeEEEEE-ecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEE
Q 006952          293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCC  370 (624)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~  370 (624)
                      ....+.++-+-|+     +.||+|+++.|-.++ +.+|.++|||++.+.......++.+|++++.+.+ |+||++|+++|
T Consensus        71 ~~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   71 LSGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             ccchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            3445677766664     569999999999988 6689999999999998888999999999999995 99999999999


Q ss_pred             EecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eE
Q 006952          371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN---PK  447 (624)
Q Consensus       371 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~k  447 (624)
                      ++++..|||||-|.||+|..+|.   ++..+++.++..++.+|+.||.+||.+|   |.||||||+|||-.+...   +|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCcee
Confidence            99999999999999999998885   4556999999999999999999999997   999999999999976554   79


Q ss_pred             EeccccccccCCCC--C---CccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          448 ISDFGMARIFGGNQ--S---KANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       448 l~Dfg~a~~~~~~~--~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                      |+||.+..-+....  +   ...-...+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||.-.-..+-
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            99999875432211  1   11122467888999999863     34588999999999999999999999863222110


Q ss_pred             CCHHHHHHHHHhcCC-----ccccccchhhc--CCCHHHHH----HHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          518 PSLLAYIWKLWCEGH-----AAELMDSVVKQ--SCDQAELL----KYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~-----~~~~~d~~l~~--~~~~~~~~----~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            .   |..+.     ...++..+..+  +++..++.    +.-+++...+..|+.+|.++.+++.
T Consensus       300 ------G---WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  300 ------G---WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ------C---ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                  0   11110     01112222222  12332222    2234555667799999999988876

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-32  Score=282.11  Aligned_cols=247  Identities=29%  Similarity=0.439  Sum_probs=191.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..|...+.||+|+||.||+|+.. +++.+++|.+...   .....+++.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999965 5788999988642   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+. ++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 5776666432  235889999999999999999999985   999999999999999999999999998754321


Q ss_pred             CCCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                            ....+++.|+|||.+.   .+.++.++||||||+++|||++|+.|+....      ....... +..+......
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~-~~~~~~~~~~  235 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYH-IAQNESPALQ  235 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc------HHHHHHH-HhhcCCCCcC
Confidence                  2346788999999874   3567889999999999999999999863211      1111111 1111111110


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                              .......+.+++.+||+.+|++||++.+|++.-
T Consensus       236 --------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    112233467889999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.9e-33  Score=267.90  Aligned_cols=271  Identities=25%  Similarity=0.366  Sum_probs=199.1

Q ss_pred             hcCccccCccccCCceeEEEEEecC-----CcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~  375 (624)
                      ...|+....||+|.||.||+++-++     .+.+|||+++....  .......+|+.+++.++|||++.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4568888999999999999997443     23689999976532  223566899999999999999999999988 777


Q ss_pred             ceEEEEeccCCChhhhhhcC--CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC----CCeEEe
Q 006952          376 SLLIYEYMPNKSLDVFLFDS--TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE----MNPKIS  449 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~  449 (624)
                      .+|++||.+. +|..+|+..  .+...++...+..|+.||+.|+.|||++.   |+||||||.||||..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999977 666666532  23357889999999999999999999997   9999999999999887    899999


Q ss_pred             ccccccccCCCCCC-ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCC---CCCCCHHHH-
Q 006952          450 DFGMARIFGGNQSK-ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHS---EHGPSLLAY-  523 (624)
Q Consensus       450 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~---~~~~~~~~~-  523 (624)
                      |||++|.+...-.. .....++-|..|.|||.+.+. .||...|||+.|||+.||++-++-|.-...   ...+..... 
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999998655333 244567789999999999875 589999999999999999999877642211   111222222 


Q ss_pred             --HHHHHhcC---Cccccc---------cchhhcCCCHHHH-----------HHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          524 --IWKLWCEG---HAAELM---------DSVVKQSCDQAEL-----------LKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       524 --~~~~~~~~---~~~~~~---------d~~l~~~~~~~~~-----------~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                        +..+..-.   .++.+.         .......+....+           ..-.+|..++|+.||.+|-|.++.++..
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence              22222111   111110         0010011111000           1145677889999999999999998754

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-33  Score=292.72  Aligned_cols=264  Identities=25%  Similarity=0.316  Sum_probs=195.1

Q ss_pred             HHHHHHHhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec
Q 006952          297 LIDIVKATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE  373 (624)
Q Consensus       297 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  373 (624)
                      ..++...+++|...+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345667789999999999999999999985 468899999987542  22346678899999999999999999988653


Q ss_pred             ------CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 006952          374 ------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK  447 (624)
Q Consensus       374 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  447 (624)
                            ...+++++++ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2356777776 7888887732    35899999999999999999999985   99999999999999999999


Q ss_pred             EeccccccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH
Q 006952          448 ISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....   ......+..
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~~~~~~~  232 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILR  232 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHH
Confidence            999999875432     1223467889999998866 5678999999999999999999999742111   111111110


Q ss_pred             HHhcCCcccccc---------------chhhcCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          527 LWCEGHAAELMD---------------SVVKQSC---DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       527 ~~~~~~~~~~~d---------------~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .. ......+..               .......   .......+.+++.+|++.||.+||++.+++..
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             Hh-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00 000000000               0000000   00112357789999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-32  Score=275.83  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=192.1

Q ss_pred             CccccCccccCCceeEEEEEecC-CcEEEEEEcccc-----CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT-----SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +|.+.+.||+|+||.||+++... +..+++|.++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            46778899999999999998653 444555554432     122334567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          380 YEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +||+++++|.+++... .....+++..++.++.|+++||.|||+.+   ++|+||||+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888542 23456899999999999999999999985   999999999999975 569999999987653


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ....  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+..      ........+.. .+....   
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~------~~~~~~~~~~~-~~~~~~---  224 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG------QNFLSVVLRIV-EGPTPS---  224 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC------ccHHHHHHHHH-cCCCCC---
Confidence            3221  12235578899999999888889999999999999999999998641      11222222221 111111   


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            .+......+.+++.+||+.+|++||++.|+++
T Consensus       225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                  12223346778999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=274.17  Aligned_cols=198  Identities=28%  Similarity=0.349  Sum_probs=174.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHH---HHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQE---FKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~---~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|.||+|..++.+ .++.+|+|++++...-...+   -..|-.+|+..+||.+..|...|...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            367888999999999999999965 58899999998765433333   45688899999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||..||.|..+|   .+...+++.....+...|..||.|||+.   +||.||||.+|.|||.+|++||+|||+++.-- 
T Consensus       247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-
Confidence            9999999998887   3455688888899999999999999997   49999999999999999999999999997421 


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                       .....+..++|||.|+|||++....|...+|.|.+||++|||++|+.||
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF  368 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF  368 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence             2223456799999999999999999999999999999999999999996

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-33  Score=289.89  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc---
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE---  375 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---  375 (624)
                      ...++|...+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++|+|++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999976 57899999986532  2334667889999999999999999998876654   


Q ss_pred             ---ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          376 ---SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       376 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                         .++|+||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               79999998 5689888743    45899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh--
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC--  529 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  529 (624)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....   ...+..+.....  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~  235 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTP  235 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC
Confidence            99765332     223467889999998865 3678999999999999999999999742111   111111111000  


Q ss_pred             ---------cCCccccccchhhc---CC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 ---------EGHAAELMDSVVKQ---SC---DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ---------~~~~~~~~d~~l~~---~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                               ......++......   ..   .......+.+++.+||+.+|++|||+.||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                     00000000000000   00   0011346889999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.3e-33  Score=288.89  Aligned_cols=260  Identities=24%  Similarity=0.294  Sum_probs=188.6

Q ss_pred             CccccCccccCCceeEEEEEecC---CcEEEEEEccccC--cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec----Cc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE----NE  375 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~  375 (624)
                      +|...+.||+|+||.||+++...   +..||+|++....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            46778899999999999999653   6789999986532  22356778899999999 599999999976433    34


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 688888743   346899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh---
Q 006952          456 IFGGNQS--KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC---  529 (624)
Q Consensus       456 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  529 (624)
                      .+.....  ........|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.....   ......+.....   
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCC
Confidence            6543221  112234578999999998765 4689999999999999999999998753211   111111111000   


Q ss_pred             --------cCCcccccc-------chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 --------EGHAAELMD-------SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 --------~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                              .........       ..+. .........+.+++.+|++.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    000000000       0000 000011345778999999999999999999853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-32  Score=271.68  Aligned_cols=236  Identities=27%  Similarity=0.337  Sum_probs=190.4

Q ss_pred             cccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      ||+|+||.||++... +++.+++|.+.....   .....+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 488999999876432   2456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccc
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR  468 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  468 (624)
                      .+++...   ..+++.....++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            9998542   35899999999999999999999974   9999999999999999999999999987654322  12234


Q ss_pred             cccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       469 ~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      ..++..|++||...+...+.++|+||||+++|||++|+.|+.....      ......... ...          ..+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~----------~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DPL----------RFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CCC----------CCCCC
Confidence            5678899999999888899999999999999999999999742211      111111111 110          01111


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHH
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSS  573 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~e  573 (624)
                      ....+.+++.+||+.||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1345778999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=269.39  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=196.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.+....||.|.||+|+|-.++ .|+..|||+++.... ...+++..|.+...+- +.||||+++|.+..++..|+.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3444567999999999999876 589999999986554 6677888888876665 799999999999999999999999


Q ss_pred             ccCCChhhhhhc--CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      | ..||+.+-..  ..+...+++.-.-.|..-...||.||.+..  +|||||+||+||||+..|.+||+|||.+..+.+.
T Consensus       145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            9 4566544321  234556888888899999999999998864  8999999999999999999999999998765322


Q ss_pred             CCCccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                         ...+.-.|-..|||||.+..  ..|+.+|||||||++|+|+.||+-|+..++.     +.+.+...... ..+.+..
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g-dpp~l~~  292 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG-DPPILLF  292 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC-CCCeecC
Confidence               22334567889999998854  3589999999999999999999999764432     44444443322 2222222


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      +.    ...+....+.+++-.|+-+|-.+||...++.++
T Consensus       293 ~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11    112234457788889999999999999988653

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=258.57  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=192.2

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.+....||.|..|.|++.+.. .|..+|||.+.++. .+..+++...+.++..-+ +|.||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3444567999999999999976 47889999998764 455677888888887764 89999999999999999999998


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      |. ..++.++..  -..++++..+-++...+.+||.||.+++  .|+|||+||+|||+|+.|++|++|||.+..+-+...
T Consensus       173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            84 345555532  2345888888899999999999999886  799999999999999999999999999876644332


Q ss_pred             CccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                         .+...|-+.|||||.+.   ...|+.++||||||+.|+||.||+.|+.....+     .+..-+...+..      +
T Consensus       248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~eP------P  313 (391)
T KOG0983|consen  248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNEEP------P  313 (391)
T ss_pred             ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhcCC------C
Confidence               23457889999999885   356899999999999999999999997532221     112222222111      2


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .+...-.  -...++++...||+.|+.+||...++++.
T Consensus       314 ~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            2221110  23357788889999999999999988753

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=2.6e-31  Score=300.71  Aligned_cols=146  Identities=27%  Similarity=0.426  Sum_probs=130.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|.+.++||+|+||.||+|... +++.||||++....   ......+..|+.++..++|+||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367889999999999999999976 58899999987543   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      |||+++++|.+++..   ...+++..++.|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999853   235788999999999999999999985   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-33  Score=272.90  Aligned_cols=240  Identities=27%  Similarity=0.325  Sum_probs=191.2

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .+|.....||+|+||.|..+..+. .+.+|||++++..   .++.+--..|-.+|... +-|.+++++.+|..-+.+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            468888999999999999998664 5679999998753   23344445677777766 678999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+.||+|--.+.   +-..+.+..+..++.+|+-||-+||+++   |+.||||.+|||||.+|.+||+|||+++.-- 
T Consensus       429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-  501 (683)
T ss_pred             EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-
Confidence            99999999987774   3455778889999999999999999996   9999999999999999999999999997421 


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                       .....+..++|||.|+|||++....|+..+|.|||||+||||+.|++||+-   ++.+.+.+.+...    .       
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~eh----n-------  566 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEH----N-------  566 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHc----c-------
Confidence             223445679999999999999999999999999999999999999999752   3333333333211    0       


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                         -.++.....+.+.+...-+.++|.+|.
T Consensus       567 ---vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence               123333344555666677888998884

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.2e-31  Score=266.28  Aligned_cols=220  Identities=18%  Similarity=0.151  Sum_probs=174.0

Q ss_pred             CCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChhhhhhc
Q 006952          316 GGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFD  394 (624)
Q Consensus       316 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  394 (624)
                      |.+|.||++... +++.+|+|++....     .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999965 58899999987653     234455556666799999999999999999999999999999998853


Q ss_pred             CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccC
Q 006952          395 STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG  474 (624)
Q Consensus       395 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  474 (624)
                         ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               235899999999999999999999985   9999999999999999999999999886553321     12345678


Q ss_pred             ccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHH
Q 006952          475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI  554 (624)
Q Consensus       475 y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  554 (624)
                      |+|||.+.+..++.++||||+|+++|||++|+.|+.......            ......         ..+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~~---------~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTTL---------NIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccccc---------CCcccCCHHHH
Confidence            999999988889999999999999999999998753211100            000000         01111233577


Q ss_pred             HHHhhcccCCCCCCCCHH
Q 006952          555 HIGLLCVQGDPIDRPTMS  572 (624)
Q Consensus       555 ~l~~~Cl~~dP~~RPs~~  572 (624)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=282.11  Aligned_cols=239  Identities=21%  Similarity=0.269  Sum_probs=188.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++.|.....+|.|+|+.|-.+... .++..++|++.+...+    -.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            577888888999999999999865 5788999999876322    34677676666 79999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-cCCCCeEEeccccccccCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL-DHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      .+.++-+.+.+...   ..+. .++..|+.+|+.++.|||++|   +|||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999887766432   2223 777789999999999999986   9999999999999 58899999999999876443


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                           ....+-|..|.|||++....+++.+|+||||++||+|++|+.|+.-...+      ..+......+...      
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s------  532 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS------  532 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc------
Confidence                 12234578999999999999999999999999999999999997533222      1122222222211      


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            ..-.....+|+.+|||.||.+||+|.++..
T Consensus       533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                  111123456788999999999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.1e-30  Score=258.69  Aligned_cols=238  Identities=28%  Similarity=0.367  Sum_probs=191.8

Q ss_pred             CceeEEEEEecC-CcEEEEEEccccCccc-HHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChhhhhhc
Q 006952          317 GFGPVYKGVLAD-GKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFD  394 (624)
Q Consensus       317 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~  394 (624)
                      +||.||+++..+ ++.+++|++....... .+.+.+|+..+++++|+|++++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999864 8999999998765544 78899999999999999999999999999999999999999999998854


Q ss_pred             CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccC
Q 006952          395 STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG  474 (624)
Q Consensus       395 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  474 (624)
                      ..   .+++..++.++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            22   2889999999999999999999985   9999999999999999999999999998764432   2234567889


Q ss_pred             ccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHH
Q 006952          475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI  554 (624)
Q Consensus       475 y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  554 (624)
                      |++||.+.+..++.++||||||+++++|++|..|+...  .+.    .........+........       ......+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~----~~~~~~~~~~~~~~~~~~-------~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQL----LELFKKIGKPKPPFPPPE-------WKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcH----HHHHHHHhccCCCCcccc-------ccCCHHHH
Confidence            99999999888999999999999999999999987422  111    111111111111110000       00234688


Q ss_pred             HHHhhcccCCCCCCCCHHHHHH
Q 006952          555 HIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       555 ~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            8999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=269.00  Aligned_cols=261  Identities=21%  Similarity=0.332  Sum_probs=206.6

Q ss_pred             HHHhcCccccCccccCCceeEEEEEecC------CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEec
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE  373 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  373 (624)
                      .-...++.....+-+|.||.||.|.|.+      .+.|-+|.++... .-....+..|--++..+.|||+....+++.++
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            3334567777889999999999997653      3457778776543 33456788899999999999999999998775


Q ss_pred             C-cceEEEEeccCCChhhhhh-----cCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 006952          374 N-ESLLIYEYMPNKSLDVFLF-----DSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK  447 (624)
Q Consensus       374 ~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  447 (624)
                      . ..+.+|.++.-|+|..+|.     +......++..+...++.|++.|++|||+++   +||.||..+|.+||+..++|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEE
Confidence            4 5788899999999999998     5556667888899999999999999999986   99999999999999999999


Q ss_pred             EeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHH
Q 006952          448 ISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      |+|=.++|.+-..+...-.........||+||.+.+..|+..+|||||||+||||+| |+.|+.-.++.   ....++  
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---Em~~yl--  511 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---EMEHYL--  511 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---HHHHHH--
Confidence            999999997755555544444556789999999999999999999999999999999 78885422111   111221  


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        ++|..  +.       -+.+++.+|..++.-||...|++||+++|++.-|..
T Consensus       512 --kdGyR--la-------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  512 --KDGYR--LA-------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             --hccce--ec-------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence              22211  11       123345568889999999999999999999998864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.1e-31  Score=291.21  Aligned_cols=260  Identities=19%  Similarity=0.240  Sum_probs=168.0

Q ss_pred             HhcCccccCccccCCceeEEEEEecC-----CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeE------EE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC------CL  371 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------~~  371 (624)
                      ..++|...+.||+|+||.||+|++.+     +..||||++......  +...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999754     689999987643321  111111  1122222233222221      24


Q ss_pred             ecCcceEEEEeccCCChhhhhhcCCCC-----------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006952          372 EENESLLIYEYMPNKSLDVFLFDSTRS-----------------VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK  434 (624)
Q Consensus       372 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk  434 (624)
                      .+...++||||+++++|.+++......                 ....+..+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            556789999999999999988643210                 11123445679999999999999985   9999999


Q ss_pred             CCcEEEcC-CCCeEEeccccccccCCCCCCccccccccccCccChhhhcCC----------------------CCChhhH
Q 006952          435 TSNVLLDH-EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG----------------------IFSVKSD  491 (624)
Q Consensus       435 p~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksD  491 (624)
                      |+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57899999999986543222 222346789999999966432                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc----cccccch----hhcCC--CHHHHHHHHHHHhhcc
Q 006952          492 VFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA----AELMDSV----VKQSC--DQAELLKYIHIGLLCV  561 (624)
Q Consensus       492 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~d~~----l~~~~--~~~~~~~l~~l~~~Cl  561 (624)
                      ||||||+||||+++..+.+       ..+..+.......+..    .....+.    +...+  .........+|+.+||
T Consensus       362 VwSlGviL~el~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD-------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc-------hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            9999999999999765532       1122211111111100    0000100    00000  0001123457999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 006952          562 QGDPIDRPTMSSVAVM  577 (624)
Q Consensus       562 ~~dP~~RPs~~ev~~~  577 (624)
                      +.||++|||++|+++.
T Consensus       435 ~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        435 RFKGRQRISAKAALAH  450 (566)
T ss_pred             cCCcccCCCHHHHhCC
Confidence            9999999999999763

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=281.50  Aligned_cols=261  Identities=18%  Similarity=0.240  Sum_probs=178.0

Q ss_pred             hcCccccCccccCCceeEEEEEe-----------------cCCcEEEEEEccccCcccHHHH--------------HHHH
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-----------------ADGKEIAVKRLSRTSGQGLQEF--------------KNEV  352 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~Ei  352 (624)
                      .++|++.++||+|+||.||+|.+                 ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999974                 2356799999875443322333              3477


Q ss_pred             HHHHhcCCCCc-----ceEEeEEEe--------cCcceEEEEeccCCChhhhhhcCC---------------------CC
Q 006952          353 TVIAKLQHKNL-----VRLLGCCLE--------ENESLLIYEYMPNKSLDVFLFDST---------------------RS  398 (624)
Q Consensus       353 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~  398 (624)
                      .++.+++|.++     ++++++|..        .+..+|||||+++++|.++++...                     ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77788876654     677887753        346799999999999999886421                     11


Q ss_pred             cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccCh
Q 006952          399 VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP  478 (624)
Q Consensus       399 ~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  478 (624)
                      ..++|..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||++........ .......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            23577889999999999999999985   99999999999999999999999999976533211 111123347899999


Q ss_pred             hhhcCCCC----------------------ChhhHHHHHHHHHHHHHhCCC-CCCCCC----CCCCCCHHHHHHHHHhcC
Q 006952          479 EYAMGGIF----------------------SVKSDVFSFGVVLLEIISGKK-STGFYH----SEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       479 E~~~~~~~----------------------~~ksDv~S~Gvil~elltg~~-p~~~~~----~~~~~~~~~~~~~~~~~~  531 (624)
                      |.+.....                      ..+.||||+||+++||++|.. |+....    ...........|+.+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      235799999999999999875 543110    000001111122222222


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDP---IDRPTMSSVAV  576 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~ev~~  576 (624)
                      ....  . .+     ........+++.++|..+|   .+|+|++|+++
T Consensus       460 ~~~~--~-~~-----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDF--S-LL-----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCc--c-cc-----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1110  0 00     1112345567777887655   78999999975

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=284.21  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEe-----
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLE-----  372 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-----  372 (624)
                      +...++-|++.+.||.|.+|.||+++. ++++.+|+|++...... .++++.|.++++.+ .|||++.++|++..     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            334567899999999999999999994 56889999988765443 36778899999988 69999999999864     


Q ss_pred             cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      ++++|||||||.+|+.-+++.+.. ...+.|..+..|+..++.||.+||.+   .++|||||-.|||++.++.+||.|||
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence            567999999999999999987644 67899999999999999999999998   49999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      .+..+...  ....+...|||.|||||++..     ..|+.++|+||||++..||--|.+|....++.      ...   
T Consensus       169 vSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raL---  237 (953)
T KOG0587|consen  169 VSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RAL---  237 (953)
T ss_pred             eeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhh---
Confidence            99876433  344556889999999999854     34778999999999999999999996422221      111   


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +.-.   .-..+-+  .-+..-..++.+++..||.+|-++||++.++++
T Consensus       238 F~Ip---RNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 FLIP---RNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccCC---CCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1000   0011111  113445667899999999999999999998764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-32  Score=295.47  Aligned_cols=257  Identities=23%  Similarity=0.269  Sum_probs=197.9

Q ss_pred             HHHHHhcCccccCccccCCceeEEEEEecC-CcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          299 DIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       299 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      ++.-..++|.+.+.||+|+||.|...+.+. ++.+|+|++.+-   ......-|..|-.+|..-+.+=|++|+..|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            344445789999999999999999999865 778899999762   2334466888999999889999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ++|+||||++||+|-.++.+   ...+++..+..++..|.-||.-||+.|   +|||||||+|||||..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999843   236889999999999999999999986   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      -.+..+.. ......+|||.|++||++..     +.|+..+|.||+||++|||+.|..||-      .++++.--.+...
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm~  295 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIMN  295 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHhc
Confidence            87764432 23345789999999999852     568999999999999999999999962      2233333233322


Q ss_pred             cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 006952          530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT---MSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~  576 (624)
                      -.....+.+...    -.++...|   |..-+ -+|+.|..   +.++-.
T Consensus       296 hk~~l~FP~~~~----VSeeakdL---I~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  296 HKESLSFPDETD----VSEEAKDL---IEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hhhhcCCCcccc----cCHHHHHH---HHHHh-cChhhhcccccHHHHHh
Confidence            222222222111    12233333   33333 37888887   888754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=253.65  Aligned_cols=267  Identities=22%  Similarity=0.236  Sum_probs=197.3

Q ss_pred             HhcCcccc-CccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEec----Cc
Q 006952          303 ATQDFSQE-NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE----NE  375 (624)
Q Consensus       303 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~  375 (624)
                      .+++|.+. ++||-|-.|.|..+..+ .++++|+|++...     .+..+|+++.-.. .|||||.+++++.+.    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666654 68999999999999976 5889999998654     3457888887766 699999999998653    44


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEeccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFG  452 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg  452 (624)
                      +++|||.|+||.|..-+.+ .....+++.++-.|+.||+.|+.|||+.   +|.||||||+|+|...+   -.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            6889999999999988865 3455799999999999999999999997   69999999999999654   468999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +++.-..   .......+-||.|.|||++...+|+...|+||+||++|-|++|-+||-..+.   ..+..-.+..+..+.
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ  283 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC
Confidence            9986432   2233345679999999999999999999999999999999999999732111   111111111111111


Q ss_pred             ccccccchhhcCCCHHHHH----HHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCcccc
Q 006952          533 AAELMDSVVKQSCDQAELL----KYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL  595 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~----~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~~p~~~~  595 (624)
                      .          .++.+|+.    ..-+++...|..+|++|.|+.+++..== ....-..|..|.+..
T Consensus       284 y----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw-i~~~~~vp~tpl~t~  339 (400)
T KOG0604|consen  284 Y----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW-INQYEAVPQTPLSTS  339 (400)
T ss_pred             c----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch-hcccccCCCCCchhh
Confidence            1          22333332    3446778889999999999999865311 112233455555543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-32  Score=273.01  Aligned_cols=193  Identities=30%  Similarity=0.489  Sum_probs=167.1

Q ss_pred             cCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          310 ENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      .+.||+|.||+||-|+++ +|+.||||++.+.  ..+....+.+|+.+|++++||.||.|.-.|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999965 6999999999764  3344477899999999999999999999999999999999999665


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEeccccccccCCCCCC
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      -|.-+| . .....+++..-..++.||+.||.|||.+   +|+|+||||+||||.+.   -++||+|||++|.+++... 
T Consensus       649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            554444 3 3445688888888999999999999998   49999999999999654   3699999999999875433 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                        ...++|||.|+|||++..+.|...-|+||.|||+|--++|.-||.
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence              335789999999999999999999999999999999999998864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=250.23  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=197.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|.....||+|+|.+|..++++ ..+.+|+|++++.   ..+.+.....|-.+..+. +||.+|.|+.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367888999999999999999975 4678999998763   445566777888888887 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |.||+++|+|-.++   .+...++++.+..+..+|.-||.|||+.|   |+.||||.+|||||.+|.+||.|+|+++.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999997666   44556899999999999999999999986   9999999999999999999999999998532


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCC-CCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS-EHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .  ....+..++|||.|+|||++.+..|...+|.|++||+++||+.|+.||+.-.. ..+.+...+..+.+.+..+. + 
T Consensus       403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-i-  478 (593)
T KOG0695|consen  403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-I-  478 (593)
T ss_pred             C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-c-
Confidence            2  22335568999999999999999999999999999999999999999985332 22333334444443333221 1 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                              +.....+...+...-|.+||.+|.
T Consensus       479 --------prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 --------PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --------cceeehhhHHHHHHhhcCCcHHhc
Confidence                    111122334555567888888884

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=261.45  Aligned_cols=255  Identities=26%  Similarity=0.341  Sum_probs=190.0

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEcccc--Ccc-----cHHHHHHHHHHHHhcCCCCcceEEeEEEec-Cc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT--SGQ-----GLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-NE  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~  375 (624)
                      ++|-..++||+|+|+.||++.. ...+-||+|+-..+  -.+     ..+...+|..+.+.|.||.||++++++.-+ +.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            5577789999999999999994 45677888874322  111     123345799999999999999999999754 55


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEeccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFG  452 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  452 (624)
                      .+-|+|||+|.+|+.+|.   ....+++.++..|++||+.||.||.+.. ++|||-||||.||||.+   -|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence            789999999999999994   4556899999999999999999999874 78999999999999954   4679999999


Q ss_pred             cccccCCCCCC-----ccccccccccCccChhhhcCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHH
Q 006952          453 MARIFGGNQSK-----ANTNRVVGTYGYMAPEYAMGG----IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       453 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  523 (624)
                      +++.+.++...     ..+....||..|++||.+.-+    +.+.|+||||.|||+|.-+.|+.||+...  ...++++.
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQQdILqe  696 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQQDILQE  696 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hHHHHHhh
Confidence            99998765433     223456799999999987533    57889999999999999999999986322  22222221


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV  574 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  574 (624)
                             ..+.+...-.+  ...+.-..+...++.+||+.--++|-...++
T Consensus       697 -------NTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  697 -------NTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -------hchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence                   11111110000  0001111234567789999999999876655

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.5e-31  Score=249.17  Aligned_cols=264  Identities=24%  Similarity=0.401  Sum_probs=190.0

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccC-ccc-HHHHHHHHHHHHhcCCCCcceEEeEEEec--------
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS-GQG-LQEFKNEVTVIAKLQHKNLVRLLGCCLEE--------  373 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------  373 (624)
                      ..|+..++||+|.||.||+++.++ |++||+|++.... +.. -....+|+.+|..|+|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            456667899999999999999764 7788998765432 222 23457899999999999999999887542        


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      ...++|+.+|+. +|.-+|.+  ....++..++.+++.++.+||.|+|..   .|+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            236899999976 56666633  345688899999999999999999987   599999999999999999999999999


Q ss_pred             ccccCCCCC--CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH--
Q 006952          454 ARIFGGNQS--KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW--  528 (624)
Q Consensus       454 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--  528 (624)
                      ++.+.....  ....+..+-|..|.+||.+.+ .+|+.+.|||+-|||+.||.++.+-+..   ......+..+..+.  
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg---nteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG---NTEQQQLHLISQLCGS  247 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC---ChHHHHHHHHHHHhcc
Confidence            987754322  223334556999999998876 5689999999999999999999876532   22223333333221  


Q ss_pred             -hcCCccccccchhhcC-----CC-------HHH------HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          529 -CEGHAAELMDSVVKQS-----CD-------QAE------LLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       529 -~~~~~~~~~d~~l~~~-----~~-------~~~------~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                       ..+.+++...-.+-..     .+       .+.      .....+|+.+++..||.+|+...+++..
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence             1222222211111000     00       000      1134567778899999999999998653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-31  Score=267.35  Aligned_cols=266  Identities=22%  Similarity=0.284  Sum_probs=205.0

Q ss_pred             cCccccCccccCCceeEEEEEecCCc-EEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGK-EIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .+++....||-|+||.|=....++.. .+|+|.+++.   .....+.+..|-.+|...+.|.||+++--|.++...|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566678999999999988875433 3788887654   2334466778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      |-|-||.|...|.   .+..++......++..+.+|++|||+++   ||+|||||+|.+|+.+|-+||.|||+++.+...
T Consensus       500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999994   4566888889999999999999999986   999999999999999999999999999988644


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                         ..+-.++|||.|.|||++.+...+..+|.||+|+++|||++|++||.-.++....+   .+.   +.-...++    
T Consensus       574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn---~IL---kGid~i~~----  640 (732)
T KOG0614|consen  574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN---LIL---KGIDKIEF----  640 (732)
T ss_pred             ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH---HHH---hhhhhhhc----
Confidence               34556899999999999999999999999999999999999999986433322211   111   11111111    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHHHh--cc------CCCCCCCCCCCccc
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAVML--AS------DILTLPKPTQPAFS  594 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~L--~~------~~~~~~~p~~p~~~  594 (624)
                           |........+++...+..+|.+|..     +.+|-+.-  .+      ..-.+|+|-.|+..
T Consensus       641 -----Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va  702 (732)
T KOG0614|consen  641 -----PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA  702 (732)
T ss_pred             -----ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence                 2222234556777777889999976     55664321  11      13346666666543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=225.52  Aligned_cols=195  Identities=27%  Similarity=0.457  Sum_probs=163.4

Q ss_pred             CccccCccccCCceeEEEEEecC-CcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +|...++||+|.||+||+++..+ ++.||+|+++-.+  +..-....+||-+++.++|+|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45667889999999999999654 7789999886543  22345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      |.. +|..+...  -+..++...+..++.|+++||.++|++   ++.||||||.|.||+.||.+|++|||+++.++-+-.
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            954 66665532  345688899999999999999999998   599999999999999999999999999998764432


Q ss_pred             CccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCC
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKS  508 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p  508 (624)
                      -  ....+-|..|.+|.++-+.+ |+...|+||-|||+.||.....|
T Consensus       157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            1  12235689999999988765 78999999999999999986666

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=256.57  Aligned_cols=258  Identities=21%  Similarity=0.277  Sum_probs=196.9

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcC-C-C----CcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-H-K----NLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-~----niv~l~~~~~~~~~~  376 (624)
                      +.+|.+...+|+|.||.|-++.... +..||||+++.-. ...+..+-|+++++++. + |    -+|++.+||.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6789999999999999999998654 6789999886533 33455677999999993 2 2    368888999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--------------
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH--------------  442 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------------  442 (624)
                      ++|+|.+ |.|+.++|.. .+..+++...+..|+.|+++++++||+..   ++|.||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999998 6688898854 34567899999999999999999999984   999999999999831              


Q ss_pred             ------CCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006952          443 ------EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH  516 (624)
Q Consensus       443 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~  516 (624)
                            +..+||+|||.++.-....     ..++.|..|.|||++.+-.++..+||||+||||.||.+|..-|...+.  
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen--  314 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN--  314 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc--
Confidence                  3358999999998653332     357789999999999999999999999999999999999977643221  


Q ss_pred             CCCHHHHHHHHHhcCCccccccch------------------------h---------hcCCCHHHHHHHHHHHhhcccC
Q 006952          517 GPSLLAYIWKLWCEGHAAELMDSV------------------------V---------KQSCDQAELLKYIHIGLLCVQG  563 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~d~~------------------------l---------~~~~~~~~~~~l~~l~~~Cl~~  563 (624)
                       ...+....+... .-...++...                        .         .....+.+...|.+|+..||..
T Consensus       315 -~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  315 -LEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             -HHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence             111122111111 1111111100                        0         0123456677899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 006952          564 DPIDRPTMSSVAV  576 (624)
Q Consensus       564 dP~~RPs~~ev~~  576 (624)
                      ||.+|+|+.|++.
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-30  Score=232.38  Aligned_cols=202  Identities=28%  Similarity=0.402  Sum_probs=165.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +.+.....||+|++|.|-+-++. +|...|+|++...- .+..++..+|+.+..+. .+|.+|.++|....+...++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            34445678999999999888854 68999999997543 45566778899887665 79999999999999999999999


Q ss_pred             eccCCChhhhhhc-CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          382 YMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       382 y~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      .| ..||+.+-.+ -.+...+++..+-+|+..+..||.|||++  +.++|||+||+|||++.+|++||+|||.+-.+.+.
T Consensus       126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            99 4577665432 23556789999999999999999999997  58999999999999999999999999999776433


Q ss_pred             CCCccccccccccCccChhhhcC----CCCChhhHHHHHHHHHHHHHhCCCCCCCC
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG----GIFSVKSDVFSFGVVLLEIISGKKSTGFY  512 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~S~Gvil~elltg~~p~~~~  512 (624)
                      -.   .+...|-..|||||.+..    ..|+.|+||||||+.+.||.+++.|++.+
T Consensus       203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            22   222457788999998853    46899999999999999999999997643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3.8e-28  Score=234.36  Aligned_cols=211  Identities=37%  Similarity=0.615  Sum_probs=183.4

Q ss_pred             cccCCceeEEEEEecC-CcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChhh
Q 006952          313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDV  390 (624)
Q Consensus       313 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~  390 (624)
                      ||+|.+|.||++...+ ++++++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999998765443 45778999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccccccccCCCCCCcccccc
Q 006952          391 FLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGNQSKANTNRV  469 (624)
Q Consensus       391 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~  469 (624)
                      ++....  ..+++..++.++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985422  45889999999999999999999985   999999999999999 89999999999986643321  12234


Q ss_pred             ccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHH
Q 006952          470 VGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA  548 (624)
Q Consensus       470 ~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  548 (624)
                      .+...|++||..... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 788999999999999999                                              


Q ss_pred             HHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       549 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                        ..+.+++..|++.+|++||++.++++.+
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3577889999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.1e-29  Score=259.43  Aligned_cols=200  Identities=25%  Similarity=0.379  Sum_probs=170.7

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..|...+.||-|+||.|.++...| ...+|.|.+.+.+.   ......+.|-.||.....+-||+|+..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            447778999999999999998554 55689998877542   33455788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC-
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG-  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-  459 (624)
                      +|++||++-.+|.   +...+++..+..++.++..|+++.|..|   +|||||||+|||||.+|.+||.|||++.-+.- 
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999998884   4456888999999999999999999986   99999999999999999999999999964411 


Q ss_pred             --------CCCC-------------------------------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHH
Q 006952          460 --------NQSK-------------------------------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLL  500 (624)
Q Consensus       460 --------~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~  500 (624)
                              ....                               ......+||+.|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    0000                               0012457999999999999999999999999999999


Q ss_pred             HHHhCCCCCC
Q 006952          501 EIISGKKSTG  510 (624)
Q Consensus       501 elltg~~p~~  510 (624)
                      ||+.|++||-
T Consensus       863 em~~g~~pf~  872 (1034)
T KOG0608|consen  863 EMLVGQPPFL  872 (1034)
T ss_pred             HHhhCCCCcc
Confidence            9999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=270.69  Aligned_cols=246  Identities=27%  Similarity=0.389  Sum_probs=185.4

Q ss_pred             ccccCccccCCcee-EEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEecc
Q 006952          307 FSQENKLGEGGFGP-VYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       307 ~~~~~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      |...+.+|.|..|+ ||+|.. +|++||||++-...   .....+||..|+.- +|||||++++.-.++...|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            45557889999875 699999 58999999986543   23557899999998 69999999999888899999999994


Q ss_pred             CCChhhhhhcCCCC-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---C--CCeEEeccccccccC
Q 006952          385 NKSLDVFLFDSTRS-VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---E--MNPKISDFGMARIFG  458 (624)
Q Consensus       385 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~~  458 (624)
                       .+|.+++...... ....-...+.+..|+++||++||+.   +||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5899999763111 1111144577899999999999996   5999999999999976   3  468999999999886


Q ss_pred             CCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          459 GNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG-KKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       459 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .+... .......||-+|+|||++.....+..+||||+||++|..++| +.||+...       ...+ ...........
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-------~R~~-NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-------ERQA-NILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH-------Hhhh-hhhcCccceee
Confidence            65433 334567899999999999998888999999999999998886 88986211       1111 11111111111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +.+.     ++.   ...+|+.+|+..+|..||++.+|+.
T Consensus       735 L~~~-----~d~---eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEPL-----PDC---EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eccC-----chH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1111     111   5567888999999999999999963

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3e-29  Score=230.82  Aligned_cols=257  Identities=21%  Similarity=0.371  Sum_probs=192.9

Q ss_pred             HhcCccccCccccCCceeEEEEE-ecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecC--cceE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEEN--ESLL  378 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~~l  378 (624)
                      ..++|++.+++|+|.++.||.|. ..+.++++||+++.-.   .+.+++|+.+|+.|. ||||++|++...+..  ...|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35788999999999999999999 4568899999987543   367899999999997 999999999988754  4689


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEecccccccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  457 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  457 (624)
                      |+||+.+.+...+-      +.++...+...+.++++||.|+|+.|   |+|||+||.|++||+.. .++|+|+|+|.+.
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998876543      34677788899999999999999997   99999999999999765 5899999999887


Q ss_pred             CCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .....   .+..+.+..|.-||.+.. ..|+.+-|+|||||+|.+|+..+.||  ++..+..+.+-.+.+..........
T Consensus       184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG~dN~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc--cCCCCCHHHHHHHHHHhChHHHHHH
Confidence            54432   223456778899998866 45789999999999999999999996  4444444444333333221111000


Q ss_pred             -------ccch----hhc------------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 -------MDSV----VKQ------------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 -------~d~~----l~~------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                             +++.    +..            +...-...+.++++-+.|..|..+|||++|...
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                   1111    111            000111234566777889999999999998754

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=253.45  Aligned_cols=196  Identities=27%  Similarity=0.422  Sum_probs=167.4

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc--------ccHHHHHHHHHHHHhcC---CCCcceEEeEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG--------QGLQEFKNEVTVIAKLQ---HKNLVRLLGCCL  371 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~  371 (624)
                      ..+|...+.||+|+||.|+.++++. ..+|+||.+.+..-        ...-.+--||.+|..|+   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3457888999999999999999764 66899998876531        11223456999999997   999999999999


Q ss_pred             ecCcceEEEEec-cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          372 EENESLLIYEYM-PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       372 ~~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                      +++.++|+||-. ++.+|.++|.   .+..+++.+...|+.|++.|+++||+++   |||||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999976 4567888883   4567999999999999999999999996   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCC
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      ||.+......    ....++||..|.|||++.+..| ...-|||++|++||.++....|+
T Consensus       714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9998765433    3446889999999999999887 55689999999999999988885

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=9e-27  Score=228.16  Aligned_cols=198  Identities=32%  Similarity=0.500  Sum_probs=171.4

Q ss_pred             ccccCccccCCceeEEEEEecC-CcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999875 889999999876554 67889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +++|.+++.....  .+++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            9999999854221  1789999999999999999999985   999999999999999999999999999876543211 


Q ss_pred             cccccccccCccChhhh-cCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          465 NTNRVVGTYGYMAPEYA-MGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      ......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22335678899999998 66778889999999999999999999973

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-29  Score=235.11  Aligned_cols=261  Identities=23%  Similarity=0.336  Sum_probs=187.7

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----CcceE
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NESLL  378 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~l  378 (624)
                      .+..+.||-|+||.||..+.. +|+.|++|++..-  +-...+.+.+|+.+|.-.+|.|++..++...-.     .+.|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            445678999999999999864 7999999998643  223457889999999999999999998876543     24567


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +.|.+ ..+|+.+|..   ...++-..+.-++.||++||.|||+.+   |.||||||.|.|++.|-.+||+|||+++...
T Consensus       135 ~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            78877 4578877743   345777778889999999999999985   9999999999999999999999999999765


Q ss_pred             CCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc--
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE--  535 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  535 (624)
                      .+.....+ ..+-|..|.|||++++. .|+...||||.|||+.||+..+--|.-..+   ...++.+.........+.  
T Consensus       208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P---iqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP---IEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh---HHHHHHHHHHhCCCcHHHHH
Confidence            44443333 34568999999999985 589999999999999999987755432111   122222222222211111  


Q ss_pred             ---------cccchhhc---------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          536 ---------LMDSVVKQ---------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       536 ---------~~d~~l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                               ++....+.         ..+...-.+-..+..+++..||.+|-+..+.+..+
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                     11111100         01112222344566678899999999998887765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=3e-28  Score=254.37  Aligned_cols=252  Identities=24%  Similarity=0.373  Sum_probs=200.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|+..+++|.|.+|.|||++.+ .++..|+|+++-.......-+..|+-+++..+|+|||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467888999999999999999965 5888999999988888888889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      |.+|+|.+.-+   -...+++.++....+...+||+|||+.+   -+|||||-.|||+++.+.+|++|||.+-.+...  
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence            99999988664   3456888999999999999999999986   799999999999999999999999998766432  


Q ss_pred             CccccccccccCccChhhh---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC-Ccccccc
Q 006952          463 KANTNRVVGTYGYMAPEYA---MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG-HAAELMD  538 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d  538 (624)
                      -.....+.||+.|||||+.   ..+.|..++|||+.|+...|+---++|-...++      .+...-.-..+ +...+-|
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTkS~~qpp~lkD  239 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTKSGFQPPTLKD  239 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhccCCCCCcccC
Confidence            2334468899999999986   457799999999999999999888877321111      11111111111 1112222


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +       ..-...+-+++..|+.++|.+||+.+.++.
T Consensus       240 k-------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 K-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             C-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1       112334567888899999999999987653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.1e-27  Score=219.98  Aligned_cols=253  Identities=19%  Similarity=0.303  Sum_probs=191.7

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeE-EEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGC-CLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~-~~~~~~~~lV~  380 (624)
                      .+.|.+.+.||+|.||.+-.+.++. ...+++|-+.+.- ...++|.+|...--.| .|.||+.-+++ |...+.+.+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4578899999999999999999875 5678999876543 3457889998877667 59999987765 66777888999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCCeEEeccccccccC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNPKISDFGMARIFG  458 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~  458 (624)
                      ||+|.|+|..-+..    ..+.+.....++.|+++||.|||++   ++||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999877643    3477888889999999999999998   599999999999993  33479999999987654


Q ss_pred             CCCCCccccccccccCccChhhhcCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGG-----IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      ..-     ....-+..|.+||.....     ...+.+|||.||++++..+||+.||. ....  .+.-.|-|..|.++..
T Consensus       175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~--~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASI--MDKPYWEWEQWLKRKN  246 (378)
T ss_pred             cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhc--cCchHHHHHHHhcccC
Confidence            321     122335678999976432     24678999999999999999999986 3333  3344555666777766


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      ....+..-  .+    ..+++++..+-+..+|++|--..++.++.
T Consensus       247 ~~~P~~F~--~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALPKKFN--PF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCchhhc--cc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            65544331  11    23466677788999999996666666554

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-25  Score=224.29  Aligned_cols=131  Identities=24%  Similarity=0.364  Sum_probs=108.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-----C---CCcceEEeEEEe---
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-----H---KNLVRLLGCCLE---  372 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~~---  372 (624)
                      .+|...++||-|.|++||.+... +.+-||+|+.+... .-.+....||.+|++++     |   .+||+|+++|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67888999999999999999965 46679999886432 23455688999999984     2   479999999975   


Q ss_pred             -cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          373 -ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       373 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                       +.+.+||+|++ |-+|..+|... ....++...+.+|+.||+.||.|||.+.  +|||.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             45689999999 55666766543 3456889999999999999999999987  89999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-26  Score=221.10  Aligned_cols=255  Identities=25%  Similarity=0.323  Sum_probs=187.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------c
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------E  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~  375 (624)
                      .+|.....+|.|.- .|..+... .++.||+|++...  .....++..+|..++..++|+|+++++.++.-.+      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666778888887 55555532 5889999987643  2344567789999999999999999999987543      4


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++|||+| ..+|...+.     ..++......|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            68999999 457777774     45788889999999999999999986   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH----------
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW----------  525 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~----------  525 (624)
                      .-...   -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.-   +  ..+-+|.+          
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g---~--d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG---K--DHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC---c--hHHHHHHHHHHHhcCCCH
Confidence            54322   234456788999999999998899999999999999999999966531   1  11112211          


Q ss_pred             ----------HHHhcCCcc-------cc-ccchhhc--CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          526 ----------KLWCEGHAA-------EL-MDSVVKQ--SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       526 ----------~~~~~~~~~-------~~-~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                +.+......       +. .|.....  ..+.........++.+||-.+|++|-|.+++++.
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                      111110000       00 0100000  0111223446678899999999999999999764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.4e-26  Score=265.18  Aligned_cols=196  Identities=19%  Similarity=0.247  Sum_probs=137.8

Q ss_pred             hcCC-CCcceEEeEE-------EecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006952          357 KLQH-KNLVRLLGCC-------LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI  428 (624)
Q Consensus       357 ~l~h-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i  428 (624)
                      .++| +||++++++|       ...+..++++||+ +++|.++|...  ...+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 6888888887       2334567788887 66999999542  345899999999999999999999985   9


Q ss_pred             EecCCCCCcEEEcC-------------------CCCeEEeccccccccCCCCC--------------CccccccccccCc
Q 006952          429 IHRDLKTSNVLLDH-------------------EMNPKISDFGMARIFGGNQS--------------KANTNRVVGTYGY  475 (624)
Q Consensus       429 vH~Dlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y  475 (624)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   34556666666653211000              0001124578899


Q ss_pred             cChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHH
Q 006952          476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIH  555 (624)
Q Consensus       476 ~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  555 (624)
                      ||||++.+..++.++|||||||+||||++|.+|+..    . .......    ...    ...+..     .........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~----~-~~~~~~~----~~~----~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE----K-SRTMSSL----RHR----VLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh----H-HHHHHHH----HHh----hcChhh-----hhcCHHHHH
Confidence            999999999999999999999999999998877421    0 0011101    000    011110     111234567


Q ss_pred             HHhhcccCCCCCCCCHHHHHH
Q 006952          556 IGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       556 l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ++.+||+.+|.+||+|.||++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            788999999999999999975

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.4e-26  Score=235.28  Aligned_cols=197  Identities=24%  Similarity=0.318  Sum_probs=167.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC------CCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ------HKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~~~~~~~~~~~  377 (624)
                      ..|.+....|+|-|++|.+|... -|++||||++..+.. ..+.=+.|+++|++|+      ..|+++|+-.|....+++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC  510 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC  510 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence            57888889999999999999965 488999999976532 2233467999999996      358999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARI  456 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  456 (624)
                      ||+|-+ ..+|.++|....+...|....+..++.|+.-||..|..-+   |+|.||||.||||++.- .+||+|||.|..
T Consensus       511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccc
Confidence            999988 5689999988777888999999999999999999999875   99999999999998764 579999999976


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      ...+..    +...-+..|.|||++.|-.|+...|+||.||.||||.||+.-|.
T Consensus       587 ~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  587 ASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             cccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            644332    12334567999999999999999999999999999999997654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=3.4e-25  Score=221.80  Aligned_cols=199  Identities=26%  Similarity=0.464  Sum_probs=165.4

Q ss_pred             HHHhcCccccCccccCCceeEEEEEecC----CcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      ....+.|...++||+|.|++||++++..    .+.||+|.+...+..  .++.+|+++|..+ -+.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3345678889999999999999999543    568999999876554  5689999999999 59999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEeccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMA  454 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a  454 (624)
                      ..+|+||++.-...++...      ++..++..+++.+..||.++|.+|   ||||||||+|+|.+.. +.-.|.|||++
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence            9999999999998888743      678889999999999999999996   9999999999999754 56789999999


Q ss_pred             cccCCCC-------------C-----------------------------CccccccccccCccChhhhcC-CCCChhhH
Q 006952          455 RIFGGNQ-------------S-----------------------------KANTNRVVGTYGYMAPEYAMG-GIFSVKSD  491 (624)
Q Consensus       455 ~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksD  491 (624)
                      .......             .                             ........||++|.|||++.. +..+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7221000             0                             000113469999999999865 56789999


Q ss_pred             HHHHHHHHHHHHhCCCCCC
Q 006952          492 VFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       492 v~S~Gvil~elltg~~p~~  510 (624)
                      |||-|||++-+++++.||-
T Consensus       261 iws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             eeeccceeehhhccccccc
Confidence            9999999999999999973

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.2e-24  Score=203.63  Aligned_cols=165  Identities=18%  Similarity=0.161  Sum_probs=122.5

Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      |+|.+++...  ...++|.+++.|+.||++||.|||+.+         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6888888542  345999999999999999999999873         999999999999999  99988654321    


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                         ..||+.|||||++.+..++.++||||||+++|||++|+.|+.....  ...............    ....    ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~----~~~~----~~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD----DPRD----RS  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC----Cccc----cc
Confidence               2588999999999999999999999999999999999999742211  111111111111110    0000    00


Q ss_pred             CHHHH---HHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          546 DQAEL---LKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       546 ~~~~~---~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .....   ..+.+++.+||+.+|++||++.|+++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            11111   258899999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.90  E-value=4e-24  Score=183.30  Aligned_cols=101  Identities=33%  Similarity=0.712  Sum_probs=78.2

Q ss_pred             cCCCC-C-CCCC-CCCChHHHHHHHHHHHhhhhcCCC--CCceeeeccCCCCeEEEEEecCCCCChhhhHHHHHHHHHHH
Q 006952           22 YKFCP-R-GTNN-TASIIYVYNLSKLFNRKLHEDGGN--SLYRNASVGDYPDKVYGLFLCRFDVSHQVCQNCIFDAIDIL   96 (624)
Q Consensus        22 ~~~C~-~-~~~~-~~~s~f~~nl~~l~~~l~~~~~~~--~~~~~~~~g~~~~~vyg~~~C~~d~~~~~C~~C~~~a~~~~   96 (624)
                      |+.|+ | .++| +++++|++||+.||+.|...++.+  .+|++++.|.++++|||++||++|+++++|..||+.|+..+
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~   80 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI   80 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence            56898 4 4566 678889999999999999998764  46999999999999999999999999999999999999999


Q ss_pred             HHhCCCCccEEEEcceeEEEEccccc
Q 006952           97 VESCNGTKEATIWYDICMVRYSNNFF  122 (624)
Q Consensus        97 ~~~C~~~~~~~~~~~~C~~ry~~~~f  122 (624)
                      .+.|+.+++|+||++.|+||||+++|
T Consensus        81 ~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   81 SSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHhCCCCceEEEECCCEEEEEECCCC
Confidence            99999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.7e-23  Score=214.28  Aligned_cols=167  Identities=19%  Similarity=0.227  Sum_probs=129.7

Q ss_pred             HHhcCccccCccccCCceeEEEEEec--CCcEEEEEEcccc-----CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA--DGKEIAVKRLSRT-----SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      ...++|...+.||+|+||+||+|.++  +++.+|||++...     .....+.+.+|+++|++++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            44578999999999999999999865  4777899986533     12235678999999999999999853322   24


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCCeEEecccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDL-KTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~  453 (624)
                      ..++||||+++++|....    ..   .   ...++.|++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            679999999999996321    11   1   1467889999999999985   999999 99999999999999999999


Q ss_pred             ccccCCCCCCcc------ccccccccCccChhhhcCC
Q 006952          454 ARIFGGNQSKAN------TNRVVGTYGYMAPEYAMGG  484 (624)
Q Consensus       454 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  484 (624)
                      ++.+........      -....+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            997754332111      1356788899999988643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=6.9e-22  Score=205.09  Aligned_cols=259  Identities=22%  Similarity=0.258  Sum_probs=190.7

Q ss_pred             CccccCccccCCceeEEEEEecCC--cEEEEEEccccCcccHHHHHHHHHHHHhcCC----CCcceEEeEE-EecCcceE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLADG--KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH----KNLVRLLGCC-LEENESLL  378 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~~l  378 (624)
                      +|.+.+.||+|+||.||.+.....  ..+|+|............++.|+.++..++.    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997654  4788888766543333377889999999973    6899999988 46777899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-----CCeEEecccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-----MNPKISDFGM  453 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~  453 (624)
                      ||+.+ |.+|.++..... ...++....+.|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 889988775433 567999999999999999999999987   9999999999999765     3589999999


Q ss_pred             cc--ccCCCC----CCcc--ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          454 AR--IFGGNQ----SKAN--TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       454 a~--~~~~~~----~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ++  .+....    ....  .....||..|.+++...+...+.+.|+||++.++.|++.|..||........   .....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence            98  332211    1111  2345699999999999999999999999999999999999999853222211   11111


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +.........      .......+...+.+   .+-..+...+|....+...|...
T Consensus       251 ~~~~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KDPRKLLTDR------FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHhhhhcccc------ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHH
Confidence            1111111111      11223333333333   33447999999999998887554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=9.3e-21  Score=195.31  Aligned_cols=262  Identities=30%  Similarity=0.408  Sum_probs=196.4

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEccccCcc---cHHHHHHHHHHHHhcCCC-CcceEEeEEEecCcceEEEEe
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHK-NLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556788999999999999986  88999998765433   467899999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  461 (624)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++... .+++.|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643221136888999999999999999999986   99999999999999998 69999999998654433


Q ss_pred             CCc----cccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          462 SKA----NTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       462 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ...    ......|+..|++||.+.+   ...+...|+||+|++++++++|..|+......   ......+.........
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            221    2356789999999999988   57899999999999999999999995432221   1111222222111111


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                       .................+.+++..|+..+|..|.++.+....
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000000000001223456778888999999999999887664

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5e-23  Score=194.25  Aligned_cols=246  Identities=23%  Similarity=0.323  Sum_probs=185.2

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCC
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      ...+|.+...|..|+|++. |..+++|++...  .....++|..|.-.|+-..||||+.++|.|....+..++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3457889999999999995 667777877543  2334567899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe--ccccccccCCCCCCc
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS--DFGMARIFGGNQSKA  464 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfg~a~~~~~~~~~~  464 (624)
                      +|+.+|+. ......+..++.+++.+|++|+.|||+.. +-|.---|+...|++|++.+.+|+  |--++-.        
T Consensus       273 slynvlhe-~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--------  342 (448)
T KOG0195|consen  273 SLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------  342 (448)
T ss_pred             HHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--------
Confidence            99999976 34456788899999999999999999986 335555799999999999988874  3222211        


Q ss_pred             cccccccccCccChhhhcCCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIF---SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~---~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       .....-.|.||+||.++..+-   -..+|+|||.+++|||.|...||....+-      +...+.-.++-.        
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm------ecgmkialeglr--------  407 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM------ECGMKIALEGLR--------  407 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch------hhhhhhhhcccc--------
Confidence             111223688999999987653   35789999999999999999998633222      122222222221        


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                       -..++.....+.+++.-|+.+||.+||.+..|+-.|++.
T Consensus       408 -v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 -VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence             122222333456677779999999999999999888754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.9e-22  Score=221.04  Aligned_cols=254  Identities=24%  Similarity=0.291  Sum_probs=186.2

Q ss_pred             cccCccccCCceeEEEEEec-CCcEEEEEEcc----cc-Ccc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLA-DGKEIAVKRLS----RT-SGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~----~~-~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ...+.+|.|++|.|+..... ..+..+.|.+.    .. ... ....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988777643 23334444332    11 111 1122556777888889999988888777766666669


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++ +|..++..   ...+...++..++.|+..|+.|||+.|   |.|||||++|+++..++.+||+|||.+..+.-.
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 99888843   245788888999999999999999997   999999999999999999999999999877554


Q ss_pred             CCC--ccccccccccCccChhhhcCCCCCh-hhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          461 QSK--ANTNRVVGTYGYMAPEYAMGGIFSV-KSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       461 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ...  .....++|+..|+|||++.+..|.+ -.||||.|+++..|++|+.||......+... .+     ..........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~-----~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT-----NNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh-----hccccccccc
Confidence            443  4556788999999999999999965 5799999999999999999987655444322 00     0000111111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...  .........+...++..+|+.+|.+|-|+++|++
T Consensus       548 ~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            100  0112334456778899999999999999999975

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.84  E-value=1.6e-21  Score=167.14  Aligned_cols=92  Identities=41%  Similarity=0.671  Sum_probs=74.7

Q ss_pred             CChhHHHHHHHHHHHHHHHHhccC-CccceeeeeeccCCCceeEEEecCCCCCccchhhhHhhhhccccccCCCCcccEE
Q 006952          141 KEPDKFTQILNQTFNDVIRNATSS-DSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTCSKGKRGARI  219 (624)
Q Consensus       141 ~~~~~f~~~~~~l~~~l~~~a~~~-~~~~~~~~~~~~~~~~vyglaQC~~dls~~~C~~CL~~~~~~~~~~~~~~~g~~v  219 (624)
                      ++++.|.+++..+|..|...|+.+ +.+|++++. ..+.++||||+||++||+++||..||+.++..++.+|+++.||+|
T Consensus        14 ~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v   92 (106)
T PF01657_consen   14 TDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRV   92 (106)
T ss_dssp             -TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEE
T ss_pred             CCCchHHHHHHHHHHHHHHHHhhccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEE
Confidence            455669999999999999998644 468988876 447789999999999999999999999999999999999999999


Q ss_pred             eccccceeeeeccc
Q 006952          220 FCPSCSIRYELYRF  233 (624)
Q Consensus       220 ~~~~C~~ry~~~~f  233 (624)
                      ++++|+||||+++|
T Consensus        93 ~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   93 WYDSCFLRYENYPF  106 (106)
T ss_dssp             EESSEEEEEESS--
T ss_pred             ECCCEEEEEECCCC
Confidence            99999999999988

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=6.5e-21  Score=177.40  Aligned_cols=202  Identities=23%  Similarity=0.346  Sum_probs=165.7

Q ss_pred             hcCccccCccccCCceeEEEEE-ecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCC-CCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH-KNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ...|...++||.|+||.+|.|. ..+|++||||.-+.....  -.+..|..+...|+| ..|..+.-+..+.+.-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4679999999999999999999 567999999987655443  345778899999975 667777777788888899999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEeccccccccC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIFG  458 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~  458 (624)
                      .+ |.+|.++..-..  ..++....+-++.|++.-++|+|.++   ++||||||+|+|..-   -..+.++|||+++.+.
T Consensus        92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 788888764332  34778889999999999999999985   999999999999954   3468999999998875


Q ss_pred             CCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC
Q 006952          459 GNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH  513 (624)
Q Consensus       459 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~  513 (624)
                      +..+.     .......||.+|.+-....+...+.+.|+-|+|.+|..+--|..||.-..
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            43322     23345679999999888888888999999999999999999999986433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=7.1e-20  Score=177.94  Aligned_cols=203  Identities=24%  Similarity=0.364  Sum_probs=169.2

Q ss_pred             cCccccCccccCCceeEEEEE-ecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      -+|++.++||+|.||.++.|+ +-+++.||||.-.+.++.  -++..|....+.| ..++|...+.+-..+.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478999999999999999999 457999999976554432  4567889999888 579999988888888888999998


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-----CCeEEecccccccc
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-----MNPKISDFGMARIF  457 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~a~~~  457 (624)
                      + |-||+++..-.  ...++.+.+.-|+.|++.-++|+|++.   +|.|||||+|+||..-     ..+.|+|||+++.+
T Consensus       106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 77888766322  235888999999999999999999985   9999999999999543     35889999999988


Q ss_pred             CCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 006952          458 GGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSE  515 (624)
Q Consensus       458 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~  515 (624)
                      .+..+.     .......||.+||+-....+.+.+.+.|+-|+|-++...+-|..||.-....
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            665433     2334577999999999999999999999999999999999999998744433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=1.6e-20  Score=179.06  Aligned_cols=139  Identities=15%  Similarity=0.155  Sum_probs=107.8

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcc--c-------HH-----------------HHHHHHHHHHhcCCCCc
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ--G-------LQ-----------------EFKNEVTVIAKLQHKNL  363 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~h~ni  363 (624)
                      ...||+|++|.||+|...+|+.||||+++.....  .       ..                 ...+|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  1       11                 22359999999988776


Q ss_pred             ceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEEcC
Q 006952          364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL-HEDSRLKIIHRDLKTSNVLLDH  442 (624)
Q Consensus       364 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~  442 (624)
                      .......  ....+|||||++++++...+.   ....+++.....++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4433222  223489999999987765432   224588899999999999999999 6765   99999999999998 


Q ss_pred             CCCeEEecccccccc
Q 006952          443 EMNPKISDFGMARIF  457 (624)
Q Consensus       443 ~~~~kl~Dfg~a~~~  457 (624)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=6.8e-21  Score=183.74  Aligned_cols=170  Identities=14%  Similarity=0.170  Sum_probs=133.0

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHH---H------HHHHHHHHHhcCCCCcceEEeEEEec-
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQ---E------FKNEVTVIAKLQHKNLVRLLGCCLEE-  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---~------~~~Ei~~l~~l~h~niv~l~~~~~~~-  373 (624)
                      .++|+..+.||+|+||.||.... ++..+|||.+........+   .      +.+|+..+.+++|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            47899999999999999999655 5778999999754333222   2      68999999999999999999886643 


Q ss_pred             -------CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          374 -------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       374 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                             ...+|+|||++|.+|.++..       ++.    ....+++.+|..||+.+   ++|||+||+||+++.++ +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                   35789999999999977631       222    24569999999999986   99999999999999988 9


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII  503 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ell  503 (624)
                      +|+|||...........              ..++....+..++|+||||+.+.-+.
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988654221110              11445556678999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=173.52  Aligned_cols=140  Identities=19%  Similarity=0.248  Sum_probs=110.7

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCccc--------------------------HHHHHHHHHHHHhcCCCCc
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG--------------------------LQEFKNEVTVIAKLQHKNL  363 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~h~ni  363 (624)
                      ...||+|++|.||+|+..+|+.||||++.......                          ...+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999998789999999987642110                          1224679999999999987


Q ss_pred             ceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcC
Q 006952          364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE-DSRLKIIHRDLKTSNVLLDH  442 (624)
Q Consensus       364 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~  442 (624)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554444332  3589999999886543321   12356778889999999999999999 75   99999999999999 


Q ss_pred             CCCeEEeccccccccC
Q 006952          443 EMNPKISDFGMARIFG  458 (624)
Q Consensus       443 ~~~~kl~Dfg~a~~~~  458 (624)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=1.4e-20  Score=207.00  Aligned_cols=251  Identities=18%  Similarity=0.217  Sum_probs=182.1

Q ss_pred             CccccCccccCCceeEEEEEecCCcEEEEEEccccC-cccHHHHHHHHHHHH--hcCCCCcceEEeEEEecCcceEEEEe
Q 006952          306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS-GQGLQEFKNEVTVIA--KLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~--~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++...+.||.+.|=+|.+++.++|. |+||++-+.. .-..+.|+++++-++  .++|||.+++.-+-..+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6777889999999999999998887 9999986654 445566666555444  45899999999888788888999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC-CC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG-NQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~  461 (624)
                      +.+ +|++-|   ..++-+...+..+|+.|++.||..+|..+   |.|||||.+||||+.-..+.|+||...+..-- .+
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            865 666666   45566788889999999999999999986   99999999999999999999999987654211 11


Q ss_pred             CCccccccc----cccCccChhhhcCC-----------CCChhhHHHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHH
Q 006952          462 SKANTNRVV----GTYGYMAPEYAMGG-----------IFSVKSDVFSFGVVLLEIISG-KKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       462 ~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~ksDv~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ......-+.    .-..|+|||.+...           ..+++.||||+||++.||++. +++|.         +.+...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~a  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLA  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHh
Confidence            111121222    23479999987441           167899999999999999985 66664         111110


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        ++.+. .......+++-.    ...+.++++.|+|.||++|.++++.++.-+.
T Consensus       247 --Yr~~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  247 --YRSGN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             --HhccC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence              11111 111111111111    1147789999999999999999999987544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7e-20  Score=193.10  Aligned_cols=216  Identities=23%  Similarity=0.417  Sum_probs=163.7

Q ss_pred             HHhcCCCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006952          355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK  434 (624)
Q Consensus       355 l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk  434 (624)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..  ....++|.....++.+|++||.|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999965  4567999999999999999999999874  23999999


Q ss_pred             CCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCC-------CChhhHHHHHHHHHHHHHhCCC
Q 006952          435 TSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-------FSVKSDVFSFGVVLLEIISGKK  507 (624)
Q Consensus       435 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDv~S~Gvil~elltg~~  507 (624)
                      ++|.++|..+.+||+|||+.................-...|.|||.+.+..       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999987664311111111222345799999987632       4677999999999999999999


Q ss_pred             CCCCCCCCCCC-CHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          508 STGFYHSEHGP-SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       508 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ||......... .+...+.+     .....+.|.+....  +....+..++.+||.++|++||++++|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            98754333322 23333222     12222333222111  2223688899999999999999999998888654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=1.4e-18  Score=164.06  Aligned_cols=184  Identities=16%  Similarity=0.144  Sum_probs=139.7

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccCcc----cHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEe
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ----GLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .....|++|+||+||...- .+.+++.+.+.....-    ....+.+|+++|++|+ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997665 6788888877655431    1236889999999995 5889999886    456999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDL-KTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      +.|.+|...+..          ....++.|+.++|.++|+.+   |+|||| ||.|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654311          11357789999999999986   999999 7999999999999999999998654322


Q ss_pred             CC----cc-------ccccccccCccChhhhcCC-CCC-hhhHHHHHHHHHHHHHhCCCCC
Q 006952          462 SK----AN-------TNRVVGTYGYMAPEYAMGG-IFS-VKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       462 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~ksDv~S~Gvil~elltg~~p~  509 (624)
                      ..    ..       ......++.|++|+...-. ..+ ...+.++.|.-+|.++|+..+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            11    00       1122357888999865432 233 6779999999999999999874

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=8.3e-19  Score=174.32  Aligned_cols=234  Identities=20%  Similarity=0.287  Sum_probs=152.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEcccc---CcccHHHHHHHHHHHHhcCC----------CCcceEEeEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQH----------KNLVRLLGCC  370 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~~  370 (624)
                      ..+.....||.|+++.||.++..+ ++++|+|++...   ....++.+++|......+.+          -.++--++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            345667899999999999999865 889999987533   23456778888776666433          2222222222


Q ss_pred             E---------ecC--------cceEEEEeccCCChhhhhh---c-CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 006952          371 L---------EEN--------ESLLIYEYMPNKSLDVFLF---D-STRSVQLDWKRRISIIKGIARGILYLHEDSRLKII  429 (624)
Q Consensus       371 ~---------~~~--------~~~lV~Ey~~~gsL~~~l~---~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv  429 (624)
                      .         ...        ..+++|+-+ .++|.+++.   . ......+....++.+..|+++.+++||+.|   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1         111        225566666 567776653   1 122234556667788899999999999997   99


Q ss_pred             ecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcC--------CCCChhhHHHHHHHHHHH
Q 006952          430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG--------GIFSVKSDVFSFGVVLLE  501 (624)
Q Consensus       430 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~S~Gvil~e  501 (624)
                      |+||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|++|+++|.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            9999999999999999999999987754332111     233577999997643        247899999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCC
Q 006952          502 IISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDR  568 (624)
Q Consensus       502 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  568 (624)
                      |.++..|++....+.....                    .-..|. +....+..|+..+|+.||++|
T Consensus       243 lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999875433322111                    123455 566677888999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=2.4e-19  Score=201.53  Aligned_cols=198  Identities=22%  Similarity=0.269  Sum_probs=158.2

Q ss_pred             HHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcce
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESL  377 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~  377 (624)
                      +...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-.   |---.+++.+|+   -+-|..+.....-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            34457789999999999999999999889999999877654321   111223344444   234445555556677889


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-------CCCCeEEec
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-------HEMNPKISD  450 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~D  450 (624)
                      ||+||.+.|+|.+++.   ....++|.....++.|+++.++.||..+   |||+||||+|.||.       ++..++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999994   5667999999999999999999999986   99999999999993       234589999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCC
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK  507 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~  507 (624)
                      ||.+..+.--.........++|-.+-.+|...|..++...|.|.+.-+++-|+.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999875543333334456678899999999999999999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3.1e-18  Score=164.80  Aligned_cols=137  Identities=20%  Similarity=0.337  Sum_probs=106.5

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-----CCCCcceEEeEEEecC---c-ce
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-----QHKNLVRLLGCCLEEN---E-SL  377 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~-~~  377 (624)
                      +...+.||+|+||.||.  +++....+||++........+.+.+|+.+++++     .||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996  433333479988765555567899999999999     5799999999998874   2 33


Q ss_pred             EEEEe--ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEEcC----CCCeEEec
Q 006952          378 LIYEY--MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI-LYLHEDSRLKIIHRDLKTSNVLLDH----EMNPKISD  450 (624)
Q Consensus       378 lV~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D  450 (624)
                      +|+||  +++++|.+++.+.    .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  6689999999542    25544  35677888777 8999985   999999999999974    34799999


Q ss_pred             cccc
Q 006952          451 FGMA  454 (624)
Q Consensus       451 fg~a  454 (624)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.4e-19  Score=190.56  Aligned_cols=223  Identities=25%  Similarity=0.290  Sum_probs=172.8

Q ss_pred             ccccCCceeEEEEE----ecCCcEEEEEEccccCcc--cHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEecc
Q 006952          312 KLGEGGFGPVYKGV----LADGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      .+|+|.||.|+...    .+.|.-+++|.+++....  .....+.|-.++..++ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999998765    334677888888764321  1224567888888886 9999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +|.|...+.   +...+++.........++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999987763   3445777777788889999999999986   99999999999999999999999999986532221  


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh--
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK--  542 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--  542 (624)
                          .+||..|||||+++  .....+|.||||++++||++|..||..       +..                ..+++  
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~----------------~~Il~~~  203 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTM----------------KRILKAE  203 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHH----------------HHHhhhc
Confidence                28999999999998  457789999999999999999999752       111                11111  


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                      -..+.+.......++..++..+|.+|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            12233444455566667778888888655

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=3.7e-17  Score=161.21  Aligned_cols=144  Identities=17%  Similarity=0.197  Sum_probs=112.0

Q ss_pred             hcCccccCccccCCceeEEEEE--ecCCcEEEEEEccccCcc------------------------cHHHHHHHHHHHHh
Q 006952          304 TQDFSQENKLGEGGFGPVYKGV--LADGKEIAVKRLSRTSGQ------------------------GLQEFKNEVTVIAK  357 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~  357 (624)
                      ...|.+.+.||+|++|.||+|+  ..+|+.||+|++......                        ....+.+|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457788999999999999998  568999999998753210                        11235689999999


Q ss_pred             cCCC--CcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 006952          358 LQHK--NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKT  435 (624)
Q Consensus       358 l~h~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp  435 (624)
                      +.+.  .+.+.+++    ...++||||+++.+|......   ...+.......++.||+.+|.+||+.+  .|+||||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            9753  34445543    245899999999888665422   234556667889999999999999984  399999999


Q ss_pred             CcEEEcCCCCeEEecccccccc
Q 006952          436 SNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       436 ~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=4.6e-17  Score=158.46  Aligned_cols=134  Identities=19%  Similarity=0.314  Sum_probs=113.2

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcc--------cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ--------GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.||+|++|.||+|.. +|..+++|+.......        ....+.+|+.++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 6788999976543211        124578899999999999998888888788889999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999888431      12 77899999999999999985   99999999999999 78899999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=5e-18  Score=175.66  Aligned_cols=124  Identities=28%  Similarity=0.474  Sum_probs=109.5

Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++.|++|...+|.+||.........++...+.++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999876667778899999999999999999   43   899999999999999999999999998


Q ss_pred             cccCCCC----CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh
Q 006952          455 RIFGGNQ----SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS  504 (624)
Q Consensus       455 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt  504 (624)
                      .......    .....+...||..||+||.+.+..|+.|+||||||+||+||++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7665443    2234456789999999999999999999999999999999997

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=9.7e-17  Score=154.59  Aligned_cols=143  Identities=21%  Similarity=0.223  Sum_probs=111.2

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcc----------------------cHHHHHHHHHHHHh
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ----------------------GLQEFKNEVTVIAK  357 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~~  357 (624)
                      +.+....|...+.||+|+||.||++..++|+.||||++......                      ....+..|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333447778999999999999999888999999986543210                      11235778999999


Q ss_pred             cCCCC--cceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 006952          358 LQHKN--LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKT  435 (624)
Q Consensus       358 l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp  435 (624)
                      +.|++  ++..++    ....++||||+++++|......         .....++.++++++.++|+.+   |+||||||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            98774  444444    2456899999999998765420         234578899999999999975   99999999


Q ss_pred             CcEEEcCCCCeEEeccccccccC
Q 006952          436 SNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       436 ~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +||++++++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=1.1e-16  Score=154.20  Aligned_cols=130  Identities=20%  Similarity=0.343  Sum_probs=106.6

Q ss_pred             ccccCCceeEEEEEecCCcEEEEEEccccCc--------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSG--------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .||+|++|.||+|.+ ++..+++|+......        ....++.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 578899998654321        11356778999999999887766666666777789999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++++|.+++....          ..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988774311          078999999999999985   99999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.7e-16  Score=175.95  Aligned_cols=138  Identities=17%  Similarity=0.314  Sum_probs=112.2

Q ss_pred             HhcCccccCccccCCceeEEEEEecCCcEEEEEE-cccc-C------cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKR-LSRT-S------GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      ....|...+.||+|+||.||+|.+.+.. +++|+ +.+. .      ....+++.+|++++.+++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445567889999999999999876443 44443 2221 1      112356889999999999999998888888877


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999988873           35678999999999999985   9999999999999 6779999999998


Q ss_pred             cc
Q 006952          455 RI  456 (624)
Q Consensus       455 ~~  456 (624)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            75

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=1.1e-15  Score=152.24  Aligned_cols=198  Identities=21%  Similarity=0.300  Sum_probs=133.0

Q ss_pred             CCCCcceEEeEEEec---------------------------CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHH
Q 006952          359 QHKNLVRLLGCCLEE---------------------------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK  411 (624)
Q Consensus       359 ~h~niv~l~~~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  411 (624)
                      +|||||++++.|.++                           ...++||.-++ .+|.+++...    ..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence            599999999887642                           12467777664 3677777432    345566677899


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCCC--CeEEeccccccccCCCCC----CccccccccccCccChhhhcC
Q 006952          412 GIARGILYLHEDSRLKIIHRDLKTSNVLL--DHEM--NPKISDFGMARIFGGNQS----KANTNRVVGTYGYMAPEYAMG  483 (624)
Q Consensus       412 qia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~  483 (624)
                      |+++|+.|||.++   |.|||+|.+||||  |+|+  .+.|+|||++-.-.....    ....-...|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999996   9999999999998  3443  468899998753222111    111123457778999999865


Q ss_pred             CC------CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHH
Q 006952          484 GI------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG  557 (624)
Q Consensus       484 ~~------~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  557 (624)
                      ..      .-.|+|.|+.|-+.||+++...||-  ..++.  .++.  +.+.+....-+.+     .+    ...+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY--~rGem--~L~~--r~Yqe~qLPalp~-----~v----pp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY--KRGEM--LLDT--RTYQESQLPALPS-----RV----PPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccc--ccchh--eech--hhhhhhhCCCCcc-----cC----ChHHHHHH
Confidence            32      2369999999999999999999963  22211  0000  0122222222222     22    23467788


Q ss_pred             hhcccCCCCCCCCHHHHHHHhc
Q 006952          558 LLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       558 ~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ...|+.||.+||+..-....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            8889999999999876666664

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=3.5e-15  Score=136.21  Aligned_cols=135  Identities=21%  Similarity=0.228  Sum_probs=115.0

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCC--CCcceEEeEEEecCcceEEEEeccCC
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH--KNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            34679999999999999854 7899999866543  4678999999999976  58999999888888899999999988


Q ss_pred             ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       387 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      .+..+          +......++.+++++|.+||......++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4566678899999999999986545699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=3.9e-15  Score=141.98  Aligned_cols=136  Identities=20%  Similarity=0.255  Sum_probs=98.4

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcc--cHHH----------------------HHHHHHHHHhcCCC--Cc
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ--GLQE----------------------FKNEVTVIAKLQHK--NL  363 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~h~--ni  363 (624)
                      .+.||+|+||.||++...+++.||||++......  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999987653221  1111                      13566666666443  34


Q ss_pred             ceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcC
Q 006952          364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE-DSRLKIIHRDLKTSNVLLDH  442 (624)
Q Consensus       364 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~  442 (624)
                      .+.++.    ...++||||++++.+.........   .. .....++.+++.++.++|. .   +|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            444443    346899999999654321111000   11 5677899999999999998 6   499999999999999 


Q ss_pred             CCCeEEecccccccc
Q 006952          443 EMNPKISDFGMARIF  457 (624)
Q Consensus       443 ~~~~kl~Dfg~a~~~  457 (624)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            889999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1.7e-15  Score=167.44  Aligned_cols=210  Identities=20%  Similarity=0.284  Sum_probs=136.5

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+|+..+.|..|++|.||..+++. .+.+|+| +.++.-     +.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence            3578889999999999999998774 5677874 332211     1110  22222334333                  


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                         |+=...+..   -+.++.        +++.+++|||+.+   |+|||+||+|.+|+.-|.+|+.|||+.+.......
T Consensus       136 ---gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               222222211   112221        2378999999986   99999999999999999999999999876422111


Q ss_pred             -------------CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          463 -------------KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       463 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                                   ......++||+.|+|||++....|..-+|+|++|+|+||.+-|+.||.-...   +.++.   ++..
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg---~vis  272 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFG---QVIS  272 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHh---hhhh
Confidence                         1122356899999999999999999999999999999999999999742111   11221   2221


Q ss_pred             cC-CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          530 EG-HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       530 ~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                      +. .+.+- |..        ...+...++.+.|+.+|..|--.
T Consensus       273 d~i~wpE~-dea--------~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  273 DDIEWPEE-DEA--------LPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             hhcccccc-CcC--------CCHHHHHHHHHHHHhChHhhccc
Confidence            11 12222 111        12235566677889999999533

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=2.6e-14  Score=141.31  Aligned_cols=135  Identities=20%  Similarity=0.287  Sum_probs=104.9

Q ss_pred             cCccc-cCCceeEEEEEecCCcEEEEEEccccC-------------cccHHHHHHHHHHHHhcCCCCc--ceEEeEEEec
Q 006952          310 ENKLG-EGGFGPVYKGVLADGKEIAVKRLSRTS-------------GQGLQEFKNEVTVIAKLQHKNL--VRLLGCCLEE  373 (624)
Q Consensus       310 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~  373 (624)
                      ...|| .|+.|+||..... +..++||++.+..             ......+.+|+.++.+|+|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999998874 7889999875421             1223567889999999998775  6777775443


Q ss_pred             Cc----ceEEEEeccC-CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          374 NE----SLLIYEYMPN-KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       374 ~~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      ..    .++|+|++++ .+|.+++..    ..++..    .+.+|+.+|.+||+.|   |+|+||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 688888743    234433    3578999999999986   999999999999999999999


Q ss_pred             eccccccc
Q 006952          449 SDFGMARI  456 (624)
Q Consensus       449 ~Dfg~a~~  456 (624)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=4.3e-16  Score=172.22  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=187.2

Q ss_pred             cCccccCccccCCceeEEEEEecC--CcEEEEEEccccC--cccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD--GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..|...+.||+|.|+.|-......  ...+++|.+....  ....+....|..+-..+. |+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456667789999999998887643  3456777665543  334455566888888886 99999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEEcCCC-CeEEecccccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH-EDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  457 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  457 (624)
                      .||..++++.+.+.... ....+.........|+..++.|+| ..+   +.|+||||+|.++++.+ ..+++|||++..+
T Consensus       100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999988773211 113444556678899999999999 664   99999999999999999 9999999999887


Q ss_pred             CC-CCCCcccccccc-ccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          458 GG-NQSKANTNRVVG-TYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       458 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.+....+. ....|.     +..  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~-----~~~--  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWK-----SNK--  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeec-----ccc--
Confidence            66 444455556678 9999999998884 457789999999999999999999876554442 111111     111  


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA  575 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  575 (624)
                      .......    -........++..+++..+|..|.+.+++.
T Consensus       248 ~~~~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 GRFTQLP----WNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccCc----cccCChhhhhcccccccCCchhcccccccc
Confidence            0000000    001112345566678889999999988773

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=2.9e-13  Score=145.32  Aligned_cols=141  Identities=22%  Similarity=0.293  Sum_probs=99.7

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccH----------------------------------------HHHH
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL----------------------------------------QEFK  349 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~  349 (624)
                      .+.||.|++|.||+|++++|+.||||+.+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            478999999999999999999999999865421110                                        0244


Q ss_pred             HHHHHHHhcC----CCCcceEEeEEE-ecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHH-HHHHHHhc
Q 006952          350 NEVTVIAKLQ----HKNLVRLLGCCL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR-GILYLHED  423 (624)
Q Consensus       350 ~Ei~~l~~l~----h~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~yLH~~  423 (624)
                      +|...+.+++    |.+-+.+-..+. .....+|||||++|++|.++......  ..   .+..++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5666555552    333333333332 24457999999999999887642111  11   23456666666 46788887


Q ss_pred             CCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       424 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +   ++|+|+||.||+++++++++++|||++..++
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            5   9999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=1.5e-13  Score=134.19  Aligned_cols=206  Identities=22%  Similarity=0.264  Sum_probs=137.6

Q ss_pred             HHHHHhcCCCCcceEEeEEEecC-----cceEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCC
Q 006952          352 VTVIAKLQHKNLVRLLGCCLEEN-----ESLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSR  425 (624)
Q Consensus       352 i~~l~~l~h~niv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~  425 (624)
                      ...|-++-|-|||+++.++.+..     ...++.||+..|++..+|.... ....+......+|+.||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            34455667999999999876543     4689999999999999997533 2345666777789999999999999974 


Q ss_pred             CCeEecCCCCCcEEEcCCCCeEEeccc--cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHH
Q 006952          426 LKIIHRDLKTSNVLLDHEMNPKISDFG--MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII  503 (624)
Q Consensus       426 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg--~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ell  503 (624)
                      |+|+|+++.-+-|++..++-+|+.---  .....-.......+....+-++|.+||.-...+.+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            789999999999999999988874211  111000000111122234678999999877777888999999999999998


Q ss_pred             hCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          504 SGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       504 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      -+..-..  ..+.......-+.     ..+. ....-++           ..++..|++..|..||+|++++..
T Consensus       277 ilEiq~t--nseS~~~~ee~ia-----~~i~-~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQST--NSESKVEVEENIA-----NVII-GLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccC--CCcceeehhhhhh-----hhee-eccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence            8763311  1111000000000     0000 0111111           135567999999999999987643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=5.9e-12  Score=117.86  Aligned_cols=129  Identities=22%  Similarity=0.179  Sum_probs=97.4

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcc-eEEeEEEecCcceEEEEeccCCChh
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV-RLLGCCLEENESLLIYEYMPNKSLD  389 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~gsL~  389 (624)
                      +.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56899999999999875 78899998765432 223568899999999655554 454443  33468999999998875


Q ss_pred             hhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       390 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ...        .   ....+..+++++|..||..+  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            420        0   11245678999999999875  23469999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.29  E-value=3.9e-12  Score=138.21  Aligned_cols=145  Identities=17%  Similarity=0.217  Sum_probs=94.5

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCccc----------------------------------HH--
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQG----------------------------------LQ--  346 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~~--  346 (624)
                      ..+|+. +.||.|++|+||++++++ |++||||+++....+.                                  .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 799999999999999987 9999999987542110                                  01  


Q ss_pred             ----HHHHHHHHHHhcC----CCCcceEEeEEEe-cCcceEEEEeccCCChhhhhhcCCCC---cccCHHHHHHHHHHHH
Q 006952          347 ----EFKNEVTVIAKLQ----HKNLVRLLGCCLE-ENESLLIYEYMPNKSLDVFLFDSTRS---VQLDWKRRISIIKGIA  414 (624)
Q Consensus       347 ----~~~~Ei~~l~~l~----h~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia  414 (624)
                          ++.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++..-....   ..+.......++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                1334444444442    3333333333333 45678999999999997742111111   123233333333443 


Q ss_pred             HHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEeccccccccCC
Q 006952          415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFGMARIFGG  459 (624)
Q Consensus       415 ~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~  459 (624)
                            +..   +++|+|+||.||+++.++    +++++|||++..++.
T Consensus       277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  334   499999999999999988    999999999987643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=4.9e-12  Score=134.08  Aligned_cols=249  Identities=21%  Similarity=0.248  Sum_probs=176.8

Q ss_pred             cCccccCcccc--CCceeEEEEEe---cCCcEEEEEEccccC--cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          305 QDFSQENKLGE--GGFGPVYKGVL---ADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       305 ~~~~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      +.|...+.+|.  |.+|.||.+..   .++..+|+|+-+...  ......=.+|+....++ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34566788999  99999999987   357889999854332  23333335677777777 599999988888889999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEecc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR----GILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDF  451 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  451 (624)
                      ++-.|++. .+|..+.+..  ...++....+.+..+..+    ||.++|..   +++|-|+||.||++.++ ...++.||
T Consensus       194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999985 6776666432  233566777788888888    99999997   49999999999999999 78999999


Q ss_pred             ccccccCCCCCCccc---cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          452 GMARIFGGNQSKANT---NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       452 g~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      |+...++........   ....|...|++||..+ +.++...|+|++|.+..|-.++..........        .|.  
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~--  336 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWS--  336 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccc--
Confidence            999988765532221   2235778899999765 45689999999999999998886543211000        011  


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ..+...+.++....     -..++..++.++++++|-.|++.+.+..
T Consensus       337 -~~r~~~ip~e~~~~-----~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 -QLRQGYIPLEFCEG-----GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -ccccccCchhhhcC-----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             11111111111111     1123344778899999999999887754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.24  E-value=5.7e-11  Score=127.09  Aligned_cols=166  Identities=19%  Similarity=0.275  Sum_probs=128.0

Q ss_pred             ecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHH
Q 006952          326 LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR  405 (624)
Q Consensus       326 ~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~  405 (624)
                      ..++.+|.|+..+..+....+..++-++.|+.++||||++++...+.++..|||+|-+.  .|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34688899998887766555667888999999999999999999999999999999874  45555532      23455


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCC
Q 006952          406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI  485 (624)
Q Consensus       406 ~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  485 (624)
                      ....+.||+.||.+||+.+  +++|++|.-..|+|+..|..||++|.++........  .......-..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6677899999999999877  799999999999999999999999998865432221  111112223466776543322


Q ss_pred             CChhhHHHHHHHHHHHHHhC
Q 006952          486 FSVKSDVFSFGVVLLEIISG  505 (624)
Q Consensus       486 ~~~ksDv~S~Gvil~elltg  505 (624)
                        -..|.|.||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              356999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.22  E-value=2.7e-10  Score=107.83  Aligned_cols=136  Identities=14%  Similarity=0.118  Sum_probs=98.7

Q ss_pred             CccccCCceeEEEEEecC-------CcEEEEEEccccC----------------------cccHHHHH----HHHHHHHh
Q 006952          311 NKLGEGGFGPVYKGVLAD-------GKEIAVKRLSRTS----------------------GQGLQEFK----NEVTVIAK  357 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~  357 (624)
                      ..||.|.=+.||.|...+       +..+|||+.+...                      ....+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998653       4789999764321                      01122333    89999999


Q ss_pred             cCC--CCcceEEeEEEecCcceEEEEeccCCChhh-hhhcCCCCcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 006952          358 LQH--KNLVRLLGCCLEENESLLIYEYMPNKSLDV-FLFDSTRSVQLDWKRRISIIKGIARGILYL-HEDSRLKIIHRDL  433 (624)
Q Consensus       358 l~h--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~Dl  433 (624)
                      +..  -++.+.+++    ...+|||||+.+..+.. .+.    ...++..+...+..+++.+|..| |+.+   |+|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            953  466677764    56789999998754421 121    12344456677889999999999 7764   999999


Q ss_pred             CCCcEEEcCCCCeEEeccccccccC
Q 006952          434 KTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       434 kp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ++.|||++ ++.++|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=3.2e-10  Score=110.90  Aligned_cols=142  Identities=18%  Similarity=0.297  Sum_probs=110.7

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCC--CCcceEEeEEEecC---cceEEEEecc
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQH--KNLVRLLGCCLEEN---ESLLIYEYMP  384 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~---~~~lV~Ey~~  384 (624)
                      +.|+.|..+.||++...+|+.+++|....... .....+.+|+.+++.+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999998765432 245678999999999975  44577777766532   5689999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS----------------------------------------  424 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------------  424 (624)
                      +.++...+..    ..++...+..++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765521    24677777888888888888888531                                        


Q ss_pred             -------------CCCeEecCCCCCcEEEcC--CCCeEEeccccccc
Q 006952          425 -------------RLKIIHRDLKTSNVLLDH--EMNPKISDFGMARI  456 (624)
Q Consensus       425 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~  456 (624)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.12  E-value=1.6e-09  Score=112.58  Aligned_cols=170  Identities=21%  Similarity=0.339  Sum_probs=130.9

Q ss_pred             CceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe----cCcceEEEEeccC-CChhh
Q 006952          317 GFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE----ENESLLIYEYMPN-KSLDV  390 (624)
Q Consensus       317 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~  390 (624)
                      .-.+.||+... +|..|++|+++............-+++++++.|.|||++..++..    +...++||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            33578999854 799999999965544444344567889999999999999999873    3457899999997 56666


Q ss_pred             hhhcCC------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          391 FLFDST------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       391 ~l~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +-+...            .....++..+|.++.|+..||.++|+.|   +.-+-|.+++|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            554322            2234678999999999999999999997   8889999999999999999999999877654


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCC
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKS  508 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p  508 (624)
                      .+..                |-+++   ..+-|.=-||.+++.|.||...
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3320                11111   2367888999999999999765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.1e-09  Score=100.22  Aligned_cols=131  Identities=21%  Similarity=0.350  Sum_probs=101.7

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEE-ccccC-------cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKR-LSRTS-------GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+++|+=+.+|.+.+. |..+++|. +.+.-       .-...+-.+|..++.+++--.|....=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 44566664 22211       11234567899999999766666666667788888999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++.... +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888543          2467778888889999986   99999999999998764 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.3e-10  Score=123.35  Aligned_cols=244  Identities=20%  Similarity=0.208  Sum_probs=170.1

Q ss_pred             hcCccccCccccCCceeEEEEEec--CCcEEEEEEccccCcccHHHH--HHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--DGKEIAVKRLSRTSGQGLQEF--KNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      ..+|.....||.|.|+.|++...+  ++..+++|.+.+.......++  ..|+.+...+ .|.+++++...+...++.++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456888899999999999998744  577899998876554433332  3567777766 58999998887777777889


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEecccccccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIF  457 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~  457 (624)
                      --||++++++...+   .-...++...++.+..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+..+
T Consensus       344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence            99999999987665   23345777888999999999999999875   9999999999999886 77899999998642


Q ss_pred             CCCCCCccccccccccCcc--ChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          458 GGNQSKANTNRVVGTYGYM--APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .-..    . ...+.-+++  +|+......+-.+.|+||||.-+.|.+++..-.+-     .   .+  |.....+....
T Consensus       418 ~~~~----~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~---~~--~~~i~~~~~p~  482 (524)
T KOG0601|consen  418 AFSS----G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----G---VQ--SLTIRSGDTPN  482 (524)
T ss_pred             ceec----c-cccccccccccchhhccccccccccccccccccccccccCcccCcc-----c---cc--ceeeecccccC
Confidence            1111    0 112223344  55555666788999999999999999998754210     0   00  00011111111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML  578 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  578 (624)
                      .         +. ....+..+...+...++..||.+.++..+.
T Consensus       483 ~---------~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  483 L---------PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             C---------Cc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            1         01 112344445557889999999988876554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.04  E-value=3.1e-09  Score=96.64  Aligned_cols=143  Identities=22%  Similarity=0.344  Sum_probs=107.3

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEE-ccccC-------cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKR-LSRTS-------GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ....|-+|+=+.|+++.+. |+..+||. +.+.-       .-..++.++|+.++.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999984 77777774 33221       223466789999999997666666566677777888999


Q ss_pred             EeccC-CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEeccccccc
Q 006952          381 EYMPN-KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARI  456 (624)
Q Consensus       381 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  456 (624)
                      ||+++ .++.+++.........+ .....++..|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46777775433322222 233678899999999999986   99999999999997655   358999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=8.2e-09  Score=97.44  Aligned_cols=125  Identities=25%  Similarity=0.321  Sum_probs=82.3

Q ss_pred             eEEEEEecCCcEEEEEEccccC--------------c-------c-----cHHHHHHHHHHHHhcCCC--CcceEEeEEE
Q 006952          320 PVYKGVLADGKEIAVKRLSRTS--------------G-------Q-----GLQEFKNEVTVIAKLQHK--NLVRLLGCCL  371 (624)
Q Consensus       320 ~Vy~~~~~~g~~vavK~~~~~~--------------~-------~-----~~~~~~~Ei~~l~~l~h~--niv~l~~~~~  371 (624)
                      .||.|...+|..+|||..+...              .       .     .....++|...|.++..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899999899999999764321              0       0     123457899999999765  56666654  


Q ss_pred             ecCcceEEEEecc--CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          372 EENESLLIYEYMP--NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL-HEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       372 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                        ....|||||++  +..+..+... .    ++......++.+++..+..+ |..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              25689999999  6555543321 1    11233456777888866664 6664   9999999999999988 9999


Q ss_pred             ecccccccc
Q 006952          449 SDFGMARIF  457 (624)
Q Consensus       449 ~Dfg~a~~~  457 (624)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=2e-08  Score=100.49  Aligned_cols=135  Identities=21%  Similarity=0.181  Sum_probs=98.0

Q ss_pred             CceeEEEEEecCCcEEEEEEccccCcc-----------cHHHHHHHHHHHHhcCCCCc--ceEEeEEEe-----cCcceE
Q 006952          317 GFGPVYKGVLADGKEIAVKRLSRTSGQ-----------GLQEFKNEVTVIAKLQHKNL--VRLLGCCLE-----ENESLL  378 (624)
Q Consensus       317 ~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~-----~~~~~l  378 (624)
                      ....|++..+ +|+.+.||+.......           ....+.+|...+.++...+|  +.++++.+.     ....+|
T Consensus        34 ~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            3345667666 6789999977443311           11247799999999854443  445556543     234689


Q ss_pred             EEEeccCC-ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------CCCeEEec
Q 006952          379 IYEYMPNK-SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-------EMNPKISD  450 (624)
Q Consensus       379 V~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~D  450 (624)
                      |+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..|   |+|+|++++|||++.       +..+.++|
T Consensus       113 Vte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             EEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            99999986 7888874321 233456677889999999999999996   999999999999975       46789999


Q ss_pred             cccccc
Q 006952          451 FGMARI  456 (624)
Q Consensus       451 fg~a~~  456 (624)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.80  E-value=1e-07  Score=97.00  Aligned_cols=260  Identities=14%  Similarity=0.132  Sum_probs=156.0

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEE------EecC-cceEEE
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCC------LEEN-ESLLIY  380 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~------~~~~-~~~lV~  380 (624)
                      ....||+|+-+.+|..-.  -...+.|+..........+   .+..|... .||-+-.-+.|=      -+.. ...++|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            456799999999997432  1223557766554432222   23334444 566443312221      1112 245778


Q ss_pred             EeccCCChhhhhhcC----CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          381 EYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ..+++.---..+...    ..-...+|...+..+..++.+.+.||+.|   .+-+|++++|+|+.+++.+.|.|-+....
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            777765321222221    22346789999999999999999999997   78899999999999999999988665443


Q ss_pred             cCCCCCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhC-CCCCCC-CCCCCCCCHHH-HHHH-H
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISG-KKSTGF-YHSEHGPSLLA-YIWK-L  527 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg-~~p~~~-~~~~~~~~~~~-~~~~-~  527 (624)
                      ...   .......+|..+|.+||...     +-.-+..+|.|.+|+++++|+.| +.|+.- +.........+ .+-. .
T Consensus       167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            211   12223457889999999765     23346789999999999998887 888763 22222222222 1110 0


Q ss_pred             --HhcCCccccccchhhcCCCHH-HHHHHHHHHhhcccC--CCCCCCCHHHHHHHhccC
Q 006952          528 --WCEGHAAELMDSVVKQSCDQA-ELLKYIHIGLLCVQG--DPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 --~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~--dP~~RPs~~ev~~~L~~~  581 (624)
                        +..+.......+ . ...+-+ ....+..+..+|+..  ++.-|||.+..+..|...
T Consensus       244 f~ya~~~~~g~~p~-P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         244 FAYASDQRRGLKPP-P-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eeechhccCCCCCC-C-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence              000100000000 0 111111 123466677788865  367899999988887543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.78  E-value=1.4e-09  Score=121.48  Aligned_cols=203  Identities=22%  Similarity=0.272  Sum_probs=139.9

Q ss_pred             HHhcCccccCccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ...+.+.+.+.+-+|.++.++...-.. |...++|......   ....+....+-.++-..+||-++....-+.-.....
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            455677788888899999998876432 3233333322211   111122122222222234566665554455567789


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      |+++|+.+++|...++...   ..+..-....+..+..+++|||..   .+.|+|++|.|++...++..++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999988886533   334444455667788999999986   4899999999999999999999999844332


Q ss_pred             CCC-------------------------CCC----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCC
Q 006952          458 GGN-------------------------QSK----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKS  508 (624)
Q Consensus       458 ~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p  508 (624)
                      +..                         ...    .......||+.|.+||.+.+......+|+|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                         000    112345789999999999999999999999999999999999999


Q ss_pred             CC
Q 006952          509 TG  510 (624)
Q Consensus       509 ~~  510 (624)
                      +.
T Consensus      1035 ~n 1036 (1205)
T KOG0606|consen 1035 FN 1036 (1205)
T ss_pred             CC
Confidence            74

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=1e-07  Score=92.49  Aligned_cols=136  Identities=19%  Similarity=0.243  Sum_probs=97.6

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEcccc----------Cc------------ccHHHHHHHHHHHHhcCCC--C
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRT----------SG------------QGLQEFKNEVTVIAKLQHK--N  362 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~----------~~------------~~~~~~~~Ei~~l~~l~h~--n  362 (624)
                      ..+.++||.|.=+.||.|..++|.++|||.-+..          ..            -.....++|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3456889999999999999999999999943211          00            0123356899999999654  7


Q ss_pred             cceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 006952          363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH  442 (624)
Q Consensus       363 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  442 (624)
                      +.+.+++    +...+||||+++-.|...-.        +....-.|+..|++-+.-+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            7777665    45689999999977754321        22223344445555555444444   999999999999999


Q ss_pred             CCCeEEecccccccc
Q 006952          443 EMNPKISDFGMARIF  457 (624)
Q Consensus       443 ~~~~kl~Dfg~a~~~  457 (624)
                      |+.+.++||--+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999876543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=1.9e-07  Score=101.13  Aligned_cols=145  Identities=17%  Similarity=0.294  Sum_probs=93.5

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccH------------------------------HH-------
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL------------------------------QE-------  347 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------------~~-------  347 (624)
                      .+|+ .+.|+.++-|+||+|++++|++||||+.+.+-.+..                              ++       
T Consensus       126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            3444 378999999999999999999999998766431110                              11       


Q ss_pred             ---HHHHHHHHHhcC-----CCCcceEEeEEE-ecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHH-
Q 006952          348 ---FKNEVTVIAKLQ-----HKNLVRLLGCCL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI-  417 (624)
Q Consensus       348 ---~~~Ei~~l~~l~-----h~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-  417 (624)
                         +.+|...+.+++     .+++ .+=.++. -.....|+|||++|..+.+......  ..++-+   .++..++++. 
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~  278 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFL  278 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHH
Confidence               233444444442     2222 2222232 2456789999999999988753222  234422   2333333322 


Q ss_pred             HHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       418 ~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ..+-..   ++.|.|.+|.||+++.++++.+.|||+...++.
T Consensus       279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            122223   499999999999999999999999999876643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=3.6e-07  Score=88.35  Aligned_cols=107  Identities=26%  Similarity=0.313  Sum_probs=84.1

Q ss_pred             HHHHHHHHHHHHhcCCC--CcceEEeEEEecC----cceEEEEeccCC-ChhhhhhcCCCCcccCHHHHHHHHHHHHHHH
Q 006952          345 LQEFKNEVTVIAKLQHK--NLVRLLGCCLEEN----ESLLIYEYMPNK-SLDVFLFDSTRSVQLDWKRRISIIKGIARGI  417 (624)
Q Consensus       345 ~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L  417 (624)
                      .....+|...+.+|...  ...+.+++.+...    ..+||+|++++. +|.+++.....   .+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            34678899988888543  3456677665532    348999999984 78888854222   55567788999999999


Q ss_pred             HHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEecccccccc
Q 006952          418 LYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIF  457 (624)
Q Consensus       418 ~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~  457 (624)
                      .-||+.+   |+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999996   99999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.56  E-value=1.5e-06  Score=82.72  Aligned_cols=147  Identities=19%  Similarity=0.201  Sum_probs=105.7

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC------cccHHHHHHHHHHHHhcCCC--CcceEEeEEE-ec-
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS------GQGLQEFKNEVTVIAKLQHK--NLVRLLGCCL-EE-  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~-~~-  373 (624)
                      ..++-..=--|+||-+.|++-.+. |+.+-+|+.....      +.....|.+|+..|.+|..-  .+.+.+ ++. .. 
T Consensus        17 ~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~   94 (216)
T PRK09902         17 EGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI   94 (216)
T ss_pred             CCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc
Confidence            333333333477888899997764 5579999865211      23457899999999999532  344554 332 11 


Q ss_pred             ---CcceEEEEeccC-CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--eE
Q 006952          374 ---NESLLIYEYMPN-KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN--PK  447 (624)
Q Consensus       374 ---~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~k  447 (624)
                         ....||+|-+++ .+|.+++.+. ...+.+...+..++.++++.+.-||+.+   +.|+|+.+.||+++.++.  ++
T Consensus        95 ~~~~rA~LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         95 EGEWRALLVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             CCceEEEEEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEE
Confidence               225799997764 5788887442 2234677778899999999999999986   999999999999986667  99


Q ss_pred             Eeccccccc
Q 006952          448 ISDFGMARI  456 (624)
Q Consensus       448 l~Dfg~a~~  456 (624)
                      ++||.-++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999998764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.51  E-value=2.1e-08  Score=108.22  Aligned_cols=151  Identities=21%  Similarity=0.319  Sum_probs=99.5

Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC-------ccccccccccCccChhhhcC
Q 006952          411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-------ANTNRVVGTYGYMAPEYAMG  483 (624)
Q Consensus       411 ~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~  483 (624)
                      .+++.||.|+|..-  .+||++|.|++|.++.++..||+.|+++.........       ...--......|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            45569999999874  8999999999999999999999999998654431110       00001123467999999999


Q ss_pred             CCCChhhHHHHHHHHHHHHHhCCCC-CCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhccc
Q 006952          484 GIFSVKSDVFSFGVVLLEIISGKKS-TGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQ  562 (624)
Q Consensus       484 ~~~~~ksDv~S~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  562 (624)
                      ...+.++|+||+|+++|-+..|..+ +......     +.+....        ..+..-...+..+...++.+=+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~--------~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSR--------NLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhh--------cccccccccccccCcHHHHHHHHHHhc
Confidence            8889999999999999999955544 2211111     1110000        011111111222333445566667889


Q ss_pred             CCCCCCCCHHHHHH
Q 006952          563 GDPIDRPTMSSVAV  576 (624)
Q Consensus       563 ~dP~~RPs~~ev~~  576 (624)
                      .++..||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.45  E-value=3e-06  Score=83.07  Aligned_cols=139  Identities=18%  Similarity=0.202  Sum_probs=85.9

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC--cceEEeEEEecCcceEEEEeccCCC-
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRLLGCCLEENESLLIYEYMPNKS-  387 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lV~Ey~~~gs-  387 (624)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   25567888876533  2355688999999986433  4677777777777889999999963 


Q ss_pred             hhhhhh--------------------cCCCCcccCHHHHHH-HHH----------HHHH-HHHHHHh-cCCCCeEecCCC
Q 006952          388 LDVFLF--------------------DSTRSVQLDWKRRIS-IIK----------GIAR-GILYLHE-DSRLKIIHRDLK  434 (624)
Q Consensus       388 L~~~l~--------------------~~~~~~~l~~~~~~~-i~~----------qia~-~L~yLH~-~~~~~ivH~Dlk  434 (624)
                      +...+.                    +.............. +..          .+.+ ...+|.. ...+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            221111                    000000111111000 000          0111 1122221 123457999999


Q ss_pred             CCcEEEcCCCCeEEecccccc
Q 006952          435 TSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       435 p~NIll~~~~~~kl~Dfg~a~  455 (624)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.37  E-value=5.7e-06  Score=78.99  Aligned_cols=137  Identities=17%  Similarity=0.216  Sum_probs=92.0

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHH---------HHHHHHHHhcCCC---CcceEEeEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEF---------KNEVTVIAKLQHK---NLVRLLGCCL  371 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~h~---niv~l~~~~~  371 (624)
                      ..+|...+.+-......|.+-.. +|+.+++|..........+.|         .+++..+.+++..   ....++.+.+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            35677777777777777777666 579999998876544333333         2445555555332   2223222222


Q ss_pred             e-----cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          372 E-----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       372 ~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      .     ....+|+|||++|..|.++.       .++.    .+...+.+++.-||+.|   ++|+|.+|.|++++++ .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence            1     23457899999998886543       1222    34567788899999996   9999999999999865 49


Q ss_pred             EEeccccccc
Q 006952          447 KISDFGMARI  456 (624)
Q Consensus       447 kl~Dfg~a~~  456 (624)
                      +++||+.-+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=9.2e-06  Score=78.39  Aligned_cols=150  Identities=17%  Similarity=0.235  Sum_probs=99.2

Q ss_pred             HHHHHHhcCcccc---CccccCCceeEEEEEecCCcEEEEEEccccCccc------------------------HHHHHH
Q 006952          298 IDIVKATQDFSQE---NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG------------------------LQEFKN  350 (624)
Q Consensus       298 ~~~~~~~~~~~~~---~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------~~~~~~  350 (624)
                      ..+........+.   ..|+.|.-+.||+|...++..+|||++.......                        .....+
T Consensus        38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k  117 (268)
T COG1718          38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK  117 (268)
T ss_pred             HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence            3344444444433   3566777889999998889999999876432110                        011346


Q ss_pred             HHHHHHhcC--CCCcceEEeEEEecCcceEEEEeccCCCh-hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006952          351 EVTVIAKLQ--HKNLVRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK  427 (624)
Q Consensus       351 Ei~~l~~l~--h~niv~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~  427 (624)
                      |+..|.++.  +-.+.+.+++.    +-.|||||+..... .-.|    +..++...+...+..++++.+.-|-...  +
T Consensus       118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~  187 (268)
T COG1718         118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--G  187 (268)
T ss_pred             HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence            788888873  44455555543    44799999976421 1111    1112233356667788888888887743  5


Q ss_pred             eEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       428 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      +||+||+.-|||+. ++.+.|+|||-+....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999999999999 7899999999887554

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.29  E-value=3.9e-06  Score=79.59  Aligned_cols=105  Identities=20%  Similarity=0.230  Sum_probs=84.5

Q ss_pred             HHHHHHHHhcCC-CCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006952          349 KNEVTVIAKLQH-KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK  427 (624)
Q Consensus       349 ~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~  427 (624)
                      .+|..+++.+++ +++++++|.|    ...++.||.+.+++...-..-.+-...+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468899999976 6999999999    44789999998766422100012234699999999999999999999865556


Q ss_pred             eEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       428 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +.-.|++++|+-+++++++|++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999987544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.25  E-value=1.3e-07  Score=100.96  Aligned_cols=185  Identities=18%  Similarity=0.167  Sum_probs=135.6

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC-cceEEeEEEecCcceEEEEeccC
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN-LVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +..-+.+++|++++++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..++..+++++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3344668899999999988544444445555433     34456899999999999 77777777778888999999987


Q ss_pred             C-ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          386 K-SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       386 g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      + +-....  ......+...+...+...-.+++++||+..   -+|+|    ||+..+ +..+..||+....+....   
T Consensus       319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence            7 221111  112223444455567777788999999862   48888    777766 578999999987765443   


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      ..+...+++.|+|||+.+.+.+..+.|+|+.|+=..++--|-+|.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            344577999999999999999999999999998777777777663

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.22  E-value=1.6e-05  Score=79.00  Aligned_cols=140  Identities=15%  Similarity=0.185  Sum_probs=86.5

Q ss_pred             ccccCCc-eeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEeccCCChh
Q 006952          312 KLGEGGF-GPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKSLD  389 (624)
Q Consensus       312 ~lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~  389 (624)
                      .|..|.+ ..||+.... +..+.+|+.....   ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 788998764 4788888876543   345678999998883 444667888777666789999999998876


Q ss_pred             hhhh------------------cCCC--CcccC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 006952          390 VFLF------------------DSTR--SVQLD--WKRRISIIK--------------------GIARGILYLHE----D  423 (624)
Q Consensus       390 ~~l~------------------~~~~--~~~l~--~~~~~~i~~--------------------qia~~L~yLH~----~  423 (624)
                      ....                  +...  ...+.  .........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421                  0000  00111  000000000                    01111222211    1


Q ss_pred             CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       424 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23458999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.22  E-value=1.2e-05  Score=78.91  Aligned_cols=142  Identities=22%  Similarity=0.247  Sum_probs=85.3

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCC--CcceEEeEEEec---CcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK--NLVRLLGCCLEE---NESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~---~~~~lV~Ey~~~  385 (624)
                      +.|+.|..+.||+....+ +.+++|.....  .....+.+|..+++.+...  .+.+++......   ...+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578999999999999877 69999987655  4556788999999888533  356677654332   235789999999


Q ss_pred             CChhh----------------hh---hcC-CCCcccCHHH---------HHHH------------HHHHHH-HHHHHHhc
Q 006952          386 KSLDV----------------FL---FDS-TRSVQLDWKR---------RISI------------IKGIAR-GILYLHED  423 (624)
Q Consensus       386 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qia~-~L~yLH~~  423 (624)
                      ..+..                .+   +.. .....+.+..         ....            ...+.+ .+..+++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   011 0111111110         0000            112222 33333321


Q ss_pred             ----CCCCeEecCCCCCcEEEc-CCCCeEEecccccc
Q 006952          424 ----SRLKIIHRDLKTSNVLLD-HEMNPKISDFGMAR  455 (624)
Q Consensus       424 ----~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~  455 (624)
                          ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                345699999999999999 66666899999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.16  E-value=1.2e-05  Score=87.01  Aligned_cols=142  Identities=15%  Similarity=0.232  Sum_probs=88.6

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCccc---------------------------HH----------HHHHHH
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG---------------------------LQ----------EFKNEV  352 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------------------~~----------~~~~Ei  352 (624)
                      .+.||.-+.|.||++++++|+.||||+.+..-++.                           .+          +|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            37899999999999999999999999876542111                           00          133444


Q ss_pred             HHHHhc----CCCCcce---EEeEEEe-cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC
Q 006952          353 TVIAKL----QHKNLVR---LLGCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS  424 (624)
Q Consensus       353 ~~l~~l----~h~niv~---l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~  424 (624)
                      +...+.    .|-++..   .=.++.+ .....|+|||++|..+.+...-..  ..++...   |+..+.++...+=-. 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~~~qIf~-  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAYLEQIFK-  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHHHHHHHh-
Confidence            444333    3444111   1122222 346789999999998877643211  2233333   333333332221111 


Q ss_pred             CCCeEecCCCCCcEEEcC----CCCeEEeccccccccC
Q 006952          425 RLKIIHRDLKTSNVLLDH----EMNPKISDFGMARIFG  458 (624)
Q Consensus       425 ~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~a~~~~  458 (624)
                       .+++|.|-+|.||++..    ++.+.+.|||+...+.
T Consensus       320 -~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 -TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             -cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence             14999999999999984    6689999999987653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=5.9e-05  Score=71.91  Aligned_cols=130  Identities=18%  Similarity=0.273  Sum_probs=90.8

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccC----------------cccHHHHHHHHHHHHhcC------CCCcce
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS----------------GQGLQEFKNEVTVIAKLQ------HKNLVR  365 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~  365 (624)
                      +....||+|+.-.||.  +++.....||+.....                ....++..+|+.....+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3456899999999997  4455667888876554                223456677777766665      889999


Q ss_pred             EEeEEEecCcceEEEEeccC------CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006952          366 LLGCCLEENESLLIYEYMPN------KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL  439 (624)
Q Consensus       366 l~~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIl  439 (624)
                      ++|+.+++....+|+|.+.+      .+|.+++.+    ..++. .....+.   +-..||-++   .|+.+|++|+||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEE
Confidence            99999999999999998764      346666632    23444 3333333   444566655   3999999999999


Q ss_pred             EcCCC----CeEEec
Q 006952          440 LDHEM----NPKISD  450 (624)
Q Consensus       440 l~~~~----~~kl~D  450 (624)
                      +..+.    .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            95432    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=0.0001  Score=86.21  Aligned_cols=79  Identities=18%  Similarity=0.390  Sum_probs=58.4

Q ss_pred             cCccccCCceeEEEEEecCC---cEEEEEEccccC-cccHHHHHHHHHHHHhcC-CCCc--ceEEeEEEec---CcceEE
Q 006952          310 ENKLGEGGFGPVYKGVLADG---KEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQ-HKNL--VRLLGCCLEE---NESLLI  379 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV  379 (624)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  .+.+.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999887654   467888765432 123356889999999995 6665  7788887664   457899


Q ss_pred             EEeccCCCh
Q 006952          380 YEYMPNKSL  388 (624)
Q Consensus       380 ~Ey~~~gsL  388 (624)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.97  E-value=6e-05  Score=68.92  Aligned_cols=130  Identities=21%  Similarity=0.270  Sum_probs=89.3

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcc-eEEeEEEecCcceEEEEeccC
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV-RLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      ....+.|++|.+|.||+|.+. |..+|+|+-..++.  ...++.|+++|..++-.++- +++.+-.    -.+.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            344678999999999999996 56889998765544  36788999999999866664 3444432    2345999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCcEEEcCCCCeEEeccccccc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK-TSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      -.|.++-...      +-    +-+..+++.-.-|-..   .|-|+.|. |..++|-.+..+.|+||..|+.
T Consensus        97 ~~L~~~~~~~------~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8887654211      11    2233445554444444   49999986 5555555555999999999874

>PRK10593 hypothetical protein; Provisional

Probab=97.93  E-value=0.00018  Score=73.65  Aligned_cols=78  Identities=14%  Similarity=0.126  Sum_probs=57.8

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCC---CCcceEEeEEEec---CcceEEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH---KNLVRLLGCCLEE---NESLLIYE  381 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~---~~~~lV~E  381 (624)
                      ...+.||+|..+.||+....++ .+.+|..+...  ....+.+|...|+.|.-   -.+.+.++++...   +..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999876555 46667643311  23578899999999853   3678888887643   56899999


Q ss_pred             eccCCCh
Q 006952          382 YMPNKSL  388 (624)
Q Consensus       382 y~~~gsL  388 (624)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.90  E-value=0.00017  Score=71.11  Aligned_cols=140  Identities=17%  Similarity=0.237  Sum_probs=83.1

Q ss_pred             CccccCCceeEEEEEecC--CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC-cceEEeEEEecCcceEEEEeccCCC
Q 006952          311 NKLGEGGFGPVYKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN-LVRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      +.|..|-...+|+....+  ++.+++|+........ ....+|+.+++.+...+ .+++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467888889999988764  6789999776543222 23357999999885433 444544332    248999999977


Q ss_pred             hhhh-------h----------hcCCCC--------ccc-CHHHHHHHHH----------------------HHHHHHHH
Q 006952          388 LDVF-------L----------FDSTRS--------VQL-DWKRRISIIK----------------------GIARGILY  419 (624)
Q Consensus       388 L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~----------------------qia~~L~y  419 (624)
                      +...       +          +.....        ... -|..+..+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6322       0          110100        011 1222112111                      11111122


Q ss_pred             H----Hhc-CCCCeEecCCCCCcEEEcC-CCCeEEecccccc
Q 006952          420 L----HED-SRLKIIHRDLKTSNVLLDH-EMNPKISDFGMAR  455 (624)
Q Consensus       420 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~  455 (624)
                      |    ... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            2    111 2346999999999999998 5789999999875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=0.00012  Score=72.32  Aligned_cols=73  Identities=14%  Similarity=0.247  Sum_probs=46.9

Q ss_pred             CccccCCce-eEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCC---CcceEEeEEEecC---cceEEEEec
Q 006952          311 NKLGEGGFG-PVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK---NLVRLLGCCLEEN---ESLLIYEYM  383 (624)
Q Consensus       311 ~~lG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~---~~~lV~Ey~  383 (624)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   -+.+.++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777776 48875    345777765542  2345788999999888532   3444554433322   347899999


Q ss_pred             cCCChh
Q 006952          384 PNKSLD  389 (624)
Q Consensus       384 ~~gsL~  389 (624)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00015  Score=72.69  Aligned_cols=139  Identities=16%  Similarity=0.116  Sum_probs=81.1

Q ss_pred             ccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc-ceEEeEEEecCcceEEEEeccCCChhh
Q 006952          312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL-VRLLGCCLEENESLLIYEYMPNKSLDV  390 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~  390 (624)
                      .+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .+++...    ..++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            456788889998874 577888987654433221235789999999864333 3444443    2479999999877643


Q ss_pred             h-----------------hhcCC-CCcccCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeEecCCCCCc
Q 006952          391 F-----------------LFDST-RSVQLDWKRR-ISIIKG---------IARGILYLHED-----SRLKIIHRDLKTSN  437 (624)
Q Consensus       391 ~-----------------l~~~~-~~~~l~~~~~-~~i~~q---------ia~~L~yLH~~-----~~~~ivH~Dlkp~N  437 (624)
                      .                 ++... ....++.... .....+         +...+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11110 0111222111 111111         11112222211     12358999999999


Q ss_pred             EEEcCCCCeEEeccccccc
Q 006952          438 VLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       438 Ill~~~~~~kl~Dfg~a~~  456 (624)
                      |++++++ +.|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.76  E-value=2.3e-05  Score=55.46  Aligned_cols=44  Identities=36%  Similarity=0.617  Sum_probs=35.3

Q ss_pred             CCCCCCCCCCCcccccccccccc-ccCCC--CCCCcCceeeccccCC
Q 006952          581 DILTLPKPTQPAFSLSRVVSAQF-VSHSE--DHCSVNAITLSTMSPR  624 (624)
Q Consensus       581 ~~~~~~~p~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~r  624 (624)
                      +...||.|++|+|+.++...... +++..  ..+|+|+||+|.+++|
T Consensus         2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            45689999999999998865443 33333  6899999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.64  E-value=0.00074  Score=71.38  Aligned_cols=75  Identities=15%  Similarity=0.255  Sum_probs=54.7

Q ss_pred             CccccCCceeEEEEEecCC-cEEEEEEcccc-----C--cccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcceEE
Q 006952          311 NKLGEGGFGPVYKGVLADG-KEIAVKRLSRT-----S--GQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV  379 (624)
                      +.||.|.+..||+....+| +.++||.-...     .  ....++...|.+.|..+.   ..++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998877 48999985421     1  224567778888888863   2456667766  44567899


Q ss_pred             EEeccCCC
Q 006952          380 YEYMPNKS  387 (624)
Q Consensus       380 ~Ey~~~gs  387 (624)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.57  E-value=0.00091  Score=68.52  Aligned_cols=142  Identities=16%  Similarity=0.163  Sum_probs=86.8

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC--cceEEeE------EEecCcceEEEE
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRLLGC------CLEENESLLIYE  381 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E  381 (624)
                      .+.|..|....+|+.... +..+++|+...   .....+..|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            466788888899998764 45788898764   22356677888888885332  4444432      123445689999


Q ss_pred             eccCCChhhh----h----------hcCC--------CCcccCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 006952          382 YMPNKSLDVF----L----------FDST--------RSVQLDWKRRI----------SIIKGIARGILYLHE----DSR  425 (624)
Q Consensus       382 y~~~gsL~~~----l----------~~~~--------~~~~l~~~~~~----------~i~~qia~~L~yLH~----~~~  425 (624)
                      |++|..+...    .          +...        ......|....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998776430    0          0000        00111222211          011223344555543    122


Q ss_pred             CCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          426 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       426 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ..++|+|+.|.||+++++..+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            359999999999999998777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.51  E-value=0.0011  Score=62.76  Aligned_cols=125  Identities=27%  Similarity=0.410  Sum_probs=88.9

Q ss_pred             cCccccCccccCCc-eeEEEEEecCCcEEEEEEccc---cCc------------------ccHHHHHHHHHHHHhcC---
Q 006952          305 QDFSQENKLGEGGF-GPVYKGVLADGKEIAVKRLSR---TSG------------------QGLQEFKNEVTVIAKLQ---  359 (624)
Q Consensus       305 ~~~~~~~~lG~G~~-g~Vy~~~~~~g~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~---  359 (624)
                      .+++..+.||.|.- |.||+... +|+.+|+|.+..   ...                  ....-|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999998 578999999321   110                  11234778999888884   


Q ss_pred             CCCc--ceEEeEEEecC------------------cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHH
Q 006952          360 HKNL--VRLLGCCLEEN------------------ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY  419 (624)
Q Consensus       360 h~ni--v~l~~~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y  419 (624)
                      +.++  |+.+||..-..                  ...||.||++...            .+.    ..=+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4566  89999974321                  1256777765533            111    2234567777888


Q ss_pred             HHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       420 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            89876   999999999986     3489999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.50  E-value=0.00046  Score=79.41  Aligned_cols=198  Identities=19%  Similarity=0.162  Sum_probs=132.6

Q ss_pred             HHHHHHHHHHHhcCCCCcceEEeEEEecCcc----eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH
Q 006952          346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH  421 (624)
Q Consensus       346 ~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH  421 (624)
                      .....|+..+.++.|+|++.++.|-......    .+..|++..-++...+.   ....++....+.+..++.+||.|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence            3445677788888999999999997665433    23457777777766663   3345778888889999999999999


Q ss_pred             hcCCCCeEecCCCCC---cEEEcCCCCeEEe--ccccccccCCCCCCccccccccccCccChhhhcCCCCCh--hhHHHH
Q 006952          422 EDSRLKIIHRDLKTS---NVLLDHEMNPKIS--DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV--KSDVFS  494 (624)
Q Consensus       422 ~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDv~S  494 (624)
                      +..   ..|.-+..+   +--.+.++.+.++  ||+...........   ....-+..|.+||.........  ..|+|.
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence            873   555555444   4445666667776  88888765433221   1123355688888777665544  479999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 006952          495 FGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV  574 (624)
Q Consensus       495 ~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  574 (624)
                      +|..+..+..|..+......                      +.+.+......    .......+|+..++++|++..++
T Consensus       378 lgll~~~~~~~~~i~~~~~~----------------------~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAV----------------------PVSLLDVLSTS----ELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCcccccccc----------------------hhhhhccccch----hhhhhhhhhcchhhhhccchhhh
Confidence            99999999998866321100                      11111111111    23445567999999999999999


Q ss_pred             HHHh
Q 006952          575 AVML  578 (624)
Q Consensus       575 ~~~L  578 (624)
                      +...
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            8765

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.39  E-value=0.0013  Score=67.70  Aligned_cols=140  Identities=24%  Similarity=0.332  Sum_probs=84.8

Q ss_pred             CccccCCceeEEEEEecC-------CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC-cceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLAD-------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN-LVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.|..|-...+|+....+       ++.+++|+....... .....+|..++..+.... ..++++.+.    -.+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-LIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-eechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456667777899988655       578999987654332 245578888888885333 345555553    2468999


Q ss_pred             ccCCChhhhh-----------------hcCCCCc------cc--CHHHHHH--------------------------HHH
Q 006952          383 MPNKSLDVFL-----------------FDSTRSV------QL--DWKRRIS--------------------------IIK  411 (624)
Q Consensus       383 ~~~gsL~~~l-----------------~~~~~~~------~l--~~~~~~~--------------------------i~~  411 (624)
                      ++|..+....                 +......      ..  -|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9987764311                 1100000      00  0111111                          112


Q ss_pred             HHHHHHHHHHh------cCCCCeEecCCCCCcEEEcCC----CCeEEecccccc
Q 006952          412 GIARGILYLHE------DSRLKIIHRDLKTSNVLLDHE----MNPKISDFGMAR  455 (624)
Q Consensus       412 qia~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~  455 (624)
                      .+...+..|..      ..+..++|+|+.+.|||++++    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22233344432      234578999999999999985    789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.33  E-value=0.0033  Score=65.17  Aligned_cols=141  Identities=17%  Similarity=0.212  Sum_probs=77.6

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC--cceEEe------EEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRLLG------CCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~Ey  382 (624)
                      +.|+.|....+|+....+| .+++|++...   ..+....|+.++..|...+  +.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            5567777789999887555 6888987622   2234445666666663222  333332      11234557899999


Q ss_pred             ccCCChhh-----h------h---hcCCC--------CcccCH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 006952          383 MPNKSLDV-----F------L---FDSTR--------SVQLDW-KRRIS------------II-KGIARGILYLHED---  423 (624)
Q Consensus       383 ~~~gsL~~-----~------l---~~~~~--------~~~l~~-~~~~~------------i~-~qia~~L~yLH~~---  423 (624)
                      ++|..+..     .      +   +....        ...+.| .....            .+ ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875421     0      0   10000        011112 11111            11 1111222333211   


Q ss_pred             -CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          424 -SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       424 -~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                       -+..++|+|++|.||+++++...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23469999999999999976556899999875

>PLN02236 choline kinase

Probab=97.25  E-value=0.0035  Score=65.57  Aligned_cols=141  Identities=18%  Similarity=0.259  Sum_probs=84.9

Q ss_pred             CccccCCceeEEEEEecC-----CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc-ceEEeEEEecCcceEEEEecc
Q 006952          311 NKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL-VRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ..|..|-.-.+|+....+     ++.+++|+..........+ .+|..+++.+...++ .++++.+...    .|.||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            355567778899987532     3679999887665444443 789999999854444 4566665332    6899998


Q ss_pred             CCChhhh-----------------hhcCC---CCcccCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 006952          385 NKSLDVF-----------------LFDST---RSVQLDWKRRISIIKGI-----------------ARGILYL----HE-  422 (624)
Q Consensus       385 ~gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~qi-----------------a~~L~yL----H~-  422 (624)
                      +.++...                 +|...   ......|.+...+..++                 ..-+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776422                 11100   01111233333332211                 1112222    21 


Q ss_pred             cCCCCeEecCCCCCcEEEcC-CCCeEEeccccccc
Q 006952          423 DSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARI  456 (624)
Q Consensus       423 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  456 (624)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 46799999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.17  E-value=0.009  Score=61.57  Aligned_cols=143  Identities=16%  Similarity=0.172  Sum_probs=82.9

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC--cceEEeEE------EecCcceEEEE
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRLLGCC------LEENESLLIYE  381 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~E  381 (624)
                      .+.++.|....+|+....+| .+++|+......  .+.+..|+.++..|....  +.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876544 678887654321  244566777777774222  34444321      12345689999


Q ss_pred             eccCCChhhh--------------hhcCCCC---------cccCHHHHH------------HHHHHHHHHHHHHHh----
Q 006952          382 YMPNKSLDVF--------------LFDSTRS---------VQLDWKRRI------------SIIKGIARGILYLHE----  422 (624)
Q Consensus       382 y~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~qia~~L~yLH~----  422 (624)
                      |++|..+...              ++.....         ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654211              1110000         011222111            011223345555543    


Q ss_pred             cCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       423 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .....++|+|+++.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999988767899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.13  E-value=0.0051  Score=62.27  Aligned_cols=31  Identities=23%  Similarity=0.534  Sum_probs=25.8

Q ss_pred             CCeEecCCCCCcEEEcCCCC-eEEeccccccc
Q 006952          426 LKIIHRDLKTSNVLLDHEMN-PKISDFGMARI  456 (624)
Q Consensus       426 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~  456 (624)
                      +.++|+|++|.|||++++++ .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997565 46999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.08  E-value=0.0047  Score=62.64  Aligned_cols=75  Identities=17%  Similarity=0.284  Sum_probs=49.3

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcceEEEEecc
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ...+.|+.|....+|+.. .+++.+.||.-..   .....|..|..-|+.|.   --.+.+.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678999999999987 5788999998762   23356788888888883   4557788998887778899999998


Q ss_pred             CC
Q 006952          385 NK  386 (624)
Q Consensus       385 ~g  386 (624)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.05  E-value=0.00097  Score=66.80  Aligned_cols=134  Identities=18%  Similarity=0.204  Sum_probs=93.0

Q ss_pred             ccccCccccCCceeEEEEEecCCcEEEEEEcc--ccC---------------cccH-----HHHHHHHHHHHhcC-C-CC
Q 006952          307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLS--RTS---------------GQGL-----QEFKNEVTVIAKLQ-H-KN  362 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~---------------~~~~-----~~~~~Ei~~l~~l~-h-~n  362 (624)
                      ++..+.||-|.-+.||.+-..+|++.++|.-.  +.+               ...|     -...+|+..|+.|. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56789999999999999999999999998421  110               1111     12346888888884 3 23


Q ss_pred             cceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 006952          363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH  442 (624)
Q Consensus       363 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  442 (624)
                      +.+.+++    ...++|||++.+-.|...-+.      .+..   .+...+..-+.-|-.+|   +||+|.+-=||++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            4445544    356899999998887654321      1222   33444445556666665   999999999999999


Q ss_pred             CCCeEEeccccccc
Q 006952          443 EMNPKISDFGMARI  456 (624)
Q Consensus       443 ~~~~kl~Dfg~a~~  456 (624)
                      ++.++++||--...
T Consensus       238 d~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVS  251 (465)
T ss_pred             CCCEEEeechHhhc
Confidence            99999999976543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.94  E-value=0.011  Score=60.50  Aligned_cols=137  Identities=17%  Similarity=0.273  Sum_probs=81.9

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEcc-ccCcccHHHHHHHHHHHHhcCC--CCcceEEeEEEecC--cceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQH--KNLVRLLGCCLEEN--ESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--~~~lV~Ey~~~  385 (624)
                      +.+..|..-.+|..... ++++++.+-. ...........+|..+|+.+.-  --+...++.|.++.  ..+.||+|++|
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            33434444445554443 7788888221 1223345566788888888743  33445667776665  56999999988


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHH-HHHHHHHH----------------------------------------------
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISII-KGIARGIL----------------------------------------------  418 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~-~qia~~L~----------------------------------------------  418 (624)
                      ..+...+....    ..    ..++ ..+++.|.                                              
T Consensus       110 e~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         110 EVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             eeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            54322221100    00    0111 13333333                                              


Q ss_pred             ----HHHhc-----CCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          419 ----YLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       419 ----yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                          ||+.+     +++.++|+|+++.||+++.+.-+-|.||+++..
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                44332     235699999999999999998899999999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.84  E-value=0.0096  Score=60.89  Aligned_cols=144  Identities=16%  Similarity=0.201  Sum_probs=97.9

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccC----------------------ccc----HHHHHHHHHHHHhcCCC
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS----------------------GQG----LQEFKNEVTVIAKLQHK  361 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------------~~~----~~~~~~Ei~~l~~l~h~  361 (624)
                      .+...|..|.-+.||.++..+|..+|||+++..-                      ...    .-....|+.-|.+|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456788899999999999999999999764321                      000    11235688888888644


Q ss_pred             CcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       362 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                      .|.-.--...  ....|||+|+....   |-.-..+...++...+..+-.|++.-|.-|.+.+  ++||.||.--|+|+.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            4321111110  23479999985321   1111123345666778888889999999998887  799999999999985


Q ss_pred             CCCCeEEeccccccccCC
Q 006952          442 HEMNPKISDFGMARIFGG  459 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~  459 (624)
                       +|.+.|+|.+-+.....
T Consensus       300 -dG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             -CCEEEEEEccccccCCC
Confidence             56899999988765443

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.74  E-value=0.024  Score=59.92  Aligned_cols=73  Identities=14%  Similarity=0.138  Sum_probs=51.1

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEcccc----Cc---ccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcceEE
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRT----SG---QGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV  379 (624)
                      .+.||.|....||+.... ++.++||+-...    ..   ....+-..|...|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998764 567999976521    11   23444455677776663   347778888776  557889


Q ss_pred             EEeccC
Q 006952          380 YEYMPN  385 (624)
Q Consensus       380 ~Ey~~~  385 (624)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.59  E-value=0.0078  Score=58.29  Aligned_cols=123  Identities=17%  Similarity=0.203  Sum_probs=62.0

Q ss_pred             CcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEeccCCChhhhhh--------------
Q 006952          329 GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF--------------  393 (624)
Q Consensus       329 g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~--------------  393 (624)
                      +++|+||+....... .-.-.+|..+++.+. +..-.++++.+.+    .+|+||+++..|..--.              
T Consensus         2 ~~~~~~Ri~g~~t~~-~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTEN-FIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGCS-HHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCccc-ccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            467888888766443 345578999999985 4444566666533    36789997766532110              


Q ss_pred             ---c--C--CCCcccCHHHHHHH----------------------HHHHHHHHHHHHh----c-CCCCeEecCCCCCcEE
Q 006952          394 ---D--S--TRSVQLDWKRRISI----------------------IKGIARGILYLHE----D-SRLKIIHRDLKTSNVL  439 (624)
Q Consensus       394 ---~--~--~~~~~l~~~~~~~i----------------------~~qia~~L~yLH~----~-~~~~ivH~Dlkp~NIl  439 (624)
                         .  .  ......-|.....+                      ...+.+-+..+.+    . ...-+.|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence               0  0  00111112222221                      1111222222221    1 1234899999999999


Q ss_pred             E-cCCCCeEEeccccccc
Q 006952          440 L-DHEMNPKISDFGMARI  456 (624)
Q Consensus       440 l-~~~~~~kl~Dfg~a~~  456 (624)
                      + +.++.++++||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.53  E-value=0.028  Score=58.57  Aligned_cols=141  Identities=17%  Similarity=0.248  Sum_probs=82.1

Q ss_pred             CccccCCceeEEEEEecC----CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc-ceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL-VRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.|..|-.-.+|+....+    +..|++|+.......... -.+|..+++.+..-++ .++++++.  +  .+|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~--~--G~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFG--N--GMIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeC--C--cEeehhhcC
Confidence            455557777889887543    237899988765543333 3789999999965444 45666652  2  258999987


Q ss_pred             CChhhh-------h----------hcCC---CCcccCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 006952          386 KSLDVF-------L----------FDST---RSVQLDWKRRISIIKGI----------------------ARGILYLHE-  422 (624)
Q Consensus       386 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~qi----------------------a~~L~yLH~-  422 (624)
                      ..|..-       +          |...   .....-|....++..++                      .+-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321       1          1100   00011233322222221                      111222211 


Q ss_pred             ----cCCCCeEecCCCCCcEEEcC-CCCeEEeccccccc
Q 006952          423 ----DSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARI  456 (624)
Q Consensus       423 ----~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  456 (624)
                          ..+.-+.|.|+.+.|||+++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11234799999999999975 56899999998753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.44  E-value=0.031  Score=58.05  Aligned_cols=72  Identities=14%  Similarity=0.266  Sum_probs=48.3

Q ss_pred             ccccCCceeEEEEEecCC-cEEEEEEccc-------cCcccHHHHHHHHHHHHhcC--CCC-cceEEeEEEecCcceEEE
Q 006952          312 KLGEGGFGPVYKGVLADG-KEIAVKRLSR-------TSGQGLQEFKNEVTVIAKLQ--HKN-LVRLLGCCLEENESLLIY  380 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~Ei~~l~~l~--h~n-iv~l~~~~~~~~~~~lV~  380 (624)
                      .||.|...-||++..++| +.|+||.-..       .-+-..++..-|...|+...  -|. +.+++.  .+++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998754 5899997431       11334456667778876663  343 444443  3455667999


Q ss_pred             EeccC
Q 006952          381 EYMPN  385 (624)
Q Consensus       381 Ey~~~  385 (624)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.43  E-value=0.00068  Score=79.73  Aligned_cols=160  Identities=13%  Similarity=-0.015  Sum_probs=114.2

Q ss_pred             HHHHHHHHHhcCCCCcceEEeEEEe--cCcceEEEEeccCCChhhhhhcCCC-CcccCHHHHHHHHHHHHHHHHHHHhcC
Q 006952          348 FKNEVTVIAKLQHKNLVRLLGCCLE--ENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHEDS  424 (624)
Q Consensus       348 ~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~  424 (624)
                      ...|...++...|+++.....-...  ..+.+..++|+..|.+...|.+... ...++..-+.....+......-+|...
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555666789888776555433  3456889999999999988866433 334444444433334355555555432


Q ss_pred             --CCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHH
Q 006952          425 --RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI  502 (624)
Q Consensus       425 --~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~el  502 (624)
                        ..--+|+++|+-|.+|..+.++|+.++|+.+.....  ........+++.|+.|++.+.-.++.++|+|..|+-+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              234699999999999999999999999999833221  2223345678899999999999999999999999999999


Q ss_pred             HhCCCCC
Q 006952          503 ISGKKST  509 (624)
Q Consensus       503 ltg~~p~  509 (624)
                      -.|..++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8887663

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.03  E-value=0.07  Score=55.01  Aligned_cols=31  Identities=26%  Similarity=0.343  Sum_probs=27.9

Q ss_pred             CCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       425 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      +..++|+|+.++|||+++++.+.|+||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3469999999999999999999999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.03  E-value=0.11  Score=53.41  Aligned_cols=29  Identities=24%  Similarity=0.347  Sum_probs=25.4

Q ss_pred             CCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          426 LKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       426 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46899999999999988 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.91  E-value=0.31  Score=50.63  Aligned_cols=98  Identities=15%  Similarity=0.108  Sum_probs=56.1

Q ss_pred             CCCCCCCHHHHHHHhcCcccc--C--ccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCC--Cc
Q 006952          290 FPLFPLDLIDIVKATQDFSQE--N--KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK--NL  363 (624)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~--~--~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--ni  363 (624)
                      .+...++...+..+...+-..  .  ..-.+.-..||+....+++.+++|...... .....+..|+..+..|...  .+
T Consensus         6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv   84 (325)
T PRK11768          6 FPFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV   84 (325)
T ss_pred             CCCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence            344455555555555444221  1  111234467999888788889999875332 2446677788888777321  12


Q ss_pred             ceEE---e--EEEecCcceEEEEeccCCCh
Q 006952          364 VRLL---G--CCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       364 v~l~---~--~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      +..+   |  ....++..+.++++++|...
T Consensus        85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         85 VAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            2211   1  12224556789999987654

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.90  E-value=0.084  Score=54.58  Aligned_cols=136  Identities=21%  Similarity=0.258  Sum_probs=81.2

Q ss_pred             CceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-C--CC---cceEEeE----EEecCcceEEEEeccCC
Q 006952          317 GFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-H--KN---LVRLLGC----CLEENESLLIYEYMPNK  386 (624)
Q Consensus       317 ~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h--~n---iv~l~~~----~~~~~~~~lV~Ey~~~g  386 (624)
                      .-..+|+....+|+. ++|.....  ....++..|+..|..|. +  +=   +..+=|-    ........-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            445788888877766 88877765  34466777888888873 2  11   1111121    11122667899999998


Q ss_pred             Chhh-hh--------------h---------cCCCCcccCHHH-------------HHHHHHHHHHHHHHHHhc------
Q 006952          387 SLDV-FL--------------F---------DSTRSVQLDWKR-------------RISIIKGIARGILYLHED------  423 (624)
Q Consensus       387 sL~~-~l--------------~---------~~~~~~~l~~~~-------------~~~i~~qia~~L~yLH~~------  423 (624)
                      .+.. ..              +         ++.......|..             ......++...+..+.+.      
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8873 11              0         000111233431             011233444444444433      


Q ss_pred             -CCCCeEecCCCCCcEEEcCCCC-eEEecccccc
Q 006952          424 -SRLKIIHRDLKTSNVLLDHEMN-PKISDFGMAR  455 (624)
Q Consensus       424 -~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~  455 (624)
                       .+..+||+|+.|.||+++++.. +.++||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             1123999999999999999885 8899999875

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.85  E-value=0.29  Score=47.21  Aligned_cols=181  Identities=20%  Similarity=0.308  Sum_probs=105.2

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcceEEEEeccCC
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESLLIYEYMPNK  386 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~Ey~~~g  386 (624)
                      .+.+..|..-..|.... +..++-||+-.   ......|..|+.-|..|.   .-.+.+.+.+-.+.++.++|+||++-+
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            34555565555565544 45678888643   333467788888777773   456788888888899999999999987


Q ss_pred             Chhhh-----------hhcCC---------------CCcccCHHH---------HHHHHHH--------------HHHHH
Q 006952          387 SLDVF-----------LFDST---------------RSVQLDWKR---------RISIIKG--------------IARGI  417 (624)
Q Consensus       387 sL~~~-----------l~~~~---------------~~~~l~~~~---------~~~i~~q--------------ia~~L  417 (624)
                      .++..           |+...               ...+-+|..         |+-+..|              +.+.+
T Consensus        97 ~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v  176 (286)
T COG3001          97 PLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKI  176 (286)
T ss_pred             CCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHH
Confidence            77511           11100               011112222         2212222              22333


Q ss_pred             HHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcC--------CCCC
Q 006952          418 LYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG--------GIFS  487 (624)
Q Consensus       418 ~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~  487 (624)
                      .-+=.+.  +|.++|+||-..|.....+| +.+.|  =+...++...........|.   .+||+..+        ..+.
T Consensus       177 ~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD--PA~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~G~~  250 (286)
T COG3001         177 QELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD--PACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPAGYL  250 (286)
T ss_pred             HHHHhcCCCCcceeecccccccccccCCC-Ceeec--cccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCCchH
Confidence            3332222  47899999999999999998 76655  23333333333333334443   46776644        2355


Q ss_pred             hhhHHHHHHHHHH
Q 006952          488 VKSDVFSFGVVLL  500 (624)
Q Consensus       488 ~ksDv~S~Gvil~  500 (624)
                      ++-++|.+=-+|-
T Consensus       251 eRk~iYqLY~lln  263 (286)
T COG3001         251 ERKPIYQLYHLLN  263 (286)
T ss_pred             HHhHHHHHHHHHH
Confidence            6777777544443

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.80  E-value=0.046  Score=57.47  Aligned_cols=74  Identities=11%  Similarity=0.132  Sum_probs=50.1

Q ss_pred             cCccccCCceeEEEEEecC-CcEEEEEEccc------cCcccHHHHHHHHHHHHhcC--CC-CcceEEeEEEecCcceEE
Q 006952          310 ENKLGEGGFGPVYKGVLAD-GKEIAVKRLSR------TSGQGLQEFKNEVTVIAKLQ--HK-NLVRLLGCCLEENESLLI  379 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lV  379 (624)
                      .+.||.|...-||++...+ ++.|+||.-..      .-+-..++..-|.+.|+...  .| ++++++.+  +++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3578999999999999753 56899996432      11334566777888888763  34 34445433  45556788


Q ss_pred             EEeccC
Q 006952          380 YEYMPN  385 (624)
Q Consensus       380 ~Ey~~~  385 (624)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.60  E-value=0.04  Score=57.22  Aligned_cols=62  Identities=19%  Similarity=0.138  Sum_probs=42.7

Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE  443 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  443 (624)
                      ..|+=+|.++.++..++...    ..++..+.+++.=.++|+.-+-.-.  +++|.|++|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~----~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK----SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhcc----cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEec
Confidence            45667788888888888432    2344556666666666666544433  69999999999999543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.56  E-value=0.066  Score=51.15  Aligned_cols=151  Identities=14%  Similarity=0.123  Sum_probs=91.1

Q ss_pred             ceeEEEEEecCCcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCC
Q 006952          318 FGPVYKGVLADGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST  396 (624)
Q Consensus       318 ~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~  396 (624)
                      -.+.-++..+- ....+|++..-.-. ....|.++..++++++  .|++|..-  +...+.++.|+|.....        
T Consensus        75 NsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------  141 (308)
T PF07387_consen   75 NSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------  141 (308)
T ss_pred             ceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------
Confidence            34444444333 33455665443333 3456788888888875  45666522  33446789998843221        


Q ss_pred             CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCcc
Q 006952          397 RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM  476 (624)
Q Consensus       397 ~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  476 (624)
                          ..    ..++..=+++|.-.|+.. ...+|||..|+|||-|.+|.+||.|=+..-.              .+..|.
T Consensus       142 ----~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~v  198 (308)
T PF07387_consen  142 ----NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMV  198 (308)
T ss_pred             ----ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEE
Confidence                11    122222246788889653 4799999999999999999999999775421              011222


Q ss_pred             ChhhhcCCCCChhhHHHHHHHHHHHHHhCCC
Q 006952          477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKK  507 (624)
Q Consensus       477 aPE~~~~~~~~~ksDv~S~Gvil~elltg~~  507 (624)
                      --|   ....+.++.+=+|=.-++++.....
T Consensus       199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  199 NIE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             eee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            211   1234677888788777788776553

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=95.31  E-value=0.17  Score=53.57  Aligned_cols=74  Identities=19%  Similarity=0.358  Sum_probs=46.7

Q ss_pred             CccccCCceeEEEEEecCC--cE-----EEEEEccccCcccHHHHHHHHHHHHhcCCCCc-ceEEeEEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLADG--KE-----IAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL-VRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g--~~-----vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey  382 (624)
                      +.|..|-...+|++...++  ..     |.++.......... .-.+|+.+++.+...++ .++++.+.    -++|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            4566688889999876543  22     44443322222222 23678999999965555 45666653    2699999


Q ss_pred             ccCCChh
Q 006952          383 MPNKSLD  389 (624)
Q Consensus       383 ~~~gsL~  389 (624)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998774

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	624
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-51
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-42
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-25
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-23
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-23
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-22
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-22
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-22
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-22
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-20
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-19
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-19
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-19
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-19
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-19
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-19
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-19
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-19
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-19
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-19
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-18
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-18
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-18
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-18
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-18
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-18
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-18
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-18
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-16
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
3soa_A	444	Full-Length Human Camkii Length = 444		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  201 bits (512), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 118/292 (40%), Positives = 168/292 (57%), Gaps = 5/292 (1%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQ-EFKNEVTVI 355
           L ++  A+ +FS +N LG GGFG VYKG LADG  +AVKRL     QG + +F+ EV +I
Sbjct: 30  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMI 89
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIA 414
           +   H+NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +R  I  G A
Sbjct: 90  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           RG+ YLH+    KIIHRD+K +N+LLD E    + DFG+A++            V GT G
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGTIG 208
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH--SEHGPSLLAYIWKLWCEGH 532
           ++APEY   G  S K+DVF +GV+LLE+I+G+++       ++    LL ++  L  E  
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 268
Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT 584
              L+D  ++ +    E+ + I + LLC Q  P++RP MS V  ML  D L 
Sbjct: 269 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  198 bits (503), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 118/287 (41%), Positives = 164/287 (57%), Gaps = 7/287 (2%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRL--SRTSGQGLQEFKNEVTVIAKLQH 360
           A+ +F  +N LG GGFG VYKG LADG  +AVKRL   RT G  LQ F+ EV +I+   H
Sbjct: 28  ASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-FQTEVEMISMAVH 86
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILY 419
           +NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +R  I  G ARG+ Y
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH+    KIIHRD+K +N+LLD E    + DFG+A++            V G  G++APE
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGXIGHIAPE 205
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH--SEHGPSLLAYIWKLWCEGHAAELM 537
           Y   G  S K+DVF +GV+LLE+I+G+++       ++    LL ++  L  E     L+
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265
Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT 584
           D  ++ +    E+ + I + LLC Q  P++RP MS V  ML  D L 
Sbjct: 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  168 bits (425), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 165/287 (57%), Gaps = 6/287 (2%)
Query: 290 FPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK 349
           F  + + L+D+ +AT +F  +  +G G FG VYKGVL DG ++A+KR +  S QG++EF+
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRIS 408
            E+  ++  +H +LV L+G C E NE +LIY+YM N +L   L+ S   ++ + W++R+ 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
           I  G ARG+ YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++  G    + +   
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLXX 199
Query: 469 VV-GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           VV GT GY+ PEY + G  + KSDV+SFGVVL E++  + +          +L  +  + 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
              G   +++D  +        L K+    + C+     DRP+M  V
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 165/287 (57%), Gaps = 6/287 (2%)
Query: 290 FPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK 349
           F  + + L+D+ +AT +F  +  +G G FG VYKGVL DG ++A+KR +  S QG++EF+
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRIS 408
            E+  ++  +H +LV L+G C E NE +LIY+YM N +L   L+ S   ++ + W++R+ 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
           I  G ARG+ YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++  G    + +   
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXX 199
Query: 469 VV-GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           VV GT GY+ PEY + G  + KSDV+SFGVVL E++  + +          +L  +  + 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
              G   +++D  +        L K+    + C+     DRP+M  V
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (405), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 93/199 (46%), Positives = 125/199 (62%), Gaps = 9/199 (4%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSR----TSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ V+AK QH+NLV L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           LG   + ++  L+Y YMPN SL   L     +  L W  R  I +G A GI +LHE+   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
             IHRD+K++N+LLD     KISDFG+AR           +R+VGT  YMAPE A+ G  
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEI 211
Query: 487 SVKSDVFSFGVVLLEIISG 505
           + KSD++SFGVVLLEII+G
Sbjct: 212 TPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  160 bits (404), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/199 (46%), Positives = 124/199 (62%), Gaps = 9/199 (4%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSR----TSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ V+AK QH+NLV L
Sbjct: 31  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           LG   + ++  L+Y YMPN SL   L     +  L W  R  I +G A GI +LHE+   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
             IHRD+K++N+LLD     KISDFG+AR            R+VGT  YMAPE A+ G  
Sbjct: 149 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEI 205
Query: 487 SVKSDVFSFGVVLLEIISG 505
           + KSD++SFGVVLLEII+G
Sbjct: 206 TPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 93/199 (46%), Positives = 124/199 (62%), Gaps = 9/199 (4%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSR----TSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ V+AK QH+NLV L
Sbjct: 37  NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           LG   + ++  L+Y YMPN SL   L     +  L W  R  I +G A GI +LHE+   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
             IHRD+K++N+LLD     KISDFG+AR            R+VGT  YMAPE A+ G  
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEI 211
Query: 487 SVKSDVFSFGVVLLEIISG 505
           + KSD++SFGVVLLEII+G
Sbjct: 212 TPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/199 (45%), Positives = 121/199 (60%), Gaps = 9/199 (4%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSR----TSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           NK GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ V AK QH+NLV L
Sbjct: 28  NKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           LG   + ++  L+Y Y PN SL   L     +  L W  R  I +G A GI +LHE+   
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH- 145
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
             IHRD+K++N+LLD     KISDFG+AR           +R+VGT  Y APE A+ G  
Sbjct: 146 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEI 202
Query: 487 SVKSDVFSFGVVLLEIISG 505
           + KSD++SFGVVLLEII+G
Sbjct: 203 TPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNL 363
           D + + K+G G FG V++     G ++AVK L       + + EF  EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V  +G   +     ++ EY+   SL   L  S    QLD +RR+S+   +A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               I+HRDLK+ N+L+D +   K+ DFG++R+         +    GT  +MAPE    
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRD 213
Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTG 510
              + KSDV+SFGV+L E+ + ++  G
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 115/207 (55%), Gaps = 6/207 (2%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNL 363
           D + + K+G G FG V++     G ++AVK L       + + EF  EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V  +G   +     ++ EY+   SL   L  S    QLD +RR+S+   +A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               I+HR+LK+ N+L+D +   K+ DFG++R+     +  ++    GT  +MAPE    
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRD 213
Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTG 510
              + KSDV+SFGV+L E+ + ++  G
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 28/218 (12%)
Query: 306 DFSQ---ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKL 358
           DF++   E  +G GGFG VY+     G E+AVK           Q ++  + E  + A L
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS--TRSVQLDWKRRISIIKGIARG 416
           +H N++ L G CL+E    L+ E+     L+  L        + ++W  +I      ARG
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARG 117
Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--------KISDFGMARIFGGNQSKANTNR 468
           + YLH+++ + IIHRDLK+SN+L+  ++          KI+DFG+AR       +     
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMS 173
Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             G Y +MAPE     +FS  SDV+S+GV+L E+++G+
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 100/194 (51%), Gaps = 6/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G   +  ++AVK L +     +Q F  E  ++  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
             E    +I EYM   SL  FL  S    ++   + I     IA G+ Y+    R   IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +NVL+   +  KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 192
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 193 DVWSFGILLYEIVT 206

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/215 (35%), Positives = 118/215 (54%), Gaps = 25/215 (11%)
Query: 311 NKLGEGGFGPVYKGVL---ADGKE---IAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNL 363
            +LGE  FG VYKG L   A G++   +A+K L  +  G   +EF++E  + A+LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLF-----------DSTRSVQ--LDWKRRISII 410
           V LLG   ++    +I+ Y  +  L  FL            D  R+V+  L+    + ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRV 469
             IA G+ YL   S   ++H+DL T NVL+  ++N KISD G+ R ++  +  K   N +
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +    +MAPE  M G FS+ SD++S+GVVL E+ S
Sbjct: 209 LPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 140/286 (48%), Gaps = 26/286 (9%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +LG G FG V+ G      ++A+K L +      + F  E  ++ KL+H  LV+L     
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 372 EENESLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           EE    ++ EYM   SL  FL D   R+++L     + +   +A G+ Y+    R+  IH
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+++N+L+ + +  KI+DFG+AR+   N+  A          + APE A+ G F++KS
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 187
Query: 491 DVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAEL 550
           DV+SFG++L E+++  K    Y   +   +L             E ++   +  C Q   
Sbjct: 188 DVWSFGILLTELVT--KGRVPYPGMNNREVL-------------EQVERGYRMPCPQDCP 232
Query: 551 LKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPT-QPAFSL 595
           +    + + C + DP +RPT   +   L  D  T  +P  QP  +L
Sbjct: 233 ISLHELMIHCWKKDPEERPTFEYLQSFL-EDYFTATEPQYQPGENL 277

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/215 (35%), Positives = 118/215 (54%), Gaps = 25/215 (11%)
Query: 311 NKLGEGGFGPVYKGVL---ADGKE---IAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNL 363
            +LGE  FG VYKG L   A G++   +A+K L  +  G   +EF++E  + A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLF-----------DSTRSVQ--LDWKRRISII 410
           V LLG   ++    +I+ Y  +  L  FL            D  R+V+  L+    + ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRV 469
             IA G+ YL   S   ++H+DL T NVL+  ++N KISD G+ R ++  +  K   N +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +    +MAPE  M G FS+ SD++S+GVVL E+ S
Sbjct: 192 LPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 86  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 140
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 199
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 200 DVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 84  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 197
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 198 DVWSFGILLTEIVT 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 80  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 193
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 194 DVWSFGILLTEIVT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 191
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 191
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 79  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 192
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 193 DVWSFGILLTEIVT 206

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 87  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 141
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKS 200
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 201 DVWSFGILLTEIVT 214

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 84  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKS 197
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 198 DVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 83  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 137
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKS 196
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 197 DVWSFGILLTEIVT 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            KLG G FG V+ G   +  ++AVK L +     +Q F  E  ++  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I E+M   SL  FL  S    ++   + I     IA G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +NVL+   +  KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 191
Query: 491 DVFSFGVVLLEIIS 504
           +V+SFG++L EI++
Sbjct: 192 NVWSFGILLYEIVT 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKS 191
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 88  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 142
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKS 201
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 202 DVWSFGILLTEIVT 215

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 111/201 (55%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L  S    + + K+ I I +  ARG+ YLH  S   I
Sbjct: 76  YSTKPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  +   KI DFG+A +           ++ G+  +MAPE         
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 73  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KS
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKS 186
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 187 DVWSFGILLTEIVT 200

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           +D   + +LGEG FG V+           D   +AVK L   S    Q+F+ E  ++  L
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 77
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ------------LDWKRR 406
           QH+++VR  G C E    L+++EYM +  L+ FL       +            L   + 
Sbjct: 78  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           +++   +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R           
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF 511
            R +    +M PE  +   F+ +SDV+SFGVVL EI +  K   +
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 122/230 (53%), Gaps = 23/230 (10%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRLSRTSGQGLQ-EFKNE 351
           + I+K T+   +   LG G FG VYKG+     E     +A+K L+ T+G     EF +E
Sbjct: 32  LRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 90
Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRRI 407
             ++A + H +LVRLLG CL     L + + MP+  L  ++ +   ++     L+W  +I
Sbjct: 91  ALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI 149
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                 A+G++YL E    +++HRDL   NVL+    + KI+DFG+AR+  G++ + N +
Sbjct: 150 ------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 200
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS--GKKSTGFYHSE 515
                  +MA E      F+ +SDV+S+GV + E+++  GK   G    E
Sbjct: 201 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 250

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 123/233 (52%), Gaps = 22/233 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRLSRTSGQGLQ-EFKNEVT 353
           I+K T+   +   LG G FG VYKG+     E     +A+K L+ T+G     EF +E  
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRRISI 409
           ++A + H +LVRLLG CL     L + + MP+  L  ++ +   ++     L+W  +I  
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 126
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
               A+G++YL E    +++HRDL   NVL+    + KI+DFG+AR+  G++ + N +  
Sbjct: 127 ----AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLL 521
                +MA E      F+ +SDV+S+GV + E+++ G K      +   P LL
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           +D   + +LGEG FG V+           D   +AVK L   S    Q+F+ E  ++  L
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 71
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ------------LDWKRR 406
           QH+++VR  G C E    L+++EYM +  L+ FL       +            L   + 
Sbjct: 72  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           +++   +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R           
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF 511
            R +    +M PE  +   F+ +SDV+SFGVVL EI +  K   +
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 145/293 (49%), Gaps = 38/293 (12%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQG-------LQEFKNEVTV 354
           A  +   E ++G+GGFG V+KG L   K  +A+K L     +G        QEF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           ++ L H N+V+L G  L  N   ++ E++P   L   L D    ++  W  ++ ++  IA
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIA 132
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNP---KISDFGMARIFGGNQSKANTNRV 469
            GI Y+ ++    I+HRDL++ N+ L    E  P   K++DFG+++     QS  + + +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 470 VGTYGYMAPEY--AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           +G + +MAPE   A    ++ K+D +SF ++L  I++G+        E+    + +I  +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMI 242
Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
             EG     +   + + C      +  ++  LC  GDP  RP  S +   L+ 
Sbjct: 243 REEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAV-KRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D      LG+G FG   K    +  E+ V K L R   +  + F  EV V+  L+H N++
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           + +G   ++     I EY+   +L   +   +   Q  W +R+S  K IA G+ YLH   
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS-- 126
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR------------VVGT 472
            + IIHRDL + N L+    N  ++DFG+AR+    +++    R            VVG 
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +MAPE   G  +  K DVFSFG+VL EII 
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 13  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 72  VSEEP-IXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIK 185
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 186 SDVWSFGILLTELTT 200

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/193 (34%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IHR
Sbjct: 75  QE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSD 491
           +L+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G F++KSD
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 188
Query: 492 VFSFGVVLLEIIS 504
           V+SFG++L EI++
Sbjct: 189 VWSFGILLTEIVT 201

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           +D   + +LGEG FG V+           D   +AVK L   S    Q+F+ E  ++  L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ------------LDWKRR 406
           QH+++VR  G C E    L+++EYM +  L+ FL       +            L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           +++   +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R           
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKK 507
            R +    +M PE  +   F+ +SDV+SFGVVL EI + GK+
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 144/293 (49%), Gaps = 38/293 (12%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQG-------LQEFKNEVTV 354
           A  +   E ++G+GGFG V+KG L   K  +A+K L     +G        QEF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           ++ L H N+V+L G  L  N   ++ E++P   L   L D    ++  W  ++ ++  IA
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIA 132
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNP---KISDFGMARIFGGNQSKANTNRV 469
            GI Y+ ++    I+HRDL++ N+ L    E  P   K++DFG ++     QS  + + +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 470 VGTYGYMAPEY--AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           +G + +MAPE   A    ++ K+D +SF ++L  I++G+        E+    + +I  +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMI 242
Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
             EG     +   + + C      +  ++  LC  GDP  RP  S +   L+ 
Sbjct: 243 REEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 16  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 75  VSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 188
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 189 SDVWSFGILLTELTT 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 VSEE-PIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 331 VSEE-PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 445 SDVWSFGILLTELTT 459

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 115/205 (56%), Gaps = 21/205 (10%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L  S    + + K+ I I +  ARG+ YLH  S   I
Sbjct: 88  YSTKPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
           IHRDLK++N+ L  +   KI DFG+A    R  G +Q +    ++ G+  +MAPE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 197
Query: 483 -GGIFSVKSDVFSFGVVLLEIISGK 506
               +S +SDV++FG+VL E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 114/205 (55%), Gaps = 21/205 (10%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                  + ++ ++    SL   L  S    + + K+ I I +  ARG+ YLH  S   I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
           IHRDLK++N+ L  +   KI DFG+A    R  G +Q +    ++ G+  +MAPE     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 197
Query: 483 -GGIFSVKSDVFSFGVVLLEIISGK 506
               +S +SDV++FG+VL E+++G+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE   ++I EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 79  VSEEP-IYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIK 192
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE   ++I EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 79  VSEEP-IYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 192
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 144/293 (49%), Gaps = 38/293 (12%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQG-------LQEFKNEVTV 354
           A  +   E ++G+GGFG V+KG L   K  +A+K L     +G        QEF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           ++ L H N+V+L G  L  N   ++ E++P   L   L D    ++  W  ++ ++  IA
Sbjct: 77  MSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIA 132
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNP---KISDFGMARIFGGNQSKANTNRV 469
            GI Y+ ++    I+HRDL++ N+ L    E  P   K++DF +++     QS  + + +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 470 VGTYGYMAPEY--AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           +G + +MAPE   A    ++ K+D +SF ++L  I++G+        E+    + +I  +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMI 242
Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
             EG     +   + + C      +  ++  LC  GDP  RP  S +   L+ 
Sbjct: 243 REEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 12  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 71  VSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 184
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 14  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 73  VSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 186
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 28/289 (9%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 190 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 249 VSEE-PIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+ R+   N+  A          + APE A+ G F++K
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 362
Query: 490 SDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI---WKLWCEGHAAELMDSVVKQSCD 546
           SDV+SFG++L E+ +  K    Y       +L  +   +++ C     E +  ++ Q   
Sbjct: 363 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ--- 417
Query: 547 QAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL 595
                        C + DP +RPT   +   L     +     QP  +L
Sbjct: 418 -------------CWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPGENL 453

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEP-IYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    ++ EYMP  +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAMEYLEKKN 150
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 151 ---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 206
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS+KSDV++FGV+L EI +
Sbjct: 207 TFSIKSDVWAFGVLLWEIAT 226

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 240
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 241 GCPE----KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 192
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 240
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 241 GCPE----KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 240
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 241 GCPE----KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 235
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 236 GCPE----KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ K++H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G  G V+ G      ++AVK L + S      F  E  ++ +LQH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++ E +    IH
Sbjct: 78  TQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKS 490
           RDL+ +N+L+   ++ KI+DFG+AR+    +  A          + APE    G F++KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF-PIKWTAPEAINYGTFTIKS 191
Query: 491 DVFSFGVVLLEIIS 504
           DV+SFG++L EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 135
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 191
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 239
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 240 GCPE----KVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 235
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 236 GCPE----KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 132
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 188
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 236
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 237 GCPE----KVYELMRACWQWNPSDRPSFAEI 263

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 74  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL  +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 77  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 310 ENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +LGEG FG V+           D   +AVK L   S    ++F  E  ++  LQH+++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL----------FDSTRSVQLDWKRRISIIKGI 413
           V+  G C+E +  ++++EYM +  L+ FL           +     +L   + + I + I
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGT 472
           A G++YL   +    +HRDL T N L+   +  KI DFGM+R ++  +  +   + ++  
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF 511
             +M PE  M   F+ +SDV+S GVVL EI +  K   +
Sbjct: 195 R-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG+AR+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 133
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 237
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 238 GCPE----KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM    L  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEP-IYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 144
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 145 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 200
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 248
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 249 GCPE----KVYELMRACWQWNPSDRPSFAEI 275

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 99  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                  + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 72  YSTAPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM    L  FL        L   + + +   IA G+ Y+    R+  +
Sbjct: 82  VSEEP-IYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 195
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 240
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 241 GCPE----KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGI 485
           IHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S +SDV++FG+VL E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 133
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 237
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 238 GCPE----KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G FG VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 129
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            FS+KSDV++FGV+L EI +   S    +    PS               EL++   +  
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPS------------QVYELLEKDYRME 230
Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
             +    K   +   C Q +P DRP+ + +
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L     + ++D  + +     I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 140/297 (47%), Gaps = 52/297 (17%)
Query: 313 LGEGGFGPVYK----GVLA--DGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVR 365
           +GEG FG V++    G+L       +AVK L   +   +Q +F+ E  ++A+  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFD--------------STRS-------VQLDWK 404
           LLG C       L++EYM    L+ FL                STR+         L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSK 463
            ++ I + +A G+ YL E    K +HRDL T N L+   M  KI+DFG++R I+  +  K
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG--KKSTGFYHSEHGPSLL 521
           A+ N  +    +M PE      ++ +SDV+++GVVL EI S   +   G  H E    ++
Sbjct: 232 ADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----VI 286
Query: 522 AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
            Y+     +G+           +C +   L+  ++  LC    P DRP+  S+  +L
Sbjct: 287 YYVR----DGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 129
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            FS+KSDV++FGV+L EI +   S    +    PS               EL++   +  
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPS------------QVYELLEKDYRME 230
Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
             +    K   +   C Q +P DRP+ + +
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 235
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 236 GCPE----KVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 240
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 241 GCPE----KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 235
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 236 GCPE----KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           ++G G FG VYKG       + + ++   + +  Q F+NEV V+ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           ++N + ++ ++    SL   L       Q+   + I I +  A+G+ YLH  +   IIHR
Sbjct: 103 KDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---IIHR 156
Query: 432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGIFSV 488
           D+K++N+ L   +  KI DFG+A +           +  G+  +MAPE         FS 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 489 KSDVFSFGVVLLEIISGK 506
           +SDV+S+G+VL E+++G+
Sbjct: 217 QSDVYSYGIVLYELMTGE 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 75
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 235
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 236 GCPE----KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 132
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A          + APE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 188
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 236
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 237 GCPE----KVYELMRACWQWNPSDRPSFAEI 263

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 235
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 236 GCPE----KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 133
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A          + APE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYN 189
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 237
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 238 GCPE----KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 102
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 161 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 130
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV-VGTYGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++              + APE    
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 117/214 (54%), Gaps = 16/214 (7%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFK-NEVTVIAKL 358
           + ++  F Q  KLG G +  VYKG+    G  +A+K +   S +G       E++++ +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPN---KSLDVFLFDST-RSVQLDWKRRISIIKGIA 414
           +H+N+VRL      EN+  L++E+M N   K +D     +T R ++L+  +       + 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLL 118
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-NRVVGTY 473
           +G+ + HE+   KI+HRDLK  N+L++     K+ DFG+AR FG      NT +  V T 
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVVTL 172
Query: 474 GYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            Y AP+  MG   +S   D++S G +L E+I+GK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 151 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 129
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 310 ENKLGEGGFGPVYKGVL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V +G L A GK+   +A+K L    + +  +EF +E +++ + +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           RL G        +++ E+M N +LD FL       Q    + + +++GIA G+ YL E  
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG---TYGYMAPEYA 481
            +  +HRDL   N+L++  +  K+SDFG++R    N S       +G      + APE  
Sbjct: 137 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               F+  SD +S+G+V+ E++S
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG+ R+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 135
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV-VGTYGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++              + APE    
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 310 ENKLGEGGFGPVYKGVL-ADGKE---IAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V +G L A GK+   +A+K L    + +  +EF +E +++ + +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           RL G        +++ E+M N +LD FL       Q    + + +++GIA G+ YL E  
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 134
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG---TYGYMAPEYA 481
            +  +HRDL   N+L++  +  K+SDFG++R    N S       +G      + APE  
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               F+  SD +S+G+V+ E++S
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 90/164 (54%), Gaps = 14/164 (8%)
Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 405
           ++F +E +++ +  H N++RL G       ++++ EYM N SLD FL   T   Q    +
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQ 152
Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
            + +++G+  G+ YL   S L  +HRDL   NVL+D  +  K+SDFG++R+   +   A 
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 466 TNRVVGTYG-----YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           T     T G     + APE      FS  SDV+SFGVV+ E+++
Sbjct: 210 TT----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 21/205 (10%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 72  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
           IHRDLK++N+ L  ++  KI DFG+A    R  G +Q +    ++ G+  +MAPE     
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 181
Query: 483 -GGIFSVKSDVFSFGVVLLEIISGK 506
               +S +SDV++FG+VL E+++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 132/248 (53%), Gaps = 29/248 (11%)
Query: 275 IIRRRNKRK--QEESQAFPLFPLD------LIDIVKATQDFSQENKLGEGGFGPVYKGV- 325
           I+R+R  R+  QE     PL P        L+ I+K T+ F +   LG G FG VYKG+ 
Sbjct: 12  IVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLW 70
Query: 326 LADGKEI----AVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY 380
           + +G+++    A+  L   TS +  +E  +E  V+A + + ++ RLLG CL     L I 
Sbjct: 71  IPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IT 129
Query: 381 EYMPNKSLDVFLFDSTRSVQ----LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTS 436
           + MP   L  ++ +   ++     L+W  +I      A+G+ YL ED RL  +HRDL   
Sbjct: 130 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL-EDRRL--VHRDLAAR 180
Query: 437 NVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFG 496
           NVL+    + KI+DFG+A++ G  + + +         +MA E  +  I++ +SDV+S+G
Sbjct: 181 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 240
Query: 497 VVLLEIIS 504
           V + E+++
Sbjct: 241 VTVWELMT 248

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           F QE  +G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV+L
Sbjct: 11  FVQE--IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
            G CLE+    L++E+M +  L  +L   T+      +  + +   +  G+ YL E S  
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS-- 123
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +IHRDL   N L+      K+SDFGM R    +Q  ++T        + +PE      +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRY 181
Query: 487 SVKSDVFSFGVVLLEIISGKK 507
           S KSDV+SFGV++ E+ S  K
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGK 202

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 114/204 (55%), Gaps = 12/204 (5%)
Query: 308 SQENKLGEGGFGPVYKGVL--ADGKE---IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHK 361
           +++  +G G FG VYKG+L  + GK+   +A+K L     +  + +F  E  ++ +  H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N++RL G   +    ++I EYM N +LD FL +  +  +    + + +++GIA G+ YL 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL- 163
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN-QSKANTNRVVGTYGYMAPEY 480
             + +  +HRDL   N+L++  +  K+SDFG++R+   + ++   T+       + APE 
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 481 AMGGIFSVKSDVFSFGVVLLEIIS 504
                F+  SDV+SFG+V+ E+++
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 21/205 (10%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 92  YSTKPQLA-IVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
           IHRDLK++N+ L  ++  KI DFG+A    R  G +Q +    ++ G+  +MAPE     
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 201
Query: 483 -GGIFSVKSDVFSFGVVLLEIISGK 506
               +S +SDV++FG+VL E+++G+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 147
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 171
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 232 KFTTKSDVWSFGVLLWELMT 251

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 90/164 (54%), Gaps = 14/164 (8%)
Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 405
           ++F +E +++ +  H N++RL G       ++++ EYM N SLD FL   T   Q    +
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQ 152
Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
            + +++G+  G+ YL   S L  +HRDL   NVL+D  +  K+SDFG++R+   +   A 
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 466 TNRVVGTYG-----YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           T     T G     + APE      FS  SDV+SFGVV+ E+++
Sbjct: 210 TT----TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 129
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYN 185
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            FS+KSDV++FGV+L EI +   S    +    PS               EL++   +  
Sbjct: 186 KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDPS------------QVYELLEKDYRME 230
Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
             +    K   +   C Q +P DRP+ + +
Sbjct: 231 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 150
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 149
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 210 KFTTKSDVWSFGVLLWELMT 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 170
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 231 KFTTKSDVWSFGVLLWELMT 250

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYAM 482
             + IHRDL T N+L+++E   KI DFG+ ++   ++   K         + Y APE   
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLT 190
Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              FSV SDV+SFGVVL E+ +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ YL   +  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 144
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 205 KFTTKSDVWSFGVLLWELMT 224

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 21/205 (10%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            ++G G FG VYKG      ++AVK L+ T  + Q LQ FKNEV V+ K +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +   + ++ ++    SL   L       + +  + I I +  A+G+ YLH  S   I
Sbjct: 100 YSTKPQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMA----RIFGGNQSKANTNRVVGTYGYMAPEYAM-- 482
           IHRDLK++N+ L  ++  KI DFG+A    R  G +Q +    ++ G+  +MAPE     
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQ 209
Query: 483 -GGIFSVKSDVFSFGVVLLEIISGK 506
               +S +SDV++FG+VL E+++G+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG G FG V+        ++AVK + +     ++ F  E  V+  LQH  LV+L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             +E    +I E+M   SL  FL     S Q    + I     IA G+ ++ + +    I
Sbjct: 79  VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YI 133
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A          + APE    G F++K
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 192
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L+EI++
Sbjct: 193 SDVWSFGILLMEIVT 207

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI E++P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
             + IHRDL T N+L+++E   KI DFG+ ++   ++          +   + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FSV SDV+SFGVVL E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 150
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 134/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 338
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHR+L   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 394
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 442
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 443 GCPE----KVYELMRACWQWNPSDRPSFAEI 469

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  +++    + +   I+  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN 377
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHR+L   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYN 433
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL-LAYIWKLWCEGHAAELMDSVVKQ 543
            FS+KSDV++FGV+L EI +       Y     P + L+ +++L  + +  E       +
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRMER-----PE 481
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            C +    K   +   C Q +P DRP+ + +
Sbjct: 482 GCPE----KVYELMRACWQWNPSDRPSFAEI 508

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG G FG V+        ++AVK + +     ++ F  E  V+  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             +E    +I E+M   SL  FL     S Q    + I     IA G+ ++ + +    I
Sbjct: 252 VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A          + APE    G F++K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIK 365
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L+EI++
Sbjct: 366 SDVWSFGILLMEIVT 380

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 157
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 218 KFTTKSDVWSFGVLLWELMT 237

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           F QE  +G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV+L
Sbjct: 11  FVQE--IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
            G CLE+    L++E+M +  L  +L   T+      +  + +   +  G+ YL E    
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 123
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +IHRDL   N L+      K+SDFGM R    +Q  ++T        + +PE      +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRY 181
Query: 487 SVKSDVFSFGVVLLEIISGKK 507
           S KSDV+SFGV++ E+ S  K
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGK 202

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           F QE  +G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV+L
Sbjct: 9   FVQE--IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
            G CLE+    L++E+M +  L  +L   T+      +  + +   +  G+ YL E    
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +IHRDL   N L+      K+SDFGM R    +Q  ++T        + +PE      +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRY 179
Query: 487 SVKSDVFSFGVVLLEIISGKK 507
           S KSDV+SFGV++ E+ S  K
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGK 200

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLAD--GKEI--AVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVRLL 367
           +G G FG VY G L D  GK+I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G CL  E   L++  YM +  L  F+ + T +  +  K  I     +A+G+ +L   +  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 211
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGG 484
           K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E     
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 75
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ E M N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           F QE  +G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV+L
Sbjct: 14  FVQE--IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 70
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
            G CLE+    L++E+M +  L  +L   T+      +  + +   +  G+ YL E    
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 126
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +IHRDL   N L+      K+SDFGM R    +Q  ++T        + +PE      +
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRY 184
Query: 487 SVKSDVFSFGVVLLEIISGKK 507
           S KSDV+SFGV++ E+ S  K
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGK 205

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 8   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 126 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 9   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 67
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 127 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 178 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ E M N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 306 DFSQENKLGEGGFGPVYKG--VLADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQ 359
           + S +  +G G FG V  G   L   KEI+V     ++  T  Q  ++F  E +++ +  
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    +++ E M N SLD FL       Q    + + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAP 478
           L   S +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      F+  SDV+S+G+VL E++S
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 9   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 67
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 127 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 178 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 312 KLGEGGFGPVYK---GVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYAM 482
             + IHR+L T N+L+++E   KI DFG+ ++   ++   K         + Y APE   
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLT 191
Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              FSV SDV+SFGVVL E+ +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 12  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 70
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 130 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 181 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSRTS---GQGLQEFKNEVTVI 355
           I +  +DF   N LG+G F  VY+   +  G E+A+K + + +      +Q  +NEV + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            +L+H +++ L     + N   L+ E   N  ++ +L +  +    +  R    +  I  
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIIT 123
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           G+LYLH      I+HRDL  SN+LL   MN KI+DFG+A        K  T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           ++PE A      ++SDV+S G +   ++ G+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 2   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 120 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 8   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 126 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 8   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 126 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 11  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 69
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 129 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 18  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 76
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 77  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 135
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 136 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 187 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 10  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 68
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 128 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 52/280 (18%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS---RTSGQGLQEFKNEVTVIAKLQHKN 362
           FS   ++G G FG VY        E+ A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
            ++  GC L E+ + L+ EY    + D+          L      ++  G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +   +IHRD+K  N+LL      K+ DFG A I       A  N  VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 483 G---GIFSVKSDVFSFGVVLLEIISGKKS-------TGFYH--SEHGPSLLAYIWKLWCE 530
               G +  K DV+S G+  +E+   K         +  YH      P+L +        
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-------- 236
Query: 531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
           GH +E   + V                  C+Q  P DRPT
Sbjct: 237 GHWSEYFRNFVDS----------------CLQKIPQDRPT 260

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 114/227 (50%), Gaps = 24/227 (10%)
Query: 305 QDFSQENKLGEGGFGPVYKG------VLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL 358
           +D   + +LGEG FG V+           D   +AVK L   +    ++F+ E  ++  L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF----DSTRSV---------QLDWKR 405
           QH+++V+  G C + +  ++++EYM +  L+ FL     D+   V         +L   +
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKA 464
            + I   IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++  +  + 
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF 511
             + ++    +M PE  M   F+ +SDV+SFGV+L EI +  K   F
Sbjct: 192 GGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 14  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 72
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 73  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 131
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 132 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 183 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           F++ +++G+G FG VYKG+    KE+ A+K +    +   +++ + E+TV+++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           R  G  L+  +  +I EY+   S      D  +   L+     +I++ I +G+ YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 136
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL  + + K++DFG+A      Q K N    VGT  +MAPE     
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 191
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYH 513
            +  K+D++S G+  +E+  G+      H
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLH 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 10  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 68
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 128 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 11  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 69
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 129 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 11  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 69
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 129 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 8   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 126 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 117/205 (57%), Gaps = 11/205 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKN 362
           + + +  K+GEG +G VYK   + G+ +A+KR+      +G+      E++++ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L+     E    L++E+M  K L   L ++   +Q D + +I + + + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLYQ-LLRGVAHCHQ 137
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
               +I+HRDLK  N+L++ +   K++DFG+AR F G   ++ T+ VV T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 483 GG-IFSVKSDVFSFGVVLLEIISGK 506
           G   +S   D++S G +  E+I+GK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 15  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 73
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 133 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 117/205 (57%), Gaps = 11/205 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKN 362
           + + +  K+GEG +G VYK   + G+ +A+KR+      +G+      E++++ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L+     E    L++E+M  K L   L ++   +Q D + +I + + + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLYQ-LLRGVAHCHQ 137
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
               +I+HRDLK  N+L++ +   K++DFG+AR F G   ++ T+ VV T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 483 GG-IFSVKSDVFSFGVVLLEIISGK 506
           G   +S   D++S G +  E+I+GK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 11  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 69
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 129 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 52/280 (18%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS---RTSGQGLQEFKNEVTVIAKLQHKN 362
           FS   ++G G FG VY        E+ A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
            ++  GC L E+ + L+ EY    + D+          L      ++  G  +G+ YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +   +IHRD+K  N+LL      K+ DFG A I       A  N  VGT  +MAPE  +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 483 G---GIFSVKSDVFSFGVVLLEIISGKKS-------TGFYH--SEHGPSLLAYIWKLWCE 530
               G +  K DV+S G+  +E+   K         +  YH      P+L +        
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS-------- 275
Query: 531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
           GH +E   + V                  C+Q  P DRPT
Sbjct: 276 GHWSEYFRNFVDS----------------CLQKIPQDRPT 299

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 121/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 33  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 91
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 92  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 150
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 151 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 202 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 117/229 (51%), Gaps = 26/229 (11%)
Query: 294 PLDLIDIVKATQDFSQE---------NKLGEGGFGPVYKGVL-ADGKE---IAVKRL-SR 339
           P    D  +A ++F++E           +G G FG V  G L   GK    +A+K L + 
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG 68
Query: 340 TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS- 398
            + +  ++F +E +++ +  H N++ L G   +    ++I EYM N SLD FL  +    
Sbjct: 69  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF 128
Query: 399 --VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 456
             +QL     + +++GI  G+ YL   S +  +HRDL   N+L++  +  K+SDFGM+R+
Sbjct: 129 TVIQL-----VGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRV 180
Query: 457 FGGNQSKANTNRVVGT-YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              +   A T R       + APE      F+  SDV+S+G+V+ E++S
Sbjct: 181 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WKRRISIIKGI 413
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R            + +   
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G  
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGY 250
Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
            +  D+  ++  D   L++      +C Q +P  RPT   +  +L  D+
Sbjct: 251 LDQPDNCPERVTD---LMR------MCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WKRRISIIKGI 413
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R            + +   
Sbjct: 137 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G  
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGY 247
Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF 593
            +  D+  ++  D   L++      +C Q +P  RPT   +  +L  D+     P+ P  
Sbjct: 248 LDQPDNCPERVTD---LMR------MCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEV 294
Query: 594 SL 595
           S 
Sbjct: 295 SF 296

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 36/298 (12%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR-------RISIIKGIARGI 417
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL+     K +HRDL   N ++ H+   KI DFGM R            + +    +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G   +  
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGYLDQP 254
Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL 595
           D+  ++  D   L++      +C Q +P  RPT   +  +L  D+     P+ P  S 
Sbjct: 255 DNCPERVTD---LMR------MCWQFNPNMRPTFLEIVNLLKDDL----HPSFPEVSF 299

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 22/228 (9%)
Query: 294 PLDLIDIVKATQDFSQE---------NKLGEGGFGPVYKGVLA-DGKE---IAVKRL-SR 339
           P    D  +A ++F++E           +G G FG V  G L   GK    +A+K L S 
Sbjct: 13  PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 72
Query: 340 TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV 399
            + +  ++F +E +++ +  H N++ L G   +    ++I E+M N SLD FL       
Sbjct: 73  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDG 130
Query: 400 QLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 459
           Q    + + +++GIA G+ YL +   +  +HRDL   N+L++  +  K+SDFG++R    
Sbjct: 131 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 460 NQSKANTNRVVG---TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           + S       +G      + APE      F+  SDV+S+G+V+ E++S
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 132
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 121/220 (55%), Gaps = 21/220 (9%)
Query: 295 LDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEF 348
           + L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E 
Sbjct: 3   MALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 349 KNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWK 404
            +E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W 
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC 120
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
            +I      A G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + 
Sbjct: 121 VQI------AEGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 171
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +         +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 310 ENKLGEGGFGPVYKGVLA-DGKE---IAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V  G L   GK    +A+K L    + +  ++F  E +++ +  H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L G   +    +++ EYM N SLD FL       Q    + + +++GI+ G+ YL   S
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYL---S 141
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEYAMG 483
            +  +HRDL   N+L++  +  K+SDFG++R+   +   A T R       + APE    
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             F+  SDV+S+G+V+ E++S
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS 222

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 12  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 70
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + + + 
Sbjct: 130 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 180
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 181 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           F QE  +G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV+L
Sbjct: 12  FVQE--IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
            G CLE+    L+ E+M +  L  +L   T+      +  + +   +  G+ YL E    
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +IHRDL   N L+      K+SDFGM R    +Q  ++T        + +PE      +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRY 182
Query: 487 SVKSDVFSFGVVLLEIISGKK 507
           S KSDV+SFGV++ E+ S  K
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGK 203

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 7/216 (3%)
Query: 292 LFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNE 351
           L P   + +V    + +   ++G G FG V+ G   +  ++A+K +   S     +F  E
Sbjct: 14  LVPRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEE 72
Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
             V+ KL H  LV+L G CLE+    L++E+M +  L  +L   T+      +  + +  
Sbjct: 73  AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCL 130
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            +  G+ YL E     +IHRDL   N L+      K+SDFGM R    +Q  ++T     
Sbjct: 131 DVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 187
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK 507
              + +PE      +S KSDV+SFGV++ E+ S  K
Sbjct: 188 V-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 123
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 10  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 68
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + + + 
Sbjct: 128 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 310 ENKLGEGGFGPVYKGVL-ADGKE---IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V  G L   GK    +A+K L +  + +  ++F +E +++ +  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS---VQLDWKRRISIIKGIARGILYLH 421
            L G   +    ++I EYM N SLD FL  +      +QL     + +++GI  G+ YL 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 126
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEY 480
             S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T R       + APE 
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 481 AMGGIFSVKSDVFSFGVVLLEIIS 504
                F+  SDV+S+G+V+ E++S
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 10  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 68
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + + + 
Sbjct: 128 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 8   LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + + + 
Sbjct: 126 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 310 ENKLGEGGFGPVYKGVL-ADGKE---IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V  G L   GK    +A+K L +  + +  ++F +E +++ +  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS---VQLDWKRRISIIKGIARGILYLH 421
            L G   +    ++I EYM N SLD FL  +      +QL     + +++GI  G+ YL 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 132
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT-YGYMAPEY 480
             S +  +HRDL   N+L++  +  K+SDFGM+R+   +   A T R       + APE 
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 481 AMGGIFSVKSDVFSFGVVLLEIIS 504
                F+  SDV+S+G+V+ E++S
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 17/203 (8%)
Query: 311 NKLGEGGFGPVYKGVLADGK----EIAVKRL---SRTSGQGLQEFKNEVTVIAKLQHKNL 363
           +KLG GG   VY   LA+      ++A+K +    R   + L+ F+ EV   ++L H+N+
Sbjct: 17  DKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V ++    E++   L+ EY+   +L  ++ +S   + +D    I+    I  GI + H+ 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTA--INFTNQILDGIKHAHD- 129
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
             ++I+HRD+K  N+L+D     KI DFG+A+      S   TN V+GT  Y +PE A G
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
                 +D++S G+VL E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 10  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 68
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + + + 
Sbjct: 128 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   LG G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 15  LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 73
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG A++ G  + + + 
Sbjct: 133 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WKRRISIIKGI 413
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R            + +   
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G  
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGY 250
Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF 593
            +  D+  ++  D   L++      +C Q +P  RPT   +  +L  D+     P+ P  
Sbjct: 251 LDQPDNCPERVTD---LMR------MCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEV 297
Query: 594 SL 595
           S 
Sbjct: 298 SF 299

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WKRRISIIKGI 413
           RLLG   +   +L++ E M +  L  +L    RS++ +            +  I +   I
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A G+ YL+     K +HRDL   N ++ H+   KI DFGM R            + +   
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G  
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGY 250
Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
            +  D+  ++  D   L++      +C Q +P  RPT   +  +L  D+
Sbjct: 251 LDQPDNCPERVTD---LMR------MCWQFNPKMRPTFLEIVNLLKDDL 290

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   L  G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 8   LLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 126 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   L  G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 15  LLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 73
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 133 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 116/217 (53%), Gaps = 11/217 (5%)
Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS-RTSGQGLQEFKNEVTVIA 356
           +I    + F++  ++G+G FG V+KG+    +++ A+K +    +   +++ + E+TV++
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           +     + +  G  L+ ++  +I EY+   S      D  R+   D  +  +++K I +G
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKG 132
Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YLH + +   IHRD+K +NVLL  + + K++DFG+A      Q K NT   VGT  +M
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 187
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH 513
           APE      +  K+D++S G+  +E+  G+      H
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 224

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 138
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              + +    +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 129
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              + +    +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+KL H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 131
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 120/218 (55%), Gaps = 21/218 (9%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+ F +   L  G FG VYKG+ + +G+++    A+K L   TS +  +E  +
Sbjct: 15  LLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 73
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----LDWKRR 406
           E  V+A + + ++ RLLG CL     L I + MP   L  ++ +   ++     L+W  +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
           I      A+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+A++ G  + + + 
Sbjct: 133 I------AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                   +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 131
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 132
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              + +    +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+KL H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 211
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD--------WKRRI 407
            +    ++VRLLG   +   +L+I E M    L  +L  S R    +          + I
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 141
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R            
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           + +    +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 313 LGEGGFGPV----YKGVLAD-GKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V    Y     + G+++AVK L   + G  + + K E+ ++  L H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 367 LGCCLEE--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C E+  N   LI E++P+ SL  +L  +   + L  K+++     I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYL--GS 144
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT--NRVVGTYGYMAPEYAM 482
           R + +HRDL   NVL++ E   KI DFG+ +    ++       +R    + Y APE  M
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              F + SDV+SFGV L E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD--------WKRRI 407
            +    ++VRLLG   +   +L+I E M    L  +L  S R    +          + I
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMI 131
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R            
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           + +    +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 15/220 (6%)
Query: 307 FSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           F++  K+G+G FG V+KG+     K +A+K +    +   +++ + E+TV+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +  G  L++ +  +I EY+   S      D      LD  +  +I++ I +G+ YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL      K++DFG+A      Q K NT   VGT  +MAPE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI 524
            +  K+D++S G+  +E+  G+      HSE  P  + ++
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL 215

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 160
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 125
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R         
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
              + +    +M+PE    G+F+  SDV+SFGVVL EI
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 313 LGEGGFGPV----YKGVLAD-GKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V    Y     + G+++AVK L   + G  + + K E+ ++  L H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 367 LGCCLEE--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            G C E+  N   LI E++P+ SL  +L  +   + L  K+++     I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYL--GS 132
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT--NRVVGTYGYMAPEYAM 482
           R + +HRDL   NVL++ E   KI DFG+ +    ++       +R    + Y APE  M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              F + SDV+SFGV L E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 15/214 (7%)
Query: 307 FSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           F++  K+G+G FG V+KG+     K +A+K +    +   +++ + E+TV+++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +  G  L++ +  +I EY+   S      D      LD  +  +I++ I +G+ YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL      K++DFG+A      Q K NT   VGT  +MAPE     
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 199
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
            +  K+D++S G+  +E+  G+      HSE  P
Sbjct: 200 AYDSKADIWSLGITAIELARGEPP----HSELHP 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 32/285 (11%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR-------RISIIKGIARGI 417
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL+     K +HRDL   N ++ H+   KI DFGM R            + +    +MA
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G   +  
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGYLDQP 253
Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           D+  ++  D   L++      +C Q +P  RPT   +  +L  D+
Sbjct: 254 DNCPERVTD---LMR------MCWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 30/230 (13%)
Query: 283 KQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAV----KRLS 338
           KQ E     L P D  +I+          +LG+G FG VYK   A  KE +V    K + 
Sbjct: 24  KQYEHVTRDLNPEDFWEII---------GELGDGAFGKVYK---AQNKETSVLAAAKVID 71
Query: 339 RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS 398
             S + L+++  E+ ++A   H N+V+LL     EN   ++ E+    ++D  + +  R 
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 131
Query: 399 VQLDWKRRISII-KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 457
           +    + +I ++ K     + YLH++   KIIHRDLK  N+L   + + K++DFG++   
Sbjct: 132 LT---ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-- 183
Query: 458 GGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEI 502
              ++    +  +GT  +MAPE  M        +  K+DV+S G+ L+E+
Sbjct: 184 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG G FG V+        ++AVK + +     ++ F  E  V+  LQH  LV+L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             +E    +I E+M   SL  FL     S Q    + I     IA G+ ++ + +    I
Sbjct: 246 VTKE-PIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  KI+DFG+AR+      K           + APE    G F++K
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIK 349
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L+EI++
Sbjct: 350 SDVWSFGILLMEIVT 364

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 29/298 (9%)
Query: 295 LDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV 354
           L +ID     ++   E  +G G FG V K      K++A+K++   S +  + F  E+  
Sbjct: 2   LHMIDY----KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQ 54
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           ++++ H N+V+L G CL  N   L+ EY    SL   L  +           +S     +
Sbjct: 55  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTY 473
           +G+ YLH      +IHRDLK  N+LL       KI DFG A      Q+    N+  G+ 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSA 167
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE   G  +S K DVFS+G++L E+I+ +K       E G      +W +   G  
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAV-HNGTR 222
Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQP 591
             L+ ++ K             +   C   DP  RP+M  +  ++   +   P   +P
Sbjct: 223 PPLIKNLPK---------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 132/298 (44%), Gaps = 29/298 (9%)
Query: 295 LDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV 354
           L +ID     ++   E  +G G FG V K      K++A+K++   S +  + F  E+  
Sbjct: 3   LHMIDY----KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQ 55
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           ++++ H N+V+L G CL  N   L+ EY    SL   L  +           +S     +
Sbjct: 56  LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 113
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTY 473
           +G+ YLH      +IHRDLK  N+LL       KI DFG A      Q+    N+  G+ 
Sbjct: 114 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSA 168
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
            +MAPE   G  +S K DVFS+G++L E+I+ +K       E G      +W +   G  
Sbjct: 169 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAV-HNGTR 223
Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQP 591
             L+ ++ K             +   C   DP  RP+M  +  ++   +   P   +P
Sbjct: 224 PPLIKNLPK---------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 122/238 (51%), Gaps = 21/238 (8%)
Query: 277 RRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVK 335
           RR+ K+  E+S      P ++ D+++         KLGEG +G VYK +  + G+ +A+K
Sbjct: 12  RRQLKKLDEDS--LTKQPEEVFDVLE---------KLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 336 RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS 395
           ++   S   LQE   E++++ +    ++V+  G   +  +  ++ EY    S+   +   
Sbjct: 61  QVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--R 116
Query: 396 TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 455
            R+  L      +I++   +G+ YLH    ++ IHRD+K  N+LL+ E + K++DFG+A 
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH 513
                 +K N   V+GT  +MAPE      ++  +D++S G+  +E+  GK      H
Sbjct: 174 QLTDXMAKRNX--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVG----TY 473
           E+     IHRD+   N LL     P    KI DFGMAR    +  +A+  R  G      
Sbjct: 173 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPV 224
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 114/211 (54%), Gaps = 10/211 (4%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 127
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK +T  +VGT  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 211
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 310 ENKLGEGGFGPVYKGVLA-DGKE---IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V  G L   GK    +A+K L S  + +  ++F +E +++ +  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L G   +    ++I E+M N SLD FL       Q    + + +++GIA G+ YL +  
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-- 127
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG---TYGYMAPEYA 481
            +  +HR L   N+L++  +  K+SDFG++R    + S       +G      + APE  
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               F+  SDV+S+G+V+ E++S
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 36/298 (12%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR-------RISIIKGIARGI 417
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL+     K +HR+L   N ++ H+   KI DFGM R            + +    +MA
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G   +  
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGYLDQP 254
Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL 595
           D+  ++  D   L++      +C Q +P  RPT   +  +L  D+     P+ P  S 
Sbjct: 255 DNCPERVTD---LMR------MCWQFNPNMRPTFLEIVNLLKDDL----HPSFPEVSF 299

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 202
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 217
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVG----TY 473
           E+     IHRD+   N LL     P    KI DFGMAR    +  +A+  R  G      
Sbjct: 158 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPV 209
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVG----TY 473
           E+     IHRD+   N LL     P    KI DFGMAR    +  +A+  R  G      
Sbjct: 175 EN---HFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPV 226
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 303 ATQDFSQENKLGEGGFGPVY----KGVLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTVI 355
           A +  +   +LG+G FG VY    KGV+ D  E  +A+K ++  +    + EF NE +V+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK----------- 404
            +    ++VRLLG   +   +L+I E M    L  +L    RS++ + +           
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLS 125
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           + I +   IA G+ YL+ +   K +HRDL   N  +  +   KI DFGM R         
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              + +    +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 30/230 (13%)
Query: 283 KQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAV----KRLS 338
           KQ E     L P D  +I+          +LG+G FG VYK   A  KE +V    K + 
Sbjct: 24  KQYEHVTRDLNPEDFWEII---------GELGDGAFGKVYK---AQNKETSVLAAAKVID 71
Query: 339 RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS 398
             S + L+++  E+ ++A   H N+V+LL     EN   ++ E+    ++D  + +  R 
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 131
Query: 399 VQLDWKRRISII-KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 457
           +    + +I ++ K     + YLH++   KIIHRDLK  N+L   + + K++DFG++   
Sbjct: 132 LT---ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-- 183
Query: 458 GGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEI 502
              +     +  +GT  +MAPE  M        +  K+DV+S G+ L+E+
Sbjct: 184 KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A   R  G       
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 251
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 36/298 (12%)
Query: 312 KLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLV 364
           +LG+G FG VY+G   D         +AVK ++ ++  +   EF NE +V+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR-------RISIIKGIARGI 417
           RLLG   +   +L++ E M +  L  +L       + +  R        I +   IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL+     K +HR+L   N ++ H+   KI DFGM R            + +    +MA
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE    G+F+  SD++SFGVVL EI S  +    Y       +L ++     +G   +  
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV----MDGGYLDQP 255
Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL 595
           D+  ++  D   L++      +C Q +P  RPT   +  +L  D+     P+ P  S 
Sbjct: 256 DNCPERVTD---LMR------MCWQFNPNMRPTFLEIVNLLKDDL----HPSFPEVSF 300

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 237
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMAR    +  +A   R  G       
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 228
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 30/230 (13%)
Query: 283 KQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAV----KRLS 338
           KQ E     L P D  +I+          +LG+G FG VYK   A  KE +V    K + 
Sbjct: 24  KQYEHVTRDLNPEDFWEII---------GELGDGAFGKVYK---AQNKETSVLAAAKVID 71
Query: 339 RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS 398
             S + L+++  E+ ++A   H N+V+LL     EN   ++ E+    ++D  + +  R 
Sbjct: 72  TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 131
Query: 399 VQLDWKRRISII-KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 457
           +    + +I ++ K     + YLH++   KIIHRDLK  N+L   + + K++DFG++   
Sbjct: 132 LT---ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA-- 183
Query: 458 GGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEI 502
              +     +  +GT  +MAPE  M        +  K+DV+S G+ L+E+
Sbjct: 184 KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 109/246 (44%), Gaps = 33/246 (13%)
Query: 286 ESQAFPLFPLDLIDIVKATQ-------------------------DFSQENKLGEGGFGP 320
           E + FP  PL LID + +TQ                         D     ++G G FG 
Sbjct: 71  EGEGFPSIPL-LIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGE 129
Query: 321 VYKGVL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLGCCLEENESLL 378
           V+ G L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G C ++    +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV 438
           + E +  +  D   F  T   +L  K  + ++   A G+ YL        IHRDL   N 
Sbjct: 190 VMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNC 244
Query: 439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVV 498
           L+  +   KISDFGM+R        A+         + APE    G +S +SDV+SFG++
Sbjct: 245 LVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
Query: 499 LLEIIS 504
           L E  S
Sbjct: 305 LWETFS 310

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 307 FSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           F++  K+G+G FG V+KG+     K +A+K +    +   +++ + E+TV+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +  G  L++ +  +I EY+   S      D      LD  +  +I++ I +G+ YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL      K++DFG+A      Q K N    VGT  +MAPE     
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 194
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI 524
            +  K+D++S G+  +E+  G+      HSE  P  + ++
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL 230

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 15/220 (6%)
Query: 307 FSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           F++  K+G+G FG V+KG+     K +A+K +    +   +++ + E+TV+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +  G  L++ +  +I EY+   S      D      LD  +  +I++ I +G+ YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRD+K +NVLL      K++DFG+A      Q K N    VGT  +MAPE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 179
Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI 524
            +  K+D++S G+  +E+  G+      HSE  P  + ++
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 109/246 (44%), Gaps = 33/246 (13%)
Query: 286 ESQAFPLFPLDLIDIVKATQ-------------------------DFSQENKLGEGGFGP 320
           E + FP  PL LID + +TQ                         D     ++G G FG 
Sbjct: 71  EGEGFPSIPL-LIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGE 129
Query: 321 VYKGVL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLGCCLEENESLL 378
           V+ G L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G C ++    +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV 438
           + E +  +  D   F  T   +L  K  + ++   A G+ YL        IHRDL   N 
Sbjct: 190 VMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNC 244
Query: 439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVV 498
           L+  +   KISDFGM+R        A+         + APE    G +S +SDV+SFG++
Sbjct: 245 LVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
Query: 499 LLEIIS 504
           L E  S
Sbjct: 305 LWETFS 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 139/290 (47%), Gaps = 36/290 (12%)
Query: 313 LGEGGFGPVYKGVLA--DGK--EIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V +G L   DG   ++AVK  +L  +S + ++EF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 367 LGCCLEEN-----ESLLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGIL 418
           LG C+E +     + ++I  +M    L  +L  S   T    +  +  +  +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGT-YGYM 476
           YL   S    +HRDL   N +L  +M   ++DFG++ +I+ G+  +    R+      ++
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAKMPVKWI 216
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           A E     +++ KSDV++FGV + EI +  +    Y       +  Y+      GH    
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYL----LHGHR--- 267
Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
               +KQ  D  + L  I     C + DP+DRPT S + + L   + +LP
Sbjct: 268 ----LKQPEDCLDELYEIMYS--CWRTDPLDRPTFSVLRLQLEKLLESLP 311

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 117/208 (56%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 174
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 113/211 (53%), Gaps = 10/211 (4%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 127
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK   + +VGT  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYW 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 313 LGEGGFGPVYKGVLADGK------EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVR 365
           LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDS----TRSVQLDWKRRISIIKGIARGILYLH 421
            +G  L+     ++ E M    L  FL ++    ++   L     + + + IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 422 EDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG----TYG 474
           E+     IHRD+   N LL         KI DFGMA+    +  +A+  R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKGGCAMLPVK 211
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 182
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
             ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 173
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           F+ + +   QL  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 210 TNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 260
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 261 LFKLLKEGH 269

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ + A L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 312 KLGEGGFGPVYKGVLADGK---EIAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +LG G FG V +GV    K   ++A+K L + T     +E   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G C  E   +L+ E      L  FL      + +       ++  ++ G+ YL E +   
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN--- 130
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGGI 485
            +HRDL   NVLL +    KISDFG+++  G + S   T R  G +   + APE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 486 FSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYI 524
           FS +SDV+S+GV + E +S G+K    Y    GP ++A+I
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAFI 226

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 179
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 115/204 (56%), Gaps = 11/204 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 182
Query: 482 MG-GIFSVKSDVFSFGVVLLEIIS 504
           +G   +S   D++S G +  E+++
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 114/211 (54%), Gaps = 10/211 (4%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 128
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHR++K+ N+LL  + + K++DFG        QSK +T  +VGT  +
Sbjct: 129 ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 183
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E+I G+
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 116/206 (56%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 113/211 (53%), Gaps = 10/211 (4%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 127
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK +   +VGT  +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYW 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E+I G+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 113/211 (53%), Gaps = 10/211 (4%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVI 355
           ++ +    + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            + ++ N+V  L   L  +E  ++ EY+   SL     D      +D  +  ++ +   +
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQ 128
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + +LH +   ++IHRD+K+ N+LL  + + K++DFG        QSK +   +VGT  +
Sbjct: 129 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYW 183
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           MAPE      +  K D++S G++ +E+I G+
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR         NT   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 176
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 122/234 (52%), Gaps = 18/234 (7%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI----AVKRLSR-TSGQGLQEFKN 350
           L+ I+K T+   +   LG G FG VYKG+ + DG+ +    A+K L   TS +  +E  +
Sbjct: 10  LLRILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD 68
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS--VQLDWKRRIS 408
           E  V+A +    + RLLG CL     L + + MP   L     D  R    +L  +  ++
Sbjct: 69  EAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCL----LDHVRENRGRLGSQDLLN 123
Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
               IA+G+ YL ED RL  +HRDL   NVL+    + KI+DFG+AR+   ++++ + + 
Sbjct: 124 WCMQIAKGMSYL-EDVRL--VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 180
Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLL 521
                 +MA E  +   F+ +SDV+S+GV + E+++ G K      +   P LL
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 175
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 174
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 116/235 (49%), Gaps = 34/235 (14%)
Query: 286 ESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL 345
           E+  F   PL L++ VKA            G FG V+K  L + + +AVK       Q  
Sbjct: 17  ENLYFQSMPLQLLE-VKA-----------RGRFGCVWKAQLLN-EYVAVKIFPIQDKQSW 63
Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLE----ENESLLIYEYMPNKSLDVFLFDSTRSVQL 401
           Q  + EV  +  ++H+N+++ +G        + +  LI  +    SL  FL    ++  +
Sbjct: 64  QN-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVV 118
Query: 402 DWKRRISIIKGIARGILYLHED-------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
            W     I + +ARG+ YLHED        +  I HRD+K+ NVLL + +   I+DFG+A
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FS----VKSDVFSFGVVLLEIIS 504
             F   +S  +T+  VGT  YMAPE   G I F     ++ D+++ G+VL E+ S
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 175
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+ ++   T  +G+      E++++ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 175
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+ ++   T  +G+      E++++ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +  T+ VV T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 174
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 176
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 175
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 118/249 (47%), Gaps = 41/249 (16%)
Query: 294 PLDL-IDIVKATQD----FSQEN-----KLGEGGFGPVYKGVL------ADGKEIAVKRL 337
           PL L +D  K  +D    F ++N      LGEG FG V K         A    +AVK L
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 338 SR-TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST 396
               S   L++  +E  V+ ++ H ++++L G C ++   LLI EY    SL  FL +S 
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 397 R-------------SVQLDWKRRISIIKG--------IARGILYLHEDSRLKIIHRDLKT 435
           +             S  LD     ++  G        I++G+ YL E   +K++HRDL  
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 436 SNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSF 495
            N+L+      KISDFG++R      S    ++      +MA E     I++ +SDV+SF
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 496 GVVLLEIIS 504
           GV+L EI++
Sbjct: 239 GVLLWEIVT 247

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 174
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 177
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIIS 504
             +G   +S   D++S G +  E+++
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 173
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             +G   +S   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEIL 176
Query: 482 MG-GIFSVKSDVFSFGVVLLEIISGK 506
           +G   +S   D++S G +  E+++ +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 195 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 245
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 246 LFKLLKEGH 254

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 116/209 (55%), Gaps = 13/209 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-DSTRSVQLDWKRRISIIKGIARGIL 418
           H N+V+LL     EN+  L++E++   S+D+  F D++    +      S +  + +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           + H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 479 EYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           E  +G   +S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 139
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMYS 196
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 116/209 (55%), Gaps = 13/209 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-DSTRSVQLDWKRRISIIKGIARGIL 418
           H N+V+LL     EN+  L++E++   S+D+  F D++    +      S +  + +G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           + H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y AP
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 173
Query: 479 EYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           E  +G   +S   D++S G +  E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 176
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIIS 504
             +G   +S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 312 KLGEGGFGPVYKGVLADGK---EIAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +LG G FG V +GV    K   ++A+K L + T     +E   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G C  E   +L+ E      L  FL      + +       ++  ++ G+ YL E +   
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN--- 456
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYAMGGI 485
            +HR+L   NVLL +    KISDFG+++  G + S   T R  G +   + APE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 486 FSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYI 524
           FS +SDV+S+GV + E +S G+K    Y    GP ++A+I
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPEVMAFI 552

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 210 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 260
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 261 LFKLLKEGH 269

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 66
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 123
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 124 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 180
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 181 KFSSKSDIWAFGVLMWEIYS 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 119
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 176
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 306 DFSQENKLGEGGFGPVYKG-VLADG--KEIAVKRLSR-TSGQGLQEFKNEVTVIAKL-QH 360
           D   ++ +GEG FG V K  +  DG   + A+KR+    S    ++F  E+ V+ KL  H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-------------TRSVQLDWKRRI 407
            N++ LLG C       L  EY P+ +L  FL  S             + +  L  ++ +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R   G +      
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 189
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                  +MA E     +++  SDV+S+GV+L EI+S
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 9/206 (4%)
Query: 304 TQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHK 361
            +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L H+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+  G   E N   L  EY     L   +       + D +R       +  G++YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 120
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+APE  
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGK 506
               F  +  DV+S G+VL  +++G+
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 116/209 (55%), Gaps = 13/209 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-DSTRSVQLDWKRRISIIKGIARGIL 418
           H N+V+LL     EN+  L++E++   S+D+  F D++    +      S +  + +G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           + H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y AP
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 175
Query: 479 EYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           E  +G   +S   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 313 LGEGGFGPVYKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +G+G FG V   +L D  G ++AVK +   +    Q F  E +V+ +L+H NLV+LLG  
Sbjct: 20  IGKGEFGDV---MLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 371 LEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
           +EE   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL   NVL+  +   K+SDFG+ +     Q   +T ++     + APE      FS K
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREAAFSTK 185
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 199 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 249
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 250 LFKLLKEGH 258

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 124
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 181
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 182 KFSSKSDIWAFGVLMWEIYS 201

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 118/249 (47%), Gaps = 41/249 (16%)
Query: 294 PLDL-IDIVKATQD----FSQEN-----KLGEGGFGPVYKGVL------ADGKEIAVKRL 337
           PL L +D  K  +D    F ++N      LGEG FG V K         A    +AVK L
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 338 SR-TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST 396
               S   L++  +E  V+ ++ H ++++L G C ++   LLI EY    SL  FL +S 
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 397 R-------------SVQLDWKRRISIIKG--------IARGILYLHEDSRLKIIHRDLKT 435
           +             S  LD     ++  G        I++G+ YL E   +K++HRDL  
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 436 SNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSF 495
            N+L+      KISDFG++R      S    ++      +MA E     I++ +SDV+SF
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 496 GVVLLEIIS 504
           GV+L EI++
Sbjct: 239 GVLLWEIVT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 203 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 253
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 254 LFKLLKEGH 262

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 210 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 260
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 261 LFKLLKEGH 269

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 306 DFSQENKLGEGGFGPVYKG-VLADG--KEIAVKRLSR-TSGQGLQEFKNEVTVIAKL-QH 360
           D   ++ +GEG FG V K  +  DG   + A+KR+    S    ++F  E+ V+ KL  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-------------TRSVQLDWKRRI 407
            N++ LLG C       L  EY P+ +L  FL  S             + +  L  ++ +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                +ARG+ YL   S+ + IHRDL   N+L+      KI+DFG++R   G +      
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                  +MA E     +++  SDV+S+GV+L EI+S
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 313 LGEGGFGPVYKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +G+G FG V   +L D  G ++AVK +   +    Q F  E +V+ +L+H NLV+LLG  
Sbjct: 201 IGKGEFGDV---MLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 371 LEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
           +EE   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL   NVL+  +   K+SDFG+ +     Q   +T ++     + APE      FS K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTK 366
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 116/209 (55%), Gaps = 13/209 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-DSTRSVQLDWKRRISIIKGIARGIL 418
           H N+V+LL     EN+  L++E++   S+D+  F D++    +      S +  + +G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           + H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y AP
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAP 174
Query: 479 EYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
           E  +G   +S   D++S G +  E+++ +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 138/293 (47%), Gaps = 37/293 (12%)
Query: 311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQ---EFKNEVTVIAKLQHKNLVRL 366
           + LG G FG V  G     G ++AVK L+R   + L    + + E+  +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                  ++  ++ EY+    L  ++  + R   LD K    + + I  G+ Y H   R 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RH 135
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            ++HRDLK  NVLLD  MN KI+DFG++ +    +    +    G+  Y APE   G ++
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRLY 192
Query: 487 S-VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG--HAAELMDSVVKQ 543
           +  + D++S GV+L  ++ G   T  +  +H P+L   I    C+G  +  + ++  V  
Sbjct: 193 AGPEVDIWSSGVILYALLCG---TLPFDDDHVPTLFKKI----CDGIFYTPQYLNPSV-- 243
Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM--LASDILTLPKPTQPAFS 594
                 LLK++      +Q DP+ R T+  +        D+     P  P++S
Sbjct: 244 ----ISLLKHM------LQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYS 286

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 202 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 252
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 253 LFKLLKEGH 261

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 82
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 139
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYS 196
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 73
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 130
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 131 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYS 187
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 188 KFSSKSDIWAFGVLMWEIYS 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 210 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 260
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 261 LFKLLKEGH 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 25/204 (12%)
Query: 311 NKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            +LG+G FG VYK      G LA  K I  K     S + L+++  E+ ++A   H  +V
Sbjct: 17  GELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIV 71
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYLHED 423
           +LLG    + +  ++ E+ P  ++D  + +  R +    + +I ++ + +   + +LH  
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK 128
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM- 482
              +IIHRDLK  NVL+  E + +++DFG++      ++    +  +GT  +MAPE  M 
Sbjct: 129 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 483 ----GGIFSVKSDVFSFGVVLLEI 502
                  +  K+D++S G+ L+E+
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 25/204 (12%)
Query: 311 NKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            +LG+G FG VYK      G LA  K I  K     S + L+++  E+ ++A   H  +V
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIV 79
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYLHED 423
           +LLG    + +  ++ E+ P  ++D  + +  R +    + +I ++ + +   + +LH  
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK 136
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM- 482
              +IIHRDLK  NVL+  E + +++DFG++      ++    +  +GT  +MAPE  M 
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 483 ----GGIFSVKSDVFSFGVVLLEI 502
                  +  K+D++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG +G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 67
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     Q   ++ + + K +   + YL    
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK- 124
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 125 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYS 181
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            FS KSD+++FGV++ EI S
Sbjct: 182 KFSSKSDIWAFGVLMWEIYS 201

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 44/249 (17%)
Query: 313 LGEGGFGPVYKGVLADG-----------KEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
           LGEG FG V   VLA+             ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L           ++ + +   QL  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAY 523
           TN  +    +MAPE     I++ +SDV+SFGV+L EI  + G    G    E        
Sbjct: 251 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------- 301
Query: 524 IWKLWCEGH 532
           ++KL  EGH
Sbjct: 302 LFKLLKEGH 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 115/206 (55%), Gaps = 11/206 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQ 359
           + ++F +  K+GEG +G VYK      G+ +A+K++   T  +G+      E++++ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN+  L++E++ ++ L  F+ D++    +      S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            H     +++HRDLK  N+L++ E   K++DFG+AR F G   +   + VV T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPE 176
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIIS 504
             +G   +S   D++S G +  E+++
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 311 NKLGEGGFGPV---YKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 366 LLGCCLEEN--ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
             G        E  L+ EY+P+  L  FL       +LD  R +     I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAP 478
           SR + +HRDL   N+L++ E + KI+DFG+A++   ++       VV   G     + AP
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----VVREPGQSPIFWYAP 183
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E     IFS +SDV+SFGVVL E+ +
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 310 ENKLGEGGFGPVYKGVLA-DGKE---IAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLV 364
           E  +G G FG V  G L   GK    +A+K L    + +  ++F  E +++ +  H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L G        +++ E+M N +LD FL       Q    + + +++GIA G+ YL +  
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYLAD-- 163
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAPE 479
            +  +HRDL   N+L++  +  K+SDFG++R+   +     T     T G     + APE
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----TGGKIPVRWTAPE 218
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F+  SDV+S+G+V+ E++S
Sbjct: 219 AIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY     + K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     K+IHRD+K  N+LL      KI+DFG + +   +  +A    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA---LCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 313 LGEGGFGPVYKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +G+G FG V   +L D  G ++AVK +   +    Q F  E +V+ +L+H NLV+LLG  
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 371 LEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
           +EE   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FV 124
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL   NVL+  +   K+SDFG+ +     Q   +T ++     + APE      FS K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTK 179
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 317
Query: 528 WCEGH 532
             EGH
Sbjct: 318 LKEGH 322

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 102/195 (52%), Gaps = 17/195 (8%)
Query: 313 LGEGGFGPVYKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +G+G FG V   +L D  G ++AVK +   +    Q F  E +V+ +L+H NLV+LLG  
Sbjct: 29  IGKGEFGDV---MLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 371 LEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
           +EE   L ++ EYM   SL  +L    RSV L     +     +   + YL  ++    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL   NVL+  +   K+SDFG+ +     Q   +T ++     + APE      FS K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTK 194
Query: 490 SDVFSFGVVLLEIIS 504
           SDV+SFG++L EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 117/249 (46%), Gaps = 41/249 (16%)
Query: 294 PLDL-IDIVKATQD----FSQEN-----KLGEGGFGPVYKGVL------ADGKEIAVKRL 337
           PL L +D  K  +D    F ++N      LGEG FG V K         A    +AVK L
Sbjct: 2   PLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61
Query: 338 SR-TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST 396
               S   L++  +E  V+ ++ H ++++L G C ++   LLI EY    SL  FL +S 
Sbjct: 62  KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 397 R-------------SVQLDWKRRISIIKG--------IARGILYLHEDSRLKIIHRDLKT 435
           +             S  LD     ++  G        I++G+ YL E   + ++HRDL  
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAA 178
Query: 436 SNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSF 495
            N+L+      KISDFG++R      S    ++      +MA E     I++ +SDV+SF
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 496 GVVLLEIIS 504
           GV+L EI++
Sbjct: 239 GVLLWEIVT 247

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 262 LISRLLKHNPSQRPMLREV 280

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 237 LISRLLKHNPSQRPMLREV 255

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNEVTVIAKL 358
           V   +D+     LGEG  G V   V    +E +AVK +         E  K E+ +   L
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H+N+V+  G   E N   L  EY     L   +       + D +R       +  G++
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 479 EYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           E      F  +  DV+S G+VL  +++G+
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      +I+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 258
Query: 528 WCEGH 532
             EGH
Sbjct: 259 LKEGH 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 313 LGEGGFGPVYKG-VLADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFL-------FDSTRSVQLDWKRRISIIKGIARGI 417
            LLG C      L+I EY     L  FL        D      L+ +  +     +A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +L   +    IHRD+   NVLL +    KI DFG+AR    + +            +MA
Sbjct: 166 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           PE     +++V+SDV+S+G++L EI S
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 311 NKLGEGGFGPV---YKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 366 LLGCCLEEN-ESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
             G       +SL L+ EY+P+  L  FL       +LD  R +     I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAP 478
           SR + +HRDL   N+L++ E + KI+DFG+A++   ++       VV   G     + AP
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 186
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E     IFS +SDV+SFGVVL E+ +
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 311 NKLGEGGFGPV---YKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 366 LLGCCLEEN-ESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
             G       +SL L+ EY+P+  L  FL       +LD  R +     I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAP 478
           SR + +HRDL   N+L++ E + KI+DFG+A++   ++       VV   G     + AP
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E     IFS +SDV+SFGVVL E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 23/285 (8%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           LG+G +G VY G  L++   IA+K +     +  Q    E+ +   L+HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           E     +  E +P  SL   L      ++ + +      K I  G+ YLH++   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 432 DLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI--FSV 488
           D+K  NVL++ +    KISDFG ++   G      T    GT  YMAPE    G   +  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 489 KSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQA 548
            +D++S G  ++E+ +GK    FY  E G    A ++K+       E+ +S+       A
Sbjct: 205 AADIWSLGCTIIEMATGKPP--FY--ELGEPQAA-MFKVGMFKVHPEIPESM------SA 253
Query: 549 ELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF 593
           E   +I   L C + DP  R   + + V     + +  K TQP  
Sbjct: 254 EAKAFI---LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 263
Query: 528 WCEGH 532
             EGH
Sbjct: 264 LKEGH 268

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG +       S+  T  + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 201
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 262 LISRLLKHNPSQRPMLREV 280

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I EY    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 260
Query: 528 WCEGH 532
             EGH
Sbjct: 261 LKEGH 265

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 311 NKLGEGGFGPV---YKGVLAD--GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 366 LLGCCLEEN-ESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
             G       +SL L+ EY+P+  L  FL       +LD  R +     I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAP 478
           SR + +HRDL   N+L++ E + KI+DFG+A++   ++       VV   G     + AP
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 187
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E     IFS +SDV+SFGVVL E+ +
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 313 LGEGGFGPVYKG-VLADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
            LLG C      L+I EY     L  FL   +R ++ D    I+      R +L+     
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 424 -------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
                  +    IHRD+   NVLL +    KI DFG+AR    + +            +M
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           APE     +++V+SDV+S+G++L EI S
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 306 DFSQENKLGEGGFGPVYKG-VLADG--KEIAVKRLSR-TSGQGLQEFKNEVTVIAKL-QH 360
           D   ++ +GEG FG V K  +  DG   + A+KR+    S    ++F  E+ V+ KL  H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-------------TRSVQLDWKRRI 407
            N++ LLG C       L  EY P+ +L  FL  S             + +  L  ++ +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                +ARG+ YL   S+ + IHR+L   N+L+      KI+DFG++R   G +      
Sbjct: 143 HFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 196
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                  +MA E     +++  SDV+S+GV+L EI+S
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 236 LISRLLKHNPSQRPMLREV 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG +       S+  T  + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 192
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 252
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 253 LISRLLKHNPSQRPMLREV 271

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            +LG G FG V  G      ++AVK +   S     EF  E   + KL H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +E    ++ EY+ N  L  +L    +   L+  + + +   +  G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMGGIFS 487
           RDL   N L+D ++  K+SDFGM R    +Q  ++    VGT     + APE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYS 183
Query: 488 VKSDVFSFGVVLLEIIS-GKKSTGFY 512
            KSDV++FG+++ E+ S GK     Y
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLY 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 237 LISRLLKHNPSQRPMLREV 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 313 LGEGGFGPVYKG-VLADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFL-------FDSTRSVQLDWKRRISIIKGIARGI 417
            LLG C      L+I EY     L  FL        D      L+ +  +     +A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +L   +    IHRD+   NVLL +    KI DFG+AR    + +            +MA
Sbjct: 174 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           PE     +++V+SDV+S+G++L EI S
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG + +   +  +A    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA---LCGTLDYLPP 178
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG + +   +  +A    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA---LCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           LG+G +G VY G  L++   IA+K +     +  Q    E+ +   L+HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           E     +  E +P  SL   L      ++ + +      K I  G+ YLH++   +I+HR
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 432 DLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI--FSV 488
           D+K  NVL++ +    KISDFG ++   G      T    GT  YMAPE    G   +  
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 489 KSDVFSFGVVLLEIISGK 506
            +D++S G  ++E+ +GK
Sbjct: 191 AADIWSLGCTIIEMATGK 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKE----IAVKRL--SRTSGQGLQ-EFKNEVTVI 355
           A +DF     LG+G FG VY   LA  K+    +A+K L  ++    G++ + + EV + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVY---LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           + L+H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A 
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELAN 116
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDY 169
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           + PE   G +   K D++S GV+  E + GK
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 313 LGEGGFGPVYKG-VLADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-----------IIKGI 413
            LLG C      L+I EY     L  FL   +R ++ D    I+               +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR    + +           
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            +MAPE     +++V+SDV+S+G++L EI S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    L+ EY     +  +L    R  + + + +    + I   + Y H+     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGGIF- 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GN+  A      G   Y APE   G  + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 487 SVKSDVFSFGVVLLEIISG 505
             + DV+S GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I  Y    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 20/201 (9%)
Query: 312 KLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           K+GEG  G V    LA     G+++AVK +     Q  +   NEV ++   QH N+V + 
Sbjct: 52  KIGEGSTGIV---CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
              L   E  ++ E++   +L     D    V+L+ ++  ++ + + + + YLH      
Sbjct: 109 KSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG--- 161
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGI 485
           +IHRD+K+ ++LL  +   K+SDFG    F    SK    R  +VGT  +MAPE     +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKXLVGTPYWMAPEVISRSL 217
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           ++ + D++S G++++E++ G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    L+ EY     +  +L    R  + + + +    + I   + Y H+     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGGIF- 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GN+     +   G+  Y APE   G  + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYD 190
Query: 487 SVKSDVFSFGVVLLEIISG 505
             + DV+S GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 313 LGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           LG G FG V+K    A G ++A K +     +  +E KNE++V+ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 372 EENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            +N+ +L+ EY+    L D  + +S    +LD    I  +K I  GI ++H+   + I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---MYILH 210
Query: 431 RDLKTSNVL-LDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
            DLK  N+L ++ +    KI DFG+AR +   + K   N   GT  ++APE       S 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVN--FGTPEFLAPEVVNYDFVSF 267
Query: 489 KSDVFSFGVVLLEIISG 505
            +D++S GV+   ++SG
Sbjct: 268 PTDMWSVGVIAYMLLSG 284

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG +       S+  T  + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 180
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G     K D++S GV+  E + GK
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   +   L    +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKNLVRLLGC 369
           K+GEG +G VYK     G+  A+K++      +G+      E++++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 370 CLEENESLLIYEYMPN---KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
              +   +L++E++     K LDV       SV        S +  +  GI Y H+    
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAK-----SFLLQLLNGIAYCHDR--- 119
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-I 485
           +++HRDLK  N+L++ E   KI+DFG+AR FG    K  T+ VV T  Y AP+  MG   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYRAPDVLMGSKK 177
Query: 486 FSVKSDVFSFGVVLLEIISG 505
           +S   D++S G +  E+++G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    L+ EY     +  +L    R  + + + +    + I   + Y H+     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGGIF- 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GN+     +   G+  Y APE   G  + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYD 190
Query: 487 SVKSDVFSFGVVLLEIISG 505
             + DV+S GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKNLVRLLGC 369
           K+GEG +G VYK     G+  A+K++      +G+      E++++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 370 CLEENESLLIYEYMPN---KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
              +   +L++E++     K LDV       SV        S +  +  GI Y H+    
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAK-----SFLLQLLNGIAYCHDR--- 119
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-I 485
           +++HRDLK  N+L++ E   KI+DFG+AR FG    K  T+ VV T  Y AP+  MG   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYRAPDVLMGSKK 177
Query: 486 FSVKSDVFSFGVVLLEIISG 505
           +S   D++S G +  E+++G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKE----IAVKRL--SRTSGQGLQ-EFKNEVTVI 355
           A +DF     LG+G FG VY   LA  K+    +A+K L  ++    G++ + + EV + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           + L+H N++RL G   +     LI EY P   +   L    +  + D +R  + I  +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELAN 124
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDY 177
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           + PE   G +   K D++S GV+  E + GK
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G+G FG VY G   D  +     A+K LSR T  Q ++ F  E  ++  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 368 GCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           G  L  E    ++  YM +  L  F+    R+  +  K  IS    +ARG+ YL E    
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQ--- 143
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVG-TYGYMAPEYAMGG 484
           K +HRDL   N +LD     K++DFG+AR I          +R       + A E     
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 485 IFSVKSDVFSFGVVLLEIIS 504
            F+ KSDV+SFGV+L E+++
Sbjct: 204 RFTTKSDVWSFGVLLWELLT 223

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 313 LGEGGFGPVYK----GVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKL-QHKN 362
           LGEG FG V      G+  D  +    +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTR--SVQLDWKRRISI 409
           ++ LLG C ++    +I  Y    +L  +L           +D  R    Q+ +K  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +ARG+ YL   +  K IHRDL   NVL+      KI+DFG+AR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEI--ISGKKSTGFYHSEHGPSLLAYIWKL 527
                +MAPE     +++ +SDV+SFGV++ EI  + G    G    E        ++KL
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL 271
Query: 528 WCEGH 532
             EGH
Sbjct: 272 LKEGH 276

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 19/200 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  G+E+A+K + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 20  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    LI EY     +  +L    R   +  K   S  + I   + Y H+    +I
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RI 132
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GG       +   G+  Y APE   G  +
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-----KLDTFCGSPPYAAPELFQGKKY 187
Query: 487 -SVKSDVFSFGVVLLEIISG 505
              + DV+S GV+L  ++SG
Sbjct: 188 DGPEVDVWSLGVILYTLVSG 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  G+E+A+K + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    LI EY     +  +L    R   +  K   S  + I   + Y H+    +I
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RI 135
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GG       +   G   Y APE   G  +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-----KLDAFCGAPPYAAPELFQGKKY 190
Query: 487 -SVKSDVFSFGVVLLEIISG 505
              + DV+S GV+L  ++SG
Sbjct: 191 DGPEVDVWSLGVILYTLVSG 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AV+ + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    L+ EY     +  +L    R  + + + +    + I   + Y H+     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGGIF- 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GN+     +   G+  Y APE   G  + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAPELFQGKKYD 190
Query: 487 SVKSDVFSFGVVLLEIISG 505
             + DV+S GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQ--GLQ-EFKNEVTVIAKLQH 360
           +DF     LG+G FG VY       K I A+K L +T  +  G++ + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 481 AMGGIFSVKSDVFSFGVVLLEIISG 505
             G +   K D++S GV+  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 313 LGEGGFG--------PVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNL 363
           LGEG FG        P   G    G+ +AVK L    G Q    +K E+ ++  L H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           ++  GCC ++ E    L+ EY+P  SL  +L     S+ L   + +   + I  G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPE 479
                  IHR+L   NVLLD++   KI DFG+A+    G    +   +     + Y APE
Sbjct: 135 SQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 190
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F   SDV+SFGV L E+++
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 313 LGEGGFG--------PVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNL 363
           LGEG FG        P   G    G+ +AVK L    G Q    +K E+ ++  L H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           ++  GCC ++ E    L+ EY+P  SL  +L     S+ L   + +   + I  G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH 134
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPE 479
                  IHR+L   NVLLD++   KI DFG+A+    G    +   +     + Y APE
Sbjct: 135 AQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 190
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F   SDV+SFGV L E+++
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKNLVRLLGC 369
           K+GEG +G VYK     G+  A+K++      +G+      E++++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 370 CLEENESLLIYEYMPN---KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
              +   +L++E++     K LDV       SV        S +  +  GI Y H+    
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAK-----SFLLQLLNGIAYCHDR--- 119
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-I 485
           +++HRDLK  N+L++ E   KI+DFG+AR FG    K  T+ +V T  Y AP+  MG   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLMGSKK 177
Query: 486 FSVKSDVFSFGVVLLEIISG 505
           +S   D++S G +  E+++G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 205 EVDIWSLGIMVIEMVDGE 222

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 306 DFSQENKLGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHK 361
           ++  +  +G+G F  V   + VL  G+E+AVK + +T  +   LQ+   EV ++  L H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+L      E    L+ EY     +  +L    R  + + + +    + I   + Y H
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 131
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEY 480
           +     I+HRDLK  N+LLD +MN KI+DFG +  F  GN+     +   G+  Y APE 
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAPEL 184
Query: 481 AMGGIF-SVKSDVFSFGVVLLEIISG 505
             G  +   + DV+S GV+L  ++SG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 207 EVDIWSLGIMVIEMVDGE 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 200 EVDIWSLGIMVIEMVDGE 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 313 LGEGGFG--------PVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNL 363
           LGEG FG        P   G    G+ +AVK L   +G Q    +K E+ ++  L H+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           ++  GCC +   +   L+ EY+P  SL  +L     S+ L   + +   + I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH 151
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPE 479
                  IHRDL   NVLLD++   KI DFG+A+    G    +   +     + Y APE
Sbjct: 152 AQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APE 207
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F   SDV+SFGV L E+++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           A +DF     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK---KSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G +   K D++S GV+  E + GK   ++  +  +    S + + +  +    A +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 238
Query: 536 LMDSVVKQSCDQAELLKYI 554
           L+  ++K +  Q  +L+ +
Sbjct: 239 LISRLLKHNPSQRPMLREV 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQ--GLQ-EFKNEVTVIAKLQH 360
           +DF     LG+G FG VY       K I A+K L +T  +  G++ + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N++RL G   +     LI EY P   L     +  +  + D +R  + I  +A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 481 AMGGIFSVKSDVFSFGVVLLEIISG 505
             G +   K D++S GV+  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 116/237 (48%), Gaps = 25/237 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 124
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 180
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 234
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           E   G  +SV+SD++S G+ L+E+  G+       ++     L  ++    EG AAE
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVEGDAAE 287

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AV+ + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    L+ EY     +  +L    R  + + + +    + I   + Y H+     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGGIF- 486
           +HRDLK  N+LLD +MN KI+DFG +  F  GN+     +   G+  Y APE   G  + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYD 190
Query: 487 SVKSDVFSFGVVLLEIISG 505
             + DV+S GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 81
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 137
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 191
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG 510
           E   G  +SV+SD++S G+ L+E+  G+   G
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 62
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 65
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 121
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G       N  VGT  YM+P
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSP 175
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 313 LGEGGFG--------PVYKGVLADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNL 363
           LGEG FG        P   G    G+ +AVK L    G  L+  ++ E+ ++  L H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           V+  GCC ++ E    L+ EY+P  SL  +L      V L   + +   + I  G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLH 129
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPE 479
                  IHR L   NVLLD++   KI DFG+A+    G    +   +     + Y APE
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 185
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F   SDV+SFGV L E+++
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 313 LGEGGFG--------PVYKGVLADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNL 363
           LGEG FG        P   G    G+ +AVK L    G  L+  ++ E+ ++  L H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           V+  GCC ++ E    L+ EY+P  SL  +L      V L   + +   + I  G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLH 128
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPE 479
                  IHR L   NVLLD++   KI DFG+A+    G    +   +     + Y APE
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 184
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F   SDV+SFGV L E+++
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 327 EVDIWSLGIMVIEMVDGE 344

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 23/231 (9%)
Query: 291 PLFPLDLIDIVKATQD----FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQ 346
           P   LD ID+  A +D    F     +G G +G VYKG      ++A  ++   +G   +
Sbjct: 7   PARSLDEIDL-SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE 65
Query: 347 EFKNEVTVIAKL-QHKNLVRLLGCCLEEN------ESLLIYEYMPNKSLDVFLFDSTRSV 399
           E K E+ ++ K   H+N+    G  +++N      +  L+ E+    S+   L  +T+  
Sbjct: 66  EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGN 124
Query: 400 QLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 459
            L  +    I + I RG+ +LH+    K+IHRD+K  NVLL      K+ DFG++     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 460 NQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISG 505
              + NT   +GT  +MAPE           +  KSD++S G+  +E+  G
Sbjct: 182 TVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V    V + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL H+   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 249
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E++ G+
Sbjct: 250 EVDIWSLGIMVIEMVDGE 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V+K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHECN 89
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGIL 418
              +V   G    + E  +  E+M   SLD  L  + R   Q+  K  I++IKG+     
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT---- 145
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  + KI+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YM+P
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 199
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G  +SV+SD++S G+ L+E+  G+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 37/232 (15%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           ++   DF +   LG+G FG V K   A D +  A+K++ R + + L    +EV ++A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 360 HKNLVRLLGCCLE------------ENESLLI-YEYMPNKSLDVFLFDSTRSVQLD--WK 404
           H+ +VR     LE            +  +L I  EY  N++L   +     + Q D  W+
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN---- 460
               + + I   + Y+H      IIHRDLK  N+ +D   N KI DFG+A+    +    
Sbjct: 121 ----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 461 --------QSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEII 503
                    S  N    +GT  Y+A E   G G ++ K D++S G++  E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG---- 368
           +G G +G VYKG L D + +AVK  S  + Q     KN +  +  ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 369 -CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH------ 421
                  E LL+ EY PN SL  +L   T     DW     +   + RG+ YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ----SKANTNRV--VGTYGY 475
           +  +  I HRDL + NVL+ ++    ISDFG++    GN+     + +   +  VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 476 MAPEYAMGGI------FSVKS-DVFSFGVVLLEI 502
           MAPE   G +       ++K  D+++ G++  EI
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 302 KATQDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRL--SRTSGQGLQEFKNEVTVI 355
           ++ + + +  K+GEG FG   K +L     DG++  +K +  SR S +  +E + EV V+
Sbjct: 21  QSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 356 AKLQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVF-LFDSTRSVQLDWKRRISIIKGI 413
           A ++H N+V+      EEN SL ++ +Y   +  D+F   ++ + V     + +     I
Sbjct: 78  ANMKHPNIVQYRES-FEENGSLYIVMDYC--EGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
              + ++H+    KI+HRD+K+ N+ L  +   ++ DFG+AR+   N +       +GT 
Sbjct: 135 CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTP 189
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEI 502
            Y++PE      ++ KSD+++ G VL E+
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAV----KRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRL 366
           LG G FG V+KGV + +G+ I +    K +   SG Q  Q   + +  I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 367 LGCCLEENESL-LIYEYMPNKSLDVFLFDSTRS--------VQLDWKRRISIIKGIARGI 417
           LG C     SL L+ +Y+P  SL     D  R         + L+W  +I      A+G+
Sbjct: 99  LGLC--PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQI------AKGM 146
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL E     ++HR+L   NVLL      +++DFG+A +   +  +   +       +MA
Sbjct: 147 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            E    G ++ +SDV+S+GV + E+++
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           DF +   +G GGFG V+K     DGK   ++R+   +    ++ + EV  +AKL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 365 RLLGCC-------LEENESLLIYEYMPNKSLD--------VFL-------------FDST 396
              GC           ++SL   +Y P  S +        +F+              +  
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 397 RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI 456
           R  +LD    + + + I +G+ Y+H     K+IHRDLK SN+ L      KI DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
               ++     R  GT  YM+PE      +  + D+++ G++L E++
Sbjct: 186 L---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AVK + +T  +   LQ+   EV +   L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
               E    L+ EY     +  +L    R  + + + +    + I   + Y H+     I
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGGIF- 486
           +HRDLK  N+LLD + N KI+DFG +  F  GN+  A      G   Y APE   G  + 
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 487 SVKSDVFSFGVVLLEIISG 505
             + DV+S GV+L  ++SG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 135/286 (47%), Gaps = 33/286 (11%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNL 363
           D+  +  +G G    V     A  KE +A+KR++    Q  + E   E+  +++  H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 364 VRLLGCCLEENESLLIYEYMPNKS-LDVFLF----DSTRSVQLDWKRRISIIKGIARGIL 418
           V      + ++E  L+ + +   S LD+          +S  LD     +I++ +  G+ 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRV-VGTYGY 475
           YLH++ +   IHRD+K  N+LL  + + +I+DFG++     GG+ ++    +  VGT  +
Sbjct: 131 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 476 MAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
           MAPE  M  +  +  K+D++SFG+  +E+ +G      YH    P +   +  L  +  +
Sbjct: 188 MAPE-VMEQVRGYDFKADIWSFGITAIELATG---AAPYHKY--PPMKVLMLTLQNDPPS 241
Query: 534 AELMDSVVKQSCDQAELLK-----YIHIGLLCVQGDPIDRPTMSSV 574
            E             E+LK     +  +  LC+Q DP  RPT + +
Sbjct: 242 LE-------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAV----KRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRL 366
           LG G FG V+KGV + +G+ I +    K +   SG Q  Q   + +  I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 367 LGCCLEENESL-LIYEYMPNKSLDVFLFDSTRS--------VQLDWKRRISIIKGIARGI 417
           LG C     SL L+ +Y+P  SL     D  R         + L+W  +I      A+G+
Sbjct: 81  LGLC--PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQI------AKGM 128
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL E     ++HR+L   NVLL      +++DFG+A +   +  +   +       +MA
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            E    G ++ +SDV+S+GV + E+++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +G+G F  V   + +L  GKE+AVK + +T  +   LQ+   EV ++  L H N+V+L  
Sbjct: 15  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW---KRRISIIKGIARGILYLHEDSR 425
               E    L+ EY     +  +L      V   W   K   +  + I   + Y H+   
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF- 126
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYGYMAPEYAMGG 484
             I+HRDLK  N+LLD +MN KI+DFG +  F  GN+     +   G+  Y APE   G 
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGK 180
Query: 485 IF-SVKSDVFSFGVVLLEIISG 505
            +   + DV+S GV+L  ++SG
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSG 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 135/286 (47%), Gaps = 33/286 (11%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNL 363
           D+  +  +G G    V     A  KE +A+KR++    Q  + E   E+  +++  H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 364 VRLLGCCLEENESLLIYEYMPNKS-LDVFLF----DSTRSVQLDWKRRISIIKGIARGIL 418
           V      + ++E  L+ + +   S LD+          +S  LD     +I++ +  G+ 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRV-VGTYGY 475
           YLH++ +   IHRD+K  N+LL  + + +I+DFG++     GG+ ++    +  VGT  +
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 476 MAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
           MAPE  M  +  +  K+D++SFG+  +E+ +G      YH    P +   +  L  +  +
Sbjct: 193 MAPE-VMEQVRGYDFKADIWSFGITAIELATG---AAPYHKY--PPMKVLMLTLQNDPPS 246
Query: 534 AELMDSVVKQSCDQAELLK-----YIHIGLLCVQGDPIDRPTMSSV 574
            E             E+LK     +  +  LC+Q DP  RPT + +
Sbjct: 247 LE-------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNL 363
           DF     LG GGFG V++     D    A+KR+   + +  +E    EV  +AKL+H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW---------KRR---ISIIK 411
           VR     LE+N +  +    P   L + +    +    DW         + R   + I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-------- 463
            IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ +        
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 464 --ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
             A     VGT  YM+PE   G  +S K D+FS G++L E++
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 306 DFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           DF + ++LG G  G V K      G++   K I ++       Q ++E +    V+ +  
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECN 72
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
              +V   G    + E  +  E+M   SLD  L ++ R +  +   ++SI   + RG+ Y
Sbjct: 73  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI--AVLRGLAY 129
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           L E  + +I+HRD+K SN+L++     K+ DFG++    G    +  N  VGT  YMAPE
Sbjct: 130 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPE 183
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK 506
              G  +SV+SD++S G+ L+E+  G+
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 313 LGEGGFGPVYKG-VLADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFL-----------FDSTRSV--QLDWKRRISIIK 411
            LLG C      L+I EY     L  FL           ++ + +   QL  +  +    
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR    + +         
Sbjct: 174 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              +MAPE     +++V+SDV+S+G++L EI S
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 316 GGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL-----GCC 370
           G FG V+K  L +   +AVK       Q  Q  + E+     ++H+NL++ +     G  
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED------- 423
           LE  E  LI  +    SL  +L  +     + W     + + ++RG+ YLHED       
Sbjct: 84  LE-VELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 424 -SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
             +  I HRD K+ NVLL  ++   ++DFG+A  F   +   +T+  VGT  YMAPE   
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 483 GGI-FS----VKSDVFSFGVVLLEIIS 504
           G I F     ++ D+++ G+VL E++S
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 21/195 (10%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V        G+++A+K      L+++  QG    + E++ +  L+H ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 69
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 ++E +++ EY  N+  D ++    +  + + +R     + I   + Y H   R 
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARR---FFQQIISAVEYCH---RH 122
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGI 485
           KI+HRDLK  N+LLD  +N KI+DFG++ I   GN  K +     G+  Y APE   G +
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 178
Query: 486 FS-VKSDVFSFGVVL 499
           ++  + DV+S GV+L
Sbjct: 179 YAGPEVDVWSCGVIL 193

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE----IAVKRL--SRTSGQGLQ-EFKNEVTVIAKL 358
           DF     LG+G FG VY   LA  K+    +A+K L  S+   +G++ + + E+ + A L
Sbjct: 24  DFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL 80
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H N++RL     +     LI EY P   L   L    +S   D +R  +I++ +A  ++
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALM 137
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     K+IHRD+K  N+LL  +   KI+DFG    +  +        + GT  Y+ P
Sbjct: 138 YCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPP 190
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E   G + + K D++  GV+  E++ G
Sbjct: 191 EMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 21/195 (10%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V        G+++A+K      L+++  QG    + E++ +  L+H ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 78
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 ++E +++ EY  N+  D ++    +  + + +R     + I   + Y H   R 
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARR---FFQQIISAVEYCH---RH 131
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGI 485
           KI+HRDLK  N+LLD  +N KI+DFG++ I   GN  K +     G+  Y APE   G +
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 187
Query: 486 FS-VKSDVFSFGVVL 499
           ++  + DV+S GV+L
Sbjct: 188 YAGPEVDVWSCGVIL 202

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 34/257 (13%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFKNEVT 353
           + I    +DF     LG+G FG V+   LA+ K+     A+K L +     L +   E T
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVV--LMDDDVECT 65
Query: 354 VIAK------LQHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRR 406
           ++ K       +H  L  +  C  +  E+L  + EY+    L   ++      + D  R 
Sbjct: 66  MVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRA 121
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
                 I  G+ +LH      I++RDLK  N+LLD + + KI+DFGM +        A T
Sbjct: 122 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKT 176
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI-- 524
           N   GT  Y+APE  +G  ++   D +SFGV+L E++ G+     +H +    L   I  
Sbjct: 177 NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSIRM 233
Query: 525 ----WKLWCEGHAAELM 537
               +  W E  A +L+
Sbjct: 234 DNPFYPRWLEKEAKDLL 250

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 21/195 (10%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V        G+++A+K      L+++  QG    + E++ +  L+H ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 79
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 ++E +++ EY  N+  D ++    +  + + +R     + I   + Y H   R 
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARR---FFQQIISAVEYCH---RH 132
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGI 485
           KI+HRDLK  N+LLD  +N KI+DFG++ I   GN  K +     G+  Y APE   G +
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 188
Query: 486 FS-VKSDVFSFGVVL 499
           ++  + DV+S GV+L
Sbjct: 189 YAGPEVDVWSCGVIL 203

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 21/195 (10%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LGEG FG V        G+++A+K      L+++  QG    + E++ +  L+H ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 73
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 ++E +++ EY  N+  D ++    +  + + +R     + I   + Y H   R 
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARR---FFQQIISAVEYCH---RH 126
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGI 485
           KI+HRDLK  N+LLD  +N KI+DFG++ I   GN  K +     G+  Y APE   G +
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 182
Query: 486 FS-VKSDVFSFGVVL 499
           ++  + DV+S GV+L
Sbjct: 183 YAGPEVDVWSCGVIL 197

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKG--VLADGKEIAVKRLSRTSGQGLQEFKN--EVTVI 355
           + +A Q +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 356 AKLQ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
             L+   H N+VRL   C       E +  L++E++ ++ L  +L D      +  +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  + RG+ +LH     +++HRDLK  N+L+      K++DFG+ARI+    +  +  
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 179 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 312 KLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           K+GEG  G V        GK++AVK++     Q  +   NEV ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
           L  +E  ++ E++   +L     D     +++ ++  ++   + R + YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYAMGGIFSV 488
           RD+K+ ++LL  +   K+SDFG    F    SK    R  +VGT  +MAPE      +  
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 489 KSDVFSFGVVLLEIISGK 506
           + D++S G++++E+I G+
Sbjct: 221 EVDIWSLGIMVIEMIDGE 238

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 313 LGEGGFGPVYKG-VLADGKE-----IAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +      GKE     +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFL--------------------FDSTRSVQLDWK 404
            LLG C      L+I EY     L  FL                     D      L+ +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
             +     +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR    + +  
Sbjct: 159 DLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                     +MAPE     +++V+SDV+S+G++L EI S
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQHK 361
           +F  E K+G G F  VY+   L DG  +A+K++        +   +   E+ ++ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD-----WKRRISIIKGIARG 416
           N+++     +E+NE  ++ E      L   +    +  +L      WK  + +   +   
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE-- 150
Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
               H  SR +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT  YM
Sbjct: 151 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +PE      ++ KSD++S G +L E+ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGK----EIAVKRLSRT-SGQGLQEFKNEVTVIAK 357
           A +D      LGEG FG VY+GV  + K     +AVK   +  +    ++F +E  ++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H ++V+L+G  +EE  + +I E  P   L  +L  +  S+++      S+   I + +
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAM 122
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYM 476
            YL     +  +HRD+   N+L+      K+ DFG++R I   +  KA+  R+     +M
Sbjct: 123 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 177
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           +PE      F+  SDV+ F V + EI+S  K   F+
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           DF +   +G GGFG V+K     DGK   +KR+   +    ++ + EV  +AKL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 365 RLLGC---------CLEENES-------LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
              GC            +N S        +  E+    +L+ ++ +  R  +LD    + 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
           + + I +G+ Y+H     K+I+RDLK SN+ L      KI DFG+       ++     R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
             GT  YM+PE      +  + D+++ G++L E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 305 QDFSQENKLGEGGFGPVYK-GVLADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQH 360
           +D+     +G G +G   K    +DGK +  K L   S T  +  Q   +EV ++ +L+H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 64
Query: 361 KNLVRLLGCCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGI 417
            N+VR     ++   + L  + EY     L   +   T+  Q LD +  + ++  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 418 LYLHE--DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
              H   D    ++HRDLK +NV LD + N K+ DFG+ARI   + S A T   VGT  Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYY 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEI 502
           M+PE      ++ KSD++S G +L E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQ---EFKNEVTVIAKLQHKNLVRL 366
           + LG G FG V  G     G ++AVK L+R   + L    + K E+  +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                   +  ++ EY+    L  ++    R  +++ +R   + + I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCH---RH 130
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            ++HRDLK  NVLLD  MN KI+DFG++ +    +   ++    G+  Y APE   G ++
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLY 187
Query: 487 S-VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI 524
           +  + D++S GV+L  ++ G   T  +  EH P+L   I
Sbjct: 188 AGPEVDIWSCGVILYALLCG---TLPFDDEHVPTLFKKI 223

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 37/232 (15%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           ++   DF +   LG+G FG V K   A D +  A+K++ R + + L    +EV ++A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 360 HKNLVRLLGCCLE------------ENESLLI-YEYMPNKSLDVFLFDSTRSVQLD--WK 404
           H+ +VR     LE            +  +L I  EY  N +L   +     + Q D  W+
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN---- 460
               + + I   + Y+H      IIHRDLK  N+ +D   N KI DFG+A+    +    
Sbjct: 121 ----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 461 --------QSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEII 503
                    S  N    +GT  Y+A E   G G ++ K D++S G++  E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG GG   V+    L D +++AVK     L+R     L+ F+ E    A L H  +V + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 368 GCCLEENES----LLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
                E  +     ++ EY+   +L D+   +      +  KR I +I    + + + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAPEYA 481
           +    IIHRD+K +N+L+      K+ DFG+AR I     S   T  V+GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
            G     +SDV+S G VL E+++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 313 LGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQG--LQEFKNEVTVIAKLQHKNLVRLLGC 369
           LG+G FG V K       +E AVK +++ S +         EV ++ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             + +   ++ E      L   +    R  + D  R   IIK +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 430 HRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           HRDLK  N+LL   + + + KI DFG++  F   Q        +GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 487 SVKSDVFSFGVVLLEIISG 505
             K DV+S GV+L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKG--VLADGKEIAVKRLSRTSGQGLQEFKN--EVTVI 355
           + +A Q +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 356 AKLQ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
             L+   H N+VRL   C       E +  L++E++ ++ L  +L D      +  +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  + RG+ +LH     +++HRDLK  N+L+      K++DFG+ARI+    +  +  
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 179 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKG--VLADGKEIAVKRLSRTSGQGLQEFKN--EVTVI 355
           + +A Q +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV V+
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 356 AKLQ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
             L+   H N+VRL   C       E +  L++E++ ++ L  +L D      +  +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  + RG+ +LH     +++HRDLK  N+L+      K++DFG+ARI+    +  +  
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 179 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 313 LGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQG--LQEFKNEVTVIAKLQHKNLVRLLGC 369
           LG+G FG V K       +E AVK +++ S +         EV ++ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             + +   ++ E      L   +    R  + D  R   IIK +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 430 HRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           HRDLK  N+LL   + + + KI DFG++  F   Q        +GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 487 SVKSDVFSFGVVLLEIISG 505
             K DV+S GV+L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGK----EIAVKRLSRT-SGQGLQEFKNEVTVIAK 357
           A +D      LGEG FG VY+GV  + K     +AVK   +  +    ++F +E  ++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H ++V+L+G  +EE  + +I E  P   L  +L  +  S+++      S+   I + +
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAM 138
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYM 476
            YL     +  +HRD+   N+L+      K+ DFG++R I   +  KA+  R+     +M
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 193
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           +PE      F+  SDV+ F V + EI+S  K   F+
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 14/216 (6%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGK----EIAVKRLSRT-SGQGLQEFKNEVTVIAK 357
           A +D      LGEG FG VY+GV  + K     +AVK   +  +    ++F +E  ++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H ++V+L+G  +EE  + +I E  P   L  +L  +  S+++      S+   I + +
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAM 126
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYM 476
            YL     +  +HRD+   N+L+      K+ DFG++R I   +  KA+  R+     +M
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 181
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           +PE      F+  SDV+ F V + EI+S  K   F+
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 115/213 (53%), Gaps = 15/213 (7%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN-----E 351
           +D+    + + + + LGEG F  VYK    +  +I A+K++        ++  N     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
           + ++ +L H N++ LL     ++   L++++M    L+V + D+  S+ L      + + 
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDN--SLVLTPSHIKAYML 119
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
              +G+ YLH+     I+HRDLK +N+LLD     K++DFG+A+ F G+ ++A  ++VV 
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV- 174
Query: 472 TYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEII 503
           T  Y APE   G  ++ V  D+++ G +L E++
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 311 NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQ---EFKNEVTVIAKLQHKNLVRL 366
           + LG G FG V  G     G ++AVK L+R   + L    + K E+  +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                   +  ++ EY+    L  ++    R  +++ +R   + + I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCH---RH 130
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            ++HRDLK  NVLLD  MN KI+DFG++ +    +    +    G+  Y APE   G ++
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLY 187
Query: 487 S-VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI 524
           +  + D++S GV+L  ++ G   T  +  EH P+L   I
Sbjct: 188 AGPEVDIWSCGVILYALLCG---TLPFDDEHVPTLFKKI 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 311 NKLGEGGFGPVYKGV--LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +KLGEG +  VYKG   L D   +A+K  RL    G      + EV+++  L+H N+V L
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 E    L++EY+ +K L  +L D    + +    ++ + + + RG+ Y H   R 
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMH-NVKLFLFQ-LLRGLAYCH---RQ 119
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI- 485
           K++HRDLK  N+L++     K++DFG+AR      +K   N VV T  Y  P+  +G   
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVV-TLWYRPPDILLGSTD 177
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           +S + D++  G +  E+ +G+
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 34/257 (13%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFKNEVT 353
           + I    +DF     LG+G FG V+   LA+ K+     A+K L +     L +   E T
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVV--LMDDDVECT 64
Query: 354 VIAK------LQHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRR 406
           ++ K       +H  L  +  C  +  E+L  + EY+    L   ++      + D  R 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRA 120
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
                 I  G+ +LH      I++RDLK  N+LLD + + KI+DFGM +        A T
Sbjct: 121 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKT 175
Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI-- 524
           N   GT  Y+APE  +G  ++   D +SFGV+L E++ G+     +H +    L   I  
Sbjct: 176 NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSIRM 232
Query: 525 ----WKLWCEGHAAELM 537
               +  W E  A +L+
Sbjct: 233 DNPFYPRWLEKEAKDLL 249

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG GG   V+    L D +++AVK     L+R     L+ F+ E    A L H  +V + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 368 GCCLEENES----LLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
                E  +     ++ EY+   +L D+   +      +  KR I +I    + + + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAPEYA 481
           +    IIHRD+K +N+++      K+ DFG+AR I     S   T  V+GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
            G     +SDV+S G VL E+++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVK----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG GG   V+    L D +++AVK     L+R     L+ F+ E    A L H  +V + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 368 GCCLEENES----LLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
                E  +     ++ EY+   +L D+   +      +  KR I +I    + + + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAPEYA 481
           +    IIHRD+K +N+++      K+ DFG+AR I     S   T  V+GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
            G     +SDV+S G VL E+++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           ++   DF +   LG+G FG V K   A D +  A+K++ R + + L    +EV ++A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLN 60
Query: 360 HKNLVRLLGCCLE------------ENESLLI-YEYMPNKSLDVFLFDSTRSVQLD--WK 404
           H+ +VR     LE            +  +L I  EY  N++L   +     + Q D  W+
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN---- 460
               + + I   + Y+H      IIHR+LK  N+ +D   N KI DFG+A+    +    
Sbjct: 121 ----LFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 461 --------QSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEII 503
                    S  N    +GT  Y+A E   G G ++ K D +S G++  E I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 313 LGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQG--LQEFKNEVTVIAKLQHKNLVRLLGC 369
           LG+G FG V K       +E AVK +++ S +         EV ++ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             + +   ++ E      L   +    R  + D  R   IIK +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 430 HRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           HRDLK  N+LL   + + + KI DFG++  F  N    +    +GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 487 SVKSDVFSFGVVLLEIISG 505
             K DV+S GV+L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 306 DFSQEN-----KLGEGGFGPVYK----GVLADGK--EIAVKRLSRTSGQGLQE-FKNEVT 353
           +F +EN      LG G FG V      G+   G   ++AVK L   +    +E   +E+ 
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 354 VIAKL-QHKNLVRLLGCCLEENESLLIYEY-------------MPNKSLDVFLFDSTRSV 399
           ++ +L  H+N+V LLG C       LI+EY                 S D   +++ + +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 400 Q-------LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG 452
           +       L ++  +     +A+G+ +L   S    +HRDL   NVL+ H    KI DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFG 217
Query: 453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +AR    + +            +MAPE    GI+++KSDV+S+G++L EI S
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 305 QDFSQENKLGEGGFGPVYK-GVLADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQH 360
           +D+     +G G +G   K    +DGK +  K L   S T  +  Q   +EV ++ +L+H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 64
Query: 361 KNLVRLLGCCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGI 417
            N+VR     ++   + L  + EY     L   +   T+  Q LD +  + ++  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 418 LYLHE--DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
              H   D    ++HRDLK +NV LD + N K+ DFG+ARI   + S A     VGT  Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYY 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEI 502
           M+PE      ++ KSD++S G +L E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 313 LGEGGFGPVYKGVL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG GGFG V+   + A GK  A   + +      +G Q    E  ++AK+  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               + +  L+   M    +   +++    +      R I     I  G+ +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           II+RDLK  NVLLD + N +ISD G+A      Q+K  T    GT G+MAPE  +G  + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 488 VKSDVFSFGVVLLEIISGK 506
              D F+ GV L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKNLVRLL 367
           LG+G FG V   K  +  G+E AVK +S+   +     +    EV ++ +L H N+++L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               ++    L+ E      L   +    R  ++D  R   II+ +  GI Y+H++   K
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 146
Query: 428 IIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+LL+    + N +I DFG++  F  ++   +    +GT  Y+APE  + G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHG 202
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +  K DV+S GV+L  ++SG
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 313 LGEGGFGPVYKGVLAD----GKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKNLVR 365
           LG+G FG V   +L      G+E AVK +S+   +     +    EV ++ +L H N+++
Sbjct: 40  LGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L     ++    L+ E      L   +    R  ++D  R   II+ +  GI Y+H++  
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN-- 151
Query: 426 LKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
            KI+HRDLK  N+LL+    + N +I DFG++  F  ++   +    +GT  Y+APE  +
Sbjct: 152 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VL 206
Query: 483 GGIFSVKSDVFSFGVVLLEIISG 505
            G +  K DV+S GV+L  ++SG
Sbjct: 207 HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 313 LGEGGFGPVYKGVL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG GGFG V+   + A GK  A   + +      +G Q    E  ++AK+  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               + +  L+   M    +   +++    +      R I     I  G+ +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           II+RDLK  NVLLD + N +ISD G+A      Q+K  T    GT G+MAPE  +G  + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 488 VKSDVFSFGVVLLEIISGK 506
              D F+ GV L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 313 LGEGGFGPVYKGVL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG GGFG V+   + A GK  A   + +      +G Q    E  ++AK+  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               + +  L+   M    +   +++    +      R I     I  G+ +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           II+RDLK  NVLLD + N +ISD G+A      Q+K  T    GT G+MAPE  +G  + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 488 VKSDVFSFGVVLLEIISGK 506
              D F+ GV L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 313 LGEGGFGPVYKGVL-ADGKEIA---VKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG GGFG V+   + A GK  A   + +      +G Q    E  ++AK+  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               + +  L+   M    +   +++    +      R I     I  G+ +LH+ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           II+RDLK  NVLLD + N +ISD G+A      Q+K  T    GT G+MAPE  +G  + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 488 VKSDVFSFGVVLLEIISGK 506
              D F+ GV L E+I+ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L  C  ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 148
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 305 QDFSQENKLGEGGFGPVYK-GVLADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQH 360
           +D+     +G G +G   K    +DGK +  K L   S T  +  Q   +EV ++ +L+H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 64
Query: 361 KNLVRLLGCCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGI 417
            N+VR     ++   + L  + EY     L   +   T+  Q LD +  + ++  +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 418 LYLHE--DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
              H   D    ++HRDLK +NV LD + N K+ DFG+ARI   N  +      VGT  Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGTPYY 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEI 502
           M+PE      ++ KSD++S G +L E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ-GLQ-EFKNEVTVIAKLQ 359
           AT  +    ++G G +G VYK      G  +A+K +   +G+ GL      EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 360 ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
              H N+VRL+  C       E +  L++E++ ++ L  +L D      L  +    +++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
              RG+ +LH +    I+HRDLK  N+L+      K++DFG+ARI+    + A    VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKNLVRLL 367
           LG+G FG V   K  +  G+E AVK +S+   +     +    EV ++ +L H N+++L 
Sbjct: 57  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               ++    L+ E      L   +    R  ++D  R   II+ +  GI Y+H++   K
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 169
Query: 428 IIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+LL+    + N +I DFG++  F  ++   +    +GT  Y+APE  + G
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHG 225
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +  K DV+S GV+L  ++SG
Sbjct: 226 TYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG+G FG V   K  +  G+E AVK +S+         +    EV ++ +L H N+++L 
Sbjct: 58  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               ++    L+ E      L   +    R  ++D  R   II+ +  GI Y+H++   K
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 170
Query: 428 IIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+LL+    + N +I DFG++  F  ++   +    +GT  Y+APE  + G
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHG 226
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +  K DV+S GV+L  ++SG
Sbjct: 227 TYDEKCDVWSTGVILYILLSG 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLA--DGK--EIAVKRLSR--TSGQGLQEFKN 350
           L D++   Q F+    LG+G FG V +  L   DG   ++AVK L     +   ++EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 351 EVTVIAKLQHKNLVRLLGCCLEENES------LLIYEYMPNKSLDVFLFDS---TRSVQL 401
           E   + +  H ++ +L+G  L           ++I  +M +  L  FL  S        L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 460
             +  +  +  IA G+ YL   S    IHRDL   N +L  +M   ++DFG++R I+ G+
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +      +    ++A E     +++V SDV++FGV + EI++
Sbjct: 192 YYRQGCASKLPV-KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 302 KATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQE--FKNEVTVIAKL 358
           ++ + +     +GEG +G V K    D G+ +A+K+   +    + +     E+ ++ +L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           +H+NLV LL  C ++    L++E++ +  L D+ LF +    Q+  K    II GI  G 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GF 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            + H      IIHRD+K  N+L+      K+ DFG AR         +    V T  Y A
Sbjct: 140 CHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRA 192
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE  +G + +    DV++ G ++ E+  G+
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKLQHK 361
           DF     LG+G FG VY       K I A+K L  S+   +G++ + + E+ + + L+H 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N++R+     +     L+ E+ P   L   L    R    D +R  + ++ +A  + Y H
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH 131
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           E    K+IHRD+K  N+L+ ++   KI+DFG    +  +        + GT  Y+ PE  
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMI 184
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
            G     K D++  GV+  E + G
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 37/210 (17%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  +L   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 368 GCCLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIKGIAR 415
                         + P KSL+ F        L D+  S    ++LD +R   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
            APE  +G  +    D++S GV++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LGEG FG V         +++A+K +SR            + E++ +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                 + +++ EY   +  D ++ +  R  + + +R     + I   I Y H   R KI
Sbjct: 77  VITTPTDIVMVIEYAGGELFD-YIVEKKRMTEDEGRR---FFQQIICAIEYCH---RHKI 129
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK  N+LLD  +N KI+DFG++ I   GN  K +     G+  Y APE   G +++
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKLYA 185
Query: 488 -VKSDVFSFGVVLLEIISGK 506
             + DV+S G+VL  ++ G+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 40/293 (13%)
Query: 313 LGEGGFGPV-----YKGVLADGK-EIAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V     Y  + +D    +AVK L  ++    +E   +E+ V++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 365 RLLGCCLEENESLLIYEY--------MPNKSLDVFLFDSTRSVQLDWKRRI-------SI 409
            LLG C     +L+I EY           +  D F+   T    ++            S 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + +       
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                +MAPE     +++ +SDV+S+G+ L E+ S   S        G  + +  +K+  
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKMIK 262
Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           EG     M S      +  +++K       C   DP+ RPT   +  ++   I
Sbjct: 263 EGFR---MLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLIEKQI 306

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEI-AVKRL--SRTSGQGLQ-EFKNEVTVIAKLQHK 361
           DF     LG+G FG VY       K I A+K L  S+   +G++ + + E+ + + L+H 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N++R+     +     L+ E+ P   L   L    R    D +R  + ++ +A  + Y H
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH 132
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           E    K+IHRD+K  N+L+ ++   KI+DFG    +  +        + GT  Y+ PE  
Sbjct: 133 ER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMI 185
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
            G     K D++  GV+  E + G
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ-GLQ-EFKNEVTVIAKLQ 359
           AT  +    ++G G +G VYK      G  +A+K +   +G+ GL      EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 360 ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
              H N+VRL+  C       E +  L++E++ ++ L  +L D      L  +    +++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
              RG+ +LH +    I+HRDLK  N+L+      K++DFG+ARI+    +    + VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LDPVVV 173
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 37/210 (17%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  +L   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 368 GCCLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIKGIAR 415
                         + P KSL+ F        L D+  S    ++LD +R   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
            APE  +G  +    D++S GV++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 40/293 (13%)
Query: 313 LGEGGFGPV-----YKGVLADGK-EIAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V     Y  + +D    +AVK L  ++    +E   +E+ V++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 365 RLLGCCLEENESLLIYEY--------MPNKSLDVFLFDSTRSVQLDWKRRI-------SI 409
            LLG C     +L+I EY           +  D F+   T    ++            S 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + +       
Sbjct: 169 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                +MAPE     +++ +SDV+S+G+ L E+ S   S        G  + +  +K+  
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKMIK 280
Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           EG     M S      +  +++K       C   DP+ RPT   +  ++   I
Sbjct: 281 EGFR---MLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLIEKQI 324

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 40/293 (13%)
Query: 313 LGEGGFGPV-----YKGVLADGK-EIAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V     Y  + +D    +AVK L  ++    +E   +E+ V++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 365 RLLGCCLEENESLLIYEY--------MPNKSLDVFLFDSTRSVQLDWKRRI-------SI 409
            LLG C     +L+I EY           +  D F+   T    ++            S 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + +       
Sbjct: 174 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                +MAPE     +++ +SDV+S+G+ L E+ S   S        G  + +  +K+  
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKMIK 285
Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           EG     M S      +  +++K       C   DP+ RPT   +  ++   I
Sbjct: 286 EGFR---MLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLIEKQI 329

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 104/208 (50%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+  S    ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LG+G FG V   K  +  G+E AVK +S+         +    EV ++ +L H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               ++    L+ E      L   +    R  ++D  R   II+ +  GI Y H++   K
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKN---K 146
Query: 428 IIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+LL+    + N +I DFG++  F  ++   +    +GT  Y+APE  + G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGTAYYIAPE-VLHG 202
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +  K DV+S GV+L  ++SG
Sbjct: 203 TYDEKCDVWSTGVILYILLSG 223

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 40/293 (13%)
Query: 313 LGEGGFGPV-----YKGVLADGK-EIAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V     Y  + +D    +AVK L  ++    +E   +E+ V++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 365 RLLGCCLEENESLLIYEY--------MPNKSLDVFLFDSTRSVQLDWKRRI-------SI 409
            LLG C     +L+I EY           +  D F+   T    ++            S 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + +       
Sbjct: 174 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                +MAPE     +++ +SDV+S+G+ L E+ S   S        G  + +  +K+  
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKMIK 285
Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           EG     M S      +  +++K       C   DP+ RPT   +  ++   I
Sbjct: 286 EGFR---MLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLIEKQI 329

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 112/222 (50%), Gaps = 36/222 (16%)
Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQ-HKNLVRL 366
           KLG+G +G V+K +    G+ +AVK++    + S    + F+ E+ ++ +L  H+N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 367 LGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           L     +N+    L+++YM     +  L    R+  L+   +  ++  + + I YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG------------NQSKANTN----- 467
              ++HRD+K SN+LL+ E + K++DFG++R F              N++  N +     
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 468 --RVVGTYGYMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
               V T  Y APE  +G     K  D++S G +L EI+ GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 40/293 (13%)
Query: 313 LGEGGFGPV-----YKGVLADGK-EIAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V     Y  + +D    +AVK L  ++    +E   +E+ V++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 365 RLLGCCLEENESLLIYEY--------MPNKSLDVFLFDSTRSVQLDWKRRI-------SI 409
            LLG C     +L+I EY           +  D F+   T    ++            S 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR    + +       
Sbjct: 167 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                +MAPE     +++ +SDV+S+G+ L E+ S   S        G  + +  +K+  
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKMIK 278
Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
           EG     M S      +  +++K       C   DP+ RPT   +  ++   I
Sbjct: 279 EGFR---MLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLIEKQI 322

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLV 364
           +  + +LG GGFG V + +  D G+++A+K+  +  S +  + +  E+ ++ KL H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 365 --RLLGCCLEE----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
             R +   L++    +  LL  EY     L  +L        L      +++  I+  + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 419 YLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           YLHE+   +IIHRDLK  N++L      +  KI D G A+    +Q +  T   VGT  Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQY 189
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           +APE      ++V  D +SFG +  E I+G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLV 364
           +  + +LG GGFG V + +  D G+++A+K+  +  S +  + +  E+ ++ KL H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 365 --RLLGCCLEE----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
             R +   L++    +  LL  EY     L  +L        L      +++  I+  + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           YLHE+   +IIHRDLK  N++L      +  KI D G A+    +Q +  T   VGT  Y
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQY 190
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           +APE      ++V  D +SFG +  E I+G
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 104/208 (50%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+  S    ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHK 361
           F  +  LG G F  V   VLA+    GK  AVK + + + +G +   +NE+ V+ K++H+
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW---KRRISIIKGIARGIL 418
           N+V L       N   L+ + +    L    FD  R V+  +   K   ++I+ +   + 
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGEL----FD--RIVEKGFYTEKDASTLIRQVLDAVY 134
Query: 419 YLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           YLH   R+ I+HRDLK  N+L    D E    ISDFG++++ G     +      GT GY
Sbjct: 135 YLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA---CGTPGY 188
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           +APE      +S   D +S GV+   ++ G
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 348 FKNEVTVIAKLQHKNLVRLLGCCLEENES----LLIYEYMPNKSL-DVFLFDSTRSVQLD 402
           F+ E    A L H  +V +      E  +     ++ EY+   +L D+   +      + 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MT 114
Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQ 461
            KR I +I    + + + H++    IIHRD+K +N+++      K+ DFG+AR I     
Sbjct: 115 PKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           S   T  V+GT  Y++PE A G     +SDV+S G VL E+++G+
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 51/294 (17%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE 372
           +G+G FG VY G       I +  + R +   L+ FK EV    + +H+N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRD 432
                +I      ++L   + D+   + LD  +   I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 433 LKTSNVLLDHEMNPK--ISDFGMARIFGGNQSKANTNRVVGTYGY---MAPEYAM----- 482
           LK+ NV  D   N K  I+DFG+  I G  Q+    +++    G+   +APE        
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 483 ----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP----SLLAYIWKLWCEGHAA 534
                  FS  SDVF+ G +  E+          H+   P       A IW+        
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYEL----------HAREWPFKTQPAEAIIWQ-------- 254
Query: 535 ELMDSVVKQSCDQAELLKYI-HIGLLCVQGDPIDRPTMSSVAVMLASDILTLPK 587
             M + +K +  Q  + K I  I L C   +  +RPT + +  ML      LPK
Sbjct: 255 --MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK----LPK 302

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPEVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 302 KATQDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK 357
           K  +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKG 412
           L H   V+L     ++ +      Y  N  L  ++     FD T +       R    + 
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE- 115
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             Y++PE          SD+++ G ++ ++++G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 302 KATQDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK 357
           K  +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKG 412
           L H   V+L     ++ +      Y  N  L  ++     FD T +       R    + 
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE- 117
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             Y++PE          SD+++ G ++ ++++G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 302 KATQDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK 357
           K  +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKG 412
           L H   V+L     ++ +      Y  N  L  ++     FD T +       R    + 
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE- 118
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             Y++PE          SD+++ G ++ ++++G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 302 KATQDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK 357
           K  +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKG 412
           L H   V+L     ++ +      Y  N  L  ++     FD T +       R    + 
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE- 116
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             Y++PE          SD+++ G ++ ++++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCT-------RFYTAE-IVS 143
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE       S  SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 33/214 (15%)
Query: 307 FSQENKLGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + Q   +G G  G V   +  VL  G  +AVK+LSR        F+N+    AK  ++ L
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRP-------FQNQTH--AKRAYREL 74
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIK 411
           V LL C   +N   L+  + P K+L+ F        L D+       ++LD +R   ++ 
Sbjct: 75  V-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY 133
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            +  GI +LH      IIHRDLK SN+++  +   KI DFG+AR    N     T  VV 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVT 188
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
            Y Y APE  +G  ++   D++S G ++ E++ G
Sbjct: 189 RY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 348 FKNEVTVIAKLQHKNLVRLLGCCLEENES----LLIYEYMPNKSL-DVFLFDSTRSVQLD 402
           F+ E    A L H  +V +      E  +     ++ EY+   +L D+   +      + 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MT 114
Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQ 461
            KR I +I    + + + H++    IIHRD+K +N+++      K+ DFG+AR I     
Sbjct: 115 PKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           S   T  V+GT  Y++PE A G     +SDV+S G VL E+++G+
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           Q + +  K+GEG +G V+K    +  EI A+KR+      +G+      E+ ++ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+VRL      + +  L++E+  ++ L  + FDS     LD +   S +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
             +   ++HRDLK  N+L++     K++DFG+AR F G   +  +  VV T  Y  P+  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173
Query: 482 MGG-IFSVKSDVFSFGVVLLEIISGKK 507
            G  ++S   D++S G +  E+ +  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 131/310 (42%), Gaps = 49/310 (15%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D +++ K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 25  FPRDRLNLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 75
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPY 134
Query: 404 KRRISIIKG-------------IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 450
           K    + K              +A+G+ +L   +  K IHRDL   N+LL  +   KI D
Sbjct: 135 KTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG 510
           FG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S  
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-- 249
Query: 511 FYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
                  P     I + +C      L +    ++ D      Y    L C  G+P  RPT
Sbjct: 250 -------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPT 297
Query: 571 MSSVAVMLAS 580
            S +   L +
Sbjct: 298 FSELVEHLGN 307

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ-GLQ-EFKNEVTVIAKLQ 359
           AT  +    ++G G +G VYK      G  +A+K +   +G+ GL      EV ++ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 360 ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
              H N+VRL+  C       E +  L++E++ ++ L  +L D      L  +    +++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
              RG+ +LH +    I+HRDLK  N+L+      K++DFG+ARI+    +      VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LFPVVV 173
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKLQH- 360
            +D     ++G G +G V K V    G+ +AVKR+  T  +  Q +   ++ V+ +    
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVF------LFDSTRSVQLDWKRRISIIKGIA 414
             +V+  G    E +  +  E M + S D F      + D     ++  K  ++ +K + 
Sbjct: 81  PYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
                 H    LKIIHRD+K SN+LLD   N K+ DFG++   G         R  G   
Sbjct: 140 ------HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRP 190
Query: 475 YMAPEY----AMGGIFSVKSDVFSFGVVLLEIISGK 506
           YMAPE     A    + V+SDV+S G+ L E+ +G+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 109/225 (48%), Gaps = 35/225 (15%)
Query: 307 FSQENKLGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + Q   +G G  G V   +  VL  G  +AVK+LSR        F+N+    AK  ++ L
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRP-------FQNQTH--AKRAYREL 72
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIK 411
           V LL C   +N   L+  + P K+L+ F        L D+       ++LD +R   ++ 
Sbjct: 73  V-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY 131
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            +  GI +LH      IIHRDLK SN+++  +   KI DFG+AR    N     T  VV 
Sbjct: 132 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVT 186
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
            Y Y APE  +G  +    D++S G ++ E++ G  S  F  ++H
Sbjct: 187 RY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG--SVIFQGTDH 228

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 194
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 186
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  +L   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 368 GCCLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIKGIAR 415
                         + P KSL+ F        L D+  S    ++LD +R   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
            APE  +G  +    D++S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 348 FKNEVTVIAKLQHKNLVRLLGCCLEENES----LLIYEYMPNKSL-DVFLFDSTRSVQLD 402
           F+ E    A L H  +V +      E  +     ++ EY+   +L D+   +      + 
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MT 131
Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQ 461
            KR I +I    + + + H++    IIHRD+K +N+++      K+ DFG+AR I     
Sbjct: 132 PKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           S   T  V+GT  Y++PE A G     +SDV+S G VL E+++G+
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 125
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 141
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 143
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 140
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 141
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 141
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 140
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGP-VYKGVLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F   V    LA  +E A+K L +        +     E  V+++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 141
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  +L   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 368 GCCLEENESLLIYEYMPNKSLDVF--------LFDSTRS----VQLDWKRRISIIKGIAR 415
                         + P KSL+ F        L D+  S    ++LD +R   ++  +  
Sbjct: 90  NV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
            APE  +G  +    D++S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 143
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 117
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 178 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 231
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 143
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 144
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 144
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 143
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 146
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  VL   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 368 GC-----CLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
                   LEE + + L+ E M      V        ++LD +R   ++  +  GI +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVI------QMELDHERMSYLLYQMLXGIKHLH 143
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                 IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVI 197
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
           +G  +    D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 96/220 (43%), Gaps = 16/220 (7%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQ 346
           PL  +  +   +D     KLG+G FG V +G      GK   +AVK L     +  + + 
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 347 EFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR 406
           +F  EV  +  L H+NL+RL G  L     + + E  P  SL   L        L    R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA-- 464
            ++   +A G+ YL      + IHRDL   N+LL      KI DFG+ R    N      
Sbjct: 126 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 180
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +R V  + + APE      FS  SD + FGV L E+ +
Sbjct: 181 QEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 96/220 (43%), Gaps = 16/220 (7%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQ 346
           PL  +  +   +D     KLG+G FG V +G      GK   +AVK L     +  + + 
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 347 EFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR 406
           +F  EV  +  L H+NL+RL G  L     + + E  P  SL   L        L    R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK--A 464
            ++   +A G+ YL      + IHRDL   N+LL      KI DFG+ R    N      
Sbjct: 126 YAV--QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +R V  + + APE      FS  SD + FGV L E+ +
Sbjct: 181 QEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIAR 415
              V+L     ++ +      Y  N  L  ++     FD T +       R    + I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-IVS 143
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           ++PE          SD+++ G ++ ++++G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 78
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 139 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 192
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 117
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 178 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 231
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 44/306 (14%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D +++ K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 24  FPRDRLNLGKP---------LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFL------FDSTR 397
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L      F   +
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 398 SVQLDW---KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
            +  D+   +  I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+A
Sbjct: 135 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS 514
           R    +              +MAPE     +++++SDV+SFGV+L EI S   S      
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------ 245
Query: 515 EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
              P     I + +C      L +    ++ D      Y    L C  G+P  RPT S +
Sbjct: 246 ---PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSEL 297
Query: 575 AVMLAS 580
              L +
Sbjct: 298 VEHLGN 303

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 187
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 194
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 186
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 194
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  VL   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P K+L+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 187
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 302 KATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKL 358
           K + ++  + +LG+G F  V + V    G E A K ++  + S +  Q+ + E  +  KL
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARGI 417
           QH N+VRL     EE+   L+++ +        LF+   + +   +   S  I+ I   I
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESI 117
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYG 474
            Y H +    I+HR+LK  N+LL  +      K++DFG+A     N S+A  +   GT G
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 171
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           Y++PE      +S   D+++ GV+L  ++ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 302 KATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKL 358
           K + ++  + +LG+G F  V + V    G E A K ++  + S +  Q+ + E  +  KL
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARGI 417
           QH N+VRL     EE+   L+++ +        LF+   + +   +   S  I+ I   I
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESI 118
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYG 474
            Y H +    I+HR+LK  N+LL  +      K++DFG+A     N S+A  +   GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 172
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           Y++PE      +S   D+++ GV+L  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D +++ K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 24  FPRDRLNLGKP---------LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFL------FDSTR 397
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L      F   +
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 398 SVQLDWKRRISIIK---GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
            +  D+     +I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+A
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           R    +              +MAPE     +++++SDV+SFGV+L EI S
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 345 LQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK 404
           +++   E+ ++ KL H N+V+L+    + NE  L   +       V    + + +  D  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
           R     + + +GI YLH     KIIHRD+K SN+L+  + + KI+DFG++  F G  S A
Sbjct: 140 R--FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG--SDA 192
Query: 465 NTNRVVGTYGYMAPE--YAMGGIFSVKS-DVFSFGVVLLEIISGK 506
             +  VGT  +MAPE       IFS K+ DV++ GV L   + G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLS-RTSGQGLQEFK-NEVTVIAKLQHK 361
           Q + +  K+GEG +G V+K    +  EI A+KR+      +G+      E+ ++ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+VRL      + +  L++E+  ++ L  + FDS     LD +   S +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH 118
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
             +   ++HRDLK  N+L++     K+++FG+AR F G   +  +  VV T  Y  P+  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173
Query: 482 MGG-IFSVKSDVFSFGVVLLEIISGKK 507
            G  ++S   D++S G +  E+ +  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 7/204 (3%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLV 364
           ++Q   +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            +           +   Y+    ++  L+   +S QL        +  I RG+ Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMG 483
              ++HRDLK SN+L++   + KI DFG+ARI              V T  Y APE  + 
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 484 GIFSVKS-DVFSFGVVLLEIISGK 506
                KS D++S G +L E++S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKL------QHKNLVR 365
           LG+G FG V    + + G   AVK L +     LQ+   E T+  K        H  L +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L  C    +    + E++    L   +F   +S + D  R       I   +++LH+   
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHDKG- 144
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             II+RDLK  NVLLDHE + K++DFGM +   G  +   T    GT  Y+APE     +
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 486 FSVKSDVFSFGVVLLEIISG 505
           +    D ++ GV+L E++ G
Sbjct: 201 YGPAVDWWAMGVLLYEMLCG 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 61
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 118
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 119 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 174
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 175 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 146
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 202
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 146
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 202
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 33/208 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 81
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S      VV  Y Y A
Sbjct: 142 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMVPFVVTRY-YRA 195
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE  +G  +    D++S G ++ E+I G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 127/314 (40%), Gaps = 58/314 (18%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 26  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 76
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIY------------------EYMPNK 386
               +E+ ++  +  H N+V LLG C +    L++                   E++P K
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 387 SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP 446
             D++         L  +  I     +A+G+ +L   +  K IHRDL   N+LL  +   
Sbjct: 137 PEDLY------KDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVV 187
Query: 447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           KI DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S  
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 507 KSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPI 566
            S         P     I + +C      L +    ++ D      Y    L C  G+P 
Sbjct: 248 AS---------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPS 293
Query: 567 DRPTMSSVAVMLAS 580
            RPT S +   L +
Sbjct: 294 QRPTFSELVEHLGN 307

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 302 KATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKL 358
           K + ++  + +LG+G F  V + V    G E A K ++  + S +  Q+ + E  +  KL
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARGI 417
           QH N+VRL     EE+   L+++ +        LF+   + +   +   S  I+ I   I
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESI 118
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYG 474
            Y H +    I+HR+LK  N+LL  +      K++DFG+A     N S+A  +   GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 172
Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           Y++PE      +S   D+++ GV+L  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 61
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 118
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 119 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 174
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 175 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTVI 355
             +D     KLG+G FG V +G      GK   +AVK L     +  + + +F  EV  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             L H+NL+RL G  L     + + E  P  SL   L        L    R ++   +A 
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 122
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA--NTNRVVGTY 473
           G+ YL      + IHRDL   N+LL      KI DFG+ R    N        +R V  +
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PF 178
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      FS  SD + FGV L E+ +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  VL   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 368 GC-----CLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
                   LEE + + L+ E M      V        ++LD +R   ++  +  GI +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVI------QMELDHERMSYLLYQMLCGIKHLH 143
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                 IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVI 197
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
           +G  +    D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 126
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 182
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTVI 355
             +D     KLG+G FG V +G      GK   +AVK L     +  + + +F  EV  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             L H+NL+RL G  L     + + E  P  SL   L        L    R ++   +A 
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 122
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK--ANTNRVVGTY 473
           G+ YL      + IHRDL   N+LL      KI DFG+ R    N        +R V  +
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PF 178
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      FS  SD + FGV L E+ +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 144
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 200
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 130
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 186
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 187
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 130
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY-APECI 186
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTVI 355
             +D     KLG+G FG V +G      GK   +AVK L     +  + + +F  EV  +
Sbjct: 10  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             L H+NL+RL G  L     + + E  P  SL   L        L    R ++   +A 
Sbjct: 70  HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 126
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK--ANTNRVVGTY 473
           G+ YL      + IHRDL   N+LL      KI DFG+ R    N        +R V  +
Sbjct: 127 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PF 182
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      FS  SD + FGV L E+ +
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +LG G FG V++    A G   A K +        +  + E+  ++ L+H  LV L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            ++NE ++IYE+M    L   + D    +  D    +  ++ + +G+ ++HE++    +H
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 172
Query: 431 RDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
            DLK  N++   + +   K+ DFG+       QS   T    GT  + APE A G     
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVGY 229
Query: 489 KSDVFSFGVVLLEIISG 505
            +D++S GV+   ++SG
Sbjct: 230 YTDMWSVGVLSYILLSG 246

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           +G G  G V   Y  VL   + +A+K+LSR   +    +    E+ ++  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 368 GC-----CLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
                   LEE + + L+ E M      V        ++LD +R   ++  +  GI +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 143
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                 IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVI 197
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
           +G  +    D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 124
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 125 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 180
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +LG G FG V++    A G   A K +        +  + E+  ++ L+H  LV L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
            ++NE ++IYE+M    L   + D    +  D    +  ++ + +G+ ++HE++    +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 278
Query: 431 RDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
            DLK  N++   + +   K+ DFG+       QS   T    GT  + APE A G     
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVGY 335
Query: 489 KSDVFSFGVVLLEIISG 505
            +D++S GV+   ++SG
Sbjct: 336 YTDMWSVGVLSYILLSG 352

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTVI 355
             +D     KLG+G FG V +G      GK   +AVK L     +  + + +F  EV  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             L H+NL+RL G  L     + + E  P  SL   L        L    R ++   +A 
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 122
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK--ANTNRVVGTY 473
           G+ YL      + IHRDL   N+LL      KI DFG+ R    N        +R V  +
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PF 178
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      FS  SD + FGV L E+ +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 136
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 192
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS-GKK 507
               FS KSDV+SFGV++ E  S G+K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 84
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S   T  VV  Y Y A
Sbjct: 145 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 198
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVL--ADGK--EIAVKRLSR---TSGQGLQEFKNEVTVI 355
             +D     KLG+G FG V +G      GK   +AVK L     +  + + +F  EV  +
Sbjct: 10  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
             L H+NL+RL G  L     + + E  P  SL   L        L    R ++   +A 
Sbjct: 70  HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAE 126
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK--ANTNRVVGTY 473
           G+ YL      + IHRDL   N+LL      KI DFG+ R    N        +R V  +
Sbjct: 127 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PF 182
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      FS  SD + FGV L E+ +
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 29/201 (14%)
Query: 330 KEIAVKRLSRTSG-----QGLQEFKN----EVTVIAKLQ-HKNLVRLLGCCLEENESLLI 379
           KE AVK +  T G     + +QE +     EV ++ K+  H N+++L           L+
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL 439
           ++ M    L  +L   T  V L  K    I++ +   I  LH   +L I+HRDLK  N+L
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 440 LDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI------FSVKSDV 492
           LD +MN K++DFG + ++  G + ++    V GT  Y+APE     +      +  + D+
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLRS----VCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 493 FSFGVVLLEIISGKKSTGFYH 513
           +S GV++  +++G  S  F+H
Sbjct: 213 WSTGVIMYTLLAG--SPPFWH 231

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 19/210 (9%)
Query: 312 KLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKNLVRLLGCC 370
           K+G G +G VYK    DGK+     L +  G G+      E+ ++ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 371 LE--ENESLLIYEYMPNKSLDVFLFD-----STRSVQLDWKRRISIIKGIARGILYLHED 423
           L   + +  L+++Y  +    +  F      + + VQL      S++  I  GI YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP-----KISDFGMARIFGGN-QSKANTNRVVGTYGYMA 477
               ++HRDLK +N+L+  E  P     KI+D G AR+F    +  A+ + VV T+ Y A
Sbjct: 148 W---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 478 PEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
           PE  +G     K+ D+++ G +  E+++ +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 303 ATQDFSQENKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIA 356
           AT  +    ++G G +G VYK      G     K + V       G        EV ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 357 KLQ---HKNLVRLLGCCL-----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
           +L+   H N+VRL+  C       E +  L++E++ ++ L  +L D      L  +    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
           +++   RG+ +LH +    I+HRDLK  N+L+      K++DFG+ARI+    +      
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTP 178
Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           VV T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 29/204 (14%)
Query: 330 KEIAVKRLSRTSG-----QGLQEFKN----EVTVIAKLQ-HKNLVRLLGCCLEENESLLI 379
           KE AVK +  T G     + +QE +     EV ++ K+  H N+++L           L+
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL 439
           ++ M    L  +L   T  V L  K    I++ +   I  LH   +L I+HRDLK  N+L
Sbjct: 90  FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 143
Query: 440 LDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI------FSVKSDV 492
           LD +MN K++DFG + ++  G + +     V GT  Y+APE     +      +  + D+
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 199
Query: 493 FSFGVVLLEIISGKKSTGFYHSEH 516
           +S GV++  +++G  S  F+H + 
Sbjct: 200 WSTGVIMYTLLAG--SPPFWHRKQ 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S      VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 15  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPY 124
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S 
Sbjct: 182 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 240
Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
                   P     I + +C      L +    ++ D      Y    L C  G+P  RP
Sbjct: 241 --------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRP 287
Query: 570 TMSSVAVMLAS 580
           T S +   L +
Sbjct: 288 TFSELVEHLGN 298

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              + +   ++ E    +SL   L    R   L        ++ I  G  YLH   R ++
Sbjct: 89  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 142
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
           IHRDLK  N+ L+ ++  KI DFG+A     +  +  T  + GT  Y+APE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 489 KSDVFSFGVVLLEIISGK 506
           + DV+S G ++  ++ GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 313 LGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKL-QHKNLV 364
           LG G FG V +    G+   A  + +AVK L   +         +E+ ++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 365 RLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWK--------------RRISI 409
            LLG C +    L+ I E+    +L  +L  S R+  + +K                I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
              +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR    +         
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                +MAPE     +++++SDV+SFGV+L EI S
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              + +   ++ E    +SL   L    R   L        ++ I  G  YLH   R ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
           IHRDLK  N+ L+ ++  KI DFG+A     +  +  T  + GT  Y+APE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 489 KSDVFSFGVVLLEIISGK 506
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAK 357
            K + ++  + +LG+G F  V + V    G E A K ++  + S +  Q+ + E  +  K
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARG 416
           LQH N+VRL     EE+   L+++ +        LF+   + +   +   S  I+ I   
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILES 140
Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTY 473
           I Y H +    I+HR+LK  N+LL  +      K++DFG+A     N S+A  +   GT 
Sbjct: 141 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTP 194
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           GY++PE      +S   D+++ GV+L  ++ G
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 307 FSQEN---------KLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFK 349
           F QEN         +LG G F  V K      G+    K I  KR +++S +G+  ++ +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIE 62
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 119
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK----ISDFGMA-RIFGGNQSKA 464
           +K I  G+ YLH    L+I H DLK  N++L     PK    I DFG+A +I  GN+ K 
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 175
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
               + GT  ++APE        +++D++S GV+   ++SG
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 15  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPY 124
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S 
Sbjct: 182 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 240
Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
                   P     I + +C      L +    ++ D      Y    L C  G+P  RP
Sbjct: 241 --------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRP 287
Query: 570 TMSSVAVMLAS 580
           T S +   L +
Sbjct: 288 TFSELVEHLGN 298

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 29/201 (14%)
Query: 330 KEIAVKRLSRTSG-----QGLQEFKN----EVTVIAKLQ-HKNLVRLLGCCLEENESLLI 379
           KE AVK +  T G     + +QE +     EV ++ K+  H N+++L           L+
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL 439
           ++ M    L  +L   T  V L  K    I++ +   I  LH   +L I+HRDLK  N+L
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 440 LDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI------FSVKSDV 492
           LD +MN K++DFG + ++  G + +     V GT  Y+APE     +      +  + D+
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 493 FSFGVVLLEIISGKKSTGFYH 513
           +S GV++  +++G  S  F+H
Sbjct: 213 WSTGVIMYTLLAG--SPPFWH 231

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +++   ++ E    +SL + L    ++V     R    ++   +G+ YLH +   ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 163
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ +M+ KI DFG+A    F G + K     + GT  Y+APE       
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT----LCGTPNYIAPEVLCKKGH 219
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + D++S G +L  ++ GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              + +   ++ E    +SL   L    R   L        ++ I  G  YLH   R ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSV 488
           IHRDLK  N+ L+ ++  KI DFG+A     +  +  T  + GT  Y+APE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 489 KSDVFSFGVVLLEIISGK 506
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 488
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 489 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 544
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               FS KSDV+SFGV++ E  S
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFK-NEVTVIAKLQHKNL 363
           + +  KLGEG +G VYK +     + +A+KR+      +G+      EV+++ +LQH+N+
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 364 VRLLGCCLEENESLLIYEYMPN---KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           + L       +   LI+EY  N   K +D     S R ++       S +  +  G+ + 
Sbjct: 96  IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIK-------SFLYQLINGVNFC 148
Query: 421 HEDSRLKIIHRDLKTSNVLL---DHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGY 475
           H  SR + +HRDLK  N+LL   D    P  KI DFG+AR F G   +  T+ ++ T  Y
Sbjct: 149 H--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWY 203
Query: 476 MAPEYAMGGI-FSVKSDVFSFGVVLLEII 503
             PE  +G   +S   D++S   +  E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +++   ++ E    +SL + L    ++V     R    ++   +G+ YLH +   ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 163
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ +M+ KI DFG+A    F G + K     + GT  Y+APE       
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX----LCGTPNYIAPEVLCKKGH 219
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + D++S G +L  ++ GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K +    +     +        E   E  V+ +L +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L    R V+   K  I ++  ++ G+ YL E 
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKD--KNIIELVHQVSMGMKYLEES 489
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYA 481
           +    +HRDL   NVLL  +   KISDFG+++    +++  KA T+       Y APE  
Sbjct: 490 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECI 545
Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               FS KSDV+SFGV++ E  S
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL----- 366
           LG GG G V+  V  D  K +A+K++  T  Q ++    E+ +I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 367 ---------LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
                    +G   E N   ++ EYM     +V      +   L+   R+ + + + RG+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARLFMYQ-LLRGL 133
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQS-KANTNRVVGTYGY 475
            Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI   + S K + +  + T  Y
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 476 MAPEYAMGGIFSVKS-DVFSFGVVLLEIISGK 506
            +P   +      K+ D+++ G +  E+++GK
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G  G V   Y  +L   + +A+K+LSR        F+N+    AK  ++ LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 370 CLEENESLLIYEYMPNKSLDVF--------LFDSTR----SVQLDWKRRISIIKGIARGI 417
              +N   L+  + P KSL+ F        L D+       ++LD +R   ++  +  GI
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            +LH      IIHRDLK SN+++  +   KI DFG+AR  G   S      VV  Y Y A
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRY-YRA 193
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE  +G  +    D++S G ++ E++  K
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 36/235 (15%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 24  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPY 133
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S
Sbjct: 191 DFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              + +   ++ E    +SL   L    R   L        ++ I  G  YLH   R ++
Sbjct: 107 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 160
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ ++  KI DFG+A    + G + K     + GT  Y+APE       
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGH 216
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + DV+S G ++  ++ GK
Sbjct: 217 SFEVDVWSIGCIMYTLLVGK 236

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFRRF 189
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 15  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPY 124
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S 
Sbjct: 182 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 240
Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
                   P     I + +C      L +    ++ D      Y    L C  G+P  RP
Sbjct: 241 --------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRP 287
Query: 570 TMSSVAVMLAS 580
           T S +   L +
Sbjct: 288 TFSELVEHLGN 298

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 128/310 (41%), Gaps = 48/310 (15%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 26  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 76
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFL------FDSTR 397
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L      F   +
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 398 SVQLDWKRRISIIKG-------IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 450
               D  +    ++        +A+G+ +L   +  K IHRDL   N+LL  +   KI D
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 193
Query: 451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG 510
           FG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S  
Sbjct: 194 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-- 251
Query: 511 FYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
                  P     I + +C      L +    ++ D      Y    L C  G+P  RPT
Sbjct: 252 -------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPT 299
Query: 571 MSSVAVMLAS 580
            S +   L +
Sbjct: 300 FSELVEHLGN 309

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 313 LGEGGFGPVY---KGVLAD-GKEIAVKRLSRTSGQGLQEF--KNEVTVIAKLQHKNLVRL 366
           LG+G FG V+   K    D G   A+K L + + +       K E  ++A + H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 E +  LI +++    L   L       + D K  ++    +A G+ +LH    L
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALGLDHLHS---L 149
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            II+RDLK  N+LLD E + K++DFG+++    ++ KA +    GT  YMAPE       
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQGH 207
Query: 487 SVKSDVFSFGVVLLEIISG 505
           S  +D +S+GV++ E+++G
Sbjct: 208 SHSADWWSYGVLMFEMLTG 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              + +   ++ E    +SL   L    R   L        ++ I  G  YLH   R ++
Sbjct: 83  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ ++  KI DFG+A    + G + K     + GT  Y+APE       
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGH 192
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + DV+S G ++  ++ GK
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V     +  G +IAVK+LSR     +   +   E+ ++ 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 357 KLQHKNLVRLL-----GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 161
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 162 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 213
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           T  Y APE  +  + +++  D++S G ++ E+++G+
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +++   ++ E    +SL + L    ++V     R    ++   +G+ YLH +   ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 163
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ +M+ KI DFG+A    F G + K     + GT  Y+APE       
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD----LCGTPNYIAPEVLCKKGH 219
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + D++S G +L  ++ GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 24  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPY 133
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S 
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 249
Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
                   P     I + +C      L +    ++ D      Y    L C  G+P  RP
Sbjct: 250 --------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRP 296
Query: 570 TMSSVAVMLAS 580
           T S +   L +
Sbjct: 297 TFSELVEHLGN 307

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++   AD KE+   ++   S        ++   E+++   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              + +   ++ E    +SL   L    R   L        ++ I  G  YLH   R ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ ++  KI DFG+A    + G + K     + GT  Y+APE       
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGH 218
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + DV+S G ++  ++ GK
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   Y+    D KE+   ++   S        ++   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +++   ++ E    +SL + L    ++V     R    ++   +G+ YLH +   ++
Sbjct: 94  FFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 147
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARI--FGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           IHRDLK  N+ L+ +M+ KI DFG+A    F G + K     + GT  Y+APE       
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD----LCGTPNYIAPEVLCKKGH 203
Query: 487 SVKSDVFSFGVVLLEIISGK 506
           S + D++S G +L  ++ GK
Sbjct: 204 SFEVDIWSLGCILYTLLVGK 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 15  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPY 124
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 181
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S 
Sbjct: 182 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 240
Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
                   P     I + +C      L +    ++ D      Y    L C  G+P  RP
Sbjct: 241 --------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRP 287
Query: 570 TMSSVAVMLAS 580
           T S +   L +
Sbjct: 288 TFSELVEHLGN 298

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G+G +G V++G    G+ +AVK  S R      +E +   TV+  L+H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 372 EENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH-----E 422
               S     LI  Y    SL    +D  +   LD    + I+  IA G+ +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEY 480
             +  I HRDLK+ N+L+       I+D G+A +     NQ     N  VGT  YMAPE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE- 187
Query: 481 AMGGIFSV-------KSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
            +     V       + D+++FG+VL E+     S G       P
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           F  E++LG G    VY+       K  A+K L +T  + +   + E+ V+ +L H N+++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIK 112
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW---KRRISIIKGIARGILYLHE 422
           L        E  L+ E +    L    FD  R V+  +   +     +K I   + YLHE
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL----FD--RIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 423 DSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           +    I+HRDLK  N+L      +   KI+DFG+++I    + +     V GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPE 220
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
              G  +  + D++S G++   ++ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G+G +G V++G    G+ +AVK  S R      +E +   TV+  L+H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 372 EENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH-----E 422
               S     LI  Y    SL    +D  +   LD    + I+  IA G+ +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEY 480
             +  I HRDLK+ N+L+       I+D G+A +     NQ     N  VGT  YMAPE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE- 187
Query: 481 AMGGIFSV-------KSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
            +     V       + D+++FG+VL E+     S G       P
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 111/226 (49%), Gaps = 29/226 (12%)
Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS----RTSGQGLQEFKN----EVTVI 355
           Q +  ++ +G G    V + V  A G E AVK +     R S + L+E +     E  ++
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 356 AKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
            ++  H +++ L+      +   L+++ M    L  +L   T  V L  K   SI++ + 
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLL 210
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTY 473
             + +LH ++   I+HRDLK  N+LLD  M  ++SDFG +  +  G + +     + GT 
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR----ELCGTP 263
Query: 474 GYMAPEYAMGGI------FSVKSDVFSFGVVLLEIISGKKSTGFYH 513
           GY+APE     +      +  + D+++ GV+L  +++G  S  F+H
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWH 307

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 13/222 (5%)
Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFKNEVTVIAKL 358
             QDF     +G G +  V    L     I     VK+      + +   + E  V  + 
Sbjct: 3   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 359 -QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
             H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  +
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLAL 119
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YLHE     II+RDLK  NVLLD E + K++D+GM +   G +    T+   GT  Y+A
Sbjct: 120 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIA 174
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS 519
           PE   G  +    D ++ GV++ E+++G+       S   P 
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 216

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 307 FSQENKLGEGGFGPVY---KGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +  KLG G +G V      V    + I + R +  S     +   EV V+  L H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHE 422
           ++L     ++    L+ E      L    FD     ++ +      IIK +  G+ YLH+
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
            +   I+HRDLK  N+LL+ +      KI DFG++ +F  NQ K      +GT  Y+APE
Sbjct: 155 HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKER--LGTAYYIAPE 208
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
             +   +  K DV+S GV+L  +++G
Sbjct: 209 -VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  + Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE     II+RDLK  NVLLD E + K++D+GM +   G +    T+   GT  Y+APE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPE 191
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS 519
              G  +    D ++ GV++ E+++G+       S   P 
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 27/221 (12%)
Query: 302 KATQDFSQENKLGEGGFGPVYKGVLADGK-EIAVKRLSRT---------SGQGLQEFK-- 349
           K  + + +  KLG G +G V      +G  E A+K + ++           + +++F   
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 350 --NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
             NE++++  L H N+++L     ++    L+ E+     L   + +  +  + D     
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD---AA 149
Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARIFGGNQSKA 464
           +I+K I  GI YLH+ +   I+HRD+K  N+LL+++   +N KI DFG++  F  +    
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           +    +GT  Y+APE  +   ++ K DV+S GV++  ++ G
Sbjct: 207 DR---LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 8/160 (5%)
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  + Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE     II+RDLK  NVLLD E + K++D+GM +   G +    T+   GT  Y+APE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPE 180
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS 519
              G  +    D ++ GV++ E+++G+       S   P 
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 13/219 (5%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSR----TSGQGLQEFKNEVTVIAKL-Q 359
           QDF     +G G +  V    L     I   R+ +       + +   + E  V  +   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H  LV L  C   E+    + EY+    L   +F   R  +L  +        I+  + Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LHE     II+RDLK  NVLLD E + K++D+GM +   G +    T+   GT  Y+APE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 223
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
              G  +    D ++ GV++ E+++G+       S   P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 208 TKSIDIWSVGCILAEMLSNR 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G+G +G V++G    G+ +AVK  S R      +E +   TV+  L+H+N++  +   +
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 101
Query: 372 EENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH-----E 422
               S     LI  Y    SL    +D  +   LD    + I+  IA G+ +LH      
Sbjct: 102 TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEY 480
             +  I HRDLK+ N+L+       I+D G+A +     NQ     N  VGT  YMAPE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE- 216
Query: 481 AMGGIFSV-------KSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
            +     V       + D+++FG+VL E+     S G       P
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 261

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCAKLTDDHVQFLIY 128
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 180
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 238
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 239 G--AELLKKISSESA 251

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 217
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 50/311 (16%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYK----GV--LADGKEIAVKRLSRTSGQGLQ 346
           FP D + + K          LG G FG V +    G+   A  + +AVK L   +     
Sbjct: 61  FPRDRLKLGKP---------LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 111
Query: 347 E-FKNEVTVIAKL-QHKNLVRLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDW 403
               +E+ ++  +  H N+V LLG C +    L+ I E+    +L  +L  S R+  + +
Sbjct: 112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPY 170
Query: 404 K--------------RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
           K                I     +A+G+ +L   +  K IHRDL   N+LL  +   KI 
Sbjct: 171 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 227
Query: 450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST 509
           DFG+AR    +              +MAPE     +++++SDV+SFGV+L EI S   S 
Sbjct: 228 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 286
Query: 510 GFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP 569
                   P     I + +C      L +    ++ D      Y    L C  G+P  RP
Sbjct: 287 --------PYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRP 333
Query: 570 TMSSVAVMLAS 580
           T S +   L +
Sbjct: 334 TFSELVEHLGN 344

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 186
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 191
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 194
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 153
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 213
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 214 TKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 145
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 206 TKSIDIWSVGCILAEMLSNR 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 192
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 347 EFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL-----DVFLFDSTRSVQL 401
           +FKNE+ +I  ++++  +   G     +E  +IYEYM N S+       F+ D   +  +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 461
             +    IIK +     Y+H +    I HRD+K SN+L+D     K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 462 SKANTNRVVGTYGYMAPEY--AMGGIFSVKSDVFSFGVVL 499
            K +     GTY +M PE+          K D++S G+ L
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 35/219 (15%)
Query: 313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           +G G +G V   V    G ++A+K+L R        F++E+   AK  ++ L RLL    
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSEL--FAKRAYREL-RLLKHMR 82
Query: 372 EENESLLIYEYMPNKSLDVF-------------LFDSTRSVQLDWKRRISIIKGIARGIL 418
            EN   L+  + P+++LD F             L    +  +L   R   ++  + +G+ 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q+ +     V T  Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAP 194
Query: 479 EYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E  +  + ++   D++S G ++ E+I+GK  T F  S+H
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK--TLFKGSDH 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLV 364
           F  + KLG G FG V+     + G E  +K +++   Q  +++ + E+ V+  L H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 365 RLLGCCLEENESLLIYEYMPNKS-LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           ++     + +   ++ E       L+  +    R   L       ++K +   + Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
               ++H+DLK  N+L   + +P    KI DFG+A +F  ++   N     GT  YMAPE
Sbjct: 144 H---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPE 196
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                + + K D++S GVV+  +++G
Sbjct: 197 VFKRDV-TFKCDIWSAGVVMYFLLTG 221

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKR-LSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLLG 368
           K+G+G FG V+K      G+++A+K+ L     +G       E+ ++  L+H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 369 CCLEENESL--------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            C  +            L++++  +   D+    S   V+        +++ +  G+ Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG---GNQSKANTNRVVGTYGYMA 477
           H   R KI+HRD+K +NVL+  +   K++DFG+AR F     +Q     NRVV T  Y  
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEI 502
           PE  +G   +    D++  G ++ E+
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++ + +H+N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    +   L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 165
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 153
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 214 SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 144
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 205 SIDIWSVGCILAEMLSNR 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 313 LGEGGFGPVY--KGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           LG G F  V+  K  L  GK  A+K + ++        +NE+ V+ K++H+N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARGILYLHEDSRLKII 429
                  L+ + +        LFD      +  ++  S +I+ +   + YLHE+    I+
Sbjct: 76  ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 430 HRDLKTSNVL-LDHEMNPK--ISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
           HRDLK  N+L L  E N K  I+DFG++++    +     +   GT GY+APE      +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 487 SVKSDVFSFGVVLLEIISG 505
           S   D +S GV+   ++ G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 303 ATQDFSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKL 358
           + QDF     LG G FG V+      +G+  A+K L +     L++ +   +E  +++ +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H  ++R+ G   +  +  +I +Y+    L   L  S R      K   +    +   + 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALE 120
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH      II+RDLK  N+LLD   + KI+DFG A+          T  + GT  Y+AP
Sbjct: 121 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPDYIAP 172
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS 514
           E      ++   D +SFG+++ E+++G   T FY S
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAG--YTPFYDS 206

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 145
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 206 SIDIWSVGCILAEMLSNR 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 128
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 180
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 238
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 239 G--AELLKKISSESA 251

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 312 KLGEGGFGPVYK-GVLADGKEIAVK-----RLSRTS-GQGLQEFKNEVTVIAKLQHKNLV 364
           +LG G F  V K      GKE A K     RLS +  G   +E + EV ++ +++H N++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L      + + +LI E +    L  FL +      L        +K I  G+ YLH   
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK- 134
Query: 425 RLKIIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFGGNQSKANTNRVVGTYGYMAPE 479
             +I H DLK  N+ LLD  + NP+I   DFG+A +I  GN+ K     + GT  ++APE
Sbjct: 135 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPE 188
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                   +++D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 313 LGEGGFGPVY---KGVLADGKEIAVKRLSRTSGQGLQE---FKNEVTVIAKLQHKNLVRL 366
           LG+G FG V+   K   +D +++   ++ + +   +++    K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 E +  LI +++    L   L       + D K  ++    +A  + +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLHS---L 145
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            II+RDLK  N+LLD E + K++DFG+++    ++ KA +    GT  YMAPE       
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 487 SVKSDVFSFGVVLLEIISG 505
           +  +D +SFGV++ E+++G
Sbjct: 204 TQSADWWSFGVLMFEMLTG 222

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++   +H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 208 TKSIDIWSVGCILAEMLSNR 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 152
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 213 SIDIWSVGCILAEMLSNR 230

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 312 KLGEGGFGPVYK-GVLADGKEIAVK-----RLSRTS-GQGLQEFKNEVTVIAKLQHKNLV 364
           +LG G F  V K      GKE A K     RLS +  G   +E + EV ++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L      + + +LI E +    L  FL +      L        +K I  G+ YLH   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK- 127
Query: 425 RLKIIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFGGNQSKANTNRVVGTYGYMAPE 479
             +I H DLK  N+ LLD  + NP+I   DFG+A +I  GN+ K     + GT  ++APE
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPE 181
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                   +++D++S GV+   ++SG
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKR-LSRTSGQGLQ-EFKNEVTVIAKLQHKNL 363
           + +  K+G+G FG V+K      G+++A+K+ L     +G       E+ ++  L+H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 364 VRLLGCCLEENESL--------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           V L+  C  +            L++++  +   D+    S   V+        +++ +  
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG---GNQSKANTNRVVGT 472
           G+ Y+H   R KI+HRD+K +NVL+  +   K++DFG+AR F     +Q     NRVV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 473 YGYMAPEYAMGGI-FSVKSDVFSFGVVLLEI 502
             Y  PE  +G   +    D++  G ++ E+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVT 353
           ++I     DFS    +G GGFG VY    AD GK  A+K L +      QG     NE  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 354 VIAKLQHKN--LVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           +++ +   +   +  +       + L  I + M    L   L  S   V  +   R    
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAA 299
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
           + I  G+ ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F    SK   +  V
Sbjct: 300 E-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASV 351
Query: 471 GTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           GT+GYMAPE    G+ +   +D FS G +L +++ G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVT 353
           ++I     DFS    +G GGFG VY    AD GK  A+K L +      QG     NE  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 354 VIAKLQHKN--LVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           +++ +   +   +  +       + L  I + M    L   L  S   V  +   R    
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAA 299
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
           + I  G+ ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F    SK   +  V
Sbjct: 300 E-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASV 351
Query: 471 GTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           GT+GYMAPE    G+ +   +D FS G +L +++ G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKXQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVT 353
           ++I     DFS    +G GGFG VY    AD GK  A+K L +      QG     NE  
Sbjct: 181 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 240
Query: 354 VIAKLQHKN--LVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           +++ +   +   +  +       + L  I + M    L   L  S   V  +   R    
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAA 298
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
           + I  G+ ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F    SK   +  V
Sbjct: 299 E-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASV 350
Query: 471 GTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           GT+GYMAPE    G+ +   +D FS G +L +++ G
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 285 EESQAFPLFPLDLID--IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTS 341
           E SQ  P F    ++  I +  + +   + +G G +G V        G  +AVK+LSR  
Sbjct: 5   EMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 64
Query: 342 GQGLQEFKN--EVTVIAKLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFD 394
              +   +   E+ ++  ++H+N++ LL        LEE   + +  ++    L+    +
Sbjct: 65  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----N 120
Query: 395 STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
             +  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+A
Sbjct: 121 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 177
Query: 455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYH 513
           R      +       V T  Y APE  +  + ++   D++S G ++ E+++G+  T F  
Sbjct: 178 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPG 230
Query: 514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
           ++H   L   +  +   G  AEL+  +  +S 
Sbjct: 231 TDHIDQLKLILRLVGTPG--AELLKKISSESA 260

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKR-LSRTSGQGLQ-EFKNEVTVIAKLQHKNL 363
           + +  K+G+G FG V+K      G+++A+K+ L     +G       E+ ++  L+H+N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 364 VRLLGCCLEENESL--------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           V L+  C  +            L++++  +   D+    S   V+        +++ +  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG---GNQSKANTNRVVGT 472
           G+ Y+H   R KI+HRD+K +NVL+  +   K++DFG+AR F     +Q     NRVV T
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 191
Query: 473 YGYMAPEYAMGGI-FSVKSDVFSFGVVLLEI 502
             Y  PE  +G   +    D++  G ++ E+
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 313 LGEGGFGPVYKGVLAD-GKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +G+G F  V + +  + G++ AVK     + + + G   ++ K E ++   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL----YLHE 422
           L     +    +++E+M    L    F+  +     +    ++     R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           ++   IIHRD+K  NVLL  + N    K+ DFG+A   G  +S       VGT  +MAPE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPHFMAPE 203
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQH 360
           T ++     +G+G F  V + V L  G E A K ++  + S +  Q+ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N+VRL     EE    L+++ +    L   +       + D       I+ I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHC 119
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           H+   + ++HRDLK  N+LL  +      K++DFG+A    G+Q         GT GY++
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE      +    D+++ GV+L  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 137
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVA 189
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 247
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 248 G--AELLKKISSESA 260

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVT 353
           ++I     DFS    +G GGFG VY    AD GK  A+K L +      QG     NE  
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 354 VIAKLQHKN--LVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           +++ +   +   +  +       + L  I + M    L   L  S   V  +   R    
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAA 299
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
           + I  G+ ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F    SK   +  V
Sbjct: 300 E-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASV 351
Query: 471 GTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           GT+GYMAPE    G+ +   +D FS G +L +++ G
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKR-LSRTSGQGLQ-EFKNEVTVIAKLQHKNL 363
           + +  K+G+G FG V+K      G+++A+K+ L     +G       E+ ++  L+H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 364 VRLLGCCLEENESL--------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           V L+  C  +            L++++  +   D+    S   V+        +++ +  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG---GNQSKANTNRVVGT 472
           G+ Y+H   R KI+HRD+K +NVL+  +   K++DFG+AR F     +Q     NRVV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 473 YGYMAPEYAMGGI-FSVKSDVFSFGVVLLEI 502
             Y  PE  +G   +    D++  G ++ E+
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 128
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVA 180
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 238
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 239 G--AELLKKISSESA 251

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLG 368
           +GEG +G V   Y  V  +   +A+K++S    Q   Q    E+ ++   +H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
                    +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   +
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 147
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFS 487
           +HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +     
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 207
Query: 488 VKS-DVFSFGVVLLEIISGK 506
            KS D++S G +L E++S +
Sbjct: 208 TKSIDIWSVGCILAEMLSNR 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   +   L        +  I RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 138
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 139 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 190
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 248
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 249 G--AELLKKISSESA 261

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 137
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVA 189
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 247
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 248 G--AELLKKISSESA 260

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 279 RNKRKQEESQAFPLFPLDLID--IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVK 335
           R     E SQ  P F    ++  I +  + +   + +G G +G V        G  +AVK
Sbjct: 17  RGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 76
Query: 336 RLSRTSGQGLQEFKN--EVTVIAKLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSL 388
           +LSR     +   +   E+ ++  ++H+N++ LL        LEE   + +  ++    L
Sbjct: 77  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 136
Query: 389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI 448
           +    +  +  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI
Sbjct: 137 N----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 189
Query: 449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKK 507
            DFG+AR      +       V T  Y APE  +  + ++   D++S G ++ E+++G+ 
Sbjct: 190 LDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR- 243
Query: 508 STGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
            T F  ++H   L   +  +   G  AEL+  +  +S 
Sbjct: 244 -TLFPGTDHIDQLKLILRLVGTPG--AELLKKISSESA 278

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 129
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 130 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 181
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 239
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 240 G--AELLKKISSESA 252

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 128
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 180
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 238
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 239 G--AELLKKISSESA 251

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 7/198 (3%)
Query: 313 LGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGL-QEFKNEVTVIAKLQHKNLVRLLGCC 370
           +GEG +G V        K  +A++++S    Q   Q    E+ ++ + +H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIH 430
                  +   Y+    ++  L+   ++  L        +  I RG+ Y+H  +   ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLH 151
Query: 431 RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN-TNRVVGTYGYMAPEYAMGGIFSVK 489
           RDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  +      K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 490 S-DVFSFGVVLLEIISGK 506
           S D++S G +L E++S +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 25/242 (10%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIAKLQHKNLVRLLGC 369
           +G G +G V        G  +AVK+LSR     +   +   E+ ++  ++H+N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 370 -----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
                 LEE   + +  ++    L+    +  +  +L       +I  I RG+ Y+H   
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 153
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              IIHRDLK SN+ ++ +   KI DFG+AR      +       V T  Y APE  +  
Sbjct: 154 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNW 207
Query: 485 I-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
           + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   G  AEL+  +  +
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTPG--AELLKKISSE 263
Query: 544 SC 545
           S 
Sbjct: 264 SA 265

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
            +LG+G F  V + V +  G+E A K ++  + S +  Q+ + E  +   L+H N+VRL 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               EE    LI++ +    L   +       + D       I+ I   +L+ H+   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQILEAVLHCHQ---MG 141
Query: 428 IIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           ++HRDLK  N+LL  ++     K++DFG+A    G Q         GT GY++PE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKD 199
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +    D+++ GV+L  ++ G
Sbjct: 200 PYGKPVDLWACGVILYILLVG 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 129
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 130 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 181
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 239
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 240 G--AELLKKISSESA 252

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
           +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G  + EN   +I E      L  FL    R   LD    I     ++  + YL      +
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            +HRD+   NVL+      K+ DFG++R        KA+  ++     +MAPE      F
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 487 SVKSDVFSFGVVLLEII 503
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 130
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 131 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 182
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 240
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 241 G--AELLKKISSESA 253

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHK 361
           + + +  K+GEG +G V+K    D G+ +A+K+   +    +  +    E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR---ISIIKGIA---- 414
           NLV LL     +    L++EY           D T   +LD  +R     ++K I     
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC----------DHTVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           + + + H+ +    IHRD+K  N+L+      K+ DFG AR+  G     +    V T  
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRW 167
Query: 475 YMAPEYAMGGI-FSVKSDVFSFGVVLLEIISG 505
           Y +PE  +G   +    DV++ G V  E++SG
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 282 RKQEESQAFPLFPLDLID--IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS 338
           R    SQ  P F    ++  I +  + +   + +G G +G V        G  +AVK+LS
Sbjct: 16  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS 75
Query: 339 RTSGQGLQEFKN--EVTVIAKLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVF 391
           R     +   +   E+ ++  ++H+N++ LL        LEE   + +  ++    L+  
Sbjct: 76  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-- 133
Query: 392 LFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF 451
             +  +  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DF
Sbjct: 134 --NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 188
Query: 452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTG 510
           G+AR      +       V T  Y APE  +  + ++   D++S G ++ E+++G+  T 
Sbjct: 189 GLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TL 241
Query: 511 FYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
           F  ++H   L   +  +   G  AEL+  +  +S 
Sbjct: 242 FPGTDHIDQLKLILRLVGTPG--AELLKKISSESA 274

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 313 LGEGGFGPVY---KGVLADGKEIAVKRLSRTSGQGLQE---FKNEVTVIAKLQHKNLVRL 366
           LG+G FG V+   K   +D +++   ++ + +   +++    K E  ++ ++ H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 E +  LI +++    L   L       + D K  ++    +A  + +LH    L
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLHS---L 146
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            II+RDLK  N+LLD E + K++DFG+++    ++ KA +    GT  YMAPE       
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 204
Query: 487 SVKSDVFSFGVVLLEIISG 505
           +  +D +SFGV++ E+++G
Sbjct: 205 TQSADWWSFGVLMFEMLTG 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 224
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKXQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 104
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 165 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 218
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 313 LGEGGFGPVY---KGVLADGKEIAVKRLSRTSGQGLQE---FKNEVTVIAKLQHKNLVRL 366
           LG+G FG V+   K   +D +++   ++ + +   +++    K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
                 E +  LI +++    L   L       + D K  ++    +A  + +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDHLHS---L 145
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            II+RDLK  N+LLD E + K++DFG+++    ++ KA +    GT  YMAPE       
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 487 SVKSDVFSFGVVLLEIISG 505
           +  +D +SFGV++ E+++G
Sbjct: 204 TQSADWWSFGVLMFEMLTG 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 152
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 153 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 204
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 262
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 263 G--AELLKKISSESA 275

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 311 NKLGEGGFGPVYK-GVLADGKEIAVK----RLSRTSGQGL--QEFKNEVTVIAKLQHKNL 363
            +LG G F  V K    + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           + L        + +LI E +    L  FL    +   L  +   S IK I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSKANTNRVVGTYGYMAP 478
              KI H DLK  N++L  +  P    K+ DFG+A  I  G + K     + GT  ++AP
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAP 187
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 139
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 191
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 249
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 250 G--AELLKKISSESA 262

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 84
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 145 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 198
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 199 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 139
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVA 191
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 249
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 250 G--AELLKKISSESA 262

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 285 EESQAFPLFPLDLID--IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTS 341
           E SQ  P F    ++  I +  + +   + +G G +G V        G  +AVK+LSR  
Sbjct: 6   EMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 65
Query: 342 GQGLQEFKN--EVTVIAKLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFD 394
              +   +   E+ ++  ++H+N++ LL        LEE   + +  ++    L+    +
Sbjct: 66  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----N 121
Query: 395 STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
             +  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+A
Sbjct: 122 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 178
Query: 455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYH 513
           R      +       V T  Y APE  +  + ++   D++S G ++ E+++G+  T F  
Sbjct: 179 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPG 231
Query: 514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
           ++H   L   +  +   G  AEL+  +  +S 
Sbjct: 232 TDHIDQLKLILRLVGTPG--AELLKKISSESA 261

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 139
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVA 191
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 249
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 250 G--AELLKKISSESA 262

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 139
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVA 191
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 249
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 250 G--AELLKKISSESA 262

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 137
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 189
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 247
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 248 G--AELLKKISSESA 260

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 81
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 142 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 195
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 196 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)
Query: 285 EESQAFPLFPLDLID--IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTS 341
           E SQ  P F    ++  I +  + +   + +G G +G V        G  +AVK+LSR  
Sbjct: 6   EMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 65
Query: 342 GQGLQEFKN--EVTVIAKLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFD 394
              +   +   E+ ++  ++H+N++ LL        LEE   + +  ++    L+    +
Sbjct: 66  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----N 121
Query: 395 STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
             +  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+A
Sbjct: 122 IVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLA 178
Query: 455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYH 513
           R      +       V T  Y APE  +  + ++   D++S G ++ E+++G+  T F  
Sbjct: 179 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPG 231
Query: 514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
           ++H   L   +  +   G  AEL+  +  +S 
Sbjct: 232 TDHIDQLKLILRLVGTPG--AELLKKISSESA 261

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 131
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 132 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 183
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 241
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 242 G--AELLKKISSESA 254

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 143
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 144 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVA 195
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 253
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 254 G--AELLKKISSESA 266

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 171 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 224
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 149 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 202
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 112
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 173 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 226
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 134
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 135 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 186
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 244
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 245 G--AELLKKISSESA 257

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 149 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 202
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 95
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 156 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 209
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 210 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 77
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 138 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 191
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 192 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 152
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 153 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGXVA 204
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 262
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 263 G--AELLKKISSESA 275

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 133 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 134
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 135 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 186
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 244
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 245 G--AELLKKISSESA 257

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLL 367
           LG G F  V   +LA+ K     +A+K +++ + +G +   +NE+ V+ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 428 IIHRDLKTSNVL---LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+L   LD +    ISDFG++++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 134
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 135 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVA 186
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 244
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 245 G--AELLKKISSESA 257

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 134
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 135 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 186
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 244
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 245 G--AELLKKISSESA 257

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIA--VKRLSRTSGQGLQEFKNEVTV 354
           I   + T+++    +LG+G F  V + V +  G+E A  +    + S +  Q+ + E  +
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
              L+H N+VRL     EE    LI++ +    L   +       + D       I+ I 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQQIL 120
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVG 471
             +L+ H+   + ++HR+LK  N+LL  ++     K++DFG+A    G Q         G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           T GY++PE      +    D+++ GV+L  ++ G
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G +G V   +    G+++A+K+LSR     +  +    E+ ++  +QH+N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 370 CLEENESLLIYEY---MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
               +     Y++   MP    D+        ++   ++   ++  + +G+ Y+H     
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG-- 146
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI- 485
            ++HRDLK  N+ ++ +   KI DFG+AR      + A     V T  Y APE  +  + 
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           ++   D++S G ++ E+++GK
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +S +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKSQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+ R      +       V 
Sbjct: 133 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 114
Query: 365 RLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL       G   +E    L+ +Y+P     V    S     L        +  + R + 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 175 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 228
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 138
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 139 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 190
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 248
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 249 G--AELLKKISSESA 261

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 80
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 141 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YRA 194
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 89
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 150 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 203
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 204 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLL 367
           LG G F  V   +LA+ K     +A+K +++ + +G +   +NE+ V+ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 428 IIHRDLKTSNVL---LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+L   LD +    ISDFG++++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 190
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 155
Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +   Y Y A
Sbjct: 216 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRA 269
Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
           PE   G   ++   DV+S G VL E++ G+
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLL 367
           LG G F  V   +LA+ K     +A+K +++ + +G +   +NE+ V+ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 428 IIHRDLKTSNVL---LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+L   LD +    ISDFG++++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 144
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 145 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 196
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 254
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 255 G--AELLKKISSESA 267

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 313 LGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQ-EFKNEVTVIAKLQHKNLVRLL 367
           LG G F  V   +LA+ K     +A+K +++ + +G +   +NE+ V+ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
                     LI + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 428 IIHRDLKTSNVL---LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           I+HRDLK  N+L   LD +    ISDFG++++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 485 IFSVKSDVFSFGVVLLEIISG 505
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 144
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 145 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 196
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 254
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 255 G--AELLKKISSESA 267

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G +G V   +    G+++A+K+LSR     +  +    E+ ++  +QH+N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 370 CLEENESLLIYEY---MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
               +     Y++   MP    D+        ++   ++   ++  + +G+ Y+H     
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDL---QKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG-- 164
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI- 485
            ++HRDLK  N+ ++ +   KI DFG+AR      + A     V T  Y APE  +  + 
Sbjct: 165 -VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 486 FSVKSDVFSFGVVLLEIISGK 506
           ++   D++S G ++ E+++GK
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 143
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 144 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 195
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 253
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 254 G--AELLKKISSESA 266

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 312 KLGEGGFGPVYK-GVLADGKEIAVK-----RL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +LG G F  V K      GKE A K     RL S   G   +E + EV ++ +++H N++
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L      + + +LI E +    L  FL +      L        +K I  G+ YLH   
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK- 148
Query: 425 RLKIIHRDLKTSNV-LLDHEM-NPKIS--DFGMA-RIFGGNQSKANTNRVVGTYGYMAPE 479
             +I H DLK  N+ LLD  + NP+I   DFG+A +I  GN+ K     + GT  ++APE
Sbjct: 149 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPE 202
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                   +++D++S GV+   ++SG
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +ARG+ +L   S  K IHRDL   N+LL      KI DFG+AR    N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             +MAPE     I+S KSDV+S+GV+L EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 155
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 156 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGYVA 207
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 265
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 266 G--AELLKKISSESA 278

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 282 RKQEESQAFPLFPLDLID--IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS 338
           R    SQ  P F    ++  I +  + +   + +G G +G V        G  +AVK+LS
Sbjct: 16  RGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 75
Query: 339 RTSGQGLQEFKN--EVTVIAKLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVF 391
           R     +   +   E+ ++  ++H+N++ LL        LEE   + +  ++    L+  
Sbjct: 76  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-- 133
Query: 392 LFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF 451
             +  +  +L       +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DF
Sbjct: 134 --NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 188
Query: 452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTG 510
           G+AR      +       V T  Y APE  +  + ++   D++S G ++ E+++G+  T 
Sbjct: 189 GLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TL 241
Query: 511 FYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
           F  ++H   L   +  +   G  AEL+  +  +S 
Sbjct: 242 FPGTDHIDQLKLILRLVGTPG--AELLKKISSESA 274

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE 372
           +G+G +G V++G L  G+ +AVK  S    Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 373 ENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED----- 423
              S     LI  Y  + SL  FL   T    L  +  +S   G+A    +LH +     
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLA----HLHVEIFGTQ 129
Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPEYA 481
            +  I HRD K+ NVL+   +   I+D G+A +   G +      N  VGT  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 482 MGGIFS------VKSDVFSFGVVLLEI 502
              I +        +D+++FG+VL EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 152
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 153 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 204
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 262
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 263 G--AELLKKISSESA 275

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKN 362
           F Q   LG+GGFG V    V A GK  A K+L +   +   G     NE  ++ K+  + 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L      ++   L+   M    L   ++   ++      R +     I  G+  LH 
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLH- 303
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYA 481
             R +I++RDLK  N+LLD   + +ISD G+A  +  G   K      VGT GYMAPE  
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVV 357
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
               ++   D ++ G +L E+I+G+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
            ++G+G +G V+ G    G+++AVK +  T+ +     + E+     ++H+N++  +   
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 371 LEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED--- 423
           ++   S     LI +Y  N SL    +D  +S  LD K  + +      G+ +LH +   
Sbjct: 101 IKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 424 --SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAPE 479
              +  I HRDLK+ N+L+       I+D G+A  F    N+     N  VGT  YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 480 YAMGGIFS------VKSDVFSFGVVLLEI 502
                +        + +D++SFG++L E+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI--AVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
           Q ++ EN +G G +G V K  +  G  I  A K++ +   + +  FK E+ ++  L H N
Sbjct: 9   QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           ++RL     +  +  L+ E      L   +       + D  R   I+K +   + Y H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 123
Query: 423 DSRLKIIHRDLKTSNVLL--DHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
             +L + HRDLK  N L   D   +P K+ DFG+A  F   +        VGT  Y++P+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 178
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
             + G++  + D +S GV++  ++ G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 311 NKLGEGGFGPVYK-GVLADGKEIAVK----RLSRTSGQGL--QEFKNEVTVIAKLQHKNL 363
            +LG G F  V K    + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           + L        + +LI E +    L  FL    +   L  +   S IK I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSKANTNRVVGTYGYMAP 478
              KI H DLK  N++L  +  P    K+ DFG+A  I  G + K     + GT  ++AP
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAP 187
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 313 LGEGGFGPV---YKGVLADGKEIAVKRLSRTSGQGLQEFKN--EVTVIAKLQHKNLVRLL 367
           +G G +G V   Y   L   +++AVK+LSR     +   +   E+ ++  L+H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 368 -----GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
                   +E+   +    Y+    +   L +  +S  L  +    ++  + RG+ Y+H 
Sbjct: 94  DVFTPATSIEDFSEV----YLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
                IIHRDLK SNV ++ +   +I DFG+AR     Q+       V T  Y APE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIML 201
Query: 483 GGI-FSVKSDVFSFGVVLLEIISGK 506
             + ++   D++S G ++ E++ GK
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 311 NKLGEGGFGPVYK-GVLADGKEIAVK----RLSRTSGQGL--QEFKNEVTVIAKLQHKNL 363
            +LG G F  V K    + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           + L        + +LI E +    L  FL    +   L  +   S IK I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSKANTNRVVGTYGYMAP 478
              KI H DLK  N++L  +  P    K+ DFG+A  I  G + K     + GT  ++AP
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAP 187
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 311 NKLGEGGFGPVYK-GVLADGKEIAVK----RLSRTSGQGL--QEFKNEVTVIAKLQHKNL 363
            +LG G F  V K    + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           + L        + +LI E +    L  FL    +   L  +   S IK I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSKANTNRVVGTYGYMAP 478
              KI H DLK  N++L  +  P    K+ DFG+A  I  G + K     + GT  ++AP
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAP 187
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI--AVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
           Q ++ EN +G G +G V K  +  G  I  A K++ +   + +  FK E+ ++  L H N
Sbjct: 26  QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           ++RL     +  +  L+ E      L   +       + D  R   I+K +   + Y H 
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 140
Query: 423 DSRLKIIHRDLKTSNVLL--DHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
             +L + HRDLK  N L   D   +P K+ DFG+A  F   +        VGT  Y++P+
Sbjct: 141 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 195
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
             + G++  + D +S GV++  ++ G
Sbjct: 196 -VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 307 FSQENKLGEGGFGPVYK-GVLADGKEIAVKRLSRTSGQ---GLQEFKNEVTVIAKLQHKN 362
           F Q   LG+GGFG V    V A GK  A K+L +   +   G     NE  ++ K+  + 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L      ++   L+   M    L   ++   ++      R +     I  G+  LH 
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLH- 303
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-RIFGGNQSKANTNRVVGTYGYMAPEYA 481
             R +I++RDLK  N+LLD   + +ISD G+A  +  G   K      VGT GYMAPE  
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVV 357
Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
               ++   D ++ G +L E+I+G+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 311 NKLGEGGFGPVYK-GVLADGKEIAVK----RLSRTSGQGL--QEFKNEVTVIAKLQHKNL 363
            +LG G F  V K    + G E A K    R SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           + L        + +LI E +    L  FL    +   L  +   S IK I  G+ YLH  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 424 SRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSKANTNRVVGTYGYMAP 478
              KI H DLK  N++L  +  P    K+ DFG+A  I  G + K     + GT  ++AP
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAP 187
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE 372
           LG G FG V++ V    K+  + +  +  G      K E++++   +H+N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRD 432
             E ++I+E++    LD+F   +T + +L+ +  +S +  +   + +LH  +   I H D
Sbjct: 73  MEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 433 LKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTN-RVVGTY-GYMAPEYAMGGIFSV 488
           ++  N++     +   KI +FG AR     Q K   N R++ T   Y APE     + S 
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQAR-----QLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 489 KSDVFSFGVVLLEIISG 505
            +D++S G ++  ++SG
Sbjct: 183 ATDMWSLGTLVYVLLSG 199

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNE 351
            P    D+ K T +      LGEG +  V   V L +GKE AVK + + +G        E
Sbjct: 6   LPGKFEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFRE 60
Query: 352 VTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           V  + + Q +KN++ L+    ++    L++E +   S+   L    +    + +    ++
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVV 117
Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNP-KISDFGMARIFGGNQS----- 462
           + +A  + +LH      I HRDLK  N+L +   +++P KI DF +      N S     
Sbjct: 118 RDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 463 KANTNRVVGTYGYMAPEYA-----MGGIFSVKSDVFSFGVVLLEIISG 505
                   G+  YMAPE           +  + D++S GVVL  ++SG
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI D+G+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 311 NKLGEGGFGPVYK------GVLADGKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHKN 362
            +LG G F  V K      G+    K I  KR SR S +G+  +E + EV+++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           ++ L        + +LI E +    L  FL    +   L  +   S IK I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMA-RIFGGNQSKANTNRVVGTYGYMA 477
               KI H DLK  N++L  +  P    K+ DFG+A  I  G + K     + GT  ++A
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT-SGQGLQEFKNEVTV-IAK 357
           VKA  D     +LG G +G V K   +  G+ +AVKR+  T + Q  +    ++ + +  
Sbjct: 4   VKA-DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVF---LFDSTRSVQLDWKRRISIIKGIA 414
           +     V   G    E +  +  E M + SLD F   + D  +++  D   +I++   I 
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIV 119
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           + + +LH  S+L +IHRD+K SNVL++     K+ DFG++     + +K   +   G   
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKP 174
Query: 475 YMAPEYAMGGI----FSVKSDVFSFGVVLLEI 502
           YMAPE     +    +SVKSD++S G+ ++E+
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 313 LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLVRLLGCCL 371
           +G G FG V++  L +  E+A+K++ +      + FKN E+ ++  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 372 EENESL------LIYEYMPNKSLDVFLFDSTRS-VQLDWKRRISIIK----GIARGILYL 420
              +        L+ EY+P       ++ ++R   +L     + +IK     + R + Y+
Sbjct: 103 SNGDKKDEVFLNLVLEYVPET-----VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           H    + I HRD+K  N+LLD      K+ DFG A+I    +   N + +   Y Y APE
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY-YRAPE 211
Query: 480 YAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
              G   ++   D++S G V+ E++ G+     +  E G   L  I K+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQP---LFPGESGIDQLVEIIKV 257

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT-SGQGLQEFKNEVTV-IAK 357
           VKA  D     +LG G +G V K   +  G+ +AVKR+  T + Q  +    ++ + +  
Sbjct: 48  VKA-DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 106
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVF---LFDSTRSVQLDWKRRISIIKGIA 414
           +     V   G    E +  +  E M + SLD F   + D  +++  D   +I++   I 
Sbjct: 107 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIV 163
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           + + +LH  S+L +IHRD+K SNVL++     K+ DFG++     + +K       G   
Sbjct: 164 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID---AGCKP 218
Query: 475 YMAPEYAMGGI----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           YMAPE     +    +SVKSD++S G+ ++E+                ++L + +  W  
Sbjct: 219 YMAPERINPELNQKGYSVKSDIWSLGITMIEL----------------AILRFPYDSW-- 260
Query: 531 GHAAELMDSVVKQSCDQAELLK----YIHIGLLCVQGDPIDRPT 570
           G   + +  VV++   Q    K    ++     C++ +  +RPT
Sbjct: 261 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 304

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 309 QENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRL 366
           QE+ LGEG    V   + L   +E AVK + +  G        EV ++ + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           +    EE+   L++E M   S+   +       +L+      +++ +A  + +LH     
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG-- 131
Query: 427 KIIHRDLKTSNVLLDH--EMNP-KISDFGMAR--IFGGNQSKANTNRVV---GTYGYMAP 478
            I HRDLK  N+L +H  +++P KI DFG+       G+ S  +T  ++   G+  YMAP
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 479 EYA-----MGGIFSVKSDVFSFGVVLLEIISG 505
           E          I+  + D++S GV+L  ++SG
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LS+     +   +   E+ ++ 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 144
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +       V 
Sbjct: 145 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVA 196
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 254
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 255 G--AELLKKISSESA 267

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK 349
           P + +D VK T DF+    LG+G FG V   +LAD K      A+K L +     +Q+  
Sbjct: 9   PSNNLDRVKLT-DFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVV--IQDDD 62
Query: 350 NEVTVIAK-----LQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDW 403
            E T++ K     L     +  L  C +  + L  + EY+    L   ++   +  +   
Sbjct: 63  VECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKE 119
Query: 404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK 463
            + +     I+ G+ +LH   +  II+RDLK  NV+LD E + KI+DFGM +        
Sbjct: 120 PQAVFYAAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDG 174
Query: 464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             T    GT  Y+APE      +    D +++GV+L E+++G+
Sbjct: 175 VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 313 LGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQEFKN--EVTVIAKLQHKNLVRLL-- 367
           +G G +G V     A  ++ +AVK+LSR     +   +   E+ ++  L+H+N++ LL  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 368 ---GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
                 +E+   +    Y+    +   L +  +   L  +    ++  + RG+ Y+H   
Sbjct: 88  FTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 143
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              IIHRDLK SNV ++ +   +I DFG+AR     Q+       V T  Y APE  +  
Sbjct: 144 ---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 195
Query: 485 I-FSVKSDVFSFGVVLLEIISGK 506
           + ++   D++S G ++ E++ GK
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 117/255 (45%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI DF +AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 313 LGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQEFKN--EVTVIAKLQHKNLVRLL-- 367
           +G G +G V     A  ++ +AVK+LSR     +   +   E+ ++  L+H+N++ LL  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 368 ---GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
                 +E+   +    Y+    +   L +  +   L  +    ++  + RG+ Y+H   
Sbjct: 96  FTPATSIEDFSEV----YLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
              IIHRDLK SNV ++ +   +I DFG+AR     Q+       V T  Y APE  +  
Sbjct: 152 ---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203
Query: 485 I-FSVKSDVFSFGVVLLEIISGK 506
           + ++   D++S G ++ E++ GK
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 311 NKLGEGGFGPV--YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
            KLGEGGF  V   +G L DG   A+KR+     Q  +E + E  +     H N++RL+ 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 369 CCLEE----NESLLIYEYMPNKSLDVFLFDSTRSVQ-----LDWKRRISIIKGIARGILY 419
            CL E    +E+ L+  +    +    L++    ++     L   + + ++ GI RG+  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGT----LWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-----RIFGGNQSKANTNRVVG--T 472
           +H        HRDLK +N+LL  E  P + D G        + G  Q+    +      T
Sbjct: 150 IHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 473 YGYMAPEYAMGGIFSVKS--------DVFSFGVVLLEIISGK 506
             Y APE     +FSV+S        DV+S G VL  ++ G+
Sbjct: 207 ISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 117/255 (45%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI  FG+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 107/234 (45%), Gaps = 26/234 (11%)
Query: 304 TQDFSQENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTVI 355
            +D      LG+G F  ++KGV  +          E+ +K L +      + F    +++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           +KL HK+LV   G C+  +E++L+ E++   SLD +L  +   + + WK  + + K +A 
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAA 124
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTY 473
            + +L E++   +IH ++   N+LL  E + K  +    ++   G + +    + +    
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 474 GYMAPE-YAMGGIFSVKSDVFSFGVVLLEIISG----------KKSTGFYHSEH 516
            ++ PE        ++ +D +SFG  L EI SG          ++   FY   H
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 304 TQDFSQENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTVI 355
            +D      LG+G F  ++KGV  +          E+ +K L +      + F    +++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           +KL HK+LV   G C   +E++L+ E++   SLD +L  +   + + WK  + + K +A 
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAW 124
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTY 473
            + +L E++   +IH ++   N+LL  E + K  +    ++   G + +    + +    
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 474 GYMAPE-YAMGGIFSVKSDVFSFGVVLLEIISG----------KKSTGFYHSEH 516
            ++ PE        ++ +D +SFG  L EI SG          ++   FY   H
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 117/255 (45%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI D G+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 72/267 (26%)
Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNL 363
           DF     +G GGFG V++     D    A+KR+   + +  +E    EV  +AKL+H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 364 VRLLGCCL--------EENESLLIYEYMPN----------------KSLDVF-------- 391
           VR     L        EE + + + +   +                + +D F        
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 392 LFDSTRSVQL-------------DWKRR------------ISIIKGIARGILYLHEDSRL 426
           L  S+  V L             DW  R            + I   IA  + +LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK----------ANTNRVVGTYGYM 476
            ++HRDLK SN+    +   K+ DFG+      ++ +          A     VGT  YM
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYM 243
Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEII 503
           +PE   G  +S K D+FS G++L E++
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSR--------TSGQGLQEFKNEVTV 354
           +Q +S  + LG G FG V+  V  +  KE+ VK + +             L +   E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +++++H N++++L     +    L+ E      LD+F F   R  +LD      I + + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAF-IDRHPRLDEPLASYIFRQLV 140
Query: 415 RGILYLHEDSRLK-IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
             + YL    RLK IIHRD+K  N+++  +   K+ DFG A      +         GT 
Sbjct: 141 SAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTI 193
Query: 474 GYMAPEYAMGGIF-SVKSDVFSFGVVLLEII 503
            Y APE  MG  +   + +++S GV L  ++
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 117/255 (45%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI D G+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 309 QENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRL 366
           QE+ LGEG    V   + L   +E AVK + +  G        EV ++ + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
           +    EE+   L++E M   S+   +       +L+      +++ +A  + +LH     
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNKG-- 131
Query: 427 KIIHRDLKTSNVLLDH--EMNP-KISDF--GMARIFGGNQSKANTNRVV---GTYGYMAP 478
            I HRDLK  N+L +H  +++P KI DF  G      G+ S  +T  ++   G+  YMAP
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 479 EYA-----MGGIFSVKSDVFSFGVVLLEIISG 505
           E          I+  + D++S GV+L  ++SG
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 313 LGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN---EVTVIAKLQHKNLVRLLG 368
           +G+G FG V      D K++ A+K +++       E +N   E+ ++  L+H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +E +  ++ + +    L   L    ++V    +     I  +   + YL      +I
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYLQNQ---RI 136
Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY---AMGGI 485
           IHRD+K  N+LLD   +  I+DF +A +      +     + GT  YMAPE      G  
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYH 513
           +S   D +S GV   E++ G++    YH
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRP---YH 218

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 117/255 (45%), Gaps = 25/255 (9%)
Query: 300 IVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--EVTVIA 356
           I +  + +   + +G G +G V        G  +AVK+LSR     +   +   E+ ++ 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 357 KLQHKNLVRLLGC-----CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
            ++H+N++ LL        LEE   + +  ++    L+    +  +  +L       +I 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIY 132
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I RG+ Y+H      IIHRDLK SN+ ++ +   KI D G+AR      +       V 
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGYVA 184
Query: 472 TYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           T  Y APE  +  + ++   D++S G ++ E+++G+  T F  ++H   L   +  +   
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQLKLILRLVGTP 242
Query: 531 GHAAELMDSVVKQSC 545
           G  AEL+  +  +S 
Sbjct: 243 G--AELLKKISSESA 255

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE     +++++SDV+SFGV+L EI S   S         P     I + +C   
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---------PYPGVKIDEEFCR-- 312
Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
              L +    ++ D      Y    L C  G+P  RPT S +   L +
Sbjct: 313 --RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGN 357

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE     +++++SDV+SFGV+L EI S   S         P     I + +C   
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---------PYPGVKIDEEFCR-- 314
Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
              L +    ++ D      Y    L C  G+P  RPT S +   L +
Sbjct: 315 --RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGN 359

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 307 FSQENKLGEGGFGPVY--KGVLADGKEIAVKRLSR-----TSGQGLQEFKNEVTVIAKLQ 359
           + +  KLG G +G V   K  L  G E A+K + +     TS  G     +EV V+ +L 
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQLD 79
Query: 360 HKNLVRLLGCCLEENESLLIYE-YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           H N+++L     ++    L+ E Y   +  D  +     S ++D      I+K +  G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS-EVD---AAVIMKQVLSGTT 135
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGY 475
           YLH+ +   I+HRDLK  N+LL+ +      KI DFG++  F   +        +GT  Y
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYY 189
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           +APE  +   +  K DV+S GV+L  ++ G
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE     +++++SDV+SFGV+L EI S   S         P     I + +C   
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---------PYPGVKIDEEFCR-- 307
Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
              L +    ++ D      Y    L C  G+P  RPT S +   L +
Sbjct: 308 --RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGN 352

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE     +++++SDV+SFGV+L EI S   S         P     I + +C   
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---------PYPGVKIDEEFCR-- 305
Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
              L +    ++ D      Y    L C  G+P  RPT S +   L +
Sbjct: 306 --RLKEGTRMRAPDYTTPEMY-QTMLDCWHGEPSQRPTFSELVEHLGN 350

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +  +G+G FG V++G    G+E+AVK  S R      +E +   TV+  L+H+N++  + 
Sbjct: 9   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIA 65
Query: 369 CCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A G+ +LH + 
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 121
Query: 424 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVGTYG 474
                +  I HRDLK+ N+L+       I+D G+A     + S  +T     N  VGT  
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKR 178
Query: 475 YMAPEYA-----MGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEH 516
           YMAPE       M    S K +D+++ G+V  E I+ + S G  H ++
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 225

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQH 360
           T D+    +LG+G F  V + V     +E A K ++  + S +  Q+ + E  +   L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N+VRL     EE    L+++ +    L   +       + D       I  I   + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIHQILESVNHI 146
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           H+     I+HRDLK  N+LL  +      K++DFG+A    G Q         GT GY++
Sbjct: 147 HQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLS 201
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE      +    D+++ GV+L  ++ G
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +  +G+G FG V++G    G+E+AVK  S R      +E +   TV+  L+H+N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIA 64
Query: 369 CCLEEN----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
              ++N    +  L+ +Y  + SL  +L   T +V+      I +    A G+ +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 120
Query: 424 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVGTYG 474
                +  I HRDLK+ N+L+       I+D G+A     + S  +T     N  VGT  
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKR 177
Query: 475 YMAPEYA-----MGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEH 516
           YMAPE       M    S K +D+++ G+V  E I+ + S G  H ++
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE---IAVKRLSRTSGQGLQE-FK 349
           P+DL  I+  +  +     +G G FG     ++ D +    +AVK + R  G+ + E  K
Sbjct: 9   PMDL-PIMHDSDRYELVKDIGAGNFG--VARLMRDKQANELVAVKYIER--GEKIDENVK 63
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            E+     L+H N+VR     L      ++ EY     L   + ++ R  + + +     
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FF 120
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTN 467
            + +  G+ Y H    +++ HRDLK  N LLD    P  KI+DFG ++    +   +   
Sbjct: 121 FQQLISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPK 174
Query: 468 RVVGTYGYMAPEYAMGGIFSVK-SDVFSFGVVLLEIISG 505
             VGT  Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 175 SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQH 360
           + DF  ++ LGEG +G V        G+ +A+K++         L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 361 KNLVRLLGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           +N++ +      +     NE  +I E M     D+    ST+ +  D  +    I    R
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQ--YFIYQTLR 123
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--------KANTN 467
            +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   + +        ++   
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 468 RVVGTYGYMAPEYAM-GGIFSVKSDVFSFGVVLLEI 502
             V T  Y APE  +    +S   DV+S G +L E+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 307 FSQENKLGEGGFGPVY--KGVLADGKEIAVKRLSR-----TSGQGLQEFKNEVTVIAKLQ 359
           + +  KLG G +G V   K  L  G E A+K + +     TS  G     +EV V+ +L 
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQLD 62
Query: 360 HKNLVRLLGCCLEENESLLIYE-YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           H N+++L     ++    L+ E Y   +  D  +     S ++D      I+K +  G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS-EVD---AAVIMKQVLSGTT 118
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIF--GGNQSKANTNRVVGTY 473
           YLH+ +   I+HRDLK  N+LL+ +      KI DFG++  F  GG   +      +GT 
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-----LGTA 170
Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
            Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQH 360
           + DF  ++ LGEG +G V        G+ +A+K++         L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 361 KNLVRLLGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           +N++ +      +     NE  +I E M     D+    ST+ +  D  +    I    R
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQ--YFIYQTLR 123
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--------KANTN 467
            +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   + +        ++   
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 468 RVVGTYGYMAPEYAM-GGIFSVKSDVFSFGVVLLEI 502
             V T  Y APE  +    +S   DV+S G +L E+
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQH 360
           T ++    +LG+G F  V + + +  G+E A K ++  + S +  Q+ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N+VRL     EE    L+++ +    L   +       + D       I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESVNHC 119
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           H +    I+HRDLK  N+LL  +      K++DFG+A    G+Q         GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE      +    D+++ GV+L  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +  +G+G FG V++G    G+E+AVK  S R      +E +   TV+  L+H+N++  + 
Sbjct: 34  QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIA 90
Query: 369 CCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A G+ +LH + 
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 146
Query: 424 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVGTYG 474
                +  I HRDLK+ N+L+       I+D G+A     + S  +T     N  VGT  
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKR 203
Query: 475 YMAPEYA-----MGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEH 516
           YMAPE       M    S K +D+++ G+V  E I+ + S G  H ++
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 250

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +  +G+G FG V++G    G+E+AVK  S R      +E +   TV+  L+H+N++  + 
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIA 103
Query: 369 CCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A G+ +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 159
Query: 424 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVGTYG 474
                +  I HRDLK+ N+L+       I+D G+A     + S  +T     N  VGT  
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKR 216
Query: 475 YMAPEYA-----MGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEH 516
           YMAPE       M    S K +D+++ G+V  E I+ + S G  H ++
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 263

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +  +G+G FG V++G    G+E+AVK  S R      +E +   TV+  L+H+N++  + 
Sbjct: 11  QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIA 67
Query: 369 CCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A G+ +LH + 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 123
Query: 424 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVGTYG 474
                +  I HRDLK+ N+L+       I+D G+A     + S  +T     N  VGT  
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKR 180
Query: 475 YMAPEYA-----MGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEH 516
           YMAPE       M    S K +D+++ G+V  E I+ + S G  H ++
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 227

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQH 360
           T ++    +LG+G F  V + + +  G+E A K ++  + S +  Q+ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N+VRL     EE    L+++ +    L   +       + D       I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESVNHC 119
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           H +    I+HRDLK  N+LL  +      K++DFG+A    G+Q         GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE      +    D+++ GV+L  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           +  +G+G FG V++G    G+E+AVK  S R      +E +   TV+  L+H+N++  + 
Sbjct: 14  QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIA 70
Query: 369 CCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED- 423
              ++N +     L+ +Y  + SL  +L   T +V+      I +    A G+ +LH + 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEI 126
Query: 424 ----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVGTYG 474
                +  I HRDLK+ N+L+       I+D G+A     + S  +T     N  VGT  
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKR 183
Query: 475 YMAPEYA-----MGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEH 516
           YMAPE       M    S K +D+++ G+V  E I+ + S G  H ++
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 230

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQH 360
           + DF  ++ LGEG +G V        G+ +A+K++         L+  + E+ ++   +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 361 KNLVRLLGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           +N++ +      +     NE  +I E M     D+    ST+ +  D  +    I    R
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQ--YFIYQTLR 123
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG---- 471
            +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   ++S A+ +   G    
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSG 178
Query: 472 ------TYGYMAPEYAM-GGIFSVKSDVFSFGVVLLEI 502
                 T  Y APE  +    +S   DV+S G +L E+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 313 LGEGGFGPVY---KGVLAD-GKEIAVKRLSRT----SGQGLQEFKNEVTVIAKLQHKNLV 364
           LG+GG+G V+   K   A+ GK  A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 365 RLLGCCLEENESLLIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIIKGIARGI 417
            L+       +  LI EY+    L        +F+ D+              +  I+  +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYLAEISMAL 134
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGY 475
            +LH+     II+RDLK  N++L+H+ + K++DFG+ +  I  G      T+   GT  Y
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THXFCGTIEY 187
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           MAPE  M    +   D +S G ++ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQE-FKNE 351
           PLD+  I+  +  +     +G G FG          KE +AVK + R  G  + E  + E
Sbjct: 10  PLDM-PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQRE 66
Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
           +     L+H N+VR     L      +I EY     L   + ++ R  + + +      +
Sbjct: 67  IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR---FFFQ 123
Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRV 469
            +  G+ Y H    ++I HRDLK  N LLD    P  KI DFG ++    +   +     
Sbjct: 124 QLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 177
Query: 470 VGTYGYMAPEYAMGGIFSVK-SDVFSFGVVLLEIISG 505
           VGT  Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 313 LGEGGFGPVY---KGVLAD-GKEIAVKRLSRT----SGQGLQEFKNEVTVIAKLQHKNLV 364
           LG+GG+G V+   K   A+ GK  A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 365 RLLGCCLEENESLLIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIIKGIARGI 417
            L+       +  LI EY+    L        +F+ D+              +  I+  +
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYLAEISMAL 134
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVVGTYGY 475
            +LH+     II+RDLK  N++L+H+ + K++DFG+ +  I  G      T+   GT  Y
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTIEY 187
Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           MAPE  M    +   D +S G ++ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 313 LGEGGFGPVYKGVLAD-GKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +G+G F  V + +  + G++ AVK     + + + G   ++ K E ++   L+H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL----YLHE 422
           L     +    +++E+M    L    F+  +     +    ++     R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           ++   IIHRD+K   VLL  + N    K+  FG+A   G  +S       VGT  +MAPE
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPE 203
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVV 470
           IA G+ +L       II+RDLK  NV+LD E + KI+DFGM +  I+ G      T    
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 503
Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           GT  Y+APE      +    D ++FGV+L E+++G+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
            +LG G FG V++ V  A G+    K ++          KNE++++ +L H  L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 370 CLEENESLLIYEYMPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
             ++ E +LI E++        LFD  +    ++     I+ ++    G+ ++HE S   
Sbjct: 117 FEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 428 IIHRDLKTSNVLLDHEM--NPKISDFGMARIFGGNQSKANTNRVV----GTYGYMAPEYA 481
           I+H D+K  N++ + +   + KI DFG+A       +K N + +V     T  + APE  
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLA-------TKLNPDEIVKVTTATAEFAAPEIV 222
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
                   +D+++ GV+   ++SG
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 313 LGEGGFGPVYKGVLAD-GKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           +G+G F  V + +  + G++ AVK     + + + G   ++ K E ++   L+H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL----YLHE 422
           L     +    +++E+M    L    F+  +     +    ++     R IL    Y H+
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           ++   IIHRD+K   VLL  + N    K+  FG+A   G  +S       VGT  +MAPE
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPE 205
Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISG 505
                 +    DV+  GV+L  ++SG
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 39/209 (18%)
Query: 312 KLGEGGFGPVYKGVLADGK------EIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           ++G G F  VYKG+  +        E+  ++L+++     Q FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEXLKGLQHPNIVR 89
Query: 366 LLGC---------CLEENESLLIYEYMPNKSLDVFL--FDSTR-SVQLDWKRRISIIKGI 413
                        C+     +L+ E   + +L  +L  F   +  V   W R+      I
Sbjct: 90  FYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------I 138
Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGT 472
            +G+ +LH  +   IIHRDLK  N+ +       KI D G+A +   + +KA    V+GT
Sbjct: 139 LKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGT 193
Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLE 501
             + APE      +    DV++FG   LE
Sbjct: 194 PEFXAPE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   +G G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EYMP   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   +G G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EYMP   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR--IFGGNQSKANTNRVV 470
           IA G+ +L       II+RDLK  NV+LD E + KI+DFGM +  I+ G      T    
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 182
Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           GT  Y+APE      +    D ++FGV+L E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L+E +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   K++DFG+A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 120 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 120 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 210

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 11  DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 124
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 125 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 179
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 215

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 120 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAP 174
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 210

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 9   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 122
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 123 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 177
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 213

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 120 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKL 358
           DF     LG+G FG V   +L    A G+  A+K L +       E  + VT   V+   
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H  L  L       +    + EY     L    F  +R      +R       I   + 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALE 119
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH  SR  +++RD+K  N++LD + + KI+DFG+ +   G    A      GT  Y+AP
Sbjct: 120 YLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 174
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           E      +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 210

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN---EVTVIAKLQH- 360
           D     ++G G  G V+K      G  IAVK++ R+  +  +E K    ++ V+ K    
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDC 83
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIIKGIARGIL 418
             +V+  G  +   +  +  E M   +  +      + +Q     RI   +   I + + 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKL-----KKRMQGPIPERILGKMTVAIVKALY 138
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YL E  +  +IHRD+K SN+LLD     K+ DFG++     +++K   +R  G   YMAP
Sbjct: 139 YLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAP 193
Query: 479 EY-----AMGGIFSVKSDVFSFGVVLLEIISGK 506
           E           + +++DV+S G+ L+E+ +G+
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT-SGQGLQEFKNEVTVIAK- 357
           VKA  D     +LG G +G V K   +  G+  AVKR+  T + Q  +    ++ +  + 
Sbjct: 31  VKA-DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRT 89
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVF---LFDSTRSVQLDWKRRISIIKGIA 414
           +     V   G    E +  +  E + + SLD F   + D  +++  D   +I++   I 
Sbjct: 90  VDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIV 146
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           + + +LH  S+L +IHRD+K SNVL++     K  DFG++     + +K   +   G   
Sbjct: 147 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK---DIDAGCKP 201
Query: 475 YMAPEYAMGGI----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           Y APE     +    +SVKSD++S G+  +E+                ++L + +  W  
Sbjct: 202 YXAPERINPELNQKGYSVKSDIWSLGITXIEL----------------AILRFPYDSW-- 243
Query: 531 GHAAELMDSVVKQSCDQAELLK----YIHIGLLCVQGDPIDRPT 570
           G   + +  VV++   Q    K    ++     C++ +  +RPT
Sbjct: 244 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 287

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 313 LGEGGFGPVYKGVLADGKE---IAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLLG 368
           +G G FG     ++ D +    +AVK + R  G+ + E  K E+     L+H N+VR   
Sbjct: 26  IGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRSLRHPNIVRFKE 81
Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
             L      ++ EY     L   + ++ R  + + +      + +  G+ Y H    +++
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FFFQQLISGVSYCHA---MQV 135
Query: 429 IHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            HRDLK  N LLD    P  KI DFG ++    +   +     VGT  Y+APE  +   +
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEY 192
Query: 487 SVK-SDVFSFGVVLLEIISG 505
             K +DV+S GV L  ++ G
Sbjct: 193 DGKVADVWSCGVTLYVMLVG 212

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A G+  A+K L +       E  + +T   V+   +H  L  
Sbjct: 18  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L       +    + EY     L    F  +R       R       I   + YLH  S 
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 129
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +++RDLK  N++LD + + KI+DFG+ +   G +  A      GT  Y+APE      
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A G+  A+K L +       E  + +T   V+   +H  L  
Sbjct: 16  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L       +    + EY     L    F  +R       R       I   + YLH  S 
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 127
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +++RDLK  N++LD + + KI+DFG+ +   G +  A      GT  Y+APE      
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 214

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQ-EFKNEVTVIAKLQH-KNLVRLL 367
           +LG G F  V + +  + G+E A K L  R  GQ  + E  +E+ V+   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
                 +E +LI EY     +          + +     I +IK I  G+ YLH+++   
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQILEGVYYLHQNN--- 151
Query: 428 IIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
           I+H DLK  N+LL   + P    KI DFGM+R  G          ++GT  Y+APE    
Sbjct: 152 IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNY 207
Query: 484 GIFSVKSDVFSFGVV 498
              +  +D+++ G++
Sbjct: 208 DPITTATDMWNIGII 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN- 362
           +S   ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 363 -LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RL    + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 172
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +     I+H DLK +N L+   M  K+ DFG+A     + +    +  VGT  YM PE A
Sbjct: 173 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-A 227
Query: 482 MGGIFSVKS------------DVFSFGVVLLEIISGK 506
           +  + S +             DV+S G +L  +  GK
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN- 362
           +S   ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 363 -LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RL    + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H
Sbjct: 73  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 128
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +     I+H DLK +N L+   M  K+ DFG+A     + +    +  VGT  YM PE A
Sbjct: 129 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-A 183
Query: 482 MGGIFSVKS------------DVFSFGVVLLEIISGK 506
           +  + S +             DV+S G +L  +  GK
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A G+  A+K L +       E  + +T   V+   +H  L  
Sbjct: 17  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L       +    + EY     L    F  +R       R       I   + YLH  S 
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 128
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +++RDLK  N++LD + + KI+DFG+ +   G +  A      GT  Y+APE      
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 215

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN- 362
           +S   ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 363 -LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RL    + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H
Sbjct: 89  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 144
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +     I+H DLK +N L+   M  K+ DFG+A     + +    +  VGT  YM PE A
Sbjct: 145 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-A 199
Query: 482 MGGIFSVKS------------DVFSFGVVLLEIISGK 506
           +  + S +             DV+S G +L  +  GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L+E +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   +++DFG+A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 21/219 (9%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE---IAVKRLSRTSGQGLQ-EFK 349
           P+DL  I+  +  +     +G G FG     ++ D +    +AVK + R  G+ +    K
Sbjct: 9   PMDL-PIMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIAANVK 63
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            E+     L+H N+VR     L      ++ EY     L   + ++ R  + + +     
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FF 120
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTN 467
            + +  G+ Y H    +++ HRDLK  N LLD    P  KI DFG ++    +   +   
Sbjct: 121 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 174
Query: 468 RVVGTYGYMAPEYAMGGIFSVK-SDVFSFGVVLLEIISG 505
             VGT  Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEII 196
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   +G G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R +    +         I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R +    +         I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN- 362
           +S   ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 363 -LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RL    + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H
Sbjct: 69  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 124
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +     I+H DLK +N L+   M  K+ DFG+A     + +    +  VGT  YM PE A
Sbjct: 125 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-A 179
Query: 482 MGGIFSVKS------------DVFSFGVVLLEIISGK 506
           +  + S +             DV+S G +L  +  GK
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 36  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 148
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 200
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGILYLH 421
           LV+L     + +   ++ EY P   +    F   R +    +         I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A G+  A+K L +       E  + +T   V+   +H  L  
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L       +    + EY     L    F  +R       R       I   + YLH  S 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 267
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +++RDLK  N++LD + + KI+DFG+ +   G +  A      GT  Y+APE      
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 354

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 36  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGIL 418
              LV+L     + +   ++ EY+P   +    F   R +    +         I     
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFE 148
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 200
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN- 362
           +S   ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 363 -LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RL    + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H
Sbjct: 70  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 125
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +     I+H DLK +N L+   M  K+ DFG+A     + +    +  VGT  YM PE A
Sbjct: 126 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-A 180
Query: 482 MGGIFSVKS------------DVFSFGVVLLEIISGK 506
           +  + S +             DV+S G +L  +  GK
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R +    +         I     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 211
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 313 LGEGGFGPVYKGVL----ADGKEIAVKRLSRTSGQGLQEFKNEVT---VIAKLQHKNLVR 365
           LG+G FG V   +L    A G+  A+K L +       E  + +T   V+   +H  L  
Sbjct: 159 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L       +    + EY     L    F  +R       R       I   + YLH  S 
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 270
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +++RDLK  N++LD + + KI+DFG+ +   G +  A      GT  Y+APE      
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           +    D +  GVV+ E++ G+    FY+ +H
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDH 357

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 211
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 21/219 (9%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE---IAVKRLSRTSGQGLQE-FK 349
           P+DL  I+  +  +     +G G FG     ++ D +    +AVK + R  G+ + E  K
Sbjct: 9   PMDL-PIMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVK 63
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            E+     L+H N+VR     L      ++ EY     L   + ++ R  + + +     
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FF 120
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTN 467
            + +  G+ Y H    +++ HRDLK  N LLD    P  KI  FG ++    +   +   
Sbjct: 121 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPK 174
Query: 468 RVVGTYGYMAPEYAMGGIFSVK-SDVFSFGVVLLEIISG 505
             VGT  Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+P   +    F   R + +            I     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEII 211
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN- 362
           +S   ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 363 -LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RL    + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H
Sbjct: 89  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIH 144
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +     I+H DLK +N L+   M  K+ DFG+A     +      +  VGT  YM PE A
Sbjct: 145 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE-A 199
Query: 482 MGGIFSVKS------------DVFSFGVVLLEIISGK 506
           +  + S +             DV+S G +L  +  GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE---IAVKRLSRTSGQGLQE-FK 349
           P+DL  I+  +  +     +G G FG     ++ D +    +AVK + R  G+ + E  K
Sbjct: 9   PMDL-PIMHDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVK 63
Query: 350 NEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            E+     L+H N+VR     L      ++ EY     L   + ++ R  + + +     
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR---FF 120
Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTN 467
            + +  G+ Y H    +++ HRDLK  N LLD    P  KI  FG ++    +    +T 
Sbjct: 121 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT- 176
Query: 468 RVVGTYGYMAPEYAMGGIFSVK-SDVFSFGVVLLEIISG 505
             VGT  Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 177 --VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 36/241 (14%)
Query: 296 DLIDIVKATQD-FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL--------- 345
           DLI  + A Q  ++ +  +  G +G V  GV ++G  +A+KR+  T   G          
Sbjct: 12  DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSF 71
Query: 346 --QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW 403
             +    E+ ++    H N++ L    +   E  +   Y+  + +       T   Q+  
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM------RTDLAQVIH 125
Query: 404 KRRISI--------IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 455
            +RI I        +  I  G+  LHE     ++HRDL   N+LL    +  I DF +AR
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 456 IFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK---KSTGF 511
               + + AN    V    Y APE  M    F+   D++S G V+ E+ + K   + + F
Sbjct: 183 ---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239
Query: 512 Y 512
           Y
Sbjct: 240 Y 240

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 304 TQDFSQENKLGEGGFGPV----YKGVLADGKEIAVKRLSRTSGQGLQE---FKNEVTVIA 356
            +D+     +G G FG V    +K   A  K  A+K LS+       +   F  E  ++A
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHK---ASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 357 KLQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
                 +V+L  C  ++++ L ++ EYMP   L   +  S   V   W +  +     A 
Sbjct: 131 FANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYT-----AE 182
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            +L L     + +IHRD+K  N+LLD   + K++DFG            + +  VGT  Y
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVHCDTAVGTPDY 241
Query: 476 MAPEY----AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           ++PE        G +  + D +S GV L E++ G   T FY
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 36/241 (14%)
Query: 296 DLIDIVKATQD-FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGL--------- 345
           DLI  + A Q  ++ +  +  G +G V  GV ++G  +A+KR+  T   G          
Sbjct: 12  DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSF 71
Query: 346 --QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW 403
             +    E+ ++    H N++ L    +   E  +   Y+  + +       T   Q+  
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM------RTDLAQVIH 125
Query: 404 KRRISI--------IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 455
            +RI I        +  I  G+  LHE     ++HRDL   N+LL    +  I DF +AR
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 456 IFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK---KSTGF 511
               + + AN    V    Y APE  M    F+   D++S G V+ E+ + K   + + F
Sbjct: 183 ---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239
Query: 512 Y 512
           Y
Sbjct: 240 Y 240

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 312 KLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRL 366
           ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  +  ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
               + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H+    
Sbjct: 122 YDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG-- 175
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            I+H DLK +N L+   M  K+ DFG+A     + +    +  VGT  YM PE A+  + 
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMS 232
Query: 487 SVKS------------DVFSFGVVLLEIISGK 506
           S +             DV+S G +L  +  GK
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 112/248 (45%), Gaps = 47/248 (18%)
Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADG-KEIAVKRLSRTSGQGL--QEFKNEVT 353
           +I  VK   ++  ++ +G G +G VY     +  K +A+K+++R     +  +    E+T
Sbjct: 20  IIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREIT 79
Query: 354 VIAKLQHKNLVRLLGCCLEEN-----ESLLIYEYMPNKSLDVF---LFDSTRSVQLDWKR 405
           ++ +L+   ++RL    + E+     E  ++ E   +    +F   +F + + V+     
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVK----- 134
Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG------ 459
             +I+  +  G  ++HE     IIHRDLK +N LL+ + + KI DFG+AR          
Sbjct: 135 --TILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189
Query: 460 ------------------NQSKANTNRVVGTYGYMAPEYA-MGGIFSVKSDVFSFGVVLL 500
                             N  K  T+ VV T  Y APE   +   ++   D++S G +  
Sbjct: 190 VNDLEEKEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWSTGCIFA 248
Query: 501 EIISGKKS 508
           E+++  KS
Sbjct: 249 ELLNMMKS 256

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTV 354
           D+    +D+     +G G FG V        +++ A+K LS+       +   F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +A      +V+L     ++    ++ EYMP   L   +  S   V   W R  +     A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYT-----A 180
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
             +L L     +  IHRD+K  N+LLD   + K++DFG        +     +  VGT  
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPD 239
Query: 475 YMAPEY----AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           Y++PE        G +  + D +S GV L E++ G   T FY
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 279

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTV 354
           D+    +D+     +G G FG V        +++ A+K LS+       +   F  E  +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +A      +V+L     ++    ++ EYMP   L   +  S   V   W R  +     A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYT-----A 175
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
             +L L     +  IHRD+K  N+LLD   + K++DFG        +     +  VGT  
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPD 234
Query: 475 YMAPEY----AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           Y++PE        G +  + D +S GV L E++ G   T FY
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTV 354
           D+    +D+     +G G FG V        +++ A+K LS+       +   F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +A      +V+L     ++    ++ EYMP   L   +  S   V   W R  +     A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYT-----A 180
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
             +L L     +  IHRD+K  N+LLD   + K++DFG        +     +  VGT  
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPD 239
Query: 475 YMAPEY----AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
           Y++PE        G +  + D +S GV L E++ G   T FY
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 279

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY P   +    F   R + +            I     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+++D +   K++DFG A+     + K  T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 306 DFSQEN---KLGEGGFGPVYKGVLADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQH 360
           DF Q N   KL E   G ++KG    G +I VK  ++   S +  ++F  E   +    H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 361 KNLVRLLGCCLEE--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            N++ +LG C         LI  +MP  SL   L + T  V +D  + +     +ARG+ 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMA 125
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           +LH    L I    L + +V++D +M  +IS   MA +    QS       +    ++AP
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARIS---MADVKFSFQSPGR----MYAPAWVAP 177
Query: 479 EYAMGGIFSVK---SDVFSFGVVLLEIIS 504
           E             +D++SF V+L E+++
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-----QHKNLV 364
           E  LG G  G V       G+ +AVKR+       L +F +   +  KL      H N++
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVI 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIARGILY 419
           R   C    +  L I   + N +L   +      D    +Q ++   IS+++ IA G+ +
Sbjct: 73  RYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVAH 130
Query: 420 LHEDSRLKIIHRDLKTSNVLL--------DHEMNPK-----ISDFGMARIFGGNQS--KA 464
           LH    LKIIHRDLK  N+L+        D +   +     ISDFG+ +     QS  + 
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 465 NTNRVVGTYGYMAPE-------YAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTG 510
           N N   GT G+ APE              +   D+FS G V   I+S GK   G
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 64  FERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+P   +    F   R + +            I     
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 176
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           F +   LG G FG V     +  G   A+K L +     L++ ++ +     LQ  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 366 L--LGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGILYLH 421
           L  L    ++N +L ++ EY P   +    F   R +    +         I     YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 211
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 310 ENKLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-----QHKNL 363
           E  LG G  G V ++G    G+ +AVKR+       L +F +   +  KL      H N+
Sbjct: 38  EKILGYGSSGTVVFQGSFQ-GRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNV 89
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIARGIL 418
           +R   C    +  L I   + N +L   +      D    +Q ++   IS+++ IA G+ 
Sbjct: 90  IRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVA 147
Query: 419 YLHEDSRLKIIHRDLKTSNVLL--------DHEMNPK-----ISDFGMARIFGGNQS--K 463
           +LH    LKIIHRDLK  N+L+        D +   +     ISDFG+ +     Q   +
Sbjct: 148 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 464 ANTNRVVGTYGYMAPEY---AMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHS 514
            N N   GT G+ APE    +     +   D+FS G V   I+S GK   G  +S
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY P   +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           F +   LG G FG V     +  G   A+K L +     L++ ++ +     LQ  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 366 L--LGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           L  L    ++N +L ++ EY P   +    F   R + +            I     YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 211
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           F +   LG G FG V     +  G   A+K L +     L++ ++ +     LQ  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 366 L--LGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           L  L    ++N +L ++ EY P   +    F   R + +            I     YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+++D +   K++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 211
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 43/231 (18%)
Query: 310 ENKLGEGGFGPV-YKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-----QHKNL 363
           E  LG G  G V ++G    G+ +AVKR+       L +F +   +  KL      H N+
Sbjct: 38  EKILGYGSSGTVVFQGSFQ-GRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNV 89
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIARGIL 418
           +R   C    +  L I   + N +L   +      D    +Q ++   IS+++ IA G+ 
Sbjct: 90  IRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVA 147
Query: 419 YLHEDSRLKIIHRDLKTSNVLL--------DHEMNPK-----ISDFGMARIFGGNQS--K 463
           +LH    LKIIHRDLK  N+L+        D +   +     ISDFG+ +     Q   +
Sbjct: 148 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 464 ANTNRVVGTYGYMAPEY---AMGGIFSVKSDVFSFGVVLLEIIS-GKKSTG 510
            N N   GT G+ APE    +     +   D+FS G V   I+S GK   G
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKEI----AVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  +   + 
Sbjct: 44  FERIRTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY P   +    F   R + +            I     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   K++DFG A+     + K  T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 45/221 (20%)
Query: 307 FSQENKLGEGGFGP-VYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLV 364
           F  ++ LG G  G  VY+G+  D +++AVKR+     +       EV ++ +  +H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVI 81
Query: 365 RLLGCCLEENESL----------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           R    C E++              + EY+  K       +            I++++   
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------ITLLQQTT 128
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDH-----EMNPKISDFGMARIFG-GNQSKANTNR 468
            G+ +LH    L I+HRDLK  N+L+       ++   ISDFG+ +    G  S +  + 
Sbjct: 129 SGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 469 VVGTYGYMAPEY-----AMGGIFSVKSDVFSFGVVLLEIIS 504
           V GT G++APE           ++V  D+FS G V   +IS
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTV--DIFSAGCVFYYVIS 224

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 312 KLGEGGFGPVYKGVLADGKEI-AVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRL 366
           ++G GG   V++ VL + K+I A+K   L     Q L  ++NE+  + KLQ  +  ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRL 426
               + +     IY  M   ++D+  +   +     W+R+ S  K +   +  +H+    
Sbjct: 122 YDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG-- 175
Query: 427 KIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF 486
            I+H DLK +N L+   M  K+ DFG+A     + +    +  VG   YM PE A+  + 
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232
Query: 487 SVKS------------DVFSFGVVLLEIISGK 506
           S +             DV+S G +L  +  GK
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 313 LGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQGLQEFKNEVT----------VIAKLQHK 361
           LG+GGFG V+ G  L D  ++A+K + R    G     + VT          V A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            ++RLL    E  E  ++    P  + D+F + + +    +   R    + +A  I + H
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-AIQHCH 156
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
                 ++HRD+K  N+L+D      K+ DFG   +      +  T+   GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVYSPPEW 209
Query: 481 -AMGGIFSVKSDVFSFGVVLLEIISG 505
            +     ++ + V+S G++L +++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKN 362
            + + +LG G FG V++  + D   G + AVK++       L+ F+  E+   A L    
Sbjct: 74  MTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 125
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L G   E     +  E +   SL   +    +   L   R +  +     G+ YLH 
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 182
Query: 423 DSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIF---GGNQSKANTNRVVGTYGYMAP 478
               +I+H D+K  NVLL  + +   + DFG A      G  +S    + + GT  +MAP
Sbjct: 183 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  MG     K D++S   ++L +++G
Sbjct: 240 EVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 309 QENKLGEGGFGPVYKGVLADGKE-IAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRL 366
           ++  LGEG F    K V     +  AVK +S+      Q+   E+T +   + H N+V+L
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKL 71
Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-IIKGIARGILYLHEDSR 425
                ++  + L+ E +    L    F+  +  +   +   S I++ +   + ++H+   
Sbjct: 72  HEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD--- 124
Query: 426 LKIIHRDLKTSNVLLDHE---MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
           + ++HRDLK  N+L   E   +  KI DFG AR+   +     T     T  Y APE   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLN 182
Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
              +    D++S GV+L  ++SG+
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 312 KLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKNLVRLL 367
           +LG G FG V++  + D   G + AVK++       L+ F+  E+   A L    +V L 
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G   E     +  E +   SL   + +      L   R +  +     G+ YLH  SR +
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--SR-R 205
Query: 428 IIHRDLKTSNVLLDHE-MNPKISDFGMARIF---GGNQSKANTNRVVGTYGYMAPEYAMG 483
           I+H D+K  NVLL  +  +  + DFG A      G  +S    + + GT  +MAPE  +G
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 484 GIFSVKSDVFSFGVVLLEIISG 505
                K DV+S   ++L +++G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 147
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 148 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 200
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 233

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 99/234 (42%), Gaps = 45/234 (19%)
Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-----QHKNLV 364
           E  LG G  G V       G+ +AVKR+       L +F +   +  KL      H N++
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVI 72
Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIIKGIARGILY 419
           R   C    +  L I   + N +L   +      D    +Q ++   IS+++ IA G+ +
Sbjct: 73  RYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP-ISLLRQIASGVAH 130
Query: 420 LHEDSRLKIIHRDLKTSNVLL--------DHEMNPK-----ISDFGMARIFGGNQS--KA 464
           LH    LKIIHRDLK  N+L+        D +   +     ISDFG+ +     Q   + 
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 465 NTNRVVGTYGYMAPE-------YAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTG 510
           N N   GT G+ APE              +   D+FS G V   I+S GK   G
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 305 QDFSQENKLGEGGFGPVY--KGVLAD--GKEIAVKRLSRTS----GQGLQEFKNEVTVIA 356
           ++F     LG G +G V+  + +     GK  A+K L + +     +  +  + E  V+ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 357 KL-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IA 414
            + Q   LV L      E +  LI +Y+    L   L    R  +      + I  G I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 169
Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
             + +LH   +L II+RD+K  N+LLD   +  ++DFG+++ F  ++++   +   GT  
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIE 225
Query: 475 YMAPEYAMGGI--FSVKSDVFSFGVVLLEIISG 505
           YMAP+   GG        D +S GV++ E+++G
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 128
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 129 XG---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 181
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 214

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 147
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 148 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 200
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 233

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 213
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 246

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 148
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 201
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 234

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 148
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 201
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 234

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 132
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 133 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 185
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 218

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 307 FSQENKLGEGGFGPVY-KGVLADGKEIAVKRLSRTSGQGLQEFK---NEVTVIAKLQHKN 362
           F +   LG G FG V     +  G   A+K L +     L++ +   NE  ++  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGILYLH 421
           LV+L     + +   ++ EY+    +    F   R + +            I     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEII 210
Query: 482 MGGIFSVKSDVFSFGVVLLEIISG 505
           +   ++   D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKN 362
            + + ++G G FG V++  + D   G + AVK++       L+ F+  E+   A L    
Sbjct: 60  MTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 111
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L G   E     +  E +   SL   +    +   L   R +  +     G+ YLH 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 423 DSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIF---GGNQSKANTNRVVGTYGYMAP 478
               +I+H D+K  NVLL  + +   + DFG A      G  +S    + + GT  +MAP
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  MG     K D++S   ++L +++G
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGIL 418
              LV+L     + +   ++ EY+    +    F   R +    +         I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 148
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 149 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 201
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 234

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 214
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 247

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 128
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 181
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 214

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 131
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 132 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 184
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 217

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 133
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 134 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 186
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 219

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 213
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 246

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 214
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 247

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 213
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 246

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 214
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 247

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCH- 132
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 186
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 219

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 161
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 162 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 214
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 247

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 160
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 161 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 213
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 246

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 175
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 176 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 228
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 261

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCH- 132
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 186
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 219

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 175
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 176 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 228
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 261

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 307 FSQENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKN 362
            + + ++G G FG V++  + D   G + AVK++       L+ F+  E+   A L    
Sbjct: 76  MTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 127
Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V L G   E     +  E +   SL   +    +   L   R +  +     G+ YLH 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 184
Query: 423 DSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIF---GGNQSKANTNRVVGTYGYMAP 478
               +I+H D+K  NVLL  + +   + DFG A      G  +S    + + GT  +MAP
Sbjct: 185 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  MG     K D++S   ++L +++G
Sbjct: 242 EVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 30  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 142
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 194
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 128
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 181
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 214

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGIL 418
              LV+L     + +   ++ EY+    +    F   R +    +         I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 38  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGIL 418
              LV+L     + +   ++ EY+    +    F   R +    +         I     
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFE 150
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 202
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGIL 418
              LV+L     + +   ++ EY+    +    F   R +    +         I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 167
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 168 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 220
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 253

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQH--KNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 180
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 181 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 233
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 266

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 44  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 64  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG-IARGIL 418
              LV+L     + +   ++ EY+    +    F   R +    +         I     
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFE 176
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E M     D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERM-EPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 132
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 133 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 185
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 218

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRT------SGQGLQEFKNEVTVIAKLQHKNLVR 365
           +G G +G V        G+++A+K++         + + L+E K    ++   +H N++ 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIA 118
Query: 366 L---LGCCLEENESLLIYEYMPNKSLDVF-LFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           +   L   +   E   +Y  +     D+  +  S++ + L+  R    +  + RG+ Y+H
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVR--YFLYQLLRGLKYMH 176
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--TNRVVGTYGYMAPE 479
                ++IHRDLK SN+L++     KI DFGMAR    + ++        V T  Y APE
Sbjct: 177 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGKK 507
             +    ++   D++S G +  E+++ ++
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 56/252 (22%)
Query: 313 LGEGGFGPVYKGVLAD-GKEIAVKRLS-----RTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           LG+G    V++G     G   A+K  +     R     ++EF+    V+ KL HKN+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIVKL 72
Query: 367 LGCCLEEN--ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
                E      +LI E+ P  SL   L + + +  L     + +++ +  G+ +L E+ 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 425 RLKIIHRDLKTSNVLL----DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
              I+HR++K  N++     D +   K++DFG AR    ++   +   + GT  Y+ P+ 
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDM 186
Query: 481 AMGGI--------FSVKSDVFSFGV-----------------------VLLEIISGKKS- 508
               +        +    D++S GV                       V+ +II+GK S 
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 509 --TGFYHSEHGP 518
             +G   +E+GP
Sbjct: 247 AISGVQKAENGP 258

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQ--HKNL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHE 422
           +RLL      +  +LI E  P    D+F F + R ++Q +  R  S    +   + + H 
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCH- 154
Query: 423 DSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D +    K+ DFG   +    +    T+   GT  Y  PE+ 
Sbjct: 155 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWI 208
Query: 482 MGGIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSE 515
               +  +S  V+S G++L +++ G     F H E
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE 241

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 312 KLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHKNLVRLL 367
           +LG G FG V++  + D   G + AVK++       L+ F+  E+   A L    +V L 
Sbjct: 81  RLGRGSFGEVHR--MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
           G   E     +  E +   SL   + +      L   R +  +     G+ YLH  SR +
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--SR-R 186
Query: 428 IIHRDLKTSNVLLDHE-MNPKISDFGMARIF---GGNQSKANTNRVVGTYGYMAPEYAMG 483
           I+H D+K  NVLL  +  +  + DFG A      G  +     + + GT  +MAPE  +G
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 484 GIFSVKSDVFSFGVVLLEIISG 505
                K DV+S   ++L +++G
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 178
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 313 LGEGGFGPVYKGVLA-DGKEIAVKRLSRT------SGQGLQEFKNEVTVIAKLQHKNLVR 365
           +G G +G V        G+++A+K++         + + L+E K    ++   +H N++ 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIA 117
Query: 366 L---LGCCLEENESLLIYEYMPNKSLDVF-LFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           +   L   +   E   +Y  +     D+  +  S++ + L+  R    +  + RG+ Y+H
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVR--YFLYQLLRGLKYMH 175
Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--TNRVVGTYGYMAPE 479
                ++IHRDLK SN+L++     KI DFGMAR    + ++        V T  Y APE
Sbjct: 176 S---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 480 YAMG-GIFSVKSDVFSFGVVLLEIISGKK 507
             +    ++   D++S G +  E+++ ++
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 179
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL--QEFKNEVTVIAKLQHKNLVRLLGC 369
           +G G +G V +     + + +A+K++ R     +  +    E+ ++ +L H ++V++L  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 370 CL----EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
            +    E+ + L +   + +              +L  K   +++  +  G+ Y+H    
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK---TLLYNLLVGVKYVHSAG- 176
Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIF----GGN------------------QSK 463
             I+HRDLK +N L++ + + K+ DFG+AR       GN                   +K
Sbjct: 177 --ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 464 ANTNRVVG---TYGYMAPEYA-MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
               ++ G   T  Y APE   +   ++   DV+S G +  E+++  K    YH++ GP
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 179
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFKN---EVTVIAK- 357
           DF     +G+G FG V   +LA  K      AVK L + +    +E K+   E  V+ K 
Sbjct: 39  DFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           ++H  LV L       ++   + +Y+     ++F         L+ + R    + IA  +
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHLQRERCFLEPRARFYAAE-IASAL 152
Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YLH    L I++RDLK  N+LLD + +  ++DFG+ +     +  + T+   GT  Y+A
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLA 207
Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           PE      +    D +  G VL E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 179
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAP 228
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 185
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
           +DF     +G G FG V    + + + I A+K L++       E   F+ E  V+     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           + +  L     +EN   L+ +Y     L   L      +  D  R       I   +L +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY-----IGEMVLAI 188
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
               +L  +HRD+K  NVLLD   + +++DFG   +   +     ++  VGT  Y++PE 
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 481 AMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                   G +  + D +S GV + E++ G+  T FY
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 318
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGT 472
            + YLHE+    IIHRDLK  NVLL  +      KI+DFG ++I G     +    + GT
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 304
Query: 473 YGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +      ++   D +S GV+L   +SG
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+L+D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 46/208 (22%)
Query: 351 EVTVIAKLQHKNLVRLLGCCLEEN--ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
           E  V+ KL HKN+V+L     E      +LI E+ P  SL   L + + +  L     + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMARIFGGNQSKA 464
           +++ +  G+ +L E+    I+HR++K  N++     D +   K++DFG AR    ++   
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 465 NTNRVVGTYGYMAPEYAMGGI--------FSVKSDVFSFGV------------------- 497
               + GT  Y+ P+     +        +    D++S GV                   
Sbjct: 174 X---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 498 ----VLLEIISGKKS---TGFYHSEHGP 518
               V+ +II+GK S   +G   +E+GP
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGP 258

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 307 FSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQEFK---NEVTVIAKLQ 359
           F +   LG G FG V   +L   KE     A+K L +     L++ +   NE  ++  + 
Sbjct: 43  FDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV-QLDWKRRISIIKGIARGIL 418
              LV+L     + +   ++ EY+    +    F   R + +            I     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH    L +I+RDLK  N+++D +   +++DFG A+     + K  T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISG 505
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 17/217 (7%)
Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
           +DF     +G G FG V    + + + I A+K L++       E   F+ E  V+     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           + +  L     +EN   L+ +Y     L   L      +  D  R       I   +L +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY-----IGEMVLAI 204
Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
               +L  +HRD+K  NVLLD   + +++DFG   +   +     ++  VGT  Y++PE 
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 481 AMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                   G +  + D +S GV + E++ G+  T FY
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFY 298

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCC 370
           L EGGF  VY+   +  G+E A+KRL     +  +    EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 371 ---LEENES-----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
               EE+++     LL+ E    + ++ FL        L     + I     R + ++H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA 454
             +  IIHRDLK  N+LL ++   K+ DFG A
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	624
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-145
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-145
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-127
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-100
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-86
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-70
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-67
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-65
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-61
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-54
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-49
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-48
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-48
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-48
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-47
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-47
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-47
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-46
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-46
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-46
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-46
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-46
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-45
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-45
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-45
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-45
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-45
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-45
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-45
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-45
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-45
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-45
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-45
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-45
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-44
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-44
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-44
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-44
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-44
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-44
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-44
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-44
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-43
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-43
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-43
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-42
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-42
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-38
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-35
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-31
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-30
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-30
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-22
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	1e-21
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  423 bits (1091), Expect = e-145
 Identities = 118/289 (40%), Positives = 169/289 (58%), Gaps = 5/289 (1%)

Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAK 357
           ++  A+ +FS +N LG GGFG VYKG LADG  +AVKRL     QG + +F+ EV +I+ 
Sbjct: 24  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS-VQLDWKRRISIIKGIARG 416
             H+NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +R  I  G ARG
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + YLH+    KIIHRD+K +N+LLD E    + DFG+A++     +   T  V GT G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHI 202

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKST--GFYHSEHGPSLLAYIWKLWCEGHAA 534
           APEY   G  S K+DVF +GV+LLE+I+G+++       ++    LL ++  L  E    
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262

Query: 535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL 583
            L+D  ++ +    E+ + I + LLC Q  P++RP MS V  ML  D L
Sbjct: 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  422 bits (1087), Expect = e-145
 Identities = 105/297 (35%), Positives = 154/297 (51%), Gaps = 19/297 (6%)

Query: 299 DIVKATQDFSQE------NKLGEGGFGPVYKGVLADGKEIAVKRLS----RTSGQGLQEF 348
           ++   T +F +       NK+GEGGFG VYKG + +   +AVK+L+     T+ +  Q+F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77

Query: 349 KNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
             E+ V+AK QH+NLV LLG   + ++  L+Y YMPN SL   L     +  L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
           I +G A GI +LHE+     IHRD+K++N+LLD     KISDFG+AR          T+R
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW 528
           +VGT  YMAPE  + G  + KSD++SFGVVLLEII+G  +   +       LL    ++ 
Sbjct: 195 IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIE 251

Query: 529 CEGHA-AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT 584
            E     + +D  +    D   +     +   C+      RP +  V  +L     +
Sbjct: 252 DEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  377 bits (971), Expect = e-127
 Identities = 105/288 (36%), Positives = 162/288 (56%), Gaps = 8/288 (2%)

Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEV 352
            PL   D+ +AT +F  +  +G G FG VYKGVL DG ++A+KR +  S QG++EF+ E+
Sbjct: 29  VPLV--DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 353 TVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIK 411
             ++  +H +LV L+G C E NE +LIY+YM N +L   L+ S      + W++R+ I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVV 470
           G ARG+ YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++     +Q+  +T  V 
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVK 202

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           GT GY+ PEY + G  + KSDV+SFGVVL E++  + +          +L  +  +    
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262

Query: 531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           G   +++D  +        L K+    + C+     DRP+M  V   L
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  307 bits (788), Expect = e-100
 Identities = 73/312 (23%), Positives = 127/312 (40%), Gaps = 34/312 (10%)

Query: 294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVT 353
            L   ++   +           G FG V+K  L   + +AVK       Q   + + EV 
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVY 70

Query: 354 VIAKLQHKNLVRLLGCCLEEN----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 409
            +  ++H+N+++ +G          +  LI  +    SL  FL  +     + W     I
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126

Query: 410 IKGIARGILYLHED-------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
            + +ARG+ YLHED        +  I HRD+K+ NVLL + +   I+DFG+A  F   +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 463 KANTNRVVGTYGYMAPEYAMGGI-----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG 517
             +T+  VGT  YMAPE   G I       ++ D+++ G+VL E+ S   +      E+ 
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY- 245

Query: 518 PSLLAYIWKLWCEGHAAELMDSVVKQ--------SCDQAELLK-YIHIGLLCVQGDPIDR 568
             +L +  ++       ++ + VV +           +   +         C   D   R
Sbjct: 246 --MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 569 PTMSSVAVMLAS 580
            +   V   +  
Sbjct: 304 LSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  270 bits (692), Expect = 9e-86
 Identities = 73/326 (22%), Positives = 121/326 (37%), Gaps = 45/326 (13%)

Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV--IAKLQH 360
              +      +G G +G VYKG L D + +AVK  S  + Q    F NE  +  +  ++H
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66

Query: 361 KNLVRLLGCCLE-----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            N+ R +            E LL+ EY PN SL  +L   T     DW     +   + R
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTR 122

Query: 416 GILYLHED------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN------QSK 463
           G+ YLH +       +  I HRDL + NVL+ ++    ISDFG++    GN      +  
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 464 ANTNRVVGTYGYMAPEYAMGGI-------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
                 VGT  YMAPE   G +          + D+++ G++  EI              
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG-ESV 241

Query: 517 GPSLLAYIWKLWCEGHAAELMDSVVKQ----------SCDQAELLKYIHIGLLCVQGDPI 566
               +A+  ++       ++   V ++            +   +         C   D  
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301

Query: 567 DRPTMSSVAVMLASDILTLPKPTQPA 592
            R T       +A  ++   +    +
Sbjct: 302 ARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  228 bits (583), Expect = 5e-70
 Identities = 79/302 (26%), Positives = 145/302 (48%), Gaps = 44/302 (14%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRL--SRTSGQGLQEFKNEVTVIAKLQHKNL 363
           D + + K+G G FG V++     G ++AVK L       + + EF  EV ++ +L+H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V  +G   +     ++ EY+   SL   L  S    QLD +RR+S+   +A+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN- 155

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               I+HR+LK+ N+L+D +   K+ DFG++R+       + +    GT  +MAPE    
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRD 213

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
              + KSDV+SFGV+L E+ + ++          P         W   + A+++ +V  +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQ----------P---------WGNLNPAQVVAAVGFK 254

Query: 544 --------SCDQ--AELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT--LPKPTQP 591
                   + +   A +++       C   +P  RP+ +++  +L   ++   +P P + 
Sbjct: 255 CKRLEIPRNLNPQVAAIIEG------CWTNEPWKRPSFATIMDLL-RPLIKSAVPPPNRS 307

Query: 592 AF 593
             
Sbjct: 308 DL 309

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  221 bits (566), Expect = 1e-67
 Identities = 83/313 (26%), Positives = 130/313 (41%), Gaps = 33/313 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D      LG+G FG   K      G+ + +K L R   +  + F  EV V+  L+H N++
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           + +G   ++     I EY+   +L   +       Q  W +R+S  K IA G+ YLH   
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH--- 125

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR------------VVGT 472
            + IIHRDL + N L+    N  ++DFG+AR+    +++    R            VVG 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH 532
             +MAPE   G  +  K DVFSFG+VL EII    +      ++ P  + +   L   G 
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD----PDYLPRTMDFG--LNVRGF 239

Query: 533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPA 592
               +D     +C  +    +  I + C   DP  RP+   +   L   +        P 
Sbjct: 240 ----LDRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWL-ETLRMHLAGHLPL 290

Query: 593 FSLSRVVSAQFVS 605
                 +   F  
Sbjct: 291 GPQLEQLDRGFWE 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  220 bits (562), Expect = 5e-67
 Identities = 78/305 (25%), Positives = 127/305 (41%), Gaps = 47/305 (15%)

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIA 356
           +ID     ++   E  +G G FG V K      K++A+K++   S    + F  E+  ++
Sbjct: 4   MIDY----KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLS 56

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           ++ H N+V+L G CL      L+ EY    SL   L  +           +S     ++G
Sbjct: 57  RVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           + YLH      +IHRDLK  N+LL       KI DFG A        + +     G+  +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAW 169

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           MAPE   G  +S K DVFS+G++L E+I+ +K    +    GP+                
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRI------------- 213

Query: 536 LMDSVVK-------QSCDQ--AELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
            M +V         ++  +    L+        C   DP  RP+M  +  ++   +   P
Sbjct: 214 -MWAVHNGTRPPLIKNLPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFP 266

Query: 587 KPTQP 591
              +P
Sbjct: 267 GADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  217 bits (554), Expect = 3e-66
 Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 59/298 (19%)

Query: 306 DFSQ---ENKLGEGGFGPVYKGVLADGKEIAVKRL----SRTSGQGLQEFKNEVTVIAKL 358
           DF++   E  +G GGFG VY+     G E+AVK           Q ++  + E  + A L
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N++ L G CL+E    L+ E+     L+  L       ++     ++    IARG+ 
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMN 119

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP--------KISDFGMARIFGGNQSKANTNRVV 470
           YLH+++ + IIHRDLK+SN+L+  ++          KI+DFG+AR +      +      
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---- 175

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           G Y +MAPE     +FS  SDV+S+GV+L E+++G+           P         +  
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV----------P---------FRG 216

Query: 531 GHAAELMDSVVKQ--------SCDQ--AELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                +   V           +C +  A+L++       C   DP  RP+ +++   L
Sbjct: 217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQL 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  215 bits (549), Expect = 2e-65
 Identities = 78/304 (25%), Positives = 141/304 (46%), Gaps = 42/304 (13%)

Query: 290 FPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG---- 344
           FP   L  +       +   E ++G+GGFG V+KG  + D   +A+K L     +G    
Sbjct: 8   FPKSRLPTLAD----NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63

Query: 345 ---LQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQL 401
               QEF+ EV +++ L H N+V+L G         ++ E++P   L   L D  ++  +
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAHPI 119

Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-----HEMNPKISDFGMARI 456
            W  ++ ++  IA GI Y+  +    I+HRDL++ N+ L        +  K++DFG+++ 
Sbjct: 120 KWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178

Query: 457 FGGNQSKANTNRVVGTYGYMAPE--YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS 514
              + S       +G + +MAPE   A    ++ K+D +SF ++L  I++G+     +  
Sbjct: 179 SVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-D 229

Query: 515 EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
           E+    + +I  +  EG    +      + C      +  ++  LC  GDP  RP  S +
Sbjct: 230 EYSYGKIKFINMIREEGLRPTI-----PEDCPP----RLRNVIELCWSGDPKKRPHFSYI 280

Query: 575 AVML 578
              L
Sbjct: 281 VKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  212 bits (543), Expect = 2e-64
 Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 27/281 (9%)

Query: 306 DFSQ---ENKLGEGGFGPVYKGVLADGKEIAVKRL--SRTSGQGLQEFKNEVTVIAKLQH 360
              Q     ++G G FG VYKG      ++AVK L  +  + Q LQ FKNEV V+ K +H
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N++  +G       ++ + ++    SL   L       + + K+ I I +  ARG+ YL
Sbjct: 80  VNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYL 136

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE- 479
           H      IIHRDLK++N+ L  +   KI DFG+A             ++ G+  +MAPE 
Sbjct: 137 H---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 480 --YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
                   +S +SDV++FG+VL E+++G+     Y   +  +    I  +     + +L 
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPDL- 247

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
            S V+ +C +        +   C++    +RP+   +   +
Sbjct: 248 -SKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  209 bits (535), Expect = 2e-63
 Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 56/298 (18%)

Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRL--SRTSGQGLQEFKNEVTVI 355
           ID     +  +   KL E   G ++KG    G +I VK L     S +  ++F  E   +
Sbjct: 7   IDF----KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 356 AKLQHKNLVRLLGCCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGI 413
               H N++ +LG C          I  +MP  SL   L + T  V +D  + +     +
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDM 120

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
           ARG+ +LH      I    L + +V++D +M  +IS   +   F   QS           
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAP 172

Query: 474 GYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
            ++APE             +D++SF V+L E+++ +           P         + +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV----------P---------FAD 213

Query: 531 GHAAELMDSVVKQ--------SCDQ--AELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
               E+   V  +              ++L+K      +C+  DP  RP    +  +L
Sbjct: 214 LSNMEIGMKVALEGLRPTIPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  206 bits (526), Expect = 1e-61
 Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 44/292 (15%)

Query: 306 DFSQ---ENKLGEGGFGPVYKGVLADGKEIAVKRL--SRTSGQGLQEFKNEVTVIAKLQH 360
            F Q      +G+G FG VY G      E+A++ +   R +   L+ FK EV    + +H
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           +N+V  +G C+      +I      ++L   + D    + LD  +   I + I +G+ YL
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR---VVGTYGYMA 477
           H      I+H+DLK+ NV  D      I+DFG+  I G  Q+    ++     G   ++A
Sbjct: 147 H---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 478 PE---------YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW 528
           PE               FS  SDVF+ G +  E+ + +     +         A IW++ 
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQM- 255

Query: 529 CEGHAAELMDSVVKQSCDQ--AELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                    + + +    +  +++L +      C   +  +RPT + +  ML
Sbjct: 256 ---GTGMKPN-LSQIGMGKEISDILLF------CWAFEQEERPTFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  195 bits (497), Expect = 3e-57
 Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 52/305 (17%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV--IAKLQHKNLVRLL 367
             ++G+G +G V+ G    G+++AVK            +  E  +     ++H+N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 368 GCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
              ++   S     LI +Y  N SL  +L    +S  LD K  + +      G+ +LH +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 424 -----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYM 476
                 +  I HRDLK+ N+L+       I+D G+A  F    N+     N  VGT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 477 APEYAMGGIFSV------KSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
            PE     +          +D++SFG++L E+     S G          L Y   +  +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSD 269

Query: 531 GHAAELMDSVVKQ-------------SCDQ--AELLKYIHIGLLCVQGDPIDRPTMSSVA 575
               ++ + V  +              C +   +L+        C   +P  R T   V 
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE------CWAHNPASRLTALRVK 323

Query: 576 VMLAS 580
             LA 
Sbjct: 324 KTLAK 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  191 bits (487), Expect = 3e-56
 Identities = 72/307 (23%), Positives = 117/307 (38%), Gaps = 44/307 (14%)

Query: 304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV--IAKLQHK 361
            +D +    +G+G +G V++G    G+ +AVK  S    +  + +  E  +     L+H+
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHE 62

Query: 362 NLVRLLGCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           N++  +   +    S     LI  Y    SL  +L    +   LD    + I+  IA G+
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118

Query: 418 LYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVV 470
            +LH +      +  I HRDLK+ N+L+       I+D G+A +     NQ     N  V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 471 GTYGYMAPE------YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI 524
           GT  YMAPE               + D+++FG+VL E+     S G       P      
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP------ 232

Query: 525 WKLWCEGHAA-ELMDSVV----------KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSS 573
           +        + E M  VV           +      L     +   C   +P  R T   
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292

Query: 574 VAVMLAS 580
           +   L  
Sbjct: 293 IKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  188 bits (478), Expect = 2e-54
 Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 48/303 (15%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV--IAKLQHKNLVRLL 367
           +  +G+G FG V++G    G+E+AVK  S    +  + +  E  +     L+H+N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102

Query: 368 GCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
               ++N +     L+ +Y  + SL  +L        +  +  I +    A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 424 -----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYM 476
                 +  I HRDLK+ N+L+       I+D G+A       +      N  VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 477 APEYAMGGI------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
           APE     I         ++D+++ G+V  EI       G     H    L Y   +  +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSD 274

Query: 531 GHAAELMDSVVKQ-----------SCDQAELLKYIHIGLL--CVQGDPIDRPTMSSVAVM 577
               E+   V +Q           SC+   ++      ++  C   +   R T   +   
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA----KIMRECWYANGAARLTALRIKKT 330

Query: 578 LAS 580
           L+ 
Sbjct: 331 LSQ 333

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  173 bits (440), Expect = 3e-49
 Identities = 78/304 (25%), Positives = 122/304 (40%), Gaps = 42/304 (13%)

Query: 310 ENKLGEGGFGPVYKGVL---ADGKEI--AVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNL 363
              LGEG FG V         DG     AVK L   +G Q    +K E+ ++  L H+++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           ++  GCC +   +   L+ EY+P  SL  +L        +   + +   + I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YM 476
                  IHRDL   NVLLD++   KI DFG+A+              V   G     + 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           APE      F   SDV+SFGV L E+++    S            +A       +     
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-----GQMTVLR 259

Query: 536 LMDSVVK-------QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKP 588
           L + + +         C   E+  Y H+   C + +   RPT  ++  +L   +    + 
Sbjct: 260 LTELLERGERLPRPDKCPA-EV--Y-HLMKNCWETEASFRPTFENLIPIL-KTVHEKYQG 314

Query: 589 TQPA 592
             P+
Sbjct: 315 QAPS 318

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  171 bits (436), Expect = 2e-48
 Identities = 79/316 (25%), Positives = 127/316 (40%), Gaps = 60/316 (18%)

Query: 310 ENKLGEGGFGPVYKGV---LADGKEI--AVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            ++LG+G FG V       L D      AVK+L  +     ++F+ E+ ++  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 365 RLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +  G           L+ EY+P+  L  FL       +LD  R +     I +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMA 477
               + +HRDL   N+L++ E + KI+DFG+A++   ++       VV   G     + A
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           PE     IFS +SDV+SFGVVL E+ +   KS                            
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSAEFLR 239

Query: 537 MDSVVKQSCDQAELLKYIHIG-----------------LLCVQGDPIDRPTMSSVAVMLA 579
           M    +     + LL+ +  G                  LC    P DRP+ S++   L 
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL- 298

Query: 580 SDILTLPKPT-QPAFS 594
             + +  +     AF+
Sbjct: 299 DMLWSGSRGCETHAFT 314

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  171 bits (436), Expect = 4e-48
 Identities = 75/292 (25%), Positives = 113/292 (38%), Gaps = 39/292 (13%)

Query: 306 DFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNL 363
           D     ++G G FG V+ G L AD   +AVK            +F  E  ++ +  H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VRL+G C ++    ++ E +       FL   T   +L  K  + ++   A G+ YL   
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES- 231

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
                IHRDL   N L+  +   KISDFGM+R        A+         + APE    
Sbjct: 232 --KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 484 GIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWK-------LWCEGHAAE 535
           G +S +SDV+SFG++L E  S G      Y +        ++ K         C      
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346

Query: 536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPK 587
           LM                      C   +P  RP+ S++   L   I    +
Sbjct: 347 LM--------------------EQCWAYEPGQRPSFSTIYQEL-QSIRKRHR 377

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  169 bits (429), Expect = 7e-48
 Identities = 67/292 (22%), Positives = 126/292 (43%), Gaps = 43/292 (14%)

Query: 310 ENKLGEGGFGPVYKGVLA-----DGKEIAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNL 363
              LGEG FG V            G+++AVK L   + G  + + K E+ ++  L H+N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 364 VRLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           V+  G C E+  +   LI E++P+ SL  +L       +++ K+++     I +G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS--KANTNRVVGTYG----- 474
                + +HRDL   NVL++ E   KI DFG+ +    ++       +            
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD------RDSPVF 194

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA 534
           + APE  M   F + SDV+SFGV L E+++   S     +     +     ++       
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM----TVT 250

Query: 535 ELMDSVVK-------QSCDQAELLKYIH-IGLLCVQGDPIDRPTMSSVAVML 578
            L++++ +        +C        ++ +   C +  P +R +  ++    
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDE-----VYQLMRKCWEFQPSNRTSFQNLIEGF 297

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  169 bits (431), Expect = 7e-48
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 33/219 (15%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +LGEG FG V+     +         +AVK L   S    Q+F+ E  ++  LQH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL------------FDSTRSVQLDWKRRISIIK 411
           VR  G C E    L+++EYM +  L+ FL             +      L   + +++  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN--- 467
            +A G++YL   + L  +HRDL T N L+   +  KI DFGM+R I+  +  +       
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 468 --RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
             R      +M PE  +   F+ +SDV+SFGVVL EI +
Sbjct: 223 PIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  168 bits (427), Expect = 1e-47
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 34/220 (15%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +LGEG FG V+     +         +AVK L   +    ++F+ E  ++  LQH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL-------------FDSTRSVQLDWKRRISII 410
           V+  G C + +  ++++EYM +  L+ FL                    +L   + + I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN-- 467
             IA G++YL   +    +HRDL T N L+   +  KI DFGM+R ++  +  +   +  
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 468 ---RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              R      +M PE  M   F+ +SDV+SFGV+L EI +
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  168 bits (427), Expect = 1e-47
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 35/288 (12%)

Query: 310 ENKLGEGGFGPVYKGV---LADGKEI--AVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
             +LG+G FG V       L D      AVK+L  ++ + L++F+ E+ ++  LQH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 365 RLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +  G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMA 477
               + IHRDL T N+L+++E   KI DFG+ ++   ++        V   G     + A
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE      FSV SDV+SFGVVL E+ +  + +    +E    +               L+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLI 242

Query: 538 DSVVK-------QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           + +           C   E+  Y  I   C   +   RP+   +A+ +
Sbjct: 243 ELLKNNGRLPRPDGC-PDEI--Y-MIMTECWNNNVNQRPSFRDLALRV 286

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  167 bits (425), Expect = 2e-47
 Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 35/221 (15%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKN 362
             +LGE  FG VYKG L           +A+K L  +  G   +EF++E  + A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL-------------FDSTRSVQLDWKRRISI 409
           +V LLG   ++    +I+ Y  +  L  FL              D T    L+    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN- 467
           +  IA G+ YL   S   ++H+DL T NVL+  ++N KISD G+ R ++  +  K   N 
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 468 ----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
               R      +MAPE  M G FS+ SD++S+GVVL E+ S
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (426), Expect = 3e-47
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 37/289 (12%)

Query: 310 ENKLGEGGFGPVYKGV---LADGKEI--AVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
             +LG+G FG V       L D      AVK+L  ++ + L++F+ E+ ++  LQH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 365 RLLGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +  G C         LI EY+P  SL  +L       ++D  + +     I +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMA 477
               + IHRDL T N+L+++E   KI DFG+ ++   ++        V   G     + A
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE      FSV SDV+SFGVVL E+ +  + +    +E    +               L+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLI 273

Query: 538 DSVVK-------QSCDQAELLKYIH-IGLLCVQGDPIDRPTMSSVAVML 578
           + +           C        I+ I   C   +   RP+   +A+ +
Sbjct: 274 ELLKNNGRLPRPDGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRV 317

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  165 bits (421), Expect = 2e-46
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 29/214 (13%)

Query: 311 NKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNL 363
            +LG+G FG VY+GV     +      +A+K +    S +   EF NE +V+ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL-------FDSTRSVQLDWKRRISIIKGIARG 416
           VRLLG   +   +L+I E M    L  +L        ++         + I +   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN-----RVV 470
           + YL+     K +HRDL   N ++  +   KI DFGM R I+  +  +         R  
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
               +M+PE    G+F+  SDV+SFGVVL EI +
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  164 bits (417), Expect = 3e-46
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGK-EIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
            D + ++KLG G +G VY+GV       +AVK L +     ++EF  E  V+ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V+LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL--- 127

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN-----RVVGTYGYMAP 478
            +   IHRDL   N L+      K++DFG++R+  G+   A+       +      + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAP 181

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E      FS+KSDV++FGV+L EI +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  164 bits (417), Expect = 4e-46
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 29/215 (13%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE----IAVKRLSR--TSGQGLQEFKNEVTVIAKLQHKNL 363
              LGEG FG V +G L         +AVK +    +S + ++EF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 364 VRLLGCCLEEN-----ESLLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIAR 415
           +RLLG C+E +     + ++I  +M    L  +L  S   T    +  +  +  +  IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN-----RV 469
           G+ YL   S    +HRDL   N +L  +M   ++DFG+++ I+ G+  +         + 
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214

Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                ++A E     +++ KSDV++FGV + EI +
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  163 bits (414), Expect = 6e-46
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           D +   +LG G FG V  G      ++A+K + +       EF  E  V+  L H+ LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L G C ++    +I EYM N  L  +L       +   ++ + + K +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ES 138

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN-----RVVGTYGYMAPEY 480
            + +HRDL   N L++ +   K+SDFG++R    ++  ++       R      +  PE 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEV 192

Query: 481 AMGGIFSVKSDVFSFGVVLLEIIS 504
            M   FS KSD+++FGV++ EI S
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYS 216

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  164 bits (417), Expect = 6e-46
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 23/214 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRL-SRTSGQGLQEFKNEVTVIAKLQ 359
           +F +   LG G FG VYKG+     E     +A+K L   TS +  +E  +E  V+A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           + ++ RLLG CL      LI + MP   L  ++ +   ++    +  ++    IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNY 132

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG----- 474
           L      +++HRDL   NVL+    + KI+DFG+A++ G  + + +        G     
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIK 184

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKK 507
           +MA E  +  I++ +SDV+S+GV + E+++ G K
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  164 bits (417), Expect = 7e-46
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 21/210 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGVL--ADGKEI--AVKRL-SRTSGQGLQEFKNEVTVIAKLQH 360
               E  +G G  G V  G L     +++  A+K L +  + +  ++F +E +++ +  H
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N++RL G       ++++ EYM N SLD FL   T   Q    + + +++G+  G+ YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------ 474
              S L  +HRDL   NVL+D  +  K+SDFG++R+   +   A T     T G      
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIR 219

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           + APE      FS  SDV+SFGVV+ E+++
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  161 bits (411), Expect = 9e-46
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            + +   ++G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G CLE+    L+ E+M +  L  +L   T+      +  + +   +  G+ YL    
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYA 481
              +IHRDL   N L+      K+SDFGM R    +Q  ++T    GT     + +PE  
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 177

Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               +S KSDV+SFGV++ E+ S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  162 bits (413), Expect = 1e-45
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 13/203 (6%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLV 364
           +  +G+G FG VY G   D  +     A+K LSR T  Q ++ F  E  ++  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 365 RLLGCCLEENESLLI-YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
            L+G  L       +   YM +  L  F+    R+  +  K  IS    +ARG+ YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY--GYMAPEYA 481
           +  K +HRDL   N +LD     K++DFG+AR     +  +            + A E  
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200

Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               F+ KSDV+SFGV+L E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  164 bits (416), Expect = 1e-45
 Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 52/246 (21%)

Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGL 345
           +P + I+ V+          +GEG FG V++              +AVK L    S    
Sbjct: 44  YPRNNIEYVR---------DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 94

Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL------------- 392
            +F+ E  ++A+  + N+V+LLG C       L++EYM    L+ FL             
Sbjct: 95  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154

Query: 393 --------FDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM 444
                     S     L    ++ I + +A G+ YL   S  K +HRDL T N L+   M
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENM 211

Query: 445 NPKISDFGMAR-IFGGNQSKANTN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVV 498
             KI+DFG++R I+  +  KA+ N     R      +M PE      ++ +SDV+++GVV
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVV 265

Query: 499 LLEIIS 504
           L EI S
Sbjct: 266 LWEIFS 271

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  161 bits (409), Expect = 2e-45
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 13/202 (6%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           + +   +LG G FG V  G      ++AVK + +       EF  E   + KL H  LV+
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
             G C +E    ++ EY+ N  L  +L   +    L+  + + +   +  G+ +L     
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ES 122

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAM 482
            + IHRDL   N L+D ++  K+SDFGM R    +Q  ++     GT     + APE   
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFH 178

Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              +S KSDV++FG+++ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  162 bits (411), Expect = 2e-45
 Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE----IAVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLV 364
              +G G FG VY G L D        AVK L+R T    + +F  E  ++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 365 RLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
            LLG CL    S L +  YM +  L  F+ + T       K  I     +A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLAS- 146

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------YMA 477
              K +HRDL   N +LD +   K++DFG+AR             V    G      +MA
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMA 200

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            E      F+ KSDV+SFGV+L E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  162 bits (413), Expect = 2e-45
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE----IAVKRL--SRTSGQGLQEFKNEVTVIAKLQHKNL 363
              LG+G FG V +  L         +AVK L     +   ++EF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 364 VRLLGCCLEENES------LLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIA 414
            +L+G  L           ++I  +M +  L  FL  S        L  +  +  +  IA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN-----R 468
            G+ YL   S    IHRDL   N +L  +M   ++DFG++R I+ G+  +         +
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 469 VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                 ++A E     +++V SDV++FGV + EI++
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  162 bits (412), Expect = 3e-45
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 22/211 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRL-SRTSGQGLQEFKNEVTVIAKLQ 359
             +++  +G G FG VYKG+L          +A+K L +  + +   +F  E  ++ +  
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N++RL G   +    ++I EYM N +LD FL    +  +    + + +++GIA G+ Y
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG----- 474
           L   + +  +HRDL   N+L++  +  K+SDFG++R+   +     T     T G     
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPI 214

Query: 475 -YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            + APE      F+  SDV+SFG+V+ E+++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  161 bits (409), Expect = 4e-45
 Identities = 64/315 (20%), Positives = 118/315 (37%), Gaps = 49/315 (15%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKN 362
            DF     LG GGFG V++     D    A+KR+         ++   EV  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 363 LVRLLGCCLEENE---------SLLIY---EYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           +VR     LE+N           + +Y   +    ++L  ++       + +    + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV- 469
             IA  + +LH      ++HRDLK SN+    +   K+ DFG+      ++ +       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 470 ---------VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL 520
                    VGT  YM+PE   G  +S K D+FS G++L E++         +       
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------YPFSTQME 232

Query: 521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
                          L     ++   +  +++        +   P++RP   ++   + +
Sbjct: 233 RVRTLTDVRNLKFPPLFT---QKYPCEYVMVQ------DMLSPSPMERPEAINI---IEN 280

Query: 581 DILT-LPKPTQPAFS 594
            +   L  P +    
Sbjct: 281 AVFEDLDFPGKTVLR 295

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  160 bits (407), Expect = 4e-45
 Identities = 65/202 (32%), Positives = 91/202 (45%), Gaps = 25/202 (12%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
              +G+G FG V  G    G ++AVK +   +    Q F  E +V+ +L+H NLV+LLG 
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 370 CLEENESLLI-YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
            +EE   L I  EYM   SL  +L    RS  L     +     +   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------YMAPEYAM 482
           +HRDL   NVL+  +   K+SDFG+ +                         + APE   
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 187

Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              FS KSDV+SFG++L EI S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  165 bits (419), Expect = 5e-45
 Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 19/235 (8%)

Query: 273 WCIIRRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI 332
            C    + K  +    A   F      +    ++      +G+G FG V  G    G ++
Sbjct: 163 LCTRLIKPKVMEGTVAAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKV 219

Query: 333 AVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVF 391
           AVK +   +    Q F  E +V+ +L+H NLV+LLG  +EE   L ++ EYM   SL  +
Sbjct: 220 AVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277

Query: 392 LFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF 451
           L    RS  L     +     +   + YL        +HRDL   NVL+  +   K+SDF
Sbjct: 278 LRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDF 333

Query: 452 GMARIFGGNQSKANTNRVVGTYGY--MAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           G+ +       +A++ +  G       APE      FS KSDV+SFG++L EI S
Sbjct: 334 GLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  160 bits (407), Expect = 5e-45
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
                 +LG G FG V+ G      ++AVK L +        F  E  ++ +LQH+ LVR
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L     +E    +I EYM N SL  FL  +   ++L   + + +   IA G+ ++     
Sbjct: 73  LYAVVTQE-PIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EE 127

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY--MAPEYAMG 483
              IHRDL+ +N+L+   ++ KI+DFG+AR+   N+    T R    +     APE    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 184

Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
           G F++KSDV+SFG++L EI++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  162 bits (413), Expect = 6e-45
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 15/203 (7%)

Query: 310 ENKLGEGGFGPVYKGVL--ADGKEI--AVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +  +G G FG V  G L     KEI  A+K L    + +  ++F  E +++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           RL G   +    +++ EYM N SLD FL       Q    + + +++GIA G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYA 481
            +  +HRDL   N+L++  +  K+SDFG+ R+   +   A T R  G      + +PE  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAI 222

Query: 482 MGGIFSVKSDVFSFGVVLLEIIS 504
               F+  SDV+S+G+VL E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  160 bits (407), Expect = 7e-45
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 38/221 (17%)

Query: 306 DFSQENKLGEGGFGPVYKGVL--------ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK 357
           D      LG+G F  ++KGV             E+ +K L +      + F    ++++K
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L HK+LV   G C+  +E++L+ E++   SLD +L  +   + + WK  + + K +A  +
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAM 126

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP--------KISDFGMARIFGGNQSKANTNRV 469
            +L       +IH ++   N+LL  E +         K+SD G++               
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175

Query: 470 VGTYGY-----MAPE-YAMGGIFSVKSDVFSFGVVLLEIIS 504
                      + PE        ++ +D +SFG  L EI S
Sbjct: 176 ---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  161 bits (410), Expect = 7e-45
 Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 47/241 (19%)

Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE--------IAVKRL-SRTSGQ 343
           FP D + + K          LGEG FG V         +        +AVK L    + +
Sbjct: 32  FPRDKLTLGK---------PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82

Query: 344 GLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL---------- 392
            L +  +E+ ++  + +HKN++ LLG C ++    +I EY    +L  +L          
Sbjct: 83  DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142

Query: 393 ---FDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
               +     Q+ +K  +S    +ARG+ YL   +  K IHRDL   NVL+      KI+
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 199

Query: 450 DFGMAR-IFGGNQSKANTN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
           DFG+AR I   +  K  TN     +      +MAPE     +++ +SDV+SFGV++ EI 
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

Query: 504 S 504
           +
Sbjct: 254 T 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  161 bits (409), Expect = 9e-45
 Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 43/250 (17%)

Query: 278 RRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE---IAV 334
             + +   +   +P+   + I              +GEG FG V K  +         A+
Sbjct: 7   HHHGKNNPDPTIYPVLDWNDIKFQD---------VIGEGNFGQVLKARIKKDGLRMDAAI 57

Query: 335 KRL-SRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL 392
           KR+    S    ++F  E+ V+ KL  H N++ LLG C       L  EY P+ +L  FL
Sbjct: 58  KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117

Query: 393 -------------FDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL 439
                          ++ +  L  ++ +     +ARG+ YL   S+ + IHRDL   N+L
Sbjct: 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNIL 174

Query: 440 LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAPEYAMGGIFSVKSDVFS 494
           +      KI+DFG++R             V  T G     +MA E     +++  SDV+S
Sbjct: 175 VGENYVAKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226

Query: 495 FGVVLLEIIS 504
           +GV+L EI+S
Sbjct: 227 YGVLLWEIVS 236

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  160 bits (408), Expect = 9e-45
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKN 362
              LGEG FG V K      K       +AVK L    S   L++  +E  V+ ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL---------------------FDSTRSVQL 401
           +++L G C ++   LLI EY    SL  FL                      D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 460
                IS    I++G+ YL   + +K++HRDL   N+L+      KISDFG++R ++  +
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 461 QSKANTN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                +      +      +MA E     I++ +SDV+SFGV+L EI++
Sbjct: 205 SYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  160 bits (408), Expect = 1e-44
 Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 29/215 (13%)

Query: 310 ENKLGEGGFGPVYKGVLADGK------EIAVKRL-SRTSGQGLQEFKNEVTVIAKLQHKN 362
              LG G FG VY+G ++         ++AVK L    S Q   +F  E  +I+K  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFL----FDSTRSVQLDWKRRISIIKGIARGIL 418
           +VR +G  L+     ++ E M    L  FL       ++   L     + + + IA G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 419 YLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMAR-IFGGNQSKANTN-----RV 469
           YL        IHRD+   N LL         KI DFGMAR I+  +  +         + 
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK- 210

Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 211 -----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  164 bits (418), Expect = 1e-44
 Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 7/201 (3%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
            D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V+LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL--- 334

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
            +   IHR+L   N L+      K++DFG++R+  G+   A+         + APE    
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393

Query: 484 GIFSVKSDVFSFGVVLLEIIS 504
             FS+KSDV++FGV+L EI +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  161 bits (409), Expect = 2e-44
 Identities = 70/232 (30%), Positives = 101/232 (43%), Gaps = 38/232 (16%)

Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGK------EIAVKRL-SRTSGQGL 345
            P   I +++          LG G FG VY+G ++         ++AVK L    S Q  
Sbjct: 68  VPRKNITLIR---------GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118

Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL----FDSTRSVQL 401
            +F  E  +I+K  H+N+VR +G  L+     ++ E M    L  FL       ++   L
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178

Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMAR-IF 457
                + + + IA G  YL        IHRD+   N LL         KI DFGMAR I+
Sbjct: 179 AMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

Query: 458 GGNQSKANTN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                +         +      +M PE  M GIF+ K+D +SFGV+L EI S
Sbjct: 236 RAGYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  161 bits (409), Expect = 2e-44
 Identities = 70/241 (29%), Positives = 111/241 (46%), Gaps = 47/241 (19%)

Query: 293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKE--------IAVKRL-SRTSGQ 343
           FP D + + K          LGEG FG V         +        +AVK L    + +
Sbjct: 78  FPRDKLTLGK---------PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128

Query: 344 GLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL---------- 392
            L +  +E+ ++  + +HKN++ LLG C ++    +I EY    +L  +L          
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188

Query: 393 ---FDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS 449
               +     Q+ +K  +S    +ARG+ YL   +  K IHRDL   NVL+      KI+
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 245

Query: 450 DFGMAR-IFGGNQSKANTN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
           DFG+AR I   +  K  TN     +      +MAPE     +++ +SDV+SFGV++ EI 
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

Query: 504 S 504
           +
Sbjct: 300 T 300

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  161 bits (409), Expect = 3e-44
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 310 ENKLGEGGFGPVYKGVL--ADGKEI--AVKRLSR-TSGQGLQEFKNEVTVIAKLQHKNLV 364
              +G G FG VY G L   DGK+I  AVK L+R T    + +F  E  ++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 365 RLLGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
            LLG CL    S L +  YM +  L  F+ + T       K  I     +A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFL--- 208

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYG-----YMA 477
           +  K +HRDL   N +LD +   K++DFG+AR ++       +      T       +MA
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 264

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            E      F+ KSDV+SFGV+L E+++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  163 bits (414), Expect = 3e-44
 Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 13/198 (6%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG G FG V+        ++AVK + +     ++ F  E  V+  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             +E    +I E+M   SL  FL     S +    + I     IA G+ ++    +   I
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAMGGIF 486
           HRDL+ +N+L+   +  KI+DFG+AR+   N+  A      G      + APE    G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362

Query: 487 SVKSDVFSFGVVLLEIIS 504
           ++KSDV+SFG++L+EI++
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  160 bits (406), Expect = 3e-44
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 34/220 (15%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHK 361
              LG G FG V +       +      +AVK L S       +   +E+ +++ L QH+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-----------LDWKRRISII 410
           N+V LLG C      L+I EY     L  FL   +R ++              +  +   
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN-- 467
             +A+G+ +L   +    IHRD+   NVLL +    KI DFG+AR I   +      N  
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 468 ---RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
              +      +MAPE     +++V+SDV+S+G++L EI S
Sbjct: 228 LPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  159 bits (404), Expect = 3e-44
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 311 NKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHKN 362
             LG G FG V +       +      +AVK L    +    +   +E+ ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 363 LVRLLGCCLEENESL-LIYEYMPNKSLDVFL-------------FDSTRSVQLDWKRRIS 408
           +V LLG C +    L +I E+    +L  +L              +      L  +  I 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTN 467
               +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR I+         +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 468 -----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                +      +MAPE     +++++SDV+SFGV+L EI S
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  159 bits (404), Expect = 4e-44
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE-----IAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNL 363
              LG G FG V+KGV     E     + +K +   SG Q  Q   + +  I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VRLLG C       L+ +Y+P  SL   +     ++    +  ++    IA+G+ YL   
Sbjct: 78  VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYL--- 131

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAP 478
               ++HR+L   NVLL      +++DFG+A +   +  +   +            +MA 
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMAL 186

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIIS 504
           E    G ++ +SDV+S+GV + E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  158 bits (403), Expect = 5e-44
 Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 38/224 (16%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHK 361
              LG G FG V +       +      +AVK L         +   +E+ V++ L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFL---------------FDSTRSVQLDWKRR 406
           N+V LLG C     +L+I EY     L  FL                     + LD +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +A+G+ +L   +    IHRDL   N+LL H    KI DFG+AR I   +     
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 466 TN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
            N     +      +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 205 GNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  159 bits (403), Expect = 7e-44
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 22/210 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRL-SRTSGQGLQEFKNEVTVIAKLQ 359
           +F +   LG G FG VYKG+     E     +A+K L   TS +  +E  +E  V+A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           + ++ RLLG CL      LI + MP   L  ++ +      +  +  ++    IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNY 132

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG----- 474
           L      +++HRDL   NVL+    + KI+DFG+A++ G  + + +        G     
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIK 184

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  157 bits (399), Expect = 8e-44
 Identities = 66/214 (30%), Positives = 90/214 (42%), Gaps = 19/214 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL--ADGKEI--AVKRL---SRTSGQGLQEFKNEVTVIAK 357
           +D     KLG+G FG V +G      GK +  AVK L     +  + + +F  EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H+NL+RL G  L      ++ E  P  SL   L        L           +A G+
Sbjct: 78  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGM 134

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YG 474
            YL E  R   IHRDL   N+LL      KI DFG+ R    N               + 
Sbjct: 135 GYL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKK 507
           + APE      FS  SD + FGV L E+ + G++
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  156 bits (396), Expect = 2e-43
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 310 ENKLGEGGFGPVYKGVL-ADGKEI--AVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           + +LG G FG V +GV     K+I  A+K L   T     +E   E  ++ +L +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L+G C  E   +L+ E      L  FL    +  ++       ++  ++ G+ YL     
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------YMAPE 479
              +HRDL   NVLL +    KISDFG+++  G + S                  + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPE 183

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 FS +SDV+S+GV + E +S
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  158 bits (402), Expect = 3e-43
 Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 38/224 (16%)

Query: 310 ENKLGEGGFGPVYKGVLADGK--------EIAVKRL-SRTSGQGLQEFKNEVTVIAKL-Q 359
              LGEG FG V                 ++AVK L S  + + L +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-------------FDSTRSVQLDWKRR 406
           HKN++ LLG C ++    +I EY    +L  +L                    QL  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 407 ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKAN 465
           +S    +ARG+ YL   +  K IHRDL   NVL+  +   KI+DFG+AR I   +  K  
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 466 TN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           TN     +      +MAPE     I++ +SDV+SFGV+L EI +
Sbjct: 251 TNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (395), Expect = 3e-43
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGVL--ADGKEI--AVKRLSR-TSGQGLQEFKNEVTVIAKLQH 360
           D      LGEG FG VY+GV     G++I  AVK   +  +    ++F +E  ++  L H
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            ++V+L+G   EE  + +I E  P   L  +L  +  S+++     +     I + + YL
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 129

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMA 477
                +  +HRD+   N+L+      K+ DFG++R            +   T     +M+
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMS 182

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           PE      F+  SDV+ F V + EI+S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  155 bits (393), Expect = 5e-43
 Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 306 DFSQENKLGEGGFGPVYKGVL--ADGKEI--AVKRL-SRTSGQGLQEFKNEVTVIAKLQH 360
                  +GEG FG V++G+    +   +  A+K   + TS    ++F  E   + +  H
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            ++V+L+G   E     +I E      L  FL    R   LD    I     ++  + YL
Sbjct: 76  PHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL 132

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------ 474
                 + +HRD+   NVL+      K+ DFG++R    +                    
Sbjct: 133 ---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIK 182

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           +MAPE      F+  SDV+ FGV + EI+ 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILM 212

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  154 bits (392), Expect = 1e-42
 Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 35/290 (12%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQH 360
            +F  E K+G G F  VY+   L DG  +A+K++        +   +   E+ ++ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 361 KNLVRLLGCCLEENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRI-SIIKGIARGIL 418
            N+++       E+  L I  E      L   +    +  +L  +R +      +   + 
Sbjct: 92  PNVIKYYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           ++H     +++HRD+K +NV +      K+ D G+ R F    + A++  +VGT  YM+P
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY-HSEHGPSLLAYIWKLWCEGHAAELM 537
           E      ++ KSD++S G +L E+ + +    FY    +  SL   I     +     L 
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKI----EQCDYPPLP 259

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPK 587
                 S +  +L+       +C+  DP  RP          + +  + K
Sbjct: 260 SDHY--SEELRQLVN------MCINPDPEKRPD--------VTYVYDVAK 293

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  154 bits (391), Expect = 1e-42
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 309 QENKLGEGGFGPVYKGVLADGK---EIAVKRL--SRTSGQGLQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG     K    +AVK L           E   E  V+ +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C  E+  +L+ E      L+ +L    ++  +  K  I ++  ++ G+ YL   
Sbjct: 81  VRMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL--- 133

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG------YMA 477
                +HRDL   NVLL  +   KISDFG+++    +++                  + A
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIIS 504
           PE      FS KSDV+SFGV++ E  S
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  153 bits (389), Expect = 2e-42
 Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 31/267 (11%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           ++G G F  VYKG+      E+A    +  + +    Q FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 369 CCL---EENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
                 +  + +++  E M + +L  +L    R   +  K   S  + I +G+ +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 425 RLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              IIHRDLK  N+ +     + KI D G+A +   + +KA    V+GT  +MAPE    
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
             +    DV++FG+ +LE+ + +     Y         A I++    G      D V   
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP---YSECQNA---AQIYRRVTSGVKPASFDKV--A 255

Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPT 570
             +  E+++       C++ +  +R +
Sbjct: 256 IPEVKEIIE------GCIRQNKDERYS 276

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (400), Expect = 2e-42
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 37/286 (12%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L +      + F  E  V+ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 490 SDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK-------LWCEGHAAELMDSVVK 542
           SDV+SFG++L E+ +  +    Y       +L  + +         C     +LM     
Sbjct: 362 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPCPPECPESLHDLM----- 414

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKP 588
                            C + +P +RPT   +   L  D  T  +P
Sbjct: 415 ---------------CQCWRKEPEERPTFEYLQAFL-EDYFTSTEP 444

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  154 bits (392), Expect = 3e-42
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 43/229 (18%)

Query: 310 ENKLGEGGFGPVYKGVLADGKE------IAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHK 361
              LG G FG V         +      +AVK L  +      +   +E+ ++ +L  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFL--------------------FDSTRSVQL 401
           N+V LLG C       LI+EY     L  +L                     +      L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGN 460
            ++  +     +A+G+ +L        +HRDL   NVL+ H    KI DFG+AR I   +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 461 QSKANTN-----RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                 N     +      +MAPE    GI+++KSDV+S+G++L EI S
Sbjct: 227 NYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  159 bits (403), Expect = 3e-42
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 37/286 (12%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           E KLG+G FG V+ G       +A+K L   +    + F  E  V+ KL+H+ LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             EE    ++ EYM   SL  FL   T    L   + + +   IA G+ Y+    R+  +
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 430 HRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G F++K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 490 SDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK-------LWCEGHAAELMDSVVK 542
           SDV+SFG++L E+ +  +    Y       +L  + +         C     +LM     
Sbjct: 445 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPCPPECPESLHDLM----- 497

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKP 588
                            C + +P +RPT   +   L  D  T  +P
Sbjct: 498 ---------------CQCWRKEPEERPTFEYLQAFL-EDYFTSTEP 527

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  153 bits (389), Expect = 8e-42
 Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 33/285 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHK 361
           + + +  K+GEG FG         DG++  +K   +SR S +  +E + EV V+A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+V+      E     ++ +Y     L   + ++ + V     + +     I   + ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
           +    KI+HRD+K+ N+ L  +   ++ DFG+AR+       A     +GT  Y++PE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
               ++ KSD+++ G VL E+ + K +   + +    +L+  I      G    +     
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLVLKI----ISGSFPPVSLHY- 249

Query: 542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
             S D   L+          + +P DRP+         + IL   
Sbjct: 250 --SYDLRSLVS------QLFKRNPRDRPS--------VNSILEKG 278

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  151 bits (383), Expect = 1e-41
 Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 69/305 (22%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
            DF +   +G GGFG V+K     DGK   +KR+   +    ++ + EV  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 364 VRLLGCCLEENESL----------------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           V   GC    +                   +  E+    +L+ ++ +  R  +LD    +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            + + I +G+ Y+H     K+I+RDLK SN+ L      KI DFG+      N  K    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR- 180

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
              GT  YM+PE      +  + D+++ G++L E++     T F                
Sbjct: 181 -SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFE--------------- 223

Query: 528 WCEGHAAELMDSVVKQ------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD 581
                 ++    +            +  LL+        +   P DRP          S+
Sbjct: 224 -----TSKFFTDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPN--------TSE 264

Query: 582 ILTLP 586
           IL   
Sbjct: 265 ILRTL 269

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  148 bits (377), Expect = 8e-41
 Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 34/290 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHK 361
           +D+     +G G +G   K    +DGK +  K       +    Q   +EV ++ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 362 NLVRLLGCCLEE-NESLLIY-EYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGIL 418
           N+VR     ++  N +L I  EY     L   +   T+  Q LD +  + ++  +   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 419 YLHE--DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
             H   D    ++HRDLK +NV LD + N K+ DFG+ARI   + S A T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           +PE      ++ KSD++S G +L E+ +      F       S      K+  EG    +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FT----AFSQKELAGKI-REGKFRRI 236

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
                  S +  E++         +      RP+          +IL  P
Sbjct: 237 PYRY---SDELNEIIT------RMLNLKDYHRPS--------VEEILENP 269

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  155 bits (394), Expect = 1e-40
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 310 ENKLGEGGFGPVYKGVL-ADGKEI--AVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           + +LG G FG V +GV     K+I  A+K L   T     +E   E  ++ +L +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L+G C  E   +L+ E      L  FL    +  ++       ++  ++ G+ YL     
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT---YGYMAPEYAM 482
              +HR+L   NVLL +    KISDFG+++  G + S               + APE   
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECIN 512

Query: 483 GGIFSVKSDVFSFGVVLLEIIS 504
              FS +SDV+S+GV + E +S
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  148 bits (376), Expect = 2e-40
 Identities = 72/314 (22%), Positives = 119/314 (37%), Gaps = 64/314 (20%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
             DF +   LG+G FG V K     D +  A+K++  T  + L    +EV ++A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 363 LVRLLGCCLEENESLL----------IY---EYMPNKSLDVFLFD--STRSVQLDWKRRI 407
           +VR     LE    +           ++   EY  N +L    +D   + ++        
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF---------- 457
            + + I   + Y+H      IIHRDLK  N+ +D   N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 458 ----GGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                G+     +   +GT  Y+A E   G G ++ K D++S G++  E+I         
Sbjct: 177 SQNLPGSSDNLTS--AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----ST 230

Query: 513 HSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS 572
             E        I K           D    +   + ++++     L+    DP  RP   
Sbjct: 231 GMER-----VNILKKLRSVSIEFPPDFDDNKMKVEKKIIR----LLIDH--DPNKRPG-- 277

Query: 573 SVAVMLASDILTLP 586
                 A  +L   
Sbjct: 278 ------ARTLLNSG 285

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  155 bits (392), Expect = 3e-40
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 22/205 (10%)

Query: 310 ENKLGEGGFGPVYKGVL--ADGKEI--AVKRL-SRTSGQGLQEFKNEVTVIAKLQHKNLV 364
              +GEG FG V++G+    +   +  A+K   + TS    ++F  E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L+G   E     +I E      L  FL    R   LD    I     ++  + YL    
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG-----YMAPE 479
             + +HRD+   NVL+      K+ DFG++R         ++     + G     +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 562

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIIS 504
                 F+  SDV+ FGV + EI+ 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  145 bits (367), Expect = 3e-39
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 9/198 (4%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL 371
           LG+G +G VY G  L++   IA+K +     +  Q    E+ +   L+HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
           E     +  E +P  SL   L      ++ + +      K I  G+ YLH++   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 432 DLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI--FSV 488
           D+K  NVL++ +    KISDFG ++   G      T    GT  YMAPE    G   +  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204

Query: 489 KSDVFSFGVVLLEIISGK 506
            +D++S G  ++E+ +GK
Sbjct: 205 AADIWSLGCTIIEMATGK 222

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  143 bits (363), Expect = 1e-38
 Identities = 69/292 (23%), Positives = 107/292 (36%), Gaps = 42/292 (14%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKL-QH 360
           Q F + ++LG G +G V+K     DG+  AVK         +       EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 361 KNLVRLLGCCLEENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
              VRL     EE   L +  E     SL            L   +    ++     + +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH      ++H D+K +N+ L      K+ DFG+     G           G   YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE 226

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS 539
              G  +   +DVFS G+ +LE+    +         G       W+   +G+      +
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEVACNME-----LPHGGEG-----WQQLRQGYLPPEFTA 275

Query: 540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQP 591
            +  S +   +L       + ++ DP  R T        A  +L LP   QP
Sbjct: 276 GL--SSELRSVLV------MMLEPDPKLRAT--------AEALLALPVLRQP 311

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  142 bits (359), Expect = 1e-37
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEF-KNEVTVIAKLQHKN 362
            DF + ++LG G  G V+K      G  +A K +       ++     E+ V+ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V   G    + E  +  E+M   SLD  L    ++ ++  +    +   + +G+ YL E
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
               KI+HRD+K SN+L++     K+ DFG++       S AN+   VGT  YM+PE   
Sbjct: 150 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMSPERLQ 203

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
           G  +SV+SD++S G+ L+E+  G+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (356), Expect = 1e-37
 Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 29/223 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
           + +    KLGEGGF  V     L DG   A+KR+     Q  +E + E  +     H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 364 VRLLGCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGI 413
           +RL+  CL E  +     L+  +    +L   +         D    ++      ++ GI
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGI 143

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV--- 470
            RG+  +H        HRDLK +N+LL  E  P + D G       +   +     +   
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 471 ----GTYGYMAPE---YAMGGIFSVKSDVFSFGVVLLEIISGK 506
                T  Y APE        +   ++DV+S G VL  ++ G+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (356), Expect = 1e-37
 Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 37/283 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKN 362
           + +S   ++G GG   V++ +    +  A+K   L     Q L  ++NE+  + KLQ  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 363 L--VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
              +RL    + +    ++ E   N  L+ +L    +   +D   R S  K +   +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE- 479
           H+     I+H DLK +N L+  +   K+ DFG+A     + +    +  VGT  YM PE 
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 480 ----------YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                            S KSDV+S G +L  +  GK  T F    +  S L  I     
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIID--- 254

Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS 572
             H  E  D       D  ++LK       C++ DP  R ++ 
Sbjct: 255 PNHEIEFPDIP---EKDLQDVLK------CCLKRDPKQRISIP 288

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (355), Expect = 4e-37
 Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 37/283 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKN 362
           + +S   ++G GG   V++ +    +  A+K   L     Q L  ++NE+  + KLQ  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 363 L--VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
              +RL    + +    ++ E   N  L+ +L    +   +D   R S  K +   +  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE- 479
           H+     I+H DLK +N L+  +   K+ DFG+A     + +    +  VGT  YM PE 
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 480 ----------YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC 529
                            S KSDV+S G +L  +  GK  T F    +  S L  I     
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIID--- 235

Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS 572
             H  E  D       D  ++LK       C++ DP  R ++ 
Sbjct: 236 PNHEIEFPDIP---EKDLQDVLK------CCLKRDPKQRISIP 269

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  141 bits (357), Expect = 4e-37
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 37/282 (13%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKLQHKNL 363
            +S   ++G GG   V++ +    +  A+K   L     Q L  ++NE+  + KLQ  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 364 --VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
             +RL    + +    ++ E   N  L+ +L        +D   R S  K +   +  +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIH 172

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE-- 479
           +     I+H DLK +N L+  +   K+ DFG+A     + +    +  VG   YM PE  
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 480 ---------YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
                           S KSDV+S G +L  +  GK  T F    +  S L  I      
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIID---P 283

Query: 531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS 572
            H  E  D       D  ++LK       C++ DP  R ++ 
Sbjct: 284 NHEIEFPDIP---EKDLQDVLK------CCLKRDPKQRISIP 316

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  139 bits (353), Expect = 5e-37
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 38/281 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHK 361
           +D     ++G G +G V K V    G+ +AVKR+  T   +  ++   ++ V+ +     
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS--IIKGIARGIL- 418
            +V+  G    E +  +  E M + S D F     + V       I   I+  I    + 
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136

Query: 419 ---YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
              +L E+  LKIIHRD+K SN+LLD   N K+ DFG++     + +K       G   Y
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191

Query: 476 MAPE----YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF-YHSEHGP-SLLAYIWKLWC 529
           MAPE     A    + V+SDV+S G+ L E+ +G+    F Y   +     L  +     
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----FPYPKWNSVFDQLTQV----V 243

Query: 530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
           +G   +L +S  ++       + +++   LC+  D   RP 
Sbjct: 244 KGDPPQLSNSEEREFSP--SFINFVN---LCLTKDESKRPK 279

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  138 bits (350), Expect = 6e-37
 Identities = 57/205 (27%), Positives = 113/205 (55%), Gaps = 12/205 (5%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
            + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYLH 421
           +V  L   L  +E  ++ EY+   SL     D      +D + +I+ + +   + + +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVCRECLQALEFLH 133

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
            +   ++IHRD+K+ N+LL  + + K++DFG        QSK +T  +VGT  +MAPE  
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
               +  K D++S G++ +E+I G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (351), Expect = 1e-36
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 32/273 (11%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFK-NEVTVIAKLQHK 361
               + + ++G G FG V++      G + AVK++       L+ F+  E+   A L   
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSP 110

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            +V L G   E     +  E +   SL   +    +   L   R +  +     G+ YLH
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH 167

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNR---VVGTYGYMA 477
                +I+H D+K  NVLL  + +   + DFG A     +    +      + GT  +MA
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE  MG     K D++S   ++L +++G      +       L   I           + 
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP---WTQYFRGPLCLKIAS-----EPPPIR 276

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT 570
           +     +   A+ ++        ++ +P+ R +
Sbjct: 277 EIPPSCAPLTAQAIQ------EGLRKEPVHRAS 303

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  138 bits (349), Expect = 1e-36
 Identities = 59/236 (25%), Positives = 110/236 (46%), Gaps = 15/236 (6%)

Query: 276 IRRRNKRKQEESQAFPLFPLDLIDIVKA---TQDFSQENKLGEGGFGPVYKGV-LADGKE 331
           +   N   Q        F   L  +V             K+GEG  G V        G++
Sbjct: 13  LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72

Query: 332 IAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVF 391
           +AVK +     Q  +   NEV ++   QH N+V +    L   E  ++ E++   +L   
Sbjct: 73  VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-- 130

Query: 392 LFDSTRSVQLDWKRRISII-KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD 450
             D    V+L+ + +I+ + + + + + YLH      +IHRD+K+ ++LL  +   K+SD
Sbjct: 131 --DIVSQVRLN-EEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSD 184

Query: 451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           FG       +  K  +  +VGT  +MAPE     +++ + D++S G++++E++ G+
Sbjct: 185 FGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  135 bits (341), Expect = 1e-35
 Identities = 65/309 (21%), Positives = 111/309 (35%), Gaps = 63/309 (20%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKL-Q 359
           T +F +  K+G G FG V+K V   DG   A+KR           Q    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 360 HKNLVRLLGCCLEENESLLIY-EYMPNKSLDVFLFDSTRSVQLDWKRRI-SIIKGIARGI 417
           H ++VR       E++ +LI  EY    SL   + ++ R +    +  +  ++  + RG+
Sbjct: 70  HSHVVRYFSAW-AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNP-------------------KISDFGMARIFG 458
            Y+H      ++H D+K SN+ +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182

Query: 459 GNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG 517
                ++     G   ++A E          K+D+F+  + ++     +           
Sbjct: 183 ---RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE---------PL 230

Query: 518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM 577
           P      W    +G    +   +   S +  ELLK      + +  DP  RP+       
Sbjct: 231 PRNGD-QWHEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRPS------- 273

Query: 578 LASDILTLP 586
            A  ++   
Sbjct: 274 -AMALVKHS 281

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  134 bits (340), Expect = 1e-35
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 30/235 (12%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHK 361
            D     +LG G +G V K   +  G+ +AVKR+  T   Q  +    ++ +  +     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS--IIKGIARGIL- 418
             V   G    E +  +  E M + SLD F             + I   I+  IA  I+ 
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVK 120

Query: 419 ---YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
              +LH  S+L +IHRD+K SNVL++     K+ DFG++     + +K   +   G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPY 175

Query: 476 MAPE----YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF-YHSEHGP-SLLAYI 524
           MAPE          +SVKSD++S G+ ++E+   +    F Y S   P   L  +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQLKQV 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  134 bits (340), Expect = 2e-35
 Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 15/210 (7%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
            + +    +LG+G FG VYK      G   A K +   S + L+++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYLH 421
           +V+LLG    + +  ++ E+ P  ++D  + +  R +       I ++ + +   + +LH
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLH 134

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                +IIHRDLK  NVL+  E + +++DFG++        K ++   +GT  +MAPE  
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVV 189

Query: 482 MGGIFS-----VKSDVFSFGVVLLEIISGK 506
           M           K+D++S G+ L+E+   +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  134 bits (340), Expect = 2e-35
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 24/219 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKN 362
             +   + LG+G    V++G     G   A+K  +  S     +    E  V+ KL HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 363 LVRLLGCCLEENESLLIY---EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           +V+L     EE  +       E+ P  SL   L + + +  L     + +++ +  G+ +
Sbjct: 69  IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 420 LHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           L E     I+HR++K  N++     D +   K++DFG AR    ++ +  +  + GT  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEY 181

Query: 476 MAPE--------YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           + P+              +    D++S GV      +G 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  133 bits (336), Expect = 6e-35
 Identities = 63/206 (30%), Positives = 110/206 (53%), Gaps = 13/206 (6%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHK 361
            + F++  K+G+G FG V+KG+     K +A+K +     +  +++ + E+TV+++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGILYL 420
            + +  G  L++ +  +I EY+   S      D      LD + +I+ I + I +G+ YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYL 135

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H +   K IHRD+K +NVLL      K++DFG+A      Q K NT   VGT  +MAPE 
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 190

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
                +  K+D++S G+  +E+  G+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE 216

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  133 bits (336), Expect = 7e-35
 Identities = 63/231 (27%), Positives = 115/231 (49%), Gaps = 16/231 (6%)

Query: 282 RKQEESQAFPLFPLDLIDIVKATQD----FSQENKLGEGGFGPVYKGV-LADGKEIAVKR 336
            +  + +  P   L  +D    T+     F    KLGEG +G VYK +    G+ +A+K+
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 337 LSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDST 396
           +       LQE   E++++ +    ++V+  G   +  +  ++ EY    S+   +    
Sbjct: 62  VPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119

Query: 397 RSVQLDWKRRISII-KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 455
           +++  D    I+ I +   +G+ YLH     + IHRD+K  N+LL+ E + K++DFG+A 
Sbjct: 120 KTLTEDE---IATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173

Query: 456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
                 +K NT  V+GT  +MAPE      ++  +D++S G+  +E+  GK
Sbjct: 174 QLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (341), Expect = 2e-34
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 19/210 (9%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLV 364
            F  ++ LG G  G +    + D +++AVKR+     +       EV ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           R      +     +  E       +       +         I++++    G+ +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 425 RLKIIHRDLKTSNVLL-----DHEMNPKISDFGMARIFGGNQ-SKANTNRVVGTYGYMAP 478
            L I+HRDLK  N+L+       ++   ISDFG+ +     + S +  + V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 479 EYAMGGIF---SVKSDVFSFGVVLLEIISG 505
           E          +   D+FS G V   +IS 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  133 bits (337), Expect = 2e-34
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 24/219 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKN 362
             +   + LG+G    V++G     G   A+K  +  S     +    E  V+ KL HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 363 LVRLLGCCLEENESLLIY---EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           +V+L     EE  +       E+ P  SL   L + + +  L     + +++ +  G+ +
Sbjct: 69  IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 420 LHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           L E     I+HR++K  N++     D +   K++DFG AR    +  +  +  + GT  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGTEEY 181

Query: 476 MAPE--------YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           + P+              +    D++S GV      +G 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  130 bits (329), Expect = 8e-34
 Identities = 54/230 (23%), Positives = 100/230 (43%), Gaps = 22/230 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHK 361
            D     ++G G  G V+K      G  IAVK++ R+   +  +    ++ V+ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            +V+  G  +   +  +  E M     +         +      +++    I + + YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMT--VAIVKALYYLK 141

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE-- 479
           E     +IHRD+K SN+LLD     K+ DFG++     +++K   +R  G   YMAPE  
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERI 196

Query: 480 ---YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF-YHSEHGP-SLLAYI 524
                    + +++DV+S G+ L+E+ +G+    F Y +      +L  +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ----FPYKNCKTDFEVLTKV 242

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (336), Expect = 5e-33
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)

Query: 302 KATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQ 359
           +    +  + +LG GGFG V + +    G+++A+K+  +      +E +  E+ ++ KL 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 360 HKNLVRLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGI 413
           H N+V               +  LL  EY     L  +L        L      +++  I
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFGGNQSKANTNRVV 470
           +  + YLHE    +IIHRDLK  N++L      +  KI D G A+              V
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FV 184

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           GT  Y+APE      ++V  D +SFG +  E I+G 
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  128 bits (323), Expect = 9e-33
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQ 359
            + FS   ++G G FG VY    + + + +A+K++S   + S +  Q+   EV  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII-KGIARGIL 418
           H N ++  GC L E+ + L+ EY    + D+          L  +  I+ +  G  +G+ 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQ-EVEIAAVTHGALQGLA 168

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           YLH      +IHRD+K  N+LL      K+ DFG A       + AN+   VGT  +MAP
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAP 219

Query: 479 EYAMG---GIFSVKSDVFSFGVVLLEIISGK 506
           E  +    G +  K DV+S G+  +E+   K
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (318), Expect = 1e-32
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQHKNLVRLL 367
           KLG GG   VY         ++A+K +    R   + L+ F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 368 GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLK 427
               E++   L+ EY+   +L  ++        L     I+    I  GI + H    ++
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131

Query: 428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFS 487
           I+HRD+K  N+L+D     KI DFG+A+      S   TN V+GT  Y +PE A G    
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 488 VKSDVFSFGVVLLEIISGK 506
             +D++S G+VL E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  124 bits (314), Expect = 6e-32
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTS--GQGLQE-FKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++       +  A K + ++       +E    E+++   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGILYLHE 422
              + +   ++ E    +SL     +  +      ++ ++       ++ I  G  YLH 
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH- 132

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
             R ++IHRDLK  N+ L+ ++  KI DFG+A     +  +     + GT  Y+APE   
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 188

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
               S + DV+S G ++  ++ GK
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGK 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  125 bits (316), Expect = 7e-32
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTS--GQGLQE-FKNEVTVIAKLQHKNLVRLLG 368
           LG+GGF   ++       +  A K + ++       +E    E+++   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGILYLHE 422
              + +   ++ E    +SL     +  +      ++ ++       ++ I  G  YLH 
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH- 158

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
             R ++IHRDLK  N+ L+ ++  KI DFG+A     +  +     + GT  Y+APE   
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLS 214

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
               S + DV+S G ++  ++ GK
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGK 238

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  125 bits (315), Expect = 7e-32
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 24/227 (10%)

Query: 295 LDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVT 353
           +DL  +      F     +G G +G VYKG  +  G+  A+K +   +G   +E K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEIN 72

Query: 354 VIAKL-QHKNLVRLLGCCLEENESL------LIYEYMPNKSL-DVFLFDSTRSVQLDWKR 405
           ++ K   H+N+    G  +++N         L+ E+    S+ D+       +++ +W  
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-- 130

Query: 406 RISII-KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
            I+ I + I RG+ +LH+    K+IHRD+K  NVLL      K+ DFG++        + 
Sbjct: 131 -IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186

Query: 465 NTNRVVGTYGYMAPEYAMGGIFS-----VKSDVFSFGVVLLEIISGK 506
           NT   +GT  +MAPE              KSD++S G+  +E+  G 
Sbjct: 187 NT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (320), Expect = 8e-32
 Identities = 58/228 (25%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNL 363
                E  LG G  G V       G+ +AVKR+             E+ ++ +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFL----FDSTRSVQLDWKRRISIIKGIARGILY 419
           +R       +    +  E   N +L   +                  IS+++ IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNP-------------KISDFGMARIFGGNQS--KA 464
           LH    LKIIHRDLK  N+L+                    ISDFG+ +     QS  + 
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 465 NTNRVVGTYGYMAPEYAMGGIFSV-------KSDVFSFGVVLLEIISG 505
           N N   GT G+ APE                  D+FS G V   I+S 
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  123 bits (311), Expect = 1e-31
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTS--GQGLQE-FKNEVTVIAKLQH 360
           +DF   N LG+G F  VY+   +  G E+A+K + + +    G+ +  +NEV +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            +++ L     + N   L+ E   N  ++ +L +  +    +  R    +  I  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYL 128

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H      I+HRDL  SN+LL   MN KI+DFG+A        K  T  + GT  Y++PE 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
           A      ++SDV+S G +   ++ G+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (325), Expect = 2e-31
 Identities = 43/203 (21%), Positives = 82/203 (40%), Gaps = 24/203 (11%)

Query: 312 KLGEGGFGPVYKGV--LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL- 367
            +  GG G +Y  +    +G+ + +K L  +     Q     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 368 -GCCLEENESLLIY---EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
                + +   + Y   EY+  +SL           +L     I+ +  I   + YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
             + +++ DLK  N++L  E   K+ D G                + GT G+ APE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251

Query: 484 GIFSVKSDVFSFGVVLLEIISGK 506
           G  +V +D+++ G  L  +    
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 4e-31
 Identities = 52/219 (23%), Positives = 81/219 (36%), Gaps = 23/219 (10%)

Query: 310 ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLL 367
              L EGGF  VY+   +  G+E A+KRL     +  +    EV  + KL  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 368 GCCLEENES-------LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
                  E         L+   +    L  FL        L     + I     R + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR----------VV 470
           H   +  IIHRDLK  N+LL ++   K+ DFG A         + + +            
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 471 GTYGYMAPE---YAMGGIFSVKSDVFSFGVVLLEIISGK 506
            T  Y  PE            K D+++ G +L  +   +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  122 bits (308), Expect = 6e-31
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLL 367
            LG GG   V+    L D +++AVK  R            F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 368 GCCLEENESLLIY----EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
                E  +  +     EY+   +L   +        +  KR I +I    + + + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGGNQSKANTNRVVGTYGYMAPEYAM 482
            +  IIHRD+K +N+++      K+ DFG+AR I     S   T  V+GT  Y++PE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 483 GGIFSVKSDVFSFGVVLLEIISGK 506
           G     +SDV+S G VL E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  121 bits (305), Expect = 1e-30
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 23/211 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKN--------EVTVIA 356
           + + +  K+GEG +G VYK   + G+ +A+KR+       L             E++++ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           +L H N+V L+     E    L++E+M  K L   L        L   +    +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRG 131

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + + H+    +I+HRDLK  N+L++ +   K++DFG+AR F G   ++ T+ VV T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186

Query: 477 APEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
           AP+  MG   +S   D++S G +  E+I+GK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (307), Expect = 2e-30
 Identities = 35/227 (15%), Positives = 73/227 (32%), Gaps = 22/227 (9%)

Query: 299 DIVKATQDFSQENKLGEGGFGPVYKGV------LADGKEIAVKRLSRTSGQGLQEFKNEV 352
           +    ++     + LGEG F  VY+          + ++  +K     +          +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 353 TVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD--VFLFDSTRSVQLDWKRRISII 410
             +        ++     L +N S+L+ E     +L   + L+ +T    +     IS  
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-----------KISDFGMARIFGG 459
             +   I  +H+    +IIH D+K  N +L +                + D G +     
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
                       T G+   E      ++ + D F     +  ++ G 
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  120 bits (303), Expect = 2e-30
 Identities = 62/346 (17%), Positives = 102/346 (29%), Gaps = 87/346 (25%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFKNEVTVIAKLQHKN 362
            DF     +G GGFG V++     D    A+KR+         ++   EV  +AKL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI-------IKGIAR 415
           +VR     LE        E       D        S        + I        K    
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 416 GILYLHEDSRLKI-----------------------------------------IH---- 430
            +        L I                                         +H    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 431 --RDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN----------RVVGTYGYMAP 478
             RDLK SN+    +   K+ DFG+      ++ +                VGT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD 538
           E   G  +S K D+FS G++L E++    +               I           L  
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFST---------QMERVRIITDVRNLKFPLLFT 296

Query: 539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT 584
              ++   +  +++        +   P +RP  + +   + + I  
Sbjct: 297 ---QKYPQEHMMVQ------DMLSPSPTERPEATDI---IENAIFE 330

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  121 bits (305), Expect = 3e-30
 Identities = 64/303 (21%), Positives = 107/303 (35%), Gaps = 46/303 (15%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA--DGKEIAVKRLSRTSGQGLQEF-------------- 348
            D+     L +G F  +    L   D K  A+K+  ++  +  ++F              
Sbjct: 31  NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 349 ---KNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSL-----DVFLFDSTRSVQ 400
              KNE+ +I  ++++  +   G     +E  +IYEYM N S+       F+ D   +  
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 401 LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN 460
           +  +    IIK +     Y+H  +   I HRD+K SN+L+D     K+SDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 461 QSKANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
             K       GTY +M PE+          K D++S G+ L  +        F       
Sbjct: 206 --KIKG--SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV--VPFSLKISLV 259

Query: 519 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIG-------LLCVQGDPIDRPTM 571
            L   I     E             +        ++           L    +P +R T 
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK--NPAERITS 317

Query: 572 SSV 574
              
Sbjct: 318 EDA 320

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  123 bits (310), Expect = 4e-30
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 34/243 (13%)

Query: 280 NKRKQEESQAFPLFPLDLIDIVKATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAV 334
            +            P   I         S+      KLG G +G V          E A+
Sbjct: 10  GRENLYFQGDLQATPGMFIT--SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 335 KRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFL 392
           K + +T  S     +   EV V+  L H N+++L     ++    L+ E          L
Sbjct: 68  KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----L 123

Query: 393 FDSTRSVQLDWKRRIS------IIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHE 443
           FD    +    + + +      IIK +  G+ YLH+     I+HRDLK  N+LL   + +
Sbjct: 124 FD--EIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175

Query: 444 MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEII 503
              KI DFG++ +F   +        +GT  Y+APE  +   +  K DV+S GV+L  ++
Sbjct: 176 ALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231

Query: 504 SGK 506
           +G 
Sbjct: 232 AGY 234

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  118 bits (299), Expect = 5e-30
 Identities = 53/213 (24%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTVI 355
           Q + +  K+GEG +G V+K       + +A+KR+       L +           E+ ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            +L+HKN+VRL      + +  L++E+   + L  +    + +  LD +   S +  + +
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLK 112

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           G+ + H      ++HRDLK  N+L++     K+++FG+AR F G   +  +  VV T  Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167

Query: 476 MAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKK 507
             P+   G  ++S   D++S G +  E+ +  +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (303), Expect = 6e-30
 Identities = 37/341 (10%), Positives = 73/341 (21%), Gaps = 66/341 (19%)

Query: 279 RNKRKQEESQAFPLFPLD-----LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEI 332
           +      E+    ++P +        + +  +       L  G    V+    +   ++ 
Sbjct: 31  KEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDF 90

Query: 333 AVKRL---SRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC------------------- 370
           A+K     +  S   L+         A+L  ++                           
Sbjct: 91  ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 371 -------LEENESLLIYEYMP---NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
                        LL+                F               +   + R    L
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
                  ++H      N+ +  +    + D       G                Y   E+
Sbjct: 211 Q---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREF 262

Query: 481 AMGG--IFSVKSDVFSFGVVLLEIISGK-----KSTGFYHSEHGPSLLAYIWKLWCEGHA 533
                  F+   + +  G+ +  +          + G   S   PSL          G  
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322

Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
             L D V         L+       L    D   R      
Sbjct: 323 TPLPDFV-------KTLIG----RFLNF--DRRRRLLPLEA 350

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (299), Expect = 7e-30
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 21/206 (10%)

Query: 310 ENKLGEGGFGPVYKG---VLADGKEIAVKRLSR--TSGQGLQE-FKNEVTVIAKLQHKNL 363
              +G GG G VY+    V    + +A+K +S   +S    +   + E     +LQ  ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 364 VRL--LGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           V +   G   E +  L +    +    L   L        L   R ++I++ I   +   
Sbjct: 97  VPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAA 150

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H        HRD+K  N+L+  +    + DFG+A      +        VGT  YMAPE 
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPER 206

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
                 + ++D+++   VL E ++G 
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGS 232

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  118 bits (298), Expect = 7e-30
 Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKN--------EVTVIA 356
           + +    K+GEG +G VYK     G+  A+K++       L++           E++++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
           +L+H N+V+L      +   +L++E++     D+          L+     S +  +  G
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           I Y H+    +++HRDLK  N+L++ E   KI+DFG+AR F G   +  T+ +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167

Query: 477 APEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
           AP+  MG   +S   D++S G +  E+++G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  118 bits (299), Expect = 9e-30
 Identities = 68/217 (31%), Positives = 116/217 (53%), Gaps = 22/217 (10%)

Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG-----LQEFKNEVTV 354
           + ++  F Q  KLG G +  VYKG+    G  +A+K +   S +G     ++E    +++
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56

Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           + +L+H+N+VRL      EN+  L++E+M    L  ++ DS           ++++K   
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQ 114

Query: 415 ----RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
               +G+ + HE+   KI+HRDLK  N+L++     K+ DFG+AR F G      ++ VV
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170

Query: 471 GTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            T  Y AP+  MG   +S   D++S G +L E+I+GK
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  122 bits (307), Expect = 9e-30
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 33/223 (14%)

Query: 300 IVKATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNE 351
           +  +T  FS     +  LG+G FG V        G+E AVK +S+         +    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 352 VTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS--- 408
           V ++ +L H N+++L     ++    L+ E          LFD    +    ++R S   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD--EIIS---RKRFSEVD 127

Query: 409 ---IIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQS 462
              II+ +  GI Y+H+    KI+HRDLK  N+LL     + N +I DFG++  F  ++ 
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
                  +GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 185 ---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (297), Expect = 1e-29
 Identities = 50/214 (23%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNL 363
           D+  +  +G G    V         +++A+KR++    Q  + E   E+  +++  H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 364 VRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWK---RRISII-KGIARGIL 418
           V      + ++E  L+ + +   S+ D+      +            I+ I + +  G+ 
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA-----RIFGGNQSKANTNRVVGTY 473
           YLH++     IHRD+K  N+LL  + + +I+DFG++                T   VGT 
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTP 190

Query: 474 GYMAPEYAM-GGIFSVKSDVFSFGVVLLEIISGK 506
            +MAPE       +  K+D++SFG+  +E+ +G 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  119 bits (300), Expect = 1e-29
 Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 23/202 (11%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVK-----RLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
            +G+G F  V + +    G++ AVK     + + + G   ++ K E ++   L+H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFD-----STRSVQLDWKRRISIIKGIARGILYL 420
           LL     +    +++E+M        L       +              ++ I   + Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           H+     IIHRD+K   VLL  + N    K+  FG+A   G +   A     VGT  +MA
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201

Query: 478 PEYAMGGIFSVKSDVFSFGVVL 499
           PE      +    DV+  GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (304), Expect = 2e-29
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 30/215 (13%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQH 360
            + ++    LG+G FG V K       +E AVK +++     +       EV ++ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGI 413
            N+++L     E++ S  ++ E          LFD    ++   ++R S      IIK +
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGE----LFD--EIIK---RKRFSEHDAARIIKQV 130

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVV 470
             GI Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  N         +
Sbjct: 131 FSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI 184

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
           GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  117 bits (296), Expect = 4e-29
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 29/223 (13%)

Query: 298 IDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------ 350
           +D+    + + + + LGEG F  VYK       + +A+K++ +   +   E K+      
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR--SEAKDGINRTA 59

Query: 351 --EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
             E+ ++ +L H N++ LL     ++   L++++M    L+V +     S+ L      S
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII--KDNSLVLT----PS 112

Query: 409 IIKGIA----RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA 464
            IK       +G+ YLH+     I+HRDLK +N+LLD     K++DFG+A+ F G+ ++A
Sbjct: 113 HIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRA 168

Query: 465 NTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            T++VV T  Y APE   G  ++ V  D+++ G +L E++   
Sbjct: 169 YTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  118 bits (297), Expect = 4e-29
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 15/199 (7%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
             S+   LG G FG V+K    A G ++A K +     +  +E KNE++V+ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDS--TRSVQLDWKRRISIIKGIARGILYLHE 422
           +L      +N+ +L+ EY+        LFD     S  L     I  +K I  GI ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
              + I+H DLK  N+L  +      KI DFG+AR +   +         GT  ++APE 
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259

Query: 481 AMGGIFSVKSDVFSFGVVL 499
                 S  +D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (289), Expect = 9e-29
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT----SGQGLQEFKNEVTVIAKLQ 359
           +DF     LG+G FG VY          +A+K L +     +G   Q  + EV + + L+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGIL 418
           H N++RL G   +     LI EY P  ++    +   + +   D +R  + I  +A  + 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     ++IHRD+K  N+LL      KI+DFG +     +  +     + GT  Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTD--LCGTLDYLPP 176

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E   G +   K D++S GV+  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  115 bits (291), Expect = 1e-28
 Identities = 58/243 (23%), Positives = 105/243 (43%), Gaps = 30/243 (12%)

Query: 279 RNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRL 337
                + ++Q      +       +   + +  KLGEG +G VYK +     + +A+KR+
Sbjct: 8   HMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI 67

Query: 338 SRTSGQGLQEFKN--------EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLD 389
                  L+  +         EV+++ +LQH+N++ L       +   LI+EY     L 
Sbjct: 68  R------LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLK 120

Query: 390 VFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--- 446
            ++ D    V +   +  S +  +  G+ + H     + +HRDLK  N+LL         
Sbjct: 121 KYM-DKNPDVSMRVIK--SFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETP 174

Query: 447 --KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEII 503
             KI DFG+AR F G   +  T+ ++ T  Y  PE  +G   +S   D++S   +  E++
Sbjct: 175 VLKIGDFGLARAF-GIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

Query: 504 SGK 506
              
Sbjct: 233 MKT 235

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  117 bits (294), Expect = 1e-28
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
              +    +LG G FG V++ V  A G+    K ++          KNE++++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYL 420
           L+ L     ++ E +LI E++        LFD  +    ++     I+ ++    G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           HE     I+H D+K  N++ + +     KI DFG+A     ++          T  + AP
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 479 EYAMGGIFSVKSDVFSFGVVL 499
           E          +D+++ GV+ 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (292), Expect = 2e-28
 Identities = 40/217 (18%), Positives = 85/217 (39%), Gaps = 20/217 (9%)

Query: 304 TQDFSQENKLGEG--GFGPVYKGV-LADGKEIAVKR--LSRTSGQGLQEFKNEVTVIAKL 358
              +     +G+G      V        G+ + V+R  L   S + +   + E+ V    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSL-DVFLFDSTRSVQLDWKRRISII-KGIARG 416
            H N+V      + +NE  ++  +M   S  D  L  +     ++ +  I+ I +G+ + 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMN-ELAIAYILQGVLKA 140

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-----NRVVG 471
           + Y+H       +HR +K S++L+  +    +S          +  +           V 
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 472 TYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGK 506
              +++PE     +  +  KSD++S G+   E+ +G 
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (286), Expect = 3e-28
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 43/218 (19%)

Query: 304 TQDFSQE----NKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIA 356
           +  FS       +LG+G F  V + V    G E A K ++    S +  Q+ + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--------- 407
           KLQH N+VRL     EE+   L+++ +        LF+            I         
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-----------DIVAREFYSEA 105

Query: 408 ---SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 461
                I+ I   I Y H      I+HR+LK  N+LL  +      K++DFG+A     ++
Sbjct: 106 DASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162

Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
           +    +   GT GY++PE      +S   D+++ GV+L
Sbjct: 163 A---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  115 bits (289), Expect = 4e-28
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 43/222 (19%)

Query: 300 IVKATQDFSQE----NKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEV 352
           ++ A+  FS       +LG+G F  V + V    G E A K ++    S +  Q+ + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 353 TVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI----- 407
            +  KLQH N+VRL     EE+   L+++ +        LF+            I     
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-----------DIVAREF 124

Query: 408 -------SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIF 457
                    I+ I   I Y H      I+HR+LK  N+LL  +      K++DFG+A   
Sbjct: 125 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
             +++    +   GT GY++PE      +S   D+++ GV+L
Sbjct: 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (283), Expect = 6e-28
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 40/214 (18%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQH 360
            + ++    LG+G FG V K       +E AVK +++     +       EV ++ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI------------S 408
            N+++L     + +   ++ E          LFD            I             
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----------EIIKRKRFSEHDAAR 125

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKAN 465
           IIK +  GI Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  N     
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
               +GT  Y+APE  + G +  K DV+S GV+L
Sbjct: 180 MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  113 bits (285), Expect = 8e-28
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 19/209 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKG-VLADGKEIAVKRLSRTSGQG-----LQEFKNEVTVIAKL 358
           + + + +KLGEG +  VYKG        +A+K +     +G     ++E    V+++  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           +H N+V L      E    L++EY+ +K L  +L        ++       +  + RG+ 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLA 114

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H     K++HRDLK  N+L++     K++DFG+AR      +K   N VV T  Y  P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169

Query: 479 EYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
           +  +G   +S + D++  G +  E+ +G+
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  115 bits (291), Expect = 1e-27
 Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 45/252 (17%)

Query: 281 KRKQEESQAFPLFPLDLIDIVKATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAVK 335
            R+    Q   + P   +   K      +      KLG G +G V          E A+K
Sbjct: 10  GRENLYFQGIAINPGMYVR--KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67

Query: 336 RLSR-------------TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY 382
            + +                +  +E  NE++++  L H N+++L     ++    L+ E+
Sbjct: 68  VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127

Query: 383 MPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGILYLHEDSRLKIIHRDLKTS 436
                    LF+     Q+  + +        I+K I  GI YLH+     I+HRD+K  
Sbjct: 128 YEGGE----LFE-----QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPE 175

Query: 437 NVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVF 493
           N+LL   +  +N KI DFG++  F  +         +GT  Y+APE  +   ++ K DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVW 231

Query: 494 SFGVVLLEIISG 505
           S GV++  ++ G
Sbjct: 232 SCGVIMYILLCG 243

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  112 bits (282), Expect = 1e-27
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 24/212 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTVI 355
           + + +  K+GEG +G V+K      G+ +A+K+          E           E+ ++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            +L+H NLV LL     +    L++EY       V          +      SI     +
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQ 113

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + + H   +   IHRD+K  N+L+      K+ DFG AR+  G  S    + V  T  Y
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWY 168

Query: 476 MAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            +PE  +G   +    DV++ G V  E++SG 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  113 bits (284), Expect = 1e-27
 Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 34/222 (15%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN--------EVTVIA 356
            + +  K+G+G FG V+K      G+++A+K++       ++  K         E+ ++ 
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQ 71

Query: 357 KLQHKNLVRLLGCCLEENESL--------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
            L+H+N+V L+  C  +            L++++      D+    S   V+        
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKR 128

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--- 465
           +++ +  G+ Y+H +   KI+HRD+K +NVL+  +   K++DFG+AR F   ++      
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 466 TNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
           TNRVV T  Y  PE  +G   +    D++  G ++ E+ +  
Sbjct: 186 TNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  112 bits (282), Expect = 2e-27
 Identities = 43/201 (21%), Positives = 88/201 (43%), Gaps = 16/201 (7%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
            + +     LG G FG V++ V  +  K    K + +  G      K E++++   +H+N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYL 420
           ++ L        E ++I+E++        +F+  +T + +L+ +  +S +  +   + +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           H      I H D++  N++     +   KI +FG AR         N   +     Y AP
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAP 172

Query: 479 EYAMGGIFSVKSDVFSFGVVL 499
           E     + S  +D++S G ++
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  111 bits (280), Expect = 2e-27
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 32/226 (14%)

Query: 296 DLIDIVKATQDFSQE----NKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL----- 345
             +    +T  F +       LG G    V + +     KE AVK +  T G        
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 346 ----QEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-TRSV 399
               +    EV ++ K+  H N+++L           L+++ M    L    FD  T  V
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKV 119

Query: 400 QLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 459
            L  K    I++ +   I  LH+   L I+HRDLK  N+LLD +MN K++DFG +     
Sbjct: 120 TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

Query: 460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKS------DVFSFGVVL 499
            +       V GT  Y+APE     +           D++S GV++
Sbjct: 177 GEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 2e-27
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 25/208 (12%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHK 361
              F  + KLG G FG V+     + G E  +K +++   Q  +++ + E+ V+  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR-------ISIIKGIA 414
           N++++     + +   ++ E          L +  R V    + +         ++K + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGE----LLE--RIVSAQARGKALSEGYVAELMKQMM 134

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
             + Y H      ++H+DLK  N+L          KI DFG+A +F  ++    +    G
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAG 188

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
           T  YMAPE       + K D++S GVV+
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (284), Expect = 3e-27
 Identities = 30/233 (12%), Positives = 66/233 (28%), Gaps = 43/233 (18%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLS---RTSGQGLQEFKNEVTVIAKLQH-------- 360
           LG+       +      G+   V       R     +++ K EV  +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 361 --------KNLVRLLGCC-----LEENESLLIYEY---MPNKSLDVFLF------DSTRS 398
                    +LV+            +   + +       P    ++  F       S+  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 399 VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 458
             L    R+ +   + R +  LH      ++H  L+  +++LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261

Query: 459 GNQSKANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGK 506
           G  + +   R        A            + +   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  111 bits (281), Expect = 3e-27
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 32/223 (14%)

Query: 302 KATQDFSQENKLGEGGFGPVYKG--VLADGKEIAVKRLSRTSGQGLQEFKN--------E 351
           +A Q +    ++GEG +G V+K   +   G+ +A+KR+       +Q  +         E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIRE 61

Query: 352 VTVIAKLQ---HKNLVRLL----GCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDW 403
           V V+  L+   H N+VRL         +    L L++E++ ++ L  +L D      +  
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPT 119

Query: 404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK 463
           +    ++  + RG+ +LH     +++HRDLK  N+L+      K++DFG+ARI+      
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--M 174

Query: 464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           A T+ VV T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 175 ALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  110 bits (277), Expect = 3e-27
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 42/218 (19%)

Query: 302 KATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIA 356
               D +Q    EN +G G +G V   V        A K++ +   + +  FK E+ ++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--------- 407
            L H N++RL     +  +  L+ E          LF+           R+         
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGE----LFE-----------RVVHKRVFRES 106

Query: 408 ---SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQ 461
               I+K +   + Y H+   L + HRDLK  N L      +   K+ DFG+A  F   +
Sbjct: 107 DAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163

Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
                   VGT  Y++P+  + G++  + D +S GV++
Sbjct: 164 ---MMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (289), Expect = 4e-27
 Identities = 54/289 (18%), Positives = 105/289 (36%), Gaps = 31/289 (10%)

Query: 220 FCPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRR 279
           F      ++   +    T  V +    + R+R   + E    +              +  
Sbjct: 80  FRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRG------------KGT 127

Query: 280 NKRKQEESQAFPLFPLDLIDIVKATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAV 334
                +              +               +LG G FG V++    A G   A 
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 335 KRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFD 394
           K +        +  + E+  ++ L+H  LV L     ++NE ++IYE+M        LF+
Sbjct: 188 KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFE 243

Query: 395 --STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISD 450
             +    ++     +  ++ + +G+ ++HE      +H DLK  N++   + +   K+ D
Sbjct: 244 KVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLID 300

Query: 451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
           FG+       Q   +     GT  + APE A G      +D++S GV+ 
Sbjct: 301 FGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  110 bits (277), Expect = 6e-27
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 22/215 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLS-RTSGQGLQEFKN----EVTVIAKLQ 359
            +    ++G G +G VYK      G  +A+K +     G G          EV ++ +L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 360 ---HKNLVRLLGCCLEENESL-----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIK 411
              H N+VRL+  C            L++E++ ++ L  +L D      L  +    +++
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 127

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
              RG+ +LH +    I+HRDLK  N+L+      K++DFG+ARI+      A T  VV 
Sbjct: 128 QFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV- 181

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           T  Y APE  +   ++   D++S G +  E+   K
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  111 bits (279), Expect = 6e-27
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 28/214 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIA------- 356
           + +     +GEG +G V K      G+ +A+K+          +    V  IA       
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78

Query: 357 -KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            +L+H+NLV LL  C ++    L++E++      +          LD++     +  I  
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GI + H      IIHRD+K  N+L+      K+ DFG AR       +   + V  T  Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWY 190

Query: 476 MAPEYAMGGIF---SVKSDVFSFGVVLLEIISGK 506
            APE  +G +    +V  DV++ G ++ E+  G+
Sbjct: 191 RAPELLVGDVKYGKAV--DVWAIGCLVTEMFMGE 222

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  110 bits (278), Expect = 6e-27
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVK------RLSRTSGQGLQEFKNEVTVIA 356
              +    +LG G F  V K    + G E A K        +   G   +E + EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIAR 415
           ++ H N++ L        + +LI E +        LFD   +   L  +   S IK I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVG 471
           G+ YLH     KI H DLK  N++L  +  P    K+ DFG+A              + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
           T  ++APE        +++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (276), Expect = 7e-27
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 38/212 (17%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
            + F     LG G F  V+       GK  A+K + ++        +NE+ V+ K++H+N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI------------SII 410
           +V L           L+ + +        LFD           RI             +I
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGE----LFD-----------RILERGVYTEKDASLVI 112

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTN 467
           + +   + YLHE     I+HRDLK  N+L    +      I+DFG++++          +
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MS 165

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
              GT GY+APE      +S   D +S GV+ 
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  111 bits (279), Expect = 9e-27
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVK------RLSRTSGQGLQEFKNEVTVIA 356
              +    +LG G F  V K    + G E A K        +   G   +E + EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIAR 415
           ++ H N++ L        + +LI E +        LFD   +   L  +   S IK I  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVG 471
           G+ YLH     KI H DLK  N++L  +  P    K+ DFG+A              + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
           T  ++APE        +++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (274), Expect = 1e-26
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 16/206 (7%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQE-FKNEVTVIAKLQHK 361
           DF     LG+G FG VY      +   +A+K L ++    +G++   + E+ + + L+H 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILYL 420
           N++R+     +     L+ E+ P   L    +   +     D +R  + ++ +A  + Y 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYC 130

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H     K+IHRD+K  N+L+ ++   KI+DFG +        +  T  + GT  Y+ PE 
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRT--MCGTLDYLPPEM 183

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
             G     K D++  GV+  E + G 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  112 bits (282), Expect = 1e-26
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 42/218 (19%)

Query: 304 TQDFSQE----NKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIA 356
              F++E     +LG+G F  V + V +  G+E A   ++    S +  Q+ + E  +  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--------- 407
            L+H N+VRL     EE    LI++ +        LF+            I         
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFE-----------DIVAREYYSEA 110

Query: 408 ---SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQ 461
                I+ I   +L+ H+   + ++HR+LK  N+LL  ++     K++DFG+A    G Q
Sbjct: 111 DASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
                    GT GY++PE      +    D+++ GV+L
Sbjct: 168 QAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  110 bits (278), Expect = 1e-26
 Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 53/251 (21%)

Query: 281 KRKQEESQAFPLFPLDLIDIVKATQDFSQE----NKLGEGGFGPVYKGV-LADGKEIAVK 335
            +  E      + P D +    A ++F Q+    + +G G    V + V  A G E AVK
Sbjct: 66  PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK 125

Query: 336 RLSRTSGQGLQE--------FKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMPNK 386
            +  T+ +   E         + E  ++ ++  H +++ L+      +   L+++ M   
Sbjct: 126 IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG 185

Query: 387 SLDVFLFDSTRSVQLDWKRRI------------SIIKGIARGILYLHEDSRLKIIHRDLK 434
            L    FD            +            SI++ +   + +LH      I+HRDLK
Sbjct: 186 EL----FD-----------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLK 227

Query: 435 TSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE------YAMGGIFSV 488
             N+LLD  M  ++SDFG +      +       + GT GY+APE            +  
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGK 284

Query: 489 KSDVFSFGVVL 499
           + D+++ GV+L
Sbjct: 285 EVDLWACGVIL 295

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (275), Expect = 2e-26
 Identities = 49/273 (17%), Positives = 93/273 (34%), Gaps = 52/273 (19%)

Query: 283 KQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVK-----R 336
               S            +++  + +  +  +G+G +G V   +        A+K     +
Sbjct: 4   HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63

Query: 337 LSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM------------- 383
           + + + + ++  K EV ++ KL H N+ RL     +E    L+ E               
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 384 ------------------PNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGILY 419
                               +  +  +  S    +              I++ I   + Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 420 LHEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMARIFGGNQSKANT--NRVVGTYGY 475
           LH      I HRD+K  N L   +     K+ DFG+++ F    +          GT  +
Sbjct: 184 LHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 476 MAPE--YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           +APE        +  K D +S GV+L  ++ G 
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  108 bits (273), Expect = 2e-26
 Identities = 69/305 (22%), Positives = 110/305 (36%), Gaps = 67/305 (21%)

Query: 309 QENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRL 366
           QE+ LGEG    V   + L   +E AVK + +  G        EV ++ + Q H+N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 367 LGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI------------SIIKGIA 414
           +    EE+   L++E M   S+                  I             +++ +A
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSI----LS-----------HIHKRRHFNELEASVVVQDVA 121

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNR--- 468
             + +LH      I HRDLK  N+L +H       KI DF +      N   +  +    
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 469 --VVGTYGYMAPEYAMGGIFSVKS-----DVFSFGVVLLEIISGKKSTGFYHSEHGPSLL 521
               G+  YMAPE                D++S GV+L  ++SG     F       S  
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG--YPPFVG--RCGSDC 234

Query: 522 AYIWKLWCEGHAAELMDSVVKQ------------SCDQAELLKYIHIGLLCVQGDPIDRP 569
            +     C      L +S+ +             SC   +L+      LL    D   R 
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS----KLLVR--DAKQRL 288

Query: 570 TMSSV 574
           + + V
Sbjct: 289 SAAQV 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (271), Expect = 2e-26
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 26/202 (12%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVK------RLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +LG G F  V K      GKE A K        S   G   +E + EV ++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW---KRRISIIKGIARGILYLH 421
            L      + + +LI E +        LFD     + +          +K I  G+ YLH
Sbjct: 72  TLHDIFENKTDVVLILELVSGGE----LFD--FLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
                +I H DLK  N++L  +  P    K+ DFG+A              + GT  ++A
Sbjct: 126 S---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVA 179

Query: 478 PEYAMGGIFSVKSDVFSFGVVL 499
           PE        +++D++S GV+ 
Sbjct: 180 PEIVNYEPLGLEADMWSIGVIT 201

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (275), Expect = 2e-26
 Identities = 33/239 (13%), Positives = 68/239 (28%), Gaps = 54/239 (22%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQ--------- 359
           LG+       +      G+   V     T       +++ K EV  +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 360 ----------------HKNLVRLLGCCLEENES--LLIYEYMPNKSLDVF--LFD-STRS 398
                            K ++R+     +        +Y  M +        L   S+  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 399 VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG 458
             L    R+ +   + R +  LH      ++H  L+  +++LD      ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 459 GNQSKANTNRVVGTYGYMAPEY-----------AMGGIFSVKSDVFSFGVVLLEIISGK 506
                        + G+  PE                + +   D ++ G+V+  I    
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (278), Expect = 3e-26
 Identities = 59/241 (24%), Positives = 96/241 (39%), Gaps = 41/241 (17%)

Query: 284 QEESQAFPLFPLDLIDIVKATQDFSQE----NKLGEGGFGPVYKGV-LADGKEIAVKRLS 338
              ++ F  F L + D     +    E      LG G  G V         K++A++ +S
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169

Query: 339 R--------TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDV 390
           +                 + E+ ++ KL H  ++++     +  +  ++ E M    L  
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL-- 226

Query: 391 FLFDSTRSVQLDWKRRIS------IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM 444
             FD  + V     +R+           +   + YLHE     IIHRDLK  NVLL  + 
Sbjct: 227 --FD--KVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQE 276

Query: 445 NP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPE---YAMGGIFSVKSDVFSFGVV 498
                KI+DFG ++I  G  S   T  + GT  Y+APE         ++   D +S GV+
Sbjct: 277 EDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

Query: 499 L 499
           L
Sbjct: 334 L 334

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (273), Expect = 3e-26
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRL------SRTSGQGLQEFKNEVTVIA 356
              +    +LG G F  V K    + G + A K +      S   G   ++ + EV+++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 357 KLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDW---KRRISIIKGI 413
           ++QH N++ L      + + +LI E +        LFD     + +    +     +K I
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGE----LFD--FLAEKESLTEEEATEFLKQI 123

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANTNRV 469
             G+ YLH    L+I H DLK  N++L     P    KI DFG+A              +
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNI 177

Query: 470 VGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
            GT  ++APE        +++D++S GV+ 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  109 bits (275), Expect = 5e-26
 Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 27/214 (12%)

Query: 312 KLGEGGFGPVYKGV---LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           K+G G +G VYK       D K+ A+K++   +G  +   + E+ ++ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 369 CCLEENE-SL-LIYEYMPNKSLDVF-LFDSTRSVQLDWKRRI-------SIIKGIARGIL 418
             L   +  + L+++Y      D++ +    R+ + + K          S++  I  GI 
Sbjct: 86  VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGG-NQSKANTNRVVGTY 473
           YLH +    ++HRDLK +N+L+  E       KI+D G AR+F    +  A+ + VV T+
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 474 GYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGK 506
            Y APE  +G   ++   D+++ G +  E+++ +
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  109 bits (274), Expect = 7e-26
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 307 FSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLVR 365
           ++    +G G FG V++  L +  E+A+K++ +      + FKN E+ ++  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96

Query: 366 LLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKG----IA 414
           L        +        L+ EY+P +++        +  Q +     + +IK     + 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMP----MLLIKLYMYQLL 151

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTY 473
           R + Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N + +   Y
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY 206

Query: 474 GYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
            Y APE   G   ++   D++S G V+ E++ G+
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  106 bits (268), Expect = 8e-26
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 18/205 (8%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLL 367
           LGEG +G V + +        AVK L +        G    K E+ ++ +L+HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 368 GCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIIKGIARGILYLHED 423
                E +    ++ EY      ++      +   +         +I G+     YLH  
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
               I+H+D+K  N+LL      KIS  G+A       +        G+  +  PE A G
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 484 --GIFSVKSDVFSFGVVLLEIISGK 506
                  K D++S GV L  I +G 
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGL 210

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  106 bits (266), Expect = 1e-25
 Identities = 65/206 (31%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLLGCC 370
           LGEG +G V   V     + +AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IIKGIARGILYL 420
            E N   L  EY     L    FD  R         +           ++ G+     YL
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YL 121

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 481 AMGGIFS-VKSDVFSFGVVLLEIISG 505
                F     DV+S G+VL  +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (267), Expect = 2e-25
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE--------FKNEVTV 354
             ++     LG G  G V         K++A+K +S+                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 355 IAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------ 408
           + KL H  ++++     +  +  ++ E M    L    FD  + V     +R+       
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FD--KVVG---NKRLKEATCKL 118

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKAN 465
               +   + YLHE     IIHRDLK  NVLL   + +   KI+DFG ++I  G  S   
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR 174

Query: 466 TNRVVGTYGYMAPEYAMGGI---FSVKSDVFSFGVVL 499
           T  + GT  Y+APE  +      ++   D +S GV+L
Sbjct: 175 T--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  106 bits (267), Expect = 2e-25
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 42/214 (19%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHK 361
           T  +  +  +G G +    + +  A   E AVK + ++          E+ ++ +  QH 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHP 76

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI------------SI 409
           N++ L     +     ++ E M    L     D           +I            ++
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGEL----LD-----------KILRQKFFSEREASAV 121

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLL-DHEMNP---KISDFGMARIFGGNQSKAN 465
           +  I + + YLH      ++HRDLK SN+L  D   NP   +I DFG A+          
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178

Query: 466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
           T     T  ++APE      +    D++S GV+L
Sbjct: 179 T--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  105 bits (265), Expect = 3e-25
 Identities = 65/206 (31%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLLGCC 370
           LGEG +G V   V     + +AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IIKGIARGILYL 420
            E N   L  EY     L    FD  R         +           ++ G+     YL
Sbjct: 75  REGNIQYLFLEYCSGGEL----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YL 121

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H    + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 481 AMGGIFS-VKSDVFSFGVVLLEIISG 505
                F     DV+S G+VL  +++G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAG 204

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (263), Expect = 7e-25
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 300 IVKATQDFSQ-----ENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNE 351
             ++ ++F+        +LG G F  V + +  + G+E A K  +  R       E  +E
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78

Query: 352 VTVIAKLQH-KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR---- 406
           + V+   +    ++ L       +E +LI EY     +    F     +    +      
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS--LCLPELAEMVSEND 132

Query: 407 -ISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQS 462
            I +IK I  G+ YLH+     I+H DLK  N+LL       + KI DFGM+R  G    
Sbjct: 133 VIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
                 ++GT  Y+APE       +  +D+++ G++ 
Sbjct: 190 ---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (262), Expect = 7e-25
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 40/209 (19%)

Query: 308 SQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVR 365
            ++  LGEG F    K V     +  AVK +S+         + E+T +   + H N+V+
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI------------SIIKGI 413
           L     ++  + L+ E +    L    F+           RI             I++ +
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGEL----FE-----------RIKKKKHFSETEASYIMRKL 115

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVV 470
              + ++H+   + ++HRDLK  N+L    +  +  KI DFG AR+   +     T    
Sbjct: 116 VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PC 170

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
            T  Y APE      +    D++S GV+L
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  103 bits (259), Expect = 3e-24
 Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 39/204 (19%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC 370
           +LG G    VY+       K  A+K L +T  +  +  + E+ V+ +L H N+++L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI------------SIIKGIARGIL 418
               E  L+ E +        LFD           RI              +K I   + 
Sbjct: 118 ETPTEISLVLELVTGGE----LFD-----------RIVEKGYYSERDAADAVKQILEAVA 162

Query: 419 YLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           YLHE     I+HRDLK  N+L      +   KI+DFG+++I            V GT GY
Sbjct: 163 YLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGY 216

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVL 499
            APE   G  +  + D++S G++ 
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIIT 240

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  102 bits (256), Expect = 4e-24
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 43/227 (18%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT--------------------------SGQGL 345
           +G+G +G V       D    A+K LS+                               +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 346 QEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY---EYMPNKSLDVFLFDSTRSVQLD 402
           ++   E+ ++ KL H N+V+L+   L++     +Y   E +    +     +      L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
             +     + + +GI YLH     KIIHRD+K SN+L+  + + KI+DFG++  F G+ +
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSV---KSDVFSFGVVLLEIISGK 506
             +    VGT  +MAPE              DV++ GV L   + G+
Sbjct: 193 LLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (257), Expect = 4e-24
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 30/209 (14%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT--------SGQGLQEFKNEVTVIAKLQHKNL 363
           LG G FG V+  V     KE+ VK + +             L +   E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGI 417
           +++L     +    L+ E   +  LD  LF       +D   R+       I + +   +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGS-GLD--LFA-----FIDRHPRLDEPLASYIFRQLVSAV 143

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YL       IIHRD+K  N+++  +   K+ DFG A      +         GT  Y A
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCA 197

Query: 478 PEYAMGGIFS-VKSDVFSFGVVLLEIISG 505
           PE  MG  +   + +++S GV L  ++  
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFE 226

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  103 bits (258), Expect = 1e-23
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 33/216 (15%)

Query: 307 FSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHKNLV 364
           ++    +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110

Query: 365 RLLGCCLEENESL------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI--IKG---- 412
           RL        E        L+ +Y+P +++       +R+ Q      + +  +K     
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQ-----TLPVIYVKLYMYQ 164

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVG 471
           + R + Y+H      I HRD+K  N+LLD +    K+ DFG A+     + + N + +  
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICS 219

Query: 472 TYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGK 506
            Y Y APE   G    +   DV+S G VL E++ G+
Sbjct: 220 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (253), Expect = 1e-23
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 25/204 (12%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +G+G F  V     +  G+E+A+K + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGILYLHED 423
              E    LI EY     +    FD   +       R+         + I   + Y H  
Sbjct: 83  IETEKTLYLIMEYASGGEV----FDYLVA-----HGRMKEKEARSKFRQIVSAVQYCH-- 131

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
            + +I+HRDLK  N+LLD +MN KI+DFG +  F     K +     G   Y APE   G
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA--FCGAPPYAAPELFQG 187

Query: 484 GIFS-VKSDVFSFGVVLLEIISGK 506
             +   + DV+S GV+L  ++SG 
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGS 211

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN------EVTVIAKLQHK--NL 363
           LG GGFG VY G+ ++D   +A+K + +       E  N      EV ++ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIARGI 417
           +RLL      +  +LI E  P    D  LFD      +  +  +           +   +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFD-----FITERGALQEELARSFFWQVLEAV 162

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
            + H      ++HRD+K  N+L+D      K+ DFG   +              GT  Y 
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYS 215

Query: 477 APEYAMGGIFS-VKSDVFSFGVVLLEIISGK 506
            PE+     +    + V+S G++L +++ G 
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 99.3 bits (248), Expect = 8e-23
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 35/225 (15%)

Query: 302 KATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRL-------SRTSGQGLQEFKNEVT 353
           K    F  E   G+G FG V  G     G  +A+K++       +R     LQ  +    
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQ---- 71

Query: 354 VIAKLQHKNLVRLLGCCLEENES-------LLIYEYMP---NKSLDVFLFDSTRSVQLDW 403
            +A L H N+V+L        E         ++ EY+P   ++    +     R V    
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY---YRRQVAPPP 128

Query: 404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQS 462
                 +  + R I  LH  S + + HRD+K  NVL++      K+ DFG A+    ++ 
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE- 186

Query: 463 KANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
             N   +   Y Y APE   G   ++   D++S G +  E++ G+
Sbjct: 187 -PNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 34/212 (16%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT------SGQGLQEFKNEVTVIAKL----QHK 361
           LG+GGFG V+ G  L D  ++A+K + R                 EV ++ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IIKGIAR 415
            ++RLL     +   +L+ E  P  + D  LFD         K  +           +  
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITE-----KGPLGEGPSRCFFGQVVA 150

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYG 474
            I + H      ++HRD+K  N+L+D      K+ DFG   +              GT  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTRV 203

Query: 475 YMAPEYAMGGIFS-VKSDVFSFGVVLLEIISG 505
           Y  PE+     +  + + V+S G++L +++ G
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 30/225 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEF---KNEVTVIAK 357
           +DF     LGEG F  V    LA      +E A+K L +       +      E  V+++
Sbjct: 30  EDFKFGKILGEGSFSTVV---LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG----- 412
           L H   V+L     ++ +      Y  N  L            +                
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL----LK-----YIRKIGSFDETCTRFYTA 137

Query: 413 -IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            I   + YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VG
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           T  Y++PE          SD+++ G ++ ++++G     F     
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL--PPFRAGNE 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.1 bits (247), Expect = 5e-22
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 12/208 (5%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
             F     LG GGFG V+   +    ++ A K+L++      +G Q    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGIL 418
           + +V L     E    L L+   M    +   +++    +      R I     I  G+ 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           +LH+     II+RDLK  NVLLD + N +ISD G+A      Q+K       GT G+MAP
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAP 358

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           E  +G  +    D F+ GV L E+I+ +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 50/213 (23%)

Query: 310 ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLL 367
           +  LG G  G V +      G++ A+K L  +      + + EV    +     ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88

Query: 368 GCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--------------SI 409
                 +      L+I E M    L    F            RI               I
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----FS-----------RIQERGDQAFTEREAAEI 133

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANT 466
           ++ I   I +LH      I HRD+K  N+L    + +   K++DFG A+    N  +   
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ--- 187

Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVL 499
                T  Y+APE      +    D++S GV++
Sbjct: 188 -TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.6 bits (238), Expect = 3e-21
 Identities = 52/250 (20%), Positives = 84/250 (33%), Gaps = 53/250 (21%)

Query: 277 RRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQ----ENKLGEGGFGPVYKGV-LADGKE 331
               +      Q FP F +     +K              LG G  G V +       ++
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 332 IAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLG----CCLEENESLLIYEYMPNK 386
            A+K L         + + EV +  +     ++VR++             L++ E +   
Sbjct: 90  FALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144

Query: 387 SLDVFLFDSTRSVQLDWKRRI--------------SIIKGIARGILYLHEDSRLKIIHRD 432
            L    F            RI               I+K I   I YLH    + I HRD
Sbjct: 145 EL----FS-----------RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRD 186

Query: 433 LKTSNVLL---DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVK 489
           +K  N+L          K++DFG A+    + S         T  Y+APE      +   
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKS 243

Query: 490 SDVFSFGVVL 499
            D++S GV++
Sbjct: 244 CDMWSLGVIM 253

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 3e-21
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
             F Q   LG+GGFG V    +    ++ A K+L +      +G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           + +V L     E  ++L L+   M    L   ++   ++      R +     I  G+  
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLED 301

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH     +I++RDLK  N+LLD   + +ISD G+A      Q+       VGT GYMAPE
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGK 506
                 ++   D ++ G +L E+I+G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG G FG V  G     G ++AVK L+R    S   + + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IIKGIARGIL 418
                 +  ++ EY+    L    FD      +    R+           I+  +     
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVD---- 125

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           Y H   R  ++HRDLK  NVLLD  MN KI+DFG++ +    +    T    G+  Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT--SCGSPNYAAP 179

Query: 479 EYAMGGIFS-VKSDVFSFGVVLLEIISGK 506
           E   G +++  + D++S GV+L  ++ G 
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 53/218 (24%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQE-FKNEVTVIAKLQHKNLVRLLG 368
           LGEG FG V         +++A+K +SR       +    + E++ +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 369 CCLEENESLLIYEYMPNKSLDVF---------LFDSTRSVQLDWKRRIS----------I 409
                      Y+ +   + D+          LFD      +  K+R++          I
Sbjct: 75  -----------YDVITTPT-DIVMVIEYAGGELFD-----YIVEKKRMTEDEGRRFFQQI 117

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV 469
           I  I     Y H   R KI+HRDLK  N+LLD  +N KI+DFG++ I         T+  
Sbjct: 118 ICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS-- 167

Query: 470 VGTYGYMAPEYAMGGIFS-VKSDVFSFGVVLLEIISGK 506
            G+  Y APE   G +++  + DV+S G+VL  ++ G+
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.3 bits (237), Expect = 1e-20
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 24/213 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRT---SGQGLQEFKNEVTVIAKLQH 360
            DFS    +G GGFG VY    AD  ++ A+K L +      QG     NE  +++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 361 KN---LVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG 416
            +   +V +        + L  I + M    L    +  ++               I  G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILG 304

Query: 417 ILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYM 476
           + ++H      +++RDLK +N+LLD   + +ISD G+A  F   +     +  VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357

Query: 477 APEYAMGGI---FSVKSDVFSFGVVLLEIISGK 506
           APE    G+    S   D FS G +L +++ G 
Sbjct: 358 APEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 4e-20
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 44/214 (20%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
           LG G FG V  G     G ++AVK L+R    S   + + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 369 CCLEENESLLIYEYMPNKSLDVF----------LFD---STRSVQLDWKRRI--SIIKGI 413
                      Y+ +   S D+F          LFD       +     RR+   I+ G+
Sbjct: 82  -----------YQVISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
                Y H   R  ++HRDLK  NVLLD  MN KI+DFG++ +    +    T+   G+ 
Sbjct: 130 D----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS--CGSP 179

Query: 474 GYMAPEYAMGGIFS-VKSDVFSFGVVLLEIISGK 506
            Y APE   G +++  + D++S GV+L  ++ G 
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKNLVRLLGCC 370
           +G G FG           + +AVK + R  G  + E  + E+     L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 371 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IIKGIARGILYL 420
           L      +I EY     L    ++  R        R S          ++ G++    Y 
Sbjct: 86  LTPTHLAIIMEYASGGEL----YE--RICN---AGRFSEDEARFFFQQLLSGVS----YC 132

Query: 421 HEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           H    ++I HRDLK  N LLD       KI DFG ++    + S+  +   VGT  Y+AP
Sbjct: 133 H---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYIAP 186

Query: 479 EYAMGGIFS-VKSDVFSFGVVL 499
           E  +   +    +DV+S GV L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTL 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 5/105 (4%)

Query: 401 LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR-IFGG 459
           L  +  I     +A+G+ +L   +  K IHRDL   N+LL  +   KI DFG+AR I+  
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS 504
                  +  +    +MAPE     +++++SDV+SFGV+L EI S
Sbjct: 247 PDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 19/155 (12%)

Query: 310 ENKLGEGGFGPVYKGVL------ADGKEIAVKRL-SRTSGQGLQEFKNEVTVIAKL-QHK 361
              LG G FG V +         A  + +AVK L    +    +   +E+ ++  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 362 NLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           N+V LLG C +    L +I E+    +L  +L            +R   +    +G  + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR 455
                +  I  DLK     +    +   S F   +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 41/220 (18%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HK 361
             D+    KLG G +  V++ + + + +++ VK L        ++ K E+ ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91

Query: 362 NLVRLLGC---CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI---------SI 409
           N++ L       +    +L+                       D+K+             
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVN----------------NTDFKQLYQTLTDYDIRFY 135

Query: 410 IKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNR 468
           +  I + + Y H  S   I+HRD+K  NV++DHE    ++ D+G+A     +  +    R
Sbjct: 136 MYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVR 190

Query: 469 VVGTYGYMAPEYAMGGIFSVKS-DVFSFGVVLLEIISGKK 507
           V   Y +  PE  +       S D++S G +L  +I  K+
Sbjct: 191 VASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.8 bits (210), Expect = 7e-18
 Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 65/251 (25%)

Query: 304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKN-EVTVIAKLQHK 361
           ++ +S    LG G FG V +    + GK  A+K++ +        +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60

Query: 362 NLVRLLGCCLEENESL--------------------------------------LIYEYM 383
           N+++L+       +                                        +I EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 384 PNKSLDVFLFDSTRSVQLDWKRRISI--IKG----IARGILYLHEDSRLKIIHRDLKTSN 437
           P  +L   L    RS +      I +  I      + R + ++H    L I HRD+K  N
Sbjct: 121 P-DTLHKVLKSFIRSGR-----SIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQN 171

Query: 438 VLLDHEMNP-KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSF 495
           +L++ + N  K+ DFG A+      S+ +   +   + Y APE  +G   ++   D++S 
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSI 228

Query: 496 GVVLLEIISGK 506
           G V  E+I GK
Sbjct: 229 GCVFGELILGK 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 26/220 (11%)

Query: 304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK------ 357
              ++ +  +  G +G V  GV ++G  +A+KR+  T   G        + + K      
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 358 -----LQHKNLVRLLGC----CLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
                  H N++ L              L L+ E M     D+      + + +  +   
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQ 137

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
             +  I  G+  LHE     ++HRDL   N+LL    +  I DF +AR    + +K  T+
Sbjct: 138 YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK--TH 192

Query: 468 RVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
            V     Y APE  M    F+   D++S G V+ E+ + K
Sbjct: 193 YVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
            + +     +G G  G V         + +A+K+LSR        F+N         E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 354 VIAKLQHKNLVRLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           ++  + HKN++ LL          E  +  ++ E M     D  L    +  +LD +R  
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHERMS 130

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  +  GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G +     T 
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTP 185

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +G  +    D++S G ++ E+I G 
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 35/221 (15%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
              ++  + +GEG +G V       +   +A+K++S         F++         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 354 VIAKLQHKNLVRLLGC----CLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
           ++ + +H+N++ +        +E+ + + ++ + M     +  L+   ++  L       
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY 132

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN--T 466
            +  I RG+ Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR+   +       T
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 467 NRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
             V  T  Y APE  +    ++   D++S G +L E++S +
Sbjct: 190 EYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 38/292 (13%), Positives = 81/292 (27%), Gaps = 61/292 (20%)

Query: 312 KLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVR 365
             G       ++ +  D    +++A+  +          LQE  +    ++++    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           +L         L++ E++   SL                  I  ++ +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +       S V         +S  G                V+     M         
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA------ 179

Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
            + + D+   G  L  ++  +            S LA            +     ++ + 
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP---LPEAGVRSGLA--------PAERDTAGQPIEPAD 227

Query: 546 DQAELLKYI-HIGLLCVQGDPIDRPTMSSVAVML----ASDILTLPKPTQPA 592
              ++   I  +    VQGD   R   + + +M      +D   +  P   A
Sbjct: 228 IDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEA 279

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 37/220 (16%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
              +     +G G +G V   V    G ++A+K+L R        F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 354 VIAKLQHKNLVRLL------GCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           ++  ++H+N++ LL          +  +  L+  +M        L    +  +L   R  
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  + +G+ Y+H      IIHRDLK  N+ ++ +   KI DFG+AR          T 
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TG 184

Query: 468 RVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +    ++   D++S G ++ E+I+GK
Sbjct: 185 YVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.8 bits (202), Expect = 1e-16
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 35/219 (15%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
            + +     +G G  G V         + +A+K+LSR        F+N         E+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 354 VIAKLQHKNLVRLL-----GCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           ++  + HKN++ LL        LEE + + L+ E M     D  L    +  +LD +R  
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQM-ELDHERMS 167

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  +  GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G +     T 
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTP 222

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +G  +    D++S G ++ E++  K
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 38/220 (17%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
            + +     +G G +G V   +    G+++A+K+LSR        F++         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 354 VIAKLQHKNLVRLL-----GCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           ++  +QH+N++ LL        L       L+  +M        L       +   ++  
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL-KFSEEKIQ 129

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            ++  + +G+ Y+H      ++HRDLK  N+ ++ +   KI DFG+AR          T 
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TG 182

Query: 468 RVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
            VV T  Y APE  +    ++   D++S G ++ E+++GK
Sbjct: 183 YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 48/226 (21%), Positives = 94/226 (41%), Gaps = 36/226 (15%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
              +     LG GG G V+  V     K +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 354 VIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF----DS-----TRSVQLDWK 404
           +I +L H N+V++          L        +   V++     ++          L  +
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120

Query: 405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSK 463
                +  + RG+ Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI   + S 
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 464 AN--TNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
               +  +V T  Y +P   +    ++   D+++ G +  E+++GK
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 34/218 (15%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEFKN---EVTVIAKLQH 360
             F     +G+G FG V      D K++ A+K +++       E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI------IKGI 413
             LV L     ++ E + ++ + +    L        R   L              I  +
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDL--------RY-HLQQNVHFKEETVKLFICEL 124

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
              + YL      +IIHRD+K  N+LLD   +  I+DF +A +            + GT 
Sbjct: 125 VMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTK 178

Query: 474 GYMAPE--YAMGGI---FSVKSDVFSFGVVLLEIISGK 506
            YMAPE   +  G    F+V  D +S GV   E++ G+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 21/220 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
            DF     +G G F  V    +    ++ A+K +++       E   F+ E  V+     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           + + +L     ++   L L+ EY     L   L      +  +  R    +  I   I  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDS 177

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           +H    L  +HRD+K  N+LLD   + +++DFG       +     +   VGT  Y++PE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPE 233

Query: 480 --YAMGGIFSVKS-----DVFSFGVVLLEIISGKKSTGFY 512
              A+GG     S     D ++ GV   E+  G+  T FY
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFY 271

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 37/220 (16%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
            + +   + +G G +G V        G  +AVK+LSR        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 354 VIAKLQHKNLVRLL-----GCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 407
           ++  ++H+N++ LL        LEE   + L+   M        L +  +  +L      
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
            +I  I RG+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR          T 
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TG 188

Query: 468 RVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
            V  T  Y APE  +    ++   D++S G ++ E+++G+
Sbjct: 189 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 19/218 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQE---FKNEVTVIAKLQH 360
           +DF     +G G FG V    L +  ++ A+K L++       E   F+ E  V+     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           K +  L     +++ +L L+ +Y      D+    S    +L  +     +  +   I  
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGG--DLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           +H+   L  +HRD+K  N+L+D   + +++DFG       + +   ++  VGT  Y++PE
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPE 246

Query: 480 -----YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY 512
                    G +  + D +S GV + E++ G+  T FY
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 282

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 17/216 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEF---KNEVTVIAKLQH 360
             F +   LG G FG V      +     A+K L +     L++     NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
             LV+L     + +   ++ EY+    +   L    R               I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H    L +I+RDLK  N+L+D +   +++DFG A+   G      T  + GT   +APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEI 209

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
            +   ++   D ++ GV++ E+ +G     F+  + 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY--PPFFADQP 243

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 32/250 (12%)

Query: 278 RRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEI-AVKR 336
           R+NK        +      + D+    +D+     +G G FG V        +++ A+K 
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101

Query: 337 LSRTSGQGLQE---FKNEVTVIAKLQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFL 392
           LS+       +   F  E  ++A      +V+L     +++  L ++ EYMP   L    
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL---- 156

Query: 393 FDSTRSVQLDWKRRISIIKG------IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP 446
                 V L     +           +   +  +H    +  IHRD+K  N+LLD   + 
Sbjct: 157 ------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHL 207

Query: 447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG----GIFSVKSDVFSFGVVLLEI 502
           K++DFG              +  VGT  Y++PE        G +  + D +S GV L E+
Sbjct: 208 KLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

Query: 503 ISGKKSTGFY 512
           + G   T FY
Sbjct: 267 LVGD--TPFY 274

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 25/213 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEF---KNEVTVIAKLQH 360
            +F     LG+G FG V            A+K L +       E      E  V+   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG------I 413
             L  L     + ++ L  + EY      ++F         L  +R  S  +       I
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGG--ELFF-------HLSRERVFSEDRARFYGAEI 257

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
              + YLH  S   +++RDLK  N++LD + + KI+DFG+ +    + +   T    GT 
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTP 313

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            Y+APE      +    D +  GVV+ E++ G+
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 36/220 (16%)

Query: 305 QDFSQENKLGEGGFGPVY---KGVLADGKEI-AVKRLSRTSGQGLQEFKNEVT------- 353
           + F     LG+GG+G V+   K   A+  +I A+K L +     +     +         
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERN 73

Query: 354 VIAKLQHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG 412
           ++ +++H  +V L+    +    L LI EY+    L  F+       QL+ +        
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FM-------QLEREGIFMEDTA 123

Query: 413 ------IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT 466
                 I+  + +LH+     II+RDLK  N++L+H+ + K++DFG+ +    + +  +T
Sbjct: 124 CFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
               GT  YMAPE  M    +   D +S G ++ ++++G 
Sbjct: 181 --FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 40/227 (17%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
           + DF  ++ LGEG +G V        G+ +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 354 VIAKLQHKNLVRLLGC----CLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
           ++   +H+N++ +         E    + +I E M        L     +  L       
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY 116

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR 468
            I    R +  LH  +   +IHRDLK SN+L++   + K+ DFG+ARI   + +  +   
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 469 V--------VGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
                    V T  Y APE  +    +S   DV+S G +L E+   +
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 305 QDFSQENKLGEGGFGPVY---KGVLADGKEI-AVKRLSRTS--GQGLQEFKNEVTVIAKL 358
             F     LG+G FG V+   K   +D +++ A+K L + +   +     K E  ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 359 QHKNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG----- 412
            H  +V+L     +    L LI +++    L  F        +L  +   +         
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FT-------RLSKEVMFTEEDVKFYLA 133

Query: 413 -IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            +A  + +LH    L II+RDLK  N+LLD E + K++DFG+++    ++ KA +    G
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 188

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           T  YMAPE       +  +D +SFGV++ E+++G 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 35/196 (17%), Positives = 82/196 (41%), Gaps = 35/196 (17%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
              +   + +G G +G V +     + + +A+K++ R        F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 354 VIAKLQHKNLVRLLGCCLEENESL-----LIYEYMP---NKSLDVFLFDSTRSVQLDWKR 405
           ++ +L H ++V++L   + ++        ++ E       K     LF +   +     +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-----LFRTPVYLTELHIK 159

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
             +++  +  G+ Y+H      I+HRDLK +N L++ + + K+ DFG+AR     ++  +
Sbjct: 160 --TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 466 TNRVVGTYGYMAPEYA 481
              +      M     
Sbjct: 215 QLPISPREDDMNLVTF 230

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 72.6 bits (179), Expect = 5e-14
 Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 26/213 (12%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEF---KNEVTVIAKLQH 360
            DF     LG+G FG V            A+K L +       E      E  V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 361 KNLVRLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG------I 413
             L  L     + ++ L  + EY      ++F         L  +R  +  +       I
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGG--ELFF-------HLSRERVFTEERARFYGAEI 114

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
              + YLH      +++RD+K  N++LD + + KI+DFG+ +    + +   T    GT 
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTP 169

Query: 474 GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            Y+APE      +    D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.6 bits (179), Expect = 5e-14
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 41/228 (17%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEI-AVKRLSRTSGQGLQEF---KNEVTVIAKLQH 360
           QDF     LG G FG V+           A+K L +     L++     +E  +++ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG------IA 414
             ++R+ G   +  +  +I +Y+    L  F         L   +R            + 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FS-------LLRKSQRFPNPVAKFYAAEVC 116

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
             + YLH      II+RDLK  N+LLD   + KI+DFG A+          T  + GT  
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 168

Query: 475 YMAPE------YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           Y+APE      Y      S+  D +SFG+++ E+++G   T FY S  
Sbjct: 169 YIAPEVVSTKPYNK----SI--DWWSFGILIYEMLAGY--TPFYDSNT 208

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 38/169 (22%), Positives = 59/169 (34%), Gaps = 52/169 (30%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGC 369
            LG G  G V +       ++ A+K L         + + EV +  +  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 370 CLEENESLLIYEYMPNKSLDVF-------LFDSTRSVQLDWKRRI--------------S 408
             E   +      +      V        LF            RI               
Sbjct: 80  Y-ENLYAGRKCLLI------VMECLDGGELFS-----------RIQDRGDQAFTEREASE 121

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMA 454
           I+K I   I YLH    + I HRD+K  N+L   +      K++DFG A
Sbjct: 122 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 52/252 (20%), Positives = 104/252 (41%), Gaps = 52/252 (20%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKN---------EVT 353
             ++  ++ +G G +G VY        K +A+K+++R        F++         E+T
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREIT 77

Query: 354 VIAKLQHKNLVRLLGCCLEENESL-----LIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRI 407
           ++ +L+   ++RL    + ++        ++ E       D  L    ++   L  +   
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIK 132

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
           +I+  +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR     +     N
Sbjct: 133 TILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 468 RV--------------------VGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGK 506
            +                    V T  Y APE  +    ++   D++S G +  E+++  
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 507 KSTGFYHSEHGP 518
           +S     +   P
Sbjct: 250 QSHINDPTNRFP 261

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I+  + YLHE     II+RDLK  NVLLD E + K++D+GM +         +T    GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y+APE   G  +    D ++ GV++ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           IA  + YLH    L I++RDLK  N+LLD + +  ++DFG+ +    + S  +T    GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y+APE      +    D +  G VL E++ G 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I+  + YLHE     II+RDLK  NVLLD E + K++D+GM +         +T    GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y+APE   G  +    D ++ GV++ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.7 bits (172), Expect = 2e-13
 Identities = 32/219 (14%), Positives = 65/219 (29%), Gaps = 57/219 (26%)

Query: 303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--------GQGLQEFKNEVTV 354
            T+   +  K+GEG FG V++ + AD   +A+K ++            +  +E   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 355 IAKLQ---------HKNLVRLLGCCL-------------------EENESLLIYEYMPNK 386
             +L           +  + L                        + + +     +  ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 387 SLDVFLF-------DSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL 439
              V  F       +  R+         SI+  +   +        L+  HRDL   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 440 LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           L      K+      +              + + G    
Sbjct: 195 LKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I   +++LH+     II+RDLK  NVLLDHE + K++DFGM +    N     T    GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y+APE     ++    D ++ GV+L E++ G 
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           I  G+ +LH      I++RDLK  N+LLD + + KI+DFGM +      +K NT    GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISG 505
             Y+APE  +G  ++   D +SFGV+L E++ G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 48/236 (20%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTV------IA 356
            + +    KLG+G +G V+K +    G+ +AVK++          F+N          I 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 357 KLQ----HKNLVRLLGCCLEEN--ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
            L     H+N+V LL     +N  +  L+++YM     +  L    R+  L+   +  ++
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVV 115

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRV- 469
             + + I YLH  S   ++HRD+K SN+LL+ E + K++DFG++R F   +   N   + 
Sbjct: 116 YQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 470 ------------------VGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
                             V T  Y APE  +G   ++   D++S G +L EI+ GK
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 12/99 (12%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF-GGNQSKANTNRVVG 471
           I   + +LH+   L II+RD+K  N+LLD   +  ++DFG+++ F      +A      G
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCG 222

Query: 472 TYGYMAPE----YAMGGIFSVKSDVFSFGVVLLEIISGK 506
           T  YMAP+       G   +V  D +S GV++ E+++G 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 46/233 (19%), Positives = 96/233 (41%), Gaps = 64/233 (27%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ----------- 359
           KLG G F  V+    + +   +A+K + R      +  ++E+ ++ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 360 HKNLVRLLGC-----------CLEENESLLIYEYMPNKSLDVF--LFDSTRSVQLDWKRR 406
             ++++LL              +                  VF  L ++  ++   ++ R
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVM------------------VFEVLGENLLALIKKYEHR 126

Query: 407 ---ISIIKGIARGIL----YLHEDSRLKIIHRDLKTSNVLLDHEMNP------KISDFGM 453
              +  +K I++ +L    Y+H   R  IIH D+K  NVL++   +P      KI+D G 
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184

Query: 454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           A  +  + +       + T  Y +PE  +G  +   +D++S   ++ E+I+G 
Sbjct: 185 ACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           IA G+ +L       II+RDLK  NV+LD E + KI+DFGM +    +     T    GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 184

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y+APE      +    D ++FGV+L E+++G+
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.1 bits (171), Expect = 1e-12
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGT 472
           IA G+ +L       II+RDLK  NV+LD E + KI+DFGM +    +     T    GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             Y+APE      +    D ++FGV+L E+++G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 48/224 (21%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVK---RLSRTSGQGLQEFKNEVTVIAKLQH-- 360
           +  ++ +G+G FG V K     + + +A+K          Q       EV ++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHD 111

Query: 361 ----KNLVRLLGC-------CL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 408
                 +V L          CL  E  S  +Y+ + N +      + TR           
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK---------- 161

Query: 409 IIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANT 466
             + +   +L+L     L IIH DLK  N+LL +      KI DFG +            
Sbjct: 162 FAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---------L 211

Query: 467 NRVVGTY----GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            + +  Y     Y +PE  +G  + +  D++S G +L+E+ +G+
Sbjct: 212 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 50/218 (22%)

Query: 313 LGEGGFGPVYKGV-LADGKEIAVKRL---SRTSGQGLQEFKNEVTVIAKLQHK------N 362
           +G+G FG V K       + +A+K +    R   Q       E+ ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTMN 160

Query: 363 LVRLLGC-------CL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           ++ +L         C+  E  S+ +YE +       F   S   V+            I 
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF---SLPLVR-------KFAHSIL 210

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGT 472
           + +  LH   + +IIH DLK  N+LL  +     K+ DFG         S    ++ V T
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG---------SSCYEHQRVYT 258

Query: 473 Y----GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           Y     Y APE  +G  + +  D++S G +L E+++G 
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV-RLLGC 369
           K+G G FG +Y G  +A G+E+A+K     +     +   E  +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             E + ++++ E +   SL+  LF+   S +   K  + +   +   I Y+H  +    I
Sbjct: 74  GAEGDYNVMVMELL-GPSLE-DLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FI 127

Query: 430 HRDLKTSNVLLDHEMNPK---ISDFGMARIFGGNQSKA-----NTNRVVGTYGYMAPEYA 481
           HRD+K  N L+          I DFG+A+ +   ++           + GT  Y A    
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINT 186

Query: 482 MGGIF-SVKSDVFSFGVVLLEIISGK 506
             GI  S + D+ S G VL+    G 
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGS 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 30/211 (14%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV-RLLGC 369
           K+G G FG +Y G  +   +E+A+K  +  +     +   E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 370 CLEENESLLIYEYMPNKSLDVFLFD------STRSVQLDWKRRISIIKGIARGILYLHED 423
            +E + ++L+ + +   SL+  LF+      S ++V +   + I+ ++       ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVE-------FVHSK 122

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPK---ISDFGMARIFGGNQSKA-----NTNRVVGTYGY 475
           S    +HRD+K  N L+          I DFG+A+ +    +           + GT  Y
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            +    +G   S + D+ S G VL+  + G 
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 46/214 (21%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV-RLLGC 369
           ++GEG FG +++G  L + +++A+K   R S     + ++E      L     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI-------IKGIARGILYLHE 422
             E   ++L+ + +   SL+  L D          R+ S+        + +AR +  +HE
Sbjct: 75  GQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLAR-VQSIHE 124

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPK-----ISDFGMARIFGGNQSKA-----NTNRVVGT 472
            S   +++RD+K  N L+    +       + DFGM + +    +K          + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             YM+    +G   S + D+ + G V +  + G 
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 46/214 (21%), Positives = 85/214 (39%), Gaps = 34/214 (15%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH-KNLVRLLGC 369
           K+G G FG +  G  L   + +A+K     S     +   E     +L     + ++   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI-------IKGIARGILYLHE 422
                 + ++ E +   SL+  LFD          R  S+       I+ I+R + Y+H 
Sbjct: 74  GPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISR-MEYVHS 123

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPK-----ISDFGMARIFGGNQSKA-----NTNRVVGT 472
            +   +I+RD+K  N L+    N       I DF +A+ +   ++K          + GT
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

Query: 473 YGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             YM+    +G   S + D+ + G + +  + G 
Sbjct: 181 ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 52/232 (22%), Positives = 85/232 (36%), Gaps = 54/232 (23%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVK---RLSRTSGQGLQEFKNEVTVIAKLQH-----KN 362
           K+G+G FG V     + + K  AVK    + + +       K E  ++ K+Q+      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 363 LVRLLGC-------CL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +V+  G        CL  E     +YE +   + + F       ++            I 
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGF---HIEDIK-------LYCIEIL 147

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR------ 468
           + + YL +   + + H DLK  N+LLD     K          G       T        
Sbjct: 148 KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 469 --------------VVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
                         ++ T  Y APE  +   + V SD++SFG VL E+ +G 
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 31/210 (14%), Positives = 69/210 (32%), Gaps = 44/210 (20%)

Query: 278 RRNKRKQEESQAFPLFP-LDLIDIVKATQDFSQENKLGEGGFGPVYKGV---------LA 327
                +   +    L     L D     + +  ++       G +Y+             
Sbjct: 16  ENLYFQSMTTSLEALPTGTVLTDKSG--RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGP 73

Query: 328 DGKEIAVKRLSRTSGQGLQEFK--------NEVTVIAKLQHKNLV---RLLGCCLEENE- 375
             ++ ++K L    G+   E           +V    KL    L+     +G  + +++ 
Sbjct: 74  QKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKY 132

Query: 376 SLLIYEYMPNKSL-DVFLFD-----STRSVQLDWKRRISIIKGIARGILYLHEDSRLKII 429
             L+   +  +SL            S RSV     R +  ++       +LHE+     +
Sbjct: 133 RFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALE-------FLHENE---YV 181

Query: 430 HRDLKTSNVLLDHEMNPKI--SDFGMARIF 457
           H ++   N+ +D E   ++  + +G A  +
Sbjct: 182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 45/265 (16%), Positives = 98/265 (36%), Gaps = 88/265 (33%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ--------HKN 362
           KLG G F  V+    +   K +A+K + +++    +   +E+ ++  ++         + 
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 363 LVRLLGC-----------CLEENESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISII 410
           +V+LL             C+       ++E +    L  ++  S  + + L   ++I  I
Sbjct: 103 VVQLLDDFKISGVNGTHICM-------VFEVL-GHHLLKWIIKSNYQGLPLPCVKKI--I 152

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLL------------------------------ 440
           + + +G+ YLH  ++ +IIH D+K  N+LL                              
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 441 -------------------DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                                ++  KI+D G A     + +       + T  Y + E  
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRSLEVL 265

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGK 506
           +G  ++  +D++S   +  E+ +G 
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 39/208 (18%), Positives = 80/208 (38%), Gaps = 40/208 (19%)

Query: 277 RRRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV------LADGK 330
            R++  K+  ++ F +    + D+      +     +G+GGFG +Y         +    
Sbjct: 10  GRQSSAKRHLAEQFAV-GEIITDMAA--AAWKVGLPIGQGGFGCIYLADMNSSESVGSDA 66

Query: 331 EIAVKRLSRTSGQGLQEFK-----NEVTVIAKLQHKNLVRLLG-----CCLEENESLLIY 380
              VK     +G    E K      +   I K      ++ LG          +++   Y
Sbjct: 67  PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY 126

Query: 381 EYMP----NKSL-DVFLFD----STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR 431
            +M        L  ++  +    S ++V     R + I++       Y+HE      +H 
Sbjct: 127 RFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILE-------YIHEHE---YVHG 176

Query: 432 DLKTSNVLLDHEMNPKI--SDFGMARIF 457
           D+K SN+LL+++   ++   D+G+A  +
Sbjct: 177 DIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 42/237 (17%), Positives = 78/237 (32%), Gaps = 68/237 (28%)

Query: 312 KLGEGGFGPVYKGV--LADGKEIAVK---RLSRTSGQGLQEFKNEVTVIAKLQHK----- 361
            LGEG FG V + +       ++A+K    + +       E    + V+ K++ K     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81

Query: 362 -NLVRLLGC-------CLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG 412
              V +          C+  E      +E++   +   +       V+        +   
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPY---PLPHVR-------HMAYQ 131

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP-------------------KISDFGM 453
           +   + +LHE    ++ H DLK  N+L  +                       +++DFG 
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 187

Query: 454 ARIFGGNQSKANTNRVVGTY----GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
                   S    +    T      Y  PE  +   ++   DV+S G +L E   G 
Sbjct: 188 --------SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 50/231 (21%), Positives = 82/231 (35%), Gaps = 56/231 (24%)

Query: 312 KLGEGGFGPVYKGV--LADGKEIAVK---RLSRTSGQGLQEFKNEVTVIAKLQHK----- 361
            LGEG FG V + +   A G+ +AVK    + R         ++E+ V+  L        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 362 -NLVRLLGC-------CL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKG 412
              V++L         C+  E   L  Y+++       F       ++        +   
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPF---RLDHIR-------KMAYQ 126

Query: 413 IARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI-------------FGG 459
           I + + +LH     K+ H DLK  N+L       +  +  + R              FG 
Sbjct: 127 ICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG- 182

Query: 460 NQSKANTNRVVGTY----GYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
             S    +    T      Y APE  +   +S   DV+S G +L+E   G 
Sbjct: 183 --SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 2e-06
 Identities = 63/481 (13%), Positives = 126/481 (26%), Gaps = 150/481 (31%)

Query: 175 ISSFDTLQTTAHC--IPD-----LSKSDCTVCLNSAVAQIPT-------CSKGKRGARIF 220
           + +FD       C  + D     LSK +    + S  A   T        SK +   + F
Sbjct: 30  VDNFD-------CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF 82

Query: 221 CPSCSIRYELYRFLVDTPTVTVTAPNKTRKRWITIAEAASAIIVFLLSTSFLWCIIRRRN 280
                +R   Y+FL+         P+   + +I                        +R+
Sbjct: 83  VEE-VLRIN-YKFLMSPIKTEQRQPSMMTRMYIE-----------------------QRD 117

Query: 281 KRKQEESQAFPLFPL----DLIDIVKATQDFSQENKL---GEGGFGPVYKGVLADGKEIA 333
            R   ++Q F  + +      + + +A  +      +   G  G G   K  +A    + 
Sbjct: 118 -RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVA----LD 169

Query: 334 VKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL-----LIYEYMPNKSL 388
           V    +       +   ++  +           L  C      L     L+Y+  PN + 
Sbjct: 170 VCLSYKV----QCKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTS 215

Query: 389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI 448
                 + +      +  +                 RL +  +  +   ++L +  N K 
Sbjct: 216 RSDHSSNIKLRIHSIQAELR----------------RL-LKSKPYENCLLVLLNVQNAKA 258

Query: 449 SD-FGM-ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            + F +  +I    + K  T+ +                                I    
Sbjct: 259 WNAFNLSCKILLTTRFKQVTDFLSAATTT-------------------------HISLDH 293

Query: 507 KSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQG--- 563
            S      E   SLL      + +    +L     ++          I I      G   
Sbjct: 294 HSMTLTPDE-VKSLLL----KYLDCRPQDLP----REVLTTNPRRLSI-IAESIRDGLAT 343

Query: 564 -DPIDRPTMSSVAVMLASDILTL-PKPTQPAFSLSRVVSAQFVSHSEDHCSVNAITLSTM 621
            D         +  ++ S +  L P   +  F        +           + I    +
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-------RLSVFPPS---AH-IPTILL 392

Query: 622 S 622
           S
Sbjct: 393 S 393

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 36/208 (17%), Positives = 72/208 (34%), Gaps = 45/208 (21%)

Query: 278 RRNKRKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIA--- 333
              +    +S  FP     L D+      +    K+G GGFG +Y        ++ A   
Sbjct: 13  LGTENLYFQSMPFPE-GKVLDDMEG--NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV 69

Query: 334 VKRLSRTSGQGLQEFK-----NEVTVIAKLQHKNLVRLLG----------CCLEENESLL 378
           VK   + +G    E K      +   I K   +  +  LG               +   +
Sbjct: 70  VKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM 129

Query: 379 IYEYMPNKSL-DVFLFDSTRSVQLDWKRRISI--IKGIARGIL----YLHEDSRLKIIHR 431
           + E +    L  +                     +  +   +L    Y+HE+     +H 
Sbjct: 130 VMERL-GIDLQKIS----------GQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHG 175

Query: 432 DLKTSNVLLDHEMNPKI--SDFGMARIF 457
           D+K +N+LL ++   ++  +D+G++  +
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSYRY 203

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	624
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.94
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.89
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.94
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.62
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.42
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.35
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.97
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.87
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.43
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.4
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.2
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.04
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.8
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.68
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.04
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.03
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.21
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	88.45
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.35
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	84.06
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.05
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.64

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.6e-54  Score=440.14  Aligned_cols=258  Identities=29%  Similarity=0.464  Sum_probs=213.1

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888899999999999999864      367899999988777778899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCC----------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          379 IYEYMPNKSLDVFLFDST----------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      ||||+++|+|.++|....          ....++|.+++.|+.||++||.|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          3457999999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      +|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.-      .+..+.... 
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~------~~~~~~~~~-  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ------LSNNEVIEC-  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT------SCHHHHHHH-
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------CCHHHHHHH-
Confidence            99999987654433333445679999999999999999999999999999999999 8999742      122222222 


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...+......     ..+    ...+.+|+.+||+.||++||||+||+++|++.
T Consensus       243 i~~~~~~~~p-----~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          243 ITQGRVLQRP-----RTC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHHTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCC-----ccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2223222211     122    34578899999999999999999999999764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=440.89  Aligned_cols=258  Identities=31%  Similarity=0.453  Sum_probs=205.9

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|...++||+|+||.||+|++.      +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778899999999999999864      477899999988777778899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCC------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          379 IYEYMPNKSLDVFLFDSTR------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      ||||+++|+|.+++.....            ...++|.+++.|+.||++||.|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999975322            246999999999999999999999985   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||..      .+..+.+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~------~~~~~~~~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ------LSNTEAID  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS------SCHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC------CCHHHHHH
Confidence            9999999987655444444455789999999999999999999999999999999999 8999742      12222222


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      . ...+......     ..+    ...+.+|+.+||+.||++||||+||++.|+..
T Consensus       272 ~-i~~g~~~~~p-----~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          272 C-ITQGRELERP-----RAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             H-HHHTCCCCCC-----TTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             H-HHcCCCCCCc-----ccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            2 2222221111     122    23578899999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-53  Score=435.09  Aligned_cols=257  Identities=30%  Similarity=0.416  Sum_probs=210.3

Q ss_pred             cCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .+++..++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34666788999999999999963      46789999997543 345678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 006952          378 LIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM  444 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  444 (624)
                      |||||+++|+|.++|.....             ...++|.+++.|+.||++||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999964321             246899999999999999999999985   99999999999999999


Q ss_pred             CeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHH
Q 006952          445 NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       445 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~  523 (624)
                      .+||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||.-.      +..+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~------~~~~~  256 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY------SNQDV  256 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC------CHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC------CHHHH
Confidence            999999999987654443334455789999999999999999999999999999999999 89997421      22222


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ... ...+.....         +......+.+|+.+||+.||++||||+||++.|+.
T Consensus       257 ~~~-i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          257 VEM-IRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHH-HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHH-HHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            222 223322221         12223457889999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-53  Score=430.91  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=203.6

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      +++...++||+|+||+||+|+++  ..||||+++..  ..+..+.|.+|+.+|++++|||||+++|++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            56778899999999999999975  36999998754  33456789999999999999999999998864 568999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.++|...  ...++|.+++.|+.||++||.|||+++   ||||||||+||||++++.+||+|||+++.......
T Consensus       113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999643  346999999999999999999999985   99999999999999999999999999987654443


Q ss_pred             CccccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          463 KANTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ........||+.|||||++.+   +.|+.++|||||||+||||+||+.||....     . ...+......+.....+. 
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~-~~~~~~~~~~~~~~p~~~-  260 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----N-RDQIIFMVGRGYASPDLS-  260 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----C-HHHHHHHHHTTCCCCCST-
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----h-HHHHHHHHhcCCCCCCcc-
Confidence            344456789999999999964   458999999999999999999999974211     1 122222222221111111 


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPK  587 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~  587 (624)
                      .    .+......+.+|+.+||+.||++||||.||++.|+...-++|+
T Consensus       261 ~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          261 K----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             T----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             c----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            1    1112234578899999999999999999999998765555554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.7e-51  Score=419.96  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=207.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +.|+..++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56888999999999999999976 58999999998766666778899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++.+    ..+++.++..|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            99999998854    35899999999999999999999985   99999999999999999999999999987654322 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.-      .+..+...... .+....+...   .
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------~~~~~~~~~i~-~~~~~~~~~~---~  294 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------EPPLKAMKMIR-DNLPPRLKNL---H  294 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHH-HSSCCCCSCG---G
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHH-cCCCCCCCcc---c
Confidence             23457899999999999999999999999999999999999999742      22222222222 2211111110   1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..    ...+.+|+.+||+.||++|||+.|+++
T Consensus       295 ~~----s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          295 KV----SPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11    234778899999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4e-51  Score=422.76  Aligned_cols=250  Identities=22%  Similarity=0.379  Sum_probs=202.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|++.+.||+|+||.||+++.. +|+.||||++.+..  ....+.+.+|+.+|++|+|||||++++++.+++..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999965 58999999997543  3456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.++|.. .+...+++.+++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+... 
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999964 23446789999999999999999999985   999999999999999999999999999875321 


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       .......+||+.|||||++.+..|+.++|||||||++|||++|+.||..      .+..+...+..... ....     
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~-~~~~-----  245 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA------GSMKNLVLKIISGS-FPPV-----  245 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHTC-CCCC-----
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHcCC-CCCC-----
Confidence             1123356899999999999999999999999999999999999999842      23333333333222 1111     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...+    ...+.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112    234778999999999999999999976

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.2e-51  Score=417.07  Aligned_cols=267  Identities=24%  Similarity=0.316  Sum_probs=201.9

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC----cceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN----ESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lV~  380 (624)
                      +++...++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++|+|.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999998 5899999999754322 223345666777899999999999998765    468999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ||+++|+|.+++..    ..++|..+.+|+.|+++||.|||++     +.++|+||||||+||||++++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999954    3589999999999999999999986     23469999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccccCccChhhhcCC------CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC--------CCC
Q 006952          456 IFGGNQSK--ANTNRVVGTYGYMAPEYAMGG------IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH--------GPS  519 (624)
Q Consensus       456 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~--------~~~  519 (624)
                      ........  ......+||+.|||||++.+.      .++.++|||||||+||||+||++|+.......        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543322  223356899999999999764      46789999999999999999998865322211        111


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ......+....+.....+...   ..+.+....+.+|+.+||+.||++||||.||++.|+.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            222333333222221111111   1123456678899999999999999999999999965

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.7e-51  Score=425.18  Aligned_cols=269  Identities=27%  Similarity=0.385  Sum_probs=216.3

Q ss_pred             CCCHHHHHHHhcCccccCccccCCceeEEEEEecC------CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCC-CCcce
Q 006952          294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQH-KNLVR  365 (624)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h-~niv~  365 (624)
                      +++..+++-..++|++.+.||+|+||.||+|++..      ++.||||++..... ...+.|.+|+.+|.+++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            34444555556789999999999999999998643      35799999976543 345779999999999965 99999


Q ss_pred             EEeEEEec-CcceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 006952          366 LLGCCLEE-NESLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR  431 (624)
Q Consensus       366 l~~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~  431 (624)
                      ++|+|.+. +..+||||||++|+|.++|.....             ...++|.+++.|+.||++||.|||+++   ||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            99999775 568999999999999999975322             345899999999999999999999985   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 006952          432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTG  510 (624)
Q Consensus       432 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~  510 (624)
                      ||||+||||++++.+||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999997765544444556789999999999999999999999999999999998 899974


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          511 FYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...   .   .+.+.+....+......+     .+    ..++.+++.+||+.||++|||+.||++.|+.
T Consensus       290 ~~~---~---~~~~~~~i~~g~~~~~p~-----~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          290 GVK---I---DEEFCRRLKEGTRMRAPD-----YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             TCC---C---SHHHHHHHHHTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC---H---HHHHHHHHHcCCCCCCCc-----cC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            211   1   122223333333222221     12    2357789999999999999999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-51  Score=417.35  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=208.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||+||+++.. +|+.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999965 5899999999753   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999953   346999999999999999999999985   999999999999999999999999999987655


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .........+||+.|||||++.+..++.++||||+||++|||++|+.||.-      .+..+...+... +.. .+.   
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------~~~~~~~~~i~~-~~~-~~p---  254 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA------GNEGLIFAKIIK-LEY-DFP---  254 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHH-TCC-CCC---
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHc-CCC-CCC---
Confidence            444455668999999999999999999999999999999999999999842      222232222222 211 111   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV  574 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  574 (624)
                        ...+    .++.+|+.+||+.||++|||++|+
T Consensus       255 --~~~s----~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          255 --EKFF----PKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             --TTCC----HHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             --cccC----HHHHHHHHHHccCCHhHCcChHHH
Confidence              1122    346788999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-50  Score=406.26  Aligned_cols=246  Identities=26%  Similarity=0.376  Sum_probs=196.8

Q ss_pred             cccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEe----cCcceEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE----ENESLLIY  380 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lV~  380 (624)
                      +..++||+|+||.||+|++. ++..||+|++...  .....+.|.+|+.+|++++|||||++++++.+    ++..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999975 5889999998654  33446789999999999999999999999876    24479999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++|+|.+++..   ...+++..+..|+.||++||.|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   346899999999999999999999874 35999999999999984 78999999999986432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .    .....+||+.|||||++.+ .++.++|||||||++|||+||+.||...     .... .+.+....+......+ 
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-----~~~~-~~~~~i~~~~~~~~~~-  252 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAA-QIYRRVTSGVKPASFD-  252 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-----SSHH-HHHHHHTTTCCCGGGG-
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CcHH-HHHHHHHcCCCCCCCC-
Confidence            2    2345789999999998875 6999999999999999999999997421     1222 2222233332211111 


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         ...+    ..+.+|+.+||+.||++|||+.|+++
T Consensus       253 ---~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 ---KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1222    24678899999999999999999976

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=420.94  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=207.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +.|+..++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 58999999998776666778999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++..    ..+++.++..|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+....  
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            99999999853    35899999999999999999999985   9999999999999999999999999998765432  


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.-      .+......... .+....+...   .
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------~~~~~~~~~i~-~~~~~~~~~~---~  371 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------EPPLKAMKMIR-DNLPPRLKNL---H  371 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHH-HSCCCCCSCT---T
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHH-cCCCCCCccc---c
Confidence            223457899999999999999999999999999999999999999741      22223222222 2211111100   1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..    ...+.+|+.+||+.||++|||+.|+++
T Consensus       372 ~~----s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          372 KV----SPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12    234778899999999999999999976

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-50  Score=417.51  Aligned_cols=253  Identities=22%  Similarity=0.256  Sum_probs=202.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .+.|...++||+|+||.||+|+.+ +|+.||||+++....     ..+|+.++++++|||||++++++.+++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456888899999999999999975 589999999975432     24799999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccccCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGGNQ  461 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  461 (624)
                      +++|+|.++|..   ...+++.++..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+++.+....
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999954   346999999999999999999999985   99999999999999987 69999999998775432


Q ss_pred             CC---ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          462 SK---ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       462 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..   ......+||+.|||||++.+..++.++|||||||++|||++|+.||.-..   ...+...+.   .......   
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~---~~~~~~~---  276 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF---RGPLCLKIA---SEPPPIR---  276 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC---CSCCHHHHH---HSCCGGG---
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHH---cCCCCch---
Confidence            21   12334689999999999999999999999999999999999999985322   222222221   1111100   


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                           ..+......+.+++.+||+.||++|||+.||++.|...
T Consensus       277 -----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          277 -----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             -----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                 01112233577889999999999999999999888653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-49  Score=397.74  Aligned_cols=246  Identities=22%  Similarity=0.385  Sum_probs=189.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|++.+.||+|+||+||+++.. +|+.||||++.+..   ....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999965 68999999987542   33456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+ +|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+||||++++++||+|||+++....
T Consensus        92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 6789888854   346999999999999999999999985   99999999999999999999999999986543


Q ss_pred             CCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..   .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.-      .+....... ...+... + .
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~------~~~~~~~~~-i~~~~~~-~-p  232 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD------ESIPVLFKN-ISNGVYT-L-P  232 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHH-HHHTCCC-C-C
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC------CCHHHHHHH-HHcCCCC-C-C
Confidence            22   2334689999999999998876 5899999999999999999999842      222222222 2222211 1 1


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ...    ...+.+++.+||+.||++|||++|+++
T Consensus       233 ----~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          233 ----KFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                112    234678899999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-49  Score=405.43  Aligned_cols=247  Identities=23%  Similarity=0.274  Sum_probs=195.4

Q ss_pred             cCccccCccccCCceeEEEEEec----CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|++.+.||+|+||+||+++..    .++.||||++++..  ......+.+|+.+|++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999853    46789999987543  2334568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   346999999999999999999999985   9999999999999999999999999998654


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...  ......+||+.|||||++.+..++.++||||+||++|||++|+.||.-      .+..+....... +... +. 
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~-~~~~-~p-  246 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG------KDRKETMTMILK-AKLG-MP-  246 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHH-CCCC-CC-
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC------cCHHHHHHHHHc-CCCC-CC-
Confidence            322  223357899999999999999999999999999999999999999842      223333333222 2111 11 


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                          ...    ...+.+|+.+||+.||++|||     ++|+++
T Consensus       247 ----~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          247 ----QFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----TTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                112    234778999999999999998     567764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-48  Score=395.71  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=189.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-------
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-------  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-------  375 (624)
                      ++|++.+.||+|+||.||+|+.+ +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999965 689999999975443 345778999999999999999999999976543       


Q ss_pred             -----ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          376 -----SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       376 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                           .++||||+++|+|.+++.........++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 5899999999999999976555556778889999999999999999985   99999999999999999999999


Q ss_pred             cccccccCCCCCC----------ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006952          451 FGMARIFGGNQSK----------ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL  520 (624)
Q Consensus       451 fg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~  520 (624)
                      ||+++.+......          ......+||+.|||||++.+..++.++|||||||++|||++   ||..     ..+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence            9999876543221          12234679999999999999999999999999999999996   5421     0011


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..... .........    ..     ......+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~-~~~~~~~p~----~~-----~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRTLT-DVRNLKFPP----LF-----TQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHH-HHHTTCCCH----HH-----HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHH-HHhcCCCCC----CC-----cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111 111111111    11     112234567899999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.1e-46  Score=386.79  Aligned_cols=282  Identities=36%  Similarity=0.629  Sum_probs=245.9

Q ss_pred             HHHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       297 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      +.++...+++|...+.||+|+||.||+|++++++.||||++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33445678899999999999999999999888999999999887777788999999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ++||||+++++|.+++.... ....++|..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999986533 2346899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...............||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.......+....
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            75443333333445689999999999999999999999999999999999999876555566667777666666777777


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .+++.+...........+.+++.+||+.||++|||+.||++.|+..
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            7777777777888889999999999999999999999999999753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-45  Score=384.55  Aligned_cols=262  Identities=19%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec------Cc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE------NE  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  375 (624)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++...  ....+.+.+|+.+|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999975 68999999997543  23456788999999999999999999997643      56


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .+|||||++ |+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            799999996 679888843   457999999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCC--CCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          456 IFGGNQ--SKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       456 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      .+....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||..   ....+.+..+........
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g---~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG---KNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC---SSHHHHHHHHHHHHCCCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC---CCHHHHHHHHHHhcCCCC
Confidence            764332  12234457899999999998875 469999999999999999999999742   122222333322221111


Q ss_pred             cccccc-------chhh-----cCCCHH-----HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMD-------SVVK-----QSCDQA-----ELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d-------~~l~-----~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ......       ..+.     ...+..     ....+.+|+.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            110000       0000     000000     1235678999999999999999999976

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.9e-45  Score=377.34  Aligned_cols=290  Identities=40%  Similarity=0.674  Sum_probs=246.4

Q ss_pred             CCCCCHHHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEE
Q 006952          292 LFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCC  370 (624)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~  370 (624)
                      ...+++.++....++|...+.||+|+||.||+|...+++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            345678889999999999999999999999999988899999999976542 2334689999999999999999999999


Q ss_pred             EecCcceEEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          371 LEENESLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       371 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                      .+.+..++||||+++++|.+++.... ....+++..++.|+.||+.||.|||+...++|+||||||+|||+++++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643 34459999999999999999999999833359999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC--CCCCCCCHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFY--HSEHGPSLLAYIWKL  527 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~--~~~~~~~~~~~~~~~  527 (624)
                      |||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...  ..........+....
T Consensus       177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999987643322 2233456999999999999999999999999999999999999998532  223344566666666


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ........+.+..+...........+.+++.+||+.||++|||+.||+++|+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            6667777778877777888899999999999999999999999999999998653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.2e-45  Score=380.09  Aligned_cols=197  Identities=24%  Similarity=0.376  Sum_probs=169.2

Q ss_pred             HhcCccccCccccCCceeEEEEEec----CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcce
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  377 (624)
                      ..+.|++.+.||+|+||+||+|+.+    .++.||||++.....  ..++.+|+.+|+.+ +||||+++++++.+.+..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3577999999999999999999853    467899999876533  35688999999998 6999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEeccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARI  456 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  456 (624)
                      +||||+++|+|.+++.      .+++.++..++.||+.||.|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999882      3889999999999999999999986   9999999999999877 7999999999986


Q ss_pred             cCCCCCC--------------------------ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          457 FGGNQSK--------------------------ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       457 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      .......                          ......+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5432211                          112345799999999999875 5899999999999999999999997


Q ss_pred             C
Q 006952          510 G  510 (624)
Q Consensus       510 ~  510 (624)
                      .
T Consensus       248 ~  248 (361)
T 4f9c_A          248 Y  248 (361)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.1e-43  Score=391.62  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=207.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|++.+.||+|+||.||+++.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999975 5899999999876666677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--CCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE--MNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~  460 (624)
                      +++|+|.++|..  +...+++.++..++.||++||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999998853  3346899999999999999999999985   9999999999999854  78999999999977543


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.-      .+..+....... .... +.++ 
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~------~~~~~~~~~i~~-~~~~-~~~~-  378 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG------ENDDETLRNVKS-CDWN-MDDS-  378 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC------SSHHHHHHHHHT-TCCC-CCSG-
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHh-CCCC-CCcc-
Confidence            2   23356899999999999999999999999999999999999999742      222222222221 1111 1111 


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .....+    ..+.+|+.+||+.||++|||+.|+++
T Consensus       379 ~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          379 AFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111122    24678899999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.4e-43  Score=358.36  Aligned_cols=284  Identities=37%  Similarity=0.569  Sum_probs=230.2

Q ss_pred             CCCCCCCHHHHHHHhcCcccc------CccccCCceeEEEEEecCCcEEEEEEccccC----cccHHHHHHHHHHHHhcC
Q 006952          290 FPLFPLDLIDIVKATQDFSQE------NKLGEGGFGPVYKGVLADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQ  359 (624)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~  359 (624)
                      .+...+++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|+.++++++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            345678899999999999887      8999999999999997 58899999986532    344678999999999999


Q ss_pred             CCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 006952          360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVL  439 (624)
Q Consensus       360 h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIl  439 (624)
                      ||||+++++++.+.+..++||||+++++|.+++........+++..++.++.||++||.|||+.+   |+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            99999999999999999999999999999999975545567999999999999999999999985   999999999999


Q ss_pred             EcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 006952          440 LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS  519 (624)
Q Consensus       440 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~  519 (624)
                      +++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence            99999999999999987654433333345679999999998865 589999999999999999999999864333221  


Q ss_pred             HHHHHHHHHhc-CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCE-GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...+....... ......+++.+ ...+......+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11221111111 12223333322 234566777899999999999999999999999999764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.4e-44  Score=393.71  Aligned_cols=248  Identities=25%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHH---HHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEF---KNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~---~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|++.+.||+|+||.||+++.+ +|+.||||++.+..   ......+   ..++.+++.++|||||++++++.+.+..+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999976 58999999986532   1222233   34466777789999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      |||||++||+|..+|..   ...+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999954   346999999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ....    ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||.....   .+............ . .+
T Consensus       343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~---~~~~~i~~~i~~~~-~-~~  413 (689)
T 3v5w_A          343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT---KDKHEIDRMTLTMA-V-EL  413 (689)
T ss_dssp             SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC---CCHHHHHHHHHHCC-C-CC
T ss_pred             CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhhcCCC-C-CC
Confidence            4332    345789999999999975 5799999999999999999999999852221   22222222222111 1 11


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                      .     ...    ...+.+|+.+||+.||++|++     +.||.+
T Consensus       414 p-----~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          414 P-----DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             C-----TTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             C-----ccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1     111    234678899999999999998     677754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.6e-43  Score=360.39  Aligned_cols=263  Identities=29%  Similarity=0.457  Sum_probs=203.8

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|++.+.||+|+||.||+++. .++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            46899999999999999999987 58899999987654  3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++........+++..++.++.||++||.|||+.+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            9999999999976444445999999999999999999999974 239999999999999999999999999997643322


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||...      .................+.    
T Consensus       194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~------~~~~~~~~~~~~~~~~~~~----  261 (309)
T 3p86_A          194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVGFKCKRLEIP----  261 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS------CHHHHHHHHHHSCCCCCCC----
T ss_pred             --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCCCCCC----
Confidence              2233467999999999999999999999999999999999999997522      1222222221111111111    


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL  585 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~  585 (624)
                       ...    ...+.+++.+||+.||++|||+.+|++.|+......
T Consensus       262 -~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          262 -RNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence             112    235778999999999999999999999998764443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=359.39  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=210.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367889999999999999999975 5889999999877777788899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++...  ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999653  345899999999999999999999985   99999999999999999999999999987643322


Q ss_pred             Cc------------cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          463 KA------------NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       463 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+............. ...    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~----  238 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRG----  238 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHH----
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhc----
Confidence            11            1114579999999999999999999999999999999999999876433322111000 000    


Q ss_pred             CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       531 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                               .+....+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       239 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          239 ---------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ---------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     000011111223477899999999999999999999999764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.7e-42  Score=350.87  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999996 46899999999876666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999854    25899999999999999999999985   99999999999999999999999999987654332


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+............... ...    
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------~~~~~~~~~~~~~~~~~-~~~----  238 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRALYLIATNGTPE-LQN----  238 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHHCSCC-CSC----
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCCCCC-CCC----
Confidence              23346799999999999999999999999999999999999999742      12222222222222111 111    


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         +......+.+++.+||+.||++|||+.|+++
T Consensus       239 ---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 ---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               1111234778899999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5e-42  Score=362.33  Aligned_cols=259  Identities=28%  Similarity=0.417  Sum_probs=210.6

Q ss_pred             hcCccccCccccCCceeEEEEEec--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++|...+.||+|+||.||+|+..        ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467899999999999999999853        34579999997653 34467899999999999 899999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999975331             245899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...   ....
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~---~~~~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---PVEE  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CGGG
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC---CHHH
Confidence            9999999999999987655443333444567889999999999999999999999999999999 99987532   1222


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +...    ...+.....         +......+.+++.+||+.||++|||+.||++.|+..
T Consensus       314 ~~~~----~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 LFKL----LKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHHH----HHTTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH----HhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2221    222221111         112233578899999999999999999999999753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-41  Score=351.60  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=213.3

Q ss_pred             CCCCCHHHHHHHhcC----------ccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCC
Q 006952          292 LFPLDLIDIVKATQD----------FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH  360 (624)
Q Consensus       292 ~~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h  360 (624)
                      ..+++..++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            345677788777764          667789999999999999976 699999999987777777889999999999999


Q ss_pred             CCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       361 ~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      |||+++++++...+..++||||+++++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999998843    35899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL  520 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~  520 (624)
                      +.++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      ..
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~------~~  246 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD------SP  246 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CH
T ss_pred             CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CH
Confidence            9999999999999987644322  223467999999999999999999999999999999999999997421      22


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....... ...........   ...    ...+.+++.+||+.||++|||+.||++
T Consensus       247 ~~~~~~~-~~~~~~~~~~~---~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 VQAMKRL-RDSPPPKLKNS---HKV----SPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHHH-HHSSCCCCTTG---GGS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHH-hcCCCCCcCcc---ccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2222222 12211111110   111    234778889999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-42  Score=357.66  Aligned_cols=268  Identities=25%  Similarity=0.347  Sum_probs=208.6

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc----ceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE----SLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----~~lV  379 (624)
                      .++|...+.||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999985 78999999975533 23455679999999999999999999988654    5999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-------SRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      |||+++|+|.+++..    ..+++..++.++.||++||.|||+.       ..++|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999954    3489999999999999999999987       01139999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHH------
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-----IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLL------  521 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~------  521 (624)
                      +++.+.............||+.|+|||++.+.     .++.++||||||+++|||++|+.||............      
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            99877655444444456799999999999873     4667899999999999999999998643322211111      


Q ss_pred             ---HHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          522 ---AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       522 ---~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         ...............+.....   .......+.+++.+||+.||++|||+.||++.|+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               111111111111111111111   22345668899999999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-42  Score=358.80  Aligned_cols=271  Identities=27%  Similarity=0.454  Sum_probs=207.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCc----EEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .++|+..+.||+|+||.||+|++. +++    +||+|.+... .....+++.+|+.++++++||||+++++++.+. ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            367999999999999999999964 344    3688887643 335567899999999999999999999999875 478


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +|+||+++|+|.+++...  ...+++..++.|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999999653  345899999999999999999999985   999999999999999999999999999887


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ......    ...+.... 
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~~~~~-  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI----LEKGERLP-  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH----HHTTCCCC-
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHH----HHcCCCCC-
Confidence            65544444444567889999999999999999999999999999999 9999753221   122221    11111111 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC--------------CCCCCCCCCCccccc
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD--------------ILTLPKPTQPAFSLS  596 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~--------------~~~~~~p~~p~~~~~  596 (624)
                              .+......+.+++.+||+.||++|||+.||++.|+..              ...+|.|..+.|+..
T Consensus       240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  305 (327)
T 3poz_A          240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA  305 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHHBCCTTGGGCCCCCTTTCHHHHH
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhhhhhcCCCccCCCCCCchHHHHh
Confidence                    1112234578899999999999999999999998542              234556666666543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.4e-42  Score=361.91  Aligned_cols=270  Identities=27%  Similarity=0.401  Sum_probs=214.7

Q ss_pred             CCCCHHHHHHHhcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcc
Q 006952          293 FPLDLIDIVKATQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLV  364 (624)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv  364 (624)
                      .+++...+....++|.+.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|+.++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3455666666778999999999999999999984      2457899999976433 3456799999999999 799999


Q ss_pred             eEEeEEEecCc-ceEEEEeccCCChhhhhhcCCC----------------------------------------------
Q 006952          365 RLLGCCLEENE-SLLIYEYMPNKSLDVFLFDSTR----------------------------------------------  397 (624)
Q Consensus       365 ~l~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------  397 (624)
                      ++++++.+.+. .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999988655 8999999999999999975432                                              


Q ss_pred             -----------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          398 -----------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       398 -----------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                                       ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999985   999999999999999999999999999876544


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..........||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   .   .........+......+ 
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~---~~~~~~~~~~~~~~~~~-  319 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---D---EEFCRRLKEGTRMRAPD-  319 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---S---HHHHHHHHHTCCCCCCT-
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---h---HHHHHHHHcCCCCCCCC-
Confidence            43334445678999999999999999999999999999999998 9999742211   1   11222222222111111 


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                              .....+.+++.+||+.||++|||+.||++.|+.
T Consensus       320 --------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          320 --------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence                    112357788999999999999999999999975

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-41  Score=351.06  Aligned_cols=248  Identities=27%  Similarity=0.388  Sum_probs=204.7

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999997 47899999998754  3345677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999854   245899999999999999999999985   999999999999999999999999999876433


Q ss_pred             CCCccccccccccCccChhhhcCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFS-VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .   ......||+.|+|||++.+..+. .++||||||+++|||++|+.||..      .+.......... +...     
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------~~~~~~~~~i~~-~~~~-----  232 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLR-GKYR-----  232 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHH-CCCC-----
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------CCHHHHHHHHHh-CCCC-----
Confidence            2   23456799999999999988774 899999999999999999999742      222222222222 1111     


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                           .+......+.+++.+||+.||.+|||+.|+++.
T Consensus       233 -----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 -----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 011112347788999999999999999999763

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.6e-42  Score=361.56  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=206.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467889999999999999999986 688999999875432 334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999864  2345899999999999999999999985   9999999999999999999999999998654332


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .........+++.|+|||.+.++.++.++||||||+++|||++ |+.|+....      ..+ .......+.....    
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~------~~~-~~~~~~~~~~~~~----  336 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS------NQQ-TREFVEKGGRLPC----  336 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC------HHH-HHHHHHTTCCCCC----
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHH-HHHHHHcCCCCCC----
Confidence            2222222345788999999999999999999999999999998 898874221      111 2222222221111    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                           +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                 11122357789999999999999999999999965

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=350.52  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             cCccccCccccCCceeEEEEEec----CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|.+.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56888899999999999999975    3446999999765 334567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999542  346899999999999999999999985   99999999999999999999999999987654


Q ss_pred             CCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...      ........ ...+....  
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~------~~~~~~~~-~~~~~~~~--  274 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM------TNRDVISS-VEEGYRLP--  274 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHHH-HHTTCCCC--
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC------CHHHHHHH-HHcCCCCC--
Confidence            3221 12223456788999999999999999999999999999999 99997421      11222222 11221111  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                             .+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       275 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          275 -------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   1111234578899999999999999999999999764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-41  Score=345.66  Aligned_cols=264  Identities=27%  Similarity=0.424  Sum_probs=204.7

Q ss_pred             hcCccccCccccCCceeEEEEEe-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      .++|+..+.||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36789999999999999999984     25889999999877777778899999999999999999999998654  558


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999653  335899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCC---------CCCCCHHHHHHH
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS---------EHGPSLLAYIWK  526 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~---------~~~~~~~~~~~~  526 (624)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....         ............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6543221 222234577889999999999999999999999999999999988652110         000001111111


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ....+....         .+......+.+++.+||+.||++|||+.||++.|+..
T Consensus       244 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          244 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111111         1122234578899999999999999999999999764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-41  Score=352.54  Aligned_cols=263  Identities=28%  Similarity=0.442  Sum_probs=211.7

Q ss_pred             HhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      ..++|...+.||+|+||.||+++..      +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4578999999999999999999975      347899999976543 345789999999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCC---------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTR---------------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK  434 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk  434 (624)
                      .++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+.+   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            9999999999999999965321                     256899999999999999999999985   9999999


Q ss_pred             CCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 006952          435 TSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYH  513 (624)
Q Consensus       435 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~  513 (624)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||... 
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence            9999999999999999999987644332233334568899999999999999999999999999999999 99887421 


Q ss_pred             CCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCC
Q 006952          514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT  584 (624)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~  584 (624)
                           ...... .....+......     ..+    ...+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       281 -----~~~~~~-~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          281 -----AHEEVI-YYVRDGNILACP-----ENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             -----CHHHHH-HHHHTTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             -----ChHHHH-HHHhCCCcCCCC-----CCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence                 122222 222223222111     112    23578899999999999999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-41  Score=349.16  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=201.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|++.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999976 688999999865432 334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++.   ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999884   3446899999999999999999999985   9999999999999999999999999998764333


Q ss_pred             CCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......   ......   +......  ..+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~---~~~~~~~--~~~~  231 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSD---WKEKKTY--LNPW  231 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHHH---HHTTCTT--STTG
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHH---Hhccccc--CCcc
Confidence            3333345679999999999988776 78999999999999999999998532221   111111   1111110  0100


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        ...    ...+.+++.+||+.||++|||+.|+++.
T Consensus       232 --~~~----~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          232 --KKI----DSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccC----CHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              111    2346788999999999999999999763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=344.47  Aligned_cols=270  Identities=21%  Similarity=0.293  Sum_probs=214.6

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--cceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--ESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV  379 (624)
                      .++|.+.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3679999999999999999999764 8899999987543 344677889999999999999999999998765  67999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEecccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMAR  455 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~  455 (624)
                      |||+++++|.+++........+++..++.++.||++||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999985   9999999999999    778889999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhc--------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAM--------GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      .......   .....||+.|+|||++.        +..++.++||||||+++|||++|+.||......  ........+.
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~  239 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKI  239 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG--GGCHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--chhHHHHHHH
Confidence            7654322   22456899999999986        577899999999999999999999998533222  1222333333


Q ss_pred             HhcCCc---cccc-----------cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          528 WCEGHA---AELM-----------DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 ~~~~~~---~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ......   ....           +-.............+.+++.+||+.||++|||++|+++....+
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            322211   1000           00111234466677788999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=356.86  Aligned_cols=264  Identities=30%  Similarity=0.428  Sum_probs=213.9

Q ss_pred             hcCccccCccccCCceeEEEEEec--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++|.+.+.||+|+||.||+++..        .+..||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999853        23579999997653 34457889999999999 999999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      +..++||||+++++|.+++.....             ...+++..++.|+.||++||.|||+.+   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999975331             245899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...      .
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~------~  298 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------P  298 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------C
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------C
Confidence            9999999999999987755443334445567899999999999999999999999999999999 99887421      1


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      ... +......+......     ..+    ...+.+++.+||+.||++|||+.||++.|+......+
T Consensus       299 ~~~-~~~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          299 VEE-LFKLLKEGHRMDKP-----SNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHH-HHHHHHTTCCCCCC-----SSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHH-HHHHHHcCCCCCCC-----ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            222 22223232222111     112    2357889999999999999999999999987644333

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.2e-42  Score=363.22  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=195.1

Q ss_pred             cCccccCccccCCceeEEEEEec----CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|.+.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57889999999999999999975    46789999997653 34567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..  ....+++.+++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999964  2346899999999999999999999985   99999999999999999999999999987654


Q ss_pred             CCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...      ...... .....+..    
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~------~~~~~~-~~i~~~~~----  268 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM------SNQDVI-KAVDEGYR----  268 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC------CHHHHH-HHHHTTEE----
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC------CHHHHH-HHHHcCCC----
Confidence            3221 12222345778999999999999999999999999999998 99997421      111211 11111110    


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                           ...+......+.+++.+||+.||++||++.+|++.|+..
T Consensus       269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                 011112234588899999999999999999999999653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.9e-41  Score=339.24  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=207.4

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|...+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            367889999999999999999998899999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            99999999954  2345899999999999999999999985   99999999999999999999999999986543221 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...      ......... ..+....  .    
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~------~~~~~~~~~-~~~~~~~--~----  228 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDI-STGFRLY--K----  228 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHH-HTTCCCC--C----
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC------CHHHHHHHH-hcCccCC--C----
Confidence            12223456788999999999999999999999999999999 89887421      122222221 1211110  0    


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         +......+.+++.+||+.||++|||+.++++.|+.
T Consensus       229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          229 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence               11112357789999999999999999999999975

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9e-41  Score=341.97  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=201.8

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHh--cCCCCcceEEeEEEec----Ccce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK--LQHKNLVRLLGCCLEE----NESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----~~~~  377 (624)
                      .++|...+.||+|+||.||+|+. +++.||||++...   ..+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 6899999998654   23455667777766  7999999999997653    3478


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH--------EDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                      +||||+++|+|.+++.    ...+++..++.++.||++||.|||        +.   +|+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    246899999999999999999999        65   59999999999999999999999


Q ss_pred             ccccccccCCCCCC--ccccccccccCccChhhhcCC------CCChhhHHHHHHHHHHHHHhC----------CCCCCC
Q 006952          450 DFGMARIFGGNQSK--ANTNRVVGTYGYMAPEYAMGG------IFSVKSDVFSFGVVLLEIISG----------KKSTGF  511 (624)
Q Consensus       450 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~S~Gvil~elltg----------~~p~~~  511 (624)
                      |||+++........  .......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999866443322  122345799999999999877      456799999999999999999          666532


Q ss_pred             CCCCCCCCHHHHHHHHHhcC-CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          512 YHSEHGPSLLAYIWKLWCEG-HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...  ............... .........    .+......+.+++.+||+.||++|||+.||++.|++
T Consensus       236 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVP--NDPSFEDMRKVVCVDQQRPNIPNRW----FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSC--SSCCHHHHHHHHTTSCCCCCCCGGG----GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCC--CCcchhhhhHHHhccCCCCCCChhh----ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            221  112222233322222 222222111    223456678999999999999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=344.56  Aligned_cols=263  Identities=28%  Similarity=0.460  Sum_probs=203.8

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|+..+.||+|+||.||+++.. ++.||||++...  ...+.+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            57888999999999999999985 788999998643  34578899999999999999999999876  45899999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-eEEeccccccccCCCCCC
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-PKISDFGMARIFGGNQSK  463 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  463 (624)
                      +++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976555556889999999999999999999943335999999999999998887 799999999765322   


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||....    .......+... .+......     .
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~-~~~~~~~~-----~  227 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG----GPAFRIMWAVH-NGTRPPLI-----K  227 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC----SSHHHHHHHHH-TTCCCCCB-----T
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC----ccHHHHHHHHh-cCCCCCcc-----c
Confidence              223468999999999999999999999999999999999999975321    12222222222 22211111     1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCC
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQP  591 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~~p  591 (624)
                      ..+    ..+.+++.+||+.||++|||+.+|++.|+.....++.+..|
T Consensus       228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            222    34778999999999999999999999998755445444433

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=356.53  Aligned_cols=258  Identities=31%  Similarity=0.437  Sum_probs=206.7

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|...+.||+|+||.||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367889999999999999999953      3668999999754 334456788999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCC----CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEe
Q 006952          377 LLIYEYMPNKSLDVFLFDST----RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKIS  449 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  449 (624)
                      ++||||+++|+|.+++....    ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996532    2245899999999999999999999985   99999999999999555   59999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      |||+++.+.............||+.|+|||++.+..++.++||||||+++|||++ |+.||...      ........ .
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~------~~~~~~~~-i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------SNQEVLEF-V  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHH-H
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHH-H
Confidence            9999986533332333344668999999999999999999999999999999998 99887421      12222222 2


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ..+......     ..+    ...+.+|+.+||+.||++|||+.+|++.|..
T Consensus       300 ~~~~~~~~~-----~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          300 TSGGRMDPP-----KNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HTTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCCCCC-----ccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            222211111     112    2347789999999999999999999999965

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.1e-41  Score=346.93  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=201.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE------  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------  375 (624)
                      .++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999986 68999999987543 3456789999999999999999999999876543      


Q ss_pred             ---------------------------------------------------ceEEEEeccCCChhhhhhcCCCCcccCHH
Q 006952          376 ---------------------------------------------------SLLIYEYMPNKSLDVFLFDSTRSVQLDWK  404 (624)
Q Consensus       376 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~  404 (624)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               68999999999999999876666677888


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC----------ccccccccccC
Q 006952          405 RRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK----------ANTNRVVGTYG  474 (624)
Q Consensus       405 ~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~  474 (624)
                      .++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999985   999999999999999999999999999877543211          12234579999


Q ss_pred             ccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHH
Q 006952          475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYI  554 (624)
Q Consensus       475 y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  554 (624)
                      |+|||++.+..++.++||||||+++|||++|..|+.        .... .............         .......+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~~---------~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPLL---------FTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCHH---------HHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCcc---------cccCChhHH
Confidence            999999999999999999999999999999876621        0111 1111111111111         112234567


Q ss_pred             HHHhhcccCCCCCCCCHHHHHH
Q 006952          555 HIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       555 ~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +++.+||+.||++|||+.|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            8999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-40  Score=336.21  Aligned_cols=253  Identities=31%  Similarity=0.502  Sum_probs=196.2

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCc----ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG----QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|+..+.||+|+||.||++... ++.||||++.....    ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367899999999999999999985 88999999875432    3457889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--------CCCeEEecc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH--------EMNPKISDF  451 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df  451 (624)
                      |||+++++|.+++.    ...+++..++.++.|+++||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999884    346899999999999999999999986455999999999999986        678999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      |++.......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...      .............
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI------DGLAVAYGVAMNK  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS------CHHHHHHHHHTSC
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHhhhcCC
Confidence            9998654322    22356899999999999999999999999999999999999997421      2222222222222


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .....         +......+.+++.+||+.||++|||+.||++.|+.
T Consensus       231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 LALPI---------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCC---------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            11111         11122357789999999999999999999999974

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-41  Score=351.49  Aligned_cols=266  Identities=27%  Similarity=0.409  Sum_probs=208.8

Q ss_pred             HhcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN  374 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  374 (624)
                      ..++|...+.||+|+||.||+|+.      .++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            357899999999999999999996      235689999997543 34567899999999999 8999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCCC--------------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRS--------------------VQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK  434 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk  434 (624)
                      ..++||||+++++|.+++......                    ..+++..++.++.||++||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999654321                    34799999999999999999999985   9999999


Q ss_pred             CCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC
Q 006952          435 TSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYH  513 (624)
Q Consensus       435 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~  513 (624)
                      |+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333344567889999999999999999999999999999998 999975321


Q ss_pred             CCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      .   .   .........+.....         +......+.+++.+||+.||.+|||+.+|++.|+......+
T Consensus       280 ~---~---~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          280 V---D---ANFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             C---S---HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             c---H---HHHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            1   1   111222222211111         11123457889999999999999999999999987654443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-40  Score=335.22  Aligned_cols=255  Identities=27%  Similarity=0.409  Sum_probs=208.4

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|+..+.||+|+||.||++..+++..||+|++..... ..+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467899999999999999999998888999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998542  345899999999999999999999985   999999999999999999999999999876443322


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...      .......... .+....  .+   
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~-~~~~~~--~~---  227 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY------TNSEVVLKVS-QGHRLY--RP---  227 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHH-TTCCCC--CC---
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc------ChHHHHHHHH-cCCCCC--CC---
Confidence             2223456778999999999899999999999999999999 99997422      1122222221 111111  11   


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...    ...+.+++.+||+.||++|||+.||++.|+..
T Consensus       228 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          228 HLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             TTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            111    23577899999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.1e-41  Score=347.92  Aligned_cols=259  Identities=18%  Similarity=0.209  Sum_probs=206.2

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36799999999999999999996 4688999999875433  24688999999999 99999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----eEEeccccccc
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-----PKISDFGMARI  456 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~  456 (624)
                      |+ +++|.+++...  ...+++..++.|+.||++||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998653  346899999999999999999999985   999999999999998887     99999999987


Q ss_pred             cCCCCCCc-----cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          457 FGGNQSKA-----NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       457 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ............. .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~---~~~~~~~~~~i~~-~  235 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK---ADTLKERYQKIGD-T  235 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC---CSSHHHHHHHHHH-H
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc---cccHHHHHHHHHh-h
Confidence            64433211     2245679999999999999999999999999999999999999986432   2223222221110 0


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .... ..+.+....    . .+.+++..||+.||.+||++.+|.+.|+.
T Consensus       236 ~~~~-~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          236 KRAT-PIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HHHS-CHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hccC-CHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            0000 001111111    1 68889999999999999999999998854

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.4e-41  Score=342.54  Aligned_cols=259  Identities=26%  Similarity=0.390  Sum_probs=204.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|++.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999999965 58899999986533   23457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999854   346899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..      ........+..... .... ..
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~------~~~~~~~~~~~~~~-~~~~-~~  234 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG------ETAVSIAIKHIQDS-VPNV-TT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS------SCHHHHHHHHHSSC-CCCH-HH
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC------CChHHHHHHHhhcc-CCCc-ch
Confidence            321 223346799999999999999999999999999999999999999742      22222222222221 1111 01


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhccC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP-TMSSVAVMLASD  581 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~  581 (624)
                      ..    .......+.+++.+||+.||++|| +++++.+.|...
T Consensus       235 ~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          235 DV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             hc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            11    112234578899999999999998 999999999765

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.3e-41  Score=341.71  Aligned_cols=263  Identities=17%  Similarity=0.226  Sum_probs=209.0

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+|.. .+++.||||++.....  .+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            36799999999999999999996 4688999999865432  34678999999999 79999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----eEEeccccccc
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-----PKISDFGMARI  456 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~  456 (624)
                      |+ +++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999653  235899999999999999999999985   999999999999987776     99999999987


Q ss_pred             cCCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          457 FGGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       457 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      .......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543321     12345679999999999999999999999999999999999999986433222222222221111111


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                      ...+     +...+    ...+.+++.+||+.||++||++++|++.|+....
T Consensus       241 ~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          241 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            1111     11122    2357889999999999999999999999986543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.6e-41  Score=345.13  Aligned_cols=259  Identities=30%  Similarity=0.440  Sum_probs=210.5

Q ss_pred             hcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|...+.||+|+||.||++..      .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            57899999999999999999986      235789999997643 34567889999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCC---------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 006952          377 LLIYEYMPNKSLDVFLFDSTR---------------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKT  435 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp  435 (624)
                      ++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234899999999999999999999985   99999999


Q ss_pred             CcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 006952          436 SNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHS  514 (624)
Q Consensus       436 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~  514 (624)
                      +|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333344567889999999999999999999999999999999 9999753221


Q ss_pred             CCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          515 EHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                         .....    ....+......         ......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       259 ---~~~~~----~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ---ERLFN----LLKTGHRMERP---------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             ---GGHHH----HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHH----HhhcCCcCCCC---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               12222    12222211111         11233578899999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.2e-41  Score=364.03  Aligned_cols=265  Identities=27%  Similarity=0.418  Sum_probs=206.9

Q ss_pred             HhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..++|...+.||+|+||.||+|.++++..||||+++.... ..+.|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3567889999999999999999998888999999986543 35789999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999532 2245899999999999999999999985   99999999999999999999999999987643321


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      . ......+++.|+|||.+.++.++.++||||||+++|||++ |+.|+...      ...+.... ...+....      
T Consensus       336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~------~~~~~~~~-i~~~~~~~------  401 (452)
T 1fmk_A          336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQ-VERGYRMP------  401 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHH-HHTTCCCC------
T ss_pred             e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHH-HHcCCCCC------
Confidence            1 1223456789999999999999999999999999999999 89887421      12222222 22221111      


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQ  590 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~~  590 (624)
                         .+......+.+++.+||+.||++|||+.+|++.|+......+++.+
T Consensus       402 ---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~  447 (452)
T 1fmk_A          402 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  447 (452)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence               1112234578899999999999999999999999876555444333

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-40  Score=347.24  Aligned_cols=249  Identities=22%  Similarity=0.242  Sum_probs=204.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|+..+.||+|+||.||+++.+ +|+.||+|++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999976 5899999999754   234567789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999998853   346899999999999999999999985   99999999999999999999999999985432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+.......... +...     
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~~-~~~~-----  223 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHERLFELILM-EEIR-----  223 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHH-CCCC-----
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC------CCHHHHHHHHHc-CCCC-----
Confidence            22  223456899999999999999999999999999999999999999742      122222222221 1110     


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~  577 (624)
                           .+......+.+++.+||+.||++||     +++||++.
T Consensus       224 -----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                 1111123577889999999999999     89999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.9e-41  Score=366.26  Aligned_cols=259  Identities=29%  Similarity=0.430  Sum_probs=209.2

Q ss_pred             HHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ...++|...+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3457899999999999999999999888999999997654 35688999999999999999999999986 567899999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999999542 2235789999999999999999999985   9999999999999999999999999998764321


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      . .......+++.|+|||++..+.++.++||||||+++|||++ |+.||...      ...+..... ..+.....    
T Consensus       339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~------~~~~~~~~i-~~~~~~~~----  406 (454)
T 1qcf_A          339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRAL-ERGYRMPR----  406 (454)
T ss_dssp             H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHH-HHTCCCCC----
T ss_pred             e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHHH-HcCCCCCC----
Confidence            1 11223446788999999999999999999999999999999 99997421      122222222 12211110    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                           +......+.+|+.+||+.||++|||+.+|++.|+....
T Consensus       407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                 11123457889999999999999999999999987543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.4e-40  Score=339.99  Aligned_cols=262  Identities=25%  Similarity=0.353  Sum_probs=202.5

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+++..+|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999999889999999987543  2335678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 77777754  2345899999999999999999999985   9999999999999999999999999998764332


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc--
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD--  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  538 (624)
                      .  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...   ........+..............  
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV---TDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---STTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHHCCCChHHhhhhh
Confidence            2  2234578999999999876 56899999999999999999999997532   22333444433332221111100  


Q ss_pred             c-------hh--hcCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 S-------VV--KQSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~-------~l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .       ..  ....+     .....++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0       00  00000     011235778999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-40  Score=345.42  Aligned_cols=251  Identities=23%  Similarity=0.266  Sum_probs=203.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .+.|.+.+.||+|+||.||+++.+ +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 588999999876432      2357899999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEeccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  452 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  452 (624)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999943   446899999999999999999999985   99999999999998877    79999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      ........ +....
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~------~~~~~~~~-i~~~~  234 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLAN-ITAVS  234 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHH-HHTTC
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC------CHHHHHHH-HHhcC
Confidence            998765432   223467999999999999999999999999999999999999997421      12222222 11111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..  .++......    ...+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 YD--FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC--CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11  111111111    234678899999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-41  Score=369.42  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=210.0

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+|...+.||+|+||.||+|+++. +..||||+++.... ..++|.+|+.+|++++||||+++++++.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4678889999999999999999875 78999999976543 467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.+++... ....+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            9999999999653 3346899999999999999999999985   99999999999999999999999999987643321


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...   ........    ...+....      
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~---~~~~~~~~----~~~~~~~~------  439 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYEL----LEKDYRME------  439 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC---CGGGHHHH----HHTTCCCC------
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHH----HHcCCCCC------
Confidence             12223456789999999999999999999999999999999 88887432   11222222    11221111      


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                         .+......+.+|+.+||+.||++|||+.+|++.|+...
T Consensus       440 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          440 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               11122345778999999999999999999999998653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-40  Score=343.37  Aligned_cols=260  Identities=28%  Similarity=0.441  Sum_probs=210.1

Q ss_pred             hcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      .++|...+.||+|+||.||+++.      .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999985      2467899999976543 3457889999999999 99999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCC---------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTR---------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      .++||||+++++|.+++.....               ...+++..++.++.||++||.|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999975432               225899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ..
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DS  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---hh
Confidence            9999999999999987655443333344567889999999999999999999999999999999 9988753211   11


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .   .............         +......+.+++.+||+.||++|||+.||++.|++.
T Consensus       256 ~---~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          256 K---FYKMIKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             H---HHHHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---HHHHhccCCCCCC---------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1   1111211111100         111224578899999999999999999999999764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.5e-41  Score=346.06  Aligned_cols=259  Identities=25%  Similarity=0.449  Sum_probs=191.8

Q ss_pred             hcCccccCccccCCceeEEEEEecCCc----EEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc-
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGK----EIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES-  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-  376 (624)
                      .++|...+.||+|+||.||+|......    .||||++...  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            468999999999999999999976432    7999998764  345567899999999999999999999999887665 


Q ss_pred             -----eEEEEeccCCChhhhhhcCC---CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          377 -----LLIYEYMPNKSLDVFLFDST---RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       377 -----~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                           ++||||+++++|.+++....   ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 89999999999999986422   2235899999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....   .......    
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~----  251 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE---NAEIYNY----  251 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHH----
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC---hHHHHHH----
Confidence            99999987654433333334557889999999999999999999999999999999 898875321   1222221    


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...+.....         +......+.+++.+||+.||++|||+.++++.|+..
T Consensus       252 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          252 LIGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            112211111         111223578899999999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-40  Score=336.51  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=204.5

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|...+.||+|+||.||++.+.++..||+|++..... ..+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            468899999999999999999998888999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            999999999642  345899999999999999999999985   99999999999999999999999999986643221 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....      ........ ..+.....  +   
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~-~~~~~~~~--~---  243 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHI-AQGLRLYR--P---  243 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHH-HTTCCCCC--C---
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC------hhHHHHHH-hcccCCCC--C---
Confidence            11223456788999999999999999999999999999998 999975221      12222222 11111100  0   


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...    ...+.+++.+||+.||++|||+.+|++.|..
T Consensus       244 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          244 HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            111    2357789999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=338.89  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .+.|...+.||+|+||.||++... +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357899999999999999999976 588999999875432      2467899999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEeccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  452 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  452 (624)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999843   456899999999999999999999985   99999999999999887    79999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      ........... ..
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~~~~-~~  233 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANVSA-VN  233 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHH-TC
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC------CHHHHHHHHHh-cC
Confidence            998764332   223457999999999999999999999999999999999999997421      11222221111 11


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      . .. ........    ...+.+++.+||+.||++|||+.|+++
T Consensus       234 ~-~~-~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 Y-EF-EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             C-CC-CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-Cc-CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0 01 11111111    234778899999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=336.80  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=194.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--------------------------ccHHHHHHHHHHHH
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--------------------------QGLQEFKNEVTVIA  356 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~  356 (624)
                      .++|...+.||+|+||.||+++.. +++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999965 588999999865431                          12356889999999


Q ss_pred             hcCCCCcceEEeEEEe--cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006952          357 KLQHKNLVRLLGCCLE--ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK  434 (624)
Q Consensus       357 ~l~h~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk  434 (624)
                      +++||||+++++++.+  .+..++||||+++++|.+++    ....+++..++.++.||++||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  55689999999999998865    2346899999999999999999999985   9999999


Q ss_pred             CCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCC
Q 006952          435 TSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI---FSVKSDVFSFGVVLLEIISGKKSTGF  511 (624)
Q Consensus       435 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~Gvil~elltg~~p~~~  511 (624)
                      |+|||++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987653322  223457999999999998765   47899999999999999999999742


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          512 YHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            ........... ..... ...   ....    ...+.+++.+||+.||++|||+.||++
T Consensus       243 ------~~~~~~~~~~~-~~~~~-~~~---~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ------ERIMCLHSKIK-SQALE-FPD---QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             ------SSHHHHHHHHH-HCCCC-CCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------ccHHHHHHHHh-cccCC-CCC---cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                  12222222221 11111 000   0112    235778999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=344.90  Aligned_cols=251  Identities=19%  Similarity=0.266  Sum_probs=203.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 47889999987543 3456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~  460 (624)
                      +++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999853  2346899999999999999999999985   999999999999987  789999999999876433


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      ........... +...  .+..
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~-~~~~--~~~~  225 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMN-AEYT--FDEE  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHH-TCCC--CCHH
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC------CHHHHHHHHHc-CCCC--CChh
Confidence            2   223467899999999999988999999999999999999999997421      12222222221 1111  0111


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .....    ...+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111    235778999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.2e-40  Score=343.61  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=208.6

Q ss_pred             hcCccccCccccCCceeEEEEEec--------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++|...+.||+|+||.||++...        ++..||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999863        46789999997653 34567889999999999 899999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      +..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975332             234899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...      .
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~  264 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------P  264 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC------C
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC------C
Confidence            9999999999999987654433333334567889999999999999999999999999999999 99987421      1


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..... .....+......     ..+    ...+.+++.+||+.||++|||+.||++.|+..
T Consensus       265 ~~~~~-~~~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          265 VEELF-KLLKEGHRMDKP-----ANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHH-HHHHHTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH-HHHhcCCCCCCC-----ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22222 222222211111     112    23577899999999999999999999999754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.4e-40  Score=343.23  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=201.5

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcE----EEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKE----IAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|+..+.||+|+||.||+|++.. ++.    |++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            578899999999999999999653 443    7888775433 344567789999999999999999999886 567899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999998643  346889999999999999999999985   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ............||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ......    ...+......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~~  239 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDL----LEKGERLAQP  239 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHHH----HHTTCBCCCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHHH----HHcCCCCCCC
Confidence            5544444455678889999999999999999999999999999999 9999753221   111111    1122111111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .         .....+.+++.+||+.||++|||+.+|++.|+..
T Consensus       240 ~---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          240 Q---------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             T---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             C---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         1112466788999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-40  Score=338.62  Aligned_cols=262  Identities=21%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|+..+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999975 58899999987543  3345778899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |++++ +.+.+..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99864 4444432  2346899999999999999999999985   9999999999999999999999999998764332


Q ss_pred             CCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .  ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.  ...........+.+..............
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            2  223457899999999998766 7999999999999999999988852  2222222233333222211111100000


Q ss_pred             ---------------hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 ---------------VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 ---------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                     ............+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                           000011122345778999999999999999999976

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.1e-40  Score=351.54  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|+..+.||+|+||.||+++.+ +++.||+|++++..   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 47789999987642   23345678999999887 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999998854   345899999999999999999999985   9999999999999999999999999998532


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC--CCHHHHHHHHHhcCCcccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG--PSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  536 (624)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+.  ........+........  
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--  280 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--  280 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--
Confidence            22  1233457899999999999999999999999999999999999999864322211  11122222222222111  


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                              .+......+.+++.+||+.||++||++
T Consensus       281 --------~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 --------IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                    111122357788999999999999995

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-40  Score=337.93  Aligned_cols=261  Identities=25%  Similarity=0.361  Sum_probs=198.7

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||+++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5788999999999999999999889999999986543  23357788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++ +|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 888887542  345899999999999999999999985   99999999999999999999999999987643221


Q ss_pred             CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc----
Q 006952          463 KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM----  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  537 (624)
                        ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...   ........+.+...........    
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHHCCCChhhchhhhc
Confidence              22235689999999999764 5899999999999999999999997522   1112222222222111111000    


Q ss_pred             ----cchhh-------cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 ----DSVVK-------QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 ----d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ++...       ..........+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                00000       0000112345778999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-40  Score=349.47  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=202.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-----CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-----SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .+.|++.+.||+|+||.||+++.+ +++.||||++...     .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999975 5899999998642     1234678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEecccc
Q 006952          378 LIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGM  453 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~  453 (624)
                      +||||+++++|.+.+.... ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775422 2345899999999999999999999985   999999999999987655   99999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...       ... .......+..
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~-~~~~i~~~~~  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-------KER-LFEGIIKGKY  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-------HHH-HHHHHHHTCC
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-------HHH-HHHHHHcCCC
Confidence            987654322  233457999999999999999999999999999999999999997421       111 1111112211


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .  ..+......    ...+.+++.+||+.||++|||+.|+++
T Consensus       250 ~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 K--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1  011111111    235778999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=345.39  Aligned_cols=268  Identities=15%  Similarity=0.194  Sum_probs=199.8

Q ss_pred             hcCccccCccccCCceeEEEEEec----CCcEEEEEEccccCcc-----------cHHHHHHHHHHHHhcCCCCcceEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTSGQ-----------GLQEFKNEVTVIAKLQHKNLVRLLG  368 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~  368 (624)
                      .++|...+.||+|+||.||+|...    .+..+|||++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    5678999998765432           1234667889999999999999999


Q ss_pred             EEEe----cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC
Q 006952          369 CCLE----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM  444 (624)
Q Consensus       369 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  444 (624)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.|+.||++||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    66789999999 9999999854   237899999999999999999999985   99999999999999887


Q ss_pred             --CeEEeccccccccCCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          445 --NPKISDFGMARIFGGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       445 --~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...  ...
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~  266 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN--LKD  266 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG--TTC
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc--ccc
Confidence              9999999999876432211     1123457999999999999999999999999999999999999997421  111


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCC
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT  584 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~  584 (624)
                      .............. ....+.....   .......+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       267 ~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          267 PVAVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             cHHHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            11112111111111 1111111100   001223578899999999999999999999999876543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.4e-40  Score=335.73  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=203.2

Q ss_pred             hcCccccCccccCCceeEEEEEecC-C-------cEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-G-------KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      .++|...+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678899999999999999998653 3       4699999987777777889999999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--------eE
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN--------PK  447 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~k  447 (624)
                      .++||||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999653  334899999999999999999999985   999999999999998887        99


Q ss_pred             EeccccccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH
Q 006952          448 ISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      |+|||++.....      .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.  ..   .........
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~--~~---~~~~~~~~~  230 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SA---LDSQRKLQF  230 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT--TT---SCHHHHHHH
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc--cc---cchHHHHHH
Confidence            999999865422      223568899999999987 778999999999999999999665532  11   111111111


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ...........            ...+.+++.+||+.||++|||+.||++.|+...
T Consensus       231 ~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          231 YEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             hhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11111111111            123678899999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.1e-40  Score=356.01  Aligned_cols=249  Identities=28%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-cceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-ESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||+|.+. ++.||||+++...  ..+.|.+|+.+|++++||||+++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888999999999999999985 7899999997654  4578999999999999999999999988765 68999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999653 2334789999999999999999999985   999999999999999999999999999854322  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....   .......+    ..+.....     
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i----~~~~~~~~-----  407 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV----EKGYKMDA-----  407 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC---TTTHHHHH----HTTCCCCC-----
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcCCCCCC-----
Confidence               112356889999999999999999999999999999998 999975322   22232222    22211111     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                          +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       408 ----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          408 ----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                11223457889999999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=344.89  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=196.1

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCC--CCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQH--KNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|++.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++.+++|  +||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999999889999999987543  3445788999999999976  9999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      || +.+++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999864   346899999999999999999999985   99999999999997 57899999999987654


Q ss_pred             CCCCccccccccccCccChhhhcC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMG-----------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      ...........||+.|+|||++.+           ..++.++||||||+++|||++|+.||...     ...........
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-----hhHHHHHHHHh
Confidence            433333445679999999999865           67899999999999999999999997421     12222222222


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ........         +......+.+++.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~---------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccCC---------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            21111111         11112357788999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-40  Score=342.06  Aligned_cols=270  Identities=27%  Similarity=0.393  Sum_probs=213.9

Q ss_pred             CCCHHHHHHHhcCccccCccccCCceeEEEEEe------cCCcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcce
Q 006952          294 PLDLIDIVKATQDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVR  365 (624)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~  365 (624)
                      +.+...+....++|...+.||+|+||.||+++.      .+++.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            445555555668999999999999999999984      2467899999976543 3456789999999999 7999999


Q ss_pred             EEeEEEecCc-ceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 006952          366 LLGCCLEENE-SLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHR  431 (624)
Q Consensus       366 l~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~  431 (624)
                      +++++...+. .++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence            9999987654 8999999999999999965432             123899999999999999999999985   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCC
Q 006952          432 DLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTG  510 (624)
Q Consensus       432 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~  510 (624)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987654443333445668899999999999999999999999999999998 999874


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          511 FYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .....      .........+......         ......+.+++.+||+.||++|||+.||++.|+..
T Consensus       253 ~~~~~------~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          253 GVKID------EEFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             TCCCS------HHHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchh------HHHHHHhccCccCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            32111      1112222222211111         11123577899999999999999999999999753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.7e-40  Score=336.91  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=193.8

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+|+..  ..||+|+++...  ....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999874  369999987543  34457899999999999999999999965 5567899999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999998854  3356899999999999999999999985   9999999999999999999999999998665433


Q ss_pred             CCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          462 SKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      .........||+.|+|||.+.   +..++.++||||||+++|||++|+.||....     . ..........+.......
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~-~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-----N-RDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-----C-HHHHHHHHHHTSCCCCTT
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-----h-HHHHHHHhcccccCcchh
Confidence            333334567999999999986   6678999999999999999999999974221     1 112222222222211111


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .. ...+    ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       249 ~~-~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          249 KV-RSNC----PKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             SS-CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hc-cccC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11 1122    34588899999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.2e-41  Score=344.91  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=196.2

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc---
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES---  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~---  376 (624)
                      .++|.+.+.||+|+||.||+++. .+++.||||++.....   ...+.+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 4688999999976432   3356789999999999999999999999876654   


Q ss_pred             -eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          377 -LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       377 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                       ++||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             999999999999999854   345899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          456 IFGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       456 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .................
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~------~~~~~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG------DSPVSVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC------CChHHHHHHHhcCCCCC
Confidence            76443221 233346799999999999999999999999999999999999999742      22233333333222211


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH-HHhcc
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA-VMLAS  580 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~-~~L~~  580 (624)
                      .   .......    ...+.+++.+||+.||++||+..+++ ..|..
T Consensus       239 ~---~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 P---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             H---HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c---ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            1   1111112    23577899999999999999666554 44433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-40  Score=344.76  Aligned_cols=269  Identities=27%  Similarity=0.396  Sum_probs=210.1

Q ss_pred             hcCccccCccccCCceeEEEEEe-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  376 (624)
                      .++|+..+.||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++..  ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999984     3578999999988777777889999999999999999999999874  4557


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            8999999999999998642  235899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCC--------CCCCCHHHHHHHH
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS--------EHGPSLLAYIWKL  527 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~--------~~~~~~~~~~~~~  527 (624)
                      ....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....        .............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543321 223345688889999999999999999999999999999999998642111        0111111112222


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      ...+....         .+......+.+++.+||+.||++|||+.||++.|+......+
T Consensus       257 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 LEEGQRLP---------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             hhcccCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            22221111         112223457889999999999999999999999987654433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.8e-40  Score=341.86  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=210.6

Q ss_pred             HHhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      ...++|...+.||+|+||.||+|+..      .++.||||++..... .....+.+|+.++++++||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            45678999999999999999999864      367899999975433 34567899999999999999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCC-------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeE
Q 006952          375 ESLLIYEYMPNKSLDVFLFDST-------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPK  447 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  447 (624)
                      ..++||||+++++|.+++....       ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence            9999999999999999986422       1245789999999999999999999985   99999999999999999999


Q ss_pred             EeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHH
Q 006952          448 ISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      |+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...      ...... .
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~-~  251 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVL-R  251 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHH-H
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC------CHHHHH-H
Confidence            999999986543332223334567889999999999999999999999999999999 78886421      122222 2


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ....+......         ......+.+++.+||+.||++|||+.||++.|+...
T Consensus       252 ~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          252 FVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            22222221111         112235778999999999999999999999998753

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.8e-40  Score=336.85  Aligned_cols=262  Identities=27%  Similarity=0.443  Sum_probs=204.7

Q ss_pred             cCccccCccccCCceeEEEEEe-----cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  376 (624)
                      +.|+..+.||+|+||.||++++     .+++.||||++.... ....+.+.+|+.++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5688899999999999999983     358899999987543 34567899999999999999999999999876  568


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999998542  245899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------CCCCCCHHHHHHHH
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYH--------SEHGPSLLAYIWKL  527 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~--------~~~~~~~~~~~~~~  527 (624)
                      ....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+....        ..............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6543321 22334568889999999999999999999999999999999998853110        01111111111122


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...+....         .+......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       256 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          256 LKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            22221111         111223457889999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-39  Score=343.51  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..++|...+.||+|+||.||+++.+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999975 58899999987543  33457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEeccccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARI  456 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  456 (624)
                      |||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999988843   346899999999999999999999985   99999999999998654   599999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      +..... .....+.... 
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~------~~~~~~-~~i~~~~~~~-  249 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLY-AQIKAGAYDY-  249 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHH-HHHHHTCCCC-
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHH-HHHHhCCCCC-
Confidence            64332   223467999999999999999999999999999999999999997421      112222 2222222111 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..+. ....    ...+.+++.+||+.||++|||+.|+++.
T Consensus       250 ~~~~-~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 PSPE-WDTV----TPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CTTG-GGGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             Cccc-ccCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1110 0111    2347789999999999999999999764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.9e-40  Score=343.52  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=199.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|...+.||+|+||.||+++.+ +++.||+|++.+..   ....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999976 58899999997643   23456788999999998 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999998854   345899999999999999999999985   9999999999999999999999999998543


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCC--CHHHHHHHHHhcCCcccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP--SLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  536 (624)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........  .......+........  
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--  237 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--  237 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--
Confidence            221  2234568999999999999999999999999999999999999998542221111  1112222222222111  


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM  571 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  571 (624)
                              .+......+.+++.+||+.||++||++
T Consensus       238 --------~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 --------IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             --------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                    111122357788999999999999995

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.1e-40  Score=349.28  Aligned_cols=267  Identities=17%  Similarity=0.216  Sum_probs=203.4

Q ss_pred             hcCccccCccccCCceeEEEEEecC------CcEEEEEEccccCcccH-----------HHHHHHHHHHHhcCCCCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSGQGL-----------QEFKNEVTVIAKLQHKNLVRL  366 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~l  366 (624)
                      .++|.+.+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999999765      47899999876542211           123346667777889999999


Q ss_pred             EeEEEec----CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-
Q 006952          367 LGCCLEE----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-  441 (624)
Q Consensus       367 ~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-  441 (624)
                      ++++...    ...++||||+ +++|.+++...  ...+++..++.|+.||+.||.|||+.+   |+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9999875    3479999999 99999998652  346999999999999999999999985   99999999999999 


Q ss_pred             -CCCCeEEeccccccccCCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 006952          442 -HEMNPKISDFGMARIFGGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSE  515 (624)
Q Consensus       442 -~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~  515 (624)
                       .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...  .
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~--~  265 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN--L  265 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG--T
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--c
Confidence             8899999999999876432211     1123456999999999999999999999999999999999999997521  1


Q ss_pred             CCCCHHHHHHHHHhcCCccccccchhh-cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          516 HGPSLLAYIWKLWCEGHAAELMDSVVK-QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                      ............+ .....+++++.+. ..+    ...+.+++..||+.+|++||++.+|++.|+....
T Consensus       266 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          266 KDPKYVRDSKIRY-RENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             TCHHHHHHHHHHH-HHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHh-hhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            1112222222111 1223333333322 122    2357788889999999999999999999976533

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.8e-40  Score=338.18  Aligned_cols=265  Identities=26%  Similarity=0.391  Sum_probs=188.8

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3568999999999999999999965 58899999987543 334577889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCC---CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          381 EYMPNKSLDVFLFDST---RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      ||++ ++|.+++....   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 58988875421   2245899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---c
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---A  533 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  533 (624)
                      .....  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....   .......+........   +
T Consensus       159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN---DEEQLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCTTTC
T ss_pred             CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhHh
Confidence            43221  22345789999999999764 68999999999999999999999975321   1122222222111110   0


Q ss_pred             ccc-----------------ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AEL-----------------MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~-----------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...                 +...+...........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000                 0000010011112235788999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-40  Score=330.43  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=207.3

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|...+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            367888999999999999999998889999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++...  ...+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            999999999643  345899999999999999999999985   99999999999999999999999999986543211 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...      ........ ...+.....      
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~-i~~~~~~~~------  226 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVED-ISTGFRLYK------  226 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHH-HHTTCCCCC------
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC------CHHHHHHH-HhcCCcCCC------
Confidence            12223456789999999999999999999999999999999 88887421      12222222 222211110      


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         +......+.+++.+||+.||++|||+.++++.|+.
T Consensus       227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          227 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               11112357789999999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=350.03  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=202.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|.+.+.||+|+||.||++... +++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999976 47889999986532   34567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++..+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999853   346899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ..   ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||......   .......... .... . 
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~-~~~~-~-  238 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---SSKEIVHTFE-TTVV-T-  238 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---CHHHHHHHHH-HCCC-C-
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHh-hccc-C-
Confidence            22   2345679999999999874   45899999999999999999999998533222   2222222211 1111 0 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-MSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~  576 (624)
                              .+......+.+++.+||+.||++||+ +.+|..
T Consensus       239 --------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 --------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    11112245788999999999999998 777764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-41  Score=351.85  Aligned_cols=248  Identities=24%  Similarity=0.312  Sum_probs=198.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|+..+.||+|+||.||+++.+ +++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999976 5889999998754   234456788999999998 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999854   345899999999999999999999985   9999999999999999999999999998543


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...      +.......... +...    
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~-~~~~----  242 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE------NEDDLFEAILN-DEVV----  242 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHH-CCCC----
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC------CHHHHHHHHHc-CCCC----
Confidence            22  22334568999999999999999999999999999999999999997421      22222222222 1110    


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH------HHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM------SSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~ev~~  576 (624)
                            .+......+.+++.+||+.||++||++      .||++
T Consensus       243 ------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 ------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  111122347788999999999999998      77765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-40  Score=346.08  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=199.3

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999996 468899999986532   23346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+ +|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6788888754   345899999999999999999999986   99999999999999999999999999986643


Q ss_pred             CCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.........               ..+..
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~  222 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNS  222 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCS
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHc
Confidence            32   2234579999999999988776 78999999999999999999997532211100               00000


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..  ...+......+.+++.+||+.||.+|||+.||++
T Consensus       223 ~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          223 CV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            00  0011112335778999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-40  Score=346.42  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=205.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999976 5889999999876655667889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~  460 (624)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998853  2346899999999999999999999985   999999999999974  467999999999876433


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      +.......... ....  .+..
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~i~~-~~~~--~~~~  272 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKR-CDWE--FDED  272 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHH-CCCC--CCSS
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC------CHHHHHHHHHh-CCCC--CCcc
Confidence            2   123457899999999999999999999999999999999999997421      22222222211 1111  0111


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .....    ...+.+++.+||+.||++|||+.|+++.
T Consensus       273 ~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            11112    2357789999999999999999999874

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=351.32  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=202.6

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..++|...+.||+|+||.||++... +|+.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999865 68899999987543  23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEeccccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARI  456 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~  456 (624)
                      |||+++|+|.+.+..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++   +++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999998854   345899999999999999999999985   99999999999998   467899999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ......  ......||+.|+|||++.+..++.++||||+|+++|+|++|++||..      .+....... ...+.... 
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~------~~~~~~~~~-i~~~~~~~-  232 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD------EDQHRLYQQ-IKAGAYDF-  232 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHH-HHHTCCCC-
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC------ccHHHHHHH-HHhCCCCC-
Confidence            644322  22346799999999999999999999999999999999999999742      112222222 22222111 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..+.. ...    ...+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPEW-DTV----TPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Ccccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11100 111    2347788999999999999999999873

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-40  Score=356.59  Aligned_cols=252  Identities=26%  Similarity=0.437  Sum_probs=205.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367899999999999999999976 68999999986542   23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999843   456899999999999999999999985   99999999999999999999999999987644


Q ss_pred             CCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...      .......+. ..+... . .
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~------~~~~~~~~i-~~~~~~-~-p  236 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD------HVPTLFKKI-CDGIFY-T-P  236 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------SSHHHHHHH-HTTCCC-C-C
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC------CHHHHHHHH-hcCCcC-C-C
Confidence            32   2234579999999999988765 78999999999999999999997521      111222222 122110 0 0


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhccC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLASD  581 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~  581 (624)
                          ...    ...+.+++.+||+.||++|||+.||++  .+...
T Consensus       237 ----~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          237 ----QYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ----TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ----ccC----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                111    234778899999999999999999987  45544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.1e-40  Score=333.53  Aligned_cols=255  Identities=30%  Similarity=0.480  Sum_probs=205.6

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|...+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            46889999999999999999999888899999987644 34578999999999999999999999986 45689999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            999999998531 2236899999999999999999999985   999999999999999999999999999876543221


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                       ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...      ........ ...+.....     .
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~-~~~~~~~~~-----~  232 (279)
T 1qpc_A          166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQN-LERGYRMVR-----P  232 (279)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHH-HHTTCCCCC-----C
T ss_pred             -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc------CHHHHHHH-HhcccCCCC-----c
Confidence             2223456889999999998999999999999999999999 88887421      11122211 222211111     1


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..+    ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       233 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          233 DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            112    23578899999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=343.18  Aligned_cols=249  Identities=27%  Similarity=0.296  Sum_probs=197.0

Q ss_pred             ccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          307 FSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +...+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            344678999999999999965 5899999999877666678899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--cCCCCeEEeccccccccCCCCCC
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL--DHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+  ++++.+||+|||+++....... 
T Consensus       171 ~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          171 GELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             CEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            999988854  2345899999999999999999999985   9999999999999  5678899999999987643322 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||...      ............. .. ..... ..
T Consensus       245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~~~-~~-~~~~~-~~  313 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD------NDAETLNNILACR-WD-LEDEE-FQ  313 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTC-CC-SCSGG-GT
T ss_pred             --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcc-CC-CChhh-hc
Confidence              22356999999999999999999999999999999999999997421      1222222222211 11 11111 11


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..    ...+.+++.+||+.||++|||+.|+++
T Consensus       314 ~~----~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 DI----SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            12    235778999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-39  Score=329.44  Aligned_cols=254  Identities=29%  Similarity=0.544  Sum_probs=201.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc-------cHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ-------GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      .++|+..+.||+|+||.||+++.. +++.||+|++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            368999999999999999999974 6889999998654322       1267899999999999999999999986544 


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----eEEec
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-----PKISD  450 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D  450 (624)
                       ++||||+++++|.+++..  ....+++..++.++.|+++||.|||+.+ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999888864  3346899999999999999999999974 23999999999999988776     99999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhh--cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYA--MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      ||+++....     ......||+.|+|||++  ....++.++||||||+++|||++|+.||.....    ..........
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----GKIKFINMIR  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----CHHHHHHHHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----cHHHHHHHHh
Confidence            999975432     23346789999999998  445678999999999999999999999753222    1222222222


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ..+....+.     ..+    ...+.+++.+||+.||++|||+.||++.|++
T Consensus       244 ~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 EEGLRPTIP-----EDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HSCCCCCCC-----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ccCCCCCCC-----ccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            222211111     112    2457889999999999999999999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-40  Score=338.65  Aligned_cols=245  Identities=24%  Similarity=0.300  Sum_probs=203.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++.+ +|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999975 68999999987542   24467788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999954   345899999999999999999999985   99999999999999999999999999986543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .     .....||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+......+..... .. +   
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------~~~~~~~~~i~~~~-~~-~---  222 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD------SNTMKTYEKILNAE-LR-F---  222 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHCC-CC-C---
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC-CC-C---
Confidence            2     2346799999999999999999999999999999999999999742      12222222222221 10 0   


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                            +......+.+++.+||+.||++||     +++||++
T Consensus       223 ------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 ------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                  111123577888999999999999     8899874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-39  Score=341.10  Aligned_cols=262  Identities=20%  Similarity=0.221  Sum_probs=202.2

Q ss_pred             HHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-----CcccHHHHHHHHHHHHhcCCCCcceEEeEEEe
Q 006952          299 DIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-----SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE  372 (624)
Q Consensus       299 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  372 (624)
                      ++....++|...+.||+|+||.||+++.. +++.||+|++...     .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34456778999999999999999999975 5788999998653     34556789999999999999999999999999


Q ss_pred             cCcceEEEEeccCCChhhhhhcCC-------------------------------------CCcccCHHHHHHHHHHHHH
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDST-------------------------------------RSVQLDWKRRISIIKGIAR  415 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~  415 (624)
                      .+..++||||+++++|.+++....                                     ....+++..++.++.||++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999884210                                     1223467788899999999


Q ss_pred             HHHHHHhcCCCCeEecCCCCCcEEEcCCC--CeEEeccccccccCCCCC--CccccccccccCccChhhhcC--CCCChh
Q 006952          416 GILYLHEDSRLKIIHRDLKTSNVLLDHEM--NPKISDFGMARIFGGNQS--KANTNRVVGTYGYMAPEYAMG--GIFSVK  489 (624)
Q Consensus       416 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~k  489 (624)
                      ||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+.....  ........||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999985   99999999999998776  899999999986543221  112335679999999999975  678999


Q ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          490 SDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       490 sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                      +||||||+++|||++|+.||..      ..................  .+.. ...    ...+.+++.+||+.||.+||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~------~~~~~~~~~~~~~~~~~~--~~~~-~~~----~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPG------VNDADTISQVLNKKLCFE--NPNY-NVL----SPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCCCCTT--SGGG-GGS----CHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCC------CChHHHHHHHHhcccccC--Cccc-ccC----CHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999999742      122233333332221111  1110 111    23577899999999999999


Q ss_pred             CHHHHHH
Q 006952          570 TMSSVAV  576 (624)
Q Consensus       570 s~~ev~~  576 (624)
                      |+.|+++
T Consensus       324 s~~~~l~  330 (345)
T 3hko_A          324 DAMRALQ  330 (345)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhc
Confidence            9999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.8e-40  Score=348.40  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcC--CCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQ--HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999986543  345678999999999996  599999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      | +.+++|.+++...   ..+++..+..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 6788999998643   36889999999999999999999985   99999999999995 578999999999876544


Q ss_pred             CCCccccccccccCccChhhhcC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG-----------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||...     ............
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-----~~~~~~~~~~~~  282 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAIID  282 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCHHHHHHHHHC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh-----hHHHHHHHHHhC
Confidence            33333345679999999999875           46899999999999999999999997421     122222222222


Q ss_pred             cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ........         ......+.+++.+||+.||++|||+.||++.
T Consensus       283 ~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHEIEFP---------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSCCCCC---------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCC---------ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11111111         1112357788999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.7e-40  Score=329.91  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec--CcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lV  379 (624)
                      .++|...+.||+|+||.||+|+.+ ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            367889999999999999999985 8899999987643  34457799999999999999999999999887  678999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++... ....+++..++.++.||++||.|||+.+ +.|+||||||+|||++.++.++|.|||+..... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999653 3346899999999999999999999873 349999999999999999999999999875432 


Q ss_pred             CCCCccccccccccCccChhhhcCCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFS---VKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                            .....||+.|+|||.+.+..++   .++||||||+++|||++|+.||..      .............+.....
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~------~~~~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD------LSNMEIGMKVALEGLRPTI  232 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT------SCHHHHHHHHHHSCCCCCC
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc------cChHHHHHHHHhcCCCCCC
Confidence                  1234689999999999876544   489999999999999999999742      1222222333323322221


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .     ...    ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       233 ~-----~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          233 P-----PGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             C-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            1     112    23577899999999999999999999999753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-40  Score=355.07  Aligned_cols=257  Identities=20%  Similarity=0.240  Sum_probs=204.0

Q ss_pred             HHHHHhcCccccCccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          299 DIVKATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       299 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      ++....++|+..+.||+|+||.||+++.++ ++.||+|++.+..   ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            344456889999999999999999999875 7889999986532   222345889999999999999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence            999999999999999999642  346899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      +....... ......+||+.|+|||++.     .+.++.++|||||||++|||++|+.||..      .+..+...+...
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~------~~~~~~~~~i~~  295 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMN  295 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHT
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC------CChhHHHHhhhh
Confidence            86643322 2233467999999999987     56789999999999999999999999742      122222222211


Q ss_pred             c---CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHH
Q 006952          530 E---GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPID--RPTMSSVAV  576 (624)
Q Consensus       530 ~---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~  576 (624)
                      .   .......     ...    ...+.+++.+||+.+|++  ||+++||++
T Consensus       296 ~~~~~~~p~~~-----~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          296 HKERFQFPTQV-----TDV----SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHCCCCSSC-----CCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccccccCCccc-----ccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1   1111110     111    224677888999888888  999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-40  Score=342.34  Aligned_cols=249  Identities=23%  Similarity=0.284  Sum_probs=179.0

Q ss_pred             cCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEeccCCC
Q 006952          310 ENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      .+.||+|+||.||+++.. +++.||||++...   ....+.+|+.++++++ ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 5889999998653   3466789999999997 9999999999999999999999999999


Q ss_pred             hhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEeccccccccCCCCCCc
Q 006952          388 LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       388 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      |.+++..   ...+++..+..|+.||++||.|||+.+   |+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            9999964   346899999999999999999999985   99999999999997765   799999999986543322  


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC-CCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG-PSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....... .....+.... ..+. ..
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~~-~~~~-~~  241 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFSF-EGEA-WK  241 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCCC-CSHH-HH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCCC-Cccc-cc
Confidence            22345689999999999999999999999999999999999999864333221 2222222 2222222110 0000 01


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .    ....+.+++.+||+.||++|||+.|+++
T Consensus       242 ~----~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          242 N----VSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             T----SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             C----CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1    1235778999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-40  Score=341.49  Aligned_cols=267  Identities=27%  Similarity=0.474  Sum_probs=198.8

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEecC----CcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE  373 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  373 (624)
                      +....++|...+.||+|+||.||+|....    +..||+|++....  ....+.+.+|+.++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33445789999999999999999998642    4579999987543  34457789999999999999999999999876


Q ss_pred             Cc-----ceEEEEeccCCChhhhhhcC---CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 006952          374 NE-----SLLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN  445 (624)
Q Consensus       374 ~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  445 (624)
                      +.     .++||||+++++|.+++...   .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            53     49999999999999998542   23456999999999999999999999985   999999999999999999


Q ss_pred             eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHH
Q 006952          446 PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYI  524 (624)
Q Consensus       446 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~  524 (624)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||....   ....... 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~-  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ---NHEMYDY-  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHH-
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHHH-
Confidence            99999999987654433233334567889999999999999999999999999999999 888864321   1122221 


Q ss_pred             HHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 006952          525 WKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL  585 (624)
Q Consensus       525 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~  585 (624)
                         ...+......     ..+    ...+.+++.+||+.||++|||+.+|++.|+.....+
T Consensus       262 ---~~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          262 ---LLHGHRLKQP-----EDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             ---HHTTCCCCCB-----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---HHcCCCCCCC-----ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence               1122111111     112    235788999999999999999999999998654433

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-39  Score=331.40  Aligned_cols=262  Identities=20%  Similarity=0.275  Sum_probs=203.5

Q ss_pred             HhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEE-EecCcceEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC-LEENESLLIY  380 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lV~  380 (624)
                      ..++|...+.||+|+||.||+|+. .+++.||||++......  +.+.+|+.++++++|++++..++.+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 46889999987554332  4578899999999988877777666 5566679999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEecccccccc
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  457 (624)
                      ||+ +++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||+   ++++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998642  335899999999999999999999985   9999999999999   78899999999999876


Q ss_pred             CCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          458 GGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       458 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543321     123356799999999999999999999999999999999999999875444444344333322211111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .     +.+...+    ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       239 ~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          239 I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             h-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            1     1111112    23578899999999999999999999999764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.2e-40  Score=365.07  Aligned_cols=261  Identities=27%  Similarity=0.411  Sum_probs=209.3

Q ss_pred             HhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..++|...+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            356788999999999999999999888899999997654 335789999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.+++... ....+++.+++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999999532 2235899999999999999999999985   99999999999999999999999999986643211


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       .......++..|+|||++.++.++.++||||||+++|||++ |+.||...      ...+.... ...+.....     
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~------~~~~~~~~-i~~~~~~~~-----  485 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQ-VERGYRMPC-----  485 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC------CHHHHHHH-HHTTCCCCC-----
T ss_pred             -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHH-HHcCCCCCC-----
Confidence             11223456789999999999999999999999999999999 89887421      12222222 222211111     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                          +......+.+|+.+||+.||++|||+.+|+++|+.......
T Consensus       486 ----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          486 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence                11223357789999999999999999999999987654443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.1e-40  Score=340.00  Aligned_cols=248  Identities=23%  Similarity=0.269  Sum_probs=192.7

Q ss_pred             hcCccccCccccCCceeEEEEEe----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      .++|+..+.||+|+||.||+++.    .+++.||+|++.+..    ......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999997    468999999987642    2345667899999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999854   345889999999999999999999985   9999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...      +......+..... . .
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~-~-~  239 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE------NRKKTIDKILKCK-L-N  239 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTC-C-C
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCC-C-C
Confidence            543222  1233467999999999999999999999999999999999999997421      2222222222211 1 0


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                               .+......+.+++.+||+.||++||     ++.|+++
T Consensus       240 ---------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          240 ---------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                     1111223577889999999999999     7778865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-39  Score=331.66  Aligned_cols=262  Identities=20%  Similarity=0.278  Sum_probs=207.3

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEE-EecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCC-LEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+|+. .+++.||||++......  +.+.+|+.++++++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999996 56899999998654433  4688999999999988877766666 45566799999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEeccccccccC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFG  458 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  458 (624)
                      |+ +++|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999998642  345899999999999999999999985   9999999999999   488899999999998765


Q ss_pred             CCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          459 GNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       459 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            43321     1224567999999999999999999999999999999999999998754444443444333221111111


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                           +.+...++    ..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       240 -----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          240 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             -----HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             -----HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence                 11111222    35788999999999999999999999998653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=342.14  Aligned_cols=266  Identities=24%  Similarity=0.301  Sum_probs=205.7

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe----cCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE----ENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~l  378 (624)
                      .++|...+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999997 4689999999977666677889999999999999999999999873    346789


Q ss_pred             EEEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          379 IYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      ||||+++++|.+++... .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999988642 13456899999999999999999999985   999999999999999999999999998764


Q ss_pred             CCCCCCc-------cccccccccCccChhhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          458 GGNQSKA-------NTNRVVGTYGYMAPEYAMGGI---FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       458 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      .......       ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||...... ........   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~---  260 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDSVALAV---  260 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSCHHHHH---
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cchhhHHh---
Confidence            3211110       112345799999999987654   689999999999999999999997421111 11111111   


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                       ....  ..       .........+.+++.+||+.||.+|||+.+|++.|.......|
T Consensus       261 -~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          261 -QNQL--SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             -HCC----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             -hccC--CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence             1100  00       0011122357889999999999999999999999987654443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-40  Score=339.47  Aligned_cols=257  Identities=28%  Similarity=0.438  Sum_probs=209.7

Q ss_pred             HhcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ..++|...+.||+|+||.||++.... +..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            45789999999999999999999765 7889999987543 346788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999653 3356899999999999999999999986   9999999999999999999999999998765332


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      . .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....   .......+    ........    
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~---~~~~~~~~----~~~~~~~~----  233 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELL----EKDYRMER----  233 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGHHHHH----HTTCCCCC----
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----hccCCCCC----
Confidence            2 22234557889999999999999999999999999999999 888874321   12222221    11111111    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                           +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       234 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                 111224578899999999999999999999999653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.6e-39  Score=328.33  Aligned_cols=253  Identities=26%  Similarity=0.364  Sum_probs=203.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            468999999999999999999976 68899999986543 3445788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++.   ....+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999884   3346899999999999999999999985   9999999999999999999999999998664333


Q ss_pred             CCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......   ....   ..+......  ... 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~~~~~~~--~~~-  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEY---SDWKEKKTY--LNP-  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHH---HHHHTTCTT--STT-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHH---HHhhhcccc--cCc-
Confidence            2223345678999999999988765 78999999999999999999998532221   1111   111111111  000 


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ....    ...+.+++.+||+.||++|||+.||++
T Consensus       231 -~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 -WKKI----DSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -hhhc----CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             0111    234678999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-39  Score=341.60  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999976 688999999976433 236788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--eEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN--PKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~  460 (624)
                      +++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999998854   335899999999999999999999985   999999999999987765  999999998743222


Q ss_pred             CCCccccccccccCccChhhhcCCCCChh-hHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVK-SDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                         .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....  ................. . ..+.
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~~~~~~~~~~~-~-~~~~  244 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPRDYRKTIQRILSVKY-S-IPDD  244 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC------CCCHHHHHHHHHTTCC-C-CCTT
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhcCCC-C-CCCc
Confidence               12234579999999999988887665 899999999999999999975322  22233333333222111 0 0000


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                         ...    ...+.+++.+||+.||++|||+.|+++.
T Consensus       245 ---~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          245 ---IRI----SPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               011    2357789999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=348.23  Aligned_cols=270  Identities=21%  Similarity=0.300  Sum_probs=213.7

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--cceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--ESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lV  379 (624)
                      .++|.+.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3679999999999999999999764 8999999997543 344677889999999999999999999998765  67999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEEecccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKISDFGMAR  455 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~  455 (624)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976544455999999999999999999999985   9999999999999    777889999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcC--------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMG--------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ......   ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||.......  .......+.
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~  239 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKI  239 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHH
Confidence            764332   2234579999999999865        567889999999999999999999985433222  223333333


Q ss_pred             HhcCCcccc--c------------cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          528 WCEGHAAEL--M------------DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       528 ~~~~~~~~~--~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ........+  +            +..............+.+++.+||+.||++||++.|+++.+...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            332211100  0            00011133466677888999999999999999999999988653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=342.58  Aligned_cols=244  Identities=25%  Similarity=0.300  Sum_probs=192.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|+..++||+|+||+||+|+.. +++.||||++.....  .....+..|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999976 689999999865432  3334555666666665 8999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+ +++|.+++...  ...++|..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 67888887543  345999999999999999999999985   999999999999999999999999999876432


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..          ...+.....+..    .+.
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~----------~~~~~~~~~~~~----~~~  272 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG----------GEGWQQLRQGYL----PPE  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS----------HHHHHHHTTTCC----CHH
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC----------ccHHHHHhccCC----Ccc
Confidence            2   2234569999999998876 789999999999999999999766421          011222222211    111


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +....    ...+.+++.+||+.||++|||+.|+++
T Consensus       273 ~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 FTAGL----SSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11122    235788999999999999999999976

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.6e-40  Score=343.86  Aligned_cols=261  Identities=28%  Similarity=0.400  Sum_probs=207.9

Q ss_pred             HHhcCccccCccccCCceeEEEEEecC------CcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLAD------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      -..++|...+.||+|+||.||+|....      ...||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999999643      24799999876543 3457789999999999 899999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCC-----------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC
Q 006952          374 NESLLIYEYMPNKSLDVFLFDST-----------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH  442 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  442 (624)
                      +..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence            99999999999999999986422           1345799999999999999999999985   999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHH
Q 006952          443 EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLL  521 (624)
Q Consensus       443 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~  521 (624)
                      ++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..||.....   ..  
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~--  274 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---NS--  274 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS---SH--
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch---hH--
Confidence            99999999999986644333333334567889999999999999999999999999999999 8888742211   11  


Q ss_pred             HHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          522 AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       522 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                       ........+.....         +......+.+++.+||+.||.+|||+.||++.|+.
T Consensus       275 -~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          275 -KFYKLVKDGYQMAQ---------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence             11122222211110         11112357789999999999999999999999965

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-39  Score=330.80  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=203.7

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe---------
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE---------  372 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~---------  372 (624)
                      ...+|+..+.||+|+||.||+++.. +++.||+|++....    +.+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999999986 68999999987654    356789999999999999999999864         


Q ss_pred             -------cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC
Q 006952          373 -------ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN  445 (624)
Q Consensus       373 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  445 (624)
                             ....++||||+++++|.+++... ....+++..++.++.||++||.|||+.+   |+|+||||+|||+++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   34478999999999999999642 2346899999999999999999999985   999999999999999999


Q ss_pred             eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          446 PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       446 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      +||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..         .....
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHH
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHH
Confidence            99999999987654322   2235689999999999999999999999999999999999987420         11111


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      .....+...        ..++    ..+.+++.+||+.||++|||+.|+++.|........
T Consensus       229 ~~~~~~~~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 TDLRDGIIS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHTTCCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHhhccccc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            222222211        1122    346788999999999999999999999987554443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-40  Score=344.24  Aligned_cols=249  Identities=24%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      ...++|...+.||+|+||.||+++.+ +++.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999976 58899999997642   34456788999999887 999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999854   345899999999999999999999985   99999999999999999999999999985


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+......... .+...  
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~-~~~~~--  236 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------QDEEELFHSIR-MDNPF--  236 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHH-HCCCC--
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC------CCHHHHHHHHH-hCCCC--
Confidence            43221  223457899999999999999999999999999999999999999742      11222222221 11110  


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHH-HHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS-SVA  575 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  575 (624)
                              .+......+.+++.+||+.||++||++. +|.
T Consensus       237 --------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 --------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                    0111123577889999999999999997 664

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-39  Score=341.63  Aligned_cols=245  Identities=21%  Similarity=0.257  Sum_probs=203.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999976 58999999986542   34567789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999854   245899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .     .....||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+......... .+... +.  
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~-~~~~~-~p--  258 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------DQPIQIYEKIV-SGKVR-FP--  258 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHH-HCCCC-CC--
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC------CCHHHHHHHHH-cCCCC-CC--
Confidence            2     2346799999999999999999999999999999999999999742      12222222222 22111 10  


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                         ...    ...+.+++.+||+.||++||+     ++||++
T Consensus       259 ---~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          259 ---SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence               112    235778999999999999998     888865

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-39  Score=346.99  Aligned_cols=203  Identities=17%  Similarity=0.269  Sum_probs=176.1

Q ss_pred             hcCccccCccccC--CceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEG--GFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|++.+.||+|  +||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            5789999999999  99999999976 68999999987543  3445778899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998653 2345899999999999999999999985   9999999999999999999999999986542


Q ss_pred             CCCC-----CccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          459 GNQS-----KANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       459 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      ....     ........||+.|+|||++.+  ..++.++||||||+++|||++|+.||.
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            2111     111223478999999999987  578999999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=340.85  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=187.4

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ..++|...+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567999999999999999999986 47889999987653  33668899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEeccccccccC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIFG  458 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~  458 (624)
                      |+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999998853   345899999999999999999999985   999999999999975   8899999999998654


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....     . .............. ...
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~-~~~~~~~i~~~~~~-~~~  272 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-----G-DQFMFRRILNCEYY-FIS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-----C-HHHHHHHHHTTCCC-CCT
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-----c-cHHHHHHHHhCCCc-cCC
Confidence            321   2234678999999999999999999999999999999999999974211     1 11111222222111 111


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +. ..    .....+.+++.+||+.||++|||+.|+++
T Consensus       273 ~~-~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PW-WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ch-hh----hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11 01    12235778999999999999999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-40  Score=334.40  Aligned_cols=254  Identities=24%  Similarity=0.364  Sum_probs=193.3

Q ss_pred             hcCccccCccccCCceeEEEEEecC----CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|...+.||+|+||.||+|....    +..||+|++.... ....+.+.+|+.++++++||||+++++++ .++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence            4688999999999999999999753    4569999987643 34457789999999999999999999998 4567899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999643  345899999999999999999999985   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...   ........+    ..+..... 
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~---~~~~~~~~i----~~~~~~~~-  238 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRI----ENGERLPM-  238 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC---CGGGHHHHH----HTTCCCCC-
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC---CHHHHHHHH----HcCCCCCC-
Confidence            33221 2223456789999999999999999999999999999997 88887532   222222222    11111111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                              +......+.+++.+||+.||++|||+.||++.|+.
T Consensus       239 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          239 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                    11123457789999999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=332.28  Aligned_cols=262  Identities=26%  Similarity=0.427  Sum_probs=207.7

Q ss_pred             cCccccC-ccccCCceeEEEEEec---CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQEN-KLGEGGFGPVYKGVLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|.+.+ .||+|+||.||+|+..   ++..||||++.... ....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 8999999999999854   57789999998653 34567899999999999999999999999 55678999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999853  3446899999999999999999999985   99999999999999999999999999987654


Q ss_pred             CCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....   .....    .....+..... 
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~----~~i~~~~~~~~-  234 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVM----AFIEQGKRMEC-  234 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHH----HHHHTTCCCCC-
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHHHH----HHHhcCCcCCC-
Confidence            3321 22233456889999999998899999999999999999998 999974321   11111    12222221111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKP  588 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p  588 (624)
                              +......+.+++.+||+.||++||++.+|++.|.....+...+
T Consensus       235 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          235 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             --------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence                    1122345788999999999999999999999998754444333

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.8e-41  Score=349.13  Aligned_cols=261  Identities=28%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             CccccCccccCCceeEEEEEec-----CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEec--Ccce
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-----DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE--NESL  377 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  377 (624)
                      .|+..+.||+|+||.||++.+.     +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3488999999999999988643     578899999986543 4467799999999999999999999999884  4578


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999854    24899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCC--------CCCCHHHHHHHHH
Q 006952          458 GGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSE--------HGPSLLAYIWKLW  528 (624)
Q Consensus       458 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~  528 (624)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......        .............
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543321 2233456788999999999999999999999999999999999997421100        0000000111111


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ..+...         ..+......+.+++.+||+.||++|||+.||++.|+...
T Consensus       265 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          265 ERGERL---------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcccCC---------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            111111         111222346888999999999999999999999997643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=343.05  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=197.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcE----EEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKE----IAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .++|+..+.||+|+||.||+|... +++.    |++|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999964 3443    577777543 3456788999999999999999999999998754 78


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +|+||+++++|.+++...  ...+++..++.|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998653  345899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....   .......+    ..+.....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~----~~~~~~~~  240 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSIL----EKGERLPQ  240 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---GGGHHHHH----HTTCCCCC
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HcCCCCCC
Confidence            54443333334557889999999999999999999999999999999 999975322   12222221    11111111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                               +......+.+++.+||+.||++|||+.||++.|+..
T Consensus       241 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          241 ---------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     111223577899999999999999999999999865

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-40  Score=352.11  Aligned_cols=257  Identities=21%  Similarity=0.262  Sum_probs=203.8

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      +....++|...+.||+|+||.||+++.+ +++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3345678999999999999999999976 48899999986521   2234567899999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999998854    34899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGI----FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      ....... ......+||+.|+|||++.+..    ++.++||||||+++|||++|+.||..      .+......+.....
T Consensus       217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~  289 (410)
T 3v8s_A          217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIMNHK  289 (410)
T ss_dssp             ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHTHH
T ss_pred             eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC------CChhhHHHHHHhcc
Confidence            7643321 1233568999999999998765    78999999999999999999999742      22222222222111


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPID--RPTMSSVAVM  577 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~  577 (624)
                      ......+.   ...    ...+.+|+.+||+.+|.+  ||+++||++.
T Consensus       290 ~~~~~p~~---~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          290 NSLTFPDD---NDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHCCCCTT---CCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccccCCCc---ccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00000000   011    234678888999999998  9999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.4e-39  Score=330.99  Aligned_cols=251  Identities=23%  Similarity=0.277  Sum_probs=204.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc------cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ------GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999976 5889999998754321      367899999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEeccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  452 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  452 (624)
                      ++||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999954   346899999999999999999999985   99999999999999888    79999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...      ......... ....
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~i-~~~~  234 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANI-TSVS  234 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHH-HTTC
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC------CHHHHHHHH-Hhcc
Confidence            998765432   223456899999999999999999999999999999999999997421      122222221 1111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .  ..++......+    ..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~--~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 Y--DFDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             C--CCCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             c--ccChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1  01111111222    34778999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-39  Score=335.97  Aligned_cols=267  Identities=23%  Similarity=0.335  Sum_probs=200.3

Q ss_pred             HHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc--CCCCcceEEeEEEec----Cc
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL--QHKNLVRLLGCCLEE----NE  375 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~----~~  375 (624)
                      ...++|.+.+.||+|+||.||+|+.. ++.||||++....   ...+..|.+++..+  +||||+++++++...    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            34578999999999999999999985 8999999986443   23445556665554  899999999999887    67


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS-----RLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                      .++||||+++++|.+++..    ..+++..++.++.|++.||.|||+..     +++|+||||||+|||++.++.+||+|
T Consensus       110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            8999999999999999954    35899999999999999999999871     22499999999999999999999999


Q ss_pred             cccccccCCCCCC--ccccccccccCccChhhhcCCCCChh------hHHHHHHHHHHHHHhC----------CCCCCCC
Q 006952          451 FGMARIFGGNQSK--ANTNRVVGTYGYMAPEYAMGGIFSVK------SDVFSFGVVLLEIISG----------KKSTGFY  512 (624)
Q Consensus       451 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k------sDv~S~Gvil~elltg----------~~p~~~~  512 (624)
                      ||+++.+......  .......||+.|+|||++.+...+.+      +||||||+++|||++|          +.|+...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999876443222  12234579999999999987766554      9999999999999999          4454322


Q ss_pred             CCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          513 HSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ...  ........................   ........+.+++.+||+.||++|||+.||++.|+..
T Consensus       266 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          266 VPS--DPSYEDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             SCS--SCCHHHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC--CCchhhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            111  112222222222222111111111   1224566789999999999999999999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-39  Score=330.11  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=203.1

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||++.... +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4679999999999999999999764 678999999877666778999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEeccccccccCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  459 (624)
                      +++++|.+++..   ...+++..++.++.|+++||.|||+.+   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999988854   345899999999999999999999985   9999999999999   7888999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..   ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...      ......... ..+.... ...
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~-~~~~~~~-~~~  229 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP------TDSEVMLKI-REGTFTF-PEK  229 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHH-HHCCCCC-CHH
T ss_pred             cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC------CHHHHHHHH-HhCCCCC-Cch
Confidence            32   22345689999999988654 899999999999999999999997521      112222222 1221110 000


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .....    ...+.+++.+||+.||++|||+.++++
T Consensus       230 -~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 -DWLNV----SPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -HHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -hhhcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00011    235778999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=328.10  Aligned_cols=252  Identities=28%  Similarity=0.397  Sum_probs=198.8

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++.....||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4455568999999999999964 578999999987766667889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-CCCeEEeccccccccCCCCCC
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-EMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      +++|.+++........+++..+..++.||++||.|||+.+   |+|+||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999976555556789999999999999999999985   999999999999987 89999999999987643221 


Q ss_pred             ccccccccccCccChhhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||....     .................+     
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~-----  247 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG-----EPQAAMFKVGMFKVHPEI-----  247 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS-----SHHHHHHHHHHHCCCCCC-----
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC-----chhHHHHhhccccccccc-----
Confidence             223457899999999987654  8999999999999999999999974211     111111111111111111     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          +......+.+++.+||+.||++|||+.++++
T Consensus       248 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 ----PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1112235778999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.9e-39  Score=339.55  Aligned_cols=246  Identities=29%  Similarity=0.439  Sum_probs=198.4

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +.|...+.||+|+||.||+|+. .+++.||||++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999996 4688999999875432   33567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||++ |+|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            9997 577777643  2346899999999999999999999985   99999999999999999999999999976532 


Q ss_pred             CCCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                           .....||+.|+|||++.   ++.++.++||||||+++|||++|+.||..      ............... ....
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~------~~~~~~~~~~~~~~~-~~~~  274 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNES-PALQ  274 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHSCC-CCCC
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC------CChHHHHHHHHhcCC-CCCC
Confidence                 22457899999999984   56789999999999999999999999742      122233333222221 1111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .    ...+    ..+.+++.+||+.||++|||+.+|++.
T Consensus       275 ~----~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          275 S----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             C----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C----CCCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1    1122    346788899999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.1e-40  Score=344.17  Aligned_cols=248  Identities=24%  Similarity=0.280  Sum_probs=202.0

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|...+.||+|+||.||+++.+. ++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4789999999999999999999864 788999998754   234567788999999988 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999854   245899999999999999999999985   9999999999999999999999999998543


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+.......... ....    
T Consensus       173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------~~~~~~~~~i~~-~~~~----  239 (353)
T 2i0e_A          173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG------EDEDELFQSIME-HNVA----  239 (353)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHH-CCCC----
T ss_pred             cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC------CCHHHHHHHHHh-CCCC----
Confidence            221  223456899999999999999999999999999999999999999742      122222222222 1111    


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                            .+......+.+++.+||+.||++||+     +++|++
T Consensus       240 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 ------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  11112235778899999999999995     577754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-39  Score=331.36  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=197.7

Q ss_pred             cCcccc-CccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQE-NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +.|.+. +.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            467764 78999999999999954 6899999999877666778899999999995 79999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEeccccccccC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGMARIFG  458 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~  458 (624)
                      |+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999854   245899999999999999999999985   999999999999998776   9999999987653


Q ss_pred             CCCC-----CccccccccccCccChhhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC--------H
Q 006952          459 GNQS-----KANTNRVVGTYGYMAPEYAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS--------L  520 (624)
Q Consensus       459 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~--------~  520 (624)
                      ....     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+...        .
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211     111223569999999999875     557899999999999999999999986432221100        0


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..........+... .... .....    ...+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~i~~~~~~-~~~~-~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKYE-FPDK-DWAHI----SCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCCC-CCHH-HHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCcc-cCch-hcccC----CHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11111112222111 1100 00111    235788999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-39  Score=336.33  Aligned_cols=259  Identities=30%  Similarity=0.443  Sum_probs=202.6

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|...+.||+|+||.||+|++.      +++.||||++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            468999999999999999999842      46789999997543 34556789999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCC----CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEe
Q 006952          377 LLIYEYMPNKSLDVFLFDSTR----SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKIS  449 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  449 (624)
                      ++||||+++++|.+++.....    ...+++..++.++.||++||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    245899999999999999999999985   999999999999984   4469999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      |||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||...      ...... ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~~~~~~-~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK------SNQEVL-EFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHH-HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc------CHHHHH-HHH
Confidence            9999986544333333344568899999999999999999999999999999998 88887421      111222 222


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..+......     ..+    ...+.+++.+||+.||++|||+.+|++.|...
T Consensus       259 ~~~~~~~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGGRMDPP-----KNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCCCCC-----CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            222211111     112    23577899999999999999999999998653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=350.51  Aligned_cols=257  Identities=20%  Similarity=0.227  Sum_probs=201.5

Q ss_pred             HHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      ....++|+..+.||+|+||.||+++.+ +|+.||||++.+..   ....+.+.+|..++.+++||||+++++++.+.+..
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            334688999999999999999999975 68999999987532   22345688999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       137 ~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhee
Confidence            9999999999999999642  236899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhc-------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAM-------GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      ...... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||..      .+......+...
T Consensus       212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~~i~~  284 (412)
T 2vd5_A          212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA------DSTAETYGKIVH  284 (412)
T ss_dssp             CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHT
T ss_pred             ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC------CCHHHHHHHHHh
Confidence            643322 1223468999999999987       45689999999999999999999999742      112222222111


Q ss_pred             cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCC---CCHHHHHH
Q 006952          530 EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDR---PTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~ev~~  576 (624)
                      ....  ...+......    ...+.+++.+||+ +|++|   |+++||++
T Consensus       285 ~~~~--~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YKEH--LSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHH--CCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cccC--cCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0000  0001111112    2357788899999 99998   68999865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.1e-39  Score=334.62  Aligned_cols=270  Identities=24%  Similarity=0.323  Sum_probs=208.7

Q ss_pred             CHHHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHh--cCCCCcceEEeEEEec
Q 006952          296 DLIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAK--LQHKNLVRLLGCCLEE  373 (624)
Q Consensus       296 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~  373 (624)
                      .+..-....++|...+.||+|+||.||+|+. +++.||||++...   ..+.+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3333345567899999999999999999998 5899999998643   34567889999888  6899999999999887


Q ss_pred             C----cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEEc
Q 006952          374 N----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH--------EDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       374 ~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~  441 (624)
                      .    ..++||||+++++|.+++..    ..+++..++.++.||++||.|||        +.   +|+||||||+|||++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK  181 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence            6    78999999999999999954    35899999999999999999999        55   599999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCc--cccccccccCccChhhhcCC------CCChhhHHHHHHHHHHHHHhC--------
Q 006952          442 HEMNPKISDFGMARIFGGNQSKA--NTNRVVGTYGYMAPEYAMGG------IFSVKSDVFSFGVVLLEIISG--------  505 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~S~Gvil~elltg--------  505 (624)
                      .++.+||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765433211  23345799999999999876      334789999999999999999        


Q ss_pred             --CCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          506 --KKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       506 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                        +.||..... .... ................+....   ........+.+++.+||+.||++|||+.+|++.|+..
T Consensus       262 ~~~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          262 DYQLPYYDLVP-SDPS-VEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCTTTTTSC-SSCC-HHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCccccCc-Cccc-HHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              556532211 1112 222233332222211111111   1235566788999999999999999999999999753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-39  Score=335.46  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=198.3

Q ss_pred             cCccccCccccCCceeEEEEEecC-----CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-----GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ++|...+.||+|+||.||+|....     +..||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999998653     2359999987653 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999998642  346899999999999999999999985   9999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          459 GNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       459 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...      ...... .....+.....
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~-~~~~~~~~~~~  271 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVM-KAINDGFRLPT  271 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHH-HHHHTTCCCCC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC------CHHHHH-HHHHCCCcCCC
Confidence            43221 12223346788999999999999999999999999999999 99997421      111222 22222211111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                               +......+.+++.+||+.||++||++.+|++.|+..
T Consensus       272 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          272 ---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ---------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                     111234578899999999999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=338.69  Aligned_cols=261  Identities=23%  Similarity=0.305  Sum_probs=196.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|...+.||+|+||.||+++.. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999976 489999999865433  235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999988743   345899999999999999999999985   9999999999999999999999999998764332


Q ss_pred             CCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh-----------
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC-----------  529 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  529 (624)
                      .  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   .+....+.....           
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD---VDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhcccccccccccc
Confidence            2  2234578999999999876 6689999999999999999999999753221   111111111111           


Q ss_pred             cCCcc---ccccchhhcC---CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAA---ELMDSVVKQS---CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~---~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .....   ...++.....   ........+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000   0000000000   00112234778999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=336.49  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             hcCccccCccccCCceeEEEEEe-----cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC--cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN--ES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~  376 (624)
                      .++|+..+.||+|+||.||+++.     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35788899999999999999984     358899999998877777788999999999999999999999987654  68


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999653  245899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCC--------C-CCCCHHHHHHH
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHS--------E-HGPSLLAYIWK  526 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~--------~-~~~~~~~~~~~  526 (624)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....        . ...........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            6543321 112234567889999999999999999999999999999999988642100        0 00000111111


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ....+....         .+......+.+++.+||+.||++|||+.||++.|+.
T Consensus       275 ~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          275 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111111111         111223457889999999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=339.96  Aligned_cols=270  Identities=27%  Similarity=0.376  Sum_probs=196.4

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHH--HHhcCCCCcceEEeEEEec-----Ccc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTV--IAKLQHKNLVRLLGCCLEE-----NES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~~~~~~~-----~~~  376 (624)
                      .++|...+.||+|+||.||+|+. +++.||||++.....   +.+..|.++  +..++||||+++++.+...     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999987 689999999875432   334444444  4558999999999876532     245


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEEcCCCCeEEec
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS------RLKIIHRDLKTSNVLLDHEMNPKISD  450 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D  450 (624)
                      ++||||+++|+|.+++...    ..++..++.++.||++||.|||+..      .++|+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            8999999999999999542    3588999999999999999999871      11499999999999999999999999


Q ss_pred             cccccccCCCCC------CccccccccccCccChhhhcC-------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          451 FGMARIFGGNQS------KANTNRVVGTYGYMAPEYAMG-------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       451 fg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                      ||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|..|+........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987653321      112224569999999999987       4567899999999999999999877532222111


Q ss_pred             -CCH----------HHHHHHHHh-cCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCC
Q 006952          518 -PSL----------LAYIWKLWC-EGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT  584 (624)
Q Consensus       518 -~~~----------~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~  584 (624)
                       ...          ......... ......+.+..   .........+.+++.+||+.||++|||+.||++.|+.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence             000          011111111 11111111111   11233456789999999999999999999999999775433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4e-39  Score=331.53  Aligned_cols=260  Identities=22%  Similarity=0.355  Sum_probs=198.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|.+.+.||+|+||.||++... +|+.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            467999999999999999999964 68999999987532   34457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          380 YEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |||+++++|.+++... .....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988542 13456899999999999999999999985   9999999999999999999999999998654


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ....  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...    ........... ..........
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~-~~~~~~~~~~  260 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCKKI-EQCDYPPLPS  260 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHH-HTTCSCCCCT
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc----chhHHHHHHHh-hcccCCCCcc
Confidence            3221  223456899999999999999999999999999999999999997421    12222222222 2222111111


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          ..+    ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       261 ----~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          261 ----DHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             ----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                112    23577899999999999999999999999765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.3e-39  Score=342.60  Aligned_cols=252  Identities=21%  Similarity=0.253  Sum_probs=190.7

Q ss_pred             hcCcccc-CccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHh-cCCCCcceEEeEEEe----cCcc
Q 006952          304 TQDFSQE-NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAK-LQHKNLVRLLGCCLE----ENES  376 (624)
Q Consensus       304 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~----~~~~  376 (624)
                      .++|... +.||+|+||.||++... +++.||||++...     ..+.+|+.++.+ .+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3566665 68999999999999976 5889999998632     457789998755 489999999999876    5568


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEecccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGM  453 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  453 (624)
                      ++||||+++|+|.+++... ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999652 2346899999999999999999999985   999999999999998   78899999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC-CCHHHHHHHHHhcCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG-PSLLAYIWKLWCEGH  532 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  532 (624)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.    .+.
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~  283 (400)
T 1nxk_A          211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQ  283 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTC
T ss_pred             ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCc
Confidence            98654322   22346789999999999999999999999999999999999999864332221 11222221    111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .. ...+. ....    ...+.+++.+||+.||++|||+.||++.
T Consensus       284 ~~-~~~~~-~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          284 YE-FPNPE-WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC-CCTTT-TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc-CCCcc-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11 00000 0112    2357789999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=333.32  Aligned_cols=263  Identities=24%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             HhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC-----cccHHHHHHHHHHHHhcC---CCCcceEEeEEEec
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEE  373 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~  373 (624)
                      ..++|++.+.||+|+||.||+++. .+++.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999996 468899999986432     222356778888887775   99999999999876


Q ss_pred             C-----cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          374 N-----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       374 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                      .     ..++||||+. ++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     3789999997 5999988643 2334899999999999999999999986   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      +|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ........+....
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN---SEADQLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS---SHHHHHHHHHHHH
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHh
Confidence            9999998664322   233467899999999999999999999999999999999999997421   1112222222222


Q ss_pred             hcCCcccccc------chhhc--CCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          529 CEGHAAELMD------SVVKQ--SCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       529 ~~~~~~~~~d------~~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..........      .....  ..+     ......+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111111000      00000  000     112245778999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=339.42  Aligned_cols=243  Identities=23%  Similarity=0.340  Sum_probs=199.5

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--------ccHHHHHHHHHHHHhcCCCCcceEEeEEEec
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE  373 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  373 (624)
                      ..++|...+.||+|+||.||+++.. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3568999999999999999999964 688999999876431        1334678899999999999999999999999


Q ss_pred             CcceEEEEeccCC-ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          374 NESLLIYEYMPNK-SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       374 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      +..++||||+.+| +|.+++..   ...+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99988853   345899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      ++.......   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......                
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            998764432   2234679999999999988877 89999999999999999999997421110                


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                           ......  .+......+.+++.+||+.||++|||+.+|++.
T Consensus       237 -----~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000000  000112347789999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-39  Score=327.26  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367999999999999999999975 58899999987654 3456889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEecccccccc
Q 006952          382 YMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIF  457 (624)
Q Consensus       382 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  457 (624)
                      |+++++|.+++.... ....+++..++.++.||++||.|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999998885421 2356899999999999999999999985   9999999999999   45678999999999865


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ....   ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...      ...................
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~------~~~~~~~~~~~~~~~~~~~  247 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT------SLEEVQQKATYKEPNYAVE  247 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCCCC-
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC------CHHHHHhhhccCCcccccc
Confidence            4322   223456899999999876 56899999999999999999999997521      1222222211111111000


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ....    ...+.+++.+||+.||++|||+.||++
T Consensus       248 ----~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          248 ----CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----cCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0111    234678899999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-39  Score=329.84  Aligned_cols=256  Identities=27%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             CccccCccccCCceeEEEEEecC-C---cEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc-eEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD-G---KEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES-LLI  379 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~lV  379 (624)
                      .|...+.||+|+||.||+|.+.+ +   ..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999998543 2   3699999876443 4567889999999999999999999999877665 999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+.+++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999964  3346899999999999999999999985   99999999999999999999999999986543


Q ss_pred             CC--CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQ--SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..  .........+++.|+|||.+.+..++.++||||||+++|||++|..|+.  ...........+.    .+..... 
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~--~~~~~~~~~~~~~----~~~~~~~-  249 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--RHIDPFDLTHFLA----QGRRLPQ-  249 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT--TTSCGGGHHHHHH----TTCCCCC-
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC--ccCCHHHHHHHhh----cCCCCCC-
Confidence            32  1122334567899999999999999999999999999999999666532  1222222222221    1111111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                              +......+.+++.+||+.||.+|||+.++++.|+..
T Consensus       250 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          250 --------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    111123577899999999999999999999999765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-39  Score=332.26  Aligned_cols=262  Identities=20%  Similarity=0.248  Sum_probs=198.5

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      ..++|...+.||+|+||.||++... +++.||+|++.....   ...+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999975 688999999875432   235778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999854   245899999999999999999999985   9999999999999999999999999997654


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      .... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...       ............... .  
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~-~--  254 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-------QLSVMGAHINQAIPR-P--  254 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-------HHHHHHHHHHSCCCC-G--
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-------hHHHHHHHhccCCCC-c--
Confidence            3321 1223456899999999999999999999999999999999999997521       111222222221110 0  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhccCCCCC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-TMSSVAVMLASDILTL  585 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~  585 (624)
                      .......    ...+.+++.+||+.||++|| +++++++.|+......
T Consensus       255 ~~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          255 STVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             GGTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            0111112    23577899999999999999 9999999998764443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.3e-40  Score=353.80  Aligned_cols=248  Identities=22%  Similarity=0.239  Sum_probs=192.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|+..+.||+|+||.||++... +|+.||||++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999965 5889999998753   334456778999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |||+++++|.+++..   ...+++..+..++.||++||.|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999998854   3468999999999999999999998 64   9999999999999999999999999998543


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+............ ..    
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------~~~~~~~~~i~~~~-~~----  367 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHEKLFELILMEE-IR----  367 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC-CC----
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC------CCHHHHHHHHHhCC-CC----
Confidence            222  223346899999999999999999999999999999999999999742      12222222222111 10    


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                            .+......+.+++.+||+.||.+||     +++|+++
T Consensus       368 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 ------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  0111123577899999999999999     9999976

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=330.36  Aligned_cols=249  Identities=28%  Similarity=0.437  Sum_probs=181.7

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999997 468999999986532   23457889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999998642  346899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   ...   +.    .....   
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~----~~~~~---  229 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLN---KV----VLADY---  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----CSSCC---
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHH---HH----hhccc---
Confidence            221  1223568999999999999899999999999999999999999975322211   000   00    00000   


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          ..+......+.+++.+||+.||++|||+.+|++
T Consensus       230 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 ----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                011112235778999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=343.76  Aligned_cols=259  Identities=23%  Similarity=0.250  Sum_probs=189.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEe--------c
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLE--------E  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--------~  373 (624)
                      ..+|...+.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457999999999999999999965 68899999997776666788999999999996 9999999999953        2


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      ...++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            33689999996 788888865444556999999999999999999999873 3499999999999999999999999999


Q ss_pred             ccccCCCCCCc----------cccccccccCccChhhh---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006952          454 ARIFGGNQSKA----------NTNRVVGTYGYMAPEYA---MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL  520 (624)
Q Consensus       454 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~  520 (624)
                      ++.........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||......     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----  259 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----  259 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence            98765432211          11134689999999998   5677899999999999999999999997421111     


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCC
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDIL  583 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~  583 (624)
                       .....     ......    ....    ...+.+++.+||+.||++|||+.|+++.|.....
T Consensus       260 -~~~~~-----~~~~~~----~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 -RIVNG-----KYSIPP----HDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ------------CCCCT----TCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HhhcC-----cccCCc----cccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             11100     000000    0111    1236688999999999999999999999976543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=342.50  Aligned_cols=252  Identities=15%  Similarity=0.144  Sum_probs=202.1

Q ss_pred             HhcCccccCccccCCceeEEEEE------ecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC---CCCcceEEeEEEec
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGV------LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEE  373 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~  373 (624)
                      ..++|.+.+.||+|+||.||+|+      ...++.||||++....   ..++..|+.++.+++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35779999999999999999994      4468899999987543   456788888888886   99999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcC--CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---------
Q 006952          374 NESLLIYEYMPNKSLDVFLFDS--TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---------  442 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---------  442 (624)
                      +..++||||+++|+|.+++...  .....+++..++.|+.||++||.|||+.+   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999642  13456999999999999999999999985   999999999999998         


Q ss_pred             --CCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006952          443 --EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL  520 (624)
Q Consensus       443 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~  520 (624)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||......     
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----  291 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----  291 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence              8999999999997654333333344567999999999999999999999999999999999999996421111     


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHhccC
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDR-PTMSSVAVMLASD  581 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~ev~~~L~~~  581 (624)
                                   ...+...+......+   .+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       292 -------------~~~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          292 -------------ECKPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -------------EEEECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -------------ceeechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                         011111111112222   34567778999999999 7888888887653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=362.31  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=196.3

Q ss_pred             ccccCCceeEEEEEec---CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccCCC
Q 006952          312 KLGEGGFGPVYKGVLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      .||+|+||.||+|.+.   ++..||||+++... ....+++.+|+.+|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   45679999998653 3456889999999999999999999999976 56899999999999


Q ss_pred             hhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC-ccc
Q 006952          388 LDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-ANT  466 (624)
Q Consensus       388 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~  466 (624)
                      |.+++..  ....+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++.+...... ...
T Consensus       422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            9999854  3456899999999999999999999985   999999999999999999999999999876433221 112


Q ss_pred             cccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCC
Q 006952          467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC  545 (624)
Q Consensus       467 ~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  545 (624)
                      ....+++.|+|||++.+..++.++||||||+++|||++ |+.||....   .....    .....+.....         
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~----~~i~~~~~~~~---------  560 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVM----AFIEQGKRMEC---------  560 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---SHHHH----HHHHTTCCCCC---------
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHH----HHHHcCCCCCC---------
Confidence            22345689999999999999999999999999999998 999975321   11122    22222221111         


Q ss_pred             CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       546 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      +......+.+|+.+||+.||++||++.+|++.|+..
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            112234578899999999999999999999999764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.6e-39  Score=326.84  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=203.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999976 47889999986542   33457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998853   346899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...      ......... ...... +   
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~-~~~~~~-~---  234 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRI-KKNEYS-I---  234 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHH-HTTCCC-C---
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH-hhccCC-C---
Confidence            222  223457899999999999999999999999999999999999997521      122222211 111110 0   


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                        ....    ...+.+++.+||+.||++|||+.|+++.
T Consensus       235 --~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          235 --PKHI----NPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --cccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              0111    2357788999999999999999999873

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-38  Score=324.02  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=202.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999975 58899999986543  344577889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEecccccccc
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~  457 (624)
                      ||+++++|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999888854   345899999999999999999999985   999999999999987665   999999999866


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...      ........ ...+.... .
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~-~~~~~~~~-~  227 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQ-IKAGAYDY-P  227 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH-HHHTCCCC-C
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC------chhHHHHH-HHhccccC-C
Confidence            43322   23457899999999999999999999999999999999999997421      12222221 11121111 1


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+. ....    ...+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~-~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 SPE-WDTV----TPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTT-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chh-hccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            110 0112    234778999999999999999999976

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.6e-40  Score=339.31  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=191.8

Q ss_pred             HHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ....++|...+.||+|+||.||+++.. +++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            345678999999999999999999965 688999999975432  23456789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-----CCCCeEEeccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-----HEMNPKISDFG  452 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfg  452 (624)
                      +||||+++ +|.+++..   ...+++..++.|+.||++||.|||+.+   |+||||||+|||++     +++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999985 89888854   335899999999999999999999985   99999999999994     45569999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      +++.......  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...   ........+.......
T Consensus       183 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          183 LARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD---SEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCC
T ss_pred             CccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC---CHHHHHHHHHHHhCCC
Confidence            9987643322  22345689999999999875 4899999999999999999999997421   1111111121111111


Q ss_pred             Cccc----------------cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 HAAE----------------LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 ~~~~----------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....                .....+...........+.+++.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000                00000000000011245778999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-39  Score=328.43  Aligned_cols=255  Identities=28%  Similarity=0.395  Sum_probs=201.3

Q ss_pred             hcCccccC-ccccCCceeEEEEEec---CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          304 TQDFSQEN-KLGEGGFGPVYKGVLA---DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       304 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      .++|...+ .||+|+||.||+|.+.   .++.||||++....  ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999643   46789999987643  23367899999999999999999999999 667789


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999964   345899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          458 GGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       458 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....      ... .......+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~-~~~~~~~~~~~~  240 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSE-VTAMLEKGERMG  240 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHH-HHHHHHTTCCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC------HHH-HHHHHHcCCCCC
Confidence            443321 11223346788999999999899999999999999999999 999974211      111 222222222111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .         +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus       241 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          241 C---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             C---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         112234578899999999999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.2e-39  Score=330.14  Aligned_cols=260  Identities=28%  Similarity=0.422  Sum_probs=201.4

Q ss_pred             hcCccccCccccCCceeEEEEEecC----CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCcce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~  377 (624)
                      ..+|...+.||+|+||.||+|+..+    ...+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568888999999999999999643    23589999876433 456788999999999999999999999754 55679


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999964  3345899999999999999999999985   999999999999999999999999999866


Q ss_pred             CCCCC--CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          458 GGNQS--KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK-KSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       458 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      .....  ........||+.|+|||.+.+..++.++||||||+++|||++|. +|+..   ...........    .+...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~----~~~~~  251 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLL----QGRRL  251 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---SCTTTHHHHHH----TTCCC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc---CCHHHHHHHHh----cCCCC
Confidence            43321  12233456788999999999999999999999999999999955 45432   22222222221    11111


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCC
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT  584 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~  584 (624)
                      ..     ....    ...+.+++.+||+.||++|||+.||++.|+.....
T Consensus       252 ~~-----~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          252 LQ-----PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             CC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC-----CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11     0112    23578899999999999999999999999865433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.5e-39  Score=327.09  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=200.5

Q ss_pred             hcCccccCccccCCceeEEEEEecC----CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|...+.||+|+||.||+|+..+    +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4689999999999999999998643    2359999987653 3456789999999999999999999999764 45789


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999642  345899999999999999999999985   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....   .......+.    .+......
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~---~~~~~~~~~----~~~~~~~~  236 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLE----KGDRLPKP  236 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---GGGHHHHHH----HTCCCCCC
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC---hHHHHHHHh----cCCCCCCC
Confidence            33221 2223457889999999999999999999999999999998 999975222   222222221    11111110


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                           ..+    ...+.+++.+||+.||++|||+.||++.|+.
T Consensus       237 -----~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          237 -----DLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             -----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence                 111    2357789999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-39  Score=336.37  Aligned_cols=266  Identities=24%  Similarity=0.330  Sum_probs=196.0

Q ss_pred             HHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-----ccHHHHHHHHHHHHhcCCCCcceEEeEEEecC
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-----QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN  374 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  374 (624)
                      ....++|...+.||+|+||.||+++.. +|+.||||++.....     ...+.+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345678999999999999999999975 589999999875322     12346789999999999999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+++ +|..++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 78877753  3345888899999999999999999986   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.+.....  ......||+.|+|||++.+. .++.++||||||+++|||++|.+|+...   .....+..+.........
T Consensus       160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~---~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCT
T ss_pred             eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHcCCCCh
Confidence            87643322  22345789999999999764 4899999999999999999999886421   111222222222111111


Q ss_pred             ccccc------chhh---cCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 AELMD------SVVK---QSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ~~~~d------~~l~---~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ....+      ....   ...+     ......+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11100      0000   0001     1112468889999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-39  Score=339.05  Aligned_cols=251  Identities=20%  Similarity=0.265  Sum_probs=198.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||.||+++.+ +++.||||++.+....    ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999976 5889999999765432    35688888888 79999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-C---CeEEecccccccc
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-M---NPKISDFGMARIF  457 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~---~~kl~Dfg~a~~~  457 (624)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.++ +   .+||+|||+++..
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999998854   345899999999999999999999985   9999999999998543 2   4999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......... ...+.... .
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~-i~~~~~~~-~  243 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTPEEILAR-IGSGKFSL-S  243 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCHHHHHHH-HHHCCCCC-C
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCHHHHHHH-HccCCccc-C
Confidence            43322  22346789999999999988899999999999999999999999853221   222222222 22222111 0


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..     ........+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 GG-----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ST-----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00     00111235778899999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-39  Score=341.54  Aligned_cols=255  Identities=23%  Similarity=0.300  Sum_probs=203.1

Q ss_pred             hcCccccCccccCCceeEEEEEe----cCCcEEEEEEccccC----cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecC
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEEN  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  374 (624)
                      .++|...+.||+|+||.||+++.    .+++.||||+++...    ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999997    368999999987532    23446678899999999 6999999999999999


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999854   245899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGG--IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +.+..... .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||......  ...............
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP  283 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCCC
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--chHHHHHHHHhccCC
Confidence            86543221 223346799999999999863  4789999999999999999999998533222  222332222221111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHh
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAVML  578 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~L  578 (624)
                                 ..+......+.+++.+||+.||++||     ++.|+++..
T Consensus       284 -----------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 -----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -----------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                       01111223577899999999999999     999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.4e-39  Score=326.06  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=198.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            478999999999999999999976 46789999986532   23356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999998854   245899999999999999999999985   99999999999999999999999999865432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..      .......... .....      
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~~~-~~~~~------  224 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRI-SRVEF------  224 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHH-HHTCC------
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC------CcHHHHHHHH-HhCCC------
Confidence            2    22345789999999999999999999999999999999999999752      1122222111 11110      


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                          ..+......+.+++.+||+.||++|||+.||++.
T Consensus       225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0111122346788999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=341.59  Aligned_cols=262  Identities=13%  Similarity=0.160  Sum_probs=203.4

Q ss_pred             hcCccccCccccCCceeEEEEEecC---------CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcce---------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD---------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR---------  365 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~---------  365 (624)
                      .++|...+.||+|+||.||+|+...         ++.||||++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999764         789999998754     46789999999999999987         


Q ss_pred             ------EEeEEEe-cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006952          366 ------LLGCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV  438 (624)
Q Consensus       366 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI  438 (624)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.|+.||++||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777776 66789999999 99999999653 2356999999999999999999999985   99999999999


Q ss_pred             EEcCCC--CeEEeccccccccCCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q 006952          439 LLDHEM--NPKISDFGMARIFGGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGF  511 (624)
Q Consensus       439 ll~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~  511 (624)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999876432211     122345799999999999999999999999999999999999999753


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCccccccchhh-cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          512 YHSEHGPSLLAYIWKLWCEGHAAELMDSVVK-QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ....  ..........+.. ....+.+.... ...+    ..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       271 ~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          271 CLPN--TEDIMKQKQKFVD-KPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GTTC--HHHHHHHHHHHHH-SCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCcC--HHHHHHHHHhccC-ChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            2211  1111111111111 11222221111 1112    35778889999999999999999999997643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-38  Score=321.78  Aligned_cols=250  Identities=23%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|...+.||+|+||.||+++.. +++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57899999999999999999976 589999999865421      24678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEecccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFGM  453 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~  453 (624)
                      +||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999854   346899999999999999999999985   99999999999998877    799999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.......   ......|++.|+|||++.+..++.++||||||+++|||++|+.||...      ........ ......
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~-~~~~~~  228 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE------TKQETLTN-ISAVNY  228 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHH-HHTTCC
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc------chHHHHHH-hHhccc
Confidence            98764322   123456899999999999999999999999999999999999997421      11122111 111111


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .  .........    ...+.+++.+||+.||++|||+.|+++
T Consensus       229 ~--~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 D--FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             C--CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0  111111112    235778999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=342.28  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=194.0

Q ss_pred             cCccccCccccCCceeEEEEEecC--C--cEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD--G--KEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~l  378 (624)
                      ..|...+.||+|+||.||+|++.+  +  ..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            346677899999999999999642  2  358999987543 3456789999999999999999999999765 457899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus       169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999964  3345889999999999999999999985   9999999999999999999999999998664


Q ss_pred             CCCCC--ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          459 GNQSK--ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       459 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...   ........+    ..+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~---~~~~~~~~~----~~~~~~~  316 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYL----LQGRRLL  316 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CSSCHHHHH----HTTCCCC
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC---CHHHHHHHH----HcCCCCC
Confidence            33211  12233457889999999999999999999999999999999 56665422   222333222    1121111


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCC
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL  585 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~  585 (624)
                        .+   ..+    ...+.+++.+||+.||++|||+.||++.|+.....+
T Consensus       317 --~p---~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          317 --QP---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             --CC---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             --CC---CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence              11   112    235778999999999999999999999998754333

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.4e-38  Score=326.26  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .+.|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356889999999999999999965 58899999987543 3456889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999998843    46899999999999999999999985   9999999999999999999999999998764432


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...      ........ ........     +
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~-~~~~~~~~-----~  239 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL------HPMKVLFL-IPKNNPPT-----L  239 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHH-HHHSCCCC-----C
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc------CHHHHHHH-hhcCCCCC-----C
Confidence            2  223457899999999999999999999999999999999999997421      11121111 11111111     1


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ...++    ..+.+++.+||+.||++|||+.+|++.
T Consensus       240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            12222    347789999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.3e-39  Score=354.49  Aligned_cols=253  Identities=26%  Similarity=0.340  Sum_probs=204.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++.. +|+.||+|++.+.   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 6899999998653   233456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999998653 2345899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .... +......... .    
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~-i~~~i~~~~~-~----  407 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREE-VERLVKEVPE-E----  407 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHH-HHHHHHHCCC-C----
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHH-HHHHhhcccc-c----
Confidence            32   2234579999999999999999999999999999999999999985322211  1112 2221111111 0    


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                           .+......+.+|+.+||+.||++||     ++.||++
T Consensus       408 -----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 -----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                 1111123577889999999999999     7888865

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.4e-39  Score=336.56  Aligned_cols=262  Identities=25%  Similarity=0.360  Sum_probs=197.1

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .++|+..+.||+|+||.||+++... ++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4689999999999999999999764 88999999865433  23466789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999887643   335899999999999999999999985   999999999999999999999999999865432


Q ss_pred             CCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH-----------H
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL-----------W  528 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~  528 (624)
                      ..  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.....   ......+...           +
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHh
Confidence            22  22345689999999999875 789999999999999999999999753211   1111111110           1


Q ss_pred             hcCC-ccccccchhhcCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          529 CEGH-AAELMDSVVKQSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       529 ~~~~-~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .... ......+.+....+     ......+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1100 00000000000011     112346889999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.7e-40  Score=346.28  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=191.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHH-HHhcCCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTV-IAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|+..+.||+|+||.||+++.+ +++.||||++.+..   ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999976 47889999997643   2234456677776 567899999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999998854   345889999999999999999999985   9999999999999999999999999998643


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+........... ... +  
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------~~~~~~~~~i~~~-~~~-~--  258 (373)
T 2r5t_A          191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS------RNTAEMYDNILNK-PLQ-L--  258 (373)
T ss_dssp             CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC------SBHHHHHHHHHHS-CCC-C--
T ss_pred             cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC------CCHHHHHHHHHhc-ccC-C--
Confidence            221  223457899999999999999999999999999999999999999742      1222222222221 111 0  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         ....    ...+.+++.+||+.||++||++.+.++
T Consensus       259 ---~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          259 ---KPNI----TNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             ---CSSS----CHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             ---CCCC----CHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence               0112    234778899999999999999854333

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-39  Score=325.35  Aligned_cols=246  Identities=23%  Similarity=0.312  Sum_probs=201.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999976 47789999986532   23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...   ..+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999998542   35899999999999999999999985   99999999999999999999999999876543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...      .......... .....     
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~-~~~~~-----  230 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP------SHTETHRRIV-NVDLK-----  230 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHH-TTCCC-----
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC------CHhHHHHHHh-ccccC-----
Confidence            2    123457899999999999999999999999999999999999997521      1222222221 11110     


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           .+......+.+++.+||+.||.+|||+.++++
T Consensus       231 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 -----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 11111235778999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-39  Score=330.21  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  378 (624)
                      ..++|...+.||+|+||.||+++.. +++.||||++....  .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3578999999999999999999976 68999999987642  33456788999999999 99999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCC-CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--------------
Q 006952          379 IYEYMPNKSLDVFLFDSTR-SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE--------------  443 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--------------  443 (624)
                      ||||+++++|.+++..... ...+++..++.++.||++||.|||+++   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999964321 245899999999999999999999985   9999999999999844              


Q ss_pred             -----CCeEEeccccccccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          444 -----MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       444 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                           ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++..      
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------  233 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN------  233 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS------
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc------
Confidence                 479999999998764322      23589999999999876 567899999999999999999877421      


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...    +.....+....+.     ...    ...+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~----~~~~~~~~~~~~~-----~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GDQ----WHEIRQGRLPRIP-----QVL----SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SHH----HHHHHTTCCCCCS-----SCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH----HHHHHcCCCCCCC-----ccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            111    1222223222221     112    235778999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=335.74  Aligned_cols=260  Identities=22%  Similarity=0.338  Sum_probs=193.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc-cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ-GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||+++.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999976 6889999998754322 222456799999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 5888887543  345899999999999999999999985   9999999999999999999999999998654322 


Q ss_pred             CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                       .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...   ........+.+.........+ ....
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~-~~~~  229 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS---TVEEQLHFIFRILGTPTEETW-PGIL  229 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTS-TTGG
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChHhc-hhhh
Confidence             12234568999999999876 56899999999999999999999997532   222233333332222111111 1000


Q ss_pred             hc-----------------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQ-----------------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~-----------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..                 .........+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00                 000011235778999999999999999999977

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=324.09  Aligned_cols=252  Identities=22%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC----cccHHHHHHHHHHHHhcCCCCcceEEeEEE--ecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQHKNLVRLLGCCL--EENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~  376 (624)
                      .++|.+.+.||+|+||.||++... +++.||+|++....    ....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 58899999987542    344678999999999999999999999985  44578


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||++++ |.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 66666442 3456899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|+.||..      ........ ....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~-~i~~~~~~  231 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG------DNIYKLFE-NIGKGSYA  231 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHH-HHHHCCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC------chHHHHHH-HHhcCCCC
Confidence            65433333334567899999999998654  47899999999999999999999752      12222222 22222111


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                            +...+    ...+.+++.+||+.||++|||+.|+++.
T Consensus       232 ------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          232 ------IPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ------CCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------CCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  01112    2357788999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.4e-39  Score=337.77  Aligned_cols=198  Identities=28%  Similarity=0.356  Sum_probs=173.8

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-----CCCcceEEeEEEecCc
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-----HKNLVRLLGCCLEENE  375 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~~~~~~~~~  375 (624)
                      ...++|.+.+.||+|+||.||+++.. +++.||||++... ....+.+..|+.+++.++     ||||+++++++...+.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            44678999999999999999999974 6889999998743 334466788999999996     9999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------------
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-------------  442 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------------  442 (624)
                      .++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.             
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence            99999999 99999998653 2335899999999999999999999985   999999999999975             


Q ss_pred             ------------CCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          443 ------------EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       443 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                                  ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                        788999999999864332     224578999999999999999999999999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-39  Score=327.92  Aligned_cols=258  Identities=25%  Similarity=0.322  Sum_probs=202.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l  378 (624)
                      .++|+..+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999976 68899999987543  3445778999999999999999999998865  556899


Q ss_pred             EEEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          379 IYEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ||||+++++|.+++.... ....+++..++.++.||++||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986532 2345899999999999999999999984  1239999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....      .... ......+....
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~-~~~i~~~~~~~  235 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKEL-AGKIREGKFRR  235 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHTCCCC
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------HHHH-HHHHhhccccc
Confidence            7643221  1223568999999999999999999999999999999999999975321      1121 22222232221


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      +.     ..+    ...+.+++.+||+.||++|||+.||++.+.
T Consensus       236 ~~-----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          236 IP-----YRY----SDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CC-----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             CC-----ccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            11     112    235778999999999999999999988664

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.2e-39  Score=328.57  Aligned_cols=252  Identities=23%  Similarity=0.407  Sum_probs=198.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            478999999999999999999986 4889999999877777788999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999988542  345899999999999999999999985   9999999999999999999999999875432111 


Q ss_pred             CccccccccccCccChhhh-----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          463 KANTNRVVGTYGYMAPEYA-----MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                       .......||+.|+|||++     .+..++.++||||||+++|||++|+.|+...      +............. ....
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~-~~~~  243 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSDP-PTLL  243 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC-CCCS
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC------CHHHHHHHHhccCC-cccC
Confidence             112235689999999998     4677899999999999999999999997522      22222222222221 1111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+   ..+    ...+.+++.+||+.||++|||+.+|++
T Consensus       244 ~~---~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 TP---SKW----SVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SG---GGS----CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             Cc---ccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11   111    235778999999999999999999865

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-38  Score=346.46  Aligned_cols=259  Identities=24%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  374 (624)
                      .++|...+.||+|+||.||++... +++.||||++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999965 5889999999764  3344677889999999999999999999997654      


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            459999999875 555552     23889999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc-
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA-  533 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  533 (624)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ..+.+..+.+....... 
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~---~~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCHH
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHH
Confidence            865432   22334679999999999999999999999999999999999999974211   11111111111110000 


Q ss_pred             -------------------c-----ccccchhhcCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 -------------------A-----ELMDSVVKQSC---DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 -------------------~-----~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                         .     ......+....   .......+.+|+.+||+.||++|||++|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                               0     00000000000   01124568899999999999999999999763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.7e-39  Score=333.82  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=203.1

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||++...+ ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4689999999999999999999764 7889999986542   33457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..   ...+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998853   346899999999999999999999985   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      .......... ..... +   
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~-~~~~~-~---  260 (335)
T 2owb_A          194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIK-KNEYS-I---  260 (335)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHH-HTCCC-C---
T ss_pred             Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC------CHHHHHHHHh-cCCCC-C---
Confidence            222  223457899999999999999999999999999999999999997521      1222221111 11110 0   


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ....    ...+.+++.+||+.||++|||+.|+++
T Consensus       261 --~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 --PKHI----NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0111    234678899999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-39  Score=337.32  Aligned_cols=197  Identities=29%  Similarity=0.424  Sum_probs=173.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            67999999999999999999976 58899999987653 34457789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++......  
T Consensus       113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999954   235899999999999999999999851  3999999999999999999999999998754321  


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  231 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP  231 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence              2234578999999999999999999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.6e-39  Score=326.42  Aligned_cols=258  Identities=28%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             hcCccccCccccCCceeEEEEEec--CCc--EEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA--DGK--EIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|+..+.||+|+||.||+|++.  +++  .||||++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999853  233  6899998754   2345678999999999999999999999998754 8


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+||+++++|.+++...  ...+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998642  345899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...      ................
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERL  244 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC------CHHHHHHHHHccCCCC
Confidence            6543321 12233557889999999999899999999999999999999 99997422      1222222222222111


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCC
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI  582 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~  582 (624)
                      ..         +......+.+++.+||+.||++|||+.+|++.|....
T Consensus       245 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          245 PR---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC---------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            11         1112345788999999999999999999999998653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.3e-39  Score=361.40  Aligned_cols=247  Identities=28%  Similarity=0.397  Sum_probs=195.2

Q ss_pred             CccccCCceeEEEEEec---CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLA---DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+.++++++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999753   46789999997643  334678999999999999999999999986 4568899999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC-c
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-A  464 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~  464 (624)
                      |+|.+++..   ...+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999954   346899999999999999999999985   999999999999999999999999999876543321 2


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...      .... +......+.....       
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~------~~~~-~~~~i~~~~~~~~-------  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM------KGSE-VTAMLEKGERMGC-------  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHH-HHHHHHTTCCCCC-------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------CHHH-HHHHHHcCCCCCC-------
Confidence            2223456789999999999999999999999999999998 99997421      1111 2222222221111       


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        +......+.+|+.+||+.||++||++.+|++.|+.
T Consensus       594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11223457889999999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.6e-39  Score=337.18  Aligned_cols=263  Identities=22%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEec-------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-------  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------  373 (624)
                      .++|...+.||+|+||.||+++.. +|+.||||++.....  .....+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999974 689999999865432  3356788999999999999999999999874       


Q ss_pred             -CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          374 -NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       374 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                       +..++||||+++ +|...+...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             457899999986 666666432  345899999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCC--CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          453 MARIFGGNQS--KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       453 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      +++.+.....  ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...   ........+.....
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLCG  246 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhC
Confidence            9987653222  222344678999999999876 45799999999999999999999997521   11122222222211


Q ss_pred             cCCccccccch----h--------hcCCCH-HH------HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAAELMDSV----V--------KQSCDQ-AE------LLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d~~----l--------~~~~~~-~~------~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ... .+.....    .        ...... ..      ...+.+|+.+||+.||++|||+.|+++
T Consensus       247 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SIT-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCC-TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC-hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111 1110000    0        000001 11      234778999999999999999999976

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-39  Score=343.58  Aligned_cols=201  Identities=29%  Similarity=0.510  Sum_probs=162.4

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecC--c
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEEN--E  375 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~  375 (624)
                      ...++|...+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999965 6899999998653  3344567889999999997 999999999998654  5


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            799999998 588888854    35889999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCC-------------------CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          456 IFGGNQS-------------------KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       456 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      .+.....                   ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            7543111                   111234579999999999987 678999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-39  Score=331.59  Aligned_cols=255  Identities=29%  Similarity=0.431  Sum_probs=200.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcE--EEEEEcccc-CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKE--IAVKRLSRT-SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|...+.||+|+||.||+++.. ++..  +++|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67899999999999999999965 4554  499988753 334456789999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          380 YEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      |||+++++|.+++....             ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996532             2346899999999999999999999985   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++.....   .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...      ...... 
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~-  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELY-  251 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHH-
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC------cHHHHH-
Confidence            99999998743211   11223456889999999999999999999999999999998 99997421      122221 


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .....+.....         +......+.+++.+||+.||++|||+.|+++.|...
T Consensus       252 ~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          252 EKLPQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             HHGGGTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22222211111         111224578899999999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-38  Score=342.16  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=190.9

Q ss_pred             HHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--------cccHHHHHHHHHHHHhcCCCCcceEEeEEEe
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--------GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE  372 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  372 (624)
                      ...++|...+.||+|+||.||+|... +++.||||++....        ......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            34678999999999999999999975 57899999986532        122335789999999999999999999975 


Q ss_pred             cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---CeEEe
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---NPKIS  449 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  449 (624)
                      .+..++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            4557999999999999998843   456899999999999999999999985   99999999999997544   59999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK  526 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~  526 (624)
                      |||+++......   ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.....  ...+...+  
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~i--  357 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQI--  357 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS--SCCHHHHH--
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc--hHHHHHHH--
Confidence            999998764322   2234679999999999863   6688999999999999999999999853222  22222222  


Q ss_pred             HHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       527 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ..+.... .. ......    ...+.+++.+||+.||++|||+.|+++
T Consensus       358 --~~~~~~~-~~-~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 --TSGKYNF-IP-EVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HTTCCCC-CH-HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --hcCCCCC-Cc-hhhccc----CHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              1121111 11 111111    235778999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-38  Score=345.42  Aligned_cols=260  Identities=19%  Similarity=0.285  Sum_probs=202.8

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCC-CCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH-KNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++......  +.+.+|+.+++.++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999996 46899999987654432  457899999999976 555666666677778899999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEeccccccccC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFG  458 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~  458 (624)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998642  345899999999999999999999985   9999999999999   688999999999998765


Q ss_pred             CCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          459 GNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       459 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      .....     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-
Confidence            43321     122356799999999999999999999999999999999999999864333222122222111111111 


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         +. .+...++    .++.+++..||+.+|++||++.+|+++|+.
T Consensus       237 ---~~-~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          237 ---IE-ALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             ---HH-HHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ---HH-HHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence               11 1111222    357889999999999999999999998854

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.4e-40  Score=346.74  Aligned_cols=242  Identities=14%  Similarity=0.171  Sum_probs=188.9

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEcccc---CcccHHHHHHHHH---HHHhcCCCCcceEE-------eE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT---SGQGLQEFKNEVT---VIAKLQHKNLVRLL-------GC  369 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ei~---~l~~l~h~niv~l~-------~~  369 (624)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 46899999998743   3345678899994   55555899999998       66


Q ss_pred             EEecCc-----------------ceEEEEeccCCChhhhhhcCC----CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006952          370 CLEENE-----------------SLLIYEYMPNKSLDVFLFDST----RSVQLDWKRRISIIKGIARGILYLHEDSRLKI  428 (624)
Q Consensus       370 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i  428 (624)
                      +.+.+.                 .++||||+ +|+|.+++....    ....+++..++.|+.||++||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            665532                 78999999 689999986421    1234557888999999999999999985   9


Q ss_pred             EecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCC-----------CCChhhHHHHHHH
Q 006952          429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-----------IFSVKSDVFSFGV  497 (624)
Q Consensus       429 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~S~Gv  497 (624)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2234567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          498 VLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       498 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ++|||++|+.||........               ...+....  ...+    ..+.+++.+||+.||++|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG---------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC---------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc---------------hhhhhhhc--cCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999742221110               01111100  1222    35778899999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-39  Score=331.00  Aligned_cols=260  Identities=24%  Similarity=0.399  Sum_probs=185.3

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..++|...+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999964 68899999986543 344577889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcC-----CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          381 EYMPNKSLDVFLFDS-----TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ||+++++|.+++...     .....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999988531     12456899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCC---CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          456 IFGGNQS---KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       456 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      .......   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......   ....   ..... 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~~~~~-  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLM---LTLQN-  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHH---HHHTS-
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHH---HHhcc-
Confidence            7643221   112234578999999999876 56899999999999999999999997532221   1111   11111 


Q ss_pred             Ccccc----ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 HAAEL----MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 ~~~~~----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .....    .+......+    ...+.+++.+||+.||++|||+.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111    111111122    235778999999999999999999976

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1e-38  Score=336.40  Aligned_cols=255  Identities=23%  Similarity=0.346  Sum_probs=203.2

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--------ccHHHHHHHHHHHHhc-CCCCcceEEeE
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--------QGLQEFKNEVTVIAKL-QHKNLVRLLGC  369 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~h~niv~l~~~  369 (624)
                      .....++|...+.||+|+||.||++++. +|+.||||++.....        ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445578999999999999999999986 699999999875432        1245678999999999 79999999999


Q ss_pred             EEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       370 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                      +......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999854   346899999999999999999999985   9999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  523 (624)
                      |||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||...      .....
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~------~~~~~  313 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR------RQILM  313 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHH
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC------CHHHH
Confidence            999998765332   2234679999999999863      35889999999999999999999997421      11222


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ... ...+.... ..+. ....    ...+.+++.+||+.||++|||+.|+++
T Consensus       314 ~~~-i~~~~~~~-~~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 LRM-IMEGQYQF-SSPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH-HHHTCCCC-CHHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHH-HHhCCCCC-CCcc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            211 11121110 0000 0111    234778999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-38  Score=349.39  Aligned_cols=255  Identities=26%  Similarity=0.352  Sum_probs=205.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++.+ +|+.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999976 58999999986542   23457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          380 YEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      |||+++|+|..++.... ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999986533 2456999999999999999999999985   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ............ .....    
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~--~~~~~~~~~~i~-~~~~~----  411 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVL-EQAVT----  411 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC--CCCHHHHHHHHH-HCCCC----
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc--chhHHHHHHHHh-hcccC----
Confidence            4322  23346899999999999999999999999999999999999999853221  112222222222 11110    


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM-----SSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~  576 (624)
                            .+......+.+++.+||+.||++||++     .+|++
T Consensus       412 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 ------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                  111122357788999999999999975     56653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.4e-39  Score=331.18  Aligned_cols=250  Identities=23%  Similarity=0.291  Sum_probs=199.9

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|...+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467999999999999999999975 6899999999876555557789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEeccccccccCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  459 (624)
                      +++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||++   ++++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999998854   235899999999999999999999985   9999999999999   7888999999999875432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...      ....... ....+... ...+
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~-~i~~~~~~-~~~~  229 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE------TESKLFE-KIKEGYYE-FESP  229 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHH-HHHHCCCC-CCTT
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHHH-HHHcCCCC-CCcc
Confidence            1    223456899999999999999999999999999999999999997421      1111111 12222111 0011


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ....    ....+.+++.+||+.||++|||+.|+++
T Consensus       230 -~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          230 -FWDD----ISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -TTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -cccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111    2245778999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.3e-39  Score=327.93  Aligned_cols=249  Identities=28%  Similarity=0.409  Sum_probs=195.1

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEec-CcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-NESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lV~Ey  382 (624)
                      .++|+..+.||+|+||.||++... |+.||||++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            468999999999999999999884 8899999987543  457889999999999999999999997654 468999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++++|.+++... ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999998542 2234789999999999999999999985   9999999999999999999999999987653321 


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                          ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....   .......    ...+.....     
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~----~~~~~~~~~-----  235 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR----VEKGYKMDA-----  235 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHH----HTTTCCCCC-----
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HhcCCCCCC-----
Confidence                22357889999999999999999999999999999998 999975322   1122211    112211111     


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...+    ...+.+++.+||+.||++|||+.||++.|+.
T Consensus       236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          236 PDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            1112    3357789999999999999999999999865

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=323.97  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=198.7

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ..++|...+.||+|+||.||+|... +|+.||||++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3567999999999999999999976 48999999987643  34778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999853  2346899999999999999999999985   9999999999999999999999999998764332


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...      ........... ........+  
T Consensus       180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~-~~~~~~~~~--  248 (314)
T 3com_A          180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI------HPMRAIFMIPT-NPPPTFRKP--  248 (314)
T ss_dssp             S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHH-SCCCCCSSG--
T ss_pred             c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHhc-CCCcccCCc--
Confidence            2  223457899999999999999999999999999999999999997521      11222222111 111111111  


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       ..+    ...+.+++.+||+.||++|||+.++++
T Consensus       249 -~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 -ELW----SDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -GGS----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             111    235778999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-38  Score=341.09  Aligned_cols=199  Identities=25%  Similarity=0.433  Sum_probs=166.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----Cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  375 (624)
                      .++|.+.+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999975 47889999997543  33457889999999999999999999999876     56


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+. ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 599998843   346899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCC--------------------ccccccccccCccChhhh-cCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          456 IFGGNQSK--------------------ANTNRVVGTYGYMAPEYA-MGGIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       456 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      ........                    .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76433211                    122456799999999986 5567999999999999999999876554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=330.96  Aligned_cols=270  Identities=26%  Similarity=0.390  Sum_probs=199.7

Q ss_pred             HhcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ..++|...+.||+|+||.||+|...+  .+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35789999999999999999999853  59999987543  334566789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.....
T Consensus       109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999954  2346899999999999999999999985   99999999999998 679999999998765322


Q ss_pred             C---CCccccccccccCccChhhhcC---------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH
Q 006952          461 Q---SKANTNRVVGTYGYMAPEYAMG---------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       461 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      .   .........|++.|+|||++.+         ..++.++||||||+++|||++|+.||..      .......+...
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~------~~~~~~~~~~~  256 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT------QPAEAIIWQMG  256 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS------CCHHHHHHHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHhc
Confidence            1   1122234568999999999874         4579999999999999999999999742      12222222222


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCCCCCCCcccc
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL  595 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~p~~p~~~~  595 (624)
                       .+........    ..    ...+.+++.+||+.||++|||+.+|+++|+...........|..+.
T Consensus       257 -~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          257 -TGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             -TTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             -cCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence             2211111111    11    1247789999999999999999999999988766655555555543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=334.39  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=194.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  374 (624)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999974 68999999986532  334567889999999999999999999998763      


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899998854    35899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.....     .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....   ..+.+..+.+..... .
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~~-~  246 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTP-P  246 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCC-C
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCC-C
Confidence            875432     234578999999999887 679999999999999999999999975211   111122111111100 0


Q ss_pred             cccc-------------------cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhccC
Q 006952          534 AELM-------------------DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLASD  581 (624)
Q Consensus       534 ~~~~-------------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~  581 (624)
                      .+..                   ...+. .........+.+++.+||+.||++|||+.|+++  .++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            0000                   00000 001112345778999999999999999999988  35443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-38  Score=321.71  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=197.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec----Ccce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE----NESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----~~~~  377 (624)
                      ..|...+.||+|+||.||+|... ++..||+|++...  .....+.+.+|+.++++++||||+++++++...    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45777889999999999999975 5778999998654  334567889999999999999999999998763    4478


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEeccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARI  456 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~  456 (624)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999954   245899999999999999999999873 2499999999999998 788999999999976


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ....    ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...     ........ ....+.....
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~-~~~~~~~~~~  250 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAAQIYR-RVTSGVKPAS  250 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-----SSHHHHHH-HHTTTCCCGG
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-----CcHHHHHH-HHhccCCccc
Confidence            4332    223456899999999876 45899999999999999999999997421     12222222 2222211111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .    ....+    ..+.+++.+||+.||++|||+.||++
T Consensus       251 ~----~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 F----DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G----GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c----CCCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1    11112    34788999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-38  Score=321.22  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|.+.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367899999999999999999976 68999999986532   34467889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++...   ..+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998542   35899999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...   .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...      ...... .....+... .  
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~-~~~~~~~~~-~--  230 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE------HVPTLF-KKIRGGVFY-I--  230 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHH-HHHHHCCCC-C--
T ss_pred             Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC------cHHHHH-HHhhcCccc-C--
Confidence            321   223568999999999988765 68999999999999999999997421      122222 112122110 0  


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                             +......+.+++.+||+.||++|||+.||++.
T Consensus       231 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          231 -------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   11112347788999999999999999999873

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-38  Score=346.77  Aligned_cols=196  Identities=22%  Similarity=0.416  Sum_probs=154.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----Cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  375 (624)
                      .++|.+.+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999965 68899999986543  33457789999999999999999999998543     46


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+ +++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5688888843   346899999999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCC-------------------------ccccccccccCccChhhh-cCCCCChhhHHHHHHHHHHHHHhCC
Q 006952          456 IFGGNQSK-------------------------ANTNRVVGTYGYMAPEYA-MGGIFSVKSDVFSFGVVLLEIISGK  506 (624)
Q Consensus       456 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~S~Gvil~elltg~  506 (624)
                      ........                         ......+||+.|+|||++ .+..++.++|||||||++|||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            76432211                         122345789999999976 5667999999999999999999953

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-38  Score=329.33  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=197.2

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEe--cCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLE--ENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++. .+++.||||++...   ..+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999986 46889999998743   3467899999999997 9999999999988  5668999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccccC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFG  458 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  458 (624)
                      |||+++++|.+++.      .+++..+..++.||++||.|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998873      3889999999999999999999985   99999999999999777 89999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH---------
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW---------  528 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  528 (624)
                      ....   .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||....  .....+..+....         
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS--SHHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC--chHHHHHHHHHhcCCchhhhHH
Confidence            3322   234578999999999887 678999999999999999999999974211  1111111111110         


Q ss_pred             hcCC--------------ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          529 CEGH--------------AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       529 ~~~~--------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....              ....................+.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000              00000001111111112346788999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.8e-39  Score=341.21  Aligned_cols=261  Identities=21%  Similarity=0.292  Sum_probs=195.4

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc------ce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE------SL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------~~  377 (624)
                      ..+|...+.||+|+||.||+++...+..+|+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3579999999999999999999988888999988654322    2369999999999999999999976543      78


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEeccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARI  456 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~  456 (624)
                      +||||++++.+............+++..++.++.||++||.|||+.+   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999988655544432233456899999999999999999999985   99999999999999 789999999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC---
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH---  532 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  532 (624)
                      ......   .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...   ...+.+..+.+......   
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE---SGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHHH
Confidence            643322   2245789999999998765 5899999999999999999999997421   11112222222111111   


Q ss_pred             ------------ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          533 ------------AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       533 ------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                                  ....................+.+++.+||+.||++|||+.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                        000000000001111123468899999999999999999999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=328.68  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             HHHHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEe--
Q 006952          297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLE--  372 (624)
Q Consensus       297 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~--  372 (624)
                      +.++....++|...+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..  
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344456788999999999999999999974 68899999987543 3357789999999999 79999999999987  


Q ss_pred             ----cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          373 ----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       373 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                          .+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence                45689999999999999998653 2356899999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHH
Q 006952          449 SDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAY  523 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~  523 (624)
                      +|||++........  ......||+.|+|||++.     +..++.++||||||+++|||++|+.||...      .....
T Consensus       171 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~  242 (326)
T 2x7f_A          171 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM------HPMRA  242 (326)
T ss_dssp             CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS------CHHHH
T ss_pred             eeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC------cHHHH
Confidence            99999886543221  223457899999999987     567899999999999999999999997421      12222


Q ss_pred             HHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       524 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ........ ......    ..+    ...+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~-~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 LFLIPRNP-APRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHSC-CCCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhhcCc-cccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            22222111 111111    112    235778899999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.8e-38  Score=325.61  Aligned_cols=257  Identities=22%  Similarity=0.278  Sum_probs=200.3

Q ss_pred             HHHhcCcccc-CccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          301 VKATQDFSQE-NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       301 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      ....+.|.+. +.||+|+||.||+++.. +++.||+|++....  ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445667776 88999999999999976 58999999987543  34467889999999999 57999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEeccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFG  452 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  452 (624)
                      .++||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             EEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            9999999999999998854 23356899999999999999999999985   999999999999998   7899999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...      ............ .
T Consensus       180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~-~  249 (327)
T 3lm5_A          180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE------DNQETYLNISQV-N  249 (327)
T ss_dssp             GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHT-C
T ss_pred             cccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CchHHHHHHHhc-c
Confidence            998764332   223457999999999999999999999999999999999999997421      111211111111 1


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .. ...+. ...    ....+.+++.+||+.||++|||+.|+++.
T Consensus       250 ~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 VD-YSEET-FSS----VSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CC-CCTTT-TTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             cc-cCchh-hcc----cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00 00000 011    12347788999999999999999999764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-38  Score=346.07  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=202.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|...+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999976 68999999986542   34567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---cCCCCeEEeccccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---DHEMNPKISDFGMARI  456 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  456 (624)
                      |||+.+++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999988854   345899999999999999999999985   9999999999999   5678999999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      +....   ......||+.|+|||++.+ .++.++||||+|+++|+|++|++||...      .......... .+.....
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~-~~~~~~~  247 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA------NEYDILKKVE-KGKYTFE  247 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHH-HCCCCCC
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHH-cCCCCCC
Confidence            64332   2234579999999999876 6899999999999999999999997521      2222222222 2221111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....  ...    ...+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~--~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 LPQW--KKV----SESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             SGGG--GGS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Cccc--ccC----CHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1110  111    234778999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-38  Score=334.09  Aligned_cols=268  Identities=20%  Similarity=0.270  Sum_probs=196.3

Q ss_pred             HHHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcc-----------cHHHHHHHHHHHHhcCCCCcce
Q 006952          297 LIDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ-----------GLQEFKNEVTVIAKLQHKNLVR  365 (624)
Q Consensus       297 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~  365 (624)
                      ..++....++|...+.||+|+||.||++...+|+.||||++......           ..+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            34667778999999999999999999999888999999998653221           2378899999999999999999


Q ss_pred             EEeEEEecC-----cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          366 LLGCCLEEN-----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       366 l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      +++++...+     ..++||||++ ++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            999986533     4689999998 577777753  3346899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---FYN  241 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHH
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---HHH
Confidence            999999999999997543222   2234578999999999887 678999999999999999999999975211   111


Q ss_pred             HHHHHHHHHhcCCccc-----------cccchhhc-------CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          520 LLAYIWKLWCEGHAAE-----------LMDSVVKQ-------SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~-----------~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....+...........           .+...+..       .........+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1121211111111000           00000000       000111235788999999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.7e-38  Score=343.53  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999975 6889999998643  234567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEeccccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARI  456 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~  456 (624)
                      |||+++++|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999888854   245899999999999999999999985   99999999999995   456799999999986


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      +....   ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||..      .......... ..+.....
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~------~~~~~~~~~i-~~~~~~~~  242 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG------KNEYDILKRV-ETGKYAFD  242 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHH-HHTCCCSC
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC------CCHHHHHHHH-HhCCCCCC
Confidence            64332   2234579999999999876 589999999999999999999999742      1222222222 22221111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ....  ...    ...+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~--~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQW--RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGGG--GGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             Cccc--CCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1110  111    2347789999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.8e-39  Score=339.72  Aligned_cols=254  Identities=11%  Similarity=0.060  Sum_probs=179.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhc--CCCCcceEE-------eEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKL--QHKNLVRLL-------GCC  370 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~~  370 (624)
                      ..+|...+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            356889999999999999999965 688999999987543   3456677886555555  699988755       455


Q ss_pred             EecC-----------------cceEEEEeccCCChhhhhhcCCCCcccCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 006952          371 LEEN-----------------ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR------ISIIKGIARGILYLHEDSRLK  427 (624)
Q Consensus       371 ~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~yLH~~~~~~  427 (624)
                      ....                 ..++||||++ ++|.+++....  ..+++..+      +.++.||++||.|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            4332                 2799999999 89999996532  22344555      778899999999999985   


Q ss_pred             eEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhC
Q 006952          428 IIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISG  505 (624)
Q Consensus       428 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg  505 (624)
                      |+||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++||||||+++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999865321     113456799999999987  6799999999999999999999


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          506 KKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       506 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +.||..........        +........................+.+++.+||+.||++|||+.|+++
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99986432221100        0000000000000000000122345778999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.2e-38  Score=322.45  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=186.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .++|+..+.||+|+||.||++... +++.||||++.....  ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            468999999999999999999974 688999999876532  22334445555678889999999999999999999999


Q ss_pred             EeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          381 EYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYLHED-SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||+++ +|.+++... .....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 887776431 2345699999999999999999999997 6   9999999999999999999999999998664


Q ss_pred             CCCCCccccccccccCccChhhh----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYA----MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ...   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||...     .................
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~  233 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-----GTPFQQLKQVVEEPSPQ  233 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-----SCHHHHHHHHHHSCCCC
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-----CchHHHHHHHhccCCCC
Confidence            332   22234689999999996    5667899999999999999999999997521     12222233322222211


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      . ..    ...    ...+.+++.+||+.||++|||+.|+++
T Consensus       234 ~-~~----~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 L-PA----DKF----SAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C-CT----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             c-cc----ccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1 11    111    235778999999999999999999976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.7e-38  Score=324.80  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             HhcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcC--CCCcceEEeEEEecCcceE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQ--HKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~l  378 (624)
                      ..++|++.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++.+++  |+||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            357799999999999999999999889999999986543  345678899999999997  5999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||| +.+++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||+++ +.+||+|||++....
T Consensus       106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 678899999864   346899999999999999999999985   999999999999965 789999999998765


Q ss_pred             CCCCCccccccccccCccChhhhcC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMG-----------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ............||+.|+|||.+.+           ..++.++||||||+++|||++|+.||...     ..........
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~~~~~~~~~~  252 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAI  252 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHHH
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH-----HHHHHHHHHH
Confidence            4433333345678999999999875           46889999999999999999999997421     1122222222


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..........+     ..    ...+.+++.+||+.||++|||+.||++
T Consensus       253 ~~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          253 IDPNHEIEFPD-----IP----EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HCTTSCCCCCC-----CS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcccccCCcc-----cc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            22111111111     11    235778899999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.7e-38  Score=343.64  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=196.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .+.|...+.||+|+||.||+++.+ ++..||+|++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999976 58899999987643  334678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEecccccccc
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~  457 (624)
                      ||+++|+|.+.+..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.+   +.+||+|||++..+
T Consensus       116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999888854   345899999999999999999999985   9999999999999764   45999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ....   ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||...      ......... ..+.... .
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i-~~~~~~~-~  257 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ------TDQEILRKV-EKGKYTF-D  257 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHH-HHTCCCC-C
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH-HhCCCCC-C
Confidence            5332   223457999999999886 56899999999999999999999997521      122222222 2221111 1


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+.. ...+    ..+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~-~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SPEW-KNVS----EGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SGGG-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhc-ccCC----HHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1110 1122    34778899999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-38  Score=336.41  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=200.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC--------CCCcceEEeEEE---
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ--------HKNLVRLLGCCL---  371 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~---  371 (624)
                      .++|.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999865 5789999998753 334567889999999995        788999999988   


Q ss_pred             -ecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC------
Q 006952          372 -EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM------  444 (624)
Q Consensus       372 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~------  444 (624)
                       .....++||||+ +++|.+.+... ....+++..++.|+.||++||.|||++.  +|+||||||+||||+.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence             455789999999 55555555432 2346899999999999999999999972  399999999999999775      


Q ss_pred             -------------------------------------------CeEEeccccccccCCCCCCccccccccccCccChhhh
Q 006952          445 -------------------------------------------NPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA  481 (624)
Q Consensus       445 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  481 (624)
                                                                 .+||+|||+++.....     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999875432     2235789999999999


Q ss_pred             cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHH---HHHHHHHhc--------CC-cccccc-----------
Q 006952          482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLL---AYIWKLWCE--------GH-AAELMD-----------  538 (624)
Q Consensus       482 ~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~--------~~-~~~~~d-----------  538 (624)
                      .+..++.++||||||+++|||++|+.||............   ..+......        +. ..+...           
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999998644333221111   111111110        00 000000           


Q ss_pred             ------chh--hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 ------SVV--KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                            ..+  ....+......+.+|+.+||+.||++|||+.||++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                  000  01234666778999999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.7e-38  Score=339.45  Aligned_cols=259  Identities=24%  Similarity=0.317  Sum_probs=191.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------ES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~  376 (624)
                      ..+|...+.||+|+||.||+|++. +|+.||||++.....    ...+|+.++++++||||+++++++....      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346889999999999999999986 589999999865432    2347999999999999999999986532      25


Q ss_pred             eEEEEeccCCChhhhhhc-CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEeccccc
Q 006952          377 LLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMA  454 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a  454 (624)
                      ++||||+++ +|.+.+.. ......+++..++.++.||++||.|||+.+   |+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 45554432 123456899999999999999999999985   9999999999999965 56899999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC--
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG--  531 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  531 (624)
                      +.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...   ...+.+..+.+.....  
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~---~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD---SGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCSCCH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCH
Confidence            87643322   2245789999999998765 7899999999999999999999997521   1111222222111111  


Q ss_pred             --------Cccccccchhh-----cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 --------HAAELMDSVVK-----QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 --------~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                              ...+...+.+.     ..++......+.+|+.+||+.||++|||+.|+++
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                    00111000000     0011112346788999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.4e-38  Score=328.39  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=202.6

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcc---c--------------HHHHHHHHHHHHhcCCCCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQ---G--------------LQEFKNEVTVIAKLQHKNLVRL  366 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~--------------~~~~~~Ei~~l~~l~h~niv~l  366 (624)
                      .++|.+.+.||+|+||.||++.. +++.||||++......   .              .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998653221   1              1789999999999999999999


Q ss_pred             EeEEEecCcceEEEEeccCCChhhh------hhcCCCCcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEE
Q 006952          367 LGCCLEENESLLIYEYMPNKSLDVF------LFDSTRSVQLDWKRRISIIKGIARGILYLHE-DSRLKIIHRDLKTSNVL  439 (624)
Q Consensus       367 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlkp~NIl  439 (624)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||++||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 225679999999999999999999998 74   999999999999


Q ss_pred             EcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCC-CCCh-hhHHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 006952          440 LDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSV-KSDVFSFGVVLLEIISGKKSTGFYHSEHG  517 (624)
Q Consensus       440 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDv~S~Gvil~elltg~~p~~~~~~~~~  517 (624)
                      ++.++.+||+|||++......    ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            999999999999999876433    23345789999999999887 6666 999999999999999999997532211  


Q ss_pred             CCHHHHHHHHHhcCCccccc------cchhh---cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          518 PSLLAYIWKLWCEGHAAELM------DSVVK---QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~------d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         .... .....+......      .+...   ..........+.+++.+||+.||++|||+.|+++
T Consensus       259 ---~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 ---VELF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ---HHHH-HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHH-HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               1111 122222111100      00000   0000122345788999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=321.89  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=191.9

Q ss_pred             hcCccccCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEE-----------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCL-----------  371 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-----------  371 (624)
                      .++|...+.||+|+||.||++.... ++.||||++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3678999999999999999999764 8899999998777677788999999999999999999999874           


Q ss_pred             ---ecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeE
Q 006952          372 ---EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-HEMNPK  447 (624)
Q Consensus       372 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k  447 (624)
                         +....++||||++ ++|.+++..    ..+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3356789999998 699988842    45889999999999999999999985   99999999999997 567899


Q ss_pred             EeccccccccCCCCC-CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          448 ISDFGMARIFGGNQS-KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      |+|||+++....... ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....      ......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~  235 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH------ELEQMQ  235 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC------HHHHHH
Confidence            999999987643221 122334567999999998865 678999999999999999999999975321      111111


Q ss_pred             HHHhcCC-------------ccccccchhh-cCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          526 KLWCEGH-------------AAELMDSVVK-QSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       526 ~~~~~~~-------------~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .......             ....+..... ...+     ......+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            1111100             0000000000 0000     012345788999999999999999999976

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.5e-38  Score=324.39  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=195.2

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--------cccHHHHHHHHHHHHhcCCCCcceEEeEEEec
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--------GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE  373 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  373 (624)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3468999999999999999999975 57899999986532        12335688999999999999999999998765


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEec
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISD  450 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  450 (624)
                      + .++||||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999998843   456899999999999999999999985   999999999999987664   99999


Q ss_pred             cccccccCCCCCCccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          451 FGMARIFGGNQSKANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       451 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ||+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|+.||.....  ...+...+.  
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~--  233 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QVSLKDQIT--  233 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC--SSCHHHHHH--
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--HHHHHHHHH--
Confidence            99998764321   123456899999999974   56789999999999999999999999753222  122222221  


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        .+....  .+......    ...+.+++.+||+.||++|||+.++++
T Consensus       234 --~~~~~~--~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 --SGKYNF--IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --HTCCCC--CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --hCcccc--Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              111110  01111111    235778999999999999999999974

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-38  Score=360.88  Aligned_cols=249  Identities=24%  Similarity=0.277  Sum_probs=203.2

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcce
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  377 (624)
                      ..++|+..+.||+|+||.||+++.+ +++.||||++++.   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467999999999999999999976 4788999998753   234457788999999988 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      |||||+++|+|..++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999642   45899999999999999999999985   999999999999999999999999999864


Q ss_pred             CCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..      .+..+....... ... .  
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~------~~~~~~~~~i~~-~~~-~--  560 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG------EDEDELFQSIME-HNV-A--  560 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHS-SCC-C--
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC------CCHHHHHHHHHh-CCC-C--
Confidence            3222  224457899999999999999999999999999999999999999742      122222222222 111 1  


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCH-----HHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTM-----SSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~  576 (624)
                             ++......+.+|+.+||+.||++||++     +||++
T Consensus       561 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                   111123357788999999999999997     77754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.4e-38  Score=330.89  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=182.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec------C
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE------N  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  374 (624)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999964 68899999987542  33456788999999999999999999998754      5


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++|+|++ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999998 7899888743    46899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ..+.+..+.+...... 
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~l~~i~~~~g~p~-  250 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPG-  250 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCC-
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCC-
Confidence            865322     234578999999999887 678999999999999999999999974221   1122222222211110 


Q ss_pred             cccccc--------hhh-----cCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 AELMDS--------VVK-----QSCDQ-----AELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ~~~~d~--------~l~-----~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .+.+..        .+.     ...+.     .....+.+|+.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000000        000     00000     112357789999999999999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.7e-38  Score=346.54  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=198.7

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-------------ccHHHHHHHHHHHHhcCCCCcceEEe
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-------------QGLQEFKNEVTVIAKLQHKNLVRLLG  368 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~~  368 (624)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999976 478999999875421             34577899999999999999999999


Q ss_pred             EEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC---C
Q 006952          369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM---N  445 (624)
Q Consensus       369 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~  445 (624)
                      ++.+....++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999988854   345899999999999999999999985   99999999999998776   6


Q ss_pred             eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          446 PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       446 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      +||+|||++.......   ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||...      .......
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ------NDQDIIK  257 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHH
Confidence            9999999998765432   223457999999999987 46899999999999999999999997521      1222222


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .. ..+.......  .....    ...+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~i-~~~~~~~~~~--~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KV-EKGKYYFDFN--DWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HH-HHCCCCCCHH--HHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH-HcCCCCCCcc--ccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            22 2221110000  00111    235778999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-37  Score=318.11  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=201.5

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---------cccHHHHHHHHHHHHhcC-CCCcceEEeEEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---------GQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCL  371 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~  371 (624)
                      ..++|...+.||+|+||.||++..+ +++.||||++....         ....+.+.+|+.++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999976 58899999986543         122456789999999995 999999999999


Q ss_pred             ecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          372 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       372 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                      ..+..++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999854   346899999999999999999999985   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhc------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAM------GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      |++.......   ......|++.|+|||++.      ...++.++||||||+++|||++|+.||...      .......
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~  239 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLR  239 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc------cHHHHHH
Confidence            9998764332   223456899999999985      456889999999999999999999997421      1122222


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      . ...+..... .+.. .    .....+.+++.+||+.||++|||+.|+++
T Consensus       240 ~-~~~~~~~~~-~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 M-IMSGNYQFG-SPEW-D----DYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H-HHHTCCCCC-TTTG-G----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-HhcCCcccC-cccc-c----ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            2 112211110 1100 1    12235788999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-38  Score=333.41  Aligned_cols=262  Identities=21%  Similarity=0.275  Sum_probs=193.2

Q ss_pred             HHHhcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC-----
Q 006952          301 VKATQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN-----  374 (624)
Q Consensus       301 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  374 (624)
                      ....++|...+.||+|+||.||+++. .+|+.||||++......    ..+|+.+++.++||||+++++++....     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999996 46899999998754332    247999999999999999999985432     


Q ss_pred             ---------------------------------cceEEEEeccCCChhhhhhcC-CCCcccCHHHHHHHHHHHHHHHHHH
Q 006952          375 ---------------------------------ESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIIKGIARGILYL  420 (624)
Q Consensus       375 ---------------------------------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yL  420 (624)
                                                       ..++||||++ ++|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                             3789999998 4777766431 2345689999999999999999999


Q ss_pred             HhcCCCCeEecCCCCCcEEEc-CCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHH
Q 006952          421 HEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVV  498 (624)
Q Consensus       421 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvi  498 (624)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||.+.+. .++.++||||+|++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9985   99999999999998 688999999999987643322   2245689999999998775 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc---------------ccccchhhcCCCHHHHHHHHHHHhhcccC
Q 006952          499 LLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA---------------ELMDSVVKQSCDQAELLKYIHIGLLCVQG  563 (624)
Q Consensus       499 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~  563 (624)
                      +|||++|+.||...   ...+.+..+.+........               ...........+......+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~---~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGE---TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999997521   1111222221111111100               00000001111112234578899999999


Q ss_pred             CCCCCCCHHHHHH
Q 006952          564 DPIDRPTMSSVAV  576 (624)
Q Consensus       564 dP~~RPs~~ev~~  576 (624)
                      ||++|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.2e-38  Score=329.53  Aligned_cols=269  Identities=22%  Similarity=0.238  Sum_probs=189.4

Q ss_pred             HHHHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-
Q 006952          298 IDIVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-  375 (624)
Q Consensus       298 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-  375 (624)
                      .......++|.+.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345667789999999999999999999975 588999999865433 23456788889999999999999999977544 


Q ss_pred             ------ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEEcC-CCCe
Q 006952          376 ------SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH--EDSRLKIIHRDLKTSNVLLDH-EMNP  446 (624)
Q Consensus       376 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~  446 (624)
                            .++||||++++.+..+.........+++..+..++.||+.||.|||  +.   +|+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence                  7899999987543333222234556899999999999999999999  66   4999999999999997 8999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++.......   .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||....   .......+.
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~~~  245 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN---SAGQLHEIV  245 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC---hHHHHHHHH
Confidence            9999999987653322   22456899999999987654 8999999999999999999999975321   111222221


Q ss_pred             HHHhcCCc------------ccccc------chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          526 KLWCEGHA------------AELMD------SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       526 ~~~~~~~~------------~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +.......            ....+      ..............+.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111000            00000      00000111123456889999999999999999999976

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-37  Score=327.72  Aligned_cols=256  Identities=24%  Similarity=0.291  Sum_probs=190.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  374 (624)
                      .++|...+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999965 58899999987542  334567889999999999999999999998765      


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            57999999975 6777763     24889999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC--
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH--  532 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  532 (624)
                      +......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ...........-.  
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD------HIDQWNKVIEQLGTP  245 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHC-CCCC
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCC
Confidence            8654321   2234578999999999999999999999999999999999999975321      1111111111000  


Q ss_pred             cc--------------------------ccccchhhcCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          533 AA--------------------------ELMDSVVKQSC---DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       533 ~~--------------------------~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ..                          ...........   .......+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00                          00000000000   11224568899999999999999999999873

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.9e-38  Score=337.61  Aligned_cols=196  Identities=21%  Similarity=0.323  Sum_probs=169.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhc------CCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL------QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~~~  376 (624)
                      ..+|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 4889999998753 23346678899988887      577999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC--eEEeccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN--PKISDFGMA  454 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a  454 (624)
                      ++||||+. ++|.+++... ....+++..++.|+.||++||.|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6888888653 2345899999999999999999999985   999999999999999987  999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      +.....     .....||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            764322     224578999999999999999999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-37  Score=327.91  Aligned_cols=262  Identities=22%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----Ccc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~  376 (624)
                      .++|...+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999965 578899999975433 3457789999999999999999999999765     357


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 488888843    35899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          457 FGGNQSK-ANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       457 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...   ........+..........
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---HYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS---SGGGHHHHHHHHHCSCCHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC---ChHHHHHHHHHHhCCCCHH
Confidence            6433221 12234679999999998754 45899999999999999999999997432   2222333332222111110


Q ss_pred             cc---cc--------chh-hcCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 EL---MD--------SVV-KQSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 ~~---~d--------~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .+   .+        ... ....+     ......+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00   00        000 00000     111235788999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.6e-38  Score=334.53  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=181.9

Q ss_pred             cCccc-cCccccCCceeEEEEEec---CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcceE
Q 006952          305 QDFSQ-ENKLGEGGFGPVYKGVLA---DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENESLL  378 (624)
Q Consensus       305 ~~~~~-~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l  378 (624)
                      +.|.. .++||+|+||.||+|+.+   +++.||||++.....  .+.+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 458999999999999965   478899999975433  3568899999999999999999999965  566899


Q ss_pred             EEEeccCCChhhhhhcC------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----cCCCCeEE
Q 006952          379 IYEYMPNKSLDVFLFDS------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL----DHEMNPKI  448 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl  448 (624)
                      ||||+.+ +|.+++...      .....+++..++.|+.||+.||.|||+.+   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 676666421      12235899999999999999999999986   9999999999999    77789999


Q ss_pred             eccccccccCCCCC-CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC------CCCH
Q 006952          449 SDFGMARIFGGNQS-KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH------GPSL  520 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~------~~~~  520 (624)
                      +|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......      ....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987653321 1233456799999999999874 58999999999999999999999985332210      0112


Q ss_pred             HHHHHHHHhcCCcc---cccc------------chhhcCCCHH---------HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          521 LAYIWKLWCEGHAA---ELMD------------SVVKQSCDQA---------ELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       521 ~~~~~~~~~~~~~~---~~~d------------~~l~~~~~~~---------~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +..+..........   .+..            ..........         ....+.+|+.+||+.||++|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            22222222111110   0000            0000000000         0235778999999999999999999987


Q ss_pred             H
Q 006952          577 M  577 (624)
Q Consensus       577 ~  577 (624)
                      .
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-37  Score=323.05  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----Ccc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~  376 (624)
                      .++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999976 588999999975433 3456788999999999999999999998764     568


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++||||+. ++|.+++..    ..+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 588888854    35899999999999999999999985   99999999999999999999999999987


Q ss_pred             cCCCCCCc--------cccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          457 FGGNQSKA--------NTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       457 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ........        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   .......+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD---YRHQLLLIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHH
Confidence            65322111        1223578999999998765 678999999999999999999999975321   11111112111


Q ss_pred             HhcCCccccc----cc----hhh-----cCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAAELM----DS----VVK-----QSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~~~~----d~----~l~-----~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..........    ..    .+.     ....     ......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111100000    00    000     0000     112345778999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-37  Score=322.51  Aligned_cols=258  Identities=21%  Similarity=0.311  Sum_probs=201.0

Q ss_pred             hcCccccCccccCCceeEEEEEe-c-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC------cceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-A-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN------LVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~  375 (624)
                      .++|++.+.||+|+||.||++.. . +++.||||++... ....+.+.+|+.+++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36899999999999999999986 3 5889999998753 234567889999999997664      9999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-------------
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-------------  442 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------------  442 (624)
                      .++||||+ +++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999988653 3346889999999999999999999985   999999999999987             


Q ss_pred             ------CCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006952          443 ------EMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH  516 (624)
Q Consensus       443 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~  516 (624)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....  
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  239 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS--  239 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH--
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--
Confidence                  668999999999864322     2245789999999999999999999999999999999999999753221  


Q ss_pred             CCCHHHHHHHHHhcCCccccc------------------------------cchh-hcCCCHHHHHHHHHHHhhcccCCC
Q 006952          517 GPSLLAYIWKLWCEGHAAELM------------------------------DSVV-KQSCDQAELLKYIHIGLLCVQGDP  565 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~------------------------------d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP  565 (624)
                       ......+...... ....+.                              .+.. ...........+.+++.+||+.||
T Consensus       240 -~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          240 -KEHLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             -HHHHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             -HHHHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence             1112222111110 000000                              0000 001123445678899999999999


Q ss_pred             CCCCCHHHHHH
Q 006952          566 IDRPTMSSVAV  576 (624)
Q Consensus       566 ~~RPs~~ev~~  576 (624)
                      ++|||+.||++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-37  Score=322.70  Aligned_cols=264  Identities=24%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             HHhcCccccCccccCCceeEEEEEe--cCCcEEEEEEccccC--cccHHHHHHHHHHHHhc---CCCCcceEEeEEE---
Q 006952          302 KATQDFSQENKLGEGGFGPVYKGVL--ADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL---QHKNLVRLLGCCL---  371 (624)
Q Consensus       302 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~---  371 (624)
                      ...++|...+.||+|+||.||++..  .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999997  357889999986533  22234566788777776   8999999999987   


Q ss_pred             --ecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          372 --EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       372 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                        .....++||||++ ++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4556899999998 6999988653 2345899999999999999999999985   9999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      |||+++.....   .......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ........+.....
T Consensus       163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~  236 (326)
T 1blx_A          163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIG  236 (326)
T ss_dssp             SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHC
T ss_pred             cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHHcC
Confidence            99999765322   1233467899999999999999999999999999999999999997522   11112222222111


Q ss_pred             cCCcccccc------chh-------hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHAAELMD------SVV-------KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~~~~~d------~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .........      ...       ...........+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111000000      000       00011112345778999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.4e-37  Score=313.59  Aligned_cols=251  Identities=26%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ..++|.+.+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3578999999999999999999976 68899999986543  34567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEeccccccc
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGMARI  456 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~  456 (624)
                      +||+++++|.+++..   ...+++..++.++.||++||.|||+.+   |+|+||||+||+++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999888854   235899999999999999999999985   9999999999999764   4699999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ......   .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...      ....... ....+.....
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~-~~~~~~~~~~  242 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK------NEYDILK-RVETGKYAFD  242 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH-HHHHCCCCCC
T ss_pred             ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC------CHHHHHH-HHHcCCCCCC
Confidence            643321   223468999999998875 4899999999999999999999997421      1222222 2222221111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...  ....    ...+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~--~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 LPQ--WRTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             SGG--GTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chh--hhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            110  0112    235778999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.4e-37  Score=315.19  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=191.4

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe---------
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE---------  372 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~---------  372 (624)
                      ..++|+..+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3568999999999999999999975 6899999998643 3345778999999999999999999999865         


Q ss_pred             ----cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEE
Q 006952          373 ----ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKI  448 (624)
Q Consensus       373 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl  448 (624)
                          ....++||||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                3457899999999999999964  2345788999999999999999999985   999999999999999999999


Q ss_pred             eccccccccCCCCC------------CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCC
Q 006952          449 SDFGMARIFGGNQS------------KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSE  515 (624)
Q Consensus       449 ~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~  515 (624)
                      +|||++........            ........||+.|+|||++.+. .++.++||||||+++|||++   |+..  . 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~-  231 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--G-  231 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--H-
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--c-
Confidence            99999986543210            1122345689999999999864 68999999999999999998   3321  0 


Q ss_pred             CCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          516 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ......... ...... . ..    ...+......+.+++.+||+.||.+|||+.++++
T Consensus       232 --~~~~~~~~~-~~~~~~-~-~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 --MERVNILKK-LRSVSI-E-FP----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHHHHH-HHSTTC-C-CC----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --hhHHHHHHh-cccccc-c-cC----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              011111111 111111 1 11    1122233345778999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-37  Score=350.40  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=199.8

Q ss_pred             hcCccccCccccCCceeEEEEEecC----CcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .++|...+.||+|+||.||+|++..    +..||||++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            4668888999999999999999743    4579999987643 334578999999999999999999999984 466899


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+++|+|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       468 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999642  345899999999999999999999985   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...      .......... .+..... 
T Consensus       543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~------~~~~~~~~i~-~~~~~~~-  613 (656)
T 2j0j_A          543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------KNNDVIGRIE-NGERLPM-  613 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHH-HTCCCCC-
T ss_pred             CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHH-cCCCCCC-
Confidence            3322 12223456789999999999999999999999999999997 88887421      1122222221 2211111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                              +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       614 --------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          614 --------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                    11123457789999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-37  Score=326.02  Aligned_cols=256  Identities=21%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc----
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES----  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~----  376 (624)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999965 58899999997643  23457788999999999999999999999887655    


Q ss_pred             --eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          377 --LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       377 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                        ++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 57877762     23899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   .......+.+..... .
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~-~  262 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVP-G  262 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC-C
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC-c
Confidence            865322     234578999999999987 678999999999999999999999975211   111111111111000 0


Q ss_pred             cccccc--------hh----hc-CC-----CHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          534 AELMDS--------VV----KQ-SC-----DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       534 ~~~~d~--------~l----~~-~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .+....        ..    .. ..     .......+.+++.+||+.||++|||+.|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000000        00    00 00     01113457889999999999999999999763

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.2e-37  Score=325.57  Aligned_cols=262  Identities=19%  Similarity=0.275  Sum_probs=199.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-----------CCCcceEEeEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-----------HKNLVRLLGCCL  371 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~  371 (624)
                      .++|...+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            367999999999999999999964 6889999998743 234567889999999886           899999999998


Q ss_pred             ecC----cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEc-----
Q 006952          372 EEN----ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-SRLKIIHRDLKTSNVLLD-----  441 (624)
Q Consensus       372 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NIll~-----  441 (624)
                      ..+    ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            754    678999999 899999886532 34589999999999999999999997 5   99999999999994     


Q ss_pred             -CCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006952          442 -HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL  520 (624)
Q Consensus       442 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~  520 (624)
                       .++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4447999999999866432     2235789999999999999999999999999999999999999864332221111


Q ss_pred             HHHHHHHHh-cCCccc--------------------cc--------cchh--hcCCCHHHHHHHHHHHhhcccCCCCCCC
Q 006952          521 LAYIWKLWC-EGHAAE--------------------LM--------DSVV--KQSCDQAELLKYIHIGLLCVQGDPIDRP  569 (624)
Q Consensus       521 ~~~~~~~~~-~~~~~~--------------------~~--------d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  569 (624)
                      ......... .+....                    .+        ...+  ....+......+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            111111110 000000                    00        0000  1124456677899999999999999999


Q ss_pred             CHHHHHH
Q 006952          570 TMSSVAV  576 (624)
Q Consensus       570 s~~ev~~  576 (624)
                      |+.||++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-37  Score=323.27  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=176.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHH-HHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVT-VIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .++|...+.||+|+||.||++... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367889999999999999999975 688999999976532 33445666666 677789999999999999999999999


Q ss_pred             EeccCCChhhhhhc--CCCCcccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          381 EYMPNKSLDVFLFD--STRSVQLDWKRRISIIKGIARGILYLHED-SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       381 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 77766642  11245689999999999999999999997 6   999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccCccChhhh----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYA----MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||......     ...... ...+..
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~  247 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQ-VVKGDP  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHH-HhcCCC
Confidence            4322   12234689999999998    4567899999999999999999999997532211     000000 001111


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..+.     ..........+.+++.+||+.||++|||+.+|++
T Consensus       248 ~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 PQLS-----NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCC-----CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC-----CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111     1001112335788999999999999999999965

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.9e-37  Score=324.06  Aligned_cols=199  Identities=24%  Similarity=0.369  Sum_probs=169.4

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CC-----CcceEEeEEEecCc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HK-----NLVRLLGCCLEENE  375 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~~~~  375 (624)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+..|+.+++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999976 5788999998743 233567788999998885 55     49999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCCeEEecccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNPKISDFGM  453 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~  453 (624)
                      .++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+ ..+|+||||||+||||+  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 59998886532 24589999999999999999999953 13599999999999994  577899999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      ++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9876432     224578999999999999999999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=318.98  Aligned_cols=255  Identities=21%  Similarity=0.298  Sum_probs=193.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  375 (624)
                      .++|...+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367889999999999999999975 58899999987643  2335678899999999999999999999987654     


Q ss_pred             -ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          376 -SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       376 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58877763     24899999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   ..+.+..+.+.......
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC---HHHHHHHHHHHHCBCCH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCH
Confidence            764322     224578999999999887 678999999999999999999999974211   11111111111100000


Q ss_pred             ------------------cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 ------------------AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                        .......+. .........+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                              000000000 011122346788999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.4e-37  Score=320.18  Aligned_cols=257  Identities=20%  Similarity=0.219  Sum_probs=172.8

Q ss_pred             HhcCccccC-ccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe----cCcc
Q 006952          303 ATQDFSQEN-KLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE----ENES  376 (624)
Q Consensus       303 ~~~~~~~~~-~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~  376 (624)
                      ..++|.+.+ .||+|+||.||+++.. +++.||||++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            357888854 6999999999999976 58999999986532    122223334566799999999999976    3447


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC---CCeEEecccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE---MNPKISDFGM  453 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~  453 (624)
                      ++||||+++++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||++.+   +.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999653 2346999999999999999999999985   9999999999999864   4599999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      ++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   .............
T Consensus       178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  250 (336)
T 3fhr_A          178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQY  250 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcccc
Confidence            98654322    2345689999999999988999999999999999999999999753222111   0000000000000


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--Hhcc
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLAS  580 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~  580 (624)
                       ....+ .    .......+.+++.+||+.||++|||+.|+++  ++..
T Consensus       251 -~~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 -GFPNP-E----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -CCCTT-T----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -ccCch-h----hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence             00000 0    0112235778999999999999999999998  4443

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=320.24  Aligned_cols=244  Identities=21%  Similarity=0.355  Sum_probs=189.2

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc------cHHHHHHHHHHHHhc----CCCCcceEEe
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ------GLQEFKNEVTVIAKL----QHKNLVRLLG  368 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~h~niv~l~~  368 (624)
                      .....++|...+.||+|+||.||+++.. +++.||||++......      ....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999864 6889999999765321      233456799999998    8999999999


Q ss_pred             EEEecCcceEEEEe-ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCe
Q 006952          369 CCLEENESLLIYEY-MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-HEMNP  446 (624)
Q Consensus       369 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~  446 (624)
                      ++...+..++|+|| +.+++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 789999999854   335899999999999999999999985   99999999999999 88999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||++.......    .....|++.|+|||++.+..+ +.++||||||+++|||++|+.||...        .... 
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~-  246 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------QEIL-  246 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHHH-
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--------HHHh-
Confidence            999999998764332    234568999999999887766 45999999999999999999997421        1110 


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                          .... .         .+......+.+++.+||+.||++|||+.|+++
T Consensus       247 ----~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 ----EAEL-H---------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HTCC-C---------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----hhcc-C---------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0100 0         11112235778999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.3e-37  Score=329.25  Aligned_cols=252  Identities=28%  Similarity=0.308  Sum_probs=184.7

Q ss_pred             CccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEecc
Q 006952          306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      .|...+.||+|+||+||.....+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            44556889999999998766668999999998653   235678999999987 89999999999999999999999996


Q ss_pred             CCChhhhhhcCCCCc----ccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-------------CCeE
Q 006952          385 NKSLDVFLFDSTRSV----QLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-------------MNPK  447 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k  447 (624)
                       |+|.+++.......    ..++..++.++.||+.||.|||+.+   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996533211    1133456789999999999999985   9999999999999754             4799


Q ss_pred             EeccccccccCCCCCCc--cccccccccCccChhhhcC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 006952          448 ISDFGMARIFGGNQSKA--NTNRVVGTYGYMAPEYAMG-------GIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHG  517 (624)
Q Consensus       448 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~  517 (624)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||....    
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~----  244 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY----  244 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT----
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch----
Confidence            99999998775433221  2234679999999999976       668999999999999999999 899974211    


Q ss_pred             CCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .....+   ..........    ...........+.+++.+||+.||++|||+.||++
T Consensus       245 -~~~~~i---~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 -SRESNI---IRGIFSLDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -THHHHH---HHTCCCCCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -hhHHHH---hcCCCCcccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             111111   1111100000    11123345567889999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=312.42  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=178.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc--cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ--GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .++|...+.||+|+||.||++... +|+.||||++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888999999999999999975 6899999999765332  2234445556788889999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+ ++.+..+...  ....+++..++.++.||++||.|||+. +   |+|+||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4555544432  234689999999999999999999985 5   99999999999999999999999999976543


Q ss_pred             CCCCccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ..   ......||+.|+|||++.     ...++.++||||||+++|||++|+.||...     .............. ..
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~-~~  248 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-----KTDFEVLTKVLQEE-PP  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-----CSHHHHHHHHHHSC-CC
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-----CccHHHHHHHhccC-CC
Confidence            22   122456899999999984     566889999999999999999999997521     11222222222221 11


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .....   ...    ...+.+++.+||+.||.+|||+.+|++
T Consensus       249 ~~~~~---~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LLPGH---MGF----SGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCSS---SCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCcc---CCC----CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11110   112    234778899999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2e-37  Score=320.50  Aligned_cols=241  Identities=23%  Similarity=0.369  Sum_probs=196.2

Q ss_pred             HhcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc------cHHHHHHHHHHHHhcC--CCCcceEEeEEEec
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ------GLQEFKNEVTVIAKLQ--HKNLVRLLGCCLEE  373 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~  373 (624)
                      ..++|...+.||+|+||.||+|+.. +++.||||++......      ..+.+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3467999999999999999999864 6889999998754321      2345678999999996  59999999999999


Q ss_pred             CcceEEEEeccC-CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEecc
Q 006952          374 NESLLIYEYMPN-KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDF  451 (624)
Q Consensus       374 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Df  451 (624)
                      +..++|+|++.+ ++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 899998854   346899999999999999999999985   99999999999999 7789999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE  530 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  530 (624)
                      |+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...        ...    .. 
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--------~~~----~~-  257 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------EEI----IR-  257 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------HHH----HH-
T ss_pred             cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh--------hhh----hc-
Confidence            9998764322    224568999999999987765 78899999999999999999997421        011    11 


Q ss_pred             CCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       531 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +..      ......+    ..+.+++.+||+.||++|||+.||++
T Consensus       258 ~~~------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQV------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCC------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccc------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110      0111222    35778999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.9e-36  Score=315.67  Aligned_cols=258  Identities=21%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CC-cEEEEEEccccCcccHHHHHHHHHHHHhcCCCC------cceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DG-KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN------LVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~  375 (624)
                      .++|.+.+.||+|+||.||++... ++ +.||+|++... ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999975 34 68999998753 234567889999999998766      8999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---------------
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL---------------  440 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll---------------  440 (624)
                      .++||||+ +++|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 55666666442 2346899999999999999999999985   9999999999999               


Q ss_pred             ----cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006952          441 ----DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH  516 (624)
Q Consensus       441 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~  516 (624)
                          +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---  243 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE---  243 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC---
Confidence                66789999999999864322     224578999999999999999999999999999999999999975321   


Q ss_pred             CCCHHHHHHHHHhcCCcccccc------------------------------ch-hhcCCCHHHHHHHHHHHhhcccCCC
Q 006952          517 GPSLLAYIWKLWCEGHAAELMD------------------------------SV-VKQSCDQAELLKYIHIGLLCVQGDP  565 (624)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~d------------------------------~~-l~~~~~~~~~~~l~~l~~~Cl~~dP  565 (624)
                      .......+.+.... ....+..                              +. ............+.+|+.+||+.||
T Consensus       244 ~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          244 NREHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             HHHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HHHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            11122222221110 0000000                              00 0001122345578899999999999


Q ss_pred             CCCCCHHHHHH
Q 006952          566 IDRPTMSSVAV  576 (624)
Q Consensus       566 ~~RPs~~ev~~  576 (624)
                      ++|||+.|+++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=325.96  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=184.6

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..+|...+.||+|+||+||.....+++.||||++......   .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3568889999999999966555567999999998754332   356899999999 799999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCCeEEecccccccc
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-----EMNPKISDFGMARIF  457 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~  457 (624)
                      +. |+|.+++....  ..+.+..++.++.||++||.|||+.+   |+||||||+||||+.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 59999886532  23444556789999999999999985   999999999999953     336889999999876


Q ss_pred             CCCCC-CccccccccccCccChhhhc---CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          458 GGNQS-KANTNRVVGTYGYMAPEYAM---GGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       458 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||....    .   ....... ...
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~----~---~~~~~~~-~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----Q---RQANILL-GAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT----T---HHHHHHT-TCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh----H---HHHHHHh-ccC
Confidence            53321 12334567999999999997   4567889999999999999999 888874211    1   1111111 111


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ......+      .......+.+++.+||+.||++|||+.||++
T Consensus       246 ~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111111      1223345678999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-37  Score=342.01  Aligned_cols=259  Identities=25%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEe------cCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE------ENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~  375 (624)
                      .++|.+.+.||+|+||.||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            378999999999999999999974 5889999998764 33446778999999999999999999999765      567


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC---eEEeccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN---PKISDFG  452 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  452 (624)
                      .++||||+++++|.+++........+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555556899999999999999999999985   999999999999997765   8999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh---
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC---  529 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  529 (624)
                      ++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....     ....+......   
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccc
Confidence            998764332   2234678999999999999999999999999999999999999974211     00110000000   


Q ss_pred             -----cCCcccc--ccch--hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 006952          530 -----EGHAAEL--MDSV--VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSS  573 (624)
Q Consensus       530 -----~~~~~~~--~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  573 (624)
                           .......  ....  ............+.+++.+||+.||++|||+.|
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence                 0000000  0000  011233345567889999999999999999965

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-36  Score=342.30  Aligned_cols=236  Identities=21%  Similarity=0.318  Sum_probs=189.6

Q ss_pred             cCccccCccccCCceeEEEEEec--CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc-----c
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA--DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE-----S  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----~  376 (624)
                      ++|.+.+.||+|+||.||++++.  +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999975  58899999987543 3445678999999999999999999999988766     6


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      +|||||+++++|.+++..     .+++.+++.|+.||++||.|||+++   |+||||||+|||++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999887632     6899999999999999999999985   9999999999999986 899999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ....      ....||+.|+|||++.++. +.++||||||+++|||++|.+|+.......                ... 
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~~-  286 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LPE-  286 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CCT-
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------ccc-
Confidence            6432      3457999999999987764 899999999999999999988854211000                000 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHHhc
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-MSSVAVMLA  579 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~~L~  579 (624)
                      ..+      .......+.+++.+||+.||++||+ ++++...|.
T Consensus       287 ~~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          287 DDP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             TCH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ccc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            000      0112245778999999999999995 555655553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.2e-35  Score=298.09  Aligned_cols=228  Identities=13%  Similarity=0.099  Sum_probs=179.5

Q ss_pred             cCccccCccccCCceeEEEEEecC-CcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|.+.+.||+|+||.||+|+... ++.||||++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            679999999999999999999764 88999999976533   33578899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++++|.+++..   .  ....++..|+.||++||.|||+++   |+||||||+|||++.++.+||++++        
T Consensus       111 e~~~g~~L~~~l~~---~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT---C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc---C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999843   1  345578889999999999999985   9999999999999999999997443        


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc-c
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD-S  539 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~  539 (624)
                                    |++|       ++.++||||||+++|||++|+.||............       .......... .
T Consensus       175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~  226 (286)
T 3uqc_A          175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPA  226 (286)
T ss_dssp             --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCCHH
T ss_pred             --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCChh
Confidence                          3333       689999999999999999999998643222110000       0000000000 0


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      .+....    ...+.+++.+||+.||++| |+.|+++.|+..
T Consensus       227 ~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          227 DIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             HHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             hcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            111122    2347889999999999999 999999999763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5e-34  Score=292.03  Aligned_cols=227  Identities=21%  Similarity=0.263  Sum_probs=176.3

Q ss_pred             hcCcccc-CccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHH-HhcCCCCcceEEeEEEe----cCcc
Q 006952          304 TQDFSQE-NKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVI-AKLQHKNLVRLLGCCLE----ENES  376 (624)
Q Consensus       304 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~~  376 (624)
                      .++|... +.||+|+||.||++... +++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4567776 77999999999999974 6889999998642     4677899988 55599999999999987    6678


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEecccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGM  453 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  453 (624)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999653 2346899999999999999999999985   999999999999998   78899999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      +....                        +..++.++||||||+++|||++|+.||........           .....
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHH
Confidence            86432                        23468899999999999999999999753221110           00000


Q ss_pred             cccccchhhcCCCH----HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AELMDSVVKQSCDQ----AELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..+....  ...+.    .....+.+++.+||+.||++|||+.|+++
T Consensus       212 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000000  00111    11345788999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-35  Score=313.84  Aligned_cols=239  Identities=15%  Similarity=0.148  Sum_probs=177.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHHHHHHHHHhcCC-CCcc---------eEE--
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQH-KNLV---------RLL--  367 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h-~niv---------~l~--  367 (624)
                      +.+|...+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+++.++| +|..         ..+  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            456788899999999999999954 68999999987433   2346889999999999987 3221         111  


Q ss_pred             ----------eEEEe-----cCcceEEEEeccCCChhhhhhc----CCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006952          368 ----------GCCLE-----ENESLLIYEYMPNKSLDVFLFD----STRSVQLDWKRRISIIKGIARGILYLHEDSRLKI  428 (624)
Q Consensus       368 ----------~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i  428 (624)
                                .++..     ....+++|++ .+++|.+++..    ......+++..++.|+.||++||.|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     1224555655 46899888741    223456889999999999999999999985   9


Q ss_pred             EecCCCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhh----------cCCCCChhhHHHHHHHH
Q 006952          429 IHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA----------MGGIFSVKSDVFSFGVV  498 (624)
Q Consensus       429 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDv~S~Gvi  498 (624)
                      +||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998865322     334567 999999999          55668899999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh--cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 006952          499 LLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK--QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA  575 (624)
Q Consensus       499 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  575 (624)
                      +|||++|+.||.......                   ..+..+.  ...+    ..+.+|+.+||+.||++|||+.+++
T Consensus       307 l~elltg~~Pf~~~~~~~-------------------~~~~~~~~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALG-------------------GSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGS-------------------CSGGGGSSCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhh-------------------hHHHHHhhcccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999975322111                   1111111  1222    4578889999999999999976653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.2e-35  Score=306.04  Aligned_cols=241  Identities=16%  Similarity=0.153  Sum_probs=182.7

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccC--------cccHHHHHHHHHHHHhcC---------CCCcceE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--------GQGLQEFKNEVTVIAKLQ---------HKNLVRL  366 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------h~niv~l  366 (624)
                      .++|...+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 68999999987542        234578899999999986         7777777


Q ss_pred             EeEEE-----------------e-------------cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHH
Q 006952          367 LGCCL-----------------E-------------ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARG  416 (624)
Q Consensus       367 ~~~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~  416 (624)
                      .+.+.                 +             .+..++||||+++|++.+.+..    ..+++..++.|+.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            77643                 1             5778999999999976666632    458999999999999999


Q ss_pred             HHHHH-hcCCCCeEecCCCCCcEEEcCCC--------------------CeEEeccccccccCCCCCCccccccccccCc
Q 006952          417 ILYLH-EDSRLKIIHRDLKTSNVLLDHEM--------------------NPKISDFGMARIFGGNQSKANTNRVVGTYGY  475 (624)
Q Consensus       417 L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  475 (624)
                      |.||| +.+   |+||||||+||||+.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 875   99999999999999887                    8999999999876432       35799999


Q ss_pred             cChhhhcCCCCChhhHHHHHHHH-HHHHHhCCCCCCCCCCCCCCCHHHHH-HHHHhcCCccccccchhhcCCCHHHHHHH
Q 006952          476 MAPEYAMGGIFSVKSDVFSFGVV-LLEIISGKKSTGFYHSEHGPSLLAYI-WKLWCEGHAAELMDSVVKQSCDQAELLKY  553 (624)
Q Consensus       476 ~aPE~~~~~~~~~ksDv~S~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  553 (624)
                      +|||++.+.. +.++||||+|.+ .+++++|..|+..      ....... ...............    .........+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFKTKCNT----PAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCSSCCCS----HHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccCcccch----hhhhhcCHHH
Confidence            9999998766 999999998776 7778889888520      0000001 111111111111111    0112345678


Q ss_pred             HHHHhhcccCCCCCCCCHHHHH
Q 006952          554 IHIGLLCVQGDPIDRPTMSSVA  575 (624)
Q Consensus       554 ~~l~~~Cl~~dP~~RPs~~ev~  575 (624)
                      .+++.+||+.|     |+.|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            89999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.6e-29  Score=278.60  Aligned_cols=184  Identities=16%  Similarity=0.138  Sum_probs=129.4

Q ss_pred             ccccCCceeEEEEEe-cCCcEEEEEEccccC----------cccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEE
Q 006952          312 KLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS----------GQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       312 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++.|+.|.+..++. --|+.+++|.+.+..          ....++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            455666666555442 248899999986542          23356799999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||++|++|.++|..   ...++..   .|+.||++||.|||+++   ||||||||+||||++++.+||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999954   3345554   58899999999999996   99999999999999999999999999987654


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCC
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK  507 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~  507 (624)
                      ...  .....+||+.|||||++.+ .+..++|+||+|+++++|.++..
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            322  2345789999999999875 46778999999999888766543

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.94  E-value=1.2e-26  Score=197.32  Aligned_cols=105  Identities=16%  Similarity=0.379  Sum_probs=95.0

Q ss_pred             CCccccCCCCCCCCCCCCChHHHHHHHHHHHhhhhcCCCCC-ceeeeccC-CCCeEEEEEecCCCCChhhhHHHHHHHHH
Q 006952           17 PADYQYKFCPRGTNNTASIIYVYNLSKLFNRKLHEDGGNSL-YRNASVGD-YPDKVYGLFLCRFDVSHQVCQNCIFDAID   94 (624)
Q Consensus        17 ~~~~~~~~C~~~~~~~~~s~f~~nl~~l~~~l~~~~~~~~~-~~~~~~g~-~~~~vyg~~~C~~d~~~~~C~~C~~~a~~   94 (624)
                      .+.++++.|++ ++|+++++|++||+.||+.|+++++.++. |+++..|. ++++|||++|||+|+++++|..||+.|+.
T Consensus         2 ~t~~v~~~Cn~-~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~   80 (108)
T 3a2e_A            2 NTAFVSSACNT-QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVN   80 (108)
T ss_dssp             CCCEEEEEECS-SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHT
T ss_pred             CcceeeeecCC-CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHH
Confidence            45678899964 69999999999999999999999876554 77776654 56999999999999999999999999999


Q ss_pred             HHHHhCCCCccEEEEcceeEEEEccccc
Q 006952           95 ILVESCNGTKEATIWYDICMVRYSNNFF  122 (624)
Q Consensus        95 ~~~~~C~~~~~~~~~~~~C~~ry~~~~f  122 (624)
                      ++.+.|+++++|+||++.|+||||+++|
T Consensus        81 ~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           81 RIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             THHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            9999999999999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.6e-26  Score=254.84  Aligned_cols=185  Identities=18%  Similarity=0.197  Sum_probs=146.1

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccCc--------ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG--------QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ...+.||+|+||.||++.. .++.+++|+......        ...+++.+|+.++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999955 578889997643221        1235589999999999999999777777788889999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++++|.+++..           +..++.||++||.|||+++   |+||||||+|||+++  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           4589999999999999985   999999999999999  999999999997654


Q ss_pred             CCCCc-----cccccccccCccChhhhcC--CCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          460 NQSKA-----NTNRVVGTYGYMAPEYAMG--GIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       460 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      .....     ......||+.|||||++..  ..|+..+|+||..+-.++.+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32111     1235689999999999987  56788899999999999988887664

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.89  E-value=7.9e-24  Score=179.90  Aligned_cols=103  Identities=25%  Similarity=0.353  Sum_probs=93.0

Q ss_pred             ceeeeCCCCCCChhHHHHHHHHHHHHHHHHhccCCccceeeeeeccCCCceeEEEecCCCCCccchhhhHhhhhcccccc
Q 006952          131 FLCVQNENYTKEPDKFTQILNQTFNDVIRNATSSDSKNAAQTVNISSFDTLQTTAHCIPDLSKSDCTVCLNSAVAQIPTC  210 (624)
Q Consensus       131 ~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~~~~~~~~~~~~vyglaQC~~dls~~~C~~CL~~~~~~~~~~  210 (624)
                      ....||.+++++.+.|+++++.||..|...++.++..|+++.....+.++||||+||+|||++++|..||+.++.+++++
T Consensus         6 v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~   85 (108)
T 3a2e_A            6 VSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSI   85 (108)
T ss_dssp             EEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHH
T ss_pred             eeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHH
Confidence            34567888888889999999999999999987766677777665556789999999999999999999999999999999


Q ss_pred             CCCCcccEEeccccceeeeeccc
Q 006952          211 SKGKRGARIFCPSCSIRYELYRF  233 (624)
Q Consensus       211 ~~~~~g~~v~~~~C~~ry~~~~f  233 (624)
                      |++++||+||+++|++|||.++|
T Consensus        86 C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           86 CNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             TTSBSSEEEEETTEEEEEESSCC
T ss_pred             CCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999987

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=3.7e-23  Score=209.17  Aligned_cols=150  Identities=19%  Similarity=0.139  Sum_probs=120.1

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCc------------------ccHHHHHHHHHHHHhcCCC
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG------------------QGLQEFKNEVTVIAKLQHK  361 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~  361 (624)
                      +......|...+.||+|+||.||+|...+|+.||||.++....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444556677799999999999999997799999999864321                  12456899999999999  


Q ss_pred             CcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       362 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.||++||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 66666543 356799999999999988 411         123469999999999999985   99999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCccccccccccCccChhhhc
Q 006952          442 HEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM  482 (624)
Q Consensus       442 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  482 (624)
                       ++.+||+|||+++.               +..++|||++.
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence             99999999999863               34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=6.8e-19  Score=175.55  Aligned_cols=136  Identities=17%  Similarity=0.195  Sum_probs=105.7

Q ss_pred             ccccCccccCCceeEEEEEe-cCCcE--EEEEEccccCcc------------------------cHHHHHHHHHHHHhcC
Q 006952          307 FSQENKLGEGGFGPVYKGVL-ADGKE--IAVKRLSRTSGQ------------------------GLQEFKNEVTVIAKLQ  359 (624)
Q Consensus       307 ~~~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  359 (624)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 67888  999987543211                        1136789999999998


Q ss_pred             CCCc--ceEEeEEEecCcceEEEEeccC-C----ChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEec
Q 006952          360 HKNL--VRLLGCCLEENESLLIYEYMPN-K----SLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH-EDSRLKIIHR  431 (624)
Q Consensus       360 h~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivH~  431 (624)
                      |+++  +.+++.    +..+|||||+.+ |    +|.++...      .++.....++.||+.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8764  444432    367899999952 4    55554421      234456789999999999999 775   9999


Q ss_pred             CCCCCcEEEcCCCCeEEecccccccc
Q 006952          432 DLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       432 Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=8.2e-17  Score=167.22  Aligned_cols=140  Identities=15%  Similarity=0.146  Sum_probs=100.7

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCc--------------ccHH--------HHHHHHHHHHhcCCC
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG--------------QGLQ--------EFKNEVTVIAKLQHK  361 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~--------~~~~Ei~~l~~l~h~  361 (624)
                      ..-|++.+.||+|++|.||+|...+|+.||||+++....              ....        ...+|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            344888999999999999999999999999998753210              0011        123466667777544


Q ss_pred             CcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc
Q 006952          362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD  441 (624)
Q Consensus       362 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~  441 (624)
                      ++....-+  .....+|||||+++++|..+...         .....++.||+.+|.|||+.+   ||||||||.|||++
T Consensus       174 gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPI--AQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEE--EEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCCCCeee--eccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence            43211111  11234799999999988765421         123467899999999999985   99999999999998


Q ss_pred             CCC----------CeEEecccccccc
Q 006952          442 HEM----------NPKISDFGMARIF  457 (624)
Q Consensus       442 ~~~----------~~kl~Dfg~a~~~  457 (624)
                      +++          .+.|+||+-+...
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCCcccccccccceEEEEeCCcccC
Confidence            876          3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=4.7e-12  Score=126.00  Aligned_cols=147  Identities=17%  Similarity=0.101  Sum_probs=115.3

Q ss_pred             HHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceE
Q 006952          300 IVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       300 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  378 (624)
                      +......|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445567888888999999999999864 6899999987532223346889999999994 7778899999988888999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-----------------------------------  423 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----------------------------------  423 (624)
                      ||||++|.+|.+.+..        ......++.+++++|..||+.                                   
T Consensus        88 v~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999999776411        112347888999999999981                                   


Q ss_pred             ---------------------CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          424 ---------------------SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       424 ---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                                           ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 11348999999999999876556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=3.8e-11  Score=118.88  Aligned_cols=137  Identities=16%  Similarity=0.154  Sum_probs=101.8

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC--cceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++......+.|..+.||+....+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            345544333466669999998877888999987654   2346788999999996444  45688888877788999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS--------------------------------------  424 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------  424 (624)
                      ++|.+|.  ...      .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999884  211      11   1256778888888888742                                      


Q ss_pred             -----------------CCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          425 -----------------RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       425 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                                       ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             1229999999999999877666799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=1.6e-09  Score=112.96  Aligned_cols=142  Identities=16%  Similarity=0.280  Sum_probs=107.4

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEEcc--ccC-cccHHHHHHHHHHHHhcC--CCCcceEEeEEEec---CcceEEE
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKRLS--RTS-GQGLQEFKNEVTVIAKLQ--HKNLVRLLGCCLEE---NESLLIY  380 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~lV~  380 (624)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998875 4688888876  322 123457888999999996  45678899988776   3478999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS------------------------------------  424 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------  424 (624)
                      ||++|..+.+..     ...++..++..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998875422     123677888899999999999999831                                    


Q ss_pred             -------------------CCCeEecCCCCCcEEEcCCCC--eEEeccccccc
Q 006952          425 -------------------RLKIIHRDLKTSNVLLDHEMN--PKISDFGMARI  456 (624)
Q Consensus       425 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  456 (624)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  58999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.94  E-value=9.6e-10  Score=111.82  Aligned_cols=186  Identities=19%  Similarity=0.231  Sum_probs=121.6

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCC--cceEEeEEEecC---cceEEEEec
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKN--LVRLLGCCLEEN---ESLLIYEYM  383 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~n--iv~l~~~~~~~~---~~~lV~Ey~  383 (624)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+.+++.+ .+..  +.+.+......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999863    56888986433  3456789999999988 4433  344554433333   347899999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED----------------------------------------  423 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~----------------------------------------  423 (624)
                      +|.+|.....     ..++..++..++.++++.|..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998865432     2356777788888888888888861                                        


Q ss_pred             ---------------CCCCeEecCCCCCcEEEcC--CCCeEEeccccccccCCCCCCcccc------------ccccccC
Q 006952          424 ---------------SRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGNQSKANTN------------RVVGTYG  474 (624)
Q Consensus       424 ---------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~------------~~~gt~~  474 (624)
                                     ..+.++|+|++|.||++++  ...+.|+||+.+..-..........            .+....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1245899999999999998  4557899999886532110000000            0000011


Q ss_pred             ccC-hhhhcCCCCChhhHHHHHHHHHHHHHhCCCC
Q 006952          475 YMA-PEYAMGGIFSVKSDVFSFGVVLLEIISGKKS  508 (624)
Q Consensus       475 y~a-PE~~~~~~~~~ksDv~S~Gvil~elltg~~p  508 (624)
                      ... |+....  .....+.|+++.++|++.+|..+
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence            111 222111  12236899999999999999866

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.42  E-value=1.7e-06  Score=87.71  Aligned_cols=136  Identities=19%  Similarity=0.156  Sum_probs=94.5

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCC---CcceEEeEEE-ecCcceEEEEeccC
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK---NLVRLLGCCL-EENESLLIYEYMPN  385 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lV~Ey~~~  385 (624)
                      .+.++.|....||+.    |+.+++|+...  ......+.+|..+|+.+.+.   .+.+.+.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899987    57788888432  23456789999999999642   3566676664 34557899999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED------------------------------------------  423 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------------------------------------------  423 (624)
                      ..+......     .++..+...++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888663211     123444445555555555555542                                          


Q ss_pred             ---------------CCCCeEecCCCCCcEEEcC---CCCe-EEeccccccc
Q 006952          424 ---------------SRLKIIHRDLKTSNVLLDH---EMNP-KISDFGMARI  456 (624)
Q Consensus       424 ---------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~Dfg~a~~  456 (624)
                                     ..+.++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2335799999999999987   4564 8999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.35  E-value=1.3e-06  Score=90.54  Aligned_cols=81  Identities=7%  Similarity=-0.003  Sum_probs=57.8

Q ss_pred             cCcc-ccCCceeEEEEEec-------CCcEEEEEEccccC---cccHHHHHHHHHHHHhcC-C--CCcceEEeEEEec--
Q 006952          310 ENKL-GEGGFGPVYKGVLA-------DGKEIAVKRLSRTS---GQGLQEFKNEVTVIAKLQ-H--KNLVRLLGCCLEE--  373 (624)
Q Consensus       310 ~~~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~--  373 (624)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88999999998764       26788999865432   111245788999998884 3  3567788887655  


Q ss_pred             -CcceEEEEeccCCChhh
Q 006952          374 -NESLLIYEYMPNKSLDV  390 (624)
Q Consensus       374 -~~~~lV~Ey~~~gsL~~  390 (624)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             34689999999877654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=3.4e-06  Score=83.62  Aligned_cols=134  Identities=16%  Similarity=0.158  Sum_probs=96.8

Q ss_pred             ccccCCce-eEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          312 KLGEGGFG-PVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       312 ~lG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556655 68987765 4667899976533   3456788999998884 44477889999988889999999999888


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS--------------------------------------------  424 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------------  424 (624)
                      .+.....       ......+..++++.|.-||...                                            
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7654221       1123345666777777777521                                            


Q ss_pred             -----------CCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          425 -----------RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       425 -----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                                 .+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1237999999999999987767799999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.03  E-value=2.3e-05  Score=82.44  Aligned_cols=75  Identities=9%  Similarity=0.200  Sum_probs=50.6

Q ss_pred             cCccccCCceeEEEEEec-CCcEEEEEEccccCc-------ccHHHHHHHHHHHHhcCC--CC-cceEEeEEEecCcceE
Q 006952          310 ENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-------QGLQEFKNEVTVIAKLQH--KN-LVRLLGCCLEENESLL  378 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--~n-iv~l~~~~~~~~~~~l  378 (624)
                      .+.||.|..+.||++... +++.++||.......       ...+++..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999764 468899997643211       234566789999988742  33 3455543  4556789


Q ss_pred             EEEeccCC
Q 006952          379 IYEYMPNK  386 (624)
Q Consensus       379 V~Ey~~~g  386 (624)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=2e-05  Score=80.77  Aligned_cols=140  Identities=15%  Similarity=0.194  Sum_probs=81.0

Q ss_pred             CccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCC--CCcceEEe------EEEecCcceEEEEe
Q 006952          311 NKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH--KNLVRLLG------CCLEENESLLIYEY  382 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~------~~~~~~~~~lV~Ey  382 (624)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|+.+++.|..  -.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999887554 5899988752    2344456666665531  12333332      12345567899999


Q ss_pred             ccCCChhh--------------hhhc--C-C--C------CcccCHHHH-------------------------------
Q 006952          383 MPNKSLDV--------------FLFD--S-T--R------SVQLDWKRR-------------------------------  406 (624)
Q Consensus       383 ~~~gsL~~--------------~l~~--~-~--~------~~~l~~~~~-------------------------------  406 (624)
                      ++|..+..              .++.  . .  .      .....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876530              0111  0 0  0      001123221                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          407 ISIIKGIARGILYLHE----------DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       407 ~~i~~qia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ..+..++.+++.+|++          ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111234446667763          124579999999999999888889999999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.97  E-value=3.8e-05  Score=76.92  Aligned_cols=80  Identities=19%  Similarity=0.234  Sum_probs=60.2

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-C--CCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-H--KNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++...+.+|.|..+.||+.++.+|+.+++|+...........|..|...|+.|. .  --+.+.+++    +..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            3455678899999999999999999999999876554444556889999999884 2  234455544    24589999


Q ss_pred             eccCCCh
Q 006952          382 YMPNKSL  388 (624)
Q Consensus       382 y~~~gsL  388 (624)
                      |++.+..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.87  E-value=8.5e-05  Score=75.19  Aligned_cols=139  Identities=18%  Similarity=0.176  Sum_probs=93.5

Q ss_pred             ccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC---CCCcceEEeEEEecCcceEEEEeccC
Q 006952          309 QENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ---HKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      ..+.|+.|....+|+... +++.+++|+....   ....+..|...|+.|.   ...+++.+.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999886 4678899986543   3567889999998883   35688899888877889999999999


Q ss_pred             CChhh-----------hhhcCCC--C-----------------cccCHHHHH---HHH----------------HHHHHH
Q 006952          386 KSLDV-----------FLFDSTR--S-----------------VQLDWKRRI---SII----------------KGIARG  416 (624)
Q Consensus       386 gsL~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~----------------~qia~~  416 (624)
                      ..+..           .|+....  .                 -.-+|....   ++.                ..+.+-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            86531           1121111  0                 012454322   111                111111


Q ss_pred             H-HHHHh-cCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          417 I-LYLHE-DSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       417 L-~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      + ..|.. ...+.++|+|+.+.||+++.++ +.|+|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23321 2356799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=0.0002  Score=75.81  Aligned_cols=78  Identities=13%  Similarity=0.106  Sum_probs=48.9

Q ss_pred             CCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcccccccc--ccCccChhhhcCC---CCChhhHHHHHHHHH
Q 006952          425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG--TYGYMAPEYAMGG---IFSVKSDVFSFGVVL  499 (624)
Q Consensus       425 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~ksDv~S~Gvil  499 (624)
                      ...++|+|++|.|||++.++ ++|+||+.+..-... ...  .....  ...|.+|+.....   .-....++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45699999999999998876 999999988642110 000  00111  1346666654321   112345667888888


Q ss_pred             HHHHhCC
Q 006952          500 LEIISGK  506 (624)
Q Consensus       500 ~elltg~  506 (624)
                      |+.++++
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8887764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.49  E-value=0.00051  Score=69.60  Aligned_cols=158  Identities=13%  Similarity=0.091  Sum_probs=87.9

Q ss_pred             CCHHHHHHHhcCccc-----cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC--cceEE
Q 006952          295 LDLIDIVKATQDFSQ-----ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN--LVRLL  367 (624)
Q Consensus       295 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~  367 (624)
                      .+..++......|..     .+.|+.|....+|+....+| .+++|......  ..+.+..|+.++..|....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555555555543     34567788899999887655 68899876531  1234566788877774212  23333


Q ss_pred             eE------EEecCcceEEEEeccCCChhhh--------------hhcCC----CC-----cccCHHHHHH----------
Q 006952          368 GC------CLEENESLLIYEYMPNKSLDVF--------------LFDST----RS-----VQLDWKRRIS----------  408 (624)
Q Consensus       368 ~~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~----~~-----~~l~~~~~~~----------  408 (624)
                      ..      ....+..+++++|++|..+...              ++...    ..     ....|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      1223456899999998664210              11100    00     0012332111          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          409 --IIKGIARGILYLHED----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       409 --i~~qia~~L~yLH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                        +...+.+.+..+++.    .+..++|+|+++.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              011244455566532    23468999999999999987556899999764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.43  E-value=0.00046  Score=69.40  Aligned_cols=138  Identities=13%  Similarity=0.140  Sum_probs=77.2

Q ss_pred             cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc-ceEEeEEEecCcceEEEEec-cCCC
Q 006952          310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL-VRLLGCCLEENESLLIYEYM-PNKS  387 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~-~~gs  387 (624)
                      .+.|+.|....+|+.     +.+++|+........ ....+|+.+++.+....+ .++++.  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577899999999998     568888876543221 223568888887743233 455544  344467999999 6655


Q ss_pred             hhhhh------------------hcCCC--CcccC-HHHHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 006952          388 LDVFL------------------FDSTR--SVQLD-WKRRISIIK--------------GIARGIL----YLHE-DSRLK  427 (624)
Q Consensus       388 L~~~l------------------~~~~~--~~~l~-~~~~~~i~~--------------qia~~L~----yLH~-~~~~~  427 (624)
                      +....                  +....  ....+ +.....+..              .+.+.+.    .|.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            53210                  11000  00011 111111100              0111111    1111 12345


Q ss_pred             eEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          428 IIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       428 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+|+.+.||+ .+++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667889999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.40  E-value=0.002  Score=65.33  Aligned_cols=163  Identities=13%  Similarity=0.135  Sum_probs=92.4

Q ss_pred             CCCCCCCHHHHHHHhcCccc-----cCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCC--C
Q 006952          290 FPLFPLDLIDIVKATQDFSQ-----ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHK--N  362 (624)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--n  362 (624)
                      .+....+...+....+.|..     ...|+ |....||+....+|+.+++|...... .....+..|..++..+...  .
T Consensus         6 ~~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~   83 (328)
T 1zyl_A            6 FTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVP   83 (328)
T ss_dssp             CCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCe
Confidence            34455555555555544432     23466 77789999887778789999986432 1345667788888887422  2


Q ss_pred             cceEEeE-----EEecCcceEEEEeccCCChhh----h----------hhc----C--CCCcccCHHHH----HHH----
Q 006952          363 LVRLLGC-----CLEENESLLIYEYMPNKSLDV----F----------LFD----S--TRSVQLDWKRR----ISI----  409 (624)
Q Consensus       363 iv~l~~~-----~~~~~~~~lV~Ey~~~gsL~~----~----------l~~----~--~~~~~l~~~~~----~~i----  409 (624)
                      +++++..     ....+..+++||+++|..+..    .          ++.    .  .....+++...    ..+    
T Consensus        84 vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  163 (328)
T 1zyl_A           84 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA  163 (328)
T ss_dssp             BCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC
T ss_pred             ecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhc
Confidence            3444432     122344578999998865431    0          110    0  01112222211    001    


Q ss_pred             -----------HHHHHHHHHHHHhc----CCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          410 -----------IKGIARGILYLHED----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       410 -----------~~qia~~L~yLH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                                 ...+.+.+..+...    .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          164 TLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                       01111223333221    234589999999999999 4 899999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.31  E-value=0.0007  Score=71.74  Aligned_cols=73  Identities=14%  Similarity=0.195  Sum_probs=50.9

Q ss_pred             cCccccCCceeEEEEEecC--------CcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEE
Q 006952          310 ENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .+.|+.|....+|+....+        ++.+++|+....  .....+.+|..+++.|. +.-..++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568889899999998753        578999987432  11245568999999885 3333667766532    3899


Q ss_pred             EeccCCCh
Q 006952          381 EYMPNKSL  388 (624)
Q Consensus       381 Ey~~~gsL  388 (624)
                      ||++|..|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.0011  Score=68.78  Aligned_cols=141  Identities=19%  Similarity=0.232  Sum_probs=84.5

Q ss_pred             CccccCCceeEEEEEec--------CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEEE
Q 006952          311 NKLGEGGFGPVYKGVLA--------DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      +.|..|-...+|+....        +++.+++|+..... .......+|..+++.|. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            46777888899998874        25789999864322 23456678999998884 4334667766543    39999


Q ss_pred             eccCCChhhh-h----------------hcCC--CCccc--CHHHHHHHHHHHHH-------------------HHHHHH
Q 006952          382 YMPNKSLDVF-L----------------FDST--RSVQL--DWKRRISIIKGIAR-------------------GILYLH  421 (624)
Q Consensus       382 y~~~gsL~~~-l----------------~~~~--~~~~l--~~~~~~~i~~qia~-------------------~L~yLH  421 (624)
                      |++|..|..- +                +...  -....  -|.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998666421 0                1100  01112  24455555443322                   233332


Q ss_pred             ----hc-CCCCeEecCCCCCcEEEcCC----CCeEEeccccccc
Q 006952          422 ----ED-SRLKIIHRDLKTSNVLLDHE----MNPKISDFGMARI  456 (624)
Q Consensus       422 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  456 (624)
                          .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 23468999999999999876    6899999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.0019  Score=65.74  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=73.5

Q ss_pred             CccccCCcee-EEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-C-CCcceEEeEEEecCcceEEEEeccCCC
Q 006952          311 NKLGEGGFGP-VYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-H-KNLVRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       311 ~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-~niv~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      +.|+.|.... +|+....+++.+++|.......   ..+..|+.+++.+. + -.+.+++.+..  +.-+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            4566665544 6677654477788876543321   23455777777763 2 23556666532  23378999998766


Q ss_pred             hhhhhhcCC-----------------------CCcccCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 006952          388 LDVFLFDST-----------------------RSVQLDWKRRI-------S-------------IIKGIARGILYLHE--  422 (624)
Q Consensus       388 L~~~l~~~~-----------------------~~~~l~~~~~~-------~-------------i~~qia~~L~yLH~--  422 (624)
                      +.+++....                       ....++.....       .             ....+.+.+..|.+  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            644332100                       00111111100       0             00111222223311  


Q ss_pred             -cCCCCeEecCCCCCcEEEcCC----CCeEEeccccccc
Q 006952          423 -DSRLKIIHRDLKTSNVLLDHE----MNPKISDFGMARI  456 (624)
Q Consensus       423 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  456 (624)
                       .....++|||+.+.|||++.+    ..+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             123469999999999999875    6789999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.20  E-value=0.002  Score=68.61  Aligned_cols=74  Identities=14%  Similarity=0.073  Sum_probs=49.8

Q ss_pred             cCccccCCceeEEEEEecC-CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc-ceEEeEEEecCcceEEEEeccCCC
Q 006952          310 ENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL-VRLLGCCLEENESLLIYEYMPNKS  387 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lV~Ey~~~gs  387 (624)
                      .+.|+.|-...+|+....+ ++.+++|+......... .-.+|..+++.|...++ .++++.+.    -.+||||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence            4578889899999998765 47888998754332221 12689999999965444 56777662    236999999865


Q ss_pred             h
Q 006952          388 L  388 (624)
Q Consensus       388 L  388 (624)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.04  E-value=0.0021  Score=66.51  Aligned_cols=74  Identities=14%  Similarity=0.159  Sum_probs=46.2

Q ss_pred             cCccccCCceeEEEEEecC---------CcEEEEEEccccCcccHHHHHHHHHHHHhcCCCC-cceEEeEEEecCcceEE
Q 006952          310 ENKLGEGGFGPVYKGVLAD---------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN-LVRLLGCCLEENESLLI  379 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lV  379 (624)
                      .+.|+.|....+|+....+         ++.+++|+....... ......|..+++.+...+ ..++++..    .-++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            3567888888999988754         268888887543322 123467888888885333 44666544    24789


Q ss_pred             EEeccCCCh
Q 006952          380 YEYMPNKSL  388 (624)
Q Consensus       380 ~Ey~~~gsL  388 (624)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.80  E-value=0.0055  Score=62.59  Aligned_cols=68  Identities=10%  Similarity=0.096  Sum_probs=43.6

Q ss_pred             ccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC---CCCcceEEeE------EEecCcceEEEEecc
Q 006952          314 GEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ---HKNLVRLLGC------CLEENESLLIYEYMP  384 (624)
Q Consensus       314 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~------~~~~~~~~lV~Ey~~  384 (624)
                      |.|....||+....+| .+++|+......      ..|+..++.|.   -|++++.+..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344678999987767 899998765432      35666666652   2224444432      233456789999999


Q ss_pred             CCCh
Q 006952          385 NKSL  388 (624)
Q Consensus       385 ~gsL  388 (624)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.04  E-value=0.021  Score=53.59  Aligned_cols=103  Identities=9%  Similarity=0.027  Sum_probs=65.9

Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCcc
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN  465 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  465 (624)
                      -+|.++|..  ...++++.++|.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|++.+.+ ..+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            367777743  4567999999999999999987762211 11 1233457999999999988764 1110          


Q ss_pred             ccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCC
Q 006952          466 TNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKS  508 (624)
Q Consensus       466 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p  508 (624)
                          .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1123456888653 4557899999999999998864444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.03  E-value=0.037  Score=58.12  Aligned_cols=141  Identities=18%  Similarity=0.183  Sum_probs=85.9

Q ss_pred             cCccccCCceeEEEEEecC--------CcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEE
Q 006952          310 ENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .+.|..|-...+|+....+        ++.+++|+......... ...+|..+++.+. +.-..++++.+    .-++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            3567778888999998753        57899998755433222 2367888888884 33345666533    237899


Q ss_pred             EeccCCChhhh-h----------------hc--C------C--CCcccCHHHHHHHHHHH-------------------H
Q 006952          381 EYMPNKSLDVF-L----------------FD--S------T--RSVQLDWKRRISIIKGI-------------------A  414 (624)
Q Consensus       381 Ey~~~gsL~~~-l----------------~~--~------~--~~~~l~~~~~~~i~~qi-------------------a  414 (624)
                      ||++|..|..- +                +.  .      .  ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998765311 0                00  0      0  11111244433333222                   2


Q ss_pred             HHHHHHHh---------------------cCCCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          415 RGILYLHE---------------------DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       415 ~~L~yLH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      ..+.+|.+                     .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     12345899999999999 7888999999998863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.21  E-value=0.21  Score=51.95  Aligned_cols=29  Identities=24%  Similarity=0.417  Sum_probs=24.5

Q ss_pred             eEecCCCCCcEEE------cCCCCeEEeccccccc
Q 006952          428 IIHRDLKTSNVLL------DHEMNPKISDFGMARI  456 (624)
Q Consensus       428 ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~  456 (624)
                      ++|+|+.+.|||+      +++..++++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4456799999998854

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=88.45  E-value=0.14  Score=34.60  Aligned_cols=20  Identities=20%  Similarity=0.359  Sum_probs=8.2

Q ss_pred             HHHHHHHhhheeeeEeeccc
Q 006952          262 IIVFLLSTSFLWCIIRRRNK  281 (624)
Q Consensus       262 ~~~~ll~~~~~~~~~~~~~k  281 (624)
                      +++++++...+|+++|||++
T Consensus        21 v~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           21 LLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHHhhhhHh
Confidence            33333333444444444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.35  E-value=1.6  Score=40.67  Aligned_cols=116  Identities=9%  Similarity=0.046  Sum_probs=77.3

Q ss_pred             CCCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 006952          359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNV  438 (624)
Q Consensus       359 ~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NI  438 (624)
                      .||+++.. ..-.+++...+.|+.-+  +...+-    .-..++...+++++.+|+....+++.     -+|--|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            58888876 45555555445454433  222221    12347788999999999988866654     48889999999


Q ss_pred             EEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          439 LLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       439 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                      +++.++.+++.--|+-..+                   +|.     ..++..=.-.+=+++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999877754322                   222     12333334567788899999987753

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=84.06  E-value=0.32  Score=32.74  Aligned_cols=21  Identities=10%  Similarity=0.342  Sum_probs=8.7

Q ss_pred             HHHHHHHhhheeeeEeecccc
Q 006952          262 IIVFLLSTSFLWCIIRRRNKR  282 (624)
Q Consensus       262 ~~~~ll~~~~~~~~~~~~~k~  282 (624)
                      +++++++....|+++|||+++
T Consensus        20 v~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           20 LFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHhhhhhhh
Confidence            333333334444444444433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.05  E-value=0.32  Score=32.64  Aligned_cols=16  Identities=31%  Similarity=0.378  Sum_probs=6.3

Q ss_pred             HHHHhhheeeeEeecc
Q 006952          265 FLLSTSFLWCIIRRRN  280 (624)
Q Consensus       265 ~ll~~~~~~~~~~~~~  280 (624)
                      +++.++++++++||+.
T Consensus        25 vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           25 VVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHhheehhhh
Confidence            3333343444444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.64  E-value=2.2  Score=39.93  Aligned_cols=114  Identities=9%  Similarity=0.078  Sum_probs=74.1

Q ss_pred             CCCCcceEEeEEEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCc
Q 006952          359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL-YLHEDSRLKIIHRDLKTSN  437 (624)
Q Consensus       359 ~h~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~-yLH~~~~~~ivH~Dlkp~N  437 (624)
                      .||++  -...-.+++...+.++.-+++.=...+      ..++...+++++.+|+.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            58888  333335556666666654333222222      24677889999999888777 5554     5888999999


Q ss_pred             EEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCC
Q 006952          438 VLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKST  509 (624)
Q Consensus       438 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~  509 (624)
                      |+++.++.++|.-.|+-..                   ++|.-     .++.-=.-++=+++..++.++..|
T Consensus       115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             EEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999987775332                   23321     122222346777888888887665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	624
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-75
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-70
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-64
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-60
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-57
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-55
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 1e-75
 Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 20/285 (7%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
             +   ++G G FG VYKG       + +  ++  + Q LQ FKNEV V+ K +H N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
            +G      +  ++ ++    SL   L       + +  + I I +  A+G+ YLH    
Sbjct: 69  FMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK-- 123

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG-- 483
             IIHRDLK++N+ L  ++  KI DFG+A +           ++ G+  +MAPE      
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 484 -GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
              +S +SDV++FG+VL E+++G+            +    I  +   G+ +  +  V  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPK 587
                        +   C++    +RP    +   +     +LPK
Sbjct: 237 NCPKAM-----KRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 3e-70
 Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 23/280 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +      +LG G FG V+ G      ++AVK L + S      F  E  ++ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           RL      +    +I EYM N SL  FL      ++L   + + +   IA G+ ++ E  
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
               IHRDL+ +N+L+   ++ KI+DFG+AR+   N+  A          + APE    G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            F++KSDV+SFG++L EI++  +    Y     P ++  + +    G+     D+  ++ 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLER----GYRMVRPDNCPEE- 238

Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILT 584
                      +  LC +  P DRPT   +  +L  D  T
Sbjct: 239 --------LYQLMRLCWKERPEDRPTFDYLRSVL-EDFFT 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 5e-67
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 22/291 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +    E KLG+G FG V+ G       +A+K L   +    + F  E  V+ KL+H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L      E    ++ EYM   SL  FL   T        + + +   IA G+ Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           R+  +HRDL+ +N+L+   +  K++DFG+AR+   N+  A          + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            F++KSDV+SFG++L E+ +  +    Y       +L  + + +      E  +S+    
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPESL---- 243

Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAFSL 595
                      +   C + +P +RPT   +   L     +     QP  +L
Sbjct: 244 ---------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 2e-66
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 22/273 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           + +   ++G G FG V+ G   +  ++A+K + R      ++F  E  V+ KL H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L G CLE+    L++E+M +  L    +  T+      +  + +   +  G   +     
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGI 485
             +IHRDL   N L+      K+SDFGM R    +Q   ++        + +PE      
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSR 178

Query: 486 FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSC 545
           +S KSDV+SFGV++ E+ S  K    Y +     ++  I   +   +   L  + V Q  
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGF-RLYKPRLASTHVYQ-- 233

Query: 546 DQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                     I   C +  P DRP  S +   L
Sbjct: 234 ----------IMNHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 3e-65
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 22/274 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           +D +   +LG G FG V  G      ++A+K +   S     EF  E  V+  L H+ LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +L G C ++    +I EYM N  L  +L +     +   ++ + + K +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
             + +HRDL   N L++ +   K+SDFG++R    ++  ++         +  PE  M  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            FS KSD+++FGV++ EI S  K                 ++ +     AE +   ++  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221

Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                  K   I   C      +RPT   +   +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (544), Expect = 3e-65
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 22/274 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           D + ++KLG G +G VY+GV       +AVK L   + + ++EF  E  V+ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
           +LLG C  E    +I E+M   +L  +L +  R  ++     + +   I+  + YL    
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE--- 132

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGG 484
           +   IHRDL   N L+      K++DFG++R+  G+   A+         + APE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 191

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            FS+KSDV++FGV+L EI +   S   Y        L+ +++L  + +  E  +   +  
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS--PYPGID----LSQVYELLEKDYRMERPEGCPE-- 243

Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                  K   +   C Q +P DRP+ + +    
Sbjct: 244 -------KVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 3e-65
 Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 28/275 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
           ++      +G+G FG V  G    G ++AVK +   +    Q F  E +V+ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 365 RLLGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           +LLG  +EE   L ++ EYM   SL  +L    RSV L     +     +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
                +HRDL   NVL+  +   K+SDFG+ +     Q     +       + APE    
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 174

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
             FS KSDV+SFG++L EI S  +    Y       ++  +     +G+  +  D     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRV----EKGYKMDAPDGCPPA 228

Query: 544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
             +         +   C   D   RP+   +   L
Sbjct: 229 VYE---------VMKNCWHLDAAMRPSFLQLREQL 254

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 3e-65
 Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 28/291 (9%)

Query: 310 ENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGC 369
           +  +G+G FG V++G    G+E+AVK  S    +     + E+     L+H+N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65

Query: 370 CLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-- 423
             ++N +     L+ +Y  + SL  +L        +  +  I +    A G+ +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 424 ---SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF--GGNQSKANTNRVVGTYGYMAP 478
               +  I HRDLK+ N+L+       I+D G+A       +      N  VGT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 479 EYAMGGI------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP----SLLAYIWKLW 528
           E     I         ++D+++ G+V  EI       G +     P           +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 529 CEGHAAELMDSVVKQSCDQAELLKYIH-IGLLCVQGDPIDRPTMSSVAVML 578
            +    + +   +       E L+ +  I   C   +   R T   +   L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 6e-65
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 303 ATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL-QEFKNEVTVIAKLQH 360
              DF + ++LG G  G V+K      G  +A K +       +  +   E+ V+ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
             +V   G    + E  +  E+M   SLD  L  + R   +  +    +   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
               + KI+HRD+K SN+L++     K+ DFG++     +      N  VGT  YM+PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGK 506
             G  +SV+SD++S G+ L+E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (541), Expect = 1e-64
 Identities = 73/302 (24%), Positives = 133/302 (44%), Gaps = 37/302 (12%)

Query: 294 PLDLIDIVKATQDFSQE---------NKLGEGGFGPVYKGVLADGKE----IAVKRL-SR 339
           P    D  +A ++F++E           +G G FG V  G L    +    +A+K L S 
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 340 TSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSV 399
            + +  ++F +E +++ +  H N++ L G   +    ++I E+M N SLD FL  +    
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-- 123

Query: 400 QLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG 459
           Q    + + +++GIA G+ YL     +  +HRDL   N+L++  +  K+SDFG++R    
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 460 NQSKANTNRVVG---TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEH 516
           + S       +G      + APE      F+  SDV+S+G+V+ E++S  +    Y    
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMT 238

Query: 517 GPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV 576
              ++  I + +      +   ++               + L C Q D   RP    +  
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSAL-------------HQLMLDCWQKDRNHRPKFGQIVN 285

Query: 577 ML 578
            L
Sbjct: 286 TL 287

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-64
 Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 26/289 (8%)

Query: 310 ENKLGEGGFGPVYKGVLA---DGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLVR 365
           + +LG G FG V +GV        ++A+K L + + +   +E   E  ++ +L +  +VR
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
           L+G C +    +L+ E      L  FL    +  ++       ++  ++ G+ YL     
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---E 127

Query: 426 LKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS-KANTNRVVGTYGYMAPEYAMGG 484
              +HRDL   NVLL +    KISDFG+++  G + S     +       + APE     
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 485 IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS 544
            FS +SDV+S+GV + E +S  +    Y    GP ++A+I     +G   E       + 
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFI----EQGKRMECPPECPPEL 241

Query: 545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQPAF 593
                      +   C      DRP   +V   + +   +L    +   
Sbjct: 242 YA---------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 1e-63
 Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 28/276 (10%)

Query: 309 QENKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTSGQG--LQEFKNEVTVIAKLQHKNL 363
           ++ +LG G FG V KG        K +AVK L   +       E   E  V+ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           VR++G C E    +L+ E      L+ +L  +     +  K  I ++  ++ G+ YL   
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN-RVVGTYGYMAPEYAM 482
                +HRDL   NVLL  +   KISDFG+++    +++             + APE   
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 483 GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
              FS KSDV+SFGV++ E  S  +    Y    G  + A +     +G          +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAML----EKGERMGCPAGCPR 237

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
           +            +  LC   D  +RP  ++V + L
Sbjct: 238 E---------MYDLMNLCWTYDVENRPGFAAVELRL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (531), Expect = 3e-63
 Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 46/301 (15%)

Query: 306 DFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQGLQ-EFKNEVTVIAKL 358
           +      +GEG FG V++              +AVK L   +   +Q +F+ E  ++A+ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTR--------------------- 397
            + N+V+LLG C       L++EYM    L+ FL   +                      
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 398 SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 457
              L    ++ I + +A G+ YL E    K +HRDL T N L+   M  KI+DFG++R  
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG 517
                            +M PE      ++ +SDV+++GVVL EI S       Y+    
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAH 248

Query: 518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM 577
             ++ Y+     +G+     ++   +           ++  LC    P DRP+  S+  +
Sbjct: 249 EEVIYYV----RDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSIHRI 295

Query: 578 L 578
           L
Sbjct: 296 L 296

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (528), Expect = 2e-62
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 34/278 (12%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG---LQEFKNEVTVIAKLQ 359
            + FS   ++G G FG VY    + + + +A+K++S +  Q     Q+   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N ++  GC L E+ + L+ EY    + D+          L      ++  G  +G+ Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH      +IHRD+K  N+LL      K+ DFG A I       A  N  VGT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 480 YAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
             +    G +  K DV+S G+  +E+   K       + +  S L +I +          
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQ---------- 228

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            +S   QS   +E  +  +    C+Q  P DRPT   +
Sbjct: 229 NESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-62
 Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 28/277 (10%)

Query: 310 ENKLGEGGFGPVYKGVLADGK----EIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLV 364
              +G G FG VY G L D        AVK L+R +  G + +F  E  ++    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 365 RLLGCCLE-ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
            LLG CL  E   L++  YM +  L  F+ + T +  +       +          +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGTYGYMAPEYA 481
           +  K +HRDL   N +LD +   K++DFG+AR     +  +  N+        +MA E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
               F+ KSDV+SFGV+L E+++       Y   +   +  Y+ +    G      +   
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ----GRRLLQPEYCP 260

Query: 542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                         + L C       RP+ S +   +
Sbjct: 261 DP---------LYEVMLKCWHPKAEMRPSFSELVSRI 288

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 8e-62
 Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 26/277 (9%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKN 362
           D+     +G G +G   K    +DGK +  K L   S      Q   +EV ++ +L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 363 LVRLLGCCLEENESLL--IYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIIKGIARGILY 419
           +VR     ++   + L  + EY     L   +   T+  Q LD +  + ++  +   +  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 420 LHE--DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            H   D    ++HRDLK +NV LD + N K+ DFG+ARI   + S A     VGT  YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE      ++ KSD++S G +L E+ +       + +     L   I     EG    + 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKI----REGKFRRIP 235

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
                 S +  E++         +      RP++  +
Sbjct: 236 YRY---SDELNEIIT------RMLNLKDYHRPSVEEI 263

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 8e-62
 Identities = 77/320 (24%), Positives = 137/320 (42%), Gaps = 42/320 (13%)

Query: 297 LIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKE----IAVKRLSR-TSGQGLQEFKN 350
           L+ I+K T +F +   LG G FG VYKG+ + +G++    +A+K L   TS +  +E  +
Sbjct: 2   LLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           E  V+A + + ++ RLLG CL      LI + MP   L    +       +  +  ++  
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCL--LDYVREHKDNIGSQYLLNWC 117

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
             IA+G+ YL      +++HRDL   NVL+    + KI+DFG+A++ G  + + +     
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
               +MA E  +  I++ +SDV+S+GV + E+++       Y       + + +     +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSIL----EK 228

Query: 531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML------------ 578
           G                        I + C   D   RP    + +              
Sbjct: 229 GERLPQPPICTID---------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279

Query: 579 --ASDILTLPKPTQPAFSLS 596
               + + LP PT   F  +
Sbjct: 280 IQGDERMHLPSPTDSNFYRA 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-61
 Identities = 75/301 (24%), Positives = 116/301 (38%), Gaps = 40/301 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSGQG-LQEFKNEVTVIAK 357
              S    LG G FG V +              +AVK L  ++     +   +E+ V++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 358 L-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRS---------------VQL 401
           L  H N+V LLG C     +L+I EY     L  FL     S               + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 402 DWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ 461
           D +  +S    +A+G+ +L        IHRDL   N+LL H    KI DFG+AR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLL 521
           +            +MAPE     +++ +SDV+S+G+ L E+ S   S             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----- 254

Query: 522 AYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD 581
           +  +K+  EG      +    +            I   C   DP+ RPT   +  ++   
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 582 I 582
           I
Sbjct: 306 I 306

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-61
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 28/289 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKE-----IAVKRLSRTSGQG-LQEFKNEVTVIAKL 358
              +++  +G G FG VYKG+L          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 359 QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
            H N++RL G   +    ++I EYM N +LD FL +  +  +    + + +++GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-NRVVGTYGYMA 477
           YL     +  +HRDL   N+L++  +  K+SDFG++R+   +     T +       + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           PE      F+  SDV+SFG+V+ E+++  +   +  S H                  + +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAI 226

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
           +   +             + + C Q +   RP  + +  +L   ++  P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL-DKLIRAP 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-61
 Identities = 74/273 (27%), Positives = 113/273 (41%), Gaps = 23/273 (8%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVIAKLQHKN 362
           +D+     LGEG +G V   V     + +AVK +         E  K E+ +   L H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V+  G   E N   L  EY     L   +        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
              + I HRD+K  N+LLD   N KISDFG+A +F  N  +   N++ GT  Y+APE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 483 GGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
              F +   DV+S G+VL  +++G+           PS     +  W E      ++   
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE------LPWDQPSDSCQEYSDWKEKK--TYLNPWK 230

Query: 542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
           K       LL      +L    +P  R T+  +
Sbjct: 231 KIDSAPLALLH----KILVE--NPSARITIPDI 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 5e-61
 Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 45/305 (14%)

Query: 306 DFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKL 358
           +      LG G FG V               ++AVK L   +     +   +E+ ++ +L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 359 -QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ----------------- 400
             H+N+V LLG C       LI+EY     L  +L                         
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 401 ---LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF 457
              L ++  +     +A+G+ +L        +HRDL   NVL+ H    KI DFG+AR  
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 458 GGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHG 517
             + +            +MAPE    GI+++KSDV+S+G++L EI S        +   G
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPG 269

Query: 518 PSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM 577
             + A  +KL   G   +      ++            I   C   D   RP+  ++   
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYI---------IMQSCWAFDSRKRPSFPNLTSF 320

Query: 578 LASDI 582
           L   +
Sbjct: 321 LGCQL 325

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 8e-61
 Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 27/280 (9%)

Query: 301 VKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ 359
           +     +    +LG+G FG VYK          A K +   S + L+++  E+ ++A   
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H N+V+LL     EN   ++ E+    ++D  + +  R   L   +   + K     + Y
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 125

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH+    KIIHRDLK  N+L   + + K++DFG++        + ++   +GT  +MAPE
Sbjct: 126 LHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 180

Query: 480 YAMG-----GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA 534
             M        +  K+DV+S G+ L+E+   +     +H  +   +L  I K   E    
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKIAK--SEPPTL 235

Query: 535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
                    S +  + LK       C++ +   R T S +
Sbjct: 236 AQPSRW---SSNFKDFLK------KCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-60
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 31/273 (11%)

Query: 310 ENKLGEGGFGPVYKGVLAD-GKEIAVKRLS--RTSGQGLQEFKNEVTVIAKLQHKNLVRL 366
           + ++G G F  VYKG+  +   E+A   L   + +    Q FK E  ++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 367 LGCCLEENES----LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
                   +     +L+ E M + +L  +L    R   +  K   S  + I +G+ +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 423 DSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
            +   IIHRDLK  N+ +     + KI D G+A +   +        V+GT  +MAPE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
               +    DV++FG+ +LE+ + +    +   ++     A I++    G      D V 
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYP--YSECQN----AAQIYRRVTSGVKPASFDKVA 238

Query: 542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
                  E+++       C++ +  +R ++  +
Sbjct: 239 IPEV--KEIIE------GCIRQNKDERYSIKDL 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 6e-60
 Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 34/306 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL------ADGKEIAVKRLSR-TSGQGLQEFKNEVTVIAK 357
           +  +   +LG+G FG VY+GV            +A+K ++   S +   EF NE +V+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-------DSTRSVQLDWKRRISII 410
               ++VRLLG   +   +L+I E M    L  +L        ++         + I + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVV 470
             IA G+ YL+ +   K +HRDL   N ++  +   KI DFGM R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 471 GTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCE 530
               +M+PE    G+F+  SDV+SFGVVL EI +  +    Y       +L ++     E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFV----ME 250

Query: 531 GHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLPKPTQ 590
           G   +  D+                +  +C Q +P  RP+   +   +  ++   P   +
Sbjct: 251 GGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIKEEM--EPGFRE 299

Query: 591 PAFSLS 596
            +F  S
Sbjct: 300 VSFYYS 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 6e-59
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 39/291 (13%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADG---KEIAVKRLSRT-SGQGLQEFKNEVTVIAKL-QH 360
           D   ++ +GEG FG V K  +       + A+KR+    S    ++F  E+ V+ KL  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFL-------------FDSTRSVQLDWKRRI 407
            N++ LLG C       L  EY P+ +L  FL               ++ +  L  ++ +
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 408 SIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTN 467
                +ARG+ YL +    + IHRDL   N+L+      KI+DFG++R   G +      
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 184

Query: 468 RVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
                  +MA E     +++  SDV+S+GV+L EI+S   +   Y       L   + + 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ- 241

Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
              G+  E   +   +            +   C +  P +RP+ + + V L
Sbjct: 242 ---GYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQILVSL 280

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 7e-59
 Identities = 75/282 (26%), Positives = 111/282 (39%), Gaps = 28/282 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL----ADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK 357
           +D     KLG+G FG V +G           +AVK L     +  + + +F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H+NL+RL G  L      ++ E  P  SL   L        L    R ++   +A G+
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-ANTNRVVGTYGYM 476
            YL      + IHRDL   N+LL      KI DFG+ R    N             + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 477 APEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL 536
           APE      FS  SD + FGV L E+ +  +    +   +G  +L  I K   EG     
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDK---EGERLPR 236

Query: 537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
            +   +            ++ + C    P DRPT  ++   L
Sbjct: 237 PEDCPQ---------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 9e-58
 Identities = 69/301 (22%), Positives = 142/301 (47%), Gaps = 34/301 (11%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKN 362
            + +++  K+G+G  G VY  + +A G+E+A+++++       +   NE+ V+ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V  L   L  +E  ++ EY+   SL   + ++      D  +  ++ +   + + +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
               ++IHRD+K+ N+LL  + + K++DFG        QSK +T  +VGT  +MAPE   
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 483 GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
              +  K D++S G++ +E+I G+    + +     +L         E    E + ++ +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKLSAIFR 247

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP--KPTQPAFSLSRVVS 600
                 + L        C+  D   R +        A ++L     K  +P  SL+ +++
Sbjct: 248 ------DFLN------RCLDMDVEKRGS--------AKELLQHQFLKIAKPLSSLTPLIA 287

Query: 601 A 601
           A
Sbjct: 288 A 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 31/274 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQH 360
           +DF     LG+G FG VY          +A+K L +          + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
            N++RL G   +     LI EY P  ++   L   ++    D +R  + I  +A  + Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
           H     ++IHRD+K  N+LL      KI+DFG +     ++       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
             G +   K D++S GV+  E + GK     + +         I +   E    + +   
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISR--VEFTFPDFVTEG 230

Query: 541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            +      +L+         ++ +P  RP +  V
Sbjct: 231 AR------DLIS------RLLKHNPSQRPMLREV 252

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 4e-56
 Identities = 71/295 (24%), Positives = 111/295 (37%), Gaps = 39/295 (13%)

Query: 306 DFSQENKLGEGGFGPVYKGV------LADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAK- 357
                  LG G FG V +         A  + +AVK L   +     +   +E+ ++   
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 358 LQHKNLVRLLGCCLEENESLLI-YEYMPNKSLDVFLF-------------DSTRSVQLDW 403
             H N+V LLG C +    L++  E+    +L  +L              +      L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 404 KRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK 463
           +  I     +A+G+ +L      K IHRDL   N+LL  +   KI DFG+AR    +   
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAY 523
                      +MAPE     +++++SDV+SFGV+L EI      +       G  +   
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----SLGASPYPGVKIDEE 245

Query: 524 IWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
             +   EG      D    +              L C  G+P  RPT S +   L
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHL 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-55
 Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 27/281 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLADGKE----IAVKRLSRTSGQGLQE-FKNEVTVIAKLQ 359
           +       +GEG FG V++G+    +     +A+K     +   ++E F  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H ++V+L+G    EN   +I E      L  FL     S  LD    I     ++  + Y
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           L      + +HRD+   NVL+      K+ DFG++R    +      ++      +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS 539
                 F+  SDV+ FGV + EI+            +       +      G    +  +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPN 233

Query: 540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS 580
                           +   C   DP  RP  + +   L++
Sbjct: 234 CPPTLYS---------LMTKCWAYDPSRRPRFTELKAQLST 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-54
 Identities = 81/303 (26%), Positives = 122/303 (40%), Gaps = 42/303 (13%)

Query: 306 DFSQENKLGEGGFGPVYKGVL--------ADGKEIAVKRLSR-TSGQGLQEFKNEVTVIA 356
                  LGEG FG V                 ++AVK L    + + L +  +E+ ++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 357 KL-QHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLF-------------DSTRSVQLD 402
            + +HKN++ LLG C ++    +I EY    +L  +L                    QL 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 403 WKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS 462
            K  +S    +ARG+ YL      K IHRDL   NVL+  +   KI+DFG+AR       
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLA 522
              T        +MAPE     I++ +SDV+SFGV+L EI +   S   Y        + 
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVP----VE 244

Query: 523 YIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDI 582
            ++KL  EGH  +   +   +            +   C    P  RPT   +   L   I
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL-DRI 294

Query: 583 LTL 585
           + L
Sbjct: 295 VAL 297

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  185 bits (470), Expect = 1e-53
 Identities = 63/296 (21%), Positives = 120/296 (40%), Gaps = 30/296 (10%)

Query: 282 RKQEESQAFPLFPLDLIDIVKATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT 340
            KQ   Q   +    ++D       +    +LG G FG V++    A G   A K +   
Sbjct: 9   WKQYYPQPVEIKHDHVLD------HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 62

Query: 341 SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ 400
                +  + E+  ++ L+H  LV L     ++NE ++IYE+M    L   + D     +
Sbjct: 63  HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNK 120

Query: 401 LDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFG 458
           +     +  ++ + +G+ ++HE      +H DLK  N++   + +   K+ DFG+     
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177

Query: 459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGP 518
             QS        GT  + APE A G      +D++S GV+   ++SG      +  E+  
Sbjct: 178 PKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---FGGENDD 231

Query: 519 SLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
             L  +    C+ +  +   S + +     + ++        +  DP  R T+   
Sbjct: 232 ETLRNVKS--CDWNMDDSAFSGISEDG--KDFIR------KLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 8e-53
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 10/209 (4%)

Query: 302 KATQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK 357
           K  +DF     LGEG F  V     LA  +E A+K L +        +     E  V+++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 358 LQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGI 417
           L H   V+L     ++ +      Y  N  L  ++         D          I   +
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121

Query: 418 LYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
            YLH      IIHRDLK  N+LL+ +M+ +I+DFG A++      +A  N  VGT  Y++
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           PE          SD+++ G ++ ++++G 
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  179 bits (454), Expect = 2e-51
 Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 24/272 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            +    +LG G FG V++ V  A G+    K ++          KNE++++ +L H  L+
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L     ++ E +LI E++    L   +  +    ++     I+ ++    G+ ++HE  
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE-- 145

Query: 425 RLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
              I+H D+K  N++ + +     KI DFG+A     ++          T  + APE   
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVD 201

Query: 483 GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
                  +D+++ GV+   ++SG      +  E     L  +             D+   
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNV----KRCDWEFDEDAFSS 254

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            S +  + +K        +Q +P  R T+   
Sbjct: 255 VSPEAKDFIKN------LLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (428), Expect = 1e-48
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 30/285 (10%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG---LQEFKNEVTVIAKLQ 359
           +  +     LG GG   V+    L   +++AVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 360 HKNLVRLLGCCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           H  +V +      E  +     ++ EY+   +L   +        +  KR I +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG-GNQSKANTNRVVGTYG 474
            + + H+     IIHRD+K +N+++      K+ DFG+AR       S   T  V+GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA 534
           Y++PE A G     +SDV+S G VL E+++G+     +  +   S+     +        
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVR------ED 230

Query: 535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA 579
            +  S   +     +L   +   L  +  +P +R    + A M A
Sbjct: 231 PIPPSARHEGLSA-DLDAVV---LKALAKNPENRY--QTAAEMRA 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  170 bits (432), Expect = 3e-48
 Identities = 74/328 (22%), Positives = 125/328 (38%), Gaps = 37/328 (11%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQ-- 359
           DFS    +G GGFG VY    AD GK  A+K L +      QG     NE  +++ +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 360 -HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
               +V +       ++   I + M    L   L       + D +        I  G+ 
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLE 121

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAP 478
           ++H      +++RDLK +N+LLD   + +ISD G+A  F   +     +  VGT+GYMAP
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAP 174

Query: 479 EYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
           E    G+ +   +D FS G +L +++ G         +H       I ++       EL 
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTMA-VELP 229

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP--KPTQPAFSL 595
           DS   +      LL+        +Q D   R          A ++   P  +        
Sbjct: 230 DSFSPELRS---LLE------GLLQRDVNRRLGCLGR---GAQEVKESPFFRSLDWQMVF 277

Query: 596 SRVVSAQFVSHSEDHCSVNAITLSTMSP 623
            +      +    +  + +A  + +   
Sbjct: 278 LQKYPPPLIPPRGEVNAADAFDIGSFDE 305

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-47
 Identities = 58/289 (20%), Positives = 115/289 (39%), Gaps = 27/289 (9%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG-LQEFKNEVTVIAKLQHKNLV 364
           ++  + +GEG +G V       +   +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            +           +   Y+    +   L+   ++  L        +  I RG+ Y+H   
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-- 127

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANT-NRVVGTYGYMAPEYAMG 483
              ++HRDLK SN+LL+   + KI DFG+AR+   +          V T  Y APE  + 
Sbjct: 128 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 484 GIFSVKS-DVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
                KS D++S G +L E++S +     +  +H    L +I  +       +L   +  
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 543 QSCDQAELLKYIHIGLL-----------------CVQGDPIDRPTMSSV 574
           ++ +    L + +                      +  +P  R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-47
 Identities = 50/272 (18%), Positives = 108/272 (39%), Gaps = 25/272 (9%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            +     LG G FG V++ V  +  K    K + +  G      K E++++   +H+N++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            L        E ++I+E++    +   +  +T + +L+ +  +S +  +   + +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120

Query: 425 RLKIIHRDLKTSNVLLDHEMNP--KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAM 482
              I H D++  N++     +   KI +FG AR         N   +     Y APE   
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 483 GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK 542
             + S  +D++S G ++  ++SG      + +E    ++  I             ++  +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGIN---PFLAETNQQIIENI----MNAEYTFDEEAFKE 229

Query: 543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            S +  + +         +  +   R T S  
Sbjct: 230 ISIEAMDFVDR------LLVKERKSRMTASEA 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 1e-46
 Identities = 52/281 (18%), Positives = 101/281 (35%), Gaps = 25/281 (8%)

Query: 307 FSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVR 365
           +    K+G G FG +Y G  +A G+E+A+K     +     +   E  +   +Q    + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66

Query: 366 LLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSR 425
            +  C  E +  ++   +   SL+      +R  +   K  + +   +   I Y+H    
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS--- 121

Query: 426 LKIIHRDLKTSNVL---LDHEMNPKISDFGMARIFGGNQSKAN-----TNRVVGTYGYMA 477
              IHRD+K  N L           I DFG+A+ +   ++  +        + GT  Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 478 PEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM 537
               +G   S + D+ S G VL+    G      +      +      ++  +  +  + 
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSL---PWQGLKAATKRQKYERISEKKMSTPIE 238

Query: 538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                   + A  L +      C      D+P  S +  + 
Sbjct: 239 VLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 39/287 (13%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGL---------QEFKNEVTV 354
           +++  +  LG G    V + +     KE AVK +  T G            +    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 355 IAKLQ-HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGI 413
           + K+  H N+++L           L+++ M    L  +L   T  V L  K    I++ +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 414 ARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTY 473
              I  LH+   L I+HRDLK  N+LLD +MN K++DFG +      +       V GT 
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 474 GYMAPEYAMGGI------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
            Y+APE     +      +  + D++S GV++  +++G      +       +L  I   
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMI--- 227

Query: 528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
              G+           S    +L+         +   P  R T    
Sbjct: 228 -MSGNYQFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (414), Expect = 3e-46
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 15/207 (7%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQH 360
           QDF     LG G FG V+      +G+  A+K L +      + ++   +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
             ++R+ G   +  +  +I +Y+    L   L  S R      K   + +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
                  II+RDLK  N+LLD   + KI+DFG A+             + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKK 507
                ++   D +SFG+++ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (411), Expect = 8e-46
 Identities = 55/279 (19%), Positives = 102/279 (36%), Gaps = 25/279 (8%)

Query: 302 KATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-FKNEVTVI 355
           K  +D        + LG G F  V         K +A+K +++ + +G +   +NE+ V+
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 356 AKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            K++H N+V L           LI + +    L   + +         +    +I  +  
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLD 118

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            + YLH+   +    +        LD +    ISDFG++++          +   GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGY 175

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE 535
           +APE      +S   D +S GV+   ++ G      ++ E+   L   I K         
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILK----AEYEF 228

Query: 536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
                   S    + ++        ++ DP  R T    
Sbjct: 229 DSPYWDDISDSAKDFIR------HLMEKDPEKRFTCEQA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-45
 Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 42/280 (15%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAK-LQ 359
           +DF     LG+G FG V+        +  A+K L +        ++    E  V++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 360 HKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILY 419
           H  L  +      +     + EY+    L   +    +    D  R       I  G+ +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 420 LHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE 479
           LH      I++RDLK  N+LLD + + KI+DFGM +      +K NT    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 480 YAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL------WCEGHA 533
             +G  ++   D +SFGV+L E++ G+     +H +    L   I         W E  A
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSIRMDNPFYPRWLEKEA 230

Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSS 573
            +L+                          +P  R  +  
Sbjct: 231 KDLLVK--------------------LFVREPEKRLGVRG 250

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 4e-44
 Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 32/296 (10%)

Query: 302 KATQDFSQENKLGEGGFGPVYKG--VLADGKEIAVKRLSRTSGQG--LQEFKNEVTVIAK 357
           +A Q +    ++GEG +G V+K   +   G+ +A+KR+   +G+         EV V+  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 358 L---QHKNLVRLLGCCLEENESLLIYEYMPNKSLD---VFLFDSTRSVQLDWKRRISIIK 411
           L   +H N+VRL   C            +  + +D       D      +  +    ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 412 GIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVG 471
            + RG+ +LH     +++HRDLK  N+L+      K++DFG+ARI+    +      VV 
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVV 177

Query: 472 TYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL---- 527
           T  Y APE  +   ++   D++S G +  E+   K     +        L  I  +    
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLP 234

Query: 528 ----WCEGHAAELMDSVVKQSCDQAELLKYIHIGLL-----CVQGDPIDRPTMSSV 574
               W    A        K +    + +  I          C+  +P  R +  S 
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-44
 Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 36/304 (11%)

Query: 311 NKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE-----FKNEVTVIAKLQHKNLV 364
           + LGEG F  VYK       + +A+K++        ++        E+ ++ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 365 RLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS 424
            LL     ++   L++++M              S+ L      + +    +G+ YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 425 RLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG- 483
              I+HRDLK +N+LLD     K++DFG+A+ FG           V T  Y APE   G 
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175

Query: 484 GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ 543
            ++ V  D+++ G +L E++       F   +     L  I++        +  D     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 544 SCDQAELLKYIHIGLL--------------CVQGDPIDRPTMSSVAVMLASDILT-LPKP 588
                +    I +  +                  +P  R T +     L     +  P P
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNRPGP 289

Query: 589 TQPA 592
           T   
Sbjct: 290 TPGC 293

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  156 bits (395), Expect = 9e-44
 Identities = 45/280 (16%), Positives = 100/280 (35%), Gaps = 27/280 (9%)

Query: 310 ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
             ++GEG FG +++G  L + +++A+K   R S     + ++E      L     +  + 
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVY 67

Query: 369 CCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKI 428
              +E    ++   +   SL+  L    R  +   K      K +   +  +HE     +
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSL 122

Query: 429 IHRDLKTSNVLLDHEMNP-----KISDFGMARIFGGNQSKAN-----TNRVVGTYGYMAP 478
           ++RD+K  N L+    +       + DFGM + +    +K +        + GT  YM+ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 479 EYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD 538
              +G   S + D+ + G V +  + G      +      +      ++  +  +  L +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSL---PWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVML 578
                  +  + + Y               P    +  + 
Sbjct: 240 LCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLF 273

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 3e-43
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 22/231 (9%)

Query: 306 DFSQENKLGEGGFGPVYKGVLAD-GKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLV 364
            ++    +G G FG VY+  L D G+ +A+K++ +      +    E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 365 RLLGCCLEENES------LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGIL 418
           RL        E        L+ +Y+P     V    S     L        +  + R + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 419 YLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMA 477
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     +   +    + +  Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190

Query: 478 PEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL 527
           PE   G   ++   DV+S G VL E++ G+     +  + G   L  I K+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKV 238

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  154 bits (389), Expect = 4e-43
 Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 29/287 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGVLADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKNL 363
            +    K+GEG +G VYK     G+  A+K  RL +           E++++ +L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 364 VRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
           V+L      +   +L++E++      +          L+     S +  +  GI Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD- 118

Query: 424 SRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMG 483
              +++HRDLK  N+L++ E   KI+DFG+AR FG    K      + T  Y AP+  MG
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMG 174

Query: 484 -GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD---- 538
              +S   D++S G +  E+++G      +        L  I+++    ++    +    
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 539 ------SVVKQSCDQAELLKYIHIGLL-----CVQGDPIDRPTMSSV 574
                   V +       LK +    +      ++ DP  R T    
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 42/288 (14%)

Query: 307 FSQEN---------KLGEGGFGPVYKGV-LADGKEIAVKRLSRTS------GQGLQEFKN 350
           F QEN         +LG G F  V K    + G + A K + +        G   ++ + 
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 351 EVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 410
           EV+++ ++QH N++ L      + + +LI E +    L  FL +      L  +     +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFL 119

Query: 411 KGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP----KISDFGMARIFGGNQSKANT 466
           K I  G   ++    L+I H DLK  N++L     P    KI DFG+A            
Sbjct: 120 KQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173

Query: 467 NRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK 526
             + GT  ++APE        +++D++S GV+   ++SG      +  +     LA +  
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANV-- 228

Query: 527 LWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
                +     +     S    + ++        +  DP  R T+   
Sbjct: 229 --SAVNYEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-42
 Identities = 63/289 (21%), Positives = 118/289 (40%), Gaps = 31/289 (10%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHKN 362
           +F +  K+GEG +G VYK      G+ +A+K  RL   +         E++++ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           +V+LL     EN+  L++E++          D++    +      S +  + +G+ + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 423 DSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPE-YA 481
               +++HRDLK  N+L++ E   K++DFG+AR FG           V T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
               +S   D++S G +  E+++ +     +  +     L  I++         +   V 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRT-LGTPDEVVWPGVT 231

Query: 542 KQSCDQAELLKYIHIGLL----------------CVQGDPIDRPTMSSV 574
                +    K+                       +  DP  R +  + 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 56/274 (20%), Positives = 104/274 (37%), Gaps = 30/274 (10%)

Query: 310 ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLL 367
              LG G  G V +       ++ A+K L         + + EV +  +  Q  ++VR++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71

Query: 368 GCC----LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED 423
                        L++ E +    L   + D         +    I+K I   I YLH  
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 424 SRLKIIHRDLKTSNVLLDHEMNP---KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
             + I HRD+K  N+L   +      K++DFG A+    + S         T  Y+APE 
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184

Query: 481 AMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
                +    D++S GV++  ++ G      ++S HG ++   +      G         
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
            + S +   L++        ++ +P  R T++  
Sbjct: 242 SEVSEEVKMLIR------NLLKTEPTQRMTITEF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-41
 Identities = 57/274 (20%), Positives = 95/274 (34%), Gaps = 43/274 (15%)

Query: 312 KLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQE------FKNEVTVIAKLQ--HKN 362
            LG GGFG VY G+ ++D   +A+K + +       E         EV ++ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 363 LVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE 422
           ++RLL      +  +LI E              T    L  +   S    +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 423 DSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                ++HRD+K  N+L+D      K+ DFG   +              GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWI 181

Query: 482 MGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV 540
                    + V+S G++L +++ G     F H E         ++         L+   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEE-IIRGQVFFRQRVSSECQHLIRW- 237

Query: 541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSV 574
                              C+   P DRPT   +
Sbjct: 238 -------------------CLALRPSDRPTFEEI 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 60/301 (19%), Positives = 117/301 (38%), Gaps = 41/301 (13%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQG--LQEFKNEVTVIAKLQHKN 362
            + +  K+G+G FG V+K      G+++A+K++   + +         E+ ++  L+H+N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 363 LVRLLGCCLE--------ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIA 414
           +V L+  C          +    L++++  +    +        V+        +++ + 
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLL 127

Query: 415 RGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR--VVGT 472
            G   L+   R KI+HRD+K +NVL+  +   K++DFG+AR F   ++         V T
Sbjct: 128 NG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 473 YGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI------- 524
             Y  PE  +G   +    D++  G ++ E+ +                LA I       
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQLCGSI 241

Query: 525 ----WKLWCEGHAAELMDSVVKQSCDQAELLKYIH-----IGLL--CVQGDPIDRPTMSS 573
               W         E ++ V  Q     + LK        + L+   +  DP  R     
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 574 V 574
            
Sbjct: 302 A 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 15/225 (6%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQHK 361
           DF     LG+G FG V      A G+  A+K L +    +   +     E  V+   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            L  L       +    + EY     L   L   +R      +R       I      L 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---LE 119

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                 +++RD+K  N++LD + + KI+DFG+ +    + +        GT  Y+APE  
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVL 177

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK 526
               +    D +  GVV+ E++ G+     ++++    L   I  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILM 219

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 31/290 (10%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVK--RLSRTSGQGLQEFKNEVTVIAKLQHK 361
           Q + +  K+GEG +G V+K       + +A+K  RL             E+ ++ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           N+VRL      + +  L++E+        F   +      D +   S +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
                 ++HRDLK  N+L++     K+++FG+AR FG       +  VV  +        
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV 541
              ++S   D++S G +  E+ +  +    +        L  I++L   G   E     +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLL--GTPTEEQWPSM 230

Query: 542 KQSCDQAELLKYIHIGLL-----------------CVQGDPIDRPTMSSV 574
            +  D      Y     L                  ++ +P+ R +    
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 64/304 (21%), Positives = 121/304 (39%), Gaps = 41/304 (13%)

Query: 299 DIVKATQDFSQ----ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNE 351
           ++ K   +          +G G +G V   V    G ++A+K+L R   S    +    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 352 VTVIAKLQHKNLVRLLGCCLEEN------ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 405
           + ++  ++H+N++ LL     +       +  L+  +M      +      +  +L   R
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDR 122

Query: 406 RISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKAN 465
              ++  + +G+ Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q+ + 
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSE 174

Query: 466 TNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK--------KSTGFYHSEH 516
               V T  Y APE  +  + ++   D++S G ++ E+I+GK                + 
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234

Query: 517 GPSLLAYIWKLWCEGHAAELMDSVVK-QSCDQAELLKYIH---IGLL--CVQGDPIDRPT 570
             +  A   +      A   M  + + +  D A +L       + LL   +  D   R T
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294

Query: 571 MSSV 574
               
Sbjct: 295 AGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 3e-36
 Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 18/225 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSR---TSGQGLQEFKNEVTVIAKLQHK 361
            F +   LG G FG V        G   A+K L +      + ++   NE  ++  +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 362 NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
            LV+L     + +   ++ EY+    +   L    R               I     YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH 158

Query: 422 EDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYA 481
               L +I+RDLK  N+L+D +   +++DFG A+   G         + GT   +APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEII 210

Query: 482 MGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWK 526
           +   ++   D ++ GV++ E+ +G      + ++    +   I  
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVS 252

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  130 bits (327), Expect = 4e-34
 Identities = 55/287 (19%), Positives = 114/287 (39%), Gaps = 24/287 (8%)

Query: 306 DFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNL 363
           D+    KLG G +  V++ + + + +++ VK L        ++ K E+ ++  L+   N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92

Query: 364 VRLLGCCLEENESL--LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLH 421
           + L     +       L++E++ N               L        +  I + + Y H
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH 146

Query: 422 EDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEY 480
               + I+HRD+K  NV++DHE    ++ D+G+A  +   Q     N  V +  +  PE 
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPEL 200

Query: 481 AMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS 539
            +   ++    D++S G +L  +I  K+   F+H       L  I K+       + +D 
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 540 V-VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTL 585
             ++      ++L               ++  +S  A+     +L  
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-33
 Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 34/293 (11%)

Query: 305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS----GQGLQEFKNEVTVIA 356
           ++F     LG G +G V+          GK  A+K L + +     +  +  + E  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 357 KLQHK-NLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
            ++    LV L      E +  LI +Y+    L   L    R  + + +  +        
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
            +L L    +L II+RD+K  N+LLD   +  ++DFG+++ F  ++++       GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 476 MAPEYAMGGI--FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA 533
           MAP+   GG        D +S GV++ E+++G      +  +   +  A I +   +   
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSE- 252

Query: 534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP 586
                       + + L K +   LL    DP  R          A +I    
Sbjct: 253 -------PPYPQEMSALAKDLIQRLLMK--DPKKRL---GCGPRDADEIKEHL 293

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 305 QDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHK 361
           + +     +G G  G V         + +A+K+LSR   +    +    E+ ++  + HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 362 NLVRLLGCCL------EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           N++ LL          E  +  L+ E M      V         +LD +R   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           GI +LH      IIHRDLK SN+++  +   KI DFG+AR  G +         V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 476 MAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
            APE  +G  +    D++S G ++ E++  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 304 TQDFSQENKLGEGGFGPVYKGV-LADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQH 360
            + +   + +G G +G V        G  +AVK+LSR   S    +    E+ ++  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 361 KNLVRLLGCC-----LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
           +N++ LL        LEE   + +  ++    L+    +  +  +L       +I  I R
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGY 475
           G+ Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      +         T  Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWY 184

Query: 476 MAPEYAMGGI-FSVKSDVFSFGVVLLEIISGK 506
            APE  +  + ++   D++S G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (287), Expect = 2e-28
 Identities = 36/212 (16%), Positives = 78/212 (36%), Gaps = 18/212 (8%)

Query: 310 ENKLGEGGFGPVYKGV-LADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLG 368
             KLG G F  V+    + +   +A+K +        +  ++E+ ++ ++   +  +   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76

Query: 369 CCLE-------------ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIAR 415
                             N   ++  +       + L        +       I K +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 416 GILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGMARIFGGNQSKANTNRVVGTYG 474
           G+ Y+H   R  IIH D+K  NVL++       +    +A +        +    + T  
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 475 YMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK 506
           Y +PE  +G  +   +D++S   ++ E+I+G 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 98.7 bits (245), Expect = 2e-24
 Identities = 39/202 (19%), Positives = 71/202 (35%), Gaps = 27/202 (13%)

Query: 311 NKLGEGGFGPVYKGVLADGKEIAVK--RLSRTSGQ--------GLQEFKNEVTVIAKLQH 360
             +GEG    V+        E  VK  ++  TS +        G   F       A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 361 KNLVRLLGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYL 420
           + L +L G  + +      Y +  N ++ + L D+    ++  +    ++  I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 421 HEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNR-VVGTYGYMAPE 479
           +      I+H DL   NVL+  E    I DF  +   G    +    R V     Y +  
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 480 YAMGGIFSVKSDVFSFGVVLLE 501
           Y        + D+ S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	624
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.08
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.65
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.03
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.8
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=411.74  Aligned_cols=264  Identities=29%  Similarity=0.462  Sum_probs=203.7

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|...+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            367888999999999999999875  36999998754  34567889999999999999999999998754 56899999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++...  ...+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999643  345899999999999999999999985   9999999999999999999999999998765444


Q ss_pred             CCccccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          462 SKANTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      .........||+.|||||++.+   +.++.++|||||||++|||+||+.||.-.      .....+......+.......
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~------~~~~~~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI------NNRDQIIFMVGRGYLSPDLS  232 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC------CCHHHHHHHHHHTSCCCCGG
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC------ChHHHHHHHHhcCCCCCcch
Confidence            4444456789999999999864   35899999999999999999999997421      11112222222222111111


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      . +...+    ...+.+|+.+||+.||++|||++||++.|+....++|
T Consensus       233 ~-~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         233 K-VRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             G-SCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             h-ccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            1 11122    2457889999999999999999999999986555554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=401.05  Aligned_cols=254  Identities=28%  Similarity=0.417  Sum_probs=198.1

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|+..+.||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788899999999999999999989999999997643 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +|+|.+++..  ....++|..++.|+.||++||.|||+.+   |+||||||+||||++++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999998864  3356899999999999999999999985   999999999999999999999999999876543322 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhcC
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQS  544 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  544 (624)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+..|+.  ..   ....+.... ...+....  .+     
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~--~~---~~~~~~~~~-i~~~~~~~--~p-----  224 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--EN---RSNSEVVED-ISTGFRLY--KP-----  224 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT--CS---CCHHHHHHH-HHHTCCCC--CC-----
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC--CC---CCHHHHHHH-HHhcCCCC--Cc-----
Confidence            2234578999999999999999999999999999999999654432  11   122222222 22221111  11     


Q ss_pred             CCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          545 CDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       545 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                        .....++.+|+.+||+.||++||||+||++.|++
T Consensus       225 --~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              1112357889999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=401.65  Aligned_cols=253  Identities=26%  Similarity=0.342  Sum_probs=202.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++.... .+..+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999975 58999999987543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++.   +...+++.++..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999984   3456999999999999999999999985   9999999999999999999999999998775444


Q ss_pred             CCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ........+||+.|||||++.+..+ +.++|||||||++|||++|+.||......   .....  ............   
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~--~~~~~~~~~~~~---  229 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYS--DWKEKKTYLNPW---  229 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---SHHHH--HHHTTCTTSTTG---
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---HHHHH--HHhcCCCCCCcc---
Confidence            3334456789999999999988876 67899999999999999999998532211   11111  111111111100   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                        ...+    ..+.+|+.+||+.||++|||++||++
T Consensus       230 --~~~s----~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 --KKID----SAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --GGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              1112    34667889999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=402.27  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=205.8

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|+..+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46788999999999999999999888899999997644 345789999999999999999999998754 5679999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++.. .....++|..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++.+..... 
T Consensus        90 ~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            99999988743 22345899999999999999999999985   99999999999999999999999999998754332 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      .......||+.|||||++.++.++.++|||||||++|||+||..|+..  .   ....+. ......+......     .
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~---~~~~~~-~~~i~~~~~~~~p-----~  233 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP--G---MTNPEV-IQNLERGYRMVRP-----D  233 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST--T---CCHHHH-HHHHHTTCCCCCC-----T
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC--C---CCHHHH-HHHHHhcCCCCCc-----c
Confidence            223345789999999999999999999999999999999997665321  1   112222 2222222211111     1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .++    ..+.+|+.+||+.||++||||+||++.|+.
T Consensus       234 ~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         234 NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            222    357889999999999999999999998864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=399.73  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=207.6

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999964 68999999998766666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++.+    ..+++.++..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999988753    35899999999999999999999985   99999999999999999999999999987643322 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..      .+...........+...-...    .
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~~~~~~~~~~~~~----~  240 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN------ENPLRALYLIATNGTPELQNP----E  240 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHHCSCCCSSG----G
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC------CCHHHHHHHHHhCCCCCCCCc----c
Confidence             23456799999999999999999999999999999999999999742      222333333333222111111    1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..    ...+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~----s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         241 KL----SAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    234778999999999999999999964

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-50  Score=403.54  Aligned_cols=257  Identities=29%  Similarity=0.458  Sum_probs=210.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|+..+.||+|+||+||+|+++ +++.||||+++... ...++|.+|+.+|++++|||||+++++|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467889999999999999999976 48889999987654 3467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +++|+|.+++... ....+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998653 3457899999999999999999999985   99999999999999999999999999987654332


Q ss_pred             CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          463 KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                      . ......|++.|+|||++.++.++.++|||||||++|||++|+.|+.  ...   +. ..+.+....+......     
T Consensus       171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~--~~~---~~-~~~~~~i~~~~~~~~~-----  238 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGI---DL-SQVYELLEKDYRMERP-----  238 (287)
T ss_dssp             E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS--TTC---CH-HHHHHHHHTTCCCCCC-----
T ss_pred             e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC--Ccc---hH-HHHHHHHhcCCCCCCC-----
Confidence            2 2234568899999999999999999999999999999999877642  111   11 1222333333222111     


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..+    ...+.+|+.+||+.||++|||+.||++.|+..
T Consensus       239 ~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         239 EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            122    23578899999999999999999999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-50  Score=405.86  Aligned_cols=254  Identities=27%  Similarity=0.414  Sum_probs=193.5

Q ss_pred             CccccCccccCCceeEEEEEecC-Cc---EEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLAD-GK---EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~~-g~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +|+..+.||+|+||+||+|+++. ++   .||||++... .....++|.+|+.+|++++|||||+++|++.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            45556899999999999999753 32   5899988654 3445678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..  ....++|.+++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999998854  3346899999999999999999999985   999999999999999999999999999876543


Q ss_pred             CCCc---cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          461 QSKA---NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       461 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ....   ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...      ...+..... ..+.... 
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~------~~~~~~~~i-~~~~~~~-  253 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------TNQDVINAI-EQDYRLP-  253 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHH-HTTCCCC-
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC------CHHHHHHHH-HcCCCCC-
Confidence            3221   2223457899999999999999999999999999999998 89887421      122222222 2221111 


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                              .+......+.+|+.+||+.||++||||.||++.|+.
T Consensus       254 --------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         254 --------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                    111223457889999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=397.44  Aligned_cols=261  Identities=27%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             hcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      .++|++.+.||+|+||.||+|+++++++||||+++... ...+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            36899999999999999999999988899999997543 34578999999999999999999999985 45689999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|..++... ....++|.+++.|+.||++||.|||+++   |+||||||+||||++++++||+|||+++....... 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999999888542 2345899999999999999999999985   99999999999999999999999999987644332 


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      .......||+.|+|||++.++.++.++||||||+++|||++|+.|+..  .   ....+.. ..+..+......     .
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~---~~~~~~~-~~i~~~~~~~~~-----~  237 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--G---MVNREVL-DQVERGYRMPCP-----P  237 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--T---CCHHHHH-HHHHTTCCCCCC-----T
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC--C---CCHHHHH-HHHHhcCCCCCC-----c
Confidence            223345789999999999999999999999999999999997766431  1   1222222 222222211111     1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccCCCCCC
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASDILTLP  586 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~  586 (624)
                      .+    ..++.+++.+||+.||++||||++|+++|+....+.+
T Consensus       238 ~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         238 EC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cc----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            22    2357789999999999999999999999987544443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=388.04  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=209.7

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEecc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMP  384 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~  384 (624)
                      ++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57889999999999999999998888999999986543 45789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCCc
Q 006952          385 NKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSKA  464 (624)
Q Consensus       385 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  464 (624)
                      +|+|..++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999998754  3446889999999999999999999985   999999999999999999999999999876543322 


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......||+.|+|||++.+..++.++||||||+++|||+| |+.||+..      ...+..... ..+....  .+   .
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~------~~~~~~~~i-~~~~~~~--~p---~  224 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------TNSETAEHI-AQGLRLY--RP---H  224 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHHHH-HTTCCCC--CC---T
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC------CHHHHHHHH-HhCCCCC--Cc---c
Confidence            2334678999999999999999999999999999999998 78887422      222222222 2222111  11   1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                      ..    ...+.+++.+||+.||++|||+++|++.|.
T Consensus       225 ~~----~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         225 LA----SEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cc----cHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            12    235788999999999999999999999884

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=396.25  Aligned_cols=254  Identities=26%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEe--cCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--ENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lV  379 (624)
                      ++|++.+.||+|+||.||+|+.+ +|+.||||++....  ....+.+.+|+.++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999975 68899999987653  3345778999999999999999999999875  4457899


Q ss_pred             EEeccCCChhhhhhcCC-CCcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          380 YEYMPNKSLDVFLFDST-RSVQLDWKRRISIIKGIARGILYLHEDS--RLKIIHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      |||+++|+|.+++.... ....+++..++.++.||++||.|||+.+  ..+|+||||||+||||++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986432 3456999999999999999999999864  23599999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          457 FGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       457 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      +.....  ......||+.|||||++.+..++.++|||||||++|||++|+.||.-      .+..+... ....+....+
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~------~~~~~~~~-~i~~~~~~~~  234 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAG-KIREGKFRRI  234 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHH-HHHHTCCCCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC------CCHHHHHH-HHHcCCCCCC
Confidence            654322  23346899999999999999999999999999999999999999742      12222222 2223332222


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ..     .++    ..+.+|+.+||+.||++|||+.||++
T Consensus       235 ~~-----~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 PY-----RYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CT-----TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Cc-----ccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11     222    34778899999999999999999965

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=391.89  Aligned_cols=245  Identities=26%  Similarity=0.379  Sum_probs=203.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.+.   .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 5889999998643   2344677899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999853   346899999999999999999999985   999999999999999999999999999865432


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||..      .+..+..... ...... +    
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i-~~~~~~-~----  223 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------NTYQETYKRI-SRVEFT-F----  223 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHH-HTTCCC-C----
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC------CCHHHHHHHH-HcCCCC-C----
Confidence                23346799999999999999999999999999999999999999742      1222222222 222111 1    


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                           +......+.+++.+||+.||++|||++||++
T Consensus       224 -----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 -----PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                 1111235778899999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=403.04  Aligned_cols=257  Identities=28%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             cCccccCccccCCceeEEEEEecC-C-----cEEEEEEcccc-CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-G-----KEIAVKRLSRT-SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENES  376 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  376 (624)
                      ++|+..+.||+|+||+||+|++.. +     ..||+|++... .....+.+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            678899999999999999999653 2     36999998654 344567889999999998 899999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCC--------------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 006952          377 LLIYEYMPNKSLDVFLFDSTR--------------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTS  436 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~  436 (624)
                      ++||||+++|+|.++|.....                    ...+++..++.|+.||++||.|||+++   |+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999965332                    235899999999999999999999985   999999999


Q ss_pred             cEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCC
Q 006952          437 NVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSE  515 (624)
Q Consensus       437 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~  515 (624)
                      |||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||..... 
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~-  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999987655444333445678999999999999999999999999999999998 8999742211 


Q ss_pred             CCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhc
Q 006952          516 HGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLA  579 (624)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  579 (624)
                        .   ....+....+.....         +......+.+|+.+||+.||++|||++||+++|.
T Consensus       273 --~---~~~~~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 --D---ANFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             --S---HHHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --H---HHHHHHHhcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence              1   112222223221111         1112235788999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=392.94  Aligned_cols=254  Identities=27%  Similarity=0.447  Sum_probs=204.9

Q ss_pred             cCccccC-ccccCCceeEEEEEec---CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQEN-KLGEGGFGPVYKGVLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      +++...+ +||+|+||.||+|+++   ++..||||+++... ....++|.+|+.+|++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999864   34579999997654 3456789999999999999999999999865 568999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..  ....+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3346899999999999999999999985   99999999999999999999999999998754


Q ss_pred             CCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          460 NQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       460 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...   ....+    ......+...+..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~---~~~~~----~~~i~~~~~~~~p  234 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEV----MAFIEQGKRMECP  234 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CTHHH----HHHHHTTCCCCCC
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC---CHHHH----HHHHHcCCCCCCC
Confidence            4322 22334568999999999999999999999999999999998 89997522   11112    2223333322221


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      +     .++    ..+.+|+.+||+.||++||||.+|++.|+.
T Consensus       235 ~-----~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         235 P-----ECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             T-----TCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-----cCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1     222    357789999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-49  Score=396.37  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~  383 (624)
                      +.|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999975 58899999998777777788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++.+.  ...+++.++..++.||++||.|||+++   |+||||||+|||++.++++||+|||+++......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999987542  345899999999999999999999985   9999999999999999999999999997543211  


Q ss_pred             ccccccccccCccChhhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          464 ANTNRVVGTYGYMAPEYAM-----GGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      .......||+.|||||++.     +..++.++|||||||++|||++|+.||...   .......   +..... ...+..
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~---~~~~~~~---~i~~~~-~~~~~~  237 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLL---KIAKSE-PPTLAQ  237 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS---CGGGHHH---HHHHSC-CCCCSS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC---CHHHHHH---HHHcCC-CCCCCc
Confidence            1223467999999999984     456899999999999999999999997422   1122222   222221 111111


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      +   ...    ...+.+++.+||+.||++|||+.|+++
T Consensus       238 ~---~~~----s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         238 P---SRW----SSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             G---GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c---ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1   112    235778899999999999999999965

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=391.23  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=199.3

Q ss_pred             cCccccCccccCCceeEEEEEecCC-----cEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADG-----KEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      +.|+..+.||+|+||.||+|.+++.     ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999997642     369999987543 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ||||+.++++.+++..  ....++|.+++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999988754  3346899999999999999999999985   9999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQS-KANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      .... ........||+.|||||++.++.++.++|||||||++|||++|..|+..  ..   ...+ +.+....+..... 
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~--~~---~~~~-~~~~i~~~~~~~~-  234 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--EL---SNHE-VMKAINDGFRLPT-  234 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TC---CHHH-HHHHHHTTCCCCC-
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc--cC---CHHH-HHHHHhccCCCCC-
Confidence            4322 2223345689999999999999999999999999999999997666421  11   1122 2222333322111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                              +......+.+|+.+||+.||++||||.||+++|+..
T Consensus       235 --------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         235 --------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             --------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence                    112234578899999999999999999999999753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=390.94  Aligned_cols=247  Identities=29%  Similarity=0.412  Sum_probs=196.8

Q ss_pred             CccccCCceeEEEEEecC---CcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEeccC
Q 006952          311 NKLGEGGFGPVYKGVLAD---GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEYMPN  385 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey~~~  385 (624)
                      ++||+|+||+||+|.+++   ++.||||+++...  ....++|.+|+.+|++++|||||+++|+|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998653   4679999986543  3345789999999999999999999999864 567899999999


Q ss_pred             CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC-c
Q 006952          386 KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK-A  464 (624)
Q Consensus       386 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~  464 (624)
                      |+|.+++..   ...+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   345899999999999999999999985   999999999999999999999999999876544322 2


Q ss_pred             cccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhhc
Q 006952          465 NTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQ  543 (624)
Q Consensus       465 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  543 (624)
                      ......||+.|||||.+.+..++.++|||||||++|||+| |+.||...      +..+.. .....+......     .
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~------~~~~~~-~~i~~~~~~~~p-----~  233 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM------KGSEVT-AMLEKGERMGCP-----A  233 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHH-HHHHTTCCCCCC-----T
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC------CHHHHH-HHHHcCCCCCCC-----c
Confidence            2334578999999999999999999999999999999998 89997421      122222 222233222211     1


Q ss_pred             CCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          544 SCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       544 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .+    ...+.+|+.+||+.||++|||+++|+++|+.
T Consensus       234 ~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         234 GC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cc----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            22    2357789999999999999999999998864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=386.97  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=195.8

Q ss_pred             cccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec----CcceEEE
Q 006952          308 SQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE----NESLLIY  380 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~----~~~~lV~  380 (624)
                      +..++||+|+||+||+|+.. +++.||+|++...  .....+.+.+|+++|++++|||||++++++.+.    ...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999976 5889999998654  334567899999999999999999999998762    3468999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc-CCCCeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD-HEMNPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  459 (624)
                      ||+++|+|.+++..   ...+++..++.++.||++||.|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999854   346899999999999999999999874 3599999999999996 578999999999986432


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      .    ......||+.|||||++.+ .++.++|||||||++|||++|+.||...     .... .+.+....+.....   
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-----~~~~-~~~~~i~~~~~~~~---  233 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-----QNAA-QIYRRVTSGVKPAS---  233 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-----SSHH-HHHHHHTTTCCCGG---
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-----ccHH-HHHHHHHcCCCCcc---
Confidence            2    2335689999999998875 5999999999999999999999997421     1222 22222333222111   


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       +....+.    ++.+|+.+||+.||++|||+.|+++
T Consensus       234 -~~~~~~~----~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 -FDKVAIP----EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -GGGCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cCccCCH----HHHHHHHHHccCCHhHCcCHHHHhC
Confidence             1122222    4678899999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=394.13  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=201.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++.+.   .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 6899999998653   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998853   346899999999999999999999985   999999999999999999999999999987654


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      ..........||+.|||||++.+..++.++|||||||++|||++|+.||..      .+......+.. .... .+.   
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------~~~~~~~~~i~-~~~~-~~p---  230 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA------GNEYLIFQKII-KLEY-DFP---  230 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHH-TTCC-CCC---
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC------cCHHHHHHHHH-cCCC-CCC---
Confidence            444444557899999999999999999999999999999999999999742      12222222222 2211 111   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVA  575 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  575 (624)
                        ...    ...+.+|+.+||+.||++|||++|++
T Consensus       231 --~~~----s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         231 --EKF----FPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             --TTC----CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             --ccC----CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence              112    23477899999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=398.55  Aligned_cols=198  Identities=29%  Similarity=0.421  Sum_probs=175.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999975 68899999987653 3445778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+++|+|.+++.+   ...+++..+..++.||++||.|||++.  +|+||||||+||||++++.+||+|||+|+.+... 
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999954   345899999999999999999999741  3999999999999999999999999999865322 


Q ss_pred             CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCC
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTG  510 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~  510 (624)
                         .....+||+.|||||++.+..++.++||||+||++|||++|+.||.
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~  204 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP  204 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence               2234689999999999999999999999999999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-48  Score=392.27  Aligned_cols=260  Identities=28%  Similarity=0.441  Sum_probs=210.4

Q ss_pred             HhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc
Q 006952          303 ATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE  375 (624)
Q Consensus       303 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  375 (624)
                      ..++|+..+.||+|+||+||+|+++      +++.||||+++.... +..++|.+|+.++++++||||+++++++.+.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4568999999999999999999964      356899999976443 345779999999999999999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCC---------------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 006952          376 SLLIYEYMPNKSLDVFLFDST---------------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLK  434 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk  434 (624)
                      .+++|||+++|+|.+++....                     ....+++..++.|+.||+.||+|||+.+   |+|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999986422                     1235899999999999999999999985   9999999


Q ss_pred             CCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCC-CCCCCC
Q 006952          435 TSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK-STGFYH  513 (624)
Q Consensus       435 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~-p~~~~~  513 (624)
                      |+||||+.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|.. |+..  
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~--  245 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG--  245 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC--
Confidence            9999999999999999999987654444444445678999999999999999999999999999999999964 5431  


Q ss_pred             CCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          514 SEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                          ....+.... ...+......+     .++    .++.+|+.+||+.||++||||.||+++|++.
T Consensus       246 ----~~~~e~~~~-v~~~~~~~~p~-----~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         246 ----MAHEEVIYY-VRDGNILACPE-----NCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             ----SCHHHHHHH-HHTTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ----CCHHHHHHH-HHcCCCCCCCc-----cch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                222233333 23333322211     222    3578899999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.5e-47  Score=391.01  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=207.8

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            458999999999999999999975 6899999999877666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC--CCCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH--EMNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~  460 (624)
                      +++|+|.+++..  ....+++..+..|+.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999998854  2346999999999999999999999985   999999999999954  578999999999876533


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||.-      .+..+......... .. . +..
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------~~~~~~~~~i~~~~-~~-~-~~~  247 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG------ENDDETLRNVKSCD-WN-M-DDS  247 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHTC-CC-S-CCG
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC-CC-C-Ccc
Confidence            2   23346799999999999999999999999999999999999999742      12222222222211 11 0 111


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      .....+    ..+.+++.+||+.||++|||++|+++.
T Consensus       248 ~~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 AFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111122    246788999999999999999999884

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-47  Score=390.35  Aligned_cols=245  Identities=29%  Similarity=0.456  Sum_probs=200.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      +.|+..+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45899999999999999999965 688899999876543   34567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|+.++..   ...+++.+++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999876643   346899999999999999999999985   99999999999999999999999999986532 


Q ss_pred             CCCccccccccccCccChhhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMG---GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                           .....||+.|||||++.+   +.++.++|||||||++|||++|+.||.-      ....+...+...... ....
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~------~~~~~~~~~i~~~~~-~~~~  235 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNES-PALQ  235 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT------SCHHHHHHHHHHSCC-CCCS
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC------CCHHHHHHHHHhCCC-CCCC
Confidence                 234579999999999864   4689999999999999999999999741      222333333332221 1111


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .    ..++    ..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~----~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 S----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C----CCCC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1    1122    34778899999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-47  Score=385.89  Aligned_cols=251  Identities=22%  Similarity=0.251  Sum_probs=188.4

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .+.|+..+.||+|+||+||+|+.+ +++.||||++.+... ...+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356999999999999999999975 588999999876432 334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc---CCCCeEEeccccccccC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD---HEMNPKISDFGMARIFG  458 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~  458 (624)
                      |+++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999953   446999999999999999999999985   99999999999994   57899999999998654


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ...   ......||+.|||||++.+..++.++|||||||++|||++|+.||.-      ............ ....  ..
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------~~~~~~~~~i~~-~~~~--~~  229 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD------ENDAKLFEQILK-AEYE--FD  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHT-TCCC--CC
T ss_pred             CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHHhc-cCCC--CC
Confidence            332   22346799999999999999999999999999999999999999742      122222222222 2111  11


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .......+    ..+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 SPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11111222    35778999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.1e-46  Score=388.70  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=209.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999964 6999999999876666667889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEc--CCCCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLD--HEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~  460 (624)
                      +++|+|.+++..  ....+++.+++.|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||++..+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999887743  3346999999999999999999999985   99999999999998  6789999999999876543


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.-      .+............ .. . ...
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~~i~~~~-~~-~-~~~  250 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG------EDDLETLQNVKRCD-WE-F-DED  250 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC------SSHHHHHHHHHHCC-CC-C-CSS
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC------CCHHHHHHHHHhCC-CC-C-Ccc
Confidence            2   23346799999999999999999999999999999999999999742      22222222222211 11 0 000


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hccCC
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM--LASDI  582 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~  582 (624)
                      .....    ...+.+|+.+||+.||++|||+.|+++.  ++...
T Consensus       251 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         251 AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            11112    2347789999999999999999999873  65443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-47  Score=386.11  Aligned_cols=268  Identities=26%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             CCHHHHHHHhcCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhc-CCCCcceE
Q 006952          295 LDLIDIVKATQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKL-QHKNLVRL  366 (624)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l  366 (624)
                      .+...++-..++|+..+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|+..+.++ +|+||+.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            344444333478999999999999999999854      24689999997543 34456788888888887 68999999


Q ss_pred             EeEEEecC-cceEEEEeccCCChhhhhhcCCC-------------CcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 006952          367 LGCCLEEN-ESLLIYEYMPNKSLDVFLFDSTR-------------SVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRD  432 (624)
Q Consensus       367 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~D  432 (624)
                      ++++...+ ..++||||+++|+|.+++.....             ...+++.+++.++.||++||.|||+++   |+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence            99987654 57899999999999999965321             345899999999999999999999985   99999


Q ss_pred             CCCCcEEEcCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCC-CCCCC
Q 006952          433 LKTSNVLLDHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK-KSTGF  511 (624)
Q Consensus       433 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~-~p~~~  511 (624)
                      |||+||||++++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||++|. +||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998766555444555678999999999999999999999999999999999975 45532


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          512 YHSEHGPSLLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      .   ...   .........+......+     ..    ..++.+++.+||+.||++|||+.||+++|++
T Consensus       240 ~---~~~---~~~~~~~~~~~~~~~~~-----~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         240 V---KID---EEFCRRLKEGTRMRAPD-----YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             C---CCS---HHHHHHHHHTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---CHH---HHHHHHHhcCCCCCCCc-----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1   111   12222233333222221     12    2357889999999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=379.84  Aligned_cols=255  Identities=29%  Similarity=0.413  Sum_probs=197.7

Q ss_pred             cCccccCccccCCceeEEEEEecC--C--cEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD--G--KEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|+..+.||+|+||.||+|++..  +  ..||||++.+.   ..+..++|.+|+.+|++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            578999999999999999998642  2  36899998754   33456789999999999999999999999965 4678


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+++|++.+.+..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988754  3346999999999999999999999985   999999999999999999999999999987


Q ss_pred             CCCCCC-ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          458 GGNQSK-ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       458 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ...... .......|+..|+|||++.+..++.++||||||+++|||+| |+.||.      ..+..+........+....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~------~~~~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQILHKIDKEGERLP  235 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT------TCCHHHHHHHHHTSCCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC------CcCHHHHHHHHHhCCCCCC
Confidence            544332 22334567889999999999999999999999999999998 899874      2233344444444432222


Q ss_pred             cccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          536 LMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       536 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ..     ..++    ..+.+|+.+||+.||++||||.||+++|.+
T Consensus       236 ~~-----~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         236 RP-----EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Cc-----cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11     1222    357889999999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=391.95  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=199.5

Q ss_pred             cCccccCccccCCceeEEEEEec-CCc----EEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGK----EIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLL  378 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  378 (624)
                      .+|+..+.||+|+||+||+|++. +|+    +||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999965 343    5899988654 345678899999999999999999999999764 5688


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccC
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFG  458 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  458 (624)
                      ++||+.+++|.+++..  ....+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999988764  3456899999999999999999999985   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 006952          459 GNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELM  537 (624)
Q Consensus       459 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (624)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |++||...   ....+...+    ..+..... 
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~---~~~~~~~~i----~~~~~~~~-  234 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSIL----EKGERLPQ-  234 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS---CGGGHHHHH----HHTCCCCC-
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC---CHHHHHHHH----HcCCCCCC-
Confidence            5544444445678999999999999999999999999999999999 78886422   122222222    22221111 


Q ss_pred             cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          538 DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       538 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                              +......+.+|+.+||+.||++|||+.||++.|..
T Consensus       235 --------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         235 --------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             --------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                    11123457889999999999999999999988754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=378.75  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=195.5

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEe-cCcceEEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE-ENESLLIYEYM  383 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lV~Ey~  383 (624)
                      ++|+..+.||+|+||.||+|+++ |.+||||+++..  ...+.|.+|+.++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            56888899999999999999985 789999999754  345789999999999999999999999965 45689999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++... ....++|..++.|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999642 2345899999999999999999999985   999999999999999999999999999865332   


Q ss_pred             ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchhh
Q 006952          464 ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVVK  542 (624)
Q Consensus       464 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  542 (624)
                        .....+|+.|+|||++.++.++.++||||||+++|||+| |++|+...   ...++...+    ..+...++.+    
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i----~~~~~~~~~~----  223 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRV----EKGYKMDAPD----  223 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHH----TTTCCCCCCT----
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHH----HcCCCCCCCc----
Confidence              223467899999999999999999999999999999998 67775422   222233222    2222222221    


Q ss_pred             cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          543 QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       543 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                       ..    ...+.+|+.+||+.||++||||.+|+++|+.
T Consensus       224 -~~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         224 -GC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             -TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -cC----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence             12    2357789999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=377.87  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=204.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC------cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS------GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .+.|++.+.||+|+||+||+|+.+ +|+.||||++.+..      ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999974 68999999986532      22467899999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC----CeEEeccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM----NPKISDFG  452 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  452 (624)
                      ++||||+++|+|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999854   346999999999999999999999985   99999999999998876    49999999


Q ss_pred             cccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          453 MARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       453 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..      .+..+...... ...
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------~~~~~~~~~i~-~~~  232 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG------DTKQETLANVS-AVN  232 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHH-TTC
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC------CCHHHHHHHHH-hcC
Confidence            998764332   22345789999999999999999999999999999999999999742      12222222222 211


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .. . ........    ...+.+++.+||+.||++|||++|+++
T Consensus       233 ~~-~-~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 YE-F-EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC-C-CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC-C-CchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11 0 11111112    234778999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=381.68  Aligned_cols=266  Identities=24%  Similarity=0.334  Sum_probs=200.3

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC----cceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN----ESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lV~  380 (624)
                      ++|...+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677788999999999999997 5899999998654321 122344555666789999999999998765    468999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHED-----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ||+++|+|.+++..    ..++|..++.++.|++.||.|||+.     +.++|+||||||+||||++++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999964    3589999999999999999999974     12469999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccccCccChhhhcCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCCCCC--------CCC
Q 006952          456 IFGGNQS--KANTNRVVGTYGYMAPEYAMGGI------FSVKSDVFSFGVVLLEIISGKKSTGFYHSEH--------GPS  519 (624)
Q Consensus       456 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDv~S~Gvil~elltg~~p~~~~~~~~--------~~~  519 (624)
                      .......  ........||+.|+|||++.+..      ++.++|||||||+||||+||..|+.......        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            7654322  22344578999999999987643      6779999999999999999998865322111        111


Q ss_pred             HHHHHHHHHhcCCcc-ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          520 LLAYIWKLWCEGHAA-ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...........+... .+.+..    .+.+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRW----QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGG----GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCccc----CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            222233333222221 111111    123455678899999999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=379.41  Aligned_cols=259  Identities=30%  Similarity=0.438  Sum_probs=208.1

Q ss_pred             hcCccccCccccCCceeEEEEEecC--------CcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEEec
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLAD--------GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEE  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  373 (624)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3688889999999999999998532        24799999976554 4457889999999888 899999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCC-------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          374 NESLLIYEYMPNKSLDVFLFDST-------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      +..++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999996532             1246899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPS  519 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~  519 (624)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||++ |++||..      ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~------~~  242 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG------VP  242 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT------CC
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC------CC
Confidence            9999999999999997765555555556789999999999999999999999999999999998 6777642      11


Q ss_pred             HHHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          520 LLAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      . ..+...+..+.......     .++    ..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       243 ~-~~~~~~i~~~~~~~~p~-----~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         243 V-EELFKLLKEGHRMDKPS-----NCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             H-HHHHHHHHTTCCCCCCS-----SCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-HHHHHHHHcCCCCCCCc-----cch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1 22333444443332221     222    3578899999999999999999999999753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=376.41  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=194.0

Q ss_pred             cCccccCccccCCceeEEEEEecC----CcEEEEEEccccCc-ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD----GKEIAVKRLSRTSG-QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|+..+.||+|+||.||+|++..    +..||||+++.... ...+.+.+|+.++++++|||||+++|++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578899999999999999998653    34689999875443 44577999999999999999999999985 4678999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999988754  3346899999999999999999999985   99999999999999999999999999987654


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIIS-GKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD  538 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  538 (624)
                      ... .......||+.|+|||++.++.++.++|||||||++|||++ |.+|+...   ....+...+    ..+...... 
T Consensus       161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~---~~~~~~~~i----~~~~~~~~~-  231 (273)
T d1mp8a_         161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRI----ENGERLPMP-  231 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC---CGGGHHHHH----HTTCCCCCC-
T ss_pred             Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC---CHHHHHHHH----HcCCCCCCC-
Confidence            322 22334568999999999999999999999999999999998 78886532   222233222    222222111 


Q ss_pred             chhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          539 SVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       539 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                          ..+    ...+.+|+.+||+.||++|||+.||++.|++
T Consensus       232 ----~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         232 ----PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                122    2357789999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=382.03  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=210.4

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccCc-ccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  375 (624)
                      .++|+..+.||+|+||.||+|++.      +++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468888999999999999999852      456899999976543 3456789999999999 79999999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCC---------------CCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 006952          376 SLLIYEYMPNKSLDVFLFDST---------------RSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLL  440 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll  440 (624)
                      .++||||+++|+|.+++....               ....+++..++.++.||++||.|||+++   |+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986532               2335899999999999999999999985   9999999999999


Q ss_pred             cCCCCeEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006952          441 DHEMNPKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSL  520 (624)
Q Consensus       441 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~  520 (624)
                      +.++.+||+|||+++...............||+.|+|||++.++.++.++||||||+++|||+|++.|+..  .....  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~--~~~~~--  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVD--  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCSS--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC--CCCHH--
Confidence            99999999999999987655444445567899999999999999999999999999999999995544321  11111  


Q ss_pred             HHHHHHHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          521 LAYIWKLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       521 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                       ..+++....+......         ......+.+|+.+||+.||++||||.||+++|++.
T Consensus       255 -~~~~~~i~~~~~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 -SKFYKMIKEGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -HHHHHHHHHTCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCCCCCc---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             1222222222221111         11224578899999999999999999999999753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-46  Score=380.08  Aligned_cols=259  Identities=28%  Similarity=0.444  Sum_probs=211.8

Q ss_pred             hcCccccCccccCCceeEEEEEec------CCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENES  376 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  376 (624)
                      .++|...+.||+|+||.||+|.++      ++..||||+++... ......|.+|+.++++++||||++++|++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            468889999999999999999864      25789999997643 34456789999999999999999999999999999


Q ss_pred             eEEEEeccCCChhhhhhcC-------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          377 LLIYEYMPNKSLDVFLFDS-------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                      ++||||+++|+|.+++...       .....+++..+..++.|+++||.|||+++   |+||||||+||||++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999988642       12245789999999999999999999984   9999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGK-KSTGFYHSEHGPSLLAYIWKLW  528 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  528 (624)
                      |||+++.+.............||+.|+|||.+.++.++.++||||||+++|||+||. +|+.      .....+..... 
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~------~~~~~~~~~~i-  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ------GLSNEQVLRFV-  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT------TSCHHHHHHHH-
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC------CCCHHHHHHHH-
Confidence            999998775544444445567899999999999999999999999999999999986 5542      12333333322 


Q ss_pred             hcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          529 CEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       529 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      ..+......+     .+    ...+.+|+.+||+.+|++||||++|+++|++.
T Consensus       249 ~~~~~~~~p~-----~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 MEGGLLDKPD-----NC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HhCCCCCCcc-----cc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2333222221     12    23588899999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=385.22  Aligned_cols=248  Identities=22%  Similarity=0.250  Sum_probs=204.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      .++|++.+.||+|+||.||+++.+ +|+.||||++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999974 6899999999754   234567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999998854   346899999999999999999999985   99999999999999999999999999986543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|++||..      .+........ ..+.. .+.  
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~------~~~~~~~~~i-~~~~~-~~p--  225 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHERLFELI-LMEEI-RFP--  225 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHH-HHCCC-CCC--
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC------cCHHHHHHHH-hcCCC-CCC--
Confidence            22  223457899999999999999999999999999999999999999742      1222222222 22221 111  


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                         ...+    ..+.+|+.+||+.||++||+     +.||++
T Consensus       226 ---~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 ---RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---ccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               1122    34678899999999999995     788875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-46  Score=379.39  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             cCccccCccccCCceeEEEEEecC-Cc--EEEEEEcccc-CcccHHHHHHHHHHHHhc-CCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLAD-GK--EIAVKRLSRT-SGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|+..+.||+|+||.||+|++++ |.  .||||++... .....+.|.+|+.+|+++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999764 33  4788887643 344567899999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhcC-------------CCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCe
Q 006952          380 YEYMPNKSLDVFLFDS-------------TRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNP  446 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  446 (624)
                      |||+++|+|.++|...             .....++|..++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23457999999999999999999999985   9999999999999999999


Q ss_pred             EEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCC-CCCCCCCCCCCCHHHHHH
Q 006952          447 KISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKK-STGFYHSEHGPSLLAYIW  525 (624)
Q Consensus       447 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~  525 (624)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. |+.      ..+..+...
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~------~~~~~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYE  237 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT------TCCHHHHHH
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC------CCCHHHHHH
Confidence            99999999865322   22234568999999999999999999999999999999999765 442      122222222


Q ss_pred             HHHhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          526 KLWCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       526 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                      . ...+......         ......+.+|+.+||+.||++||||+||++.|++.
T Consensus       238 ~-i~~~~~~~~~---------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 K-LPQGYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             H-GGGTCCCCCC---------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-HHhcCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2 2222211111         11223578899999999999999999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=376.91  Aligned_cols=252  Identities=27%  Similarity=0.424  Sum_probs=200.6

Q ss_pred             cCccccCCceeEEEEEecCC----cEEEEEEcccc-CcccHHHHHHHHHHHHhcCCCCcceEEeEEEec-CcceEEEEec
Q 006952          310 ENKLGEGGFGPVYKGVLADG----KEIAVKRLSRT-SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-NESLLIYEYM  383 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lV~Ey~  383 (624)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997542    25899999753 445568899999999999999999999998764 5689999999


Q ss_pred             cCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCCC
Q 006952          384 PNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQSK  463 (624)
Q Consensus       384 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  463 (624)
                      ++|+|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998864  3445788999999999999999999985   999999999999999999999999999876544322


Q ss_pred             --ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccchh
Q 006952          464 --ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSVV  541 (624)
Q Consensus       464 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  541 (624)
                        .......||+.|+|||.+.++.++.++||||||+++|||++|+.|+...  ....+....+    ..+......    
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~--~~~~~~~~~i----~~g~~~~~p----  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--VNTFDITVYL----LQGRRLLQP----  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCCCCC----
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC--CCHHHHHHHH----HcCCCCCCc----
Confidence              2233457899999999999999999999999999999999988875422  1222222222    222222111    


Q ss_pred             hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhccC
Q 006952          542 KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLASD  581 (624)
Q Consensus       542 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~  581 (624)
                       ..+    ...+.+|+.+||+.||++||||.||++.|++.
T Consensus       257 -~~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         257 -EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             112    23577899999999999999999999999765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-45  Score=370.56  Aligned_cols=258  Identities=25%  Similarity=0.360  Sum_probs=201.0

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc---ccHHHHHHHHHHHHhcCCCCcceEEeEEEecCc----
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENE----  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  375 (624)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++....   ...+.+.+|+.++++++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999964 689999999976432   345678999999999999999999999987654    


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+++++|.+++..   ...+++.+++.|+.||++||.|||+++   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            6899999999999988853   346899999999999999999999985   9999999999999999999999999987


Q ss_pred             ccCCCC-CCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          456 IFGGNQ-SKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       456 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ...... .........||+.|||||++.+..++.++|||||||++|||+||+.||..      .+..+...+....+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~------~~~~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG------DSPVSVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC------cCHHHHHHHHHhcCCCC
Confidence            654322 22234456799999999999999999999999999999999999999742      23333444444333221


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhcc
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRP-TMSSVAVMLAS  580 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~  580 (624)
                      .   .......+    ..+.+++.+||+.||++|| |+++++..|.+
T Consensus       234 ~---~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 P---SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             G---GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             C---chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            1   11111222    3577899999999999999 89999887753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=376.07  Aligned_cols=262  Identities=23%  Similarity=0.299  Sum_probs=196.8

Q ss_pred             ccCccccCCceeEEEEEec-CCcEEEEEEccccCcc-----cHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          309 QENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ-----GLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       309 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ..++||+|+||+||+|+.+ +|+.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999975 5899999998654321     235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +.++++..++.   ....+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99988776652   3456888999999999999999999985   99999999999999999999999999987644322


Q ss_pred             CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch-
Q 006952          463 KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV-  540 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-  540 (624)
                        ......||+.|+|||++.+. .++.++|||||||++|||++|++||...   ...+.+..+.+...........+.. 
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~---~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC---CHHHHHHHHHHhcCCCChhhccchhc
Confidence              22345799999999998754 5799999999999999999999987421   1222222232222111111110000 


Q ss_pred             ------hh--cCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhccC
Q 006952          541 ------VK--QSCDQ-----AELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLASD  581 (624)
Q Consensus       541 ------l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~  581 (624)
                            ..  ...+.     .....+.+|+.+||+.||++|||++|+++  +++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                  00  00011     11235788999999999999999999987  46543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-46  Score=380.33  Aligned_cols=244  Identities=24%  Similarity=0.309  Sum_probs=203.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||+||+++.+ +|+.||||++++.   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 5899999998753   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999988854   345788899999999999999999985   999999999999999999999999999876432


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||.-      .+..+...+..... .. + .  
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~i~~~~-~~-~-p--  221 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD------SNTMKTYEKILNAE-LR-F-P--  221 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC------SSHHHHHHHHHHCC-CC-C-C--
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC------cCHHHHHHHHHcCC-CC-C-C--
Confidence                 2346899999999999999999999999999999999999999742      22233333322221 11 1 0  


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRP-----TMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  576 (624)
                        ...    ...+.+++.+||+.||++||     |++++++
T Consensus       222 --~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 --PFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --TTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              111    23477889999999999996     8999976

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.2e-45  Score=366.55  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=201.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcc---------cHHHHHHHHHHHHhcC-CCCcceEEeEEEec
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQ---------GLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEE  373 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~  373 (624)
                      ++|+..+.||+|+||+||+++.. +|+.||||++.+....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67999999999999999999974 6889999998764321         2346889999999997 99999999999999


Q ss_pred             CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccc
Q 006952          374 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGM  453 (624)
Q Consensus       374 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  453 (624)
                      +..+|||||+++|+|.+++..   ...+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954   346899999999999999999999985   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMG------GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL  527 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~  527 (624)
                      ++.+....   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.-      .+..... +.
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~------~~~~~~~-~~  226 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH------RKQMLML-RM  226 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHH-HH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC------CCHHHHH-HH
Confidence            98775432   2234679999999999853      3468899999999999999999999742      1222222 22


Q ss_pred             HhcCCccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          528 WCEGHAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       528 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ...+... ...+. ....+    ..+.+++.+||+.||++|||+.||++
T Consensus       227 i~~~~~~-~~~~~-~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSGNYQ-FGSPE-WDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHTCCC-CCTTT-GGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC-CCCcc-cccCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2222221 11111 11222    35778999999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=371.19  Aligned_cols=251  Identities=19%  Similarity=0.266  Sum_probs=203.2

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      .++|++.+.||+|+||+||+|+.+ +++.||||+++.... ....+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999976 588999999976543 345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC--CCeEEeccccccccCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE--MNPKISDFGMARIFGGN  460 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~  460 (624)
                      +++|+|.+++..  ....+++.++..|+.||++||.|||+++   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999853  2346899999999999999999999985   9999999999999854  47999999999876432


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...      +............ ..  ++..
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~------~~~~~~~~i~~~~-~~--~~~~  225 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMNAE-YT--FDEE  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTC-CC--CCHH
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCC-CC--CChh
Confidence            2   233467899999999999999999999999999999999999997421      2222222222211 10  1111


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .....+    ..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AFKEIS----IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111122    24678999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-45  Score=378.70  Aligned_cols=244  Identities=21%  Similarity=0.252  Sum_probs=203.8

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~  380 (624)
                      ++|++.+.||+|+||.||+++.+ +|+.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 6899999998653   2345678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGN  460 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  460 (624)
                      ||+.+|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999998854   346899999999999999999999985   999999999999999999999999999876432


Q ss_pred             CCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          461 QSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       461 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||..      .+......+..... .. ..   
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~------~~~~~~~~~i~~~~-~~-~p---  258 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------DQPIQIYEKIVSGK-VR-FP---  258 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHHHHCC-CC-CC---
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC------cCHHHHHHHHhcCC-CC-CC---
Confidence                 2346799999999999999999999999999999999999999742      22333333322221 11 00   


Q ss_pred             hhcCCCHHHHHHHHHHHhhcccCCCCCC-----CCHHHHHH
Q 006952          541 VKQSCDQAELLKYIHIGLLCVQGDPIDR-----PTMSSVAV  576 (624)
Q Consensus       541 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~ev~~  576 (624)
                        ...    ...+.+++.+||+.||.+|     ||+++|++
T Consensus       259 --~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 --SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --ccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              112    2347788999999999999     48999976

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=375.79  Aligned_cols=247  Identities=24%  Similarity=0.342  Sum_probs=200.7

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEcccc---CcccHHHHHHHHHHHH-hcCCCCcceEEeEEEecCcceEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTVIA-KLQHKNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lV  379 (624)
                      ++|.+.+.||+|+||+||+|+.+ +++.||||++++.   .....+.+..|+.++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999976 5889999999753   2344566777877765 68999999999999999999999


Q ss_pred             EEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCC
Q 006952          380 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGG  459 (624)
Q Consensus       380 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  459 (624)
                      |||+++|+|.+++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   345889999999999999999999985   99999999999999999999999999986543


Q ss_pred             CCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS  539 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  539 (624)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..      .+..+..... ..+.. .+.  
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i-~~~~~-~~p--  223 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------QDEEELFHSI-RMDNP-FYP--  223 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------SSHHHHHHHH-HHCCC-CCC--
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC------CCHHHHHHHH-HcCCC-CCC--
Confidence            32  223346799999999999999999999999999999999999999742      1222222222 22211 110  


Q ss_pred             hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHH-HHHH
Q 006952          540 VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMS-SVAV  576 (624)
Q Consensus       540 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~~  576 (624)
                         ...    ...+.+|+.+||+.||++|||+. +|++
T Consensus       224 ---~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 ---RWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---TTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---ccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               112    23477889999999999999995 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.6e-45  Score=379.90  Aligned_cols=248  Identities=25%  Similarity=0.273  Sum_probs=196.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC---cccHHHHH---HHHHHHHhcCCCCcceEEeEEEecCcce
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS---GQGLQEFK---NEVTVIAKLQHKNLVRLLGCCLEENESL  377 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~---~Ei~~l~~l~h~niv~l~~~~~~~~~~~  377 (624)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.+..   ......+.   +|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999975 58999999986432   12223333   4567777788999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +||||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999854   346889999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAEL  536 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (624)
                      ....    .....||+.|+|||++.. ..++.++|||||||++|||++|+.||....   ........... ... ....
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~-~~~-~~~~  228 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK---TKDKHEIDRMT-LTM-AVEL  228 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC---SSCHHHHHHHS-SSC-CCCC
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc-ccC-CCCC
Confidence            5432    334679999999999975 468999999999999999999999975322   22222222111 111 1111


Q ss_pred             ccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          537 MDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       537 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                      .     ...+    ..+.+|+.+||+.||++|||     ++|+++
T Consensus       229 ~-----~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         229 P-----DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             C-----SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             C-----CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            1     1122    34778999999999999999     688864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=365.93  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             cCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999996 468999999986543  2346788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      |+.++.+.....  .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            997655544332  23456999999999999999999999985   9999999999999999999999999998765433


Q ss_pred             CCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccch
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDSV  540 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  540 (624)
                      .  ......||+.|+|||.+.... ++.++||||+||++|||++|+.||...   ...+....+.+....... ......
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~~  230 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD---SEIDQLFRIFRTLGTPDE-VVWPGV  230 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCT-TTSTTG
T ss_pred             c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC---CHHHHHHHHHHhcCCCch-hhcccc
Confidence            2  233457999999999887765 588999999999999999999997521   111112222111111110 000000


Q ss_pred             h----------h-cCCC-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hccC
Q 006952          541 V----------K-QSCD-----QAELLKYIHIGLLCVQGDPIDRPTMSSVAVM--LASD  581 (624)
Q Consensus       541 l----------~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~  581 (624)
                      .          . ...+     ......+.+++.+||+.||++|||++|+++.  ++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            0          0 0000     0112357788999999999999999999884  5433

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=372.37  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=195.1

Q ss_pred             hcCccccC-ccccCCceeEEEEEe-cCCcEEEEEEccccCcccHHHHHHHHHHHHhc-CCCCcceEEeEEEe----cCcc
Q 006952          304 TQDFSQEN-KLGEGGFGPVYKGVL-ADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKL-QHKNLVRLLGCCLE----ENES  376 (624)
Q Consensus       304 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~~  376 (624)
                      .++|.+.+ .||+|+||.||+|+. .+++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788765 599999999999996 46899999998642     5678899987665 89999999999876    3557


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEecccc
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGM  453 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  453 (624)
                      ++||||+++|+|.+++... ....+++.++..|+.||+.||+|||+.+   |+||||||+|||+++   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999642 2346999999999999999999999985   999999999999986   45799999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      ++......   ......||+.|||||++.+..++.++|||||||++|||++|+.||.-....   .....+......+..
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~---~~~~~~~~~i~~~~~  234 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKTRIRMGQY  234 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH---HHHHHHHHHHhcCCC
Confidence            98765432   223467999999999999999999999999999999999999997422211   111111110100100


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                       .+..+. .    .....++.+|+.+||+.||++|||+.|+++
T Consensus       235 -~~~~~~-~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 -EFPNPE-W----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -SCCTTH-H----HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCCCcc-c----ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             000000 0    112345788999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.7e-44  Score=362.55  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=199.7

Q ss_pred             cCccccCccccCCceeEEEEEecCCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~Ey  382 (624)
                      ++|...++||+|+||+||+|+.++|+.||||++....  ....+.+.+|+.+|++++||||+++++++..++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999999999999999986543  33467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQS  462 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  462 (624)
                      +.++.+..+..   ....+++..+..|+.||++||+|||+.+   |+||||||+|||++.++.+||+|||.+........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            99887777663   3456999999999999999999999985   99999999999999999999999999987644322


Q ss_pred             CccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc--
Q 006952          463 KANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMDS--  539 (624)
Q Consensus       463 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--  539 (624)
                        ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...   ...+....+.............+.  
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC---CHHHHHHHHHHhhCCCChhhccchhh
Confidence              23345689999999998764 5699999999999999999999997421   111122222222111111110000  


Q ss_pred             -------------hhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          540 -------------VVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       540 -------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                   .............+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                         0000001111235778999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=361.55  Aligned_cols=239  Identities=24%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc------ccHHHHHHHHHHHHhcC--CCCcceEEeEEEecCc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG------QGLQEFKNEVTVIAKLQ--HKNLVRLLGCCLEENE  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~  375 (624)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++.+...      ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999965 689999999865321      12244678999999996  8999999999999999


Q ss_pred             ceEEEEeccC-CChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCC-CCeEEecccc
Q 006952          376 SLLIYEYMPN-KSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHE-MNPKISDFGM  453 (624)
Q Consensus       376 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~  453 (624)
                      .++||||+.+ +++.+++..   ...+++.++..++.||++||.|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 567777643   346899999999999999999999985   9999999999999854 7899999999


Q ss_pred             ccccCCCCCCccccccccccCccChhhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 006952          454 ARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIF-SVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH  532 (624)
Q Consensus       454 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  532 (624)
                      ++.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...         ..+   .. +.
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i---~~-~~  220 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEI---IR-GQ  220 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHH---HH-CC
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHH---hh-cc
Confidence            9865432    2234679999999999987765 67799999999999999999997521         011   11 11


Q ss_pred             ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          533 AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       533 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .      ......+    .++.+++.+||+.||++|||++|+++
T Consensus       221 ~------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 V------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0      0111222    34778899999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-43  Score=357.91  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=194.7

Q ss_pred             hcCccccCccccCCceeEEEEEec-C-CcEEEEEEccccC--cccHHHHHHHHHHHHhc---CCCCcceEEeEEEec---
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-D-GKEIAVKRLSRTS--GQGLQEFKNEVTVIAKL---QHKNLVRLLGCCLEE---  373 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~---  373 (624)
                      .++|++.+.||+|+||+||+|+.. + ++.||||+++...  ......+.+|+.+++.|   +||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999964 4 5679999986532  22234566788877766   799999999998642   


Q ss_pred             --CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecc
Q 006952          374 --NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDF  451 (624)
Q Consensus       374 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  451 (624)
                        ...+++|||+.++++.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence              35789999999887765443  24456899999999999999999999985   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          452 GMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       452 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||...   ...+.+..+.......
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCC
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC---CHHHHHHHHHHhhCCC
Confidence            998754322   2334568999999999999999999999999999999999999997522   1111222222211111


Q ss_pred             Cccccc------cchh-------hcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          532 HAAELM------DSVV-------KQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       532 ~~~~~~------d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ......      ....       ...........+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            100000      0000       00011111234678899999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=361.93  Aligned_cols=258  Identities=24%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             CccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------cceE
Q 006952          306 DFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------ESLL  378 (624)
Q Consensus       306 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~l  378 (624)
                      +|+..++||+|+||+||+|+.. +|+.||||++......    ..+|+.+|++++||||+++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999999975 5899999999765432    347999999999999999999986532      3689


Q ss_pred             EEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEecccccccc
Q 006952          379 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIF  457 (624)
Q Consensus       379 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~  457 (624)
                      ||||++++.+..+.........+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987765554433344567999999999999999999999985   99999999999999775 8999999999876


Q ss_pred             CCCCCCccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHH--------
Q 006952          458 GGNQSKANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLW--------  528 (624)
Q Consensus       458 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  528 (624)
                      .....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....   .+.+..+.+..        
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCChHHhh
Confidence            44322   224579999999998865 5689999999999999999999999753211   11111111111        


Q ss_pred             ---hcC----CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          529 ---CEG----HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       529 ---~~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                         ...    .....................+.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000    000000000000111112335778899999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=357.17  Aligned_cols=265  Identities=21%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEcccc--CcccHHHHHHHHHHHHhcCCCCcceEEeEEEe--------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRT--SGQGLQEFKNEVTVIAKLQHKNLVRLLGCCLE--------  372 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------  372 (624)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++...  .....+.+.+|+.+|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999974 6899999998643  33456778999999999999999999999865        


Q ss_pred             cCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccc
Q 006952          373 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFG  452 (624)
Q Consensus       373 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  452 (624)
                      ....++||||+.++.+....   .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34578999999988776554   33456888999999999999999999985   9999999999999999999999999


Q ss_pred             cccccCCCCCC--ccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh
Q 006952          453 MARIFGGNQSK--ANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC  529 (624)
Q Consensus       453 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  529 (624)
                      +++.+......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.-   .........+.+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~---~~~~~~~~~i~~~~~  239 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCG  239 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC---CCHHHHHHHHHHhcC
Confidence            99876543221  223345799999999998765 689999999999999999999999742   111122222222221


Q ss_pred             cCCc---ccccc--------chhhcCCCHHH-------HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          530 EGHA---AELMD--------SVVKQSCDQAE-------LLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       530 ~~~~---~~~~d--------~~l~~~~~~~~-------~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ....   .....        ..........+       ...+++|+.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1110   00000        00000001111       2245678999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-42  Score=350.57  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=194.3

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCcceE-EeEEEecCcceEEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNLVRL-LGCCLEENESLLIYEY  382 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l-~~~~~~~~~~~lV~Ey  382 (624)
                      ++|++.+.||+|+||.||+|++. +|+.||||++......  +++..|++++++++|+|++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999964 5889999988764432  457889999999987765554 5555667778899999


Q ss_pred             ccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC---CCCeEEeccccccccCC
Q 006952          383 MPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH---EMNPKISDFGMARIFGG  459 (624)
Q Consensus       383 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~  459 (624)
                      +. ++|...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++.+..
T Consensus        85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 555555533  2346899999999999999999999986   999999999999854   55799999999998754


Q ss_pred             CCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 006952          460 NQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAA  534 (624)
Q Consensus       460 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (624)
                      ....     .......||+.|||||.+.+..++.++||||||+++|||++|+.||.......................  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--  236 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  236 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence            3321     223456799999999999999999999999999999999999999864433332222211111110111  


Q ss_pred             ccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          535 ELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       535 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                         .+.+...++    ..+.+++..||+.+|++||++.+|.+.|+.
T Consensus       237 ---~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         237 ---IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ---HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ---hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence               111112222    347788899999999999999999888864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-41  Score=344.80  Aligned_cols=260  Identities=17%  Similarity=0.224  Sum_probs=202.6

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcCC-CCcceEEeEEEecCcceEEEE
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQH-KNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lV~E  381 (624)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.....  ...+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999965 588999998865433  2457789999999965 899999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcC-----CCCeEEeccccccc
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDH-----EMNPKISDFGMARI  456 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~  456 (624)
                      |+ +++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 68998887543  345899999999999999999999985   999999999999974     56799999999987


Q ss_pred             cCCCCCC-----ccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 006952          457 FGGNQSK-----ANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEG  531 (624)
Q Consensus       457 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  531 (624)
                      +......     .......||+.|||||++.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6543221     22345679999999999999999999999999999999999999985333322211111111111111


Q ss_pred             CccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhcc
Q 006952          532 HAAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVMLAS  580 (624)
Q Consensus       532 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  580 (624)
                      ...     .+...++    .++.+++..|++.+|++||+++.+.+.|+.
T Consensus       236 ~~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ChH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            111     1112233    347778889999999999999998887765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=352.01  Aligned_cols=271  Identities=23%  Similarity=0.293  Sum_probs=193.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC------
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN------  374 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  374 (624)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+.+|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999965 58999999997543  334567889999999999999999999998755      


Q ss_pred             cceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccc
Q 006952          375 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMA  454 (624)
Q Consensus       375 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  454 (624)
                      +.++||||+ +.+|..++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 5677776632    45999999999999999999999985   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccccCccChhhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCC-
Q 006952          455 RIFGGNQSKANTNRVVGTYGYMAPEYAMGG-IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGH-  532 (624)
Q Consensus       455 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  532 (624)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|||++|+.||....   ....+........... 
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---HLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC---hHHHHHHHHhccCCCcH
Confidence            876432     2346789999999998764 56899999999999999999999974221   1111111111110000 


Q ss_pred             -----------------ccccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hccCCCCCCCCCCC
Q 006952          533 -----------------AAELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAVM--LASDILTLPKPTQP  591 (624)
Q Consensus       533 -----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~~~~~p~~p  591 (624)
                                       ..+.....+. .........+.+|+.+||+.||++|||+.|+++.  ++.....-.+|..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~  317 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ  317 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred             HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC
Confidence                             0000000000 0001112346788999999999999999999874  55433333334433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-42  Score=354.17  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=195.7

Q ss_pred             hcCccccCccccCCceeEEEEEe-cCCcEEEEEEccccC-cccHHHHHHHHHHHHhcCCCCcceEEeEEEecC----cce
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEEN----ESL  377 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~  377 (624)
                      +.+|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999986 479999999997544 334567899999999999999999999997654    245


Q ss_pred             EEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccccc
Q 006952          378 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIF  457 (624)
Q Consensus       378 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  457 (624)
                      +++||+.+|+|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66778889999999853    35899999999999999999999985   999999999999999999999999999876


Q ss_pred             CCCCC-CccccccccccCccChhhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 006952          458 GGNQS-KANTNRVVGTYGYMAPEYAMG-GIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAE  535 (624)
Q Consensus       458 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (624)
                      ..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||.-..   ..+................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC---HHHHHHHHhhhccCCChhh
Confidence            43322 222345679999999999854 567899999999999999999999974211   1111111111111110000


Q ss_pred             ccc-----------chh-hcCCCH-----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 006952          536 LMD-----------SVV-KQSCDQ-----AELLKYIHIGLLCVQGDPIDRPTMSSVAVM  577 (624)
Q Consensus       536 ~~d-----------~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  577 (624)
                      ...           ... ....+.     ....++.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000           000 000000     011357789999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=343.98  Aligned_cols=262  Identities=21%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEecCcceEEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEENESLLIYE  381 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lV~E  381 (624)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999965 68899999986543  3446788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEeccccccccCCCC
Q 006952          382 YMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMARIFGGNQ  461 (624)
Q Consensus       382 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  461 (624)
                      ++.+++|..++..   ...+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999999887743   346789999999999999999999985   9999999999999999999999999998765433


Q ss_pred             CCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc--
Q 006952          462 SKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHAAELMD--  538 (624)
Q Consensus       462 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  538 (624)
                      .  ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.|+.  ......+....+..............  
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC--CCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            2  222345788999999987765 6999999999999999999999963  22222222222222222111110000  


Q ss_pred             c-----------hhh--cCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          539 S-----------VVK--QSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       539 ~-----------~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      .           ...  ..........+.+|+.+||+.||.+|||++||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0           000  0011111235678889999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=349.60  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             cCccccCccccCCceeEEEEEec----CCcEEEEEEccccC----cccHHHHHHHHHHHHhcCC-CCcceEEeEEEecCc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA----DGKEIAVKRLSRTS----GQGLQEFKNEVTVIAKLQH-KNLVRLLGCCLEENE  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~  375 (624)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++++..    ....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    47899999986532    2345678899999999966 899999999999999


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .+++|||+.+|+|.+++...   ..+.+.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   34678888999999999999999985   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGG--IFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA  533 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  533 (624)
                      .+..... .......|++.|++||.+.+.  .++.++|||||||+||||++|+.||......  ..........+. ...
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~~~-~~~  253 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILK-SEP  253 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHH-CCC
T ss_pred             hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhccc-CCC
Confidence            7643322 223346799999999999765  4688999999999999999999997533222  222222222221 111


Q ss_pred             cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 006952          534 AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPT-----MSSVAV  576 (624)
Q Consensus       534 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  576 (624)
                      .          .+.....++.+++.+||+.||++|||     ++|+++
T Consensus       254 ~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 P----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             C----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             C----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1          11122345778899999999999994     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-40  Score=342.66  Aligned_cols=255  Identities=21%  Similarity=0.294  Sum_probs=193.4

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEec--CcceEEE
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEE--NESLLIY  380 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lV~  380 (624)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++..   ..+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            67999999999999999999974 6889999998753   3467899999999995 99999999999854  4588999


Q ss_pred             EeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCC-CeEEeccccccccCC
Q 006952          381 EYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEM-NPKISDFGMARIFGG  459 (624)
Q Consensus       381 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  459 (624)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997654      24899999999999999999999986   99999999999998765 589999999987654


Q ss_pred             CCCCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH---------Hh
Q 006952          460 NQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKL---------WC  529 (624)
Q Consensus       460 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~  529 (624)
                      ..   ......||+.|+|||.+.+.. ++.++||||+|+++|||++|+.||......  .+....+.+.         ..
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhh
Confidence            32   233467899999999987754 799999999999999999999997532221  1111111100         00


Q ss_pred             cCCc---cccc-----------cchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 EGHA---AELM-----------DSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ~~~~---~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                      ....   ....           ..............++.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000   0000           000000000111234778899999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=344.65  Aligned_cols=275  Identities=22%  Similarity=0.283  Sum_probs=201.5

Q ss_pred             hcCccccCccccCCceeEEEEEec-CCcEEEEEEccccCc--ccHHHHHHHHHHHHhcCCCCcceEEeEEEec-----Cc
Q 006952          304 TQDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE-----NE  375 (624)
Q Consensus       304 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  375 (624)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.+...  ...+.+.+|+.+|++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999964 699999999976433  3456788999999999999999999998743     34


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++++||+.+|+|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5788889999999998843    35999999999999999999999986   9999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHhcCCc-
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGI-FSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWCEGHA-  533 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  533 (624)
                      ...     .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...   +.......+.+....... 
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~---~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT---DHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCHH
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCChH
Confidence            542     2233467899999999877654 689999999999999999999997421   111111111111110000 


Q ss_pred             -----------------cccccchhhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhccCCCCCCCCCCCccc
Q 006952          534 -----------------AELMDSVVKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSSVAV--MLASDILTLPKPTQPAFS  594 (624)
Q Consensus       534 -----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~~~~p~~p~~~  594 (624)
                                       .......+... .......+.+|+.+||+.||++|||+.|+++  ++......-++|..++|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~  320 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD  320 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCC
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCC
Confidence                             00000000000 0011234678899999999999999999987  565544444445444443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-40  Score=343.25  Aligned_cols=257  Identities=24%  Similarity=0.299  Sum_probs=186.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccC--cccHHHHHHHHHHHHhcCCCCcceEEeEEEec------Cc
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTVIAKLQHKNLVRLLGCCLEE------NE  375 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  375 (624)
                      ++|++.++||+|+||+||+|+.. +|+.||||++....  ....+++.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999976 58999999997543  33456788999999999999999999999643      56


Q ss_pred             ceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          376 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       376 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      .++||||+.++.+..+.      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            79999999776554432      34889999999999999999999986   9999999999999999999999999988


Q ss_pred             ccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHHh------
Q 006952          456 IFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYIWKLWC------  529 (624)
Q Consensus       456 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  529 (624)
                      ......   ......||+.|+|||++.+..++.++||||+||+++||++|+.||....   .......+.....      
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~---~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHH
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC---HHHHHHHHHHhccCCCHHH
Confidence            654322   2335678999999999999999999999999999999999999974211   1111111110000      


Q ss_pred             ------------cCCc-------cccccchhhcCC---CHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 006952          530 ------------EGHA-------AELMDSVVKQSC---DQAELLKYIHIGLLCVQGDPIDRPTMSSVAV  576 (624)
Q Consensus       530 ------------~~~~-------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  576 (624)
                                  ....       ............   .......+.+|+.+||+.||++|||++||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        0000       000111111111   1223456788999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-36  Score=316.62  Aligned_cols=282  Identities=18%  Similarity=0.228  Sum_probs=199.9

Q ss_pred             cCccccCccccCCceeEEEEEec-CCcEEEEEEccccCcccHHHHHHHHHHHHhcC-----------CCCcceEEeEEEe
Q 006952          305 QDFSQENKLGEGGFGPVYKGVLA-DGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-----------HKNLVRLLGCCLE  372 (624)
Q Consensus       305 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~  372 (624)
                      .+|++.++||+|+||+||+|+.. +|+.||||++++... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999974 689999999975432 3466788999988875           5789999999865


Q ss_pred             c--CcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCC-----
Q 006952          373 E--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMN-----  445 (624)
Q Consensus       373 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----  445 (624)
                      .  ....++++++..+..............+++..+..++.||++||.|||+..  +|+||||||+||||+.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence            4  456677777766654444433445567899999999999999999999832  5999999999999987654     


Q ss_pred             -eEEeccccccccCCCCCCccccccccccCccChhhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH
Q 006952          446 -PKISDFGMARIFGGNQSKANTNRVVGTYGYMAPEYAMGGIFSVKSDVFSFGVVLLEIISGKKSTGFYHSEHGPSLLAYI  524 (624)
Q Consensus       446 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~  524 (624)
                       ++++|||.+......     .....||+.|+|||++.+..++.++||||+|++++||++|+.||...............
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             899999998765322     23467999999999999999999999999999999999999998643322222111111


Q ss_pred             HHHH-hcCCc--------------------ccccc--------ch--hhcCCCHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 006952          525 WKLW-CEGHA--------------------AELMD--------SV--VKQSCDQAELLKYIHIGLLCVQGDPIDRPTMSS  573 (624)
Q Consensus       525 ~~~~-~~~~~--------------------~~~~d--------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  573 (624)
                      .... .-+..                    ...+.        ..  ............+.+|+.+||+.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1110 00000                    00000        00  011234556678899999999999999999999


Q ss_pred             HHHH--hccC--CCCCCCCCCCccc
Q 006952          574 VAVM--LASD--ILTLPKPTQPAFS  594 (624)
Q Consensus       574 v~~~--L~~~--~~~~~~p~~p~~~  594 (624)
                      +++.  ++..  ..+...|.+|.+.
T Consensus       325 ~L~Hp~f~~~~~~~~~~~p~~~~~~  349 (362)
T d1q8ya_         325 LVNHPWLKDTLGMEEIRVPDRELYG  349 (362)
T ss_dssp             HHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred             HhcCcccCCCCCcccCCCCCcccCC
Confidence            9873  4421  3334445555443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=5.6e-23  Score=193.31  Aligned_cols=163  Identities=19%  Similarity=0.195  Sum_probs=119.8

Q ss_pred             cccCccccCCceeEEEEEecCCcEEEEEEccccCc------------------ccHHHHHHHHHHHHhcCCCCcceEEeE
Q 006952          308 SQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSG------------------QGLQEFKNEVTVIAKLQHKNLVRLLGC  369 (624)
Q Consensus       308 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv~l~~~  369 (624)
                      .+.++||+|+||.||+|+..+|++||||+++....                  .......+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35689999999999999998999999998653210                  012334568899999999999988765


Q ss_pred             EEecCcceEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEcCCCCeEEe
Q 006952          370 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDSRLKIIHRDLKTSNVLLDHEMNPKIS  449 (624)
Q Consensus       370 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  449 (624)
                      .    ..+++|||+++..+..          +++.....++.|++++|.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998876543          233345678999999999999985   9999999999999965 59999


Q ss_pred             ccccccccCCCCCCccccccccccCccC------hhhhcCCCCChhhHHHHHHHHH
Q 006952          450 DFGMARIFGGNQSKANTNRVVGTYGYMA------PEYAMGGIFSVKSDVFSFGVVL  499 (624)
Q Consensus       450 Dfg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDv~S~Gvil  499 (624)
                      |||++.....+...          .|..      .|.+ ...|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            99999765322211          1111      1111 35578889999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=6.1e-08  Score=93.54  Aligned_cols=149  Identities=17%  Similarity=0.113  Sum_probs=106.4

Q ss_pred             HHHHHHhcCccccCccccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcc
Q 006952          298 IDIVKATQDFSQENKLGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENES  376 (624)
Q Consensus       298 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  376 (624)
                      +++.+..+.|+..+..+.+..+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35566667787776655566678999865 56778889887665555556788999988874 44467888888888888


Q ss_pred             eEEEEeccCCChhhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 006952          377 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIKGIARGILYLHEDS--------------------------------  424 (624)
Q Consensus       377 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------  424 (624)
                      ++||+++++..+.+......        ....++.++++.+..||+..                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            99999999988865442211        12234556666666666421                                


Q ss_pred             ------------------------CCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          425 ------------------------RLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       425 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                                              ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    1127999999999999987666799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.08  E-value=1.2e-05  Score=76.42  Aligned_cols=130  Identities=17%  Similarity=0.147  Sum_probs=87.0

Q ss_pred             ccccCCc-eeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcC--CCCcceEEeEEEecCcceEEEEeccCCCh
Q 006952          312 KLGEGGF-GPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ--HKNLVRLLGCCLEENESLLIYEYMPNKSL  388 (624)
Q Consensus       312 ~lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lV~Ey~~~gsL  388 (624)
                      .+..|.. +.||+...+++..+++|.......   ..+..|...++.+.  .-.+.+++.+..+++..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 678999988888899997654432   34677888888774  33356788888888888999999998776


Q ss_pred             hhhhhcCCCCcccCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 006952          389 DVFLFDSTRSVQLDWKRRISIIKGIARGILYLHE----------------------------------------------  422 (624)
Q Consensus       389 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~----------------------------------------------  422 (624)
                      .+..        ...   ..++.++++.|.-||+                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        010   1112233333333332                                              


Q ss_pred             -----c----CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          423 -----D----SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       423 -----~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                           .    ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 1    12237999999999999987667899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.65  E-value=8.1e-05  Score=75.56  Aligned_cols=75  Identities=11%  Similarity=0.226  Sum_probs=49.3

Q ss_pred             CccccCCceeEEEEEecC-CcEEEEEEcccc-------CcccHHHHHHHHHHHHhc-CC--CCcceEEeEEEecCcceEE
Q 006952          311 NKLGEGGFGPVYKGVLAD-GKEIAVKRLSRT-------SGQGLQEFKNEVTVIAKL-QH--KNLVRLLGCCLEENESLLI  379 (624)
Q Consensus       311 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l-~h--~niv~l~~~~~~~~~~~lV  379 (624)
                      +.||.|....||+....+ ++.++||.-...       ......+...|...|+.+ .+  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 678999964321       112334556788888776 23  345555543  55677899


Q ss_pred             EEeccCCC
Q 006952          380 YEYMPNKS  387 (624)
Q Consensus       380 ~Ey~~~gs  387 (624)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.03  E-value=0.0008  Score=66.05  Aligned_cols=135  Identities=13%  Similarity=0.152  Sum_probs=77.6

Q ss_pred             eeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc--ceEE-----eEEEecCcceEEEEeccCCChhhh
Q 006952          319 GPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL--VRLL-----GCCLEENESLLIYEYMPNKSLDVF  391 (624)
Q Consensus       319 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~~  391 (624)
                      -.||+...++|+.+++|...... ...+++..|...+..|....+  +..+     ..+...+..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999999999999876542 245677889988888742222  1111     122345567889999887543210


Q ss_pred             ----h----------h----c--CCCCcccCHHH-------------------HHHHHHHHHHHHHHHHh----cCCCCe
Q 006952          392 ----L----------F----D--STRSVQLDWKR-------------------RISIIKGIARGILYLHE----DSRLKI  428 (624)
Q Consensus       392 ----l----------~----~--~~~~~~l~~~~-------------------~~~i~~qia~~L~yLH~----~~~~~i  428 (624)
                          +          +    .  ......+++..                   ...+...+.+.+..+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0          0    0  01111222111                   11112222223333322    223458


Q ss_pred             EecCCCCCcEEEcCCCCeEEeccccccc
Q 006952          429 IHRDLKTSNVLLDHEMNPKISDFGMARI  456 (624)
Q Consensus       429 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~  456 (624)
                      +|+|+.+.|||++++  ..++||+.+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  56899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.80  E-value=0.0022  Score=64.53  Aligned_cols=73  Identities=14%  Similarity=0.178  Sum_probs=50.7

Q ss_pred             cCccccCCceeEEEEEecCC--------cEEEEEEccccCcccHHHHHHHHHHHHhcC-CCCcceEEeEEEecCcceEEE
Q 006952          310 ENKLGEGGFGPVYKGVLADG--------KEIAVKRLSRTSGQGLQEFKNEVTVIAKLQ-HKNLVRLLGCCLEENESLLIY  380 (624)
Q Consensus       310 ~~~lG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lV~  380 (624)
                      .+.|+.|-.=.+|+...+++        +.|.+++... .. ......+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            35788888899999986543        4566666553 22 2345578999999884 5444577777642    6899


Q ss_pred             EeccCCCh
Q 006952          381 EYMPNKSL  388 (624)
Q Consensus       381 Ey~~~gsL  388 (624)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.15  E-value=0.0071  Score=58.51  Aligned_cols=158  Identities=13%  Similarity=0.042  Sum_probs=81.0

Q ss_pred             CCHHHHHHHhcCccccCc-----cccCCceeEEEEEecCCcEEEEEEccccCcccHHHHHHHHHHHHhcCCCCc--ceEE
Q 006952          295 LDLIDIVKATQDFSQENK-----LGEGGFGPVYKGVLADGKEIAVKRLSRTSGQGLQEFKNEVTVIAKLQHKNL--VRLL  367 (624)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~  367 (624)
                      ++..++.....+|...+.     |..|---+.|+.+..+| .+++|+......  .+++..|+.++..|...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            456677777777766433     34555577899887654 589998865322  2345567777777742222  1111


Q ss_pred             e------EEEecCcceEEEEeccCCChhhhh--------------h----c--CCCCcccC--H----------------
Q 006952          368 G------CCLEENESLLIYEYMPNKSLDVFL--------------F----D--STRSVQLD--W----------------  403 (624)
Q Consensus       368 ~------~~~~~~~~~lV~Ey~~~gsL~~~l--------------~----~--~~~~~~l~--~----------------  403 (624)
                      -      +.........++.++.+.......              +    .  ........  +                
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      112233455666666654332110              0    0  00000000  0                


Q ss_pred             HHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEcCCCCeEEecccccc
Q 006952          404 KRRISIIKGIARGILYLHED-SRLKIIHRDLKTSNVLLDHEMNPKISDFGMAR  455 (624)
Q Consensus       404 ~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  455 (624)
                      ......+..+...+.-.+.. -+..+||+|+.++||+++++...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            01111222222222222211 12358999999999999988777899999875